Citrus Sinensis ID: 026115
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 243 | 2.2.26 [Sep-21-2011] | |||||||
| Q41328 | 354 | Pto-interacting protein 1 | N/A | no | 0.967 | 0.663 | 0.885 | 1e-116 | |
| O80719 | 365 | Probable receptor-like pr | no | no | 0.983 | 0.654 | 0.849 | 1e-113 | |
| O49339 | 366 | PTI1-like tyrosine-protei | no | no | 0.967 | 0.642 | 0.808 | 1e-107 | |
| Q8H1G6 | 361 | PTI1-like tyrosine-protei | no | no | 0.967 | 0.650 | 0.804 | 1e-106 | |
| B9DFG5 | 408 | PTI1-like tyrosine-protei | no | no | 0.983 | 0.585 | 0.782 | 1e-105 | |
| P93749 | 365 | Probable protein kinase A | no | no | 0.991 | 0.660 | 0.739 | 1e-101 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.925 | 0.302 | 0.506 | 3e-59 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.921 | 0.316 | 0.485 | 4e-57 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.979 | 0.521 | 0.483 | 3e-56 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.925 | 0.543 | 0.480 | 2e-54 |
| >sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 419 bits (1076), Expect = e-116, Method: Compositional matrix adjust.
Identities = 208/235 (88%), Positives = 224/235 (95%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK+ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRV
Sbjct: 114 MVSRLKDENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRV 173
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAA+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHST
Sbjct: 174 KIAVGAAKGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHST 233
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+
Sbjct: 234 RVLGTFGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPR 293
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
LSEDKVKQCVD +L +YPPKAIAKMAAVAALCVQYEADFRPNM IV+KALQPLL
Sbjct: 294 LSEDKVKQCVDARLNTDYPPKAIAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 348
|
A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade. Solanum lycopersicum (taxid: 4081) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 407 bits (1047), Expect = e-113, Method: Compositional matrix adjust.
Identities = 203/239 (84%), Positives = 225/239 (94%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK++N V+L+GY VDG R+L+YE A+ GSLHDILHG+KGVKGA+PGPVLSW QRV
Sbjct: 119 MVSRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHGRKGVKGAQPGPVLSWYQRV 178
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAARGLEYLHEKA P IIHR+IKSSNVLLF+DD+AKI+DFDLSNQAPD AARLHST
Sbjct: 179 KIAVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKIADFDLSNQAPDMAARLHST 238
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDH LPRGQQSLVTWATPK
Sbjct: 239 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHRLPRGQQSLVTWATPK 298
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239
LSEDKVKQCVD +LGG+YPPKA+AK+AAVAALCVQYEADFRPNM IV+KALQPLLN R+
Sbjct: 299 LSEDKVKQCVDARLGGDYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNARA 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (995), Expect = e-107, Method: Compositional matrix adjust.
Identities = 190/235 (80%), Positives = 216/235 (91%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILHG+KGV+GA+PGP L W RV
Sbjct: 119 MVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLTRV 178
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AK++DF+LSNQAPD AARLHST
Sbjct: 179 KIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLHST 238
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+
Sbjct: 239 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 298
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
LSEDKVKQCVD KL GEYPPK++AK+AAVAALCVQYE++FRPNM IV+KALQPLL
Sbjct: 299 LSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLL 353
|
Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (985), Expect = e-106, Method: Compositional matrix adjust.
Identities = 189/235 (80%), Positives = 217/235 (92%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK+EN+++L+G+ VDG LRVLAYE A+ GSLHDILHG+KGV+GA+PGP L W RV
Sbjct: 116 MVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRV 175
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAV AARGLEYLHEK++P +IHR+I+SSNVLLF+D AKI+DF+LSNQAPD AARLHST
Sbjct: 176 KIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHST 235
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+
Sbjct: 236 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 295
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
LSEDKVKQC+D KL +YPPKA+AK+AAVAALCVQYEA+FRPNM IV+KALQPLL
Sbjct: 296 LSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 350
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 380 bits (976), Expect = e-105, Method: Compositional matrix adjust.
Identities = 187/239 (78%), Positives = 216/239 (90%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
VS+LK++N VEL GY V+G R+LAYE A+ GSLHDILHG+KGV+GA+PGP L W QRV+
Sbjct: 162 VSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVR 221
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
IAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AKI+DF+LSNQ+PD AARLHSTR
Sbjct: 222 IAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTR 281
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 181
VLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+L
Sbjct: 282 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 341
Query: 182 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
SEDKVKQCVD KL GEYPPKA+AK+AAVAALCVQYE++FRPNM IV+KALQPLL + +
Sbjct: 342 SEDKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRSSTA 400
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 368 bits (944), Expect = e-101, Method: Compositional matrix adjust.
Identities = 179/242 (73%), Positives = 221/242 (91%), Gaps = 1/242 (0%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+VSRLK+++ VEL+GY ++ R+L Y+ A+KGSLHD+LHG+KGV+GA+PGPVL+W QRV
Sbjct: 120 VVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRV 179
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIA GAA+GLE+LHEK +P I+HR+++SSNVLLFDD +AK++DF+L+N + D AARLHST
Sbjct: 180 KIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHST 239
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTWATP+
Sbjct: 240 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 299
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR-S 239
LSEDKVKQC+D KL ++PPKA+AK+AAVAALCVQYEADFRPNM IV+KALQPLLN++ +
Sbjct: 300 LSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 359
Query: 240 GP 241
GP
Sbjct: 360 GP 361
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 228 bits (581), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 120/237 (50%), Positives = 161/237 (67%), Gaps = 12/237 (5%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
M+SRL + N+V+L+G ++G R L YE GS+ LH L W R+
Sbjct: 396 MLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEG----------TLDWDARL 445
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIA+GAARGL YLHE + PR+IHR+ K+SNVLL DD K+SDF L+ +A + + + ST
Sbjct: 446 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI-ST 504
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RV+GTFGY APEYAMTG + KSDVYS+GVVLLELLTGR+PVD + P G+++LVTWA P
Sbjct: 505 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPL 564
Query: 181 LSE-DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236
L+ + ++Q VD L G Y +AK+AA+A++CV E RP MG V++AL+ + N
Sbjct: 565 LANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYN 621
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 4e-57, Method: Compositional matrix adjust.
Identities = 115/237 (48%), Positives = 156/237 (65%), Gaps = 13/237 (5%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+SR+ + ++V +VG+ + G R+L Y++ S L+ LHG+K V L WA RVK
Sbjct: 425 LSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSV--------LDWATRVK 476
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
IA GAARGL YLHE PRIIHR+IKSSN+LL D+ A++SDF L+ A D + +TR
Sbjct: 477 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHI-TTR 535
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 181
V+GTFGY APEYA +G+++ KSDV+SFGVVLLEL+TGRKPVD + P G +SLV WA P +
Sbjct: 536 VIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLI 595
Query: 182 SE----DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234
S ++ D KLGG Y + +M A CV++ A RP MG +++A + L
Sbjct: 596 SHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESL 652
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (555), Expect = 3e-56, Method: Compositional matrix adjust.
Identities = 118/244 (48%), Positives = 157/244 (64%), Gaps = 6/244 (2%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
M+S L + N+V L+GY DG R+L YE GSL D LH K A L W R+
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-----LDWNMRM 188
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIA GAA+GLE+LH+KA P +I+R+ KSSN+LL + K+SDF L+ P ST
Sbjct: 189 KIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVST 248
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RV+GT+GY APEYAMTGQ++ KSDVYSFGVV LEL+TGRK +D +P G+Q+LV WA P
Sbjct: 249 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPL 308
Query: 181 LSE-DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239
++ K + D +L G +P +A+ + AVA++C+Q +A RP + V+ AL L N
Sbjct: 309 FNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQAY 368
Query: 240 GPSK 243
PSK
Sbjct: 369 DPSK 372
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 112/233 (48%), Positives = 157/233 (67%), Gaps = 8/233 (3%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV-LSWAQR 59
M+S L ++++V L+GY DG R+L YE+ S+GSL D L P + L W R
Sbjct: 127 MLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHL------LDLTPDQIPLDWDTR 180
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
++IA+GAA GLEYLH+KA P +I+R++K++N+LL + AK+SDF L+ P + S
Sbjct: 181 IRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVS 240
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+RV+GT+GY APEY TGQ+++KSDVYSFGVVLLEL+TGR+ +D T P+ +Q+LVTWA P
Sbjct: 241 SRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQP 300
Query: 180 KLSE-DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231
E + + D L G +P KA+ + AVAA+C+Q EA RP M V+ AL
Sbjct: 301 VFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL 353
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 243 | ||||||
| 351727493 | 360 | Pti1 kinase-like protein [Glycine max] g | 1.0 | 0.675 | 0.872 | 1e-123 | |
| 351727899 | 360 | Pti1 kinase-like protein [Glycine max] g | 1.0 | 0.675 | 0.868 | 1e-122 | |
| 225432163 | 360 | PREDICTED: pto-interacting protein 1 [Vi | 0.987 | 0.666 | 0.908 | 1e-120 | |
| 449523892 | 433 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.991 | 0.556 | 0.842 | 1e-119 | |
| 449436713 | 362 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.991 | 0.665 | 0.842 | 1e-119 | |
| 226502883 | 357 | uncharacterized LOC100273920 [Zea mays] | 0.983 | 0.669 | 0.849 | 1e-119 | |
| 357442089 | 476 | Pto kinase interactor [Medicago truncatu | 0.995 | 0.508 | 0.863 | 1e-117 | |
| 374256007 | 360 | putative pto kinase interactor protein [ | 0.987 | 0.666 | 0.870 | 1e-117 | |
| 357442087 | 361 | Pto kinase interactor [Medicago truncatu | 0.995 | 0.670 | 0.863 | 1e-117 | |
| 359811321 | 361 | pto-interacting protein 1-like [Glycine | 0.995 | 0.670 | 0.863 | 1e-116 |
| >gi|351727493|ref|NP_001235115.1| Pti1 kinase-like protein [Glycine max] gi|9651969|gb|AAF91336.1|AF249317_1 Pti1 kinase-like protein [Glycine max] gi|255647015|gb|ACU23976.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 445 bits (1145), Expect = e-123, Method: Compositional matrix adjust.
Identities = 212/243 (87%), Positives = 229/243 (94%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+VSRLK+ENVVELV Y VDGP R LAYE+A KGSLHDILHG+KGVKGA+PGPVLSWAQRV
Sbjct: 113 IVSRLKHENVVELVNYCVDGPFRALAYEYAPKGSLHDILHGRKGVKGAQPGPVLSWAQRV 172
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAARGLEYLHEKAE IIHR IKSSN+LLFDDD+AKI+DFDLSNQAPDAAARLHST
Sbjct: 173 KIAVGAARGLEYLHEKAEIHIIHRYIKSSNILLFDDDVAKIADFDLSNQAPDAAARLHST 232
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ++SKSDVYSFGV+LLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 233 RVLGTFGYHAPEYAMTGQLTSKSDVYSFGVILLELLTGRKPVDHTLPRGQQSLVTWATPK 292
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
LSEDKVKQCVD +L GEYP K++AKMAAVAALCVQYEA+FRPNM I++KALQPLLNTRS
Sbjct: 293 LSEDKVKQCVDVRLKGEYPSKSVAKMAAVAALCVQYEAEFRPNMSIIVKALQPLLNTRSS 352
Query: 241 PSK 243
SK
Sbjct: 353 HSK 355
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727899|ref|NP_001235129.1| Pti1 kinase-like protein [Glycine max] gi|9651971|gb|AAF91337.1|AF249318_1 Pti1 kinase-like protein [Glycine max] gi|255641915|gb|ACU21226.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1140), Expect = e-122, Method: Compositional matrix adjust.
Identities = 211/243 (86%), Positives = 229/243 (94%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+VSRLK+ENVVELV Y VDGP R LAYE+A KGSLHDILHG+KGVKGA+PGPVLSWAQRV
Sbjct: 113 IVSRLKHENVVELVNYCVDGPFRALAYEYAPKGSLHDILHGRKGVKGAQPGPVLSWAQRV 172
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAARGLEYLHEKAE IIHR IKSSN+LLFDDD+AK++DFDLSNQAPDAAARLHST
Sbjct: 173 KIAVGAARGLEYLHEKAEIHIIHRYIKSSNILLFDDDVAKVADFDLSNQAPDAAARLHST 232
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ++SKSDVYSFGV+LLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 233 RVLGTFGYHAPEYAMTGQLTSKSDVYSFGVILLELLTGRKPVDHTLPRGQQSLVTWATPK 292
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
LSEDKVKQCVD +L GEYP K++AKMAAVAALCVQYEA+FRPNM I++KALQPLLNTRS
Sbjct: 293 LSEDKVKQCVDVRLKGEYPSKSVAKMAAVAALCVQYEAEFRPNMSIIVKALQPLLNTRSV 352
Query: 241 PSK 243
SK
Sbjct: 353 HSK 355
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432163|ref|XP_002267003.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297736804|emb|CBI26005.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1125), Expect = e-120, Method: Compositional matrix adjust.
Identities = 218/240 (90%), Positives = 232/240 (96%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLKNENVVELVGY VDG LRV+AYE+AS GSLHDILHG+KGVKGA+PGPVLSW+QRV
Sbjct: 116 MVSRLKNENVVELVGYSVDGGLRVVAYEYASNGSLHDILHGRKGVKGAQPGPVLSWSQRV 175
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAA+GLEYLHEKA P IIHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD+AARLHST
Sbjct: 176 KIAVGAAKGLEYLHEKARPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDSAARLHST 235
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 236 RVLGTFGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 295
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
LSEDKVKQCVDT+LGGEYPPKA+AKMAAVAALCVQYEADFRPNM IV+KALQPLLN R G
Sbjct: 296 LSEDKVKQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 355
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523892|ref|XP_004168957.1| PREDICTED: LOW QUALITY PROTEIN: probable receptor-like protein kinase At2g47060-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 434 bits (1117), Expect = e-119, Method: Compositional matrix adjust.
Identities = 203/241 (84%), Positives = 223/241 (92%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK++N + L+GY V G R+LAYE+AS GSLHDILHG+KGVKG++PGPVLSWAQRV
Sbjct: 186 MVSRLKHDNFLNLIGYCVGGNSRILAYEYASNGSLHDILHGRKGVKGSQPGPVLSWAQRV 245
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAA+GLEYLHEK +P I HR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHST
Sbjct: 246 KIAVGAAKGLEYLHEKVDPHITHRDIKSSNVLIFDDDLAKIADFDLSNQAPDMAARLHST 305
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ++SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 306 RVLGTFGYHAPEYAMTGQLNSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 365
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
L EDKVKQCVD KLG EYPPK++AK AAVAALCVQYEADFRPNM IV+KALQPLLN R G
Sbjct: 366 LCEDKVKQCVDAKLGNEYPPKSVAKFAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 425
Query: 241 P 241
P
Sbjct: 426 P 426
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449436713|ref|XP_004136137.1| PREDICTED: LOW QUALITY PROTEIN: probable receptor-like protein kinase At2g47060-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 433 bits (1114), Expect = e-119, Method: Compositional matrix adjust.
Identities = 203/241 (84%), Positives = 223/241 (92%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK++N + L+GY V G R+LAYE+AS GSLHDILHG+KGVKG++PGPVLSWAQRV
Sbjct: 115 MVSRLKHDNFLNLIGYCVGGNSRILAYEYASNGSLHDILHGRKGVKGSQPGPVLSWAQRV 174
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAA+GLEYLHEK +P I HR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHST
Sbjct: 175 KIAVGAAKGLEYLHEKVDPHITHRDIKSSNVLIFDDDLAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ++SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGQLNSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
L EDKVKQCVD KLG EYPPK++AK AAVAALCVQYEADFRPNM IV+KALQPLLN R G
Sbjct: 295 LCEDKVKQCVDAKLGNEYPPKSVAKFAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 354
Query: 241 P 241
P
Sbjct: 355 P 355
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|226502883|ref|NP_001141784.1| uncharacterized LOC100273920 [Zea mays] gi|194705910|gb|ACF87039.1| unknown [Zea mays] gi|413946812|gb|AFW79461.1| putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1111), Expect = e-119, Method: Compositional matrix adjust.
Identities = 203/239 (84%), Positives = 225/239 (94%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK+ NVVEL+GY VDG R+LAYE A+ GSLHD+LHG+KGVKGA+PGPVLSW QRV
Sbjct: 114 MVSRLKHGNVVELLGYCVDGNTRILAYEFATMGSLHDMLHGRKGVKGAQPGPVLSWTQRV 173
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAA+GLEYLHEKA+P IIHR+IKSSNVLLFDDD++KI+DFDLSNQAPD AARLHST
Sbjct: 174 KIAVGAAKGLEYLHEKAQPHIIHRDIKSSNVLLFDDDVSKIADFDLSNQAPDMAARLHST 233
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+
Sbjct: 234 RVLGTFGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPR 293
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239
L EDKV+QCVD++LG EYPPK++AK AAVAALCVQYEADFRPNM IV+KALQPLLN R+
Sbjct: 294 LCEDKVRQCVDSRLGVEYPPKSVAKFAAVAALCVQYEADFRPNMSIVVKALQPLLNARA 352
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442089|ref|XP_003591322.1| Pto kinase interactor [Medicago truncatula] gi|355480370|gb|AES61573.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1098), Expect = e-117, Method: Compositional matrix adjust.
Identities = 209/242 (86%), Positives = 231/242 (95%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK++N V+L+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRV
Sbjct: 230 MVSRLKHDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRV 289
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHST
Sbjct: 290 KIAVGAARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 349
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 350 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 409
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
LSEDKV+QCVDT+LGGEYPPKA+AKMAAVAALCVQYEADFRPNM IV+KALQPLL R+G
Sbjct: 410 LSEDKVRQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARAG 469
Query: 241 PS 242
P+
Sbjct: 470 PA 471
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|374256007|gb|AEZ00865.1| putative pto kinase interactor protein [Elaeis guineensis] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1095), Expect = e-117, Method: Compositional matrix adjust.
Identities = 209/240 (87%), Positives = 229/240 (95%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK+ENVVEL+GY ++G LRVLAYE A+ GSLHDILHG+KGVKGA+PGPVLSW QRV
Sbjct: 115 MVSRLKHENVVELIGYCLEGNLRVLAYEFATMGSLHDILHGRKGVKGAQPGPVLSWTQRV 174
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAA+GLEYLHEKA+P +IHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD AARLHST
Sbjct: 175 KIAVGAAKGLEYLHEKAQPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+SSKSDVYSFGV+LLELLTGRKPVDHTLPRGQQSLVTWATP+
Sbjct: 235 RVLGTFGYHAPEYAMTGQLSSKSDVYSFGVILLELLTGRKPVDHTLPRGQQSLVTWATPR 294
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
LSEDKV+QCVDT+L GEYPPKA+AK AAVAALCVQYE DFRPNM IV+KALQPLLNTRSG
Sbjct: 295 LSEDKVRQCVDTRLNGEYPPKAVAKFAAVAALCVQYEGDFRPNMSIVVKALQPLLNTRSG 354
|
Source: Elaeis guineensis Species: Elaeis guineensis Genus: Elaeis Family: Arecaceae Order: Arecales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442087|ref|XP_003591321.1| Pto kinase interactor [Medicago truncatula] gi|355480369|gb|AES61572.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 425 bits (1093), Expect = e-117, Method: Compositional matrix adjust.
Identities = 209/242 (86%), Positives = 231/242 (95%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK++N V+L+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRV
Sbjct: 115 MVSRLKHDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRV 174
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHST
Sbjct: 175 KIAVGAARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
LSEDKV+QCVDT+LGGEYPPKA+AKMAAVAALCVQYEADFRPNM IV+KALQPLL R+G
Sbjct: 295 LSEDKVRQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARAG 354
Query: 241 PS 242
P+
Sbjct: 355 PA 356
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359811321|ref|NP_001241285.1| pto-interacting protein 1-like [Glycine max] gi|223452480|gb|ACM89567.1| serine/threonine protein kinase [Glycine max] gi|255639418|gb|ACU20004.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1091), Expect = e-116, Method: Compositional matrix adjust.
Identities = 209/242 (86%), Positives = 230/242 (95%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MVSRLK+EN V+L+GY +DG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRV
Sbjct: 115 MVSRLKHENFVQLLGYCIDGSSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRV 174
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHST
Sbjct: 175 KIAVGAARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
LSEDKV+QCVDT+LGGEYPPKA+AKMAAVAALCVQYEADFRPNM IV+KALQPLL R G
Sbjct: 295 LSEDKVRQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARPG 354
Query: 241 PS 242
P+
Sbjct: 355 PA 356
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 243 | ||||||
| TAIR|locus:2088990 | 364 | AT3G17410 [Arabidopsis thalian | 0.991 | 0.662 | 0.789 | 1.7e-98 | |
| TAIR|locus:2098083 | 361 | AT3G62220 [Arabidopsis thalian | 0.995 | 0.670 | 0.768 | 1.2e-97 | |
| TAIR|locus:2023767 | 363 | AT1G48210 [Arabidopsis thalian | 0.991 | 0.663 | 0.768 | 5.9e-96 | |
| TAIR|locus:2054502 | 366 | AT2G30740 [Arabidopsis thalian | 0.967 | 0.642 | 0.740 | 6.5e-90 | |
| TAIR|locus:2009115 | 361 | AT1G06700 [Arabidopsis thalian | 0.967 | 0.650 | 0.731 | 1.7e-89 | |
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.971 | 0.578 | 0.720 | 7.5e-89 | |
| TAIR|locus:2064557 | 365 | AT2G41970 [Arabidopsis thalian | 0.991 | 0.660 | 0.665 | 4.3e-86 | |
| TAIR|locus:2054492 | 338 | AT2G30730 [Arabidopsis thalian | 0.967 | 0.695 | 0.685 | 2.2e-82 | |
| TAIR|locus:2023752 | 364 | AT1G48220 [Arabidopsis thalian | 0.991 | 0.662 | 0.662 | 4.5e-82 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.934 | 0.313 | 0.493 | 3.5e-52 |
| TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 978 (349.3 bits), Expect = 1.7e-98, P = 1.7e-98
Identities = 191/242 (78%), Positives = 203/242 (83%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRV 60
MVSRL+ ENVV L+GY VDGPLRVLAYE+A GSLHDILH LSW QRV
Sbjct: 115 MVSRLRQENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWHQRV 174
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAARGLEYLHEKA P +IHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD AARLHST
Sbjct: 175 KIAVGAARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTG +S+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQS+VTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGTLSTKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSVVTWATPK 294
Query: 181 LSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNT-RS 239
LSEDKVKQCVD +L GEYPPK LCVQYEADFRPNM IV+KALQPLLN RS
Sbjct: 295 LSEDKVKQCVDARLNGEYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNPPRS 354
Query: 240 GP 241
P
Sbjct: 355 AP 356
|
|
| TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 1.2e-97, P = 1.2e-97
Identities = 186/242 (76%), Positives = 204/242 (84%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRV 60
MVSRLK+ N VEL+GY VDG R+L +E A GSLHDILH LSW QRV
Sbjct: 115 MVSRLKHVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHGRKGVKGAKPGPLLSWHQRV 174
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAARGLEYLHEKA P +IHR+IKSSNVL+FD+D+AKI+DFDLSNQAPD AARLHST
Sbjct: 175 KIAVGAARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+S+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGQLSAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
Query: 181 LSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNTRSG 240
LSEDKVKQCVD++LGG+YPPK LCVQYEADFRPNM IV+KALQPLLN R+G
Sbjct: 295 LSEDKVKQCVDSRLGGDYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNARTG 354
Query: 241 PS 242
P+
Sbjct: 355 PA 356
|
|
| TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 5.9e-96, P = 5.9e-96
Identities = 186/242 (76%), Positives = 201/242 (83%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRV 60
MVSRL+++NV L+GY VDGPLRVLAYE A KGSLHD LH ++W QRV
Sbjct: 114 MVSRLRHDNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHGKKGAKGALRGPVMTWQQRV 173
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAVGAARGLEYLHEK P++IHR+IKSSNVLLFDDD+AKI DFDLS+QAPD AARLHST
Sbjct: 174 KIAVGAARGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKIGDFDLSDQAPDMAARLHST 233
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTG +SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 234 RVLGTFGYHAPEYAMTGTLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
Query: 181 LSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNT-RS 239
LSEDKVKQCVD +L GEYPPK LCVQYEA+FRPNM IV+KALQPLLN RS
Sbjct: 294 LSEDKVKQCVDARLLGEYPPKAVGKLAAVAALCVQYEANFRPNMSIVVKALQPLLNPPRS 353
Query: 240 GP 241
P
Sbjct: 354 AP 355
|
|
| TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 897 (320.8 bits), Expect = 6.5e-90, P = 6.5e-90
Identities = 174/235 (74%), Positives = 194/235 (82%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRV 60
MVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILH L W RV
Sbjct: 119 MVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLTRV 178
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AK++DF+LSNQAPD AARLHST
Sbjct: 179 KIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLHST 238
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+
Sbjct: 239 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 298
Query: 181 LSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLL 235
LSEDKVKQCVD KL GEYPPK LCVQYE++FRPNM IV+KALQPLL
Sbjct: 299 LSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLL 353
|
|
| TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 1.7e-89, P = 1.7e-89
Identities = 172/235 (73%), Positives = 195/235 (82%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRV 60
MVSRLK+EN+++L+G+ VDG LRVLAYE A+ GSLHDILH L W RV
Sbjct: 116 MVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRV 175
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAV AARGLEYLHEK++P +IHR+I+SSNVLLF+D AKI+DF+LSNQAPD AARLHST
Sbjct: 176 KIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHST 235
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+
Sbjct: 236 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 295
Query: 181 LSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLL 235
LSEDKVKQC+D KL +YPPK LCVQYEA+FRPNM IV+KALQPLL
Sbjct: 296 LSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 350
|
|
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 887 (317.3 bits), Expect = 7.5e-89, P = 7.5e-89
Identities = 170/236 (72%), Positives = 193/236 (81%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVK 61
VS+LK++N VEL GY V+G R+LAYE A+ GSLHDILH L W QRV+
Sbjct: 162 VSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVR 221
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
IAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AKI+DF+LSNQ+PD AARLHSTR
Sbjct: 222 IAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTR 281
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 181
VLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+L
Sbjct: 282 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 341
Query: 182 SEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNT 237
SEDKVKQCVD KL GEYPPK LCVQYE++FRPNM IV+KALQPLL +
Sbjct: 342 SEDKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRS 397
|
|
| TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 861 (308.1 bits), Expect = 4.3e-86, P = 4.3e-86
Identities = 161/242 (66%), Positives = 198/242 (81%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRV 60
+VSRLK+++ VEL+GY ++ R+L Y+ A+KGSLHD+LH L+W QRV
Sbjct: 120 VVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRV 179
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIA GAA+GLE+LHEK +P I+HR+++SSNVLLFDD +AK++DF+L+N + D AARLHST
Sbjct: 180 KIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHST 239
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTWATP+
Sbjct: 240 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 299
Query: 181 LSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNTR-S 239
LSEDKVKQC+D KL ++PPK LCVQYEADFRPNM IV+KALQPLLN++ +
Sbjct: 300 LSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 359
Query: 240 GP 241
GP
Sbjct: 360 GP 361
|
|
| TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 826 (295.8 bits), Expect = 2.2e-82, P = 2.2e-82
Identities = 161/235 (68%), Positives = 187/235 (79%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRV 60
MVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILH L W RV
Sbjct: 95 MVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQDALPGPTLDWITRV 154
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAV AARGLEYLHEK +P++IHR+I+SSN+LLFDD AKI+DF+LSNQ+PD AARL ST
Sbjct: 155 KIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKIADFNLSNQSPDNAARLQST 214
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLG+FGY++PEYAMTG+++ KSDVY FGVVLLELLTGRKPVDHT+PRGQQSLVTWATPK
Sbjct: 215 RVLGSFGYYSPEYAMTGELTHKSDVYGFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPK 274
Query: 181 LSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLL 235
LSED V++CVD KL GEY PK LCVQYE++ RP M V+KALQ LL
Sbjct: 275 LSEDTVEECVDPKLKGEYSPKSVAKLAAVAALCVQYESNCRPKMSTVVKALQQLL 329
|
|
| TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 4.5e-82, P = 4.5e-82
Identities = 161/243 (66%), Positives = 190/243 (78%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRV 60
MVSRL +ENVV L+ Y VDGPLRVLAYE A+ G+LHD+LH ++W +RV
Sbjct: 114 MVSRLHHENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVIGALQGPVMTWQRRV 173
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIA+GAARGLEYLH+K P++IHR+IK+SN+LLFDDDIAKI DFDL +QAP+ A RLHS
Sbjct: 174 KIALGAARGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDLYDQAPNMAGRLHSC 233
Query: 121 RV-LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
R+ LG H PE+AMTG +++KSDVYSFGVVLLELLTGRKPVD TLPRGQQ+LVTWATP
Sbjct: 234 RMALGASRSHCPEHAMTGILTTKSDVYSFGVVLLELLTGRKPVDRTLPRGQQNLVTWATP 293
Query: 180 KLSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNT-R 238
KLS+DKVKQCVD +L GEYPPK CV Y+ DFRP+M IV+KALQPLLN+ R
Sbjct: 294 KLSKDKVKQCVDARLLGEYPPKAVAKLAAVSARCVHYDPDFRPDMSIVVKALQPLLNSSR 353
Query: 239 SGP 241
S P
Sbjct: 354 SSP 356
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 3.5e-52, P = 3.5e-52
Identities = 116/235 (49%), Positives = 154/235 (65%)
Query: 1 MVSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQ 58
M+SRL + N+V+LVGYY D +L YE GSL LH L W
Sbjct: 427 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCP-----LDWDT 481
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 118
R+KIA+ AARGL YLHE ++P +IHR+ K+SN+LL ++ AK++DF L+ QAP+
Sbjct: 482 RMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHL 541
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
STRV+GTFGY APEYAMTG + KSDVYS+GVVLLELLTGRKPVD + P GQ++LVTW
Sbjct: 542 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTR 601
Query: 179 PKLSE-DKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQ 232
P L + D++++ VD++L G+YP + CV EA RP MG V+++L+
Sbjct: 602 PVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLK 656
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q41328 | PTI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.8851 | 0.9670 | 0.6638 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 243 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-34 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-32 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.001 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-39
Identities = 55/155 (35%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+L + N+V+L G + D L E+ GSL D+L +G LS + ++I
Sbjct: 46 KKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRI 97
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTR 121
+ GLEYLH IIHR++K N+LL D+ K++DF LS + L +
Sbjct: 98 LLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154
Query: 122 VLGTFGYHAPE-YAMTGQMSSKSDVYSFGVVLLEL 155
GT Y APE G S KSD++S GV+L EL
Sbjct: 155 --GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-37
Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+L + NVV+L+G + + E+ G L L K P LS + +
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR--------KNRPKLSLSDLLSF 107
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTR 121
A+ ARG+EYL K IHR++ + N L+ ++ + KISDF LS + D R +
Sbjct: 108 ALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGK 164
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180
+ + APE G+ +SKSDV+SFGV+L E+ T G +P P
Sbjct: 165 L--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PG 206
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231
+S ++V + + PP ++ + C + + RP +++ L
Sbjct: 207 MSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-36
Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 30/231 (12%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+L + N+V+L+G + ++ E+ G L D L + LS + +
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-------KELSLSDLLSF 108
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTR 121
A+ ARG+EYL K IHR++ + N L+ ++ + KISDF LS + D ++ +
Sbjct: 109 ALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK 165
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180
+ + APE G+ +SKSDV+SFGV+L E+ T G +P P
Sbjct: 166 L--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP----------------YPG 207
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231
+S +V + + PP ++ + C + + RP +++ L
Sbjct: 208 MSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-34
Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 26/236 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L + NVV L+G + L E+ G L D L + V + LS +
Sbjct: 49 VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHS 119
A+ A+G+EYL K + +HR++ + N L+ +D + KISDF LS + D R +
Sbjct: 109 SFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 178
L + APE G +SKSDV+SFGV+L E+ T G P
Sbjct: 166 GGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY---------------- 208
Query: 179 PKLSEDKVKQCV--DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232
P LS ++V + + +L P ++ + C Q + + RP +++ L+
Sbjct: 209 PGLSNEEVLEYLRKGYRL--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-33
Identities = 60/172 (34%), Positives = 86/172 (50%), Gaps = 15/172 (8%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
RL + N+V L+ + D L E+ G L D L LS + KIA
Sbjct: 54 RLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---------PLSEDEAKKIA 104
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
+ RGLEYLH IIHR++K N+LL ++ + KI+DF L+ + +++ L + +
Sbjct: 105 LQILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FV 159
Query: 124 GTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
GT Y APE + G K DV+S GV+L ELLTG+ P Q L+
Sbjct: 160 GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-32
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L + N+V L+G G + E+ G L D L K G L+ +
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--------KHGEKLTLKDLL 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHS 119
++A+ A+G+EYL K +HR++ + N L+ ++ + KISDF LS D R
Sbjct: 106 QMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG 162
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 178
L APE G+ +SKSDV+SFGV+L E+ T G +P
Sbjct: 163 GGKLPIKWM-APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY---------------- 205
Query: 179 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224
P +S ++V + ++ P ++ + C Y+ + RP
Sbjct: 206 PGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTF 251
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-30
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 15/159 (9%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+LK+ N+V L + D L E+ G L D+L + LS +
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFY 102
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
LEYLH K I+HR++K N+LL +D K++DF L+ Q +T V
Sbjct: 103 LRQILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV 157
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT Y APE + D++S GV+L ELLTG+ P
Sbjct: 158 -GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-27
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 16/164 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVL-SWA 57
++S L++ N+V G D L E+ S GSL +L + P PV+ +
Sbjct: 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL----PEPVIRKYT 107
Query: 58 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 117
+++ GL YLH I+HR+IK +N+L+ D + K++DF + + D
Sbjct: 108 RQI------LEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ V GT + APE + +D++S G ++E+ TG+ P
Sbjct: 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-26
Identities = 53/158 (33%), Positives = 76/158 (48%), Gaps = 16/158 (10%)
Query: 5 LKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
K+ N+V+ G Y L + E S GSL D+L L+ +Q +
Sbjct: 54 CKHPNIVKYYGSYLKKDELW-IVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVC 104
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
+GLEYLH IIHR+IK++N+LL D K+ DF LS Q D AR ++
Sbjct: 105 KELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMV 158
Query: 124 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT + APE K+D++S G+ +EL G+ P
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 3e-23
Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 38/173 (21%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP---VLSWAQR 59
+L + N+++ + + + E+A G L + KK K KP P +L W
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWF-- 109
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
V++ + L+YLH + +I+HR+IK N+ L + + K+ DF +S L S
Sbjct: 110 VQLCLA----LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-------LSS 155
Query: 120 TR-----VLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
T V+GT Y +PE Y + KSD++S G VL EL T + P
Sbjct: 156 TVDLAKTVVGTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-23
Identities = 61/157 (38%), Positives = 84/157 (53%), Gaps = 16/157 (10%)
Query: 8 ENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 66
+V G +Y +G + + E+ GSL IL K V+G P +L KIAV
Sbjct: 59 PYIVGFYGAFYNNGDI-SICMEYMDGGSLDKIL---KEVQGRIPERILG-----KIAVAV 109
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 126
+GL YLHEK +IIHR++K SN+L+ K+ DF +S Q ++ A+ T V GT
Sbjct: 110 LKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFV-GTS 163
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
Y APE S KSD++S G+ L+EL TGR P
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-23
Identities = 54/160 (33%), Positives = 92/160 (57%), Gaps = 16/160 (10%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+ L++ N+V+L+G + G + E+ +KGSL D L ++ V++ AQ++
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR-------SRGRAVITLAQQLGF 107
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
A+ G+EYL EK +HR++ + NVL+ +D +AK+SDF L A +A+ S ++
Sbjct: 108 ALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGL---AKEASQGQDSGKL 161
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ APE + S+KSDV+SFG++L E+ + GR P
Sbjct: 162 --PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 8e-23
Identities = 53/157 (33%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 6 KNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 64
++ VV+ G +Y +G + + E+ GSL D+L + P PVL+ IA
Sbjct: 57 ESPYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLA-----YIAR 106
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 124
+GL+YLH K IIHR+IK SN+L+ KI+DF +S + + +T V G
Sbjct: 107 QILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-G 162
Query: 125 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
T Y +PE S +D++S G+ LLE G+ P
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.5 bits (228), Expect = 9e-22
Identities = 54/165 (32%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 66
N+V+L ++ D L E+ GSL D+L L ++
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI------ 110
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTR---- 121
LEYLH K IIHR+IK N+LL D + K+ DF L+ PD +
Sbjct: 111 LSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
Query: 122 VLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVD 163
+GT GY APE + SS SD++S G+ L ELLTG P +
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-21
Identities = 62/222 (27%), Positives = 113/222 (50%), Gaps = 33/222 (14%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+++L ++N+V L+G + L ++ E SKG+L + L + ++S Q ++
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRA-------LVSVIQLLQ 104
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
++ A G+EYL K +++HR++ + N+L+ +D +AK+SDF L+ + +++
Sbjct: 105 FSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSK 158
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180
+ + APE + SSKSDV+S+GV+L E+ + GR P PK
Sbjct: 159 L--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY----------------PK 200
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222
+S +VK+CV+ E P A + + C + E RP
Sbjct: 201 MSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-21
Identities = 57/160 (35%), Positives = 71/160 (44%), Gaps = 13/160 (8%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
L +EN++ L G + PL + E A GSL D L K G L A
Sbjct: 52 SLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLR--KDALGHFLISTLC-----DYA 103
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
V A G+ YL K R IHR++ + N+LL DD KI DF L P L
Sbjct: 104 VQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 124 GT-FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
F + APE T S SDV+ FGV L E+ T G +P
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-20
Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 23/226 (10%)
Query: 4 RLKNENVVELVG--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
L +EN+V+ G G L E+ GSL D L + ++ + +
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------DQINLKRLLL 113
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP--DAAARLHS 119
+ +G++YL + R IHR++ + N+L+ +D+ KISDF L+ P +
Sbjct: 114 FSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE 170
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
F Y APE T + SS SDV+SFGV L EL T D + + L
Sbjct: 171 PGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT---YGDPSQSPPAEFLRMIG-I 225
Query: 180 KLSEDKVKQCVDTKLGGEY---PPKAIAKMAAVAALCVQYEADFRP 222
+ V + ++ GE PP ++ + LC + E RP
Sbjct: 226 AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 7e-20
Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
++L + +V L+G G +L E A G L L ++ + + + A +V
Sbjct: 51 AQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQV-- 104
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
A G+ YL K +HR++ + NVLL + AKISDF +S A S
Sbjct: 105 ----AMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGSDYY 152
Query: 123 LGTFG------YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
T ++APE G+ SSKSDV+S+GV L E + G KP
Sbjct: 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-19
Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+ LK+ N+V+ +G + E+A GSL I+ K GP +
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--------KFGP-FPESLVAV 103
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
+GL YLHE+ +IHR+IK++N+L D + K++DF ++ + D + S
Sbjct: 104 YVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-- 158
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
V+GT + APE S+ SD++S G ++ELLTG P
Sbjct: 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 28/241 (11%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L++ N+V+L+G L +E+ +L ++L LSW +R KIA
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------------LSWERRRKIA 786
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP---DAAARLHST 120
+G A+ L +LH + P ++ N+ +++ D LS D + S
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLRLSLPGLLCTDTKCFISS- 842
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
Y APE T ++ KSD+Y FG++L+ELLTG+ P D S+V WA
Sbjct: 843 ------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYC 895
Query: 181 LSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238
S+ + +D + G+ I ++ +A C + RP VLK L+ +
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
Query: 239 S 239
S
Sbjct: 956 S 956
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-19
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++++L + ++ ++D + E+A G LH +L ++G +P L Q
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG----RP---LPEDQVW 104
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ + GL +LH K +I+HR+IKS N+ L D KI D ++ D +
Sbjct: 105 RFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFAN 159
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
++GT Y +PE + KSDV++ GVVL E TG+ P D Q +L+
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALIL----- 211
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN 223
K+ + V + Y ++A + C+ + RP+
Sbjct: 212 ----KIIRGVFPPVSQMYSQ----QLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-19
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 25/195 (12%)
Query: 6 KNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 64
+ +V+ G Y+ + L ++ E+ GS+ DI+ L+ + I
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVM-EYCGAGSVSDIMKIT--------NKTLTEEEIAAILY 106
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 124
+GLEYLH + IHR+IK+ N+LL ++ AK++DF +S Q D A+ ++ V+G
Sbjct: 107 QTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIG 161
Query: 125 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSE 183
T + APE ++K+D++S G+ +E+ G+ P P R + P LS+
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD 221
Query: 184 ---------DKVKQC 189
D VK+C
Sbjct: 222 PEKWSPEFNDFVKKC 236
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-19
Identities = 58/173 (33%), Positives = 85/173 (49%), Gaps = 21/173 (12%)
Query: 6 KNENVVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV--K 61
K+ +V+ G ++D + A E+ GSL D ++ K +G + G ++V K
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIG------EKVLGK 109
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
IA +GL YLH + +IIHR+IK SN+LL K+ DF +S + ++ A T
Sbjct: 110 IAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTF 163
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
GT Y APE S SDV+S G+ LLE+ R P P G+ L
Sbjct: 164 T-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-19
Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 32/227 (14%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68
N+V+L+G V + E GSL L KK L+ + +++++ AA
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDAAA 104
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
G+EYL K IHR++ + N L+ ++++ KISDF +S + + +
Sbjct: 105 GMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW 161
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVK 187
APE G+ +S+SDV+S+G++L E + G P P +S + +
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY----------------PGMSNQQTR 205
Query: 188 QCVDTKLGGEYPPKAI--AKMAAVAALCVQYEADFRPNMGIVLKALQ 232
+ +++ G P + ++ + C Y+ + RP+ + LQ
Sbjct: 206 ERIES--GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 9e-18
Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV-LSWAQRVKIA 63
+ + N++ ++DG + E+A G L + K K K P W +I
Sbjct: 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIW----RIF 109
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
+ RGL+ LHE+ +I+HR++KS+N+LL +D+ KI D +S A+ +
Sbjct: 110 IQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQI 162
Query: 124 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT Y APE S KSD++S G +L E+ T P
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 61/192 (31%), Positives = 93/192 (48%), Gaps = 21/192 (10%)
Query: 16 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75
+Y DG + + EH GSL +L KK G P +L KI++ RGL YL E
Sbjct: 68 FYSDGEISICM-EHMDGGSLDQVL--KKA--GRIPENILG-----KISIAVLRGLTYLRE 117
Query: 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 135
K + I+HR++K SN+L+ K+ DF +S Q D+ A +GT Y +PE
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQ 171
Query: 136 TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 195
+ +SD++S G+ L+E+ GR P+ P + L +SE + K+ G
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPIP---PPDAKELEAMFGRPVSEGEAKESHRPVSG 228
Query: 196 GEYPPKAIAKMA 207
+PP + MA
Sbjct: 229 --HPPDSPRPMA 238
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 23/174 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV---LS 55
+++ ++EN+V+ G +G ++ +E+ G L+ L HG P L+
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 56 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 115
+Q ++IAV A G+ YL A +HR++ + N L+ D + KI DF +S
Sbjct: 121 LSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD------ 171
Query: 116 RLHST---RVLGT----FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+++T RV G + PE M + +++SDV+SFGVVL E+ T G++P
Sbjct: 172 -VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-17
Identities = 52/165 (31%), Positives = 87/165 (52%), Gaps = 22/165 (13%)
Query: 6 KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP------------ 52
K++N++ L+G +GPL V+ E+A+KG+L + L ++ PGP
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARR-----PPGPDYTFDITKVPEE 129
Query: 53 VLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 112
LS+ V A ARG+EYL + R IHR++ + NVL+ +D++ KI+DF L+ D
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
Query: 113 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
++ + APE + +SDV+SFG+++ E+ T
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 7e-17
Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
LEYLH K IIHR+IK N+LL + I+DF+++ + +T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGY 165
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE S D +S GV E L G++P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 7e-17
Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQ 58
+ L + N+V+ +G+ + E+ GS+ L +G+ + V + +
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTE 115
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 118
+V GL YLH K I+HR++K+ N+L+ D I KISDF +S ++ D
Sbjct: 116 QV------LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ 166
Query: 119 STRVLGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKP 161
+ + G+ + APE + S+K D++S G V+LE+ GR+P
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 8e-17
Identities = 53/156 (33%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 8 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 67
+V G +++ + E GSL I KKG G P +L KIAV
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKG--GPIPVEILG-----KIAVAVV 113
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
GL YL+ RI+HR+IK SN+L+ K+ DF +S + ++ A T V GT
Sbjct: 114 EGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTST 167
Query: 128 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
Y +PE G+ + KSDV+S G+ ++EL G+ P
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-16
Identities = 55/164 (33%), Positives = 90/164 (54%), Gaps = 17/164 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L+++ +V+L + P+ ++ E+ SKGSL D L K G G L V
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFL--KDG-----EGRALKLPNLV 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A A G+ Y+ IHR+++S+N+L+ D + KI+DF L+ D ++
Sbjct: 106 DMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTA 159
Query: 121 RVLGTF--GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
R F + APE A+ G+ + KSDV+SFG++L EL+T GR P
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 55/160 (34%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 6 KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK--GVKGA-----KPGPVLSWA 57
K++N++ L+G DGPL VL E+ASKG+L + L ++ G+ + P L++
Sbjct: 76 KHKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 58 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 117
V A ARG+EYL A + IHR++ + NVL+ +D++ KI+DF L+ +
Sbjct: 135 DLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
+T + APE + +SDV+SFGV+L E+ T
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-16
Identities = 55/167 (32%), Positives = 83/167 (49%), Gaps = 28/167 (16%)
Query: 50 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109
P +L KIAV + LEYLH K +IHR++K SNVL+ + K+ DF +S
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGY 153
Query: 110 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSS-----KSDVYSFGVVLLELLTGRKPVD- 163
D+ A+ T G Y APE + +++ KSDV+S G+ ++EL TGR P D
Sbjct: 154 LVDSVAK---TIDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
Query: 164 -HTLPRGQQSLVTWATPKLSEDK--------VKQCV--DTKLGGEYP 199
T + + +V +P+L +K V +C+ + K YP
Sbjct: 210 WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-16
Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L++E +V+L + P+ ++ E+ SKGSL D L G+ G L Q V
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMGK-------YLRLPQLV 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A A G+ Y+ +HR+++++N+L+ ++ + K++DF L+ D ++
Sbjct: 106 DMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTA 159
Query: 121 RVLGTF--GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 177
R F + APE A+ G+ + KSDV+SFG++L EL T GR P
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY--------------- 204
Query: 178 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222
P + +V V+ PP+ + + C + E + RP
Sbjct: 205 -PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 3e-16
Identities = 51/142 (35%), Positives = 75/142 (52%), Gaps = 26/142 (18%)
Query: 28 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 87
E+ SKGSL D L +G K L Q V +A A G+ YL + IHR++
Sbjct: 81 EYMSKGSLLDFLKSGEGKK-------LRLPQLVDMAAQIAEGMAYLESR---NYIHRDLA 130
Query: 88 SSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTF--GYHAPEYAMTGQMS 140
+ N+L+ ++ + KI+DF L ARL ++ R F + APE A G+ +
Sbjct: 131 ARNILVGENLVCKIADFGL--------ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 141 SKSDVYSFGVVLLELLT-GRKP 161
KSDV+SFG++L E++T GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-16
Identities = 71/235 (30%), Positives = 104/235 (44%), Gaps = 29/235 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+S+ + NVV+ +V G L + S GSL DI +K + P L A
Sbjct: 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIA 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ +GLEYLH + IHR+IK+ N+LL +D KI+DF +S D R
Sbjct: 106 TVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162
Query: 121 R--VLGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 176
R +GT + APE M K+D++SFG+ +EL TG P P + ++T
Sbjct: 163 RKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGAAPY-SKYPPMKVLMLTL 220
Query: 177 --ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
P L + K K+ KM +LC+Q + RP +LK
Sbjct: 221 QNDPPSLETGADYK----KYS-----KSFRKM---ISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-16
Identities = 54/233 (23%), Positives = 104/233 (44%), Gaps = 28/233 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++S L++ N++ +++D ++ E+A+ G+L+D + +KG + +
Sbjct: 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ-------LFEEEMVL 104
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ Y+H+ I+HR+IK+ N+ L + K+ DF +S +
Sbjct: 105 WYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSMAE 159
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
V+GT Y +PE + + KSD+++ G VL ELLT ++ D T P +LV
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV----- 211
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233
K+ Q T + Y +++ ++ +Q + + RP VL
Sbjct: 212 ----KIVQGNYTPVVSVYS----SELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-16
Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 16/148 (10%)
Query: 15 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74
+Y DG + + EH GSL +L K + P +L K+++ RGL YL
Sbjct: 71 AFYSDGEISI-CMEHMDGGSLDQVLKEAKRI----PEEILG-----KVSIAVLRGLAYLR 120
Query: 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 134
EK + I+HR++K SN+L+ K+ DF +S Q D+ A +GT Y +PE
Sbjct: 121 EKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERL 174
Query: 135 MTGQMSSKSDVYSFGVVLLELLTGRKPV 162
S +SD++S G+ L+EL GR P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-16
Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 6 KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGK-------KGVKGAKPGPVLSWA 57
K++N++ L+G +GPL V+ E+A+ G+L D L + P L+
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 58 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 117
V A ARG+E+L K + IHR++ + NVL+ +D + KI+DF L+
Sbjct: 133 DLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 118 HSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLT 157
+T + APE A+ ++ + +SDV+SFGV+L E+ T
Sbjct: 190 KTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 6e-16
Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 4 RLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
K+ N+V+ Y V L V E+ GSL DI+ ++ Q +
Sbjct: 71 DCKHPNIVDYYDSYLVGDELWV-VMEYMDGGSLTDIITQNF--------VRMNEPQIAYV 121
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
+GLEYLH + +IHR+IKS N+LL D K++DF + Q ++ +S V
Sbjct: 122 CREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--V 176
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT + APE K D++S G++ +E+ G P
Sbjct: 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-16
Identities = 55/160 (34%), Positives = 87/160 (54%), Gaps = 12/160 (7%)
Query: 6 KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK--GVK-----GAKPGPVLSWA 57
K++N++ L+G DGPL V+ E+ASKG+L + L ++ G++ P LS+
Sbjct: 82 KHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 58 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 117
V A ARG+EYL A + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
+T + APE + +SDV+SFGV+L E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 1e-15
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
LEYLH II+R++K N+LL D K++DF L+ + +R ++ GT Y
Sbjct: 105 ALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEY 159
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164
APE + D +S GV+L E+LTG+ P
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 61/239 (25%), Positives = 110/239 (46%), Gaps = 24/239 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV--LSW 56
+++ L++E++V+ G V+G ++ +E+ G L+ L HG V A+ L+
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 116
+Q + IA A G+ YL A +HR++ + N L+ ++ + KI DF +S
Sbjct: 120 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 117 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT 175
+ + PE M + +++SDV+S GVVL E+ T G++P
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-------------- 222
Query: 176 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234
W +LS ++V +C+ + P ++ + C Q E R N+ + LQ L
Sbjct: 223 WY--QLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 21/164 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+S+ ++ + + G ++ G + E+ GS D+L KPG +
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL---------KPGKL----DET 98
Query: 61 KIAV---GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 117
IA GLEYLHE+ IHR+IK++N+LL ++ K++DF +S Q ++
Sbjct: 99 YIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
++ +GT + APE K+D++S G+ +EL G P
Sbjct: 156 NTF--VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 42/104 (40%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIAV + L YL K E +IIHR++K SN+LL + K+ DF +S Q D+ A+ T
Sbjct: 111 KIAVATVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---T 165
Query: 121 RVLGTFGYHAPEYAMTGQMSS---KSDVYSFGVVLLELLTGRKP 161
R G Y APE +SDV+S G+ L E+ TG+ P
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-15
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 6/158 (3%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILH-GKKGVKGAKPGPVLSWAQR 59
M +L ++NVV L+G + + E+ G L L K + KP P LS Q+
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP-LSTKQK 119
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
V + A G+++L + R +HR++ + N L+ K+S LS +
Sbjct: 120 VALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKL 175
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
L + APE S+KSDV+SFGV++ E+ T
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-15
Identities = 46/169 (27%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGK-----KGVKGAKPGPV 53
+++ L+++++V G +G ++ +E+ G L+ L HG G + PG
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ- 118
Query: 54 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 113
L+ Q + IA A G+ YL A +HR++ + N L+ + KI DF +S
Sbjct: 119 LTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 175
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
R + + PE + + +++SD++SFGVVL E+ T G++P
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-15
Identities = 54/164 (32%), Positives = 90/164 (54%), Gaps = 17/164 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L+++ +V L + P+ ++ E KGSL D L K+G G L Q V
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEPIYIVT-EFMGKGSLLDFL--KEG-----DGKYLKLPQLV 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A A G+ Y+ IHR+++++N+L+ D+ + KI+DF L+ D ++
Sbjct: 106 DMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTA 159
Query: 121 RVLGTF--GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
R F + APE A+ G+ + KSDV+SFG++L EL+T GR P
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-15
Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 12/130 (9%)
Query: 28 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 87
E KGSL L + G VL A + +A A G+ YL E+ IHR++
Sbjct: 82 ELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLA 131
Query: 88 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYS 147
+ N+L+ +D + K++DF L+ + ++ + + APE A G S+KSDV+S
Sbjct: 132 ARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVWS 189
Query: 148 FGVVLLELLT 157
FG++L E+ T
Sbjct: 190 FGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-15
Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 27/200 (13%)
Query: 1 MVSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 58
++++L++ N+V+L+G V+ G L ++ E+ +KGSL D L ++ VL
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLR-------SRGRSVLGGDC 103
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 118
+K ++ +EYL +HR++ + NVL+ +D++AK+SDF L+ + A+
Sbjct: 104 LLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQ 156
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT------GRKPVDHTLPR---G 169
T L + APE + S+KSDV+SFG++L E+ + R P+ +PR G
Sbjct: 157 DTGKL-PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 215
Query: 170 QQSLVTWATPKLSEDKVKQC 189
+ P + D +KQC
Sbjct: 216 YKMDAPDGCPPVVYDVMKQC 235
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-14
Identities = 52/169 (30%), Positives = 86/169 (50%), Gaps = 32/169 (18%)
Query: 4 RLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+L++ +++L Y V + P+ ++ E GSL + L G G L Q +
Sbjct: 57 KLRHPKLIQL--YAVCTLEEPIYIVT-ELMKYGSLLEYLQGGAGRA-------LKLPQLI 106
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--- 117
+A A G+ YL + IHR++ + NVL+ +++I K++DF L AR+
Sbjct: 107 DMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGL--------ARVIKE 155
Query: 118 --HSTRVLGTF--GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ R F + APE A+ + S KSDV+SFG++L E++T GR P
Sbjct: 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-14
Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 21/166 (12%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
LK+ N+V+ G V + E+ S G+L ++L G +L
Sbjct: 54 ELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH---------GRILDEHVIRVY 104
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD----LSNQAPDAAARLH 118
+ GL YLH I+HR+IK +N+ L + + K+ DF L N +
Sbjct: 105 TLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 119 STRVLGTFGYHAPEYAMTGQMSSK---SDVYSFGVVLLELLTGRKP 161
S GT Y APE G+ +D++S G V+LE+ TG++P
Sbjct: 162 SLA--GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 16/148 (10%)
Query: 15 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74
+Y DG + + EH GSL +L KK G P +L K+++ +GL YL
Sbjct: 71 AFYSDGEISI-CMEHMDGGSLDQVL--KKA--GRIPEQILG-----KVSIAVIKGLTYLR 120
Query: 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 134
EK +I+HR++K SN+L+ K+ DF +S Q D+ A +GT Y +PE
Sbjct: 121 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERL 174
Query: 135 MTGQMSSKSDVYSFGVVLLELLTGRKPV 162
S +SD++S G+ L+E+ GR P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-14
Identities = 58/244 (23%), Positives = 103/244 (42%), Gaps = 39/244 (15%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK-PGPVLSWAQR 59
++S + N+V+L+G + + + E G D+L + + + P+L+ +
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTLKEL 108
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFDL------SN 108
+ I + A+G YL + IHR++ + N L+ + + KI DF L S+
Sbjct: 109 LDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD 165
Query: 109 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 168
L R + APE + G+ +++SDV+SFGV++ E+LT
Sbjct: 166 YYRKEGEGLLPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILT----------L 209
Query: 169 GQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228
GQQ P L+ +V Q V + P K+ + C + RP +
Sbjct: 210 GQQPY-----PALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264
Query: 229 KALQ 232
+ LQ
Sbjct: 265 EILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-14
Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 51 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110
GP L + +++ AA G+EYL K IHR++ + N L+ + ++ KISDF +S +
Sbjct: 88 GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREE 144
Query: 111 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 170
D + APE G+ SS+SDV+SFG++L E
Sbjct: 145 EDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF-------------- 190
Query: 171 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230
SL LS + ++ ++ + P + + C +Y+ RP+ V +
Sbjct: 191 -SLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249
Query: 231 LQ 232
LQ
Sbjct: 250 LQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-14
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L N +V ++G + +L E AS G L+ L GKK ++ + V++
Sbjct: 51 QLDNPYIVRMIGV-CEAEALMLVMEMASGGPLNKFLSGKK--------DEITVSNVVELM 101
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
+ G++YL K +HR++ + NVLL + AKISDF LS +A A + R
Sbjct: 102 HQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLS-KALGADDSYYKARSA 157
Query: 124 GTF--GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180
G + ++APE + SS+SDV+S+G+ + E + G+KP K
Sbjct: 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK----------------K 201
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN 223
+ +V ++ + P + +M A+ C Y+ + RPN
Sbjct: 202 MKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPN 244
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-14
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 35/232 (15%)
Query: 4 RLKNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+L + N+V+L G P+ ++ E+ + G L + L +KG G +L V
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIV-TEYMANGCLLNYLRERKGKLGT--EWLLDMCSDV-- 109
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
+EYL IHR++ + N L+ +D++ K+SDF L+ D T
Sbjct: 110 ----CEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----QYTSS 158
Query: 123 LGT---FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
GT + PE + SSKSDV+SFGV++ E+ + K +P
Sbjct: 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-----MP----------YE 203
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231
+ S +V + V P A ++ + C + + RP +L L
Sbjct: 204 RFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-14
Identities = 50/174 (28%), Positives = 86/174 (49%), Gaps = 21/174 (12%)
Query: 1 MVSRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLH----------DILHGKKGVKGAK 49
++S L++ N+V L+G + P +L +E+ + G LH D+
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 50 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109
L + + IA+ A G+EYL + +HR++ + N L+ + KISDF LS
Sbjct: 120 S---LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 110 APDAAA-RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
A R+ S +L + PE + G+ +++SD++SFGVVL E+ + G +P
Sbjct: 174 IYSADYYRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-14
Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
S LK+ N+V+ +G + + E GSL +L K G ++ + +++
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI-- 117
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTR 121
GL+YLH+ +I+HR+IK NVL+ + KISDF S + A +
Sbjct: 118 ----LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTET 168
Query: 122 VLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKP 161
GT Y APE G + +D++S G ++E+ TG+ P
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-14
Identities = 42/124 (33%), Positives = 63/124 (50%), Gaps = 14/124 (11%)
Query: 42 KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 101
K ++G P +L K+ V + L YL EK +IHR++K SN+LL K+
Sbjct: 104 LKRIQGPIPEDILG-----KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKL 156
Query: 102 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY----AMTGQMSSKSDVYSFGVVLLELLT 157
DF +S + D+ A+ TR G Y APE + ++DV+S G+ L+EL T
Sbjct: 157 CDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213
Query: 158 GRKP 161
G+ P
Sbjct: 214 GQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-14
Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 12/160 (7%)
Query: 6 KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWA 57
K++N++ L+G DGPL V+ E+ASKG+L + L ++ P +++
Sbjct: 79 KHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 58 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 117
V ARG+EYL A + IHR++ + NVL+ ++++ KI+DF L+ +
Sbjct: 138 DLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
+T + APE + +SDV+SFGV++ E+ T
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 37/242 (15%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV----LSW 56
++S+ ++N+V L+G + R + E + G L K ++ +P P L+
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTM 115
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDA 113
+ A A+G +YL E IHR+I + N LL +AKI+DF ++ A
Sbjct: 116 KDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 172
+ R + + PE + G +SK+DV+SFGV+L E+ + G P
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY---------- 222
Query: 173 LVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230
P + +V + V GG + P + + C Q+ + RPN +L+
Sbjct: 223 ------PGRTNQEVMEFV--TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
Query: 231 LQ 232
+Q
Sbjct: 275 IQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-13
Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68
N+V+L+G + E G L KK L Q VK A+ AA
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLVKFALDAAA 104
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT--F 126
G+ YL K IHR++ + N L+ ++++ KISDF +S Q D ++S+ L
Sbjct: 105 GMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG---IYSSSGLKQIPI 158
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 186
+ APE G+ SS+SDV+S+G++L E SL P ++ +
Sbjct: 159 KWTAPEALNYGRYSSESDVWSYGILLWETF---------------SLGVCPYPGMTNQQA 203
Query: 187 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231
++ V+ P K + V C Y+ + RP + K L
Sbjct: 204 REQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-13
Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 18/183 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ LKN N+V + ++ G + E+ + GSL D++ + AQ
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----------TETCMDEAQIA 118
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHS 119
+ + LE+LH ++IHR+IKS NVLL D K++DF Q P+ + R
Sbjct: 119 AVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--- 172
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWAT 178
+ ++GT + APE K D++S G++ +E++ G P + P R + T T
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232
Query: 179 PKL 181
P+L
Sbjct: 233 PEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-13
Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 16/162 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++S+L++ N+V+ +G + + E GSL +L G+ P PV+ R
Sbjct: 55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQ 110
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ GLEYLH++ +HR+IK +N+L+ + + K++DF ++ Q + S
Sbjct: 111 ILL-----GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSF 161
Query: 121 RVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKP 161
+ G+ + APE G +D++S G +LE+ TG+ P
Sbjct: 162 K--GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-13
Identities = 60/193 (31%), Positives = 93/193 (48%), Gaps = 21/193 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
M+ K+ N+V G Y+ + E GSL DI H GP LS +Q
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH--------VTGP-LSESQIA 109
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
++ +GL YLH K + +HR+IK +N+LL D+ K++DF +S Q A+ S
Sbjct: 110 YVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS- 165
Query: 121 RVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-- 175
+GT + APE A G + D+++ G+ +EL + P+ P L+T
Sbjct: 166 -FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS 224
Query: 176 -WATPKLSEDKVK 187
+ PKL +DK+K
Sbjct: 225 NFQPPKL-KDKMK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 27/242 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV----- 53
+++ L++E++V+ G DG ++ +E+ G L+ L HG + P
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 54 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 113
L +Q + IA A G+ YL A +HR++ + N L+ + + KI DF +S
Sbjct: 120 LGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 172
+ + PE M + +++SDV+SFGV+L E+ T G++P
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----------- 225
Query: 173 LVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232
W +LS +V +C+ E P ++ + C Q E R N+ + K L
Sbjct: 226 ---WF--QLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280
Query: 233 PL 234
L
Sbjct: 281 AL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-13
Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 19/236 (8%)
Query: 5 LKNENVVELVGYYVDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
L +EN+V+ G + + L E+ GSL D L P L+ AQ +
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQLLLF 112
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA--RLHST 120
A G+ YLH + IHR++ + NVLL +D + KI DF L+ P+ R+
Sbjct: 113 AQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
F Y A E + S SDV+SFGV L ELLT + P+ + ++ +
Sbjct: 170 GDSPVFWY-AVECLKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFEEMIGPKQGQ 227
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236
++ ++ + ++ + P ++ + C + EA FRP ++ L+ + +
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 63/258 (24%), Positives = 113/258 (43%), Gaps = 43/258 (16%)
Query: 1 MVSRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
++ ++ + +V++L G DGPL +L E+A GSL L + V P + S R
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPL-LLIVEYAKYGSLRSFLRESRKVG---PSYLGSDGNR 111
Query: 60 ------------------VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 101
+ A +RG++YL AE +++HR++ + NVL+ + KI
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKI 168
Query: 102 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160
SDF LS + + + ++ + A E +++SDV+SFGV+L E++T G
Sbjct: 169 SDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228
Query: 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADF 220
P P ++ +++ + T E P +M + C + E D
Sbjct: 229 PY----------------PGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDK 272
Query: 221 RPNMGIVLKALQPLLNTR 238
RP + K L+ ++
Sbjct: 273 RPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
++ VV+L+ + G VL E+ L ++L +P L AQ
Sbjct: 54 QACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLR-----DEERP---LPEAQVKSY 104
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
+G+ Y+H I+HR++K +N+L+ D + KI+DF L+ + RL+S +V
Sbjct: 105 MRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV 161
Query: 123 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
T Y APE + D+++ G + ELL G
Sbjct: 162 -ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-13
Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 1 MVSRLKNENVVELV-GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
++S K+ N+V L Y+ + L +L E G+L I+ ++ + L+ Q
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWIL-IEFCDGGALDSIM-----LELERG---LTEPQI 105
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
+ L +LH ++IHR++K+ N+LL D K++DF +S + + +
Sbjct: 106 RYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162
Query: 120 TRVLGTFGYHAPEYAMTGQMSS-----KSDVYSFGVVLLELLTGRKP 161
+GT + APE K+D++S G+ L+EL P
Sbjct: 163 --FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-13
Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 33 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 92
G L D + K G++ +L+W ++ A+G+ YL EK R++HR++ + NVL
Sbjct: 93 GCLLDYVRNHKDNIGSQY--LLNWCVQI------AKGMSYLEEK---RLVHRDLAARNVL 141
Query: 93 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 152
+ KI+DF L+ H+ + A E + + KSDV+S+GV +
Sbjct: 142 VKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTV 201
Query: 153 LELLT-GRKPVD 163
EL+T G KP +
Sbjct: 202 WELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-13
Identities = 48/167 (28%), Positives = 85/167 (50%), Gaps = 15/167 (8%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL----------HGKKGVKGAKP 50
++SRLK+ N++ L+G VD + E+ G L+ L +G V A
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 51 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQ 109
P +S++ + +A+ A G++YL + +HR++ + N L+ ++ KI+DF +S N
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 110 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156
R+ VL + A E + G+ ++ SDV++FGV L E+L
Sbjct: 189 YAGDYYRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-13
Identities = 42/121 (34%), Positives = 60/121 (49%), Gaps = 12/121 (9%)
Query: 41 GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 100
G V P VL +IAV +GL YL +I+HR++K SN+L+ K
Sbjct: 84 GSLDVYRKIPEHVLG-----RIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVK 135
Query: 101 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160
+ DF +S Q ++ A+ + +GT Y APE Q SDV+S G+ +EL GR
Sbjct: 136 LCDFGVSTQLVNSIAKTY----VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF 191
Query: 161 P 161
P
Sbjct: 192 P 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-13
Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 31/229 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++S+ + V + G Y+ + E+ GS D+L +PGP L Q
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIA 104
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
I +GL+YLH + + IHR+IK++NVLL + K++DF ++ Q D ++
Sbjct: 105 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRN 159
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+GT + APE SK+D++S G+ +EL G P P L+ P
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP 219
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
E G Y + C+ E FRP +LK
Sbjct: 220 TLE------------GNYS----KPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 5e-13
Identities = 37/100 (37%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS------NQAPDAAARLHSTRV 122
LEYLH IIHR++K N+L+ + K++DF LS Q R+
Sbjct: 105 ALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 123 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
+GT Y APE + GQ SK+ D +S G +L E L G P
Sbjct: 162 VGTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-13
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 33/230 (14%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L N +V ++G + +L E A G L+ L K V + +V
Sbjct: 49 VMQQLDNPYIVRMIGI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKN---ITELVHQV 104
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ G++YL E +HR++ + NVLL AKISDF LS +A A +
Sbjct: 105 SM------GMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALGADENYYKA 154
Query: 121 RVLGTF--GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 177
+ G + ++APE + SSKSDV+SFGV++ E + G+KP +G +
Sbjct: 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY-----KGMKG----- 204
Query: 178 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227
++V Q +++ E P + +M + LC Y D RP +V
Sbjct: 205 ------NEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 7e-13
Identities = 51/164 (31%), Positives = 76/164 (46%), Gaps = 16/164 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
M+ ++ N+V G Y+ + E+ GSL DI GP LS Q
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-------VTRGP-LSELQIA 104
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ +GL YLHE IHR+IK +N+LL +D K++DF +S Q A+ S
Sbjct: 105 YVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS- 160
Query: 121 RVLGTFGYHAPEYA---MTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT + APE A G K D+++ G+ +EL + P
Sbjct: 161 -FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-13
Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL-----HGKKGVKGAKPGPV-- 53
+++ L + N+V L+G + +E+ ++G LH+ L H G + G V
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 54 -LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 112
L + IA+ A G+EYL + +H+++ + N+L+ + KISD LS +
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 113 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
A + L + PE M G+ SS SD++SFGVVL E+ + G +P
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-13
Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 31/172 (18%)
Query: 1 MVSRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
+++RL + +++ ++G D + E + GS+ +L K G A
Sbjct: 56 LMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLS--------KYGA-FKEAVI 105
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLH 118
+ RGL YLHE +IIHR++K +N+L+ +I+DF AAARL
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFG-------AAARLA 155
Query: 119 ST---------RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ ++LGT + APE Q DV+S G V++E+ T + P
Sbjct: 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-13
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 65
KN N+V + Y+ G + E+ + GSL D++ + Q +
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQIAAVCRE 124
Query: 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLG 124
+ LE+LH ++IHR+IKS N+LL D K++DF Q P+ + R + ++G
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVG 178
Query: 125 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLS- 182
T + APE K D++S G++ +E++ G P + P R + T TP+L
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238
Query: 183 --------EDKVKQCVD 191
D + +C+D
Sbjct: 239 PEKLSAIFRDFLNRCLD 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 8e-13
Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL+YLH I+HR+IK SN+L+ +D + K++DF L+ + ++ RV+ T Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 129 HAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 159
PE + + + D++S G +L EL G+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++S+ + + G Y+ G + E+ GS D+L KPGP L
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIA 104
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
I +GL+YLH + R IHR+IK++NVLL + K++DF ++ Q D ++
Sbjct: 105 TILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRN 159
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT + APE K+D++S G+ +EL G P
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-12
Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 6/110 (5%)
Query: 52 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 111
P A+ + A GLE+LH++ RI++R++K NVLL D +ISD L A
Sbjct: 90 PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AV 143
Query: 112 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ GT GY APE D ++ G L E++ GR P
Sbjct: 144 ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 57/164 (34%), Positives = 78/164 (47%), Gaps = 28/164 (17%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L++ N +E G Y+ L E+ GS DIL K KP Q V+IA
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK-----KP------LQEVEIA 118
Query: 64 V---GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
GA +GL YLH IHR+IK+ N+LL + K++DF A+ +
Sbjct: 119 AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG------SASLVSPAN 169
Query: 121 RVLGTFGYHAPE--YAM-TGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT + APE AM GQ K DV+S G+ +E L RKP
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 6 KNENVVELVG-YYVDGPLRVLAYEHASKGSLHDIL-HGKKGVKGAKPGPVLSWAQRVKIA 63
++ N+VE+ Y V L V+ E G+L DI+ H + ++ Q +
Sbjct: 74 QHPNIVEMYSSYLVGDELWVV-MEFLEGGALTDIVTHTR-----------MNEEQIATVC 121
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
+ + L +LH + +IHR+IKS ++LL D K+SDF Q R S ++
Sbjct: 122 LAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LV 176
Query: 124 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT + APE ++ D++S G++++E++ G P
Sbjct: 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 23/162 (14%)
Query: 4 RLKNENVVEL----VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
L++ N+VEL VG ++D V+ Y SL D + P P S +Q
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM----------PTP-FSESQV 110
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
+ + RGL+YLHE IIHR++K SN+LL D KI+DF L+ A
Sbjct: 111 KCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PM 165
Query: 120 TRVLGTFGYHAPE--YAMTGQMSSKSDVYSFGVVLLELLTGR 159
T + T Y APE T ++ D+++ G +L ELL +
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-12
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ L+++ +V+L P+ ++ E +KGSL D L +G K +P P L +
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----I 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ A G+ ++ ++ IHR+++++N+L+ + KI+DF L+ D ++
Sbjct: 106 DFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTA 159
Query: 121 RVLGTF--GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP--------VDHTLPRG 169
R F + APE G + KSDV+SFG++L+E++T GR P V L RG
Sbjct: 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
Query: 170 QQSLVTWATPKLSEDKVKQCVDTK 193
+ P+ + + +C +
Sbjct: 220 YRMPRPENCPEELYNIMMRCWKNR 243
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 36/204 (17%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG--------PVLSWAQRV 60
N++ L+G + +A E+A G+L D L K V P L+ Q +
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ A A G++YL EK + IHR++ + NVL+ ++ +KI+DF LS ++
Sbjct: 123 QFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVK 174
Query: 121 RVLGTFG--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP--------VDHTLPRG 169
+ +G + A E ++KSDV+SFGV+L E+++ G P + LP+G
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234
Query: 170 QQSLVTWATPKLSEDKV----KQC 189
+ P+ +D+V +QC
Sbjct: 235 YR----MEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-12
Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 18/180 (10%)
Query: 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 65
K+ N+V + Y+ G + E+ + GSL D++ + Q +
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQIAAVCRE 123
Query: 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLG 124
+ LE+LH ++IHR+IKS N+LL D K++DF Q P+ + R + ++G
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVG 177
Query: 125 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSE 183
T + APE K D++S G++ +E++ G P + P R + T TP+L
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-12
Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++S+ + V + G Y+ G + E+ GS D+L + GP + Q
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL---------RAGPFDEF-QIA 104
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ +GL+YLH + + IHR+IK++NVLL + K++DF ++ Q D ++
Sbjct: 105 TMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRN 159
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT + APE SK+D++S G+ +EL G P
Sbjct: 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-12
Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 18/178 (10%)
Query: 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 65
KN N+V + Y+ G + E+ + GSL D++ + Q +
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQIAAVCRE 123
Query: 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLG 124
+ L++LH ++IHR+IKS N+LL D K++DF Q P+ + R + ++G
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVG 177
Query: 125 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKL 181
T + APE K D++S G++ +E++ G P + P R + T TP+L
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-12
Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 23/182 (12%)
Query: 8 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV--- 64
N+ + G Y+ GP + E+A GS+ ++ K GP+ A++ I+V
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPI---AEKY-ISVIIR 108
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 124
L+Y+H+ +IHR+IK++N+L+ + K+ DF ++ A + +G
Sbjct: 109 EVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVG 163
Query: 125 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPV-DHTLPRGQQSLVTWATPKLS 182
T + APE G+ +K+D++S G+ + E+ TG P D R + P+L
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE 223
Query: 183 ED 184
++
Sbjct: 224 DN 225
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-12
Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 10/176 (5%)
Query: 1 MVSRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK---GVKGAKPGPVLSW 56
++SRLKN N++ L+G V D PL + E+ G L+ L ++ A P +S
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPL-CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAA 115
A + +AV A G++YL A +HR++ + N L+ + KI+DF +S N
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 171
R+ VL + A E + G+ ++ SDV++FGV L E+ T K ++L +Q
Sbjct: 186 RIQGRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-12
Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 21/193 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
MV K+ N+V G Y+ + E+ GSL DI H GP LS Q
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH--------VTGP-LSELQIA 109
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ +GL YLH K + +HR+IK +N+LL D+ K++DF ++ + A+ S
Sbjct: 110 YVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS- 165
Query: 121 RVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-- 175
+GT + APE A G + D+++ G+ +EL + P+ P L++
Sbjct: 166 -FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS 224
Query: 176 -WATPKLSEDKVK 187
+ PKL +DK K
Sbjct: 225 NFQPPKL-KDKTK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-12
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 22/159 (13%)
Query: 73 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 132
+H +IHR+IKS+N+LL + + K+ DF S + GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 133 YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 192
S K+D++S GV+L ELLT ++P D E+ +++ +
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD------------------GEN-MEEVMHK 256
Query: 193 KLGGEY---PPKAIAKMAAVAALCVQYEADFRPNMGIVL 228
L G Y PP +M + + + RP+ +L
Sbjct: 257 TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-12
Identities = 47/164 (28%), Positives = 85/164 (51%), Gaps = 17/164 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L++ +V L P+ ++ E+ GSL D L +G+K L+ + +
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPEGIK-------LTINKLI 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A A G+ ++ K IHR+++++N+L+ + KI+DF L+ D ++
Sbjct: 106 DMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTA 159
Query: 121 RVLGTF--GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
R F + APE G + KSDV+SFG++L E++T GR P
Sbjct: 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-12
Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 18/166 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP-VLSWAQR 59
++ L++EN+V+ +G +D + E+ GS+ +L+ GA V ++ ++
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQ 114
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP----DAAA 115
+ +GL YLH + IIHR+IK +N+L+ + KISDF +S +
Sbjct: 115 I------LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ G+ + APE + K+D++S G +++E+LTG+ P
Sbjct: 166 NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 1e-11
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 27/163 (16%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
LK+ N+V+L+ L +E+ L L + G P + S ++
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMYQL--- 107
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS---- 119
RGL Y H RI+HR++K N+L+ D + K++DF L AR
Sbjct: 108 ---LRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGL--------ARAFGIPLR 153
Query: 120 --TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
T + T Y APE + + S + D++S G + E++TG+
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 20/159 (12%)
Query: 10 VVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68
+V+ G ++++G + + E+ GSL D L+ P VL +I +
Sbjct: 61 IVDFYGAFFIEGAV-YMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR-----RITYAVVK 113
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL++L K E IIHR++K +NVL+ + K+ DF +S + A+ + +G Y
Sbjct: 114 GLKFL--KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSY 167
Query: 129 HAPEYAMTGQMSS------KSDVYSFGVVLLELLTGRKP 161
APE +G + +SDV+S G+ +LE+ GR P
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-11
Identities = 45/164 (27%), Positives = 92/164 (56%), Gaps = 13/164 (7%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+++++K+ N+V + + + E+ G L ++ ++GV ++ +LSW V
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSWF--V 108
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHS 119
+I++G L+++H++ +I+HR+IKS N+ L + +AK+ DF ++ Q D+ ++
Sbjct: 109 QISLG----LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
+GT Y +PE ++K+D++S G VL EL T + P +
Sbjct: 162 --CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-11
Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 33/232 (14%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L +E +V+L G + E+ S G L + L ++ K +P +L + V
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDV--- 109
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
G+ YL K + IHR++ + N L+ D K+SDF LS D +++ V
Sbjct: 110 ---CEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVG 160
Query: 124 GTF--GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180
F + PE + + SSKSDV++FGV++ E+ + G+ P + +
Sbjct: 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE----------------R 204
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232
+ + + V L P A K+ A+ C +A+ RP +L +++
Sbjct: 205 FNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 19/165 (11%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L + +V+L G + L +E G L D L ++G S + +
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK--------FSQETLLGMC 106
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
+ G+ YL +IHR++ + N L+ ++ + K+SDF ++ D T
Sbjct: 107 LDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD----QYTSST 159
Query: 124 GT---FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDH 164
GT + +PE + SSKSDV+SFGV++ E+ + G+ P ++
Sbjct: 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 2e-11
Identities = 32/111 (28%), Positives = 48/111 (43%), Gaps = 21/111 (18%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ------------------A 110
LEYLH K IIHR++K N+LL D KI+DF + +
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 111 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
R +GT Y +PE SD+++ G ++ ++LTG+ P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 44/137 (32%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 28 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 87
E+ +KGSL D L +G K P + + + A G+ Y+ K IHR+++
Sbjct: 81 EYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK---NYIHRDLR 130
Query: 88 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQMSSKSDV 145
++NVL+ + + KI+DF L+ D ++ R F + APE G + KSDV
Sbjct: 131 AANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 146 YSFGVVLLELLT-GRKP 161
+SFG++L E++T G+ P
Sbjct: 188 WSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-11
Identities = 37/162 (22%), Positives = 66/162 (40%), Gaps = 13/162 (8%)
Query: 5 LKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
LK+ N+V +D + L Y E+ G L ++ K + + W +
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-W----R 109
Query: 62 IAVGAARGLEYLH--EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
I L H ++HR++K +N+ L ++ K+ DF L+ ++ +
Sbjct: 110 ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT Y +PE KSD++S G ++ EL P
Sbjct: 170 --YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 64
L + +V L+G G L + + GSL D + + P +L+W ++
Sbjct: 66 LDHAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNWCVQI---- 118
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 124
A+G+ YL E R++HRN+ + N+LL D I +I+DF +++ + +
Sbjct: 119 --AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 125 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ A E + G+ + +SDV+S+GV + E+++ G +P
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKK-GVKGAKPGPVLSWAQRVKIAVGAA 67
+VV L+G G ++ E +KG L L ++ + + + +++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQ---APDAAARLHST 120
G+ YL K + +HR++ + N ++ +D KI DF D+ L
Sbjct: 130 DGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PV 185
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
R + APE G ++KSDV+SFGVVL E+ T
Sbjct: 186 R------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 3e-11
Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 64
LK+ N++ L+ + L +E L ++ K V P + S+
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV--LTPADIKSYMLM----- 110
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 124
RGLEYLH I+HR++K +N+L+ D + K++DF L+ ++ + +V+
Sbjct: 111 -TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV- 164
Query: 125 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 161
T Y APE + D++S G + ELL R P
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 15/142 (10%)
Query: 25 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84
L E GS+ D++ G + +++ I RGL YLHE ++IHR
Sbjct: 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-----ILRETLRGLAYLHEN---KVIHR 137
Query: 85 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-----YAMTGQM 139
+IK N+LL + K+ DF +S Q R ++ +GT + APE
Sbjct: 138 DIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTPYWMAPEVIACDEQPDASY 195
Query: 140 SSKSDVYSFGVVLLELLTGRKP 161
++SDV+S G+ +EL G+ P
Sbjct: 196 DARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-11
Identities = 55/166 (33%), Positives = 82/166 (49%), Gaps = 28/166 (16%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+ +LK+ N +E G Y+ L E+ GS D+L K KP Q V+
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVE 122
Query: 62 IAV---GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 118
IA GA +GL YLH +IHR+IK+ N+LL + K++DF ++++ A +
Sbjct: 123 IAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS--- 176
Query: 119 STRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKP 161
+GT + APE + GQ K DV+S G+ +E L RKP
Sbjct: 177 ---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-11
Identities = 33/89 (37%), Positives = 51/89 (57%)
Query: 73 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 132
L E +++HR++KS+N+ L I K+ DF S Q D+ + ++ GT Y APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 133 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ S K+D++S GV+L ELLT +P
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-11
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 126
A L++LH II+R++K N+LL ++ K++DF LS ++ D + +S GT
Sbjct: 108 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
Y APE + +D +SFGV++ E+LTG P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 43/120 (35%), Positives = 60/120 (50%), Gaps = 9/120 (7%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN-QAPDAAARLHSTRVLGTF 126
RGL+YLH I+HR+IK N+L+ + + KI DF L+ + PD H T+ + T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQ 168
Query: 127 GYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--WATPKLSE 183
Y APE M + +S D++S G + ELL R P Q L+T TP L
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-11
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 22/159 (13%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68
N++ L G ++ E+ GSL L G + Q V + G A
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--------FTVGQLVGMLRGIAS 117
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VL 123
G++YL +E +HR++ + N+L+ + + K+SDF LS + D+ A ++T+ +
Sbjct: 118 GMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIPIR 173
Query: 124 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
T APE + +S SDV+SFG+V+ E+++ G +P
Sbjct: 174 WT----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-11
Identities = 54/175 (30%), Positives = 84/175 (48%), Gaps = 23/175 (13%)
Query: 1 MVSRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDIL-----HGKKG-------VKG 47
M SRL++ N+V L+G + PL ++ + + S LH+ L H G VK
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMI-FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 48 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 107
L A V I A G+E+L + ++H+++ + NVL+FD KISD L
Sbjct: 120 T-----LEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLF 171
Query: 108 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ A L + +PE M G+ S SD++S+GVVL E+ + G +P
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-11
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 15/156 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ + + +V+ + V G + + H L+ L + L Q +
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPH-YSSDLYTYLTKRSRP--------LPIDQAL 160
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
I GL YLH + RIIHR++K+ N+ + D D I D + Q P A
Sbjct: 161 IIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFLG- 215
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156
+ GT +APE + +SK+D++S G+VL E+L
Sbjct: 216 -LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-11
Identities = 48/242 (19%), Positives = 98/242 (40%), Gaps = 53/242 (21%)
Query: 1 MVSRLKNENVVELVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 56
+ R+ + N++++ G+ +D P L E+ ++G L ++L +K LS+
Sbjct: 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---------LSF 121
Query: 57 AQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 115
++ +A+ +GL L++ +P ++N+ S + L+ ++ KI L
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177
Query: 116 RLHSTRVLGTFGYHAP--------EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 167
V Y + EY + K D+YS GVVL E+ TG+ P ++
Sbjct: 178 ---FKNV-NFMVYFSYKMLNDIFSEYTI------KDDIYSLGVVLWEIFTGKIPFEN--- 224
Query: 168 RGQQSLVTWATPKLSEDKVKQCVDTKLGGEY-PPKAIAKMAAVAALCVQYEADFRPNMGI 226
L+ ++ + K P ++ + C +++ RPN+
Sbjct: 225 -------------LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271
Query: 227 VL 228
+L
Sbjct: 272 IL 273
|
Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-11
Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 65
++ENVVE+ Y+ G + E G+L DI+ + ++ Q + +
Sbjct: 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLA 124
Query: 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 125
+ L LH + +IHR+IKS ++LL D K+SDF Q R S ++GT
Sbjct: 125 VLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGT 179
Query: 126 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ APE + D++S G++++E++ G P
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-11
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 15/155 (9%)
Query: 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 66
+ENVV++ Y+ G + E G+L DI+ + ++ Q + +
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIATVCLSV 127
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 126
R L YLH + +IHR+IKS ++LL D K+SDF Q + S ++GT
Sbjct: 128 LRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTP 182
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ APE ++ D++S G++++E++ G P
Sbjct: 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-11
Identities = 44/175 (25%), Positives = 82/175 (46%), Gaps = 17/175 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILH-------------GKKGVKG 47
+++ + N+V+L+G G L +E+ + G L++ L K
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 48 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 107
LS +++ IA A G+ YL +E + +HR++ + N L+ ++ + KI+DF LS
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 108 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
A S + PE + +++SDV+++GVVL E+ + G +P
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-10
Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 19/159 (11%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG--------PVLSWAQRV 60
N++ L+G LA E+A G+L D L K V P LS Q +
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
A ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS ++
Sbjct: 116 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVK 167
Query: 121 RVLGTFG--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
+ +G + A E ++ SDV+S+GV+L E+++
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 33/233 (14%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL-HDILHGKKGVKGAKPGPVLSWAQR 59
++ +L + NV++ + +++ + E A G L I H KK K P + W
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTI-WKYF 112
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
V++ LE++H K RI+HR+IK +NV + + K+ D L HS
Sbjct: 113 VQLC----SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
++GT Y +PE + KSD++S G +L E+ + P + ++
Sbjct: 166 --LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLC 217
Query: 180 KLSEDKVKQCVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIVL 228
K K+++C +YPP ++ + + C+ + + RP++ VL
Sbjct: 218 K----KIEKC-------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-10
Identities = 59/247 (23%), Positives = 105/247 (42%), Gaps = 57/247 (23%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++S +K+ N+V+ + + + ++ G L+ ++ ++GV + +L W ++
Sbjct: 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED-QILDWFVQI 110
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A L+++H++ +I+HR+IKS N+ L D K+ DF + A L+ST
Sbjct: 111 CLA------LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGI-------ARVLNST 154
Query: 121 RVL-----GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
L GT Y +PE ++KSD+++ G VL E+ T + H G
Sbjct: 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT----LKHAFEAGN----- 205
Query: 176 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
+K V + G YPP + Y D R + + K
Sbjct: 206 ----------MKNLVLKIIRGSYPP-----------VSSHYSYDLRNLVSQLFKR----- 239
Query: 236 NTRSGPS 242
N R PS
Sbjct: 240 NPRDRPS 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 54/233 (23%), Positives = 103/233 (44%), Gaps = 31/233 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L + NV++ + +++ + E A G L ++ K K P + W
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-W---- 109
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
K V +E++H + R++HR+IK +NV + + K+ D L HS
Sbjct: 110 KYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS- 165
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
++GT Y +PE + KSD++S G +L E+ + P + +L +
Sbjct: 166 -LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSLC--- 217
Query: 181 LSEDKVKQCVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIVLK 229
K++QC +YPP K+ + ++C+ + D RP++G V +
Sbjct: 218 ---QKIEQC-------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-10
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
L YLH+ E RI+HR++ +N++L +DD I+DF L+ Q + T V+GT Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180
Query: 130 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
PE K+DV++FG +L ++ T + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 54/167 (32%), Positives = 81/167 (48%), Gaps = 27/167 (16%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+ R+K+ N +E G Y+ L E+ GS D+L K KP Q V+
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVE 126
Query: 62 IAV---GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 118
IA GA +GL YLH +IHR+IK+ N+LL + K++DF ++ A A +
Sbjct: 127 IAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS--- 180
Query: 119 STRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPV 162
+GT + APE + GQ K DV+S G+ +EL + P+
Sbjct: 181 ---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
G+E LH++ IIHR+IK N+L+ K++DF LS L + + +GT Y
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDY 159
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + SD +S G V+ E L G P
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLA-YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+RL + N+V L+ P + A +E+ +L ++L A G L + +
Sbjct: 33 ARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL--------AADGA-LPAGETGR 83
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKISDFDLSNQAPDA--AAR 116
+ + L H + I+HR++K N+++ + AK+ DF + P A
Sbjct: 84 LMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADV 140
Query: 117 LHSTR---VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162
TR VLGT Y APE ++ SD+Y++G++ LE LTG++ V
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ LK+ N+V+ +G +D + E GS+ IL+ G P PV
Sbjct: 55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFC----- 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
K G+ YLH ++HR+IK +NV+L + I K+ DF + + +
Sbjct: 106 KYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162
Query: 121 RVL----GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+L GT + APE KSD++S G + E+ TG+ P
Sbjct: 163 NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 64
+K+ N+V+L+G P + E + G+L D L ++ + VL + +A
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMAT 111
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 124
+ +EYL +K IHR++ + N L+ ++ + K++DF LS H+
Sbjct: 112 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF- 167
Query: 125 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
+ APE + S KSDV++FGV+L E+ T
Sbjct: 168 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-10
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL++LH K I++R++K N+LL D KI+DF + + A+ + GT Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + + ++ D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQR 59
+ N++ L+G LA E+A G+L D L + ++ LS Q
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
+ A ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS ++
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 178
Query: 120 TRVLGTFG--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
+ +G + A E ++ SDV+S+GV+L E+++
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 52/165 (31%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 9 NVVELVG------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
NVV+ G V G L L E + GS+ +++ G G L A I
Sbjct: 80 NVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQRLDEAMISYI 133
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
GA GL++LH RIIHR++K +N+LL + K+ DF +S Q + RL
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTS 188
Query: 123 LGTFGYHAPEYAMTGQM-----SSKSDVYSFGVVLLELLTGRKPV 162
+GT + APE Q ++ DV+S G+ +EL G P+
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-10
Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 7/160 (4%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQ 58
++SRLK+ N++ L+ + + E+ G L+ L H + +S++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARL 117
+ +A A G++YL + +HR++ + N L+ + KI+DF +S N R+
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
VL + + E + G+ ++ SDV++FGV L E+LT
Sbjct: 189 QGRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-10
Identities = 49/166 (29%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 1 MVSRLKN-ENVVELVGY-YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 58
++S L N EN+V L+G + GP+ V+ E+ G L + L K+ L+
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRES-------FLTLED 142
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAP 111
+ + A+G+ +L K IHR++ + NVLL I KI DF L SN
Sbjct: 143 LLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV 199
Query: 112 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
ARL + APE + +SDV+S+G++L E+ +
Sbjct: 200 KGNARL-------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-10
Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 19/225 (8%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG-PVLSWAQRVKIAVGAA 67
+VV L+G G ++ E + G L L + PG P + + +++A A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
G+ YL+ K + +HR++ + N ++ D KI DF ++ + + L
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 128 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 187
+ APE G ++ SD++SFGVVL E+ SL LS ++V
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVL 231
Query: 188 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232
+ V + P ++ + +C Q+ RP ++ L+
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-10
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 17/98 (17%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPD----AAARLHS 119
ARG+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD ARL
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
+ APE +++SDV+SFGV+L E+ +
Sbjct: 238 -----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 9e-10
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GLE+LH++ RII+R++K NVLL +D +ISD L+ + D ++ + GT G+
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGF 163
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + D ++ GV L E++ R P
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 8/106 (7%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGY 128
L++LH+ II+R+IK N+LL + ++DF LS + + R +S GT Y
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEY 172
Query: 129 HAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 172
APE G D +S GV+ ELLTG P + QS
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 15/156 (9%)
Query: 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 65
+++NVVE+ Y+ G + E G+L DI+ + L+ Q +
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCES 125
Query: 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 125
+ L YLH + +IHR+IKS ++LL D K+SDF Q + S ++GT
Sbjct: 126 VLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 180
Query: 126 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ APE ++ D++S G++++E++ G P
Sbjct: 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-09
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 22/163 (13%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+ +L++ N ++ G Y+ L E+ GS D+L K KP L +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-----KP---LQEVEIAA 119
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
+ GA +GL YLH +IHR++K+ N+LL + + K+ DF A+ +
Sbjct: 120 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG------SASIMAPANX 170
Query: 122 VLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKP 161
+GT + APE + GQ K DV+S G+ +E L RKP
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 10/99 (10%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVL 123
ARG+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD R S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARL- 238
Query: 124 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ APE +++SDV+SFGV+L E+ + G P
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-09
Identities = 46/168 (27%), Positives = 83/168 (49%), Gaps = 26/168 (15%)
Query: 1 MVSRLKNENVVELV-GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
+++++K+ N+V + DG L ++ E+ G L + ++G K +L W +
Sbjct: 51 LLAKMKHPNIVAFKESFEADGHLYIVM-EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQ 108
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
+ + V +++HEK R++HR+IKS N+ L + K+ DF +ARL +
Sbjct: 109 MCLGV------QHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDF--------GSARLLT 151
Query: 120 TRV------LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ +GT Y PE ++KSD++S G +L EL T + P
Sbjct: 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
A GL++LHE+ II+R++K NVLL + KI+DF + + ++
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTF 156
Query: 123 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVD 163
GT Y APE ++ Q + D ++ GV+L E+L G+ P +
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GLE LH++ RI++R++K N+LL D +ISD L+ P+ + RV GT GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 167
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + + D ++ G +L E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL++LH K II+R++K NV+L D KI+DF + + R ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + + D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 5 LKNENVVEL--VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
L+++N+V+ V Y L E+ GSL D L + + +L +A ++
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRK--LLLYASQI-- 117
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
+G+EYL K R +HR++ + N+L+ ++ KI DF L+ P + R
Sbjct: 118 ----CKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVRE 169
Query: 123 LG---TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
G F Y APE + S SDV+SFGVVL EL T
Sbjct: 170 PGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 23/182 (12%)
Query: 58 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 117
Q V + G A G++YL +E +HR++ + N+L+ + + K+SDF LS D +
Sbjct: 107 QLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163
Query: 118 HSTRVLG---TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL 173
T LG + APE + +S SDV+S+G+V+ E+++ G +P
Sbjct: 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY----------- 212
Query: 174 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233
W +S V ++ P + + C Q + + RP G ++ L
Sbjct: 213 --W---DMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267
Query: 234 LL 235
++
Sbjct: 268 MI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 13/101 (12%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-----NQAPDAAARLHSTRV 122
GL+Y+H ++HR++K N+L+ D KI DF L+ N +A T
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG---FMTEY 169
Query: 123 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 162
+ T Y APE ++ Q +K+ DV+S G +L ELL GRKPV
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68
N++ L G ++ E+ GSL L G + Q V + G A
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIAS 117
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGT 125
G++YL ++ +HR++ + N+L+ + + K+SDF LS P+AA ++
Sbjct: 118 GMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--P 172
Query: 126 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ APE + +S SDV+S+G+V+ E+++ G +P
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 24/171 (14%)
Query: 9 NVVELVGYY-----VDGPLRVLAYEHASKGSLHDILHG--KKGVKGAKPGPVLSWAQRVK 61
NVV+ G Y +G L E + GS+ D++ G K+G + +P ++++
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP--IIAY----- 128
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
I A GL++LH + IHR++K +N+LL + K+ DF +S Q + RL
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNT 183
Query: 122 VLGTFGYHAPEY-AMTGQMSS----KSDVYSFGVVLLELLTGRKPVDHTLP 167
+GT + APE A Q+ S + DV+S G+ +EL G P+ P
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-09
Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 5 LKNENVVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
L +EN+V+ G + L E GSL + L K K Q++K
Sbjct: 63 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--------QQLKY 114
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHST 120
AV +G++YL + + +HR++ + NVL+ + KI DF L+ + +
Sbjct: 115 AVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 171
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
F Y APE + + SDV+SFGV L ELLT
Sbjct: 172 LDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-09
Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 4/150 (2%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL-SWAQRVKIAVGAA 67
+VV L+G G ++ E ++G L L + P S + +++A A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
G+ YL+ + +HR++ + N ++ +D KI DF ++ + + L
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 128 YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
+ +PE G ++ SDV+SFGVVL E+ T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-09
Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 21/102 (20%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-------- 119
RGL+Y+H ++HR++K SN+LL + KI DF L AR+
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL--------ARIADPEHDHTGF 165
Query: 120 -TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
T + T Y APE + + +K+ D++S G +L E+L+ R
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 5e-09
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHSTRVLGTF 126
RGL+YLH +IHR++K SN+L+ + KI DF L+ PD + T + T
Sbjct: 114 RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 127 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE ++ +K+ D++S G + ELLT +
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-09
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 27/166 (16%)
Query: 4 RLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+L + +V+L G PL ++ E G L + L ++G +LS Q V
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVT-EFMENGCLLNYLRQRQGKLS--KDMLLSMCQDV-- 109
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
G+EYL + IHR++ + N L+ + K+SDF ++ D
Sbjct: 110 ----CEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-------DEY 155
Query: 123 LGTFG------YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ G + PE + SSKSDV+SFGV++ E+ T G+ P
Sbjct: 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 21/167 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ + + N++ L G ++ E+ G+L L G S Q V
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLV 110
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ G A G++YL ++ +HR++ + N+L+ + K+SDF LS D ++T
Sbjct: 111 GMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT 167
Query: 121 RVLGTFG-----YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ G + APE + +S SDV+SFG+V+ E+++ G +P
Sbjct: 168 ----SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL Y H+K +HR+IK SN+LL + K++DF L+ +R ++ +V+ T Y
Sbjct: 128 GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWY 183
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 162
PE + + + DV+S G +L EL T +KP+
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 14/154 (9%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68
++V+L+G + P+ ++ E A G L L K L A + + +
Sbjct: 68 HIVKLIGVITENPVWIV-MELAPLGELRSYLQVNKYS--------LDLASLILYSYQLST 118
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L YL K R +HR+I + NVL+ D K+ DF LS + + + +++ +
Sbjct: 119 ALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKLPIKW 174
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
APE + +S SDV+ FGV + E+L G KP
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 37/94 (39%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL++LH+K II+R++K NVLL D KI+DF + + + + ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + GQ ++S D +SFGV+L E+L G+ P
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-09
Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 26/145 (17%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D +TR
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 186
Y APE + +++ D++S G ++ ELLTGR TL G + D++
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-----TLFPGTDHI----------DQL 227
Query: 187 KQCVDTKLGGEYPPKAIAKMAAVAA 211
K + +L G + + K+++ +A
Sbjct: 228 KLIL--RLVGTPGAELLKKISSESA 250
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 30/146 (20%)
Query: 25 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84
+ Y + + G+L L + + P LS Q V +A+ A G+ YLH++ +IH+
Sbjct: 86 VLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACGMSYLHKR---GVIHK 141
Query: 85 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH-------------AP 131
+I + N ++ ++ KI+D LS R L YH A
Sbjct: 142 DIAARNCVIDEELQVKITDNALS-------------RDLFPMDYHCLGDNENRPVKWMAL 188
Query: 132 EYAMTGQMSSKSDVYSFGVVLLELLT 157
E + + SS SDV+SFGV+L EL+T
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 8e-09
Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 1 MVSRLKNENVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV--LSWA 57
++ +L++EN+V L + G L L +E+ + +L ++L G G P V W
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRL-YLVFEYVER-TLLELLEASPG--GLPPDAVRSYIW- 107
Query: 58 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 117
Q ++ + Y H IIHR+IK N+L+ + + K+ DF + A
Sbjct: 108 QLLQ-------AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR-ARPAS 156
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
T + T Y APE + K DV++ G ++ ELL G
Sbjct: 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-09
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 12/96 (12%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLH--STRVLG 124
+GL + H I+HR++K N+L+ + + K++DF L+ H TR
Sbjct: 109 QGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR--- 162
Query: 125 TFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGR 159
Y APE + S+ D++S G + ELL+ R
Sbjct: 163 --WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-09
Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL--SNQAPDAAARLHSTRVLG 124
A GL +LH K II+R++K NV+L + KI+DF + N R G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFCG 163
Query: 125 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
T Y APE D ++FGV+L E+L G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-09
Identities = 39/114 (34%), Positives = 60/114 (52%), Gaps = 19/114 (16%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN-QAPDAAARLHSTRVLGTF 126
RGL+Y+H ++HR++K SN+L+ ++ KI DF L+ Q P T + T
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP------QMTGYVSTR 169
Query: 127 GYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPV----DHTLPRGQQSLVT 175
Y APE +T Q + D++S G + E+L G KP+ DH Q S++T
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHV---NQFSIIT 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 45/169 (26%), Positives = 71/169 (42%), Gaps = 27/169 (15%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ L++E +V+ G D + E+ GS+ D L G + R
Sbjct: 57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--------KAYGALTETVTR- 107
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
K G+EYLH I+HR+IK +N+L K+ DF A+ RL +
Sbjct: 108 KYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDF-------GASKRLQTI 157
Query: 121 R--------VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
V GT + +PE K+DV+S G ++E+LT + P
Sbjct: 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 11/94 (11%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D T + T
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----TGYVATRW 180
Query: 128 YHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGR 159
Y APE M M + D++S G ++ ELLTG+
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 16/98 (16%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQAPDAAARLHSTRVLG 124
GLE++H + +++R++K +N+LL + +ISD D S + P A+ +G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VG 157
Query: 125 TFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 161
T GY APE G S +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 16/98 (16%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQAPDAAARLHSTRVLG 124
GLE++H + +++R++K +N+LL + +ISD D S + P A+ +G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VG 157
Query: 125 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 161
T GY APE G S +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 15/155 (9%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68
N+V L G G ++ E+ S G+L L +G L Q + + G A
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--------LVAGQLMGMLPGLAS 118
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLGTFG 127
G++YL +E +H+ + + VL+ D + KIS F + D + +++T
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE--DKSEAIYTTMSGKSPVL 173
Query: 128 YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ APE SS SDV+SFG+V+ E+++ G +P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 44/175 (25%)
Query: 1 MVSRLKNENVVELVGYYVD---GPLRVLAYEHASKGSLHDILHG--KKGVKGAKPGPVLS 55
++ + NV+ L+G + PL VL Y + HG + ++ P
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPY----------MKHGDLRNFIRSETHNPT-- 96
Query: 56 WAQRVKIAVG----AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 111
VK +G A+G+EYL A + +HR++ + N +L + K++DF L+
Sbjct: 97 ----VKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIY 149
Query: 112 D---------AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
D A+L + A E T + ++KSDV+SFGV+L EL+T
Sbjct: 150 DKEYYSVHNHTGAKL-------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GLE LH + RI++R++K N+LL D +ISD L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + + D + G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
L+YLH +IIHR++K+ NVLL D K++DF +S + R S +GT +
Sbjct: 123 LQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWM 177
Query: 130 APEYAMTGQMSS-----KSDVYSFGVVLLEL 155
APE M M K+D++S G+ L+E+
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 7/96 (7%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
G+ +LH+ I+HR++K+SN+LL + I KI DF L+ + T+++ T
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLW 171
Query: 128 YHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPV 162
Y APE + + S+ D++S G + ELLT +KP+
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GLE LH + ++R++K N+LL D +ISD L+ + P+ RV GT GY
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVGY 167
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + + D + G ++ E++ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
G+ +LH I++R++K NVLL D ++SD L+ + D T+ GT GY
Sbjct: 107 GILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGY 160
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE S D ++ G + E++ GR P
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
RGL+Y+H IIHR++K SNV + +D +I DF L+ QA D +TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE + +++ D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 18/103 (17%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPD----AAARLHS 119
A+G+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD ARL
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ APE + +SDV+SFGV+L E+ + G P
Sbjct: 244 -----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 52/163 (31%), Positives = 79/163 (48%), Gaps = 23/163 (14%)
Query: 1 MVSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 58
++S+LK+ N+V + DG L ++ G L+ L +KG +L Q
Sbjct: 52 LLSQLKHPNIVAYRESWEGEDGLLYIVM-GFCEGGDLYHKLKEQKG-------KLLPENQ 103
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD----LSNQAPDAA 114
V+ V A L+YLHEK I+HR++K+ NV L +I K+ D L NQ D A
Sbjct: 104 VVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMA 159
Query: 115 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
+ L +GT Y +PE + KSDV++ G + E+ T
Sbjct: 160 STL-----IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-08
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 25 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84
L E GS+ D++ KG L I RGL +LH+ ++IHR
Sbjct: 86 LVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQH---KVIHR 135
Query: 85 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS--- 141
+IK NVLL ++ K+ DF +S Q R ++ +GT + APE +
Sbjct: 136 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATY 193
Query: 142 --KSDVYSFGVVLLELLTGRKPV 162
KSD++S G+ +E+ G P+
Sbjct: 194 DFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 12/132 (9%)
Query: 33 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 92
G L D + K G++ +L+W ++ A+G+ YL E R++HR++ + NVL
Sbjct: 93 GCLLDYVRENKDRIGSQD--LLNWCVQI------AKGMSYLEEV---RLVHRDLAARNVL 141
Query: 93 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 152
+ + KI+DF L+ H+ + A E + + + +SDV+S+GV +
Sbjct: 142 VKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTV 201
Query: 153 LELLT-GRKPVD 163
EL+T G KP D
Sbjct: 202 WELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
RGL+Y+H ++HR++K SN+LL + KI DF L+ + + T + T
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRW 173
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 162
Y APE + + + DV+S G + ELL GRKP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 52 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 111
P LS+ V + A G+E+L K +HR++ + NVL+ + + KI DF L+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 112 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
+ + + APE ++ SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-08
Identities = 39/164 (23%), Positives = 80/164 (48%), Gaps = 14/164 (8%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ L + N++E +++ ++ E+A G+L + + K+ +L + ++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFVQI 110
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHS 119
+A L ++H K I+HR++K+ N+LL + KI DF +S + +
Sbjct: 111 LLA------LHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---A 158
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
V+GT Y +PE + KSD+++ G VL EL + ++ +
Sbjct: 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-08
Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 33/225 (14%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+++ + + ++V L+G + P L + G L D +H K G++ +L+W ++
Sbjct: 62 IMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQL--LLNWCVQI 118
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
A+G+ YL E+ R++HR++ + NVL+ + KI+DF L+ ++
Sbjct: 119 ------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP 179
+ A E + + +SDV+S+GV + EL+T G KP D + T P
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--------GIPTREIP 221
Query: 180 KLSE--DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222
L E +++ Q PP + V C +AD RP
Sbjct: 222 DLLEKGERLPQ----------PPICTIDVYMVMVKCWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-08
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GLE L + RI++R++K N+LL D +ISD L+ Q P+ RV GT GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV--RGRV-GTVGY 167
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + + D + G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-08
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 13/101 (12%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL---------SNQAPDAAARLHS 119
G+ YLHE I+HR+IK++N+L+ + I KI+DF L + +
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 120 TRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 159
T ++ T Y PE + + ++ D++ G V E+ T R
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 38/118 (32%), Positives = 53/118 (44%), Gaps = 22/118 (18%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGT 125
G+ YLH + I+HR+IK SN+L+ KI+DF +S Q D +GT
Sbjct: 180 GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-----NSSVGT 231
Query: 126 FGYHAPEYAMTGQMSSK-----SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
Y +PE T D++S GV +LE GR P G+Q WA+
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP----FGVGRQG--DWAS 283
|
Length = 353 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 12/90 (13%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVLGT 125
G+ Y+H++ RI+HR++K+ N+ L +++ KI DF +S + D A T GT
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLA-----TTFTGT 168
Query: 126 FGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155
Y +PE SKSD++S G +L E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
M+ LK EN+VEL + L +E+ K L + ++ G P V S+ ++
Sbjct: 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQL 109
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ + + H+ I+HR+IK N+L+ +D+ K+ DF + + + + T
Sbjct: 110 ------IKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYT 159
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
+ T Y +PE + D++S G +L EL G+
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 9e-08
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 17/99 (17%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----TRV 122
RG+++LH RI+HR++K N+L+ D KI+DF L AR++S T V
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL--------ARIYSFEMALTSV 166
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ T Y APE + ++ D++S G + EL R+P
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-08
Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 10/161 (6%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L + NV++ +++ + E A G L ++ K K P + W
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-W---- 109
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
K V LE++H + R++HR+IK +NV + + K+ D L HS
Sbjct: 110 KYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS- 165
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
++GT Y +PE + KSD++S G +L E+ + P
Sbjct: 166 -LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 31/125 (24%), Positives = 51/125 (40%), Gaps = 29/125 (23%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLL--------FDDDIAKI----SDFDLSNQAPDAAAR 116
+EY+H K ++HR++K N+LL D A + L +
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 117 LHST----RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT---------GRK-PV 162
S +++GT Y APE + S +D+Y+ GV+L ++LT GRK
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241
Query: 163 DHTLP 167
+
Sbjct: 242 RDVIL 246
|
Length = 932 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
EYLH + II+R++K N+LL + K+ DF + + + + GT Y
Sbjct: 106 FEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWT--FCGTPEYV 159
Query: 130 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + D +S G++L ELLTGR P
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 4/101 (3%)
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
V A+G+ YL E+ R++HR++ + NVL+ KI+DF L+ H+
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 124 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 163
+ A E + + +SDV+S+GV + EL+T G KP D
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 18/139 (12%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
LE+LH++ II+R++K N+LL K++DF L ++ H+ GT Y
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYM 167
Query: 130 APEYAMTGQMSSKSDVYSFGVVLLELLTG---------RKPVDHTLPRGQQSLVTWATPK 180
APE M D +S G ++ ++LTG +K +D L +G+ +L + TP+
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-KGKLNLPPYLTPE 226
Query: 181 ---LSEDKVKQCVDTKLGG 196
L + +K+ ++LG
Sbjct: 227 ARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 35/107 (32%), Positives = 53/107 (49%), Gaps = 7/107 (6%)
Query: 58 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 117
Q V A + GL +LH + II+R++K NV+L + KI+DF + +
Sbjct: 102 QAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-- 156
Query: 118 HSTRVL-GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
+TR GT Y APE D +++GV+L E+L G+ P D
Sbjct: 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 18/103 (17%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAARLHS 119
A+G+++L K IHR++ + NVLL D +AKI DF L SN ARL
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL-- 276
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ APE + +SDV+S+G++L E+ + G+ P
Sbjct: 277 -----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVLG 124
RGL+Y+H +IHR++K SN+L+ +D +I DF ++ +P T +
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY-FMTEYVA 173
Query: 125 TFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPV 162
T Y APE ++ + ++ D++S G + E+L GR+ +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 41/147 (27%), Positives = 76/147 (51%), Gaps = 21/147 (14%)
Query: 28 EHASKGSLHDILHGKKGVKGA-------------KPGPVLSWAQRVKIAV-GAARGLEYL 73
+HA+ +LHDI+H ++ + G ++S VKI + RGL Y
Sbjct: 61 KHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMS-MHNVKIFMFQLLRGLSYC 119
Query: 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 133
H++ +I+HR++K N+L+ + K++DF L+ +A + +S V+ T Y P+
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPDV 174
Query: 134 AM-TGQMSSKSDVYSFGVVLLELLTGR 159
+ + + S+ D++ G +L E+ TGR
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
LEYLH + +++R+IK N++L D KI+DF L + A + + GT Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 130 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE D + GVV+ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 10/92 (10%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L YLHE +IIHR++K+ N+L D K++DF +S + R S +GT +
Sbjct: 115 ALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYW 169
Query: 129 HAPEYAMTGQMSS-----KSDVYSFGVVLLEL 155
APE M K+DV+S G+ L+E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 39/108 (36%), Positives = 54/108 (50%), Gaps = 9/108 (8%)
Query: 58 QRVKIAVGA-ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAA 115
Q V+I G LE+LH+ II+R+IK N+LL + ++DF LS + D
Sbjct: 105 QEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKS--DVYSFGVVLLELLTGRKP 161
R +S GT Y AP+ G D +S GV++ ELLTG P
Sbjct: 162 RAYS--FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 17/100 (17%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----TRV 122
RGL++LH I+HR++K N+L+ K++DF L AR++S T V
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL--------ARIYSCQMALTPV 167
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162
+ T Y APE + ++ D++S G + E+ RKP+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 41/120 (34%), Positives = 54/120 (45%), Gaps = 13/120 (10%)
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD----FDLSNQAPDAAARL 117
I GA RGL YLH+ IHRNIK+S++L+ D + +S + L A
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 118 H----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
ST VL + G + KSD+YS G+ EL TGR P + R Q L
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGRVPF-QDMLRTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L+YLH +E +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 162
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE D + GVV+ E++ GR P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 5/95 (5%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L +LHE+ II+R++K NVLL D K++D+ + + ++ GT Y
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
APE + D ++ GV++ E++ GR P D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-07
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 46/241 (19%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++S+L ++++V+L G V ++ E+ G L LH +K L W ++
Sbjct: 54 LMSQLSHKHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKN------NVSLHW--KL 104
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-------AKISDFDLSNQAPDA 113
+A A L YL +K +++H N+ N+L+ + K+SD +
Sbjct: 105 DVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQ 170
R+ + APE GQ ++ +D +SFG LLE+ + G +P+
Sbjct: 162 EERVERIPWI------APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL-------- 207
Query: 171 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230
+T SE + + P A++A + C Y+ RP+ +L+
Sbjct: 208 ------STLSSSEKERFY----QDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257
Query: 231 L 231
L
Sbjct: 258 L 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-07
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 40/173 (23%)
Query: 5 LKNENVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW---AQR 59
LK+ENVV LV ++ V L +++A HD+ ++ + A+R
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQ------------IIKFHRQAKR 102
Query: 60 VKIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLS 107
V I + G+ YLH ++HR++K +N+L+ + + KI D L+
Sbjct: 103 VSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
Query: 108 N--QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLT 157
AP V+ T Y APE + + +K+ D+++ G + ELLT
Sbjct: 160 RLFNAP-LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
RGL +LH ++IHR+IK NVLL ++ K+ DF +S Q R ++ +GT
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 186
Query: 128 YHAPEYAMTGQ-----MSSKSDVYSFGVVLLELLTGRKPV 162
+ APE + +SD++S G+ +E+ G P+
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 17/100 (17%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----TRV 122
RGL++LH R++HR++K N+L+ K++DF L AR++S T V
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSV 169
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162
+ T Y APE + ++ D++S G + E+ RKP+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-07
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L+YLH +I++R++K N++L D KI+DF L + AA + + GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEY 161
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE D + GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 41/147 (27%), Positives = 76/147 (51%), Gaps = 21/147 (14%)
Query: 28 EHASKGSLHDILHGKKGV--------KGAKP-----GPVLSWAQRVKIAV-GAARGLEYL 73
+HA+ +LHDI+H K + K K G ++S VKI + RGL Y
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS-MHNVKIFLYQILRGLAYC 120
Query: 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 133
H + +++HR++K N+L+ + K++DF L+ +A + +S V+ T Y P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPDV 175
Query: 134 AM-TGQMSSKSDVYSFGVVLLELLTGR 159
+ + + S++ D++ G + E+ +GR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 15/170 (8%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRV 60
SRL + N+ L+G P + E+ G L+ L H + A LS++ +
Sbjct: 74 SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLL 133
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A A G+ YL +HR++ + N L+ + KI+DF +S + + +
Sbjct: 134 YMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDYY- 186
Query: 121 RVLGT----FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDH 164
RV G + A E + G+ ++KSDV++FGV L E+LT +P +H
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 34/130 (26%), Positives = 67/130 (51%), Gaps = 10/130 (7%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA-KISDFDLSN-QAPDAAARLHSTRVLGT 125
RGL+Y+H ++HR++K +NV + +D+ KI DF L+ P + + + + L T
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 126 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRK--PVDHTLPRGQQSLVTWATPKLS 182
Y +P ++ +K+ D+++ G + E+LTG+ H L Q L+ + P +
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILESVPVVR 239
Query: 183 EDKVKQCVDT 192
E+ + ++
Sbjct: 240 EEDRNELLNV 249
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 8/91 (8%)
Query: 71 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 130
EYLH K II+R++K N+LL + K++DF + + PD L GT Y A
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----CGTPEYLA 183
Query: 131 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
PE + D ++ GV+L E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-07
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 10/135 (7%)
Query: 23 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 82
R +Y+ ++ + ++L G +G +LS+ +V ARG+E+L A +
Sbjct: 210 RPASYKGSNDSEVKNLL-SDDGSEGLTTLDLLSFTYQV------ARGMEFL---ASKNCV 259
Query: 83 HRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK 142
HR++ + NVLL I KI DF L+ + + + APE ++
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL 319
Query: 143 SDVYSFGVVLLELLT 157
SDV+S+G++L E+ +
Sbjct: 320 SDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-07
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L YLHE+ II+R++K NVLL + K++D+ + + ++ GT Y
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
APE D ++ GV++ E++ GR P D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 7e-07
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+ L+++H I HR+IK N+L+ DDI K++DF ++ T + T
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILI-KDDILKLADF---GSCRGIYSKPPYTEYISTRW 163
Query: 128 YHAPEYAMT-GQMSSKSDVYSFGVVLLELLT 157
Y APE +T G K D+++ G V E+L+
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-07
Identities = 34/107 (31%), Positives = 51/107 (47%), Gaps = 11/107 (10%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHSTRVLGTF 126
R L+Y+H + HR++K N+L D KI DF L+ A D + T + T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 127 GYHAPEY--AMTGQMSSKSDVYSFGVVLLELLTGR-----KPVDHTL 166
Y APE + + + D++S G + E+LTG+ K V H L
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-07
Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 12/101 (11%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+GL+Y+H IIHR++K N+ + +D KI DF L+ Q TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR---KPVDH 164
Y APE + +++ D++S G ++ E+LTG+ K DH
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 9e-07
Identities = 34/121 (28%), Positives = 51/121 (42%), Gaps = 32/121 (26%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-----------------P 111
LEYLH I++R++K N+LL + +SDFDLS Q+
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 112 DAAARLHSTRV----------LGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRK 160
+ T +GT Y APE ++G S D ++ G++L E+L G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 161 P 161
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 8/98 (8%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
L YLH +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 130 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV---DH 164
APE D + GVV+ E++ GR P DH
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL+YLHE +I++R++K N+LL + KI+DF L + R ST GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT-ST-FCGTPEF 167
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + D + GV++ E+L G P
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 9 NVVELVGYYVDG--------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
NV++L+G + P+ +L + G LH L + + P+ +
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPF--MKHGDLHSFLLYSRLGGLPEKLPL---QTLL 116
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLH 118
K V A G+EYL + IHR++ + N +L +D ++DF LS + + D +
Sbjct: 117 KFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
++ + A E +SKSDV++FGV + E+ T G+ P
Sbjct: 174 IAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 46/171 (26%), Positives = 71/171 (41%), Gaps = 29/171 (16%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 58
++ L +E +V+ G D R L+ EH GS+ D L K L+
Sbjct: 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---------KSYGALTENV 107
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 118
K G+ YLH I+HR+IK +N+L K+ DF A+ RL
Sbjct: 108 TRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG-------ASKRLQ 157
Query: 119 S--------TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ V GT + +PE K+D++S G ++E+LT + P
Sbjct: 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGT 125
GL Y+H +I+HR++K++N+L+ D I K++DF L+ + + ++ ++ RV+ T
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 126 FGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPV 162
Y PE + D++ G ++ E+ T R P+
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 38/146 (26%), Positives = 71/146 (48%), Gaps = 19/146 (13%)
Query: 28 EHASKGSLHDILHGKKGV--------KGAKP-----GPVLSWAQRVKIAVGAARGLEYLH 74
+HA+ +LHDI+H +K + K K G ++ RGL Y H
Sbjct: 62 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 134
+ +++HR++K N+L+ + K++DF L+ +A + +S V+ T Y P+
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVV-TLWYRPPDIL 176
Query: 135 M-TGQMSSKSDVYSFGVVLLELLTGR 159
+ + S++ D++ G + E+ TGR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGY 128
LE+LH+ I++R+IK N+LL + ++DF LS + + R +S GT Y
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEY 172
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
APE K+ D +S G+++ ELLTG P R QS V+
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 29/106 (27%), Positives = 46/106 (43%), Gaps = 18/106 (16%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF-------------DLSNQAPDAA 114
GL LH+ +HR++ +N+ + I KI+DF LS
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 115 ARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 159
+++V+ T Y APE M + D++S G + ELLTG+
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
A A GL +LH K II+R++K NV+L + KI+DF + + + + +
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTF 161
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
GT Y APE D ++FGV+L E+L G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-06
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 15/164 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 58
++ L++E +V+ G D + L E+ GS+ D L K L+ +
Sbjct: 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---------KAYGALTESV 107
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 118
K G+ YLH I+HR+IK +N+L K+ DF S +
Sbjct: 108 TRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT 164
Query: 119 STR-VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
R V GT + +PE K+DV+S G ++E+LT + P
Sbjct: 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
L +LHE+ II+R++K NVLL + K++D+ + + ST GT Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTST-FCGTPNYI 163
Query: 130 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
APE D ++ GV++ E++ GR P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLG 124
+ L+Y+H +IHR++K SN+LL D K++DF L+ ++ + T +
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 125 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
T Y APE + +K D++S G +L E+L G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-06
Identities = 28/108 (25%), Positives = 47/108 (43%), Gaps = 3/108 (2%)
Query: 54 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 113
L Q + I L YLH + IIHR++K+ N+ L + + A + DF + +
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT ++PE +K+D++S G+VL E+
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 37/172 (21%)
Query: 1 MVSRLKNENVVEL------------VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA 48
++ LK+EN+V L V Y+D L+ H +G+L
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGAL------------- 97
Query: 49 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 108
P V S+ ++ +G+ + HE R++HR++K N+L+ K++DF L+
Sbjct: 98 DPNTVKSFTYQL------LKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA- 147
Query: 109 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
+A S V+ T Y AP+ + + S S D++S G ++ E++TGR
Sbjct: 148 RAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-06
Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 17/162 (10%)
Query: 9 NVVELVGYYVDG------PLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQR-V 60
NV+ L+G + P V+ G LH +L+ + G P Q V
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-----DCPQYLPTQMLV 115
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
K A G+EYL K IHR++ + N +L ++ ++DF LS + +
Sbjct: 116 KFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGR 172
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ A E ++KSDV+SFGV + E+ T G+ P
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAARLHS 119
A+G+ +L K IHR++ + N+LL I KI DF L SN ARL
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ APE + +SDV+S+G++L E+ + G P
Sbjct: 279 -----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-06
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
GL+Y+H IIHR++K N+ + +D KI DF L+ A DA T + T
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA-DA----EMTGYVVTRW 179
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE + +++ D++S G ++ E+LTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-06
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
R ++YLHE RIIHR+IK+ N+ + + DF + D A + GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIA 248
Query: 128 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
+APE D++S G+VL E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-06
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTACTNFMMTPYVVTRYY 188
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158
APE + D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 29/97 (29%), Positives = 56/97 (57%), Gaps = 7/97 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
G+ + H + R++HR++K N+L+ + + K++DF L+ +A R+++ V+ T Y
Sbjct: 113 GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVYTHEVV-TLWY 167
Query: 129 HAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDH 164
APE + S+ D++S G + E+ T +KP+ H
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-06
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--- 126
L +LH+K II+R++K NVLL + K++DF + + + + + TF
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG------IFNGKTTSTFCGT 159
Query: 127 -GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
Y APE D ++ GV+L E+L G P +
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-06
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 21/147 (14%)
Query: 28 EHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIAVGAARGLEYL 73
+HA+ LHDI+H K+ + PG + + R+ RGL Y+
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYI 119
Query: 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 133
H + I+HR++K N+L+ K++DF L+ +A ++ +S+ V+ T Y P+
Sbjct: 120 HGQ---HILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV-TLWYRPPDV 174
Query: 134 AM-TGQMSSKSDVYSFGVVLLELLTGR 159
+ SS D++ G + +E+L G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-05
Identities = 27/92 (29%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
RGL Y+H++ I+HR++K N+L+ D K++DF L+ +A + +S V+ T
Sbjct: 114 RGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVV-TLW 168
Query: 128 YHAPEYAM-TGQMSSKSDVYSFGVVLLELLTG 158
Y P+ + + + S+ D++ G + +E++ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 183
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
APE + D++S G ++ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
LE+LH+ I++R++K N+LL + DF LS + + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 130 APEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + + +K D +S GV++ E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 27/84 (32%), Positives = 40/84 (47%), Gaps = 5/84 (5%)
Query: 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT----G 137
IHR++K N+LL K++DF + DA + +GT Y +PE + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 138 QMSSKSDVYSFGVVLLELLTGRKP 161
+ D +S GV L E+L G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 28/93 (30%), Positives = 54/93 (58%), Gaps = 6/93 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
RGL Y H++ R++HR++K N+L+ + K++DF L+ +A ++ +S V+ T
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPSKTYSNEVV-TLW 168
Query: 128 YHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 159
Y P+ + + + S+ D++ G + E+ TGR
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 17/160 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
M+ +L++EN+V L+ + L +E L D+ G+ RV
Sbjct: 53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLD----------ESRV 102
Query: 61 -KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
K RG+E+ H IIHR+IK N+L+ + K+ DF + AA
Sbjct: 103 RKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVY 157
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTG 158
T + T Y APE + ++ D+++ G ++ E+LTG
Sbjct: 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL + H R++HR++K N+L+ + K++DF L+ +A R ++ V+ T Y
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TLWY 166
Query: 129 HAPEYAMTGQM-SSKSDVYSFGVVLLELLTGR 159
APE + + S+ D++S G + E++T R
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
LEYLH K I++R++K N+LL + K++DF + + D L GT Y
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTPEYL 165
Query: 130 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + + D ++ G+++ E+L G P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 38/143 (26%), Positives = 55/143 (38%), Gaps = 46/143 (32%)
Query: 82 IHRNIKSSNVLLFDDDIAKISDF--------------------------DLSNQAPDA-- 113
IHR+IK N+L+ D K++DF D SN+ D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 114 -------------AARLH----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156
AAR H + ++GT Y APE + + D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 157 TGRKPVDHTLP-RGQQSLVTWAT 178
G+ P P Q ++ W T
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQT 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 29/166 (17%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
M+ +LK+ N+V L+ + L +E+ L+++ +GV
Sbjct: 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH---------LIK 103
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS- 119
KI + + + H+ IHR++K N+L+ K+ DF AR+ +
Sbjct: 104 KIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF--------ARILTG 152
Query: 120 -----TRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTG 158
T + T Y APE + G Q DV++ G V ELLTG
Sbjct: 153 PGDDYTDYVATRWYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 29/95 (30%), Positives = 40/95 (42%), Gaps = 5/95 (5%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 126
A L YLH II+R++K N+LL ++DF L + ++ GT
Sbjct: 106 ASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTP 160
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
Y APE D + G VL E+L G P
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-05
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 191
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
APE + D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 26/83 (31%), Positives = 36/83 (43%), Gaps = 5/83 (6%)
Query: 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 140
IHR++K N L+ K++DF LS +S V+G+ Y APE
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPEVLRGKGYD 176
Query: 141 SKSDVYSFGVVLLELLTGRKPVD 163
D +S G +L E L G P
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 7e-05
Identities = 27/96 (28%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+GL + H ++HR++K N+L+ + K++DF L+ +A R +S V+ T
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLW 164
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 162
Y P+ ++ S S D++S G + EL +P+
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+G+ Y H R++HR++K N+L+ + K++DF L+ +A R ++ V+ T
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTHEVV-TLW 164
Query: 128 YHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 161
Y APE + Q S+ D++S G + E++ R+P
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 31/119 (26%), Positives = 46/119 (38%), Gaps = 30/119 (25%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL------------ 117
L+ +H+ IHR+IK N+L+ D K++DF L + A R
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 118 ---------------HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ +GT Y APE + D +S GV+L E+L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-05
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 4/103 (3%)
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
V+ + A G+EYL K IHR++ + N +L ++ ++DF LS +
Sbjct: 116 VRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ A E ++ SDV++FGV + E++T G+ P
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 184
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLE------LLTGRKPVDH 164
APE + D++S G ++ E L GR +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 1e-04
Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 29/103 (28%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHS----TRVL 123
GL ++H+ HR++K N+L+ ++ KI+DF L AR + S T +
Sbjct: 111 GLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGL--------AREIRSRPPYTDYV 159
Query: 124 GTFGYHAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGR 159
T Y APE Y SS D+++ G ++ EL T R
Sbjct: 160 STRWYRAPEILLRSTSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 1e-04
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 18/98 (18%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
LEYLH I++R++K N+LL D KI+DF + + L GT Y
Sbjct: 113 ALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL-----CGTPEY 164
Query: 129 HAPEYAMTGQMSSK-----SDVYSFGVVLLELLTGRKP 161
APE + SK D ++ G+++ E+L G P
Sbjct: 165 LAPEI-----ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 1e-04
Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 19/177 (10%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68
N+V L Y V L +HA G L + + V WA + +A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP---EECVKRWAAEMVVA----- 97
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L+ LH + I+ R++ +N+LL D +++ F ++ D+ + Y
Sbjct: 98 -LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----Y 148
Query: 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK-LSED 184
APE + + D +S G +L ELLTG K + P G + T P+ +SE+
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEE 204
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS 141
+HR+IK NVL+ K++DF S A ++S +GT Y APE T
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 142 KS------DVYSFGVVLLELLTGRKP 161
K D +S GV+ E++ GR P
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
L +LH +I+R++K N+LL + K++DF + + + +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYI 163
Query: 130 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + D ++ GV++ E++ G+ P
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 31/106 (29%), Positives = 45/106 (42%), Gaps = 18/106 (16%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS--------------NQAPDAAA 115
LEYLH I+HR++K N+L+ K++DF LS + D
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD-TR 169
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+V GT Y APE + D ++ G++L E L G P
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 26/85 (30%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---- 136
+IHR++K N+LL K++DF + D + +GT Y +PE +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 137 GQMSSKSDVYSFGVVLLELLTGRKP 161
G + D +S GV L E+L G P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 30/108 (27%), Positives = 45/108 (41%), Gaps = 18/108 (16%)
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS--------NQAPDAAAR 116
L+Y+H K IHR++K+S++LL D +S S Q
Sbjct: 109 DVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165
Query: 117 LHSTRVLGTFGYHAPEY---AMTGQMSSKSDVYSFGVVLLELLTGRKP 161
S + L + +PE + G + KSD+YS G+ EL G P
Sbjct: 166 KSSVKNL---PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 35/151 (23%), Positives = 53/151 (35%), Gaps = 45/151 (29%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF------------------------- 104
+E +H+ IHR+IK N+L+ D K++DF
Sbjct: 114 IESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 105 --------DLSNQAPDAAARLH---STRVL-----GTFGYHAPEYAMTGQMSSKSDVYSF 148
++ R R L GT Y APE + + D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 149 GVVLLELLTGRKPVDHTLPRG-QQSLVTWAT 178
GV+L E+L G+ P P Q ++ W T
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 73 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 132
+H + +HR+IK NVLL + +++DF + + S+ +GT Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPE 173
Query: 133 Y--AM---TGQMSSKSDVYSFGVVLLELLTGRKP 161
AM G+ + D +S GV + E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 4/95 (4%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-VLGTF 126
+G+ YLH I+HR+IK +N+L K+ DF S + + V GT
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ +PE K+DV+S ++E+LT + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 5e-04
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 14/95 (14%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR---VLGTF 126
EYL I++R++K N+LL D K++DF A++ TR + GT
Sbjct: 144 FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKVVDTRTYTLCGTP 192
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
Y APE + +D ++ G+ + E+L G P
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHSTRVLGT 125
RG+ Y H R++HR++K N LL D + K++DF L+ +A R + V+ T
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQN-LLIDRRTNALKLADFGLA-RAFGIPVRTFTHEVV-T 166
Query: 126 FGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 159
Y APE + + S+ D++S G + E++ +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 7e-04
Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 33/235 (14%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
M+S+L ++++V G V G ++ E+ GSL L K + SW ++
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SW--KL 103
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD--FDLSNQAPDAAARLH 118
++A A L +L +K + H N+ + NVLL ++ K + F + + L
Sbjct: 104 EVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160
Query: 119 STRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLVTW 176
+L + PE Q +S +D +SFG L E+ +G KP+ Q+ L
Sbjct: 161 KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QKKL--- 215
Query: 177 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231
+ ED+ + P ++A + C+ YE DFRP+ +++ L
Sbjct: 216 ---QFYEDRH----------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 23/177 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPG--PVLSW 56
++ LK+ NV+ L ++ R L +++A HD+ H K + +K PV
Sbjct: 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLP 106
Query: 57 AQRVK-IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-------DIAKISDFDLSN 108
VK + G+ YLH ++HR++K +N+L+ + IA + L N
Sbjct: 107 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 109 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 164
A L V+ TF Y APE + + +K+ D+++ G + ELLT +P+ H
Sbjct: 164 SPLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 36/160 (22%), Positives = 64/160 (40%), Gaps = 14/160 (8%)
Query: 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 64
L + NV++ +G ++ +L E G L + L +G+ + ++A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV----LQRMAC 107
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 124
A GL +LH+ IH ++ N L D KI D+ L+ + +
Sbjct: 108 EVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV 164
Query: 125 TFGYHAPEYA-------MTGQMSSKSDVYSFGVVLLELLT 157
+ APE + + KS+++S GV + EL T
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 29/95 (30%), Positives = 42/95 (44%), Gaps = 5/95 (5%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 126
A L YLH I++R++K N+LL ++DF L + + +T GT
Sbjct: 106 ASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTP 160
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
Y APE + D + G VL E+L G P
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 30/115 (26%), Positives = 53/115 (46%), Gaps = 18/115 (15%)
Query: 49 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 108
K P+L + + + A +EY+H+K ++IHR+IK N+ L D + DF
Sbjct: 261 KDRPLLKQTRAIMKQLLCA--VEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFG--- 312
Query: 109 QAPDAAARLHSTRV------LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157
A R +GT ++PE +D++S G++LL++L+
Sbjct: 313 ----TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (90), Expect = 0.002
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 24/102 (23%)
Query: 80 RIIHRNIKSSNVLLFDD-----------------DIAKISDFDLS-NQAPDAAARLHSTR 121
R++HR++K N+ L IAKI DF LS N ++ A HS
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA--HS-- 200
Query: 122 VLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT Y +PE + T KSD+++ G ++ EL +G+ P
Sbjct: 201 CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY--AM-- 135
+HR+IK NVLL + +++DF S A + S +GT Y +PE AM
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 136 -TGQMSSKSDVYSFGVVLLELLTGRKP 161
G+ + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 32/116 (27%), Positives = 43/116 (37%), Gaps = 36/116 (31%)
Query: 82 IHRNIKSSNVLLFDDDIAKISDF----------------DLSNQAPDAAARLHST----- 120
IHR+IK N+LL K+SDF LS+ P S
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 121 ----------RVL-----GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
R L GT Y APE + + + D +S GV++ E+L G P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 22/93 (23%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHSTRVLGTF 126
+G+ + H+ ++HR++K N+L+ + KI+D L +A + ++ ++ T
Sbjct: 121 KGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIPVKSYTHEIV-TL 175
Query: 127 GYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTG 158
Y APE + S+ D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 31/108 (28%), Positives = 52/108 (48%), Gaps = 4/108 (3%)
Query: 47 GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 106
GA+ P L AQ +A ++Y+H + IIHR+IK+ NVL+ + + DF
Sbjct: 251 GARLRP-LGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGA 306
Query: 107 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154
+ A + + + GT +APE + D++S G+V+ E
Sbjct: 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.004
Identities = 28/108 (25%), Positives = 48/108 (44%), Gaps = 12/108 (11%)
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL---- 117
I G + L+Y+H +HR++K+S++L+ D +S + + RL
Sbjct: 106 ILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162
Query: 118 ----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+S +VL + + G +KSD+YS G+ EL G P
Sbjct: 163 DFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.004
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLS--NQAPDAAARLHSTRVLGTF 126
LE LH+ +I+R++K N+LL + IA + DF L N D + GT
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIA-LCDFGLCKLNMKDDDK----TNTFCGTP 157
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
Y APE + + D ++ GV+L E+LTG P
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 243 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.59 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.59 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.57 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.42 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.41 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.41 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.35 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.23 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.13 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.0 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.78 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.76 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.71 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.7 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.43 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.25 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.1 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.69 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.37 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.11 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.02 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.95 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.7 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.68 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.02 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.69 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.82 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.3 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.06 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.02 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 93.98 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.94 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.7 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.57 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 93.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.52 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.29 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.05 | |
| PLN02236 | 344 | choline kinase | 92.67 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 91.93 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 91.58 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.39 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 90.97 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 90.6 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 90.12 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 88.76 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 87.89 | |
| PRK14559 | 645 | putative protein serine/threonine phosphatase; Pro | 87.01 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 86.56 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 86.46 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 85.84 | |
| PF10140 | 359 | YukC: WXG100 protein secretion system (Wss), prote | 85.33 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 82.19 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 81.35 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=296.66 Aligned_cols=202 Identities=29% Similarity=0.411 Sum_probs=172.2
Q ss_pred CCCcccCCccceeeEEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCC
Q 026115 1 MVSRLKNENVVELVGYYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAE 78 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~ 78 (243)
++++++|||||.++|.|.++. ...++||||++|+|.+++..... +++....+++.+++.||.|||. .+
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~---------i~E~~L~~ia~~VL~GL~YLh~~~~- 199 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGR---------IPEPVLGKIARAVLRGLSYLHEERK- 199 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhccC-
Confidence 467889999999999999988 49999999999999999987743 8899999999999999999996 66
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
|+||||||+|+|++..|++||+|||++....+. .....+||..|||||.+.+..|+.++||||||+.++|+++|
T Consensus 200 --IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~G 273 (364)
T KOG0581|consen 200 --IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIG 273 (364)
T ss_pred --eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhC
Confidence 999999999999999999999999999877655 35677899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+.||....+ ....--.....+...-....|.. +++++.+++..||++||.+|||+.++++
T Consensus 274 rfP~~~~~~-----------~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 274 RFPYPPPNP-----------PYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCcCC-----------CCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999975411 01111223333333333455554 8899999999999999999999999997
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=300.72 Aligned_cols=212 Identities=30% Similarity=0.434 Sum_probs=189.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++|+|+|||+++|+|..+..++|||||++.|+|.+||+...+.. +...+.+.++.||++|++||++++
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~-------l~~~~Ll~~a~qIaeGM~YLes~~--- 323 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGL-------LNLPQLLDFAAQIAEGMAYLESKN--- 323 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCc-------cchHHHHHHHHHHHHHHHHHHhCC---
Confidence 5789999999999999999989999999999999999999844433 889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++||||...|||++.+..+||+|||+++...+..... .....-+.-|.|||.+....++.++||||||+++||++| |.
T Consensus 324 ~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~ 402 (468)
T KOG0197|consen 324 YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGR 402 (468)
T ss_pred ccchhhhhhheeeccCceEEEcccccccccCCCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCC
Confidence 9999999999999999999999999999554433222 222334678999999999999999999999999999999 88
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
.|+. ......+.+.++.+.+...|..||.+++++|..||+.+|++|||++.+...++++.....
T Consensus 403 ~py~----------------~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 403 VPYP----------------GMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred CCCC----------------CCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 8875 446788999999999999999999999999999999999999999999999999877544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=293.38 Aligned_cols=214 Identities=33% Similarity=0.505 Sum_probs=182.6
Q ss_pred CCCcccCCccceeeEEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+|++++|||||+++|++.++. .+++||||+++|+|..++...... .+++..++.++.||+.|+.|||+++.
T Consensus 92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~-------~l~~~~~l~~aldiArGm~YLH~~~~- 163 (362)
T KOG0192|consen 92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKR-------KLPLKVRLRIALDIARGMEYLHSEGP- 163 (362)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhcCCC-
Confidence 467899999999999999888 799999999999999999884211 29999999999999999999999962
Q ss_pred CeEeccCCCCceEecCCC-ceeecccCCCCCCcccccccccccccccccccCchhhc--cCCCCcccchHHHHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~l~ 156 (243)
++|||||++|+|++.+. ++||+|||+++...... .......||+.|||||++. ...++.++||||||+++||++
T Consensus 164 -iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~ 240 (362)
T KOG0192|consen 164 -IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELL 240 (362)
T ss_pred -eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHH
Confidence 89999999999999997 99999999997665432 1123356999999999999 568999999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
||..||....+ ............+...+..++..+..++.+||+.||..||++.+++..|+.+..
T Consensus 241 t~~~Pf~~~~~---------------~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 241 TGEIPFEDLAP---------------VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HCCCCCCCCCH---------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 99999985522 233444455666667777788999999999999999999999999999999887
Q ss_pred hcCC
Q 026115 237 TRSG 240 (243)
Q Consensus 237 ~~~~ 240 (243)
..+.
T Consensus 306 ~~~~ 309 (362)
T KOG0192|consen 306 HISS 309 (362)
T ss_pred hhcc
Confidence 6554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=280.73 Aligned_cols=210 Identities=20% Similarity=0.326 Sum_probs=174.2
Q ss_pred CCCcccCCccceeeE-EEEeCC-eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC-
Q 026115 1 MVSRLKNENVVELVG-YYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA- 77 (243)
Q Consensus 1 ~l~~l~h~niv~~~~-~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~- 77 (243)
+|++|+|||||++++ .|..+. .+.||||+|.+|+|...++..+..+. .+++..+|+++.|++.||..+|..-
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr-----~ipE~~Vwk~f~QL~~AL~~cH~~~~ 145 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKR-----LIPEKTVWKYFVQLCRALYHCHSKIP 145 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccc-----cCchHHHHHHHHHHHHHHHHHhcccc
Confidence 578999999999999 555544 49999999999999999988765432 3889999999999999999999831
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++.+.||||||.||+++.+|.+||+|||+++.+...... ....+|||.||+||.+.+..|+.++||||+||++|||+.
T Consensus 146 r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca 223 (375)
T KOG0591|consen 146 RGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA 223 (375)
T ss_pred ccceeeccCcchheEEcCCCceeeccchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh
Confidence 234999999999999999999999999999988765443 456789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP-PKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
.++||.+. .-..+.+.+.++-..+.| ...+..+.+++..|+..||..||+.-.++..+..
T Consensus 224 L~~PF~g~----------------n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 224 LQSPFYGD----------------NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cCCCcccc----------------cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 99999754 113344444554444555 6788999999999999999999996555554443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=287.34 Aligned_cols=199 Identities=24% Similarity=0.345 Sum_probs=164.5
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||++|+|||||++.++|......|+||||++||+|.+++-.+.. +.+.....+++|++.|+.|||++|
T Consensus 229 ILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~G--- 296 (475)
T KOG0615|consen 229 ILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQG--- 296 (475)
T ss_pred HHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHcC---
Confidence 57899999999999999999999999999999999999988774 777777889999999999999999
Q ss_pred eEeccCCCCceEecCC---CceeecccCCCCCCcccccccccccccccccccCchhhccCCC---CcccchHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDD---DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLE 154 (243)
Q Consensus 81 ~~h~di~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~DiwslG~~l~~ 154 (243)
|+||||||+|||+..+ -.+||+|||+|+..+... ......||+.|.|||++.+... ..+.|+||+||++|-
T Consensus 297 I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfv 373 (475)
T KOG0615|consen 297 IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFV 373 (475)
T ss_pred cccccCCcceEEeccCCcceEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEE
Confidence 9999999999999776 578999999998876332 2345669999999999986543 347799999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG---EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+++|.+||... .......+.+..+... ..-...+++..++|.+||..||++|||+.|+|+
T Consensus 374 cLsG~pPFS~~---------------~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 374 CLSGYPPFSEE---------------YTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred EeccCCCcccc---------------cCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 99999999643 1112123333332222 233567889999999999999999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=285.91 Aligned_cols=227 Identities=54% Similarity=0.901 Sum_probs=195.2
Q ss_pred CCCcccCCccceeeEEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
++++++|||+|+++|||.+++ ..+||+||+..|+|.+.|+..... +++|.++++|+.++|.||+|||....+
T Consensus 124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~ 196 (361)
T KOG1187|consen 124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPP 196 (361)
T ss_pred HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCC
Confidence 467899999999999999988 599999999999999999986642 389999999999999999999998877
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcc-cccccccccc-cccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRV-LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
+++|||||+.|||+|.+.+.||+|||+++.... ... .... .||.+|++||....+..+.++||||||+++.|+++
T Consensus 197 ~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElit 273 (361)
T KOG1187|consen 197 PIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELIT 273 (361)
T ss_pred CEecCCCCHHHeeECCCCCEEccCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHh
Confidence 899999999999999999999999999966543 211 1112 68999999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC-CCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG-GEYPP-KAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
|+.+.....+........|..+......+.+++++.+. ...+. .....+..+..+|++.+|.+||++.+|++.|+.+.
T Consensus 274 gr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 274 GRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99888765555555577777677777789999999987 55554 67778999999999999999999999999996655
Q ss_pred hh
Q 026115 236 NT 237 (243)
Q Consensus 236 ~~ 237 (243)
..
T Consensus 354 ~~ 355 (361)
T KOG1187|consen 354 SL 355 (361)
T ss_pred cc
Confidence 43
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=291.44 Aligned_cols=197 Identities=27% Similarity=0.404 Sum_probs=170.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
-++|+|||||+++++|++.++.|+|.|+|..++|..+++... ++++..+..+++||+.|+.|||+.+ |
T Consensus 72 Hr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH~~~---I 139 (592)
T KOG0575|consen 72 HRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLHSLG---I 139 (592)
T ss_pred HHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHHhcC---c
Confidence 478999999999999999999999999999999999998554 3999999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|||||..|++++++.++||+|||+|.......+. ....-|||.|.|||++.....+..+||||+||++|-++.|++|
T Consensus 140 iHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PP 217 (592)
T KOG0575|consen 140 IHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPP 217 (592)
T ss_pred eecccchhheeecCcCcEEecccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCC
Confidence 99999999999999999999999999877654332 3456699999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|++. ...+....+..... ..|...+.+..+||.++|+.||.+|||+++|+.
T Consensus 218 Fetk---------------~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 218 FETK---------------TVKETYNKIKLNEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccc---------------hHHHHHHHHHhcCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9743 11223333333332 455577788999999999999999999999997
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=296.55 Aligned_cols=220 Identities=27% Similarity=0.446 Sum_probs=192.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCC-----CCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+|..|+|||||+++|+|.+++..++|+||+..|||.+||...... ......++++..+.+.++.||+.|+.||.+
T Consensus 542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred HHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999999999999999999999999999765432 112224458999999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
+. ++||||..+|+||.++..|||+|||+++.......+.......-+.+|||||.+..+++++++||||+||++||+
T Consensus 622 ~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEI 698 (774)
T KOG1026|consen 622 HH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEI 698 (774)
T ss_pred Cc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhh
Confidence 98 999999999999999999999999999988776655444344457899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
++ |..||.+. .++.+.+.+..+....+|..+|.++++||..||+.+|.+|||++||...|+..
T Consensus 699 FsyG~QPy~gl----------------Sn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 699 FSYGKQPYYGL----------------SNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred hccccCccccc----------------chHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 98 99998744 55777777777777899999999999999999999999999999999999987
Q ss_pred HhhcC
Q 026115 235 LNTRS 239 (243)
Q Consensus 235 ~~~~~ 239 (243)
.....
T Consensus 763 ~~~s~ 767 (774)
T KOG1026|consen 763 AQASP 767 (774)
T ss_pred HhcCc
Confidence 76543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=285.72 Aligned_cols=199 Identities=25% Similarity=0.407 Sum_probs=174.2
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|+..+|+|||.+++.|..+..+++||||++||+|.+.+.... +++.++..++++++.||+|||.+|
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~g--- 389 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARG--- 389 (550)
T ss_pred HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcc---
Confidence 4788999999999999999999999999999999999998886 999999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|||||.+||+++.+|.+||+|||++..+..... .+...+||+.|||||++....|.++.||||||++++||+-|++
T Consensus 390 IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEP 467 (550)
T KOG0578|consen 390 IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEP 467 (550)
T ss_pred eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCC
Confidence 99999999999999999999999999877765443 3566789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhc-cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVD-TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||-...+- ..++.+.. .......+...+..+.+++.+||+.|+++|+||.++|+
T Consensus 468 PYlnE~Pl---------------rAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 468 PYLNENPL---------------RALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CccCCChH---------------HHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 98644222 22222222 22234566778889999999999999999999999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=269.90 Aligned_cols=196 Identities=26% Similarity=0.395 Sum_probs=157.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||+.++|||||.+++++.+++.+++|||||.||+|..|++.... +++.++..++.|++.|+++||+++
T Consensus 62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~~--- 129 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHENN--- 129 (429)
T ss_pred HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 57899999999999999999999999999999999999998864 999999999999999999999999
Q ss_pred eEeccCCCCceEecCC------CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDD------DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 81 ~~h~di~~~nil~~~~------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 154 (243)
|+||||||+|||++.. ..+||+|||+++....... .....|++.|||||++....|+.++|+||+|+++|+
T Consensus 130 IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq 206 (429)
T KOG0595|consen 130 IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQ 206 (429)
T ss_pred eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHH
Confidence 9999999999999765 4579999999998774432 234569999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc--cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD--TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
+++|..||....+... ...++ .......+...+..+.+++...++.+|.+|.+..+-
T Consensus 207 ~l~g~~Pf~a~t~~eL----------------~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 207 CLTGKPPFDAETPKEL----------------LLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred HHhCCCCccccCHHHH----------------HHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 9999999975433211 11111 111123333444455566666666666666655543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=272.45 Aligned_cols=207 Identities=27% Similarity=0.371 Sum_probs=167.5
Q ss_pred CCCcccCCccceeeEEEEeCC--eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 1 MVSRLKNENVVELVGYYVDGP--LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
+|++++|||||+++|...... .++++|||+++|+|.+++....+ + +++..+..+++|+++||+|||++|
T Consensus 67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~-------l~E~~v~~ytr~iL~GL~ylHs~g- 137 (313)
T KOG0198|consen 67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-K-------LPEPLVRRYTRQILEGLAYLHSKG- 137 (313)
T ss_pred HHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-C-------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 478899999999999854443 79999999999999999998875 3 999999999999999999999999
Q ss_pred CCeEeccCCCCceEecC-CCceeecccCCCCCCcccccc-cccccccccccccCchhhccC-CCCcccchHHHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l 155 (243)
++||||||+|||++. ++.+||+|||.+......... .......||+.|+|||++.++ ....++|||||||++.||
T Consensus 138 --~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM 215 (313)
T KOG0198|consen 138 --IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEM 215 (313)
T ss_pred --EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEec
Confidence 999999999999999 799999999998776641111 123346799999999999953 334599999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+||..||.... ........+.........|...+.+..+++.+|+++||++||||+++|+.--
T Consensus 216 ~Tg~~PW~~~~--------------~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 216 LTGKPPWSEFF--------------EEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred cCCCCcchhhc--------------chHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 99999997420 0112222222222233667778889999999999999999999999998543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=263.71 Aligned_cols=215 Identities=21% Similarity=0.287 Sum_probs=169.8
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||++|+|||+|.++++|.....+++|+|||+. ++.+-+...+.+ ++...+.++++|++.|+.|+|+++
T Consensus 54 mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G--------~~~~~vk~~l~Q~l~ai~~cHk~n--- 121 (396)
T KOG0593|consen 54 MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNG--------VPSELVKKYLYQLLKAIHFCHKNN--- 121 (396)
T ss_pred HHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCC--------CCHHHHHHHHHHHHHHhhhhhhcC---
Confidence 58899999999999999999999999999988 666666655543 888999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+|||++.+|.+|++|||+|+....... ..+..+.|.+|+|||.+.+ .+|....|||++||++.||++|.
T Consensus 122 ~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~ 199 (396)
T KOG0593|consen 122 CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE 199 (396)
T ss_pred eecccCChhheEEecCCcEEeccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence 99999999999999999999999999998764322 2355678999999999997 68899999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhcc----ccC----------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT----KLG----------GEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
+.|.+..+.++-..+.........+...-+... +++ ....+..+..+.+++.+||+.||.+|++.+
T Consensus 200 pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ 279 (396)
T KOG0593|consen 200 PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCE 279 (396)
T ss_pred cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHH
Confidence 999987666554443322222221111100000 000 011233455799999999999999999999
Q ss_pred HHHH
Q 026115 226 IVLK 229 (243)
Q Consensus 226 ~vl~ 229 (243)
+++.
T Consensus 280 qll~ 283 (396)
T KOG0593|consen 280 QLLH 283 (396)
T ss_pred HHhc
Confidence 9986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=266.80 Aligned_cols=211 Identities=27% Similarity=0.363 Sum_probs=166.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|+.++||||++++..|..+..+++||+||.+|++.+.++..-... +++..+..+++++++||.|||++| .
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G-------l~E~~Ia~iLre~LkaL~YLH~~G---~ 147 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG-------LEEASIATILREVLKALDYLHQNG---H 147 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc-------ccHHHHHHHHHHHHHHHHHHHhcC---c
Confidence 678999999999999999999999999999999999998765332 899999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc-ccc-ccccccccccCchhhcc--CCCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHS-TRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~-~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~ 157 (243)
+|||||+.|||++.+|.|+|+|||.+......... ..+ ...+|+++|+|||++.. ..|+.++||||||++..|+.+
T Consensus 148 IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~ 227 (516)
T KOG0582|consen 148 IHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH 227 (516)
T ss_pred eecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc
Confidence 99999999999999999999999987554433322 112 45689999999999654 478999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||....+...-..-....+... .......+.....+..+.+++..||++||.+||||+++++
T Consensus 228 G~aPf~k~pPmkvLl~tLqn~pp~~-------~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 228 GHAPFSKYPPMKVLLLTLQNDPPTL-------LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCcccCChHHHHHHHhcCCCCCc-------ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 9999985533221111000000000 0011122233445568999999999999999999999997
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=261.11 Aligned_cols=192 Identities=22% Similarity=0.267 Sum_probs=164.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||.+++||.||+++-.|++.+.+++|+||+.||.|...|.+... +++..+.-++..|+.||.|||+.|
T Consensus 78 IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~g--- 145 (357)
T KOG0598|consen 78 ILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSKG--- 145 (357)
T ss_pred HHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhCC---
Confidence 46789999999999999999999999999999999999997764 889999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
|+|||+||+|||++..|.++|+|||+++........ .....||+.|+|||++.+..|+...|.||||+++|+|++|.+
T Consensus 146 IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~p 223 (357)
T KOG0598|consen 146 IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKP 223 (357)
T ss_pred eeeccCCHHHeeecCCCcEEEeccccchhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCC
Confidence 999999999999999999999999999866544333 344679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (243)
||...+. ....+.+........+...+.+..+++.++|.+||++|.
T Consensus 224 PF~~~~~----------------~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 224 PFYAEDV----------------KKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCcCccH----------------HHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 9975522 222222222222344445677899999999999999995
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=263.56 Aligned_cols=204 Identities=21% Similarity=0.351 Sum_probs=166.0
Q ss_pred CCCcccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 1 MVSRLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+|++++||||++++|++.+ ....++||||+.+|+|.+++..... +++...+.++.+++.|+.+||+.
T Consensus 71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~ 141 (283)
T PHA02988 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---------LSFKTKLDMAIDCCKGLYNLYKY 141 (283)
T ss_pred HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCC---------CChhHHHHHHHHHHHHHHHHHhc
Confidence 3678999999999999877 4578999999999999999976542 78889999999999999999985
Q ss_pred -CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc--CCCCcccchHHHHHHHH
Q 026115 77 -AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 77 -~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~ 153 (243)
+ ++||||||+||+++.++.++++|||+++...... ....|+..|+|||.+.+ ..++.++|||||||++|
T Consensus 142 ~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~ 213 (283)
T PHA02988 142 TN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLW 213 (283)
T ss_pred CC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHH
Confidence 6 8899999999999999999999999987543221 22457889999999976 67899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
||++|..||..... .+....+.....+...+..++..+.+++.+||+.||++|||++++++.|++
T Consensus 214 el~~g~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 214 EIFTGKIPFENLTT---------------KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHCCCCCCCCCH---------------HHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 99999999974421 111111222222233444567789999999999999999999999999998
Q ss_pred HHh
Q 026115 234 LLN 236 (243)
Q Consensus 234 ~~~ 236 (243)
+..
T Consensus 279 ~~~ 281 (283)
T PHA02988 279 YKF 281 (283)
T ss_pred HHh
Confidence 753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=270.04 Aligned_cols=199 Identities=22% Similarity=0.305 Sum_probs=168.6
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
|.+| .||-|++++-.|.+...+|+|+||+++|+|.+++.+... +++....-++.+|+.|++|||++|
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~G--- 194 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSNG--- 194 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhcC---
Confidence 4566 899999999999999999999999999999999998864 999999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccc---------cc--cccccccccccCchhhccCCCCcccchHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR---------LH--STRVLGTFGYHAPEYAMTGQMSSKSDVYSFG 149 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~---------~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG 149 (243)
|+||||||+|||++.++.++|+|||.++.+...... .. ...++||..|.+||++.....+.++|+|+||
T Consensus 195 IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlG 274 (604)
T KOG0592|consen 195 IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALG 274 (604)
T ss_pred ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHH
Confidence 999999999999999999999999999877543222 11 1447899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|++|+|+.|.+||.+..+ .. ..+.++.-. -.++...++...+|+.+.|..||.+|+|+.+|-+
T Consensus 275 CilyQmlaG~PPFra~Ne------------yl---iFqkI~~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 275 CILYQMLAGQPPFRAANE------------YL---IFQKIQALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHHhcCCCCCccccH------------HH---HHHHHHHhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 999999999999975411 11 122222222 2455666678999999999999999999988766
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=272.28 Aligned_cols=214 Identities=21% Similarity=0.345 Sum_probs=176.1
Q ss_pred CCccc-CCccceeeEEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLK-NENVVELVGYYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
|++|+ ||||+++.+++.+.. .+++|||||+. +|++++++... ++++..+..|+.||+.||+|+|++|
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~G-- 130 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKHG-- 130 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhcC--
Confidence 57888 999999999998877 89999999977 99999988753 3999999999999999999999999
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-cCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+.|||+||+|||+..+..+||+|||+||........ +..+.|.+|+|||++. .+.|+.+.|+|++||+++|+.+.
T Consensus 131 -fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sL 206 (538)
T KOG0661|consen 131 -FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSL 206 (538)
T ss_pred -cccccCChhheEecccceeEecccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999988765443 4566899999999876 56789999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhh------hhccccCC-------CCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQ------CVDTKLGG-------EYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
++.|.+..+.++...+..+.+.+..+...+ .++-.+.. ......+.+..++|.+|++.||++||||.
T Consensus 207 rPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~ 286 (538)
T KOG0661|consen 207 RPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTAS 286 (538)
T ss_pred cccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHH
Confidence 999999887776665544433333322222 22222211 11133677899999999999999999999
Q ss_pred HHHHH
Q 026115 226 IVLKA 230 (243)
Q Consensus 226 ~vl~~ 230 (243)
++++.
T Consensus 287 ~al~~ 291 (538)
T KOG0661|consen 287 QALQH 291 (538)
T ss_pred HHhcC
Confidence 99984
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=269.15 Aligned_cols=218 Identities=23% Similarity=0.364 Sum_probs=167.1
Q ss_pred CCcc-cCCccceeeEEEEeC-CeeEEEEeecCCCCHHHHhccCCCCC---------------------------------
Q 026115 2 VSRL-KNENVVELVGYYVDG-PLRVLAYEHASKGSLHDILHGKKGVK--------------------------------- 46 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~--------------------------------- 46 (243)
++++ +||||+++++++... ..++++|||+++|+|.+++.......
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 64 LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred HHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 4456 899999999988754 46899999999999999997542100
Q ss_pred --------------------CCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCC
Q 026115 47 --------------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 106 (243)
Q Consensus 47 --------------------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~ 106 (243)
...+..++++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~ 220 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGL 220 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccc
Confidence 0001224778889999999999999999998 99999999999999999999999999
Q ss_pred CCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCcCchhh
Q 026115 107 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 185 (243)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 185 (243)
++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... +.
T Consensus 221 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~---------------~~ 285 (338)
T cd05102 221 ARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN---------------EE 285 (338)
T ss_pred ccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc---------------HH
Confidence 876533222212223345678999999998889999999999999999997 99999753211 11
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 186 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
....+........+...+..+.+++.+||+.||++|||+.++++.|++++.+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 286 FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111112223344566899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=269.66 Aligned_cols=197 Identities=25% Similarity=0.343 Sum_probs=165.2
Q ss_pred CCCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
++++++ ||||+++++++.....+++||||+.||+|.+++..... +.+..+..++.|+++|++|||+.|
T Consensus 72 ~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~---------l~E~~ar~~F~Qlisav~y~H~~g-- 140 (370)
T KOG0583|consen 72 ILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGR---------LKEDEARKYFRQLISAVAYCHSRG-- 140 (370)
T ss_pred HHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCC---------CChHHHHHHHHHHHHHHHHHHhCC--
Confidence 356788 99999999999999999999999999999999998332 888999999999999999999999
Q ss_pred CeEeccCCCCceEecCC-CceeecccCCCCCCcccccccccccccccccccCchhhccCC-CC-cccchHHHHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MS-SKSDVYSFGVVLLELL 156 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~DiwslG~~l~~l~ 156 (243)
++||||||+|++++.+ +++||+|||++.... ..........|++.|+|||++.+.. |+ .++|+||+|++||.|+
T Consensus 141 -i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml 217 (370)
T KOG0583|consen 141 -IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL 217 (370)
T ss_pred -EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence 9999999999999999 999999999998774 1111234566999999999999877 85 6899999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhh-hhccccCCCCCHHH-HHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ-CVDTKLGGEYPPKA-IAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||..... ..... +.... ...+... +.++..++.+|+..||.+|+|+.++++
T Consensus 218 ~G~~PF~d~~~----------------~~l~~ki~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 218 CGRLPFDDSNV----------------PNLYRKIRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred hCCCCCCCccH----------------HHHHHHHhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 99999975311 11111 22221 2444455 889999999999999999999999993
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=290.37 Aligned_cols=219 Identities=25% Similarity=0.375 Sum_probs=188.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|+.++|||||+++|.+.+....+|++|||++|+|..||++........ ..+++...+.++.+|+.|..||+++.
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~--~~L~~~dLl~~a~dvA~G~~YLe~~~--- 822 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQP--SNLSMRDLLAFALDVAKGMNYLESKH--- 822 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCC--CCCCHHHHHHHHHHHhhhhHHHHhCC---
Confidence 4789999999999999999999999999999999999999886544442 34899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++||||..+|+|++....+||+|||+|+...............-+..|||||.+..+.++.++|||||||++||+++ |.
T Consensus 823 fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~ 902 (1025)
T KOG1095|consen 823 FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGA 902 (1025)
T ss_pred CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCC
Confidence 99999999999999999999999999996655544433333345678999999999999999999999999999999 88
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
.||... .+..+......+.+.+.|..|+..++++|..||+.+|++||++..+++.+.++.+..-
T Consensus 903 ~PY~~~----------------~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 903 TPYPSR----------------SNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred CCCCCc----------------chHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 998633 4455555333444889999999999999999999999999999999999998887654
Q ss_pred C
Q 026115 240 G 240 (243)
Q Consensus 240 ~ 240 (243)
+
T Consensus 967 ~ 967 (1025)
T KOG1095|consen 967 G 967 (1025)
T ss_pred c
Confidence 3
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=271.89 Aligned_cols=204 Identities=29% Similarity=0.478 Sum_probs=177.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|+.|+||||+.|.|+|.+..-+|||||||..|.|...|+.... +.......|..+|+.|+.|||.+. |
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~---------itp~llv~Wsk~IA~GM~YLH~hK---I 233 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP---------ITPSLLVDWSKGIAGGMNYLHLHK---I 233 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCc---------cCHHHHHHHHHHhhhhhHHHHHhh---H
Confidence 6789999999999999999999999999999999999988763 888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|||+|.-|||++.+..+||+|||-++........ -.+.||..|||||++.+...+++.|||||||+||||+||..|
T Consensus 234 IHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk---MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiP 310 (904)
T KOG4721|consen 234 IHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK---MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIP 310 (904)
T ss_pred hhhccCCCceEeeccceEEeccccchHhhhhhhhh---hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCC
Confidence 99999999999999999999999998876655322 345699999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
|.+.+... +-| ..-...+....|..+++.+.-|+++||+-.|..|||+++++..|+-+-
T Consensus 311 YkdVdssA----IIw-----------GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 311 YKDVDSSA----IIW-----------GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ccccchhe----eEE-----------eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 97553321 111 111233445678888999999999999999999999999999987543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=267.02 Aligned_cols=202 Identities=23% Similarity=0.356 Sum_probs=176.6
Q ss_pred CCCcccCCccceeeEEEEeCCe-eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPL-RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
++++++|||||.+.+.|..++. ++|+|+|++||++.+.+.+.++.. +++..+++++.|++.|+.|||++.
T Consensus 56 lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~-------f~E~~i~~~~~Q~~~av~ylH~~~-- 126 (426)
T KOG0589|consen 56 LLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVL-------FPEERILKWFVQILLAVNYLHENR-- 126 (426)
T ss_pred HHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhcc-------ccHHHHHHHHHHHHHHHHHHHhhh--
Confidence 3678999999999999998887 999999999999999999988554 899999999999999999999887
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++|||+|..|||++.++.++|+|||+++....... .....+||+.|+.||.+.+..|..++|||||||.+|||++-+
T Consensus 127 -iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk 203 (426)
T KOG0589|consen 127 -VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLK 203 (426)
T ss_pred -hhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcc
Confidence 99999999999999999999999999998765542 245678999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
++|...+- ..+..-+.+....+.+...+.++..++..|++.+|..||++.++|..
T Consensus 204 ~aF~a~~m----------------~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 204 PAFKASNM----------------SELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccCccch----------------HHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 99975522 22222233333456777888899999999999999999999999985
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=256.49 Aligned_cols=213 Identities=25% Similarity=0.374 Sum_probs=170.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC-------CCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+++++||||+++++++.+....+++|||+++++|.+++........ ......++...++.++.|++.|+.|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999999976532111 000123788899999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 154 (243)
+.+ ++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+|||||++||
T Consensus 142 ~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 142 SHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred hCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 998 99999999999999999999999999875533222211223346788999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
+++ |..||.+... ......+........+..++..+.+++.+||+.||.+|||+.+|++.|++
T Consensus 219 l~~~g~~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 219 IFSYGLQPYYGFSN----------------QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCCCCCCCCCH----------------HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 998 9999864421 22223333333334456677899999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=269.80 Aligned_cols=198 Identities=25% Similarity=0.313 Sum_probs=168.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||+-+.||||+++++++++.+++|+|.||+++|-|.+++..... +.+..+++++.|++.|+.|+|..+
T Consensus 65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~~--- 132 (786)
T KOG0588|consen 65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAFN--- 132 (786)
T ss_pred HHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhhc---
Confidence 57788999999999999999999999999999999999987764 889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCC-cccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~ 159 (243)
++|||+||+|++++..+++||+|||.|..-...... ....|.+.|.+||++.+..|. .++||||+|++||.+++|.
T Consensus 133 icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~ 209 (786)
T KOG0588|consen 133 ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGK 209 (786)
T ss_pred ceeccCCchhhhhhcccCEeeeccceeecccCCccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCC
Confidence 999999999999999999999999998654333222 223489999999999999994 5899999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
.||.+. .-..+..-+..+. -..|...+.+.++|+.+|+..||+.|.|.+||+++
T Consensus 210 LPFdDd----------------Nir~LLlKV~~G~-f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 210 LPFDDD----------------NIRVLLLKVQRGV-FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCCCCc----------------cHHHHHHHHHcCc-ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 999733 1122233233322 36677888899999999999999999999999984
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=265.75 Aligned_cols=216 Identities=25% Similarity=0.399 Sum_probs=167.7
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCC-----------------------------------
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV----------------------------------- 45 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------------------------- 45 (243)
++.+ +||||+++++++..+...++||||+++|+|.+++......
T Consensus 95 l~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred HHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 4566 8999999999999999999999999999999998653210
Q ss_pred --------------------------CCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCce
Q 026115 46 --------------------------KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 99 (243)
Q Consensus 46 --------------------------~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~ 99 (243)
.......++++..+++++.|++.|+.|||+.+ ++||||||+||+++.++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~ 251 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVA 251 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeE
Confidence 00011123788899999999999999999998 9999999999999999999
Q ss_pred eecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCccceeecc
Q 026115 100 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 178 (243)
Q Consensus 100 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 178 (243)
+|+|||+++...............++..|+|||++.+..++.++|+|||||++|+|++ |..||.....
T Consensus 252 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----------- 320 (374)
T cd05106 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----------- 320 (374)
T ss_pred EEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-----------
Confidence 9999999876543322111222335667999999988889999999999999999997 9999864321
Q ss_pred CcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 179 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
................+...+.++.+++.+||+.||++|||+.++++.|++++
T Consensus 321 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 321 ----NSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ----cHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11122222222222233334568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=254.03 Aligned_cols=218 Identities=25% Similarity=0.372 Sum_probs=171.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+++++||||+++++++..+...++||||+++++|.+++....... .......+++..++.++.|++.|++|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 578999999999999999999999999999999999997643210 0001112788999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 154 (243)
+++ ++|+||||+||+++.++.++++|||++................++..|+|||.+.+..++.++|+||||+++++
T Consensus 141 ~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 141 SQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred hCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 998 99999999999999999999999999876543322211223446788999999998888999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
|++ |..||..... ....+..........+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 218 l~t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~ 281 (291)
T cd05094 218 IFTYGKQPWFQLSN----------------TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA 281 (291)
T ss_pred HHhCCCCCCCCCCH----------------HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 998 9999864321 11222222222222333456689999999999999999999999999999
Q ss_pred HHhhc
Q 026115 234 LLNTR 238 (243)
Q Consensus 234 ~~~~~ 238 (243)
+.+..
T Consensus 282 ~~~~~ 286 (291)
T cd05094 282 LGKAT 286 (291)
T ss_pred HHhhc
Confidence 97754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=264.70 Aligned_cols=215 Identities=22% Similarity=0.330 Sum_probs=166.6
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC---------------------------------
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG--------------------------------- 47 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--------------------------------- 47 (243)
++++ +||||+++++++..+...++||||+++|+|.+++........
T Consensus 92 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (375)
T cd05104 92 LSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM 171 (375)
T ss_pred HHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence 4556 899999999999999999999999999999999975432100
Q ss_pred ---------------------------------CCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec
Q 026115 48 ---------------------------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 94 (243)
Q Consensus 48 ---------------------------------~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~ 94 (243)
......+++..+.+++.|++.|+.|||+.+ ++|+||||+||+++
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~ 248 (375)
T cd05104 172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLT 248 (375)
T ss_pred CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEE
Confidence 001123778889999999999999999998 99999999999999
Q ss_pred CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCccc
Q 026115 95 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL 173 (243)
Q Consensus 95 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~ 173 (243)
.++.++|+|||+++...............++..|+|||.+.+..++.++|+||||++++++++ |..||.....
T Consensus 249 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~------ 322 (375)
T cd05104 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV------ 322 (375)
T ss_pred CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc------
Confidence 999999999999876543322211222335667999999998889999999999999999998 8888864311
Q ss_pred eeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 174 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
.......+........+...+.++.+++.+||+.||++|||+.++++.|++.
T Consensus 323 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 323 ---------DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---------hHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1122222222222223334456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=250.97 Aligned_cols=205 Identities=25% Similarity=0.370 Sum_probs=165.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++||||+++|+|.+++..... .+++..++.++.|++.|++|||+.+ +
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH~~~---i 128 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSEMG---Y 128 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5678999999999999999999999999999999999976432 2789999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++|+||+||+++++++ |..
T Consensus 129 iH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~ 207 (266)
T cd05064 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207 (266)
T ss_pred eeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999987654322111 1112234578999999988889999999999999999775 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
||..... ....+.+........+..++..+.+++.+||+.+|.+|||++++++.|.++
T Consensus 208 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 208 PYWDMSG----------------QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CcCcCCH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9964421 112222222222334455677899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=253.75 Aligned_cols=217 Identities=26% Similarity=0.390 Sum_probs=173.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCC---------------CCCCCCCccCHHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV---------------KGAKPGPVLSWAQRVKIAVGA 66 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------------~~~~~~~~~~~~~~~~~~~ql 66 (243)
+++++||||+++++++..+...++++||+.+++|.+++...... ...+....+++..++.++.|+
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 57889999999999999999999999999999999998754321 011122347889999999999
Q ss_pred HHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchH
Q 026115 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY 146 (243)
Q Consensus 67 ~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw 146 (243)
+.|++|||+.+ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+|
T Consensus 137 ~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 137 SRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred HHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 99999999998 999999999999999999999999998765433222112223356789999999888889999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
|||++++++++ |..||....+ +.+.+..........+...+..+.+++.+||+.+|++||+++
T Consensus 214 slG~~l~el~t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~ 277 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAP----------------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCH----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 99999999998 9999864322 223333333333344455667899999999999999999999
Q ss_pred HHHHHHHHHHhh
Q 026115 226 IVLKALQPLLNT 237 (243)
Q Consensus 226 ~vl~~l~~~~~~ 237 (243)
++++.|++++.+
T Consensus 278 ~i~~~l~~~~~~ 289 (290)
T cd05045 278 DISKELEKMMVK 289 (290)
T ss_pred HHHHHHHHHHhc
Confidence 999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=271.39 Aligned_cols=204 Identities=23% Similarity=0.297 Sum_probs=163.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..++..++||||+++|+|.+++...... ..+++...+..++.|++.||.|||+.+ +
T Consensus 119 l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~---i 190 (478)
T PTZ00267 119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVHSRK---M 190 (478)
T ss_pred HHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 57899999999999999999999999999999999988643211 112788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++...............||+.|+|||++.+..++.++|+|||||++++|++|..|
T Consensus 191 vHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~P 270 (478)
T PTZ00267 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270 (478)
T ss_pred EECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765443222222345689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..... .+....... +.....+...+..+.+++.+||+.||++|||+++++.
T Consensus 271 f~~~~~---------------~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 271 FKGPSQ---------------REIMQQVLY-GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCH---------------HHHHHHHHh-CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 964311 111111111 1112233445678999999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=242.68 Aligned_cols=215 Identities=24% Similarity=0.272 Sum_probs=173.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|+.++||||+.++++|.+.+.+.+|+||++. +|+..+++... .++...+..++.+++.|++|||.+. +
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H~~~---I 122 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCHSKW---I 122 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHHhhh---h
Confidence 6789999999999999999999999999977 99999998774 3899999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
.|||+||.|+|++.+|.+|++|||+++.+....... ...+-|.+|+|||.+.+ ..|....||||.||++.|++-|.+
T Consensus 123 lHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P 200 (318)
T KOG0659|consen 123 LHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP 200 (318)
T ss_pred hcccCCccceEEcCCCcEEeecccchhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC
Confidence 999999999999999999999999999887655442 33367899999999986 468999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchh---------hhhhh--hccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSED---------KVKQC--VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.|.+..+-++-..+-.....+..+ ...++ .-..........++....+++.+||..||.+|+|+.|+++
T Consensus 201 ~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 201 FFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred CCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 998776655444332222222111 11111 1111111234456667899999999999999999999987
Q ss_pred H
Q 026115 230 A 230 (243)
Q Consensus 230 ~ 230 (243)
+
T Consensus 281 ~ 281 (318)
T KOG0659|consen 281 H 281 (318)
T ss_pred c
Confidence 4
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=252.20 Aligned_cols=217 Identities=24% Similarity=0.385 Sum_probs=169.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC----CCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK----GAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
+++++||||+++++++..+...++++||+.+++|.+++....... .......+++..++.++.|++.|++|||+.+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 568899999999999999999999999999999999997543210 0111123889999999999999999999998
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+||+++.++.++++|||.++...............++..|+|||.+.+..++.++|+||||+++++|++
T Consensus 141 ---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 141 ---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred ---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999876543322211223345678999999988888999999999999999998
Q ss_pred -CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 158 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
|..||..... ......+........+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 218 ~g~~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 218 YGKQPWYQLSN----------------NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CCCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 8999864421 11111111111112222345679999999999999999999999999999886
Q ss_pred h
Q 026115 237 T 237 (243)
Q Consensus 237 ~ 237 (243)
.
T Consensus 282 ~ 282 (288)
T cd05093 282 A 282 (288)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=249.28 Aligned_cols=206 Identities=25% Similarity=0.368 Sum_probs=167.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...+++|||+++++|.+++...... .+++..++.++.|++.|++|||+.+ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH~~~---i 125 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-------EVNAVVLLYMATQISSAMEYLEKKN---F 125 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 56889999999999999999999999999999999998764432 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||++.......... .....++..|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 126 ~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~ 204 (263)
T cd05052 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 204 (263)
T ss_pred eecccCcceEEEcCCCcEEeCCCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999987654432211 111224567999999988889999999999999999998 889
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
||..... +.....+........+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 205 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 205 PYPGIDL----------------SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 9864311 122222223333344445667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=256.68 Aligned_cols=217 Identities=23% Similarity=0.347 Sum_probs=163.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC----------CCCCCccCHHHHHHHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG----------AKPGPVLSWAQRVKIAVGAARGLE 71 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~~~~ql~~~l~ 71 (243)
+++++||||+++++++.+....+++|||+.+++|.+++........ ......+++..++.++.|++.|+.
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 152 (304)
T cd05096 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152 (304)
T ss_pred HhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 5789999999999999999999999999999999999865432110 111224778899999999999999
Q ss_pred HhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHH
Q 026115 72 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 151 (243)
Q Consensus 72 ~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~ 151 (243)
|||+.+ ++|+||||+||+++.++.++|+|||+++...............++..|+|||++....++.++|+||||++
T Consensus 153 ~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 229 (304)
T cd05096 153 YLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT 229 (304)
T ss_pred HHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHH
Confidence 999998 99999999999999999999999999876543322211223345778999999988889999999999999
Q ss_pred HHHHHh--CCCCCCCCCCCCCccceeeccCcCchhhhhhhhc---cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 152 LLELLT--GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD---TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 152 l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
+++|++ +..||........ . ........ .......+..++..+.+++.+||+.||++|||+.+
T Consensus 230 l~el~~~~~~~p~~~~~~~~~---~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 230 LWEILMLCKEQPYGELTDEQV---I---------ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred HHHHHHccCCCCCCcCCHHHH---H---------HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 999987 5567754321100 0 00000000 01111223345668999999999999999999999
Q ss_pred HHHHHHH
Q 026115 227 VLKALQP 233 (243)
Q Consensus 227 vl~~l~~ 233 (243)
|.+.|++
T Consensus 298 i~~~l~~ 304 (304)
T cd05096 298 IHAFLTE 304 (304)
T ss_pred HHHHHhC
Confidence 9988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=253.74 Aligned_cols=204 Identities=31% Similarity=0.490 Sum_probs=160.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||++++|++.+.+..++|+||+++|+|.+++....... +++..++.++.|++.|+.|||+.+ +
T Consensus 55 l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~-------~~~~~~~~i~~~i~~~l~~Lh~~~---i 124 (259)
T PF07714_consen 55 LRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEP-------LSEQQRLSIAIQIAEALSYLHSNN---I 124 (259)
T ss_dssp HHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTT-------SBHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccccccccccccccccc---c
Confidence 567899999999999998888999999999999999999873222 899999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|++|+++||+++.++.+||+|||++................+...|+|||.+....++.++||||||++++|+++ |..
T Consensus 125 iH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~ 204 (259)
T PF07714_consen 125 IHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKF 204 (259)
T ss_dssp EEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999876632222222233446778999999998889999999999999999999 678
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
||... ....+.+.+....+...+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 205 p~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 205 PFSDY----------------DNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTTTS----------------CHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccc----------------ccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 87533 22333333333333445556677899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=259.16 Aligned_cols=197 Identities=20% Similarity=0.257 Sum_probs=161.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++||||+.+++|.+++..... +++..+..++.|++.||+|||+.| +
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~~---i 116 (323)
T cd05571 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALGYLHSCD---V 116 (323)
T ss_pred HHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5688999999999999999999999999999999999876542 888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+||++++|++|..|
T Consensus 117 vHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 194 (323)
T cd05571 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194 (323)
T ss_pred EeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCC
Confidence 9999999999999999999999999865322111 12334589999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
|..... ......+... ....+...+..+.+++.+||+.||++|| ++.++++
T Consensus 195 f~~~~~----------------~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 195 FYNQDH----------------EKLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCH----------------HHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 964321 1111111111 1123344567899999999999999999 7999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=248.33 Aligned_cols=207 Identities=25% Similarity=0.409 Sum_probs=167.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...+++|||+.+++|.+++....+ .+++..++.++.|++.|+.|||+.+ +
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i 127 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMN---Y 127 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5788999999999999999999999999999999999976543 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 128 ~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~ 207 (266)
T cd05033 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER 207 (266)
T ss_pred ccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999887652221111122234578999999998889999999999999999998 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
||.... .......+........+...+..+.+++.+||+.+|++||++.++++.|++++
T Consensus 208 p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 208 PYWDMS----------------NQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 985331 12222222222222334455678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=261.67 Aligned_cols=199 Identities=26% Similarity=0.414 Sum_probs=170.2
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|+++++|||.++++.|..+..++++|||+.||++.+.+..... +++..+.-++++++.|+.|||..+
T Consensus 64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH~~~--- 131 (467)
T KOG0201|consen 64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLHSEK--- 131 (467)
T ss_pred HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhhhcc---
Confidence 36789999999999999999999999999999999999987762 477777889999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
.+|||||+.||++...|.++++|||++-........ ....+||+.|||||++.+..|+.++||||||++.+||.+|.+
T Consensus 132 kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GeP 209 (467)
T KOG0201|consen 132 KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEP 209 (467)
T ss_pred eecccccccceeEeccCcEEEEecceeeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCC
Confidence 999999999999999999999999998766554333 367889999999999999899999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|+....+......+ -...........+..+.+++..||++||+.||||.++|+
T Consensus 210 P~s~~hPmrvlflI----------------pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 210 PHSKLHPMRVLFLI----------------PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCcccCcceEEEec----------------cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 99877663222222 222222333466778999999999999999999999997
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=257.89 Aligned_cols=215 Identities=22% Similarity=0.269 Sum_probs=166.7
Q ss_pred CCCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 1 MVSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
||++|+||||+++.+..... ..+|||||||++ ||..++....-. ++..++..++.||++||+|+|.+|
T Consensus 169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vk--------ft~~qIKc~mkQLl~Gl~~cH~~g- 238 (560)
T KOG0600|consen 169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVK--------FTEPQIKCYMKQLLEGLEYCHSRG- 238 (560)
T ss_pred HHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcc--------cChHHHHHHHHHHHHHHHHHhhcC-
Confidence 58999999999999988765 789999999988 999998765322 899999999999999999999999
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHh
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~ 157 (243)
++|||||..|||+|.+|.+||+|||+|+.+....... .+..+-|.+|+|||.+.+ ..|+.+.|+||.||++.||+.
T Consensus 239 --vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~ 315 (560)
T KOG0600|consen 239 --VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL 315 (560)
T ss_pred --eeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc
Confidence 9999999999999999999999999999766544332 334556899999999986 478999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhh-------------hhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVK-------------QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
|.+.|++..+..+...+...-..+....+. .-....++ +.....+....+|+..+|..||.+|.||
T Consensus 316 gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~-E~~~~~~~~~l~Ll~~lL~ldP~kR~tA 394 (560)
T KOG0600|consen 316 GKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLR-ETFKDFPASALDLLEKLLSLDPDKRGTA 394 (560)
T ss_pred CCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHH-HHhccCCHHHHHHHHHHhccCccccccH
Confidence 999999876554433321111111111100 00000110 0112335578899999999999999999
Q ss_pred HHHHH
Q 026115 225 GIVLK 229 (243)
Q Consensus 225 ~~vl~ 229 (243)
.++|+
T Consensus 395 ~~aL~ 399 (560)
T KOG0600|consen 395 SSALQ 399 (560)
T ss_pred HHHhc
Confidence 99886
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=263.78 Aligned_cols=211 Identities=32% Similarity=0.449 Sum_probs=180.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++|+......+++|||+|.||+|.++|...... ++..+.+.++.+.+.|++|||+++
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~--------v~~~ek~~~~~~AA~Gl~YLh~k~--- 282 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKS--------LPTLEKLRFCYDAARGLEYLHSKN--- 282 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCC--------CCHHHHHHHHHHHHhHHHHHHHCC---
Confidence 478899999999999999999999999999999999999998753 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++||||..+|+|++.++.+||+|||+++........ .....-+..|+|||.+....++.++|||||||++||+++ |.
T Consensus 283 ~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~ 360 (474)
T KOG0194|consen 283 CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGA 360 (474)
T ss_pred CcchhHhHHHheecCCCeEEeCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCC
Confidence 999999999999999999999999998765411111 111224678999999999999999999999999999998 78
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhh-ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCV-DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
.||.+.. ...+...+ ....+...+...+..+..++.+||..+|++|||+.++.+.++.+....
T Consensus 361 ~Py~g~~----------------~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 361 EPYPGMK----------------NYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred CCCCCCC----------------HHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 8986542 22333333 566666777788889999999999999999999999999999988775
Q ss_pred CC
Q 026115 239 SG 240 (243)
Q Consensus 239 ~~ 240 (243)
..
T Consensus 425 ~~ 426 (474)
T KOG0194|consen 425 EA 426 (474)
T ss_pred cc
Confidence 54
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=252.59 Aligned_cols=209 Identities=24% Similarity=0.374 Sum_probs=167.9
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++ +||||+++++++......++++||+.+++|.+++....... +++.++..++.|++.|+.|||+++
T Consensus 92 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~-------l~~~~~~~i~~~i~~~l~~lH~~~--- 161 (302)
T cd05055 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-------LTLEDLLSFSYQVAKGMAFLASKN--- 161 (302)
T ss_pred HHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5677 79999999999999999999999999999999997644322 789999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|+||+|+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+||+|++++++++ |.
T Consensus 162 ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~ 241 (302)
T cd05055 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241 (302)
T ss_pred eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999876543322111222345678999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
.||..... ................+...+..+.+++.+||+.+|++|||+.++++.|.+++
T Consensus 242 ~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 242 NPYPGMPV---------------DSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred CCcCCCCc---------------hHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 99864311 11222222222222233344568999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=246.63 Aligned_cols=204 Identities=25% Similarity=0.405 Sum_probs=163.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++|+||+.+++|.+++..... .+++..++.++.|+++|+.|||+.+ +
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i 115 (252)
T cd05084 47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP--------RLKVKELIQMVENAAAGMEYLESKH---C 115 (252)
T ss_pred HHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5788999999999999999999999999999999999875432 2788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||++................++..|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 116 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~ 195 (252)
T cd05084 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAV 195 (252)
T ss_pred cccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875432211111111123456999999988888999999999999999997 888
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
||..... ......+........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 196 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 196 PYANLSN----------------QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CccccCH----------------HHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 8853311 2222222222333344455678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=252.88 Aligned_cols=197 Identities=22% Similarity=0.311 Sum_probs=167.5
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||+.|+||||+.++++|++...+.|||||.++|.|++|+.+... +++..+..+++||++|+.|+|+++
T Consensus 106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHknr--- 173 (668)
T KOG0611|consen 106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKNR--- 173 (668)
T ss_pred HHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhcc---
Confidence 58899999999999999999999999999999999999998764 999999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~ 159 (243)
++|||+|.+|||+|.|+++||.|||++..+....- -..+.|++.|.+||++.+..| .+..|.||||++||-++.|.
T Consensus 174 VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGt 250 (668)
T KOG0611|consen 174 VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGT 250 (668)
T ss_pred ceecccchhheeecCCCCeeeeccchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcc
Confidence 99999999999999999999999999877655432 244569999999999999988 56799999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
.||.+.+. ..-+.++-....+.+ ..+.....||++||..||+.|.|+.+|...
T Consensus 251 MPFDG~Dh---------------k~lvrQIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 251 MPFDGRDH---------------KRLVRQISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cccCCchH---------------HHHHHHhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 99986632 122333333333221 223357889999999999999999998763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=240.90 Aligned_cols=187 Identities=24% Similarity=0.340 Sum_probs=165.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||+.+.||.++++++.|.+.+.+++||||+.||.|..++++... ++...+.-++.||+.|++|||+.+
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~~--- 164 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSLD--- 164 (355)
T ss_pred HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhcC---
Confidence 47889999999999999999999999999999999999998764 889999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+++||+||+||++|.+|.+||+|||.++..... .....||+.|+|||++....+..+.|-|+||+++|||+.|.+
T Consensus 165 iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~p 239 (355)
T KOG0616|consen 165 IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYP 239 (355)
T ss_pred eeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999876543 344569999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFR 221 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 221 (243)
||....+ ......+++..+ .+|...+..+.+|+.+.|+.|-.+|
T Consensus 240 PF~~~~~---------------~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 240 PFYDDNP---------------IQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcCCCh---------------HHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 9975422 233444555554 5677778889999999999999888
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=249.91 Aligned_cols=212 Identities=22% Similarity=0.359 Sum_probs=164.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-CCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++||||+++++++..+...++||||+++++|.+++....... ........++..++.++.|++.|+.|||+.+
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--- 139 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--- 139 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 567899999999999999999999999999999999997643211 1111123678889999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+||||++++++++ |.
T Consensus 140 ~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 219 (277)
T cd05062 140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219 (277)
T ss_pred cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999876543322211122345678999999988888999999999999999998 78
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
.||..... +...+..........+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 220 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 220 QPYQGMSN----------------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 88864321 1122211111112233445668999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=252.04 Aligned_cols=215 Identities=26% Similarity=0.392 Sum_probs=169.1
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
++++ +||||+++++++..+..++++|||+.+++|..++....... .......+++..++.++.|++.|++||
T Consensus 69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 148 (293)
T cd05053 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148 (293)
T ss_pred HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4566 79999999999999999999999999999999997542110 001222488999999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++|+||+|+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+|||||++|
T Consensus 149 H~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (293)
T cd05053 149 ASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225 (293)
T ss_pred HHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHH
Confidence 9998 9999999999999999999999999988665433222122233567899999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
++++ |..||..... ...............+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 226 el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 226 EIFTLGGSPYPGIPV----------------EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred HHhcCCCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 9997 8888864311 1222222222222334455668999999999999999999999999999
Q ss_pred HHH
Q 026115 233 PLL 235 (243)
Q Consensus 233 ~~~ 235 (243)
+++
T Consensus 290 ~~~ 292 (293)
T cd05053 290 RML 292 (293)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=249.56 Aligned_cols=212 Identities=25% Similarity=0.396 Sum_probs=167.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-----CCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-----GAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+++++||||+++++++..+...+++|||+++++|.+++....... .......+++..+..++.|++.|+.+||+.
T Consensus 62 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred HHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 578899999999999999999999999999999999997653211 011122378889999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
+ ++|+||+|+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+||||+++++++
T Consensus 142 ~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~ 218 (280)
T cd05049 142 H---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIF 218 (280)
T ss_pred C---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHH
Confidence 8 9999999999999999999999999987543322211122334567899999999888999999999999999999
Q ss_pred h-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 157 T-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 157 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+ |..||..... ......+........+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 219 ~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 219 TYGKQPWYGLSN----------------EEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred hcCCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 8 9999864321 1122222222222333456678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=246.65 Aligned_cols=205 Identities=27% Similarity=0.428 Sum_probs=168.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...+++|||+++++|.+++....+.. +++..++.++.|++.|+.|||+.+ +
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~~~~~i~~al~~lH~~~---i 125 (261)
T cd05148 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-------LPVASLIDMACQVAEGMAYLEEQN---S 125 (261)
T ss_pred HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578999999999999999999999999999999999998754332 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||.+......... .....++..|+|||......++.++|+||||++++++++ |..
T Consensus 126 ~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~ 203 (261)
T cd05148 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203 (261)
T ss_pred eccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998765432211 112335678999999988888999999999999999998 899
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
||.... ................+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 204 p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 204 PYPGMN----------------NHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCcCC----------------HHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 986432 1112222223333344456677899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=264.23 Aligned_cols=212 Identities=25% Similarity=0.377 Sum_probs=190.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|+.++|||+|+++|+|.....+|||+|||..|+|.+||++..... ++....+.++.||.+|+.||...+
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkkn--- 385 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKKN--- 385 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHhh---
Confidence 4788999999999999999999999999999999999999887654 778888999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|||+...|+|+..+..+|+.|||+++.+.......+. .....+-|.|||-+..+.++.++|+|+||++||||.| |.
T Consensus 386 FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGM 464 (1157)
T KOG4278|consen 386 FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGM 464 (1157)
T ss_pred hhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCC
Confidence 999999999999999999999999999887654433222 2234678999999999999999999999999999998 88
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
.||.+. ...+++..++.+.+.+.|..|++.+++||..||+.+|.+||+++|+.+.++.|+.+.|
T Consensus 465 sPYPGi----------------dlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 465 SPYPGI----------------DLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred CCCCCc----------------cHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 898644 4467889999999999999999999999999999999999999999999999998765
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=250.39 Aligned_cols=220 Identities=23% Similarity=0.381 Sum_probs=172.5
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC-------CCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
++.+ +||||+++++++......+++|||+.+++|.+++........ ..+...+++..++.++.|++.|+.||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L 153 (304)
T cd05101 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL 153 (304)
T ss_pred HHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence 4566 799999999999999999999999999999999976532110 01122478889999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+++ ++|+||||+||+++.++.++++|||+++...............+++.|+|||++.+..++.++|+||||++++
T Consensus 154 H~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 230 (304)
T cd05101 154 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230 (304)
T ss_pred HHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHH
Confidence 9998 9999999999999999999999999987664433222222234567899999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
++++ |..||.... .....+.+........+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 231 el~~~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 231 EIFTLGGSPYPGIP----------------VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred HHHcCCCCCcccCC----------------HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 9998 777875331 12222222222222334456678999999999999999999999999999
Q ss_pred HHHhhcCC
Q 026115 233 PLLNTRSG 240 (243)
Q Consensus 233 ~~~~~~~~ 240 (243)
++.....+
T Consensus 295 ~~~~~~~~ 302 (304)
T cd05101 295 RILTLTTN 302 (304)
T ss_pred HHHHhhhc
Confidence 98876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=247.26 Aligned_cols=208 Identities=22% Similarity=0.365 Sum_probs=164.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.. ...++++||+++|+|.+++....+ .+++..+..++.|++.|+.|||+.+ +
T Consensus 63 l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 130 (279)
T cd05111 63 MGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHR---M 130 (279)
T ss_pred HhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 467899999999998864 457788999999999999976443 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+||||+++||+++ |..
T Consensus 131 iH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~ 210 (279)
T cd05111 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAE 210 (279)
T ss_pred eccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999876543222212223446778999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
||.+..+ ......+........+..++..+.+++.+||..||++|||+.++++.|..+...
T Consensus 211 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 211 PYAGMRP----------------HEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCCCCCH----------------HHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 9864422 111222222222222233455788999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=247.72 Aligned_cols=210 Identities=27% Similarity=0.398 Sum_probs=165.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+....+++|||+.+++|.+++........ ....+++..++.++.|++.|+.|||+.+ +
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i 137 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEENH---F 137 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5689999999999999988899999999999999999976643211 1123889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCC---ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-
Q 026115 82 IHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT- 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 157 (243)
+|+||+|+||+++.++ .++++|||+++................+..|+|||++.+..++.++|||||||+++++++
T Consensus 138 vH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~ 217 (277)
T cd05036 138 IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217 (277)
T ss_pred eecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcC
Confidence 9999999999998654 589999999876633222111112233567999999998889999999999999999997
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
|..||..... +.....+....+...+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 218 g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 218 GYMPYPGRTN----------------QEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 9999864322 1222222222223334455678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=255.96 Aligned_cols=197 Identities=18% Similarity=0.215 Sum_probs=160.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.|+.|||+.+ +
T Consensus 47 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 114 (312)
T cd05585 47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR---------FDLSRARFYTAELLCALENLHKFN---V 114 (312)
T ss_pred HHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999999999999976532 888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+||++++|++|..|
T Consensus 115 ~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p 192 (312)
T cd05585 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192 (312)
T ss_pred EeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCC
Confidence 9999999999999999999999999875432211 12334589999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN---MGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~vl~ 229 (243)
|..... ......+.... ...+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 193 f~~~~~---------------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 193 FYDENV---------------NEMYRKILQEP--LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCCCH---------------HHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 964311 11111122211 1334455678999999999999999975 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=253.04 Aligned_cols=210 Identities=23% Similarity=0.357 Sum_probs=167.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||++++|++..+ ..+++++|+.+|+|.+++...... ++...++.++.|++.||+|||+.+ +
T Consensus 63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~--------~~~~~~~~~~~qi~~~L~~LH~~~---i 130 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYLEERR---L 130 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcccc--------CCHHHHHHHHHHHHHHHHHHHhcC---e
Confidence 5788999999999999875 467899999999999999865432 778889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||||+||+++.++.++|+|||+++...............++..|++||.+.+..++.++|+||||+++|++++ |..
T Consensus 131 iH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~ 210 (316)
T cd05108 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 210 (316)
T ss_pred eccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999986653322211122224567999999998889999999999999999997 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
||.+... ....+..........+..++..+.+++.+||+.+|++|||+.+++..+.++....+
T Consensus 211 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 211 PYDGIPA----------------SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred CCCCCCH----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 9864311 12222333332223334455679999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=254.13 Aligned_cols=214 Identities=23% Similarity=0.365 Sum_probs=162.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++.+++..++||||+++++|.+++..... ++...+..++.|++.|+.|||+.+ ++
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~--~i 125 (331)
T cd06649 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---------IPEEILGKVSIAVLRGLAYLREKH--QI 125 (331)
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHhhcC--CE
Confidence 5789999999999999999999999999999999999976542 788899999999999999999853 39
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||||+||+++.++.++|+|||++....... .....|+..|+|||.+.+..++.++|+|||||++|++++|..|
T Consensus 126 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 201 (331)
T cd06649 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201 (331)
T ss_pred EcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987553321 2334588999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceee------------c------------------cCcCchhhhhhhh-ccccCCCCCHHHHHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTW------------A------------------TPKLSEDKVKQCV-DTKLGGEYPPKAIAKMAAVA 210 (243)
Q Consensus 162 f~~~~~~~~~~~~~~------------~------------------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li 210 (243)
|.............. . ............+ ............+.++.+++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 281 (331)
T cd06649 202 IPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFV 281 (331)
T ss_pred CCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHH
Confidence 965432110000000 0 0000000011111 11111111123566899999
Q ss_pred HhhcCCCCCCCCCHHHHHHH
Q 026115 211 ALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 211 ~~~l~~~p~~Rps~~~vl~~ 230 (243)
.+||+.||++|||+.++++.
T Consensus 282 ~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 282 NKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred HHHccCCcccCCCHHHHhcC
Confidence 99999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=250.67 Aligned_cols=203 Identities=22% Similarity=0.306 Sum_probs=162.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++|+||+++++++.++...++|+||+.+|+|..++...... .+++..++.++.|++.|+.|||+.+
T Consensus 53 il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--- 122 (285)
T cd05631 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-------GFDEQRAIFYAAELCCGLEDLQRER--- 122 (285)
T ss_pred HHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 356889999999999999999999999999999999888654322 2788999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++|+||+||++|+|++|..
T Consensus 123 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 199 (285)
T cd05631 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199 (285)
T ss_pred EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCC
Confidence 99999999999999999999999999876432211 123458999999999998899999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~ 229 (243)
||........ .+.....+. ......+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 200 pf~~~~~~~~------------~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 200 PFRKRKERVK------------REEVDRRVK-EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCCCCCcchh------------HHHHHHHhh-cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 9975422110 011111111 1112233445678999999999999999997 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=253.92 Aligned_cols=195 Identities=22% Similarity=0.274 Sum_probs=161.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... ++...+..++.|++.|++|||+.+ +
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 122 (291)
T cd05612 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---------FSNSTGLFYASEIVCALEYLHSKE---I 122 (291)
T ss_pred HHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5789999999999999999999999999999999999976542 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++..... .....|++.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 123 ~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~p 197 (291)
T cd05612 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197 (291)
T ss_pred eecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765332 1234588999999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~~ 230 (243)
|...... +....+.... ...+...+..+.+++.+||+.||.+||+ +.++++.
T Consensus 198 f~~~~~~---------------~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 198 FFDDNPF---------------GIYEKILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCCCHH---------------HHHHHHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 9643211 1111122111 1233344667999999999999999995 8888763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=244.98 Aligned_cols=203 Identities=25% Similarity=0.391 Sum_probs=162.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++..+...+++|||+++|+|.+++....+ .+++..++.++.|++.|+.|||+++
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~--- 120 (256)
T cd05114 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNS--- 120 (256)
T ss_pred HHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999875432 1788999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|+||+|+||+++.++.++++|||.++........ ......++..|+|||.+.+..++.++|+||+|++++++++ |.
T Consensus 121 i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~ 199 (256)
T cd05114 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199 (256)
T ss_pred ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence 999999999999999999999999988765432211 1112234567999999988888999999999999999999 89
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
.||..... ......+........+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 200 ~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 200 MPFEKKSN----------------YEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 99864321 111111111111122333456799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=257.09 Aligned_cols=196 Identities=21% Similarity=0.288 Sum_probs=160.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.++...++||||+.+++|.+++..... ++...+..++.|++.||+|||+.+
T Consensus 71 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~--- 138 (329)
T PTZ00263 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR---------FPNDVAKFYHAELVLAFEYLHSKD--- 138 (329)
T ss_pred HHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 35789999999999999999999999999999999999976542 778888999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||+++..... .....|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 139 ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 213 (329)
T PTZ00263 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213 (329)
T ss_pred eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCC
Confidence 999999999999999999999999998755332 123458999999999998888999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~~ 230 (243)
||....+. .....+.... ...+...+..+.+++.+||+.||.+||+ ++++++.
T Consensus 214 pf~~~~~~---------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 214 PFFDDTPF---------------RIYEKILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCHH---------------HHHHHHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99643211 1111122221 1233345567899999999999999997 6777753
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=246.21 Aligned_cols=206 Identities=24% Similarity=0.378 Sum_probs=165.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++++||+.+++|.+++....+.. ++...++.++.|++.|++|||+.+ +
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~l~~~l~~LH~~~---i 124 (261)
T cd05072 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGK-------VLLPKLIDFSAQIAEGMAYIERKN---Y 124 (261)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 568899999999999999999999999999999999997654322 778889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||++.......... .....++..|+|||......++.++|+||||+++|++++ |..
T Consensus 125 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~ 203 (261)
T cd05072 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKI 203 (261)
T ss_pred eccccchhhEEecCCCcEEECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCC
Confidence 999999999999999999999999987654432211 122335678999999988888999999999999999998 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
||..... ......+............+..+.+++.+||+.+|++|||++++.+.|+++
T Consensus 204 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 204 PYPGMSN----------------SDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9864321 111111122222222334566799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=250.04 Aligned_cols=220 Identities=26% Similarity=0.391 Sum_probs=171.3
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
++++ +||||+++++++..+...++|+||+.+++|.+++....... .......+++.+++.++.|++.|++||
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 156 (307)
T cd05098 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156 (307)
T ss_pred HHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 3456 79999999999999999999999999999999997643210 001122378899999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++|+||+|+||+++.++.++|+|||.++...............++..|+|||.+.+..++.++|+||||+++|
T Consensus 157 H~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 157 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233 (307)
T ss_pred HHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHH
Confidence 9998 9999999999999999999999999987654322111111122456899999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+|++ |..||.... .......+........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 234 el~~~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 234 EIFTLGGSPYPGVP----------------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred HHHcCCCCCCCcCC----------------HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 9998 888885331 12222222222233344456678999999999999999999999999999
Q ss_pred HHHhhcCC
Q 026115 233 PLLNTRSG 240 (243)
Q Consensus 233 ~~~~~~~~ 240 (243)
+++...+.
T Consensus 298 ~~~~~~~~ 305 (307)
T cd05098 298 RILALTSN 305 (307)
T ss_pred HHHHHhhc
Confidence 99887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=260.72 Aligned_cols=197 Identities=26% Similarity=0.326 Sum_probs=168.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
|+++++||||+.+++.|+...++++|+||+.| +|..++..... +++..+..++.++++||.|||+++
T Consensus 54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~r--- 120 (808)
T KOG0597|consen 54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSNR--- 120 (808)
T ss_pred HHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhcC---
Confidence 46899999999999999999999999999977 99999987663 999999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+.|||+||+||+++.++.+|++|||+++........ -....||+.|||||.+.+..|+..+|+||+||++||+++|++
T Consensus 121 ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 121 ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred cccccCCcceeeecCCCceeechhhhhhhcccCcee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999999876654322 345679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||.... ...-+..+..... ..|...+..+..++...|.+||.+|.|-.+++.
T Consensus 199 PF~a~s---------------i~~Lv~~I~~d~v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 199 PFYARS---------------ITQLVKSILKDPV--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CchHHH---------------HHHHHHHHhcCCC--CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 996330 0111222222222 345577889999999999999999999999987
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=245.09 Aligned_cols=206 Identities=27% Similarity=0.410 Sum_probs=166.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++++||+.+++|.+++....+. .+++..+..++.|++.|+.+||+.+ +
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i 124 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR-------ALKLPQLIDMAAQVASGMAYLEAQN---Y 124 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 56889999999999999999999999999999999999765422 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++|+|||+++......... ......+..|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 125 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 203 (261)
T cd05068 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM 203 (261)
T ss_pred eeccCCcceEEEcCCCCEEECCcceEEEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999987664321111 111223457999999988888999999999999999999 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
||.+... ......+........+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 204 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 204 PYPGMTN----------------AEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 9864311 112222222222233445567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=248.04 Aligned_cols=212 Identities=25% Similarity=0.386 Sum_probs=166.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCC-CCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA-KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++||||+++++++..+...+++|||+++++|.+++......... .....+++..++.++.|++.|+.|||+.+
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 139 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--- 139 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 56789999999999999999999999999999999999764322110 11113678899999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|+||+|+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+||||++++++++ |.
T Consensus 140 i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 219 (277)
T cd05032 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAE 219 (277)
T ss_pred ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCC
Confidence 99999999999999999999999999876543322211223346778999999988888999999999999999998 89
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
.||..... ...............+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 220 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 220 QPYQGLSN----------------EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCccCCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 89864321 1122222222222334445678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=253.28 Aligned_cols=196 Identities=23% Similarity=0.328 Sum_probs=159.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|..++.... +++..+..++.|++.|+.|||+.+ +
T Consensus 56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~al~~lH~~~---i 122 (324)
T cd05589 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV----------FSEPRAVFYAACVVLGLQYLHENK---I 122 (324)
T ss_pred ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 467889999999999999999999999999999998886543 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus 123 vHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~p 200 (324)
T cd05589 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200 (324)
T ss_pred EecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 9999999999999999999999998864322211 12334589999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
|...... +....+..... ..+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 201 f~~~~~~---------------~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 201 FPGDDEE---------------EVFDSIVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCHH---------------HHHHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 9744221 11111111111 23334567799999999999999999 5777766
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=249.68 Aligned_cols=220 Identities=25% Similarity=0.394 Sum_probs=169.9
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
++++ +||||+++++++.++...++++||+.+|+|.+++....... .......+++..+..++.|++.|+.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 150 (314)
T cd05099 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150 (314)
T ss_pred HHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence 4456 69999999999999999999999999999999997643210 001112388899999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|++| ++|+||||+||+++.++.++++|||.++...............++..|+|||.+.+..++.++|+||||+++|
T Consensus 151 H~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 227 (314)
T cd05099 151 ESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227 (314)
T ss_pred HHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHH
Confidence 9998 9999999999999999999999999997664332211111222446799999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
++++ |..||..... ....+.+........+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 228 el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 228 EIFTLGGSPYPGIPV----------------EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred HHHhCCCCCCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9999 8888854311 1122222222222334445667999999999999999999999999999
Q ss_pred HHHhhcCC
Q 026115 233 PLLNTRSG 240 (243)
Q Consensus 233 ~~~~~~~~ 240 (243)
++....+.
T Consensus 292 ~~~~~~~~ 299 (314)
T cd05099 292 KVLAAVSE 299 (314)
T ss_pred HHHHHhcC
Confidence 98865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=258.64 Aligned_cols=217 Identities=23% Similarity=0.340 Sum_probs=168.5
Q ss_pred CCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC---------------------------------
Q 026115 2 VSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG--------------------------------- 47 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--------------------------------- 47 (243)
|++++ ||||+++++++.+....++||||+++|+|.+++........
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 94 MTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred HHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 45675 99999999999999999999999999999999875421000
Q ss_pred ------------------------------------------------------CCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 48 ------------------------------------------------------AKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 48 ------------------------------------------------------~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
......+++..+..++.|++.|++||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 00012367788899999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++||||||+++|
T Consensus 254 H~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ 330 (400)
T cd05105 254 ASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330 (400)
T ss_pred HhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHH
Confidence 9998 9999999999999999999999999987654322221122334677899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+|++ |..||..... .......+........+...+..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 331 ellt~g~~P~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 331 EIFSLGGTPYPGMIV---------------DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHCCCCCCcccch---------------hHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 9997 8899864311 11111222222223334456778999999999999999999999999999
Q ss_pred HHHh
Q 026115 233 PLLN 236 (243)
Q Consensus 233 ~~~~ 236 (243)
+++.
T Consensus 396 ~l~~ 399 (400)
T cd05105 396 SLLP 399 (400)
T ss_pred HHcC
Confidence 8865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=255.09 Aligned_cols=197 Identities=21% Similarity=0.276 Sum_probs=160.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||++++++|..+...++||||+.+|+|..++..... +++..+..++.|++.||.|||+.+ +
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---i 116 (323)
T cd05595 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---V 116 (323)
T ss_pred HHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5788999999999999999999999999999999998876542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|++++|..|
T Consensus 117 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~P 194 (323)
T cd05595 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194 (323)
T ss_pred EecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCC
Confidence 9999999999999999999999998865322211 11234589999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
|...... .....+..... ..+...+..+.+++.+||+.||++|| ++.++++
T Consensus 195 f~~~~~~---------------~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 195 FYNQDHE---------------RLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCHH---------------HHHHHHhcCCC--CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 9644221 11111111111 23334566899999999999999998 8988876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=247.02 Aligned_cols=220 Identities=27% Similarity=0.371 Sum_probs=168.4
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.. +...+++|||+.+++|.+++.... +++..++.++.|++.|+.|||+++
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~~-- 127 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQH-- 127 (283)
T ss_pred HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 578899999999998865 346899999999999999997653 889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccc-cccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||||+||+++.++.++++|||+++.......... .....++..|+|||...+..++.++|+||||++++++++|
T Consensus 128 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg 206 (283)
T cd05080 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206 (283)
T ss_pred -eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhC
Confidence 99999999999999999999999999876654322111 1122345679999999888889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
..||........ ...........................+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 207 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 207 CDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCcchhh-hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 999865432111 1111111111111222222222223334456678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=247.40 Aligned_cols=212 Identities=24% Similarity=0.358 Sum_probs=165.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC------CCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK------GAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++.++...++++||+.+++|.+++....... .......+++..++.++.|++.|++|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 578899999999999999999999999999999999997653210 01111237889999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.+ ++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+|||||+++++
T Consensus 141 ~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 141 LH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred CC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 98 999999999999999999999999998654332211112223356789999999988899999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
++ |..||..... ...............+..++..+.+++.+||+.||++||++.++++.|+
T Consensus 218 ~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 218 FTYGKQPWYQLSN----------------TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCCCCCCccCCH----------------HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 98 8999864311 1111212222222333345667999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=252.56 Aligned_cols=203 Identities=30% Similarity=0.392 Sum_probs=162.4
Q ss_pred CCCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 1 MVSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
||++|+|||||+++++..+ ...+|||+|||..|.+..-=... +.+++.++++++++++.||.|||.+|
T Consensus 161 ilKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~---------~els~~~Ar~ylrDvv~GLEYLH~Qg- 230 (576)
T KOG0585|consen 161 ILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK---------PELSEQQARKYLRDVVLGLEYLHYQG- 230 (576)
T ss_pred HHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCc---------ccccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 5789999999999999976 46799999999988763322111 12889999999999999999999999
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCccccccccc---ccccccccccCchhhccCC---C-CcccchHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS---TRVLGTFGYHAPEYAMTGQ---M-SSKSDVYSFGVV 151 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~---~-~~~~DiwslG~~ 151 (243)
++||||||.|+|++.+|.+||+|||++..+......... ...+||+.|+|||...++. + +.+.||||+||+
T Consensus 231 --iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 231 --IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred --eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 999999999999999999999999998766322111111 2257999999999987632 2 568899999999
Q ss_pred HHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 152 LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 152 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
||.++.|+.||.+. ...+-...+++..+..+...+..+.+.+||.+||.+||++|.++.+|..+
T Consensus 309 LYCllfG~~PF~~~---------------~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 309 LYCLLFGQLPFFDD---------------FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HHHhhhccCCcccc---------------hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 99999999999643 22244455666666555555678899999999999999999999988653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=254.16 Aligned_cols=198 Identities=21% Similarity=0.262 Sum_probs=161.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++.+++..+...++||||+++|+|..++..... +++..+..++.|++.||+|||+.+ +
T Consensus 49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---i 116 (328)
T cd05593 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERV---------FSEDRTRFYGAEIVSALDYLHSGK---I 116 (328)
T ss_pred HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5788999999999999999999999999999999998876542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|++++|..|
T Consensus 117 vHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~P 194 (328)
T cd05593 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194 (328)
T ss_pred EecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCC
Confidence 9999999999999999999999999875322111 12234589999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~~ 230 (243)
|...... ...+.+... ....+...+..+.+++.+||+.||++|| ++.++++.
T Consensus 195 f~~~~~~----------------~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 195 FYNQDHE----------------KLFELILME-DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHH----------------HHHHHhccC-CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 9643211 111111110 1123334566799999999999999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=242.81 Aligned_cols=212 Identities=29% Similarity=0.397 Sum_probs=170.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+||+++++++.++...+++|||+++++|.+++..............+++..++.++.|++.|+++||+.+ +
T Consensus 50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i 126 (262)
T cd00192 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---F 126 (262)
T ss_pred HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---c
Confidence 5678999999999999999999999999999999999987632110111123899999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||.+................++..|+|||.+....++.++|+||+|++++++++ |..
T Consensus 127 ~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 127 VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred ccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987665432222333457789999999988888999999999999999999 689
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
||..... ....+.+........+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 207 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 207 PYPGLSN----------------EEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9865411 2222222223333445556778999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=251.87 Aligned_cols=218 Identities=23% Similarity=0.365 Sum_probs=166.9
Q ss_pred CCcc-cCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCC--------------------------------
Q 026115 2 VSRL-KNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKG-------------------------------- 47 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------------------------------- 47 (243)
++++ +||||+++++++.. +..+++++||+++++|.+++........
T Consensus 64 ~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred HHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 3456 79999999998764 5678899999999999999865321100
Q ss_pred --------------------CCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCC
Q 026115 48 --------------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 107 (243)
Q Consensus 48 --------------------~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~ 107 (243)
......+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a 220 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLA 220 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccc
Confidence 000013788899999999999999999998 999999999999999999999999998
Q ss_pred CCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhh
Q 026115 108 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV 186 (243)
Q Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 186 (243)
+...............++..|+|||++.+..++.++|+|||||+++++++ |..||...... +..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---------------~~~ 285 (337)
T cd05054 221 RDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---------------EEF 285 (337)
T ss_pred hhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---------------HHH
Confidence 76543322222223445678999999999899999999999999999998 99998653211 111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 187 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
...+........+...+.++.+++.+||+.+|++|||+.++++.|.+++.+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111122222223334556899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=246.88 Aligned_cols=213 Identities=25% Similarity=0.360 Sum_probs=166.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC--------CCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK--------GAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--------~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
+++++||||+++++++..+...+++|||+.+++|.+++....... .......+++..++.++.|++.|+.||
T Consensus 61 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred HhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 678999999999999999999999999999999999986432100 000112378888999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+++ ++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+||||++++
T Consensus 141 H~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 217 (283)
T cd05090 141 SSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLW 217 (283)
T ss_pred HhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHH
Confidence 9998 9999999999999999999999999987654332222223334567899999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
++++ |..||.+..+ ....+.+........+..++..+.+++.+||+.||++||++.++++.|.
T Consensus 218 el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 218 EIFSFGLQPYYGFSN----------------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHcCCCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 9998 8889864311 2222222222222334455678999999999999999999999999876
Q ss_pred H
Q 026115 233 P 233 (243)
Q Consensus 233 ~ 233 (243)
.
T Consensus 282 ~ 282 (283)
T cd05090 282 S 282 (283)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=243.30 Aligned_cols=204 Identities=29% Similarity=0.431 Sum_probs=164.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.. ...++||||+.+++|.+++..... +++..+..++.|++.|+++||+.+ +
T Consensus 50 l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---i 116 (257)
T cd05116 50 MQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKH---------VTEKNITELVHQVSMGMKYLEETN---F 116 (257)
T ss_pred HHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567899999999998864 467899999999999999975432 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|+||||.||+++.++.++++|||+++......... ......++..|+|||.+....++.++|+||||+++||+++ |.
T Consensus 117 ~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~ 196 (257)
T cd05116 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQ 196 (257)
T ss_pred eecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654432211 1111234578999999987788899999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
.||..... ......+........+...+.++.+++.+||+.||++||++++|.+.|++.
T Consensus 197 ~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 197 KPYKGMKG----------------NEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 99864311 122223333333344455677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=247.69 Aligned_cols=208 Identities=19% Similarity=0.249 Sum_probs=162.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++.+++.++...++||||+.+++|.+++....... +++..++.++.|++.|++|||+.+
T Consensus 46 il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~-------~~~~~~~~~~~qi~~al~~lH~~~--- 115 (277)
T cd05607 46 ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-------LEMERVIHYSAQITCGILHLHSMD--- 115 (277)
T ss_pred HHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccC-------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999999999999886544322 788899999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||+|+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++|+||+||++|++++|..
T Consensus 116 ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~ 192 (277)
T cd05607 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRT 192 (277)
T ss_pred EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999876543221 123457889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
||......... ............. ......+.++.+++.+||+.||++||+++++++.+..
T Consensus 193 p~~~~~~~~~~-----------~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 193 PFKDHKEKVAK-----------EELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred CCCCCcchhhH-----------HHHHHHhhccccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 99654221110 0111111111111 1112346679999999999999999999777654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=255.34 Aligned_cols=195 Identities=20% Similarity=0.261 Sum_probs=161.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+|+|.+++..... ++...+..++.|++.|+.|||+.+ +
T Consensus 85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---i 152 (340)
T PTZ00426 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR---------FPNDVGCFYAAQIVLIFEYLQSLN---I 152 (340)
T ss_pred HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999976542 888899999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++..... .....||+.|+|||++.+..++.++|+||+||++|+|++|..|
T Consensus 153 vHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~P 227 (340)
T PTZ00426 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227 (340)
T ss_pred EccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCC
Confidence 99999999999999999999999998755322 1234589999999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~~ 230 (243)
|....+. .....+..... ..+...+..+.+++.+||+.||.+|+ |++++++.
T Consensus 228 f~~~~~~---------------~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 228 FYANEPL---------------LIYQKILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCHH---------------HHHHHHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 9754221 11111111111 22334456789999999999999995 89988763
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=246.66 Aligned_cols=213 Identities=25% Similarity=0.326 Sum_probs=167.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+++++||||+++++++......++++||+.+++|.+++....... .......++...++.++.|++.|+.|||
T Consensus 62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 467899999999999999999999999999999999985322100 0011123778889999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 154 (243)
+.+ ++||||||+||+++.++.++++|||+++...............+++.|+|||.+.+..++.++|+||||++++|
T Consensus 142 ~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 218 (283)
T cd05091 142 SHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218 (283)
T ss_pred HcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 998 99999999999999999999999999876543322222233345778999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
+++ |..||..... ....+.+........+..++..+.+++..||+.+|.+||++++++..|+.
T Consensus 219 l~~~g~~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 219 VFSYGLQPYCGYSN----------------QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 998 8888864311 22222222222233445667789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=244.58 Aligned_cols=211 Identities=21% Similarity=0.307 Sum_probs=165.5
Q ss_pred CCcccCCccceeeEEEEeCCe------eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGPL------RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++..... .++++||+.+++|..++........ ...++...++.++.|++.|+.|||+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~aL~~lH~ 131 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL---PEKLPLQTLLKFMVDIALGMEYLSN 131 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCC---cccCCHHHHHHHHHHHHHHHHHHHh
Confidence 567899999999998865543 7999999999999999865432111 1127889999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.+ ++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+|||||+++|+
T Consensus 132 ~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el 208 (273)
T cd05035 132 RN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208 (273)
T ss_pred CC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHH
Confidence 98 999999999999999999999999998765443322111222345689999999888889999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
++ |..||..... ....+.+........+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 209 ~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 209 ATRGQTPYPGVEN----------------HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HhCCCCCCCCCCH----------------HHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99 8888864321 122222222222334445667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=242.18 Aligned_cols=205 Identities=28% Similarity=0.431 Sum_probs=164.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.. ...++||||+.+++|.+++..... .+++..++.++.|++.|+.|||+.+ +
T Consensus 49 l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 116 (257)
T cd05115 49 MHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEGKN---F 116 (257)
T ss_pred HHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---e
Confidence 578999999999998864 578999999999999999875432 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccc-cccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|+||||+||+++.++.++++|||+++.......... .....++..|+|||.+....++.++|+||||+++|++++ |.
T Consensus 117 ~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 196 (257)
T cd05115 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQ 196 (257)
T ss_pred eecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999875433221111 111223568999999988888999999999999999996 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
.||..... ......+....+...+..++..+.+++.+||+.+|++||++.+|.+.|..+
T Consensus 197 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 197 KPYKKMKG----------------PEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCcCcCCH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 99864421 223333333333445556677899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=243.52 Aligned_cols=211 Identities=25% Similarity=0.386 Sum_probs=166.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...+++|||+++++|.+++......+. ....+++..++.++.|++.|++|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i 127 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKGCVYLEQMH---F 127 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhccc--CCccccHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5788999999999999999999999999999999999976432211 1123788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCC-----ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDD-----IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~-----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
+|+||+|+||+++.++ .++++|||++................++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 128 ~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 207 (269)
T cd05044 128 IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207 (269)
T ss_pred ccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH
Confidence 9999999999999877 89999999987654332221122334567899999999888999999999999999999
Q ss_pred h-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 157 T-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 157 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
+ |..||..... ......+........+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 208 t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 208 TLGQQPYPALNN----------------QEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HcCCCCCcccCH----------------HHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 8 9999863311 11122222222223344566789999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=253.74 Aligned_cols=198 Identities=22% Similarity=0.300 Sum_probs=161.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++..+...++||||+.+++|.+++..... +....+..++.|++.|+.|||+.+
T Consensus 53 il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~--- 120 (323)
T cd05584 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI---------FMEDTACFYLSEISLALEHLHQQG--- 120 (323)
T ss_pred HHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999876542 778888889999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 121 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 198 (323)
T cd05584 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198 (323)
T ss_pred eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCC
Confidence 99999999999999999999999999864332211 1223458999999999988888999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
||...... .....+.... ...+...+..+.+++.+||+.||++|| ++.++++
T Consensus 199 pf~~~~~~---------------~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 199 PFTAENRK---------------KTIDKILKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCHH---------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 99643211 1111222111 123344566799999999999999999 8888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=250.67 Aligned_cols=215 Identities=19% Similarity=0.223 Sum_probs=158.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++||||+.++.+..+..... .+++..+..++.|++.|+.|||+.+ +
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i 121 (287)
T cd07848 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKND---I 121 (287)
T ss_pred HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578899999999999999999999999999876665543322 2888899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||||+||+++.++.++|+|||++......... ......|+..|+|||++.+..++.++|+||+||++|+|++|..|
T Consensus 122 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~p 200 (287)
T cd07848 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPL 200 (287)
T ss_pred ecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432211 11234588999999999888899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhh---------hhcccc------CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQ---------CVDTKL------GGEYPPKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
|...........+.............. ...+.. ........+..+.+++.+||+.||++|||+++
T Consensus 201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~ 280 (287)
T cd07848 201 FPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ 280 (287)
T ss_pred CCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence 976432211100000000000000000 000000 00111224567999999999999999999999
Q ss_pred HHH
Q 026115 227 VLK 229 (243)
Q Consensus 227 vl~ 229 (243)
+++
T Consensus 281 ~l~ 283 (287)
T cd07848 281 CLN 283 (287)
T ss_pred Hhc
Confidence 986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=266.70 Aligned_cols=213 Identities=23% Similarity=0.264 Sum_probs=170.9
Q ss_pred CCCccc-CCccceeeEEEE------e-CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHH
Q 026115 1 MVSRLK-NENVVELVGYYV------D-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 72 (243)
Q Consensus 1 ~l~~l~-h~niv~~~~~~~------~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~ 72 (243)
+|++|+ |||||.|+|... . ...++|+||||.||.|-+++...-... +++.++++|+++++.|+.+
T Consensus 87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-------lte~eVLkIf~dv~~AVa~ 159 (738)
T KOG1989|consen 87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-------LTEDEVLKIFYDVCEAVAA 159 (738)
T ss_pred HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-------CChHHHHHHHHHHHHHHHH
Confidence 467887 999999999432 1 246899999999999999998655433 8999999999999999999
Q ss_pred hhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc-ccc------ccccccccccCchhhc---cCCCCcc
Q 026115 73 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHS------TRVLGTFGYHAPEYAM---TGQMSSK 142 (243)
Q Consensus 73 Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~------~~~~~~~~~~aPE~~~---~~~~~~~ 142 (243)
||... ++++|||||-+|||++.++..||||||.+......... ... -....|+.|++||++. +...+++
T Consensus 160 mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK 238 (738)
T KOG1989|consen 160 MHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK 238 (738)
T ss_pred HhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch
Confidence 99984 67999999999999999999999999988544322211 000 1123789999999885 5567999
Q ss_pred cchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 026115 143 SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 143 ~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (243)
+|||+|||+||-|+....||+... -..+++.....+-....+..+..||..||+.||.+||
T Consensus 239 sDIWALGclLYkLCy~t~PFe~sg-------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 239 SDIWALGCLLYKLCYFTTPFEESG-------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred hHHHHHHHHHHHHHHhCCCcCcCc-------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCC
Confidence 999999999999999999997431 2334444444444467888999999999999999999
Q ss_pred CHHHHHHHHHHHHhhcCC
Q 026115 223 NMGIVLKALQPLLNTRSG 240 (243)
Q Consensus 223 s~~~vl~~l~~~~~~~~~ 240 (243)
++.+|++.+..+......
T Consensus 300 nI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 300 NIYQVLEEIFELANKPCP 317 (738)
T ss_pred CHHHHHHHHHHHhcCCCC
Confidence 999999999998876543
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=242.72 Aligned_cols=203 Identities=27% Similarity=0.377 Sum_probs=162.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++......+++|||+.+++|.+++..... .+++..++.++.|++.|++|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 121 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQ---F 121 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5789999999999999988899999999999999999976432 1788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|.||+++.++.++++|||.++........ ......++..|++||...+..++.++|+||||+++|++++ |..
T Consensus 122 ~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 200 (256)
T cd05113 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200 (256)
T ss_pred eccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999988755432211 1112235567999999988888999999999999999998 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
||..... ......+........+...+..+.+++.+||+.+|.+|||+.++++.++
T Consensus 201 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 201 PYERFNN----------------SETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CcCcCCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 9864321 1111111222222223334678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=242.74 Aligned_cols=210 Identities=20% Similarity=0.320 Sum_probs=167.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++++||+++++|.+++....... ..++...++.++.|++.|+.|||+++ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i 127 (267)
T cd08228 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK-----RLIPERTVWKYFVQLCSAVEHMHSRR---V 127 (267)
T ss_pred HHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 578899999999999999999999999999999999886432110 12788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 128 ~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p 205 (267)
T cd08228 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred eCCCCCHHHEEEcCCCCEEECccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999988765433221 1234578899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhcc-ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
|...... .......+.. ..........+..+.+++.+||+.+|++|||++++++.++++.
T Consensus 206 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 206 FYGDKMN--------------LFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred Ccccccc--------------HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 8643110 0111111111 1111222345678999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=243.95 Aligned_cols=212 Identities=23% Similarity=0.325 Sum_probs=162.2
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++... ...++++||+.+|+|.+++....... ....++...+..++.|++.|+.|||+
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~ 130 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD---CPQYLPTQMLVKFMTDIASGMEYLSS 130 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccC---CcccCCHHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999987532 25789999999999999875332110 11127889999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.+ ++|+||||+||+++.++.++++|||+++...............+++.|++||...+..++.++|+||||+++|++
T Consensus 131 ~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el 207 (272)
T cd05075 131 KS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207 (272)
T ss_pred CC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHH
Confidence 98 999999999999999999999999998876443221111222356789999999988899999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
++ |..||...... .....+........+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 208 ~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 208 ATRGQTPYPGVENS----------------EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCCCCCCCCHH----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99 78888643211 11111111111122334556799999999999999999999999999876
Q ss_pred H
Q 026115 235 L 235 (243)
Q Consensus 235 ~ 235 (243)
+
T Consensus 272 ~ 272 (272)
T cd05075 272 L 272 (272)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=250.72 Aligned_cols=214 Identities=20% Similarity=0.304 Sum_probs=157.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+ +|.+++..... .++...+..++.|++.|++|||+.+ +
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---i 124 (288)
T cd07871 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKRK---I 124 (288)
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5789999999999999999999999999975 99998865432 2778899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..
T Consensus 125 vH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 202 (288)
T cd07871 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202 (288)
T ss_pred ccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998654322211 123457889999999875 457899999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCch---------hhhhhhhccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSE---------DKVKQCVDTKLGG----EYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
||...........+......... ........+.... ......+.+..+++.+||+.||.+|||++|+
T Consensus 203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~ 282 (288)
T cd07871 203 MFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282 (288)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 99754322111100000000000 0111111111000 0011234568899999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 283 l~ 284 (288)
T cd07871 283 LR 284 (288)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=241.38 Aligned_cols=201 Identities=26% Similarity=0.356 Sum_probs=164.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++++||+++++|.+++...... .++...++.++.|++.|+.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~~l~~al~~lH~~~---i 122 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-------PLPEDQVWRFFIQILLGLAHLHSKK---I 122 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 57899999999999999999999999999999999999865322 2888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||++......... .....|++.|+|||+..+..++.++|+||||++++++++|..|
T Consensus 123 ~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 200 (256)
T cd08529 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200 (256)
T ss_pred ccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999988765433221 1234578899999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|..... ...............+...+..+.+++.+||+.+|++||++.++++.
T Consensus 201 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 201 FDANNQ----------------GALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCH----------------HHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 964421 11111111122223333566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=253.29 Aligned_cols=203 Identities=21% Similarity=0.225 Sum_probs=161.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---i 122 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV---------LSEDHARFYMAEMFEAVDALHELG---Y 122 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999976542 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||++..... ......|++.|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus 123 vH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 197 (333)
T cd05600 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197 (333)
T ss_pred cccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCC
Confidence 9999999999999999999999999876543 12345689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|...........+. ..................+.++.+++.+||+.+|.+|||+.++++.
T Consensus 198 f~~~~~~~~~~~i~---------~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 198 FSGSTPNETWENLK---------YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCHHHHHHHHH---------hccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 97542211000000 0000000000000012346689999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=241.78 Aligned_cols=202 Identities=26% Similarity=0.381 Sum_probs=162.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++......++++||+++++|.+++..... .+++..++.++.|++.|++|||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 121 (256)
T cd05059 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNG---F 121 (256)
T ss_pred HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5788999999999999999999999999999999999976543 2789999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||.++......... .....++..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus 122 ~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~ 200 (256)
T cd05059 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM 200 (256)
T ss_pred ccccccHhhEEECCCCcEEECCcccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCC
Confidence 999999999999999999999999987654322111 111123457999999998889999999999999999998 888
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
||....+. .....+........+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 201 p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 201 PYERFSNS----------------EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHH----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 98643221 11111222222233344567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=245.74 Aligned_cols=215 Identities=26% Similarity=0.333 Sum_probs=167.4
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC-------CCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
++++ +||||+++++++......++++||+++++|.+++........ ......++...++.++.|++.|++||
T Consensus 56 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 135 (297)
T cd05089 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL 135 (297)
T ss_pred HHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3566 799999999999999999999999999999999976432110 00112378899999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++|+||||+||+++.++.++|+|||++........ ......+..|+|||...+..++.++|+|||||+++
T Consensus 136 H~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 209 (297)
T cd05089 136 SEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209 (297)
T ss_pred HHCC---cccCcCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence 9998 99999999999999999999999999864322111 11112345799999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+|++ |..||..... ....+..........+..++..+.+++.+||+.+|.+|||++++++.|.
T Consensus 210 el~t~g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 210 EIVSLGGTPYCGMTC----------------AELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred HHHcCCCCCCCCCCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9997 9999864421 1122222222222334445678999999999999999999999999999
Q ss_pred HHHhhc
Q 026115 233 PLLNTR 238 (243)
Q Consensus 233 ~~~~~~ 238 (243)
++....
T Consensus 274 ~~~~~~ 279 (297)
T cd05089 274 RMLEAR 279 (297)
T ss_pred HHHHhh
Confidence 888754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=242.28 Aligned_cols=213 Identities=26% Similarity=0.357 Sum_probs=164.5
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC-------CCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
++++ +||||+++++++......+++|||+++++|.+++........ ......++..++..++.|++.|++||
T Consensus 49 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l 128 (270)
T cd05047 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128 (270)
T ss_pred HHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567 799999999999999999999999999999999976532110 01112378899999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++|+||||+||+++.++.++++|||++........ ......+..|+|||.+....++.++|+||||++++
T Consensus 129 H~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 202 (270)
T cd05047 129 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202 (270)
T ss_pred HHCC---EeecccccceEEEcCCCeEEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence 9998 99999999999999999999999999763322111 11122355799999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
++++ |..||..... ....+.+........+...+..+.+++.+||+.||.+|||+.++++.|.
T Consensus 203 el~~~g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 203 EIVSLGGTPYCGMTC----------------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred HHHcCCCCCccccCH----------------HHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 9997 9999864321 1111111222222233345567999999999999999999999999999
Q ss_pred HHHh
Q 026115 233 PLLN 236 (243)
Q Consensus 233 ~~~~ 236 (243)
++++
T Consensus 267 ~~~~ 270 (270)
T cd05047 267 RMLE 270 (270)
T ss_pred HhhC
Confidence 8864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=240.45 Aligned_cols=208 Identities=21% Similarity=0.317 Sum_probs=161.0
Q ss_pred CCcccCCccceeeEEEE-eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++.++||||+++++++. .+...++++||+.+++|.+++...... .+...+..++.|+++|+.|||+.+
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~--- 118 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN--------PTVKDLIGFGLQVAKGMEYLASKK--- 118 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 57899999999999775 455688999999999999999754321 567778889999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccc--cccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|+||+++.++.++++|||+++........ .......++..|+|||.+.+..++.++|+||||++++++++|
T Consensus 119 i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 198 (262)
T cd05058 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198 (262)
T ss_pred ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcC
Confidence 999999999999999999999999998754332111 011123356789999999888889999999999999999995
Q ss_pred -CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 159 -RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 159 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
.+||..... ......+........+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 199 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 199 GAPPYPDVDS----------------FDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCCCCH----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 556643211 11111122222222233445689999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=246.86 Aligned_cols=217 Identities=26% Similarity=0.356 Sum_probs=168.2
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC-------CCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
+.++ +||||+++++++..+...++++||+++++|.+++........ ....+.++..+++.++.|++.|++||
T Consensus 61 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 140 (303)
T cd05088 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140 (303)
T ss_pred HHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence 4567 899999999999999999999999999999999976532110 01112378899999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++|+||||+||+++.++.++|+|||+++....... .....++..|+|||.+.+..++.++|+||||++++
T Consensus 141 H~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 141 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred HhCC---ccccccchheEEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 9998 99999999999999999999999999864322111 11122356799999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
++++ |..||..... ....+..........+...+..+.+++.+||+.+|++|||+.++++.+.
T Consensus 215 ellt~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 215 EIVSLGGTPYCGMTC----------------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred HHHhcCCCCcccCCh----------------HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9998 9999864321 1111111122222223334567999999999999999999999999999
Q ss_pred HHHhhcCC
Q 026115 233 PLLNTRSG 240 (243)
Q Consensus 233 ~~~~~~~~ 240 (243)
++++...+
T Consensus 279 ~~~~~~~~ 286 (303)
T cd05088 279 RMLEERKT 286 (303)
T ss_pred HHHHhhhh
Confidence 98877653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=241.82 Aligned_cols=207 Identities=24% Similarity=0.364 Sum_probs=165.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++.+++.+....+++|||+.+++|.+++....+ .+++..++.++.|++.|++|||+.+ +
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~~---i 128 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSDMN---Y 128 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5788999999999999999999999999999999999976432 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccccc-ccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|+||+|+||+++.++.++++|||++............ .....+..|+|||.+.+..++.++|+||||+++|++++ |.
T Consensus 129 ~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~ 208 (268)
T cd05063 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208 (268)
T ss_pred eccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998755432211111 11123457999999988888999999999999999997 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
.||..... ......+........+...+..+.+++.+||+.+|++||++.++++.|++++
T Consensus 209 ~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 209 RPYWDMSN----------------HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCcCCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 99854311 1122222222222333445678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=243.04 Aligned_cols=209 Identities=22% Similarity=0.350 Sum_probs=165.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++... ..+++++|+++|+|.+++..... .++...++.++.|++.|++|||+++ +
T Consensus 63 l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i 130 (279)
T cd05109 63 MAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEVR---L 130 (279)
T ss_pred HHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 4678999999999999764 46789999999999999976542 2788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++|+|||+++...............++..|+|||...+..++.++|+|||||++||+++ |..
T Consensus 131 iH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 210 (279)
T cd05109 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred eccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999876643322111122234568999999988889999999999999999998 889
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
||..... ......+........+...+..+.+++.+||+.||++|||+.++++.|.++....
T Consensus 211 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 211 PYDGIPA----------------REIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CCCCCCH----------------HHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 9864311 2222222232222334455678999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=237.48 Aligned_cols=205 Identities=25% Similarity=0.352 Sum_probs=167.8
Q ss_pred CCCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
||+|+ -||||+++.++|+.+...++|+|.++.|.|.++|..... +++....++.+|+.++++|||..+
T Consensus 75 ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt---------lSEK~tR~iMrqlfegVeylHa~~-- 143 (411)
T KOG0599|consen 75 ILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT---------LSEKETRRIMRQLFEGVEYLHARN-- 143 (411)
T ss_pred HHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee---------ecHHHHHHHHHHHHHHHHHHHHhh--
Confidence 34555 599999999999999999999999999999999988764 899999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc------CCCCcccchHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT------GQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~~l~ 153 (243)
|+|||+||+|||++++.+++|+|||++.....+... ....||++|+|||.+.. ..|+...|+|++|+++|
T Consensus 144 -IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImy 219 (411)
T KOG0599|consen 144 -IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMY 219 (411)
T ss_pred -hhhcccChhheeeccccceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHH
Confidence 999999999999999999999999999877655433 34569999999998863 35788899999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhh-hccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH-
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC-VDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK- 229 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~- 229 (243)
.++.|.+||.-. ...-.... .+.... .+.=.+.+....+||.+||+.||.+|.|++|+|.
T Consensus 220 TLLaGcpPFwHR----------------kQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 220 TLLAGCPPFWHR----------------KQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHcCCCchhHH----------------HHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 999999999521 11112222 222221 1222456778999999999999999999999997
Q ss_pred -HHHHHHh
Q 026115 230 -ALQPLLN 236 (243)
Q Consensus 230 -~l~~~~~ 236 (243)
++.++..
T Consensus 284 pff~q~~~ 291 (411)
T KOG0599|consen 284 PFFIQIAQ 291 (411)
T ss_pred hHHHHHHH
Confidence 4555544
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=231.42 Aligned_cols=214 Identities=25% Similarity=0.352 Sum_probs=166.6
Q ss_pred CcccCCccceeeEEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 3 SRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
++++||||++++++...+ +..+++++|...|+|.+.+....... ..+++.+++.++.++++||++||+..
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg-----~~~sE~~iL~if~gic~gL~~lH~~~ 147 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKG-----NFVSEAQILWIFLGICRGLEALHEKE 147 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcC-----CccCHHHHHHHHHHHHHHHHHHhccC
Confidence 678999999999987533 34899999999999999987665321 12899999999999999999999985
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccc-------cccccccccccCchhhcc---CCCCcccchHH
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-------STRVLGTFGYHAPEYAMT---GQMSSKSDVYS 147 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~---~~~~~~~Diws 147 (243)
++++|+||||.||+++..+.++++|||.+....-...... .....+|..|+|||.+.- ...++++||||
T Consensus 148 -~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWS 226 (302)
T KOG2345|consen 148 -PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWS 226 (302)
T ss_pred -CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhh
Confidence 5699999999999999999999999999876543322111 112357899999999863 34588999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 148 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
|||+||.|+.|..||+....+......+... ..+..+.....++.+.+++.+|++.||.+||++.++
T Consensus 227 LGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n-------------~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~l 293 (302)
T KOG2345|consen 227 LGCTLYAMMFGESPFERIYQQGGSLALAVQN-------------AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPEL 293 (302)
T ss_pred hhHHHHHHHHcCCcchHHhhcCCeEEEeeec-------------cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHH
Confidence 9999999999999998654433332222111 111112222367789999999999999999999999
Q ss_pred HHHHHHHH
Q 026115 228 LKALQPLL 235 (243)
Q Consensus 228 l~~l~~~~ 235 (243)
+..++++.
T Consensus 294 l~~~d~Li 301 (302)
T KOG2345|consen 294 LSKLDDLI 301 (302)
T ss_pred HHHHHhhc
Confidence 99998875
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=242.42 Aligned_cols=216 Identities=24% Similarity=0.331 Sum_probs=168.4
Q ss_pred CCcccCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++||||+++++++.. +...+++++|+.+++|.+++......... ....++...++.++.|++.|+.|||+.+
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--- 137 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN-NPQALSTQQLVHMAIQIACGMSYLHKRG--- 137 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 567899999999998765 56789999999999999998765322111 1123889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|+||+|+||+++.++.++++|||+++...............++..|+|||.+.+..++.++||||||++++++++ |.
T Consensus 138 i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 138 VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 99999999999999999999999999876533221111122335667999999988888999999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
.||....+ ......+........+..++..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 218 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 218 TPYVEIDP----------------FEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCcCcCCH----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 99864322 112222222222223334567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=256.72 Aligned_cols=210 Identities=25% Similarity=0.385 Sum_probs=186.4
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|+++.||||++++|.|.+. ..++|||.++-|.|..||+..+.. ++......++.|++.|+.|||+..
T Consensus 444 iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~s--------L~l~tL~ly~~Qi~talaYLeSkr--- 511 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDS--------LPLRTLTLYCYQICTALAYLESKR--- 511 (974)
T ss_pred HHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhcccc--------chHHHHHHHHHHHHHHHHHHHhhc---
Confidence 57899999999999999865 568899999999999999988754 888999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++||||...|||+....-+|++|||+++...+......+ ...-+.-|+|||.+....++.++|+|-||+..||++. |.
T Consensus 512 fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGv 590 (974)
T KOG4257|consen 512 FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGV 590 (974)
T ss_pred hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcC
Confidence 999999999999999999999999999998876655433 2334678999999999999999999999999999997 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
.||.+. .+..+...++.+-+.+.|+.|+..++.++.+||..+|.+||++.++...|.+++.+.+
T Consensus 591 kPfqgv----------------kNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 591 KPFQGV----------------KNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred Cccccc----------------cccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 999755 3345566677788889999999999999999999999999999999999999988544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=250.63 Aligned_cols=212 Identities=22% Similarity=0.345 Sum_probs=159.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-CCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~~~~ 80 (243)
+++++||||++++++|.+++..++||||+.+++|.+++..... ++...+..++.|++.|+.|||+. +
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~~--- 124 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK--- 124 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcCC---
Confidence 5688999999999999999999999999999999999976432 78888999999999999999975 5
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||||+||+++.++.++|+|||++....... .....|+..|+|||.+.+..++.++|+|||||++|++++|..
T Consensus 125 ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 200 (333)
T cd06650 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRY 200 (333)
T ss_pred EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999986553321 223458899999999988888999999999999999999999
Q ss_pred CCCCCCCCCCcccee--------e--------------------ccCcCchhhhhhhhccccCCCC-CHHHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVT--------W--------------------ATPKLSEDKVKQCVDTKLGGEY-PPKAIAKMAAVAA 211 (243)
Q Consensus 161 pf~~~~~~~~~~~~~--------~--------------------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~ 211 (243)
||............. . ..+..........+........ ....+.++.+++.
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 280 (333)
T cd06650 201 PIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVN 280 (333)
T ss_pred CCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHH
Confidence 997543211100000 0 0000000001111111111111 1123567999999
Q ss_pred hhcCCCCCCCCCHHHHHH
Q 026115 212 LCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 212 ~~l~~~p~~Rps~~~vl~ 229 (243)
+||+.||++|||+.++++
T Consensus 281 ~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 281 KCLIKNPAERADLKQLMV 298 (333)
T ss_pred HhccCCcccCcCHHHHhh
Confidence 999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=240.44 Aligned_cols=205 Identities=27% Similarity=0.397 Sum_probs=164.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++++.||||+++++++. +...+++|||+.+++|.+++..... +++..++.++.|++.|++|||..+ +
T Consensus 50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lh~~~---i 116 (257)
T cd05060 50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRRE---------IPVSDLKELAHQVAMGMAYLESKH---F 116 (257)
T ss_pred HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHhhcC---e
Confidence 56789999999999876 4467999999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccccc-ccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|+||+|+||+++.++.++++|||.++........... ....++..|+|||.+.+..++.++|+||||++++++++ |.
T Consensus 117 ~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~ 196 (257)
T cd05060 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGA 196 (257)
T ss_pred eccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999998766443322111 11223467999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
.||..... ......+........+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 197 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 197 KPYGEMKG----------------AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCcccCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 99864321 1122222222222344455678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=251.90 Aligned_cols=193 Identities=21% Similarity=0.255 Sum_probs=157.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+|+|..++..... +++..+..++.|++.||.|||+.+ +
T Consensus 50 ~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~g---i 117 (323)
T cd05575 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSLN---I 117 (323)
T ss_pred HhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 4678999999999999999999999999999999999876542 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 118 vH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 195 (323)
T cd05575 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195 (323)
T ss_pred EeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCC
Confidence 9999999999999999999999999865322211 12334589999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
|...... +....+..... ..+...+..+.+++.+||+.||.+||++.
T Consensus 196 f~~~~~~---------------~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 196 FYSRDTA---------------EMYDNILNKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHH---------------HHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 9643211 11111222111 12223466799999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=253.44 Aligned_cols=198 Identities=20% Similarity=0.268 Sum_probs=160.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~ 80 (243)
+++++||||+++.+++.++...++||||+.+|+|..++..... +++..+..++.|++.||.|||+ .+
T Consensus 49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~~~--- 116 (325)
T cd05594 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKN--- 116 (325)
T ss_pred HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhcCC---
Confidence 5678999999999999999999999999999999998876542 8899999999999999999997 67
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 117 ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~ 194 (325)
T cd05594 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194 (325)
T ss_pred EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCC
Confidence 99999999999999999999999999864322111 1223458999999999998889999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~~ 230 (243)
||..... +.....+... ....+...+..+.+++.+||+.||++|+ ++.++++.
T Consensus 195 Pf~~~~~----------------~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 195 PFYNQDH----------------EKLFELILME-EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCH----------------HHHHHHHhcC-CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 9964321 1111111110 1122334566799999999999999996 89999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=243.83 Aligned_cols=215 Identities=22% Similarity=0.367 Sum_probs=166.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-CCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++||||+++++++.++...+++|||+.+|+|.+++....... .....+..+...+..++.|++.|+.|||+.+
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--- 139 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--- 139 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 567899999999999999999999999999999999997643211 1111123567788999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+|||||+++++++ |.
T Consensus 140 i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~ 219 (288)
T cd05061 140 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 219 (288)
T ss_pred CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999875543222111122335678999999988888999999999999999998 78
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
.||..... +.....+........+...+..+.+++.+||+.||++|||+.++++.|.+.+
T Consensus 220 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 220 QPYQGLSN----------------EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 88864321 1122221111112223344568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=241.30 Aligned_cols=206 Identities=24% Similarity=0.414 Sum_probs=164.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++++||+.+++|.+++....+. +++.+++.++.|++.|+.|||+.+ +
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~~l~~al~~lH~~g---~ 127 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYLSEMN---Y 127 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCC--------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 56889999999999999999999999999999999998765432 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccccccccc---ccccccCchhhccCCCCcccchHHHHHHHHHHHh-
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL---GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT- 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 157 (243)
+|+||+|+||+++.++.++++|||++................ .+..|+|||.+.+..++.++|+||+|++++|+++
T Consensus 128 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~ 207 (269)
T cd05065 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 207 (269)
T ss_pred eecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcC
Confidence 999999999999999999999999987554322111111111 2347999999988888999999999999999886
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
|..||..... ......+........+..++..+.+++.+||+.+|++||++.+++..|+++
T Consensus 208 g~~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 208 GERPYWDMSN----------------QDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCCCCCCH----------------HHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9999864321 112222222222233345567799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=239.83 Aligned_cols=202 Identities=28% Similarity=0.432 Sum_probs=162.1
Q ss_pred CCcccCCccceeeEEEE-eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++|+|++++++++. ++...++++||+++++|.+++...... .+++..++.++.|++.|++|||+++
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~--- 122 (256)
T cd05082 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEANN--- 122 (256)
T ss_pred HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 57899999999999764 556789999999999999998765432 2788899999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|+||+|+||+++.++.++++|||++....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |.
T Consensus 123 i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~ 197 (256)
T cd05082 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197 (256)
T ss_pred EeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999886543321 12234567999999988888999999999999999997 89
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
.||..... ......+........+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 198 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 198 VPYPRIPL----------------KDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 99863311 112222222222233445567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=247.55 Aligned_cols=218 Identities=25% Similarity=0.391 Sum_probs=169.7
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC-------CCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
++++ +||||+++++++..+...++++||+.+|+|.+++........ ......+++..++.++.|++.|+.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred HHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4567 799999999999999999999999999999999976432100 01122378889999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|+||||++++
T Consensus 151 H~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 227 (334)
T cd05100 151 ASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227 (334)
T ss_pred HHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHH
Confidence 9998 9999999999999999999999999987654332111112223456799999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+|++ |..||..... +.....+........+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 228 el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 228 EIFTLGGSPYPGIPV----------------EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred HHHhcCCCCCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 9998 8888854311 2222222222222334455668999999999999999999999999999
Q ss_pred HHHhhc
Q 026115 233 PLLNTR 238 (243)
Q Consensus 233 ~~~~~~ 238 (243)
++....
T Consensus 292 ~~~~~~ 297 (334)
T cd05100 292 RVLTVT 297 (334)
T ss_pred HHhhhc
Confidence 988544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=240.62 Aligned_cols=202 Identities=23% Similarity=0.298 Sum_probs=163.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++++||+++++|.+++..... ++...+..++.|++.|+.|||+.+ +
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~---i 125 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---------LTETVTRKYTRQILEGVEYLHSNM---I 125 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5789999999999999999999999999999999999876542 778889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccc-cccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++|+|||.++.......... .....++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 126 ~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 205 (263)
T cd06625 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205 (263)
T ss_pred ecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865433211111 122346788999999998888999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
||...... ...............+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 206 p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 206 PWAEFEAM---------------AAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CccccchH---------------HHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 98643111 11122222222233445566789999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=253.46 Aligned_cols=194 Identities=22% Similarity=0.285 Sum_probs=158.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---i 119 (318)
T cd05582 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSLG---I 119 (318)
T ss_pred HHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5789999999999999999999999999999999999876432 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||||+||+++.++.++|+|||+++........ .....|++.|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus 120 ~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 197 (318)
T cd05582 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197 (318)
T ss_pred ecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCC
Confidence 99999999999999999999999998754332111 2234588999999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
|...... .....+.... ...+...+..+.+++.+||+.||++|||+.+
T Consensus 198 ~~~~~~~---------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 198 FQGKDRK---------------ETMTMILKAK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHH---------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 9743211 1111122211 1233445668999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=238.69 Aligned_cols=210 Identities=20% Similarity=0.317 Sum_probs=167.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+||+++++++.++...+++|||+++++|.+++...... ...++..+++.++.+++.|+.|||+.+ +
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i 127 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHSKR---I 127 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 57889999999999999999999999999999999998653211 112788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||.++........ .....++..|.|||.+.+..++.++|+||+|++++++++|..|
T Consensus 128 ~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p 205 (267)
T cd08224 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred ecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999988755432211 1234578889999999888899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP-KAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
|...... .....+..........+. ..+..+.+++.+||..+|++|||+.++++.|+++.
T Consensus 206 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 206 FYGDKMN--------------LYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cccCCcc--------------HHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 8643210 011111111112222222 55668999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=239.30 Aligned_cols=202 Identities=30% Similarity=0.468 Sum_probs=165.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+||+++++++.++...++||||+++++|.+++...... .+++..+..++.|++.|+.|||+.+ +
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~~---i 123 (256)
T cd05039 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLEEKN---F 123 (256)
T ss_pred HHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 57889999999999999999999999999999999999765432 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||.++....... ....+..|+|||.+....++.++|+||||++++++++ |..
T Consensus 124 ~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~ 198 (256)
T cd05039 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred cchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999876632211 2234567999999988888999999999999999997 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
||..... ......+....+...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 199 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 199 PYPRIPL----------------KDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCCH----------------HHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 9863311 122222222222233344567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=252.29 Aligned_cols=199 Identities=24% Similarity=0.306 Sum_probs=153.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++|+||+++++++.+++.+++||||+++++|..... .....+..++.|++.||.|||+.+
T Consensus 125 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------------~~~~~~~~i~~qi~~aL~~LH~~~--- 188 (353)
T PLN00034 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI-------------ADEQFLADVARQILSGIAYLHRRH--- 188 (353)
T ss_pred HHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccccc-------------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3578899999999999999999999999999999865321 556778889999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-----CCCcccchHHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~l 155 (243)
++||||||+||+++.++.++|+|||+++........ .....|+..|+|||++... ..+.++|||||||++|+|
T Consensus 189 ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el 266 (353)
T PLN00034 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266 (353)
T ss_pred EeecCCCHHHEEEcCCCCEEEcccccceeccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHH
Confidence 999999999999999999999999998765432211 2234689999999987432 234589999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
++|..||....... ................+...+.++.+++.+||+.||++|||+.|+++.
T Consensus 267 ~~g~~pf~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 267 YLGRFPFGVGRQGD-------------WASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HhCCCCCCCCCCcc-------------HHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999997321100 001111111111223334556789999999999999999999999974
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=239.91 Aligned_cols=201 Identities=21% Similarity=0.296 Sum_probs=163.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++..+++++||+++++|.+++...... .++...++.++.|++.|+.+||+.+ +
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~~---i 121 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGK-------LFPEDTILQWFVQMCLGVQHIHEKR---V 121 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHhhCC---c
Confidence 56889999999999999999999999999999999988754332 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||.++........ .....++..|+|||++.+..++.++|+||+|+++++|++|..|
T Consensus 122 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p 199 (255)
T cd08219 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199 (255)
T ss_pred ccCCCCcceEEECCCCcEEEcccCcceeecccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCC
Confidence 99999999999999999999999998655432211 2234578899999999888899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|..... ......+........+...+..+.+++.+||+.||++|||+.+++..
T Consensus 200 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 200 FQANSW----------------KNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCH----------------HHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 964311 11111111122223344456679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=251.76 Aligned_cols=198 Identities=20% Similarity=0.231 Sum_probs=159.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++||||+.+++|..++..... +....+..++.|++.||.|||+.| +
T Consensus 50 l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~g---i 117 (325)
T cd05602 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---I 117 (325)
T ss_pred HHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 4678999999999999999999999999999999999976542 777888889999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 118 iHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 195 (325)
T cd05602 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred EecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCC
Confidence 9999999999999999999999999865322111 12334689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|...... +....+..... ..+...+..+.+++.+||+.||.+||++.+.+..
T Consensus 196 f~~~~~~---------------~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 196 FYSRNTA---------------EMYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHH---------------HHHHHHHhCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 9643211 11111111111 2223456679999999999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=240.82 Aligned_cols=208 Identities=24% Similarity=0.357 Sum_probs=167.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.. ...++++||+.+|+|.+++...... +++..++.++.|++.|++|||+.+ +
T Consensus 63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~~---i 130 (279)
T cd05057 63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDN--------IGSQYLLNWCVQIAKGMSYLEEKR---L 130 (279)
T ss_pred HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 567899999999999987 7889999999999999999765432 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++|+|||+++...............++..|+|||......++.++|+||||++++++++ |..
T Consensus 131 ~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 210 (279)
T cd05057 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred EecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999876653322211111223567999999988888999999999999999998 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
||..... ......+........+..++..+.+++.+||..||++|||+.++++.|.++.++
T Consensus 211 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 211 PYEGIPA----------------VEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCCH----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 9864321 222222222222233334556799999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=237.88 Aligned_cols=204 Identities=25% Similarity=0.428 Sum_probs=163.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+....++++||+.+++|.+++..... .++...++.++.+++.|+.|||+++ +
T Consensus 46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~---i 114 (251)
T cd05041 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKN---C 114 (251)
T ss_pred HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5789999999999999999999999999999999999875432 1788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||.++...............++..|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 115 ~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~ 194 (251)
T cd05041 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDT 194 (251)
T ss_pred ehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCC
Confidence 9999999999999999999999999876542221111111223557999999988888999999999999999998 888
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
||..... ......+........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 195 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 195 PYPGMSN----------------QQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCH----------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 8864422 1112222222222334455678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=239.87 Aligned_cols=207 Identities=24% Similarity=0.396 Sum_probs=165.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...+++|||+++++|.+++..... .++..+++.++.|++.|+.+||+.+ +
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i 127 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSDMG---Y 127 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5678999999999999999999999999999999999976542 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccccc-ccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|+||+|+||+++.++.++++|||+++........... ....++..|++||.+.+..++.++|+||||++++++++ |.
T Consensus 128 ~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~ 207 (267)
T cd05066 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207 (267)
T ss_pred eehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCC
Confidence 99999999999999999999999998766443221111 11223467999999998889999999999999999886 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
.||...... + ....+........+...+..+.+++.+||+.+|.+|||+.++++.|++++
T Consensus 208 ~p~~~~~~~---------------~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 208 RPYWEMSNQ---------------D-VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred CCcccCCHH---------------H-HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 998643211 1 11111111222233345668999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=243.16 Aligned_cols=206 Identities=21% Similarity=0.294 Sum_probs=161.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++.+++..+...++||||+++|+|..++...... ...+++..+..++.|++.|+.|||+.+
T Consensus 46 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~--- 117 (280)
T cd05608 46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLHQRR--- 117 (280)
T ss_pred HHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 357889999999999999999999999999999999887542211 112889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||+|+||+++.++.++|+|||.+......... .....|++.|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 118 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~ 195 (280)
T cd05608 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARG 195 (280)
T ss_pred cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998655432211 223458899999999998889999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
||........ ........... ....+...+..+.+++.+||+.||++|| |++++++
T Consensus 196 pf~~~~~~~~-----------~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 196 PFRARGEKVE-----------NKELKQRILND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCCCCCcchh-----------HHHHHHhhccc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 9974322110 00001111111 1123344667899999999999999999 7788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=249.18 Aligned_cols=189 Identities=21% Similarity=0.277 Sum_probs=154.6
Q ss_pred ccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 5 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
.+||||+++++++.++..+++||||+.+|+|..++..... ++...+..++.|++.|+.|||+.+ ++||
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~---------l~~~~~~~~~~ql~~~L~~lH~~~---ivH~ 120 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEITSALMFLHDKG---IIYR 120 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeC
Confidence 4799999999999999999999999999999998876542 888999999999999999999998 9999
Q ss_pred cCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026115 85 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164 (243)
Q Consensus 85 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 164 (243)
||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 121 dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred CCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999865322211 12234589999999999988899999999999999999999999974
Q ss_pred CCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 165 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
.... .....+.... ...+...+..+.+++.+||+.||++||++
T Consensus 199 ~~~~---------------~~~~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 199 ENED---------------DLFEAILNDE--VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHH---------------HHHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 4221 1111111111 12233456679999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=247.26 Aligned_cols=195 Identities=22% Similarity=0.273 Sum_probs=157.8
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
..+||||+++++++..+...++||||+.+|+|..++..... ++...+..++.|++.|+.|||+.+ ++|
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivH 119 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---------FDEARARFYAAEIICGLQFLHKKG---IIY 119 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 45899999999999999999999999999999999876542 888899999999999999999998 999
Q ss_pred ccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026115 84 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163 (243)
Q Consensus 84 ~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 163 (243)
|||||+||+++.++.++|+|||+++...... .......|++.|+|||++.+..++.++|+|||||++++|++|..||.
T Consensus 120 ~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986543221 11233458999999999998889999999999999999999999997
Q ss_pred CCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 026115 164 HTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG-IVLK 229 (243)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~vl~ 229 (243)
+... ......+.. .....+...+..+.+++.+||+.||.+||++. ++++
T Consensus 198 ~~~~----------------~~~~~~i~~-~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 198 GEDE----------------DELFDSILN-DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCH----------------HHHHHHHHc-CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 5421 111111111 11223344566789999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=242.99 Aligned_cols=213 Identities=24% Similarity=0.351 Sum_probs=164.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------------CCCCCCccCHHHHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------------GAKPGPVLSWAQRVKIAVGAAR 68 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------------~~~~~~~~~~~~~~~~~~ql~~ 68 (243)
+++++||||+++++++.++...++++||+.+++|.+++....... .......++...++.++.|++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 567899999999999999999999999999999999997543210 0111123778899999999999
Q ss_pred HHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHH
Q 026115 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSF 148 (243)
Q Consensus 69 ~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl 148 (243)
|+.|||..+ ++|+||+|+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+|||
T Consensus 142 aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 142 GMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred HHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 999999998 99999999999999999999999999875543322111122234567999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 149 GVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 149 G~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
||+++++++ |..||.+... ......+........+...+..+.+++.+||+.+|++|||+.|+
T Consensus 219 G~il~el~~~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 219 GVVLWEIFSYGMQPYYGMAH----------------EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 999999997 7788754311 11111111111122333456789999999999999999999999
Q ss_pred HHHHHH
Q 026115 228 LKALQP 233 (243)
Q Consensus 228 l~~l~~ 233 (243)
++.|++
T Consensus 283 ~~~l~~ 288 (288)
T cd05050 283 NRILQR 288 (288)
T ss_pred HHHhhC
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=249.27 Aligned_cols=204 Identities=21% Similarity=0.290 Sum_probs=158.8
Q ss_pred Ccc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 3 SRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 3 ~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++ +||||+++++++.++..+++||||+++|+|..++..... +++..+..++.|++.|+.|||+.+ +
T Consensus 50 ~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---i 117 (329)
T cd05588 50 ETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNFLHERG---I 117 (329)
T ss_pred HhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 344 799999999999999999999999999999998875532 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+||++|++++|..|
T Consensus 118 vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred EecCCCHHHeEECCCCCEEECcCccccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCC
Confidence 9999999999999999999999999864322111 12234689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhh-hhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQ-CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN------MGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~vl~ 229 (243)
|.......... ........+ +..... ..+...+..+.+++.+||+.||.+||| ++++++
T Consensus 196 f~~~~~~~~~~-------~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 196 FDIVGMSDNPD-------QNTEDYLFQVILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ccccccccccc-------ccchHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 96432111000 000011111 112111 233445667999999999999999998 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=252.13 Aligned_cols=216 Identities=25% Similarity=0.410 Sum_probs=168.4
Q ss_pred CCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC----------------------------------
Q 026115 2 VSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---------------------------------- 46 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------------------------- 46 (243)
|.++. ||||+++++++..+...++|+||+.+|+|.++++......
T Consensus 94 l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred HHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 45676 9999999999999999999999999999999997543100
Q ss_pred -------------------------------------------------------CCCCCCccCHHHHHHHHHHHHHHHH
Q 026115 47 -------------------------------------------------------GAKPGPVLSWAQRVKIAVGAARGLE 71 (243)
Q Consensus 47 -------------------------------------------------------~~~~~~~~~~~~~~~~~~ql~~~l~ 71 (243)
.....+.+++..++.++.|++.|+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 0011224677888999999999999
Q ss_pred HhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHH
Q 026115 72 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 151 (243)
Q Consensus 72 ~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~ 151 (243)
|||+.+ ++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+||||++
T Consensus 254 ~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvi 330 (401)
T cd05107 254 FLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330 (401)
T ss_pred HHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHH
Confidence 999998 99999999999999999999999999875433221111222346788999999988888999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 152 LLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 152 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
++|+++ |..||.... ..+.....+....+...+...+..+.+++.+||+.+|.+||++++|++.
T Consensus 331 l~e~l~~g~~P~~~~~---------------~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 331 LWEIFTLGGTPYPELP---------------MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCCCCCCCC---------------chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999998 888885331 1112222222333333444556789999999999999999999999999
Q ss_pred HHHHH
Q 026115 231 LQPLL 235 (243)
Q Consensus 231 l~~~~ 235 (243)
|++++
T Consensus 396 L~~~~ 400 (401)
T cd05107 396 VGDLL 400 (401)
T ss_pred HHHHh
Confidence 99876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=239.78 Aligned_cols=209 Identities=25% Similarity=0.371 Sum_probs=165.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++ ..+++|||+++++|.+++..... .+++..++.++.|++.|+.|||+.+ +
T Consensus 61 l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---~ 128 (270)
T cd05056 61 MRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESKR---F 128 (270)
T ss_pred HHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5688999999999998764 46799999999999999976432 1788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||+++......... .....++..|+|||.+....++.++|+||||++++++++ |..
T Consensus 129 ~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 207 (270)
T cd05056 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207 (270)
T ss_pred eccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999987554332111 112224567999999988888999999999999999986 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
||...... .....+........+..++..+.+++.+||..+|++|||+.++++.|+++.++.+
T Consensus 208 pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~~ 270 (270)
T cd05056 208 PFQGVKNN----------------DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEEK 270 (270)
T ss_pred CCCCCCHH----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhccC
Confidence 98644211 1111111112223334556789999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=242.30 Aligned_cols=222 Identities=23% Similarity=0.300 Sum_probs=163.1
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.. ....++|+||+++++|.+++..... .+++..++.++.|++.|+.|||+.+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~~-- 128 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSKR-- 128 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 568899999999998753 3568999999999999999975432 1788999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCccccccccc-ccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||||+||+++.++.++|+|||+++........... ....++..|+|||.+.+..++.++|+||||++++++++|
T Consensus 129 -i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 207 (284)
T cd05081 129 -YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 207 (284)
T ss_pred -ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhc
Confidence 999999999999999999999999998765432221111 111234469999999888889999999999999999998
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
..++.........................+.+........+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 208 SDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 7765433211100000000000111112222232222233344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=239.51 Aligned_cols=211 Identities=19% Similarity=0.293 Sum_probs=166.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++++||+.+++|.+++...... ...+++..++.++.|++.|+.|||+++ +
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i 127 (267)
T cd08229 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHSRR---V 127 (267)
T ss_pred HHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 56789999999999999999999999999999999988743211 112788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 128 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p 205 (267)
T cd08229 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred ecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999988765433221 1234578899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
|........ ...................+..+.+++.+||+.||++|||+.+|++.+.++.
T Consensus 206 ~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 206 FYGDKMNLY-------------SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cccccchHH-------------HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 864321100 0000111111111122346678999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=238.08 Aligned_cols=206 Identities=28% Similarity=0.447 Sum_probs=163.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+ ...+++|||+.+++|.+++....+. .+++..+..++.|++.|+++||+.+ +
T Consensus 55 l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~~---i 123 (262)
T cd05071 55 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVERMN---Y 123 (262)
T ss_pred HHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999998754 4578999999999999999764322 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++|+|||.++......... .....++..|+|||...+..++.++|+||||++++++++ |..
T Consensus 124 ~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~ 202 (262)
T cd05071 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 202 (262)
T ss_pred cccccCcccEEEcCCCcEEeccCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999987654332111 122335667999999988888999999999999999999 888
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
||..... ...............+...+..+.+++.+||+.+|++|||+.++++.|++.+
T Consensus 203 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 203 PYPGMVN----------------REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCCCh----------------HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 8864321 1111112222222334456778999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=243.33 Aligned_cols=220 Identities=20% Similarity=0.292 Sum_probs=164.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC--CCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG--AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.++...+++|||+.+++|.+++........ ......+++.+++.++.|++.|++|||+.+
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-- 150 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-- 150 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5688999999999999999999999999999999999976542211 111223778899999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh--
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-- 157 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-- 157 (243)
++|+||||+||+++.++.++++|||+++...............++..|++||......++.++|+|||||++||+++
T Consensus 151 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 151 -FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred -eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999876543322211222334678999999888889999999999999999998
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
|..||........ ... ................+..++..+.+++.+||+.||++|||+.+|++.|++
T Consensus 230 ~~~p~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 230 KEQPYSQLSDEQV---IEN------TGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCCCccccChHHH---HHH------HHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 6778754322110 000 000000000111112233455789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=237.92 Aligned_cols=205 Identities=28% Similarity=0.364 Sum_probs=163.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+ ...++++||+++++|.+++...... .+++..++.++.|++.|+.|||+.+ +
T Consensus 50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~~---i 118 (257)
T cd05040 50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALG-------HFLISTLCDYAVQIANGMRYLESKR---F 118 (257)
T ss_pred HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccc-------cCcHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 678999999999999988 8899999999999999999875421 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|+||+|+||+++.++.++++|||+++......... ......++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 119 ~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~ 198 (257)
T cd05040 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGE 198 (257)
T ss_pred cccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987764422211 1112346778999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
.||...... +..............+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 199 ~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 199 EPWAGLSGS---------------QILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCCCCHH---------------HHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 998533111 1111111111112233345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=237.50 Aligned_cols=204 Identities=28% Similarity=0.442 Sum_probs=162.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++.. ...+++|||+.+++|.+++...... .+++..+..++.|++.|+.|||+.+ +
T Consensus 55 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~~~---i 123 (260)
T cd05069 55 MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGK-------YLKLPQLVDMAAQIADGMAYIERMN---Y 123 (260)
T ss_pred HHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 578899999999998854 4678999999999999999765432 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++|+|||.+......... ......++..|+|||...+..++.++|+||||++++++++ |..
T Consensus 124 ~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~ 202 (260)
T cd05069 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred eecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432211 1112335678999999988888999999999999999999 899
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
||....+ ...............+...+..+.+++.+||+.||++|||++++++.|++
T Consensus 203 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 203 PYPGMVN----------------REVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9864321 11111122222223344566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=238.39 Aligned_cols=204 Identities=28% Similarity=0.423 Sum_probs=162.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++.. ...+++|||+.+++|.+++...... .+++..++.++.|++.|+.|||+.+ +
T Consensus 55 l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~~~---i 123 (260)
T cd05070 55 MKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGR-------ALKLPNLVDMAAQVAAGMAYIERMN---Y 123 (260)
T ss_pred HHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 578999999999998854 4578999999999999999764332 2788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||++.......... .....++..|+|||...+..++.++|+||||++++++++ |..
T Consensus 124 ~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 202 (260)
T cd05070 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred ccCCCccceEEEeCCceEEeCCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999987654322111 112234567999999988888999999999999999999 888
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
||..... ......+........+...+..+.+++.+||+.+|++|||++++.+.|++
T Consensus 203 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 203 PYPGMNN----------------REVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9864311 11222222222233444566789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=238.87 Aligned_cols=205 Identities=28% Similarity=0.432 Sum_probs=165.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++++||+++++|.+++....+.. ++...+..++.|++.|+.|||+++ +
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~-------~~~~~~~~~~~~i~~al~~lh~~~---i 124 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-------LRLPQLVDMAAQIAEGMAYLESRN---Y 124 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCC-------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 578999999999999999899999999999999999997754322 888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||.++......... .....++..|+|||.+.+..++.++|+||+|++++++++ |..
T Consensus 125 ~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 203 (261)
T cd05034 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203 (261)
T ss_pred ccCCcchheEEEcCCCCEEECccccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987654321111 112224568999999998888999999999999999998 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
||.+... ...............+...+..+.+++.+||+.+|++||+++++.+.|++
T Consensus 204 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 204 PYPGMTN----------------REVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 9864311 11222222222223333446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=247.15 Aligned_cols=194 Identities=23% Similarity=0.287 Sum_probs=156.7
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
.++||||+++++++.++...++||||+.+|+|..++..... ++...+..++.|++.|++|||+.+ ++|
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivH 119 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---------FDLYRATFYAAEIVCGLQFLHSKG---IIY 119 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEe
Confidence 35899999999999999999999999999999999876432 788899999999999999999998 999
Q ss_pred ccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026115 84 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163 (243)
Q Consensus 84 ~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 163 (243)
|||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+||++++|++|..||.
T Consensus 120 rDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred cCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 99999999999999999999999864322111 1233458999999999998889999999999999999999999996
Q ss_pred CCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 026115 164 HTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG-IVL 228 (243)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~vl 228 (243)
.... ....+.+... ....+...+..+.+++.+||+.||++||++. +++
T Consensus 198 ~~~~----------------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 198 GDDE----------------DELFESIRVD-TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCH----------------HHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 4421 1111111111 1122334566799999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=250.97 Aligned_cols=215 Identities=19% Similarity=0.290 Sum_probs=159.1
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||++++++|..+...++++|++. ++|..++..... +++..++.++.|++.||.|||+.+
T Consensus 136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~ylH~~~--- 202 (391)
T PHA03212 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRN---------IAICDILAIERSVLRAIQYLHENR--- 202 (391)
T ss_pred HHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4678999999999999999999999999995 689888866542 788899999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||+++........ ......||+.|+|||++.+..++.++|+||+||++|+|++|..
T Consensus 203 IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 281 (391)
T PHA03212 203 IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281 (391)
T ss_pred cccCCCChHhEEEcCCCCEEEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999998653322111 1223468999999999998889999999999999999999998
Q ss_pred CCCCCCCCCCcc--------ceeeccC------cCchhhhhhhh----cc--ccCCCC-----CHHHHHHHHHHHHhhcC
Q 026115 161 PVDHTLPRGQQS--------LVTWATP------KLSEDKVKQCV----DT--KLGGEY-----PPKAIAKMAAVAALCVQ 215 (243)
Q Consensus 161 pf~~~~~~~~~~--------~~~~~~~------~~~~~~~~~~~----~~--~~~~~~-----~~~~~~~~~~li~~~l~ 215 (243)
||.......... .+..... ........... .. ...... ....+.++.+++.+||+
T Consensus 282 p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~ 361 (391)
T PHA03212 282 SLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361 (391)
T ss_pred CcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhc
Confidence 875432211100 0000000 00000000000 00 000011 12346689999999999
Q ss_pred CCCCCCCCHHHHHH
Q 026115 216 YEADFRPNMGIVLK 229 (243)
Q Consensus 216 ~~p~~Rps~~~vl~ 229 (243)
.||.+|||++|+++
T Consensus 362 ~dP~~Rpta~elL~ 375 (391)
T PHA03212 362 FDAHHRPSAEALLD 375 (391)
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999996
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=248.09 Aligned_cols=193 Identities=21% Similarity=0.281 Sum_probs=157.7
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
+||||+++++++.+...+++||||+.+++|..++..... +++..+..++.|++.|+.|||+.+ ++|+|
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~d 121 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---------FDEPRARFYAAEIVLGLQFLHERG---IIYRD 121 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEccC
Confidence 799999999999999999999999999999998876542 889999999999999999999998 99999
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 165 (243)
|||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+||+++++++|..||...
T Consensus 122 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred CCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999998864322111 122345889999999999888999999999999999999999999644
Q ss_pred CCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 026115 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM-----GIVLK 229 (243)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~vl~ 229 (243)
... .....+.... ...+...+..+.+++.+||+.||++|||+ .++++
T Consensus 200 ~~~---------------~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 200 DED---------------ELFQSILEDE--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CHH---------------HHHHHHHcCC--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 211 1111111111 12333456789999999999999999999 77775
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=245.72 Aligned_cols=213 Identities=19% Similarity=0.259 Sum_probs=155.7
Q ss_pred CcccCCccceeeEEEE-----eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 3 SRLKNENVVELVGYYV-----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
++++||||+++++++. .+..+++|+||+. ++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~ 130 (290)
T cd07862 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHR 130 (290)
T ss_pred cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4568999999999985 3456899999996 5999998765432 2788999999999999999999998
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++|+||||+||+++.++.++|+|||+++...... ......|++.|+|||.+.+..++.++|+||+||++|++++
T Consensus 131 ---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 204 (290)
T cd07862 131 ---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 204 (290)
T ss_pred ---eeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHc
Confidence 9999999999999999999999999987554321 1233458899999999988888999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhh-------hhhccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVK-------QCVDTKLGG---EYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
|.+||...........+............. ......... ......+..+.+++.+||+.||++|||+.++
T Consensus 205 g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 284 (290)
T cd07862 205 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 284 (290)
T ss_pred CCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence 999997653321100000000000000000 000000000 0011234578899999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 285 l~ 286 (290)
T cd07862 285 LS 286 (290)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=243.72 Aligned_cols=217 Identities=24% Similarity=0.357 Sum_probs=164.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCC--CCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA--KPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++..+...++++|++.+++|.+++......... .....+++..++.++.|++.|++|||+.+
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-- 150 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-- 150 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 57899999999999999999999999999999999999765421111 11123889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh--
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-- 157 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-- 157 (243)
++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 151 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 151 -FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred -ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 99999999999999999999999999875543322222233446778999999988889999999999999999998
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhh---hccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC---VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
+..||....... .. ...... .........+...+.++.+++.+||+.||++|||+.++++.|++
T Consensus 230 ~~~p~~~~~~~~---~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 230 REQPYEHLTDQQ---VI---------ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CCCCCCCcChHH---HH---------HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 666775321100 00 000000 00111112233445689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=242.96 Aligned_cols=216 Identities=24% Similarity=0.300 Sum_probs=173.6
Q ss_pred CCCcccCCccceeeEEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 1 MVSRLKNENVVELVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+|+.++|+||+.+.+.+.. -+..++|+|+++. +|...++.... ++...+.-+++|++.|++|+|+
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~iik~~~~---------L~d~H~q~f~YQiLrgLKyiHS 143 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQIIKSQQD---------LTDDHAQYFLYQILRGLKYIHS 143 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHHhh-HHHHHHHcCcc---------ccHHHHHHHHHHHHHhcchhhc
Confidence 3678899999999998864 3568999999954 99999998764 8889999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-cCCCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~ 154 (243)
.+ ++|||+||.|++++.+..+|++|||+|+..........-+..+.|.+|+|||++. ...|+.+.||||+||++.|
T Consensus 144 An---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AE 220 (359)
T KOG0660|consen 144 AN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAE 220 (359)
T ss_pred cc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHH
Confidence 98 9999999999999999999999999999875442222224456799999999875 5678999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc---------CCC-----CCHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL---------GGE-----YPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~-----~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|++|++.|.+.+.-.+...+....+.+..+.+..+..... ... ..+.......+|+.+||..||.+
T Consensus 221 mL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~k 300 (359)
T KOG0660|consen 221 MLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKK 300 (359)
T ss_pred HHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccc
Confidence 9999999998877666666655555555443333331111 011 11345567999999999999999
Q ss_pred CCCHHHHHH
Q 026115 221 RPNMGIVLK 229 (243)
Q Consensus 221 Rps~~~vl~ 229 (243)
|+|++|.|+
T Consensus 301 Rita~eAL~ 309 (359)
T KOG0660|consen 301 RITAEEALA 309 (359)
T ss_pred cCCHHHHhc
Confidence 999999987
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=248.46 Aligned_cols=202 Identities=21% Similarity=0.288 Sum_probs=158.2
Q ss_pred ccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 5 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
.+||||+++++++..+...++||||+++++|..++..... ++...+..++.|++.|+.|||+.+ ++||
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~---------l~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 120 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYR 120 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeC
Confidence 4899999999999999999999999999999998876542 888999999999999999999998 9999
Q ss_pred cCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026115 85 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164 (243)
Q Consensus 85 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 164 (243)
||||+||+++.++.++|+|||+++....... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 121 Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 9999999999999999999999865322111 12234689999999999988899999999999999999999999963
Q ss_pred CCCCCCccceeeccCcCchhhhhh-hhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 026115 165 TLPRGQQSLVTWATPKLSEDKVKQ-CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM------GIVLK 229 (243)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~vl~ 229 (243)
........ ........+ +.... ...+...+..+.+++.+||+.||++|||+ .++++
T Consensus 199 ~~~~~~~~-------~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 199 VGSSDNPD-------QNTEDYLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCcCCcc-------cccHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 21111000 001111111 11111 13444556789999999999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=236.21 Aligned_cols=203 Identities=29% Similarity=0.425 Sum_probs=162.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++......++||||+++++|.+++..... .+++..++.++.|++.|+.|||+.+ +
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~ 114 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKN---C 114 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999999999999875432 1788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||++......... ......++..|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 115 ~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~ 193 (250)
T cd05085 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVC 193 (250)
T ss_pred eecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999998654332211 1111234567999999988888999999999999999998 899
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
||..... ......+....+...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 194 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 194 PYPGMTN----------------QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 9864321 1111112222222333345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=245.50 Aligned_cols=195 Identities=22% Similarity=0.291 Sum_probs=157.5
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
.++||||+++++++.++..+++||||+++|+|.+++..... ++...+..++.|++.|+.|||+.+ ++|
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivH 119 (316)
T cd05619 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---------FDLPRATFYAAEIICGLQFLHSKG---IVY 119 (316)
T ss_pred ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEe
Confidence 35899999999999999999999999999999999976432 788899999999999999999998 999
Q ss_pred ccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026115 84 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163 (243)
Q Consensus 84 ~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 163 (243)
|||||+||+++.++.++|+|||+++....... ......|+..|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 120 rdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999864322111 1223458999999999998889999999999999999999999996
Q ss_pred CCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 026115 164 HTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG-IVLK 229 (243)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~vl~ 229 (243)
.... ....+.+... ....+...+..+.+++.+||+.||++||++. ++++
T Consensus 198 ~~~~----------------~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 198 GHDE----------------EELFQSIRMD-NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCH----------------HHHHHHHHhC-CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 4321 1111111111 1123334566799999999999999999997 5644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=264.14 Aligned_cols=211 Identities=24% Similarity=0.403 Sum_probs=189.4
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||-|+.||||+++-|+....+...||+|||++|+|..||+...++ +...++..+++.|++|++||.+.+
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm~--- 751 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDMN--- 751 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhcC---
Confidence 578999999999999999999999999999999999999999875 888999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccccccc-ccccccccCchhhccCCCCcccchHHHHHHHHHHHh-C
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~-~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 158 (243)
++||||...|||++.+..+|++|||+++...+......... ..=+..|.|||.+...+++.++|+||+|+++||.++ |
T Consensus 752 YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 752 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 99999999999999999999999999997755442211111 112468999999999999999999999999999887 9
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
+.|+. .+.++.+...++.+.+.+.|.+|+..+++||..||++|-..||.+++++..|++++...
T Consensus 832 ERPYW----------------dmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 832 ERPYW----------------DMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCccc----------------ccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 99986 34678899999999999999999999999999999999999999999999999987643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=251.90 Aligned_cols=215 Identities=21% Similarity=0.270 Sum_probs=155.6
Q ss_pred CCcccCCccceeeEEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+++++||||+++++++... ...++||||+. ++|.+++..... +++..+..++.|++.||.|||+.
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~ 122 (338)
T cd07859 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------LTPEHHQFFLYQLLRALKYIHTA 122 (338)
T ss_pred HHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhccc---------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 5789999999999988643 35899999995 699998876542 88899999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc-cccccccccccccCchhhcc--CCCCcccchHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~ 153 (243)
+ ++||||||+||+++.++.++|+|||+++........ .......|++.|+|||++.+ ..++.++|+|||||+++
T Consensus 123 ~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~ 199 (338)
T cd07859 123 N---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 199 (338)
T ss_pred C---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHH
Confidence 8 999999999999999999999999998754322111 11123468999999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhh-----------hhhhhccccCCC---CCHHHHHHHHHHHHhhcCCCCC
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK-----------VKQCVDTKLGGE---YPPKAIAKMAAVAALCVQYEAD 219 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~ 219 (243)
+|++|..||...........+........... ....+....... .....+..+.+++.+||+.||+
T Consensus 200 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 279 (338)
T cd07859 200 EVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPK 279 (338)
T ss_pred HHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcc
Confidence 99999999975432111000000000000000 000011100000 0012345688999999999999
Q ss_pred CCCCHHHHHH
Q 026115 220 FRPNMGIVLK 229 (243)
Q Consensus 220 ~Rps~~~vl~ 229 (243)
+|||++++++
T Consensus 280 ~Rpt~~e~l~ 289 (338)
T cd07859 280 DRPTAEEALA 289 (338)
T ss_pred cCCCHHHHhc
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=243.99 Aligned_cols=214 Identities=20% Similarity=0.249 Sum_probs=154.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+. ++|.+++...... ++...+..++.|++.|+.|||+.+ +
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~--------~~~~~~~~~~~qi~~al~~lH~~~---i 124 (303)
T cd07869 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGG--------LHPENVKLFLFQLLRGLSYIHQRY---I 124 (303)
T ss_pred HhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578899999999999999999999999995 5888888654322 788889999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||++......... .....+++.|+|||++.+ ..++.++|+||+||++++|++|..
T Consensus 125 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 202 (303)
T cd07869 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202 (303)
T ss_pred ecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998644322111 123457889999999875 357889999999999999999999
Q ss_pred CCCCCCCCCCcc-ceeeccCcCchhhhh------hhhccccCCCCC---------HHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 161 PVDHTLPRGQQS-LVTWATPKLSEDKVK------QCVDTKLGGEYP---------PKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 161 pf~~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
||.+..+..... .+............. ...........+ ...+..+.+++.+||+.||++|||+
T Consensus 203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~ 282 (303)
T cd07869 203 AFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA 282 (303)
T ss_pred CCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH
Confidence 997542210000 000000000000000 000000000000 0123468899999999999999999
Q ss_pred HHHHH
Q 026115 225 GIVLK 229 (243)
Q Consensus 225 ~~vl~ 229 (243)
.++++
T Consensus 283 ~~~l~ 287 (303)
T cd07869 283 QAALS 287 (303)
T ss_pred HHHhc
Confidence 99986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=248.90 Aligned_cols=202 Identities=20% Similarity=0.242 Sum_probs=158.7
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++ +||||+++++++..+..+++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~--- 125 (332)
T cd05614 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---------FSEDEVRFYSGEIILALEHLHKLG--- 125 (332)
T ss_pred HHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4456 599999999999999999999999999999999876542 888999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.++|+|||+++........ ......|+..|+|||++.+. .++.++|||||||++++|++|.
T Consensus 126 ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 204 (332)
T cd05614 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA 204 (332)
T ss_pred cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence 999999999999999999999999998765332221 12234589999999998865 4688999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
.||........ ...+...+.. .....+...+..+.+++.+||+.||++|| ++.++++
T Consensus 205 ~pf~~~~~~~~------------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 205 SPFTLEGERNT------------QSEVSRRILK-CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCCCCC------------HHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 99964322111 0111111111 11123334566799999999999999999 7778876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=245.95 Aligned_cols=197 Identities=21% Similarity=0.349 Sum_probs=171.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|+-++|||||++|++......+|||+|.-++|+|.+|+.+.... +.+..+.+++.||+.|+.|+|+.. +
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~G--------l~E~La~kYF~QI~~AI~YCHqLH---V 139 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEG--------LNEDLAKKYFAQIVHAISYCHQLH---V 139 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhcc--------ccHHHHHHHHHHHHHHHHHHhhhh---h
Confidence 45679999999999999999999999999999999999877644 999999999999999999999998 9
Q ss_pred EeccCCCCceEec-CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCC
Q 026115 82 IHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 82 ~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~ 159 (243)
+|||+||+|+.+- +-|-+||+|||++..+...... ....|+..|.|||++.+..| .++.||||||++||.+++|+
T Consensus 140 VHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq 216 (864)
T KOG4717|consen 140 VHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQ 216 (864)
T ss_pred hcccCCcceeEEeeecCceEeeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCC
Confidence 9999999998764 5689999999999887665443 33458899999999999998 46889999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+||+.. ...+.+..+++-+. ..|..++.++.+||..||..||++|.|.+++..
T Consensus 217 ~PFqeA---------------NDSETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 217 PPFQEA---------------NDSETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred Cccccc---------------cchhhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 999844 23355556666555 677889999999999999999999999999875
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=241.05 Aligned_cols=222 Identities=22% Similarity=0.342 Sum_probs=165.5
Q ss_pred CCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++.+++... ...+++|||+++++|.+++..... .+++..+..++.|++.|++|||+++
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~g-- 129 (284)
T cd05079 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSRQ-- 129 (284)
T ss_pred HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5788999999999998865 568999999999999999865432 2788999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|+||+++.++.++++|||+++......... ......++..|+|||.+.+..++.++|+||||+++++++++
T Consensus 130 -i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~ 208 (284)
T cd05079 130 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY 208 (284)
T ss_pred -eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcC
Confidence 9999999999999999999999999987664432211 11233466789999999888889999999999999999997
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
..|................. ..........+........+..++..+.+++.+||+.||++|||+.++++.+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 209 CDSESSPMTLFLKMIGPTHG-QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred CCCCccccchhhhhcccccc-cccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 76643221111000000000 00111111222222222333446678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=238.36 Aligned_cols=204 Identities=24% Similarity=0.336 Sum_probs=172.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||+.+.||-++.+++.|+.++..|++||||+||+|...++++++.. +++..+.-++..++.||+|||..|
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~-------fse~~aRFYaAEvl~ALEYLHmlG--- 199 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKR-------FSESAARFYAAEVLLALEYLHMLG--- 199 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCc-------cchhhHHHHHHHHHHHHHHHHhhc---
Confidence 5788999999999999999999999999999999999999988764 899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcc---------------------------------ccc------------
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD---------------------------------AAA------------ 115 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~---------------------------------~~~------------ 115 (243)
|++||+||+|||+.++|.+-|+||+++..... ...
T Consensus 200 ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~ 279 (459)
T KOG0610|consen 200 IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRS 279 (459)
T ss_pred eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccccc
Confidence 99999999999999999999999998632210 000
Q ss_pred ---------ccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhh
Q 026115 116 ---------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 186 (243)
Q Consensus 116 ---------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 186 (243)
...+...+||-.|+|||++.+.....+.|.|+||+++|||+.|.-||.+. ...+.+
T Consensus 280 ~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~---------------~~~~Tl 344 (459)
T KOG0610|consen 280 LPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGS---------------NNKETL 344 (459)
T ss_pred chhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCC---------------CchhhH
Confidence 01123457999999999999999999999999999999999999999855 233555
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC----HHHHHH
Q 026115 187 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN----MGIVLK 229 (243)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~vl~ 229 (243)
..++.+.+.-......+-.+.+||++.|.+||++|.- |+||-+
T Consensus 345 ~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 345 RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 6666666654444577788999999999999999998 777654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=252.87 Aligned_cols=201 Identities=21% Similarity=0.271 Sum_probs=162.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... ++...+..++.|++.||+|||+.| +
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---i 122 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV---------FPEETARFYIAELVLALDSVHKLG---F 122 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999987632 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccc---------------------------cccccccccccccccCchhh
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA---------------------------ARLHSTRVLGTFGYHAPEYA 134 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~aPE~~ 134 (243)
+||||||+||+++.++.++|+|||++....... .........|++.|+|||++
T Consensus 123 iH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (350)
T cd05573 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL 202 (350)
T ss_pred eccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 999999999999999999999999987654432 00112234589999999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc--cccCCCCCHHHHHHHHHHHHh
Q 026115 135 MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD--TKLGGEYPPKAIAKMAAVAAL 212 (243)
Q Consensus 135 ~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~ 212 (243)
.+..++.++|||||||++|+|++|..||...... .....+.. ...........+..+.+++.+
T Consensus 203 ~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ 267 (350)
T cd05573 203 RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ---------------ETYNKIINWKESLRFPPDPPVSPEAIDLICR 267 (350)
T ss_pred cCCCCCCceeeEecchhhhhhccCCCCCCCCCHH---------------HHHHHHhccCCcccCCCCCCCCHHHHHHHHH
Confidence 9989999999999999999999999999754211 11111111 111111111246789999999
Q ss_pred hcCCCCCCCCC-HHHHHHH
Q 026115 213 CVQYEADFRPN-MGIVLKA 230 (243)
Q Consensus 213 ~l~~~p~~Rps-~~~vl~~ 230 (243)
|++ ||.+||+ ++++++.
T Consensus 268 ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 268 LLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred Hcc-ChhhcCCCHHHHhcC
Confidence 997 9999999 9999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=246.76 Aligned_cols=195 Identities=18% Similarity=0.259 Sum_probs=158.3
Q ss_pred ccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 5 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
.+||||+++++++.++...++||||+++++|..++..... +++..+..++.|++.||.|||+.+ ++||
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHr 120 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK---------FDEPRSRFYAAEVTLALMFLHRHG---VIYR 120 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 4799999999999999999999999999999998876542 788899999999999999999998 9999
Q ss_pred cCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026115 85 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164 (243)
Q Consensus 85 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 164 (243)
||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 121 Dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred CCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 9999999999999999999998865322211 12234589999999999988899999999999999999999999975
Q ss_pred CCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-------CHHHHHHH
Q 026115 165 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-------NMGIVLKA 230 (243)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------s~~~vl~~ 230 (243)
..+. +....+..... ..+...+.++.+++.+||+.||++|| ++.++++.
T Consensus 199 ~~~~---------------~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 199 DNED---------------DLFESILHDDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHH---------------HHHHHHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 4221 11111211111 22333456799999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=248.65 Aligned_cols=193 Identities=20% Similarity=0.230 Sum_probs=156.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|...+..... ++...+..++.|++.||.|||+.+ +
T Consensus 50 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~~---i 117 (321)
T cd05603 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC---------FLEPRARFYAAEVASAIGYLHSLN---I 117 (321)
T ss_pred HHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999988865432 778888999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 118 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred EeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCC
Confidence 9999999999999999999999999875322211 12334589999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
|...... .....+.... ...+...+..+.+++.+||+.||.+||++.
T Consensus 196 f~~~~~~---------------~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 196 FYSRDVS---------------QMYDNILHKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHH---------------HHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 9644210 1111111111 123334566799999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=241.88 Aligned_cols=199 Identities=25% Similarity=0.367 Sum_probs=160.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++||||+++++|.+++.... ++..++..++.|++.|+.|||+.+ +
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH~~g---i 137 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---V 137 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999999999999999999999999999986543 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++|+|||||+++++++|..|
T Consensus 138 ~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~p 215 (296)
T cd06654 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (296)
T ss_pred ccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987654322111 1223578899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|....+..... ............+...+..+.+++.+||..+|++|||+.++++
T Consensus 216 f~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 216 YLNENPLRALY--------------LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCHHHhHH--------------HHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 96543211100 0000111111223445667999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=251.88 Aligned_cols=208 Identities=28% Similarity=0.430 Sum_probs=168.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++-+|.||+-|+|||.++.. .||+-+|+|.+|+.+++..... +++.+.+.|+.|++.|+.|||.++ |
T Consensus 442 lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etk--------fdm~~~idIAqQiaqGM~YLHAK~---I 509 (678)
T KOG0193|consen 442 LKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETK--------FDMNTTIDIAQQIAQGMDYLHAKN---I 509 (678)
T ss_pred HhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhh--------hhHHHHHHHHHHHHHhhhhhhhhh---h
Confidence 677899999999999999887 9999999999999999887643 999999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+|+|..|||+.++++|+|+|||++.....-..........|...|+|||++. ...|+..+||||||+++|||++|
T Consensus 510 IHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg 589 (678)
T KOG0193|consen 510 IHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTG 589 (678)
T ss_pred hhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhC
Confidence 999999999999999999999999975332211111122345788999999987 35689999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc----CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL----GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
..||..... ++. .-.+.++. .......+++++.+|+..||.+++++||++.+|+..|+.+
T Consensus 590 ~lPysi~~~-dqI---------------ifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 590 ELPYSIQNR-DQI---------------IFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred cCCcCCCCh-hhe---------------EEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 999973322 111 11111110 0122345677899999999999999999999999999888
Q ss_pred Hhh
Q 026115 235 LNT 237 (243)
Q Consensus 235 ~~~ 237 (243)
..+
T Consensus 654 ~~~ 656 (678)
T KOG0193|consen 654 LPS 656 (678)
T ss_pred hhc
Confidence 774
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=242.34 Aligned_cols=203 Identities=23% Similarity=0.311 Sum_probs=162.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++||||+.+++|.+++...... .++...+..++.|++.|+.|||+.+ +
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i 123 (285)
T cd05605 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-------GFDEERAVFYAAEITCGLEDLHRER---I 123 (285)
T ss_pred HHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 56889999999999999999999999999999999888654322 2888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||+++....... .....|+..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 124 vH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~p 200 (285)
T cd05605 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200 (285)
T ss_pred EecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCC
Confidence 9999999999999999999999999876533221 1234588999999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~~ 230 (243)
|....... ........+.. .....+...+..+.+++.+||+.||++|| +++++++.
T Consensus 201 f~~~~~~~------------~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 201 FRQRKEKV------------KREEVERRVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CCCCchhh------------HHHHHHHHhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 97432210 00111111111 11233445677899999999999999999 88898763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=250.40 Aligned_cols=198 Identities=20% Similarity=0.230 Sum_probs=158.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++..+...++||||+.+|+|..++..... ++...+..++.|++.||.|||+.| +
T Consensus 50 l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---i 117 (325)
T cd05604 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSIN---I 117 (325)
T ss_pred HHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 4678999999999999999999999999999999998875442 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 118 vH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~p 195 (325)
T cd05604 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred eecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCC
Confidence 9999999999999999999999999865322211 12334589999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|...... +.......... ......+..+.+++.+|++.+|.+||++.+.++.
T Consensus 196 f~~~~~~---------------~~~~~~~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 196 FYCRDVA---------------EMYDNILHKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCCHH---------------HHHHHHHcCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 9644211 11111221111 1122345678899999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=242.64 Aligned_cols=217 Identities=24% Similarity=0.330 Sum_probs=162.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCC---CCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
+++++||||+++++++..+...++||||+.+++|.+++...... ......+.+++..++.++.|++.|++|||+.+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 149 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN- 149 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 57899999999999999999999999999999999998654211 11111223678899999999999999999998
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT- 157 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 157 (243)
++|+||+|+||+++.++.++++|||++................++..|+|||...+..++.++|+||||++++++++
T Consensus 150 --i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 150 --FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred --eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999876543322211223345678999999988889999999999999999988
Q ss_pred -CCCCCCCCCCCCCccceeeccCcCchhhhhhhh---ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV---DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 158 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
+..||........ . ....+.. ........+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 228 ~~~~p~~~~~~~~~---~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 228 CKEQPYSLLSDEQV---I---------ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCCCCCcccChHHH---H---------HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 5667753311100 0 0000000 0111111222345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=226.67 Aligned_cols=196 Identities=21% Similarity=0.299 Sum_probs=160.6
Q ss_pred CcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 026115 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 82 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~ 82 (243)
+.|+||||+++.+.+...+..++|+|++.|++|..-+-... ..++..+-....|+++|+.|+|.++ |+
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n~---Iv 132 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSNG---IV 132 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhcC---ce
Confidence 46899999999999999999999999999999987554332 2778888889999999999999999 99
Q ss_pred eccCCCCceEecC---CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 83 HRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 83 h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
|||+||+|+++.. ..-+|++|||++...... .......|||.|+|||++....|+-..|||+.|++||-++.|.
T Consensus 133 HRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~ 209 (355)
T KOG0033|consen 133 HRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 209 (355)
T ss_pred eccCChhheeeeeccCCCceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCC
Confidence 9999999999953 446899999999877622 2234567999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhh-hccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQC-VDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+||.+.+ ..++.+. ...... ...-...+++..+|+.+||..||.+|.|+.|.|+
T Consensus 210 ~PF~~~~----------------~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 210 PPFWDED----------------QHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCCCcc----------------HHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 9997531 1233333 222221 1222456778999999999999999999999875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=242.04 Aligned_cols=209 Identities=23% Similarity=0.359 Sum_probs=164.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+ ..+++++|+++|+|.+++..... .++...++.++.|++.|+.|||+.+ +
T Consensus 63 ~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---i 130 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERR---L 130 (303)
T ss_pred HHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcC---e
Confidence 5678999999999998754 46788999999999999876532 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 131 vH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~ 210 (303)
T cd05110 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 210 (303)
T ss_pred eccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999976543322211222335678999999988888999999999999999997 888
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
||..... ......+........+..++..+.+++.+||..+|++||+++++++.|.++....
T Consensus 211 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 211 PYDGIPT----------------REIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCCCH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 9864311 1122222222222223334567999999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=250.49 Aligned_cols=200 Identities=19% Similarity=0.236 Sum_probs=159.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++.++...++||||+++|+|.+++.... ++...+..++.|++.||+|||+.+ +
T Consensus 97 l~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---i 163 (370)
T cd05596 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSMG---F 163 (370)
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999987643 778888889999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC----CCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG----QMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~~l~~l~~ 157 (243)
+||||||+||+++.++.++|+|||++......... ......|++.|+|||++.+. .++.++|+|||||++|+|++
T Consensus 164 vHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt 242 (370)
T cd05596 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242 (370)
T ss_pred eccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh
Confidence 99999999999999999999999998755332111 12334689999999998653 36889999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC--HHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADF--RPNMGIVLKA 230 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~--Rps~~~vl~~ 230 (243)
|..||...... .....+.........+ ...+..+.+++.+||+.+|.+ |+|+.++++.
T Consensus 243 G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 243 GDTPFYADSLV---------------GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCcCCCCHH---------------HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 99999754211 1122222211111112 234678999999999999987 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=239.09 Aligned_cols=208 Identities=24% Similarity=0.333 Sum_probs=155.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++.++...++||||+++|+|.+++........ ...+...+..++.|++.|++|||+.+ +
T Consensus 49 ~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i 121 (269)
T cd05042 49 YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVA----QMAQKDVLQRMACEVASGLLWLHQAD---F 121 (269)
T ss_pred HHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhcccccc----ccccHHHHHHHHHHHHHHHHHHHhcC---E
Confidence 4578999999999999999999999999999999999977543211 11456778899999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-------CCCCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~ 154 (243)
+|+||||+||+++.++.++++|||++................++..|+|||+... ..++.++|+|||||++++
T Consensus 122 vH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 201 (269)
T cd05042 122 IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201 (269)
T ss_pred ecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHH
Confidence 9999999999999999999999999865432221111222345677999998753 345779999999999999
Q ss_pred HHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhcc---cc-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT---KL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+++ |..||....+. +........ .. ....+...+..+.+++..|| .||++|||+++|++
T Consensus 202 l~~~~~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 202 LFTAADQPYPDLSDE---------------QVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHhCCCCCCCcCCHH---------------HHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 999 77888643211 001111000 00 11223345567888999999 59999999999999
Q ss_pred HHH
Q 026115 230 ALQ 232 (243)
Q Consensus 230 ~l~ 232 (243)
.|.
T Consensus 266 ~l~ 268 (269)
T cd05042 266 LLT 268 (269)
T ss_pred Hhc
Confidence 873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=238.60 Aligned_cols=212 Identities=21% Similarity=0.270 Sum_probs=156.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+....++||||+++|+|.+++....... ....+...+..++.|++.|+.|||+.+ +
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i 121 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKNN---F 121 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 568899999999999999999999999999999999997543211 112566778889999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-------CCCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-------QMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~DiwslG~~l~~ 154 (243)
+|+||||+||+++.++.++++|||.++...............++..|+|||++.+. .++.++|+||+|+++++
T Consensus 122 ~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 201 (269)
T cd05087 122 IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE 201 (269)
T ss_pred eccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHH
Confidence 99999999999999999999999998654332222122234467889999988632 35779999999999999
Q ss_pred HHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+++ |..||....+....... ..........+ ......+..+.+++.+|| .+|++|||+++|+..|+
T Consensus 202 l~~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 202 LFELGSQPYRHLSDEQVLTYT-------VREQQLKLPKP----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHhCCCCCCCCCChHHHHHHH-------hhcccCCCCCC----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 996 99999644221100000 00000000011 111123456888999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=237.08 Aligned_cols=200 Identities=24% Similarity=0.381 Sum_probs=162.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++++||+.+++|.+++..... ++...+..++.|++.|+.|||+.+ +
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~l~~~l~~lH~~~---i 127 (267)
T cd06628 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---------FEETLVRNFVRQILKGLNYLHNRG---I 127 (267)
T ss_pred HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccC---------ccHHHHHHHHHHHHHHHHHHHhcC---c
Confidence 5788999999999999999999999999999999999976532 788889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc----cccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
+|+||+|+||+++.++.++|+|||.++........ .......|+..|+|||.+.+..++.++|+||+|++++++++
T Consensus 128 vH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~ 207 (267)
T cd06628 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT 207 (267)
T ss_pred ccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhh
Confidence 99999999999999999999999998766532111 11122347889999999988888999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||..... ......... ......+...+..+.+++.+||+.||++||++.++++
T Consensus 208 g~~p~~~~~~---------------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 208 GKHPFPDCTQ---------------LQAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCCCCCccH---------------HHHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 9999964311 111111111 2222344456678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=236.75 Aligned_cols=195 Identities=23% Similarity=0.389 Sum_probs=153.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...+++|||+.+++|..++..... .++...++.++.|++.|++|||+.+ +
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 126 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLEDKD---L 126 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhhhCC---e
Confidence 5678999999999999999999999999999999998875432 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCc-------eeecccCCCCCCcccccccccccccccccccCchhhc-cCCCCcccchHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDI-------AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~ 153 (243)
+|+||||+||+++.++. ++++|||++...... ....++..|+|||.+. +..++.++||||||+++|
T Consensus 127 vH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 200 (262)
T cd05077 127 VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLW 200 (262)
T ss_pred ECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHH
Confidence 99999999999986654 899999987654322 2234678899999886 456788999999999999
Q ss_pred HHH-hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 154 ELL-TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 154 ~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
+++ .|..||...... ........... .....+..+.+++.+||+.||++||++.++++.+
T Consensus 201 el~~~~~~p~~~~~~~----------------~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 201 EICYNGEIPLKDKTLA----------------EKERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHhCCCCCCCCcchh----------------HHHHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 998 478887533111 00111111111 1111245789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=237.12 Aligned_cols=219 Identities=21% Similarity=0.247 Sum_probs=165.4
Q ss_pred CCCcccCCc-cceeeEEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 1 MVSRLKNEN-VVELVGYYVDGP------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 1 ~l~~l~h~n-iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
+|++|+|+| |+.+.+++.+.+ .+++|+||++. +|..++....... ..++...+..+.+|++.|++||
T Consensus 63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~ 136 (323)
T KOG0594|consen 63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFL 136 (323)
T ss_pred HHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHH
Confidence 467899999 999999998877 89999999976 9999998876321 1166688999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVL 152 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l 152 (243)
|+++ |+|||+||+|++++.+|.+||+|||+++...-.... ....++|..|+|||++.+. .|++..||||+||++
T Consensus 137 H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIf 211 (323)
T KOG0594|consen 137 HSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIF 211 (323)
T ss_pred HhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHH
Confidence 9999 999999999999999999999999999865533222 3445688999999999876 689999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhh-----hhccccCC-----CCC---HHHHHHHHHHHHhhcCCCCC
Q 026115 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ-----CVDTKLGG-----EYP---PKAIAKMAAVAALCVQYEAD 219 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-----~~~---~~~~~~~~~li~~~l~~~p~ 219 (243)
.||+++.+.|.+..+..+...+......+.....-. -.+...+. ... ........+++.+|++.+|.
T Consensus 212 aEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~ 291 (323)
T KOG0594|consen 212 AEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPA 291 (323)
T ss_pred HHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcc
Confidence 999999999987655433322221111111111100 00000000 000 11124789999999999999
Q ss_pred CCCCHHHHHHH
Q 026115 220 FRPNMGIVLKA 230 (243)
Q Consensus 220 ~Rps~~~vl~~ 230 (243)
+|.||+..+++
T Consensus 292 ~R~Sa~~al~h 302 (323)
T KOG0594|consen 292 KRISAKGALTH 302 (323)
T ss_pred cCcCHHHHhcC
Confidence 99999999985
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=239.49 Aligned_cols=221 Identities=25% Similarity=0.366 Sum_probs=169.5
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.. +...++++||+++++|.+++..... .+++..++.++.|++.|++|||+.+
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~-- 129 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQR-- 129 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 568899999999999887 5679999999999999999976543 2888999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccc-cccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|+||+++.++.++++|||.+........... .....++..|++||...+..++.++|+||||++++++++|
T Consensus 130 -i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg 208 (284)
T cd05038 130 -YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208 (284)
T ss_pred -eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeecc
Confidence 99999999999999999999999999877653222111 1112345579999999888889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
..|+............. ...........+.+........+..++.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 209 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 209 GDPSQSPPAEFLRMIGI-AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCCcccccchhcccccc-ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 99886432221110000 0011112223333333333334445667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=237.09 Aligned_cols=195 Identities=27% Similarity=0.439 Sum_probs=154.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++||||+.+|+|.+++..... .+++..++.++.|++.|+.|||+.+ +
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 121 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKG---L 121 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999976543 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCc--------eeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDI--------AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVL 152 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l 152 (243)
+|+||||+||+++.++. ++++|||.+...... ....++..|+|||.+.+. .++.++|+||||+++
T Consensus 122 iH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 195 (258)
T cd05078 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTL 195 (258)
T ss_pred ecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence 99999999999987664 589999987654322 223467789999998763 468899999999999
Q ss_pred HHHHhCC-CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 153 LELLTGR-KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 153 ~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
|++++|. .||....+. ......... ...+...+..+.+++.+||+.||++|||++++++.|
T Consensus 196 ~~l~~g~~~~~~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 196 WEIFSGGDKPLSALDSQ----------------KKLQFYEDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHcCCCCChhhccHH----------------HHHHHHHcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 9999984 555432111 111111111 122323445799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=235.87 Aligned_cols=215 Identities=22% Similarity=0.261 Sum_probs=168.3
Q ss_pred CCCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 1 MVSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
||.+++|||||.+-++.... +.+++||||+++ +|...+..... ++...++..+..|++.|++|||++.
T Consensus 128 iLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH~~w- 197 (419)
T KOG0663|consen 128 ILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLHDNW- 197 (419)
T ss_pred HHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHhhce-
Confidence 46688999999999988743 469999999988 99999988763 2888999999999999999999999
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHh
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~ 157 (243)
|+|||+|++|+|++..|.+|++|||+|+.++..... .+..+-|.+|+|||.+.+. .|+++.|+||+||++.|+++
T Consensus 198 --ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~ 273 (419)
T KOG0663|consen 198 --ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT 273 (419)
T ss_pred --eEecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh
Confidence 999999999999999999999999999998876443 3445678999999999864 68999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchh--------------hhhhhhccccCCCCCHH-HHHHHHHHHHhhcCCCCCCCC
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSED--------------KVKQCVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rp 222 (243)
+.+.|.+..+.++...+......+... ...+.....++..+... .++.-++|+..+|..||.+|.
T Consensus 274 ~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~ 353 (419)
T KOG0663|consen 274 QKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI 353 (419)
T ss_pred cCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc
Confidence 999998876655443332211111111 00111111111122222 457789999999999999999
Q ss_pred CHHHHHH
Q 026115 223 NMGIVLK 229 (243)
Q Consensus 223 s~~~vl~ 229 (243)
||.+.|+
T Consensus 354 tA~~~L~ 360 (419)
T KOG0663|consen 354 TAEDGLK 360 (419)
T ss_pred cHHHhhc
Confidence 9999886
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=234.58 Aligned_cols=200 Identities=30% Similarity=0.482 Sum_probs=160.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++..+. .+++|||+.+++|.+++....... ++...++.++.|++.|+.|||+.+ +
T Consensus 53 l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~al~~lH~~~---~ 121 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRAL-------VSVIQLLQFSLDVAEGMEYLESKK---L 121 (254)
T ss_pred HHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCC-------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 56889999999999987654 689999999999999997654322 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++|+|||.+....... .....+..|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 122 ~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 196 (254)
T cd05083 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196 (254)
T ss_pred eccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999886543221 12234567999999988888999999999999999997 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
||..... ......+....+...+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 197 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 197 PYPKMSL----------------KEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCccCCH----------------HHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 9864421 11222222333333334556789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=256.34 Aligned_cols=205 Identities=22% Similarity=0.305 Sum_probs=161.4
Q ss_pred CCcccCCccceeeEEEEeCC--------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRLKNENVVELVGYYVDGP--------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
+.+++|+||+++.+.+.... .+++||||+.+|+|.+++...... ...++...+..++.|++.||.||
T Consensus 85 l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~l 159 (496)
T PTZ00283 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHV 159 (496)
T ss_pred HhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHH
Confidence 46789999999988775322 378999999999999998754321 11388899999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++||||||+||+++.++.++|+|||+++...............|++.|+|||++.+..++.++|||||||++|
T Consensus 160 H~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvily 236 (496)
T PTZ00283 160 HSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLY 236 (496)
T ss_pred HhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 9998 9999999999999999999999999987654332222223456899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
++++|..||..... ...............+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 237 eLltG~~Pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 237 ELLTLKRPFDGENM----------------EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHCCCCCCCCCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 99999999964311 11111111111223344566789999999999999999999999864
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=235.69 Aligned_cols=204 Identities=25% Similarity=0.397 Sum_probs=162.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++. ....++++||+.+++|.+++....+.. ++..+++.++.|++.|++|||+.+ +
T Consensus 55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~i~~~i~~al~~LH~~~---i 123 (260)
T cd05067 55 MKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIK-------LTINKLIDMAAQIAEGMAFIERKN---Y 123 (260)
T ss_pred HHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 57899999999999875 456899999999999999987654332 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||++......... ......++..|+|||.+....++.++|+||||++++++++ |..
T Consensus 124 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~ 202 (260)
T cd05067 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRI 202 (260)
T ss_pred ecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998665422111 1122335678999999988888999999999999999998 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
||..... ......+....+...+...+..+.+++.+||+.+|++|||++++++.|++
T Consensus 203 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 203 PYPGMTN----------------PEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCh----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 9964321 11222222222223334456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=234.96 Aligned_cols=201 Identities=25% Similarity=0.361 Sum_probs=164.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+||+++++++.++...+++|||+++++|.+++...... .++...+..++.|++.++.|||+.+ +
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~---i 122 (256)
T cd08221 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ-------LFEEEMVLWYLFQIVSAVSYIHKAG---I 122 (256)
T ss_pred HHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 57889999999999999999999999999999999999765322 2788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||.+........ ......++..|.|||...+..++.++|+||+|++++++++|..|
T Consensus 123 ~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~ 200 (256)
T cd08221 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200 (256)
T ss_pred cccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999998865543321 12334578999999999888888999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|..... .+....+.... ....+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 201 ~~~~~~---------------~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 201 FDATNP---------------LNLVVKIVQGN-YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCCCH---------------HHHHHHHHcCC-CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 864311 11222222211 122334556789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=223.75 Aligned_cols=198 Identities=26% Similarity=0.360 Sum_probs=169.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
-+.|+||||++++++|.++.+.|+++||...|.+...|....... ++....+.+..|++.|+.|+|..+ +
T Consensus 76 qs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~-------f~e~~~a~Yi~q~A~Al~y~h~k~---V 145 (281)
T KOG0580|consen 76 QSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKR-------FDEQRAATYIKQLANALLYCHLKR---V 145 (281)
T ss_pred ecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccccc-------ccccchhHHHHHHHHHHHHhccCC---c
Confidence 367999999999999999999999999999999999999665543 888899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+|+|++..+..+++|||-+...... .+....||..|++||++.+...+...|+|++|++.||++.|.+|
T Consensus 146 IhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~pp 221 (281)
T KOG0580|consen 146 IHRDIKPENLLLGSAGELKIADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPP 221 (281)
T ss_pred ccCCCCHHHhccCCCCCeeccCCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCc
Confidence 99999999999999999999999976544321 23445689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|+... ..+...++..-.. ..|...+....++|.+|+.++|.+|.+..|+++.
T Consensus 222 Fes~~---------------~~etYkrI~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 222 FESQS---------------HSETYKRIRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hhhhh---------------hHHHHHHHHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 97542 2233334433333 4557778899999999999999999999999863
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=235.90 Aligned_cols=198 Identities=26% Similarity=0.390 Sum_probs=163.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++.... ++...+..++.|++.|+.+||+.+ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----------l~~~~~~~~~~~l~~~l~~lh~~~---i 122 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----------FDEFQIATMLKEILKGLDYLHSEK---K 122 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 567899999999999999999999999999999999987543 778889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||||++++++++|..|
T Consensus 123 vH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06640 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred cCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999866543221 12234577889999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|....+.. .............+...+..+.+++.+||+.+|++||++.+++..
T Consensus 201 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 201 NSDMHPMR----------------VLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCcChHh----------------HhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 86442211 111111122233445677889999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=248.66 Aligned_cols=217 Identities=18% Similarity=0.270 Sum_probs=161.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++......+++||++. ++|.+++.... .+++..++.++.|++.||.|||+.+
T Consensus 139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~g--- 205 (392)
T PHA03207 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRG--- 205 (392)
T ss_pred HHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999995 58999884433 2889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||++................||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 206 ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 285 (392)
T PHA03207 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285 (392)
T ss_pred ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999876554433222234568999999999998889999999999999999999999
Q ss_pred CCCCCCCCCCccceee----c------cCcCchhhhhh---hhccccCCC--CC-----HHHHHHHHHHHHhhcCCCCCC
Q 026115 161 PVDHTLPRGQQSLVTW----A------TPKLSEDKVKQ---CVDTKLGGE--YP-----PKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~----~------~~~~~~~~~~~---~~~~~~~~~--~~-----~~~~~~~~~li~~~l~~~p~~ 220 (243)
||.+............ . .+......... ......+.. .+ ...+..+.+++.+||..||++
T Consensus 286 pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 365 (392)
T PHA03207 286 TLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEF 365 (392)
T ss_pred CCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhh
Confidence 9976533211000000 0 00000000000 000001100 00 122457889999999999999
Q ss_pred CCCHHHHHHH
Q 026115 221 RPNMGIVLKA 230 (243)
Q Consensus 221 Rps~~~vl~~ 230 (243)
|||+.+++..
T Consensus 366 Rpsa~e~l~~ 375 (392)
T PHA03207 366 RPSAQDILSL 375 (392)
T ss_pred CCCHHHHhhC
Confidence 9999999874
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=234.55 Aligned_cols=205 Identities=23% Similarity=0.403 Sum_probs=163.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++|+||+++.+++.+ ...++++||+.+++|.+++....... .++..++.++.|++.|+.|||+.+
T Consensus 54 ~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~~~~~l~~aL~~lH~~~--- 122 (260)
T cd05073 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSK-------QPLPKLIDFSAQIAEGMAFIEQRN--- 122 (260)
T ss_pred HHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccc-------cCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678999999999999887 77899999999999999997654322 778889999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+....++.++|+||||++++++++ |.
T Consensus 123 i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~ 201 (260)
T cd05073 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201 (260)
T ss_pred ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCC
Confidence 999999999999999999999999998765432211 1122335677999999988888999999999999999998 89
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
.||..... ......+........+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus 202 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 202 IPYPGMSN----------------PEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCCH----------------HHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99864321 11122222222223334456679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=249.67 Aligned_cols=201 Identities=22% Similarity=0.267 Sum_probs=158.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.++...++||||+.+|+|.+++..... ++...+..++.|++.||+|||+.+
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~~--- 121 (364)
T cd05599 54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT---------FTEEETRFYIAETILAIDSIHKLG--- 121 (364)
T ss_pred HHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 35678999999999999999999999999999999999976542 889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccc------------------------------------ccccccc
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL------------------------------------HSTRVLG 124 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~------------------------------------~~~~~~~ 124 (243)
++||||||+||+++.++.++|+|||++.......... ......|
T Consensus 122 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 201 (364)
T cd05599 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVG 201 (364)
T ss_pred eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccccc
Confidence 9999999999999999999999999986542211000 0012358
Q ss_pred cccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc--cCCCCCHHH
Q 026115 125 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LGGEYPPKA 202 (243)
Q Consensus 125 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 202 (243)
|+.|+|||++.+..++.++|+|||||++|+|++|..||....+. +....+.... .........
T Consensus 202 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~ 266 (364)
T cd05599 202 TPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ---------------ETYRKIINWKETLQFPDEVPL 266 (364)
T ss_pred CccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHH---------------HHHHHHHcCCCccCCCCCCCC
Confidence 99999999999888999999999999999999999999754221 1111111111 111111124
Q ss_pred HHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 026115 203 IAKMAAVAALCVQYEADFRPN---MGIVLK 229 (243)
Q Consensus 203 ~~~~~~li~~~l~~~p~~Rps---~~~vl~ 229 (243)
+..+.+++.+|+. +|.+|++ +.++++
T Consensus 267 s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 267 SPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 5678999999996 9999998 998887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=240.43 Aligned_cols=225 Identities=20% Similarity=0.266 Sum_probs=170.4
Q ss_pred CCCcccCCccceeeEEEEeC--C---eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 1 MVSRLKNENVVELVGYYVDG--P---LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~--~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+|+.+.|||||++.-+|... + ...+||||++. +|..+++.....+. .++...+.-+..|+..|+.|||.
T Consensus 70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~-----~mp~~~iKLYt~Qlfrgl~yLh~ 143 (364)
T KOG0658|consen 70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQ-----RMPLLEIKLYTYQLFRGLAYLHS 143 (364)
T ss_pred HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCC-----CCceeeeHHHHHHHHHHHHHHHh
Confidence 47789999999999988632 2 46899999977 99999986421110 16667778899999999999999
Q ss_pred cCCCCeEeccCCCCceEecCC-CceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~ 153 (243)
.| ++||||||+|+|+|.+ |.+||+|||.|+........ .....+.-|+|||.+.+ ..|+.+.||||.||++.
T Consensus 144 ~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~a 217 (364)
T KOG0658|consen 144 HG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMA 217 (364)
T ss_pred cC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHH
Confidence 98 9999999999999987 89999999999877655432 34457889999999886 57899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcc-------ccC-----CCCCHHHHHHHHHHHHhhcCCCCCCC
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT-------KLG-----GEYPPKAIAKMAAVAALCVQYEADFR 221 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R 221 (243)
||+.|++.|.+.+..++-..+...-+.+..+.+...-.. ... .-.....+.+..+++.++|+.+|.+|
T Consensus 218 ELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R 297 (364)
T KOG0658|consen 218 ELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKR 297 (364)
T ss_pred HHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhc
Confidence 999999999986655544444333333333332222111 111 01233456689999999999999999
Q ss_pred CCHHHHHH--HHHHHHhh
Q 026115 222 PNMGIVLK--ALQPLLNT 237 (243)
Q Consensus 222 ps~~~vl~--~l~~~~~~ 237 (243)
.++.+++. +++++...
T Consensus 298 ~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 298 LSALEALAHPFFDELRDP 315 (364)
T ss_pred CCHHHHhcchhhHHhhCc
Confidence 99999997 55665544
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=233.41 Aligned_cols=200 Identities=27% Similarity=0.372 Sum_probs=160.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++..++++|||+.+++|.+++..... .++...+..++.|++.|+.|||+.+ +
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i 122 (262)
T cd06613 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLHETG---K 122 (262)
T ss_pred HHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5789999999999999999999999999999999999876522 2888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC---CCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+... .++.++|+||+|+++++|++|
T Consensus 123 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg 200 (262)
T cd06613 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL 200 (262)
T ss_pred eecCCChhhEEECCCCCEEECccccchhhhhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999998765432211 2234578889999998766 788899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccc---cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK---LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||....+.. ......... .........+..+.+++.+||+.+|.+|||+.+++.
T Consensus 201 ~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 201 QPPMFDLHPMR---------------ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCCCCCCHHH---------------HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99986432211 111111110 011123345678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=249.73 Aligned_cols=213 Identities=24% Similarity=0.330 Sum_probs=176.4
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|.||+||||++++|+|..++.+|+|+||++.|+|.+|+....... +..+....++.||++|++||.+.+
T Consensus 588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLes~n--- 657 (807)
T KOG1094|consen 588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLESLN--- 657 (807)
T ss_pred HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHHhhc---
Confidence 4789999999999999999999999999999999999999886422 345566779999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh--C
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--G 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~--g 158 (243)
++|||+.+.|+|++.++++||+|||.++..............+-+..|+|+|.+..++++.++|+|+||+++||+++ .
T Consensus 658 fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~ 737 (807)
T KOG1094|consen 658 FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCR 737 (807)
T ss_pred hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHh
Confidence 99999999999999999999999999997776666655566677889999999999999999999999999999976 7
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhc---cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD---TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
+.||.....+.. -++..+... .......|.-++..++++|.+||..+-++|||++++...|++..
T Consensus 738 e~Py~~lt~e~v------------ven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 738 EQPYSQLTDEQV------------VENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hCchhhhhHHHH------------HHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 788864322100 011111111 12224567788999999999999999999999999999998753
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=241.38 Aligned_cols=218 Identities=18% Similarity=0.259 Sum_probs=156.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++.+++..++|+||+++++|.+++...... .+++..++.++.|++.||.|||+.+ +
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---i 122 (327)
T cd08227 53 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHHMG---Y 122 (327)
T ss_pred HHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 56789999999999999999999999999999999998654322 1788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc-----ccccccccccccCchhhcc--CCCCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~ 154 (243)
+|+||||+||+++.++.++++||+............ ......++..|+|||++.+ ..++.++|+||+||++++
T Consensus 123 iH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~e 202 (327)
T cd08227 123 VHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 202 (327)
T ss_pred ecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHH
Confidence 999999999999999999999997643322111100 0122346678999999875 357899999999999999
Q ss_pred HHhCCCCCCCCCCCCCccc-----eeeccC--cCchhhh----------------------hhhhccccCCCCCHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSL-----VTWATP--KLSEDKV----------------------KQCVDTKLGGEYPPKAIAK 205 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~-----~~~~~~--~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~ 205 (243)
+++|..||........... ...... ....+.. ................+..
T Consensus 203 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (327)
T cd08227 203 LANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282 (327)
T ss_pred HHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHH
Confidence 9999999974321110000 000000 0000000 0000000001122344668
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 206 MAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 206 ~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+.+++.+||+.||++|||++++++
T Consensus 283 ~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 283 FHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred HHHHHHHHHhhCchhcCCHHHHhc
Confidence 999999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=239.55 Aligned_cols=213 Identities=22% Similarity=0.340 Sum_probs=160.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~ 80 (243)
+++++||||+++++++.++...++++||+++++|.+++..... ++...+..++.|+++|+.|||+ .+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~~--- 120 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPENILGKISIAVLRGLTYLREKHK--- 120 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhhCC---
Confidence 5678999999999999999999999999999999999976532 7888999999999999999997 46
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||+|+||+++.++.++++|||++....... .....++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 121 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 196 (308)
T cd06615 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRY 196 (308)
T ss_pred EEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999886543321 223457889999999988888999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCc-----------------h----hhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLS-----------------E----DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEAD 219 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~-----------------~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 219 (243)
||.................... . +..................+.++.+++.+||+.+|+
T Consensus 197 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (308)
T cd06615 197 PIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPK 276 (308)
T ss_pred CCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChh
Confidence 9865432221111100000000 0 000001111000001112456799999999999999
Q ss_pred CCCCHHHHHHH
Q 026115 220 FRPNMGIVLKA 230 (243)
Q Consensus 220 ~Rps~~~vl~~ 230 (243)
+|||+.++++.
T Consensus 277 ~Rpt~~~ll~~ 287 (308)
T cd06615 277 ERADLKELTKH 287 (308)
T ss_pred hCcCHHHHhcC
Confidence 99999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=248.35 Aligned_cols=202 Identities=21% Similarity=0.221 Sum_probs=156.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++..+++||||+++|+|.+++..... +++..+..++.|++.||.|||..+ +
T Consensus 55 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~~LH~~g---i 122 (381)
T cd05626 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV---------FPEVLARFYIAELTLAIESVHKMG---F 122 (381)
T ss_pred HHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5788999999999999999999999999999999999976542 788888899999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc---------------------------------------------
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--------------------------------------------- 116 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--------------------------------------------- 116 (243)
+||||||+||+++.++.++|+|||++.........
T Consensus 123 vHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (381)
T cd05626 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQR 202 (381)
T ss_pred eecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccc
Confidence 99999999999999999999999987543110000
Q ss_pred cccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc--ccc
Q 026115 117 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD--TKL 194 (243)
Q Consensus 117 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 194 (243)
.......||+.|+|||++.+..++.++|||||||++|||++|..||....+. .....+.. ...
T Consensus 203 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~~ 267 (381)
T cd05626 203 CLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPT---------------ETQLKVINWENTL 267 (381)
T ss_pred cccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHH---------------HHHHHHHcccccc
Confidence 0001246899999999999888999999999999999999999999754221 11111111 111
Q ss_pred CCCCCHHHHHHHHHHHHhh--cCCCCCCCCCHHHHHHH
Q 026115 195 GGEYPPKAIAKMAAVAALC--VQYEADFRPNMGIVLKA 230 (243)
Q Consensus 195 ~~~~~~~~~~~~~~li~~~--l~~~p~~Rps~~~vl~~ 230 (243)
........+.++.+++.+| +..++..||++.++++.
T Consensus 268 ~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 268 HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111123456788888884 45666679999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=233.94 Aligned_cols=202 Identities=25% Similarity=0.438 Sum_probs=160.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++......++++||+.+++|.+++....+ .+++..++.++.|++.|+++||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---i 121 (256)
T cd05112 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN---V 121 (256)
T ss_pred HHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5788999999999999999999999999999999999876543 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||.++........ ......++..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus 122 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 200 (256)
T cd05112 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200 (256)
T ss_pred cccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999988654332111 1112234568999999988889999999999999999998 899
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
||..... ....+.+........+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 201 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 201 PYENRSN----------------SEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCcCCH----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 9864321 111111111111122223456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=247.89 Aligned_cols=200 Identities=19% Similarity=0.249 Sum_probs=158.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++.++...++||||+++|+|.+++.... ++...+..++.|++.||+|||+.+ +
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~~---I 163 (370)
T cd05621 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSMG---L 163 (370)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999997543 778889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC----CCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~l~~ 157 (243)
+||||||+||+++.++.++|+|||++........ .......||+.|+|||++.+.. ++.++|+||+||++|+|++
T Consensus 164 vHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~ 242 (370)
T cd05621 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 242 (370)
T ss_pred EecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh
Confidence 9999999999999999999999999876532211 1123456899999999987543 6789999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC--HHHHHHHHHHHHhhcCCCCC--CCCCHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEAD--FRPNMGIVLKA 230 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~--~Rps~~~vl~~ 230 (243)
|..||..... ......+.........+ ...+..+.+++.+|++.++. .|+|+.++++.
T Consensus 243 G~~Pf~~~~~---------------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 243 GDTPFYADSL---------------VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCCCCCCH---------------HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 9999974421 11222222222111122 23467789999999985554 38999999884
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=235.75 Aligned_cols=211 Identities=18% Similarity=0.253 Sum_probs=153.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++.+....+++|||+++|+|.+++....... ...+...+..++.|++.|++|||+.+ +
T Consensus 49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~~---i 120 (268)
T cd05086 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHR-----RNSQLLLLQRMACEIAAGVTHMHKHN---F 120 (268)
T ss_pred HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhccc-----ccccHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999997643210 12566778899999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-------CCCCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~ 154 (243)
+|+||||+||+++.++.++++|||++................++..|+|||++.. ..++.++|+||||+++++
T Consensus 121 ~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (268)
T cd05086 121 LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200 (268)
T ss_pred eccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHH
Confidence 9999999999999999999999998754322211111223457789999998743 234678999999999999
Q ss_pred HHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
|++ |..||....+....... ..+....... .......+..+.+++..|| .+|++|||++++++.|.
T Consensus 201 l~~~~~~p~~~~~~~~~~~~~-------~~~~~~~~~~----~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 201 LFENAAQPYSHLSDREVLNHV-------IKDQQVKLFK----PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHhCCCCCCCCCCHHHHHHHH-------HhhcccccCC----CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 997 56677543221000000 0000000111 1112224557888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=249.74 Aligned_cols=201 Identities=20% Similarity=0.218 Sum_probs=156.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++|+|.+++..... ++...+..++.|++.||+|||+.+ +
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~ql~~aL~~LH~~g---i 122 (377)
T cd05629 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT---------FSEDVTRFYMAECVLAIEAVHKLG---F 122 (377)
T ss_pred HHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999999999999976542 788889999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc------------c--------------------------------
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR------------L-------------------------------- 117 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~------------~-------------------------------- 117 (243)
+||||||+||+++.++.++++|||+++.+...... .
T Consensus 123 vHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (377)
T cd05629 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRR 202 (377)
T ss_pred eccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc
Confidence 99999999999999999999999998643211000 0
Q ss_pred -ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcc--cc
Q 026115 118 -HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT--KL 194 (243)
Q Consensus 118 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 194 (243)
......||+.|+|||++.+..++.++|+|||||++|+|++|..||....+. +....+... ..
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~~ 267 (377)
T cd05629 203 LMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSH---------------ETYRKIINWRETL 267 (377)
T ss_pred ccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHH---------------HHHHHHHccCCcc
Confidence 001235899999999999888999999999999999999999999644221 111111110 11
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCC---CCHHHHHHH
Q 026115 195 GGEYPPKAIAKMAAVAALCVQYEADFR---PNMGIVLKA 230 (243)
Q Consensus 195 ~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~~vl~~ 230 (243)
........+.++.+++.+|+. +|.+| +|+.++++.
T Consensus 268 ~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 268 YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 111111245678999999997 67765 599998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=248.05 Aligned_cols=200 Identities=20% Similarity=0.213 Sum_probs=158.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++|+|.+++..... .++...+..++.|++.||.|||+.+ +
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~---i 123 (330)
T cd05601 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMG---Y 123 (330)
T ss_pred HHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999987632 2888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc------cCCCCcccchHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~~l~~l 155 (243)
+||||||+||+++.++.++|+|||++......... ......|++.|+|||++. ...++.++|||||||++|+|
T Consensus 124 ~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 202 (330)
T cd05601 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202 (330)
T ss_pred EcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeee
Confidence 99999999999999999999999998765432221 122345899999999986 34567899999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc--cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++|..||...... .....+.... .........+..+.+++.+||+ +|.+|||+.++++
T Consensus 203 ~~g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 203 IYGRSPFHEGTSA---------------KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCCCCCCCCCHH---------------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 9999999644221 1111111111 1111112345679999999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=243.86 Aligned_cols=197 Identities=23% Similarity=0.284 Sum_probs=155.6
Q ss_pred cc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 026115 4 RL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 82 (243)
Q Consensus 4 ~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~ 82 (243)
++ +||||+++++++.+...+++||||+++++|..++..... +++..+..++.|++.|++|||+.+ ++
T Consensus 51 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---iv 118 (327)
T cd05617 51 QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK---------LPEEHARFYAAEICIALNFLHERG---II 118 (327)
T ss_pred hhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 44 699999999999999999999999999999998875542 889999999999999999999998 99
Q ss_pred eccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCC
Q 026115 83 HRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 83 h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 162 (243)
||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 119 HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf 196 (327)
T cd05617 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196 (327)
T ss_pred ccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCC
Confidence 999999999999999999999998864322111 123346899999999999888999999999999999999999999
Q ss_pred CCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
......... .......+..... ....+...+..+.+++.+||+.||.+|+++
T Consensus 197 ~~~~~~~~~---------~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 197 DIITDNPDM---------NTEDYLFQVILEK-PIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CccCCCccc---------ccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 643221110 0111111111111 112344456678999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=236.11 Aligned_cols=195 Identities=26% Similarity=0.432 Sum_probs=152.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|..++....+. ++...++.++.|++.|++|||+.+ +
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~---i 138 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR--------VPVAWKITVAQQLASALSYLEDKN---L 138 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHcCC---c
Confidence 57899999999999999999999999999999999998754321 788889999999999999999998 9
Q ss_pred EeccCCCCceEecCCC-------ceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDD-------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 82 ~h~di~~~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~ 153 (243)
+|+||||+||+++..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~ 212 (274)
T cd05076 139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212 (274)
T ss_pred cCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHH
Confidence 9999999999997643 3799999987543222 12246778999998875 45789999999999999
Q ss_pred HHH-hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 154 ELL-TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 154 ~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
+++ +|..||....+.. ......... ..+......+.+++.+||+.+|++|||+.++++.|
T Consensus 213 el~~~g~~p~~~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 213 EICFDGEVPLKERTPSE----------------KERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHhCCCCCccccChHH----------------HHHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 995 6888886442211 011111111 11112234689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=233.41 Aligned_cols=203 Identities=29% Similarity=0.433 Sum_probs=164.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..+++||++.+++|.+++....... +++..++.++.|++.|+++||+.+ +
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~ql~~~l~~lh~~~---~ 124 (258)
T smart00219 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKE-------LSLSDLLSFALQIARGMEYLESKN---F 124 (258)
T ss_pred HHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhcc-------CCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 567899999999999999999999999999999999998655322 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++++|||+++........... ...++..|+|||.+.+..++.++|+||+|++++++++ |..
T Consensus 125 ~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~ 203 (258)
T smart00219 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGES 203 (258)
T ss_pred eecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998766544222111 2236788999999988888999999999999999998 788
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
||... ......+..........+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 204 p~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 204 PYPGM----------------SNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCC----------------CHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 87532 11222222222222333444677899999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=249.46 Aligned_cols=218 Identities=21% Similarity=0.273 Sum_probs=157.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++..+...+++++++. ++|..++..... .+++..++.++.|++.||.|||+.+
T Consensus 213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g--- 280 (461)
T PHA03211 213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGEG--- 280 (461)
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4678999999999999999999999999995 689998865432 2889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||+++...............||..|+|||++.+..++.++|||||||++||+++|..
T Consensus 281 IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999876543222111223458999999999998889999999999999999999876
Q ss_pred CCCCCCCC-CCcc-------ceeec-------cCcCchhhhhhhhcc---ccCC--CCC-----HHHHHHHHHHHHhhcC
Q 026115 161 PVDHTLPR-GQQS-------LVTWA-------TPKLSEDKVKQCVDT---KLGG--EYP-----PKAIAKMAAVAALCVQ 215 (243)
Q Consensus 161 pf~~~~~~-~~~~-------~~~~~-------~~~~~~~~~~~~~~~---~~~~--~~~-----~~~~~~~~~li~~~l~ 215 (243)
++...... .... .+... ............... .... ..+ ......+.+|+.+||+
T Consensus 361 ~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 440 (461)
T PHA03211 361 SLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALT 440 (461)
T ss_pred CcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcc
Confidence 54322111 0000 00000 000000000000000 0000 000 1223468899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 026115 216 YEADFRPNMGIVLKA 230 (243)
Q Consensus 216 ~~p~~Rps~~~vl~~ 230 (243)
.||.+|||+.|+|+.
T Consensus 441 ~DP~~RPsa~elL~h 455 (461)
T PHA03211 441 FDGARRPSAAELLRL 455 (461)
T ss_pred cChhhCcCHHHHhhC
Confidence 999999999999974
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=237.00 Aligned_cols=197 Identities=25% Similarity=0.374 Sum_probs=160.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++|+||+++++|.+++.... ++...+..++.|++.|+.|||+.+ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~---i 122 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP----------LEETYIATILREILKGLDYLHSER---K 122 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 578899999999999999999999999999999999986533 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||||++++++++|..|
T Consensus 123 vH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06642 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred eccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543221 12234578889999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|....+... ................+..+.+++.+||+.+|++|||+.++++
T Consensus 201 ~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 201 NSDLHPMRV----------------LFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CcccchhhH----------------HhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 864422111 0111111111222345667999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=251.15 Aligned_cols=187 Identities=23% Similarity=0.338 Sum_probs=160.1
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
+||.++.++.+|...+++++||||+.||++..+.+... +++..+.-++..|+.||+|||++| |++||
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~----------F~e~rarfyaAev~l~L~fLH~~~---IIYRD 493 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDV----------FSEPRARFYAAEVVLGLQFLHENG---IIYRD 493 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEeccc----------ccHHHHHHHHHHHHHHHHHHHhcC---ceeee
Confidence 69999999999999999999999999999555544443 999999999999999999999999 99999
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 165 (243)
+|.+|||+|..|.+||+|||+++..-.... .....-||+.|+|||++.+..|+.+.|.|+|||++|||+.|+.||.+.
T Consensus 494 lKLdNiLLD~eGh~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 494 LKLDNLLLDTEGHVKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred cchhheEEcccCcEEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999987654333 245677999999999999999999999999999999999999999865
Q ss_pred CCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
+++ +....++.... .+|...+.+...++.++|.+||++|.-+
T Consensus 572 dEe---------------e~FdsI~~d~~--~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 572 DEE---------------EVFDSIVNDEV--RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CHH---------------HHHHHHhcCCC--CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 332 22222333222 5677788899999999999999999855
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=232.93 Aligned_cols=201 Identities=26% Similarity=0.393 Sum_probs=162.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++++||+.+++|.+++..... .+++..+..++.|++.|+.|||+.+ +
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~~---i 120 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHSNK---K 120 (256)
T ss_pred HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999865432 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+|++|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 121 ~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p 198 (256)
T cd06612 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198 (256)
T ss_pred ccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876544321 12334478899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|....+....... .. ........+...+..+.+++.+||+.||++|||+.++++
T Consensus 199 ~~~~~~~~~~~~~------------~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 199 YSDIHPMRAIFMI------------PN--KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCcchhhhhhhh------------cc--CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 9754322111000 00 000011223345567999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=235.69 Aligned_cols=212 Identities=25% Similarity=0.355 Sum_probs=164.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+....++||||+++++|.+++..............++...++.++.|++.||+|||+.+ +
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i 138 (275)
T cd05046 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---F 138 (275)
T ss_pred HHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---c
Confidence 5788999999999999998999999999999999999976653221111223889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++++|||++......... ......++..|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 139 ~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~ 217 (275)
T cd05046 139 VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL 217 (275)
T ss_pred ccCcCccceEEEeCCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987644322111 1122345677999999988888899999999999999998 788
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
||...... ...............+...+..+.+++.+||+.+|++|||+.+++..|.
T Consensus 218 p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 218 PFYGLSDE---------------EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CccccchH---------------HHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 88543111 1111111111111223345568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=235.80 Aligned_cols=200 Identities=22% Similarity=0.318 Sum_probs=158.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++..+...++++||+.+++|..++..... ++++..+..++.|++.|+.|||+.+ +
T Consensus 56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~~---i 124 (282)
T cd06643 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLHENK---I 124 (282)
T ss_pred HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999998765332 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~ 156 (243)
+|+||+|+||+++.++.++++|||++........ ......++..|+|||++. +..++.++|+||+||++++++
T Consensus 125 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~ 202 (282)
T cd06643 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202 (282)
T ss_pred eecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence 9999999999999999999999999865533221 123345788999999874 345678999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcc-ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||....+. +........ ......+...+..+.+++.+||+.||.+|||+.++++
T Consensus 203 ~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 203 QIEPPHHELNPM---------------RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred cCCCCccccCHH---------------HHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999998643211 111111111 0011223345568999999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=235.73 Aligned_cols=197 Identities=26% Similarity=0.390 Sum_probs=161.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++++||+.+++|.+++.... ++...++.++.|++.|+.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lh~~~---i 119 (274)
T cd06609 53 LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK----------LDETYIAFILREVLLGLEYLHEEG---K 119 (274)
T ss_pred HHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 567899999999999999999999999999999999987652 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||+++....... ......++..|+|||.+.+..++.++|+||||+++|++++|..|
T Consensus 120 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p 197 (274)
T cd06609 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197 (274)
T ss_pred ccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876654321 12334578889999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|....+.. ....+........+.. .+..+.+++.+||..+|++|||++++++
T Consensus 198 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 198 LSDLHPMR----------------VLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cccCchHH----------------HHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 96442110 1111111111111112 5567999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=242.66 Aligned_cols=195 Identities=22% Similarity=0.283 Sum_probs=157.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||....+|.||+++-+|.+...+||||||++||++..+|..... +++..+..++.+.+.|+..+|+.|
T Consensus 194 iL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~---------L~e~~arfYiaE~vlAI~~iH~~g--- 261 (550)
T KOG0605|consen 194 ILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDT---------LTEDWARFYIAETVLAIESIHQLG--- 261 (550)
T ss_pred HhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCc---------CchHHHHHHHHHHHHHHHHHHHcC---
Confidence 34557899999999999999999999999999999999998773 899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccc--------------------ccccc----------------------
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA--------------------AARLH---------------------- 118 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~--------------------~~~~~---------------------- 118 (243)
++||||||+|+|+|..|.+||+|||++.-.... .....
T Consensus 262 yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nr 341 (550)
T KOG0605|consen 262 YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNR 341 (550)
T ss_pred cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhh
Confidence 999999999999999999999999997422210 00000
Q ss_pred ---cccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc--
Q 026115 119 ---STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK-- 193 (243)
Q Consensus 119 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 193 (243)
....+|||-|+|||++.+..|...+|.|||||++|||+.|.+||.+..+. +....++.-+
T Consensus 342 r~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~---------------~T~rkI~nwr~~ 406 (550)
T KOG0605|consen 342 RQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ---------------ETYRKIVNWRET 406 (550)
T ss_pred hhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHHHhhh
Confidence 01235999999999999999999999999999999999999999866442 2222222211
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q 026115 194 LGGEYPPKAIAKMAAVAALCVQYEADFRPN 223 (243)
Q Consensus 194 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (243)
+..+.....+.+..+||.+|+. ||+.|.-
T Consensus 407 l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 407 LKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred ccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 2222333445789999999999 9999975
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=238.59 Aligned_cols=162 Identities=23% Similarity=0.369 Sum_probs=128.6
Q ss_pred CCCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 1 MVSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
++++++||||+++++++.. +...++++||+.+ +|..++..............++...+..++.|++.|+.|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 128 (317)
T cd07868 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678999999999999854 5678999999854 89888765433222222223788899999999999999999998
Q ss_pred CCeEeccCCCCceEe----cCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccC-CCCcccchHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLL----FDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVL 152 (243)
Q Consensus 79 ~~~~h~di~~~nil~----~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l 152 (243)
++||||||+||++ +.++.++|+|||+++......... ......||+.|+|||++.+. .++.++|+||+||++
T Consensus 129 --ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (317)
T cd07868 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHH
Confidence 9999999999999 456789999999997664332211 12234688999999998764 578899999999999
Q ss_pred HHHHhCCCCCCCCC
Q 026115 153 LELLTGRKPVDHTL 166 (243)
Q Consensus 153 ~~l~~g~~pf~~~~ 166 (243)
++|++|.+||....
T Consensus 207 ~el~~g~~~f~~~~ 220 (317)
T cd07868 207 AELLTSEPIFHCRQ 220 (317)
T ss_pred HHHHhCCCCccCCc
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=238.17 Aligned_cols=198 Identities=25% Similarity=0.387 Sum_probs=160.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++|+||+.+++|..++.... +++.++..++.|++.|+.+||+.+ +
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~~---i 136 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC----------MDEAQIAAVCRECLQALEFLHANQ---V 136 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999999999999999999999999999987543 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||++......... .....++..|+|||.+.+..++.++|+|||||++|++++|..|
T Consensus 137 ~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~p 214 (296)
T cd06655 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (296)
T ss_pred ccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987654332211 2234578899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhc-cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVD-TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|....+.. ....... .......+...+..+.+++.+||..||++|||+.+++.
T Consensus 215 f~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 215 YLNENPLR---------------ALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCCCCHHH---------------HHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 96542211 1111110 11111223345667999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=238.12 Aligned_cols=203 Identities=23% Similarity=0.329 Sum_probs=161.0
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++|+||+++++++.++...+++|||+.+++|.+++...... .++...+..++.|++.|+.|||+.+
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~~--- 122 (285)
T cd05630 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-------GFEEGRAVFYAAEICCGLEDLHQER--- 122 (285)
T ss_pred HHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 357899999999999999999999999999999999988654322 2788899999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||+|+||+++.++.++++|||++........ .....|+..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 123 iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 199 (285)
T cd05630 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199 (285)
T ss_pred EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998865432211 123458899999999998889999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~ 229 (243)
||........ .+....... ......+...+..+.+++.+||+.||++||| +.++++
T Consensus 200 Pf~~~~~~~~------------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 200 PFQQRKKKIK------------REEVERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCCCCCccch------------HHHHHhhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 9975321100 011111111 1111222334567899999999999999999 889987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=245.09 Aligned_cols=202 Identities=22% Similarity=0.252 Sum_probs=155.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++..+++||||+++|+|.+++..... ++...+..++.|++.||.|||+.+ +
T Consensus 55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~g---i 122 (363)
T cd05628 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT---------LTEEETQFYIAETVLAIDSIHQLG---F 122 (363)
T ss_pred HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc---------------------------------cccccccccccc
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR---------------------------------LHSTRVLGTFGY 128 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~ 128 (243)
+||||||+||+++.++.++|+|||+++........ .......||+.|
T Consensus 123 vHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y 202 (363)
T cd05628 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDY 202 (363)
T ss_pred EecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccc
Confidence 99999999999999999999999998754321100 001124689999
Q ss_pred cCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC--HHHHHHH
Q 026115 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKM 206 (243)
Q Consensus 129 ~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 206 (243)
+|||++.+..++.++|+|||||++|+|++|..||....+. +....+.........+ ...+..+
T Consensus 203 ~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~ 267 (363)
T cd05628 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ---------------ETYKKVMNWKETLIFPPEVPISEKA 267 (363)
T ss_pred cCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHcCcCcccCCCcCCCCHHH
Confidence 9999999888999999999999999999999999754221 1111111111000111 1234567
Q ss_pred HHHHHhhcC--CCCCCCCCHHHHHHH
Q 026115 207 AAVAALCVQ--YEADFRPNMGIVLKA 230 (243)
Q Consensus 207 ~~li~~~l~--~~p~~Rps~~~vl~~ 230 (243)
.+++.+|+. .++..||+++++++.
T Consensus 268 ~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 268 KDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 788877654 234456899999885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=248.47 Aligned_cols=201 Identities=21% Similarity=0.242 Sum_probs=156.1
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.++..+++||||+++|+|.+++..... ++...+..++.|++.|++|||+.+
T Consensus 54 il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~al~~lH~~~--- 121 (382)
T cd05625 54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI---------FPEDLARFYIAELTCAVESVHKMG--- 121 (382)
T ss_pred HHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 35788999999999999999999999999999999999876532 788888999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccc---------------------------------------------
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA--------------------------------------------- 115 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--------------------------------------------- 115 (243)
++||||||+||+++.++.++|+|||++........
T Consensus 122 ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (382)
T cd05625 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQ 201 (382)
T ss_pred eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccc
Confidence 99999999999999999999999999753311000
Q ss_pred ccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc--cc
Q 026115 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD--TK 193 (243)
Q Consensus 116 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 193 (243)
........||+.|+|||++.+..++.++|+||+||++|+|++|..||....+. +....+.. ..
T Consensus 202 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~ 266 (382)
T cd05625 202 RCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL---------------ETQMKVINWQTS 266 (382)
T ss_pred cccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHH---------------HHHHHHHccCCC
Confidence 00011235899999999999888999999999999999999999999754221 11111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 026115 194 LGGEYPPKAIAKMAAVAALCVQYEADFRPN---MGIVLK 229 (243)
Q Consensus 194 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~vl~ 229 (243)
.........+.+..+++.+|+ .+|.+|++ +.++++
T Consensus 267 ~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 267 LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 111112234567888888876 59999997 888775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=242.15 Aligned_cols=214 Identities=20% Similarity=0.297 Sum_probs=157.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++||||+.+ +|.+++..... .++...+..++.|++.|+.|||+.+ +
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---i 125 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRRK---V 125 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5688999999999999999999999999975 88888865532 2788889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ .....++..|+|||.+.+ ..++.++|+||+|+++++|++|..
T Consensus 126 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~ 203 (309)
T cd07872 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203 (309)
T ss_pred ecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998654332211 123357889999999875 457889999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhh---------hhhhccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKV---------KQCVDTKLGG----EYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
||........................ .....+.... ......+..+.+++.+||+.||.+|||+.++
T Consensus 204 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 283 (309)
T cd07872 204 LFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA 283 (309)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH
Confidence 99765332111111000000000000 0000000000 0112245678999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 284 l~ 285 (309)
T cd07872 284 MK 285 (309)
T ss_pred hc
Confidence 97
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=254.03 Aligned_cols=223 Identities=20% Similarity=0.261 Sum_probs=157.0
Q ss_pred CCCcccCCccceeeEEEEeC--------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHH
Q 026115 1 MVSRLKNENVVELVGYYVDG--------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 72 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~ 72 (243)
+|++++||||+++++++... ..+++||||+.+ +|.+++...... ...++...+..++.|++.||+|
T Consensus 112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~y 185 (440)
T PTZ00036 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAY 185 (440)
T ss_pred HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHH
Confidence 36789999999999987532 247799999975 787776542210 0128889999999999999999
Q ss_pred hhhcCCCCeEeccCCCCceEecCCC-ceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHH
Q 026115 73 LHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGV 150 (243)
Q Consensus 73 Lh~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ 150 (243)
||+.+ ++||||||+||+++.++ .++|+|||+++....... .....|++.|+|||++.+. .++.++|+|||||
T Consensus 186 LH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv 259 (440)
T PTZ00036 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGC 259 (440)
T ss_pred HHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHH
Confidence 99998 99999999999998665 699999999976543221 1234578999999998754 6899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhh------------hccccCCCCCHHHHHHHHHHHHhhcCCCC
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC------------VDTKLGGEYPPKAIAKMAAVAALCVQYEA 218 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p 218 (243)
++|+|++|.+||.+.........+.........+..... ....+....+...+.++.+|+.+||+.||
T Consensus 260 il~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP 339 (440)
T PTZ00036 260 IIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339 (440)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCCh
Confidence 999999999999765332111111000001111100000 00001111222345689999999999999
Q ss_pred CCCCCHHHHHH--HHHHHH
Q 026115 219 DFRPNMGIVLK--ALQPLL 235 (243)
Q Consensus 219 ~~Rps~~~vl~--~l~~~~ 235 (243)
.+|||+.++++ .+.++.
T Consensus 340 ~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 340 LKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hHCcCHHHHhCChhHHhhh
Confidence 99999999996 455543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=232.16 Aligned_cols=201 Identities=25% Similarity=0.361 Sum_probs=160.5
Q ss_pred CCcccCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++|||++++.+.+.. +..+++++||+++++|.+++...... .+++.+++.++.+++.|+.+||+.+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~-------~l~~~~~~~~~~~l~~~l~~lH~~~--- 122 (257)
T cd08223 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK-------LLPENQVVEWFVQIAMALQYLHEKH--- 122 (257)
T ss_pred HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 568899999999998864 45689999999999999999764332 2788999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||...+..++.++|+||+|++++++++|..
T Consensus 123 i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08223 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH 200 (257)
T ss_pred eeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999865533221 1233457889999999998888999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
||..... ......+.. ......+...+..+.+++.+||+.||++|||+.++++.
T Consensus 201 ~~~~~~~---------------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 201 AFNAKDM---------------NSLVYRIIE-GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCCH---------------HHHHHHHHh-cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 9863311 011111111 11123344566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=250.03 Aligned_cols=202 Identities=22% Similarity=0.242 Sum_probs=157.1
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++.+.+++.+++||||+++|+|.+++..... ++...+..++.|++.|++|||+.+
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~--- 121 (376)
T cd05598 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI---------FEEDLARFYIAELTCAIESVHKMG--- 121 (376)
T ss_pred HHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999976542 778888899999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccc-----------------------------------------cccc
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA-----------------------------------------RLHS 119 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-----------------------------------------~~~~ 119 (243)
++||||||+||+++.++.++|+|||++..+..... ....
T Consensus 122 ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (376)
T cd05598 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLA 201 (376)
T ss_pred eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccc
Confidence 99999999999999999999999999753210000 0001
Q ss_pred ccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc--cccCCC
Q 026115 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD--TKLGGE 197 (243)
Q Consensus 120 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 197 (243)
....||+.|+|||++.+..++.++|||||||++|+|++|..||....+... ...+.. ......
T Consensus 202 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---------------~~~i~~~~~~~~~~ 266 (376)
T cd05598 202 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAET---------------QLKVINWETTLHIP 266 (376)
T ss_pred cccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHH---------------HHHHhccCccccCC
Confidence 124689999999999988899999999999999999999999975532111 011111 011111
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCC---CHHHHHHH
Q 026115 198 YPPKAIAKMAAVAALCVQYEADFRP---NMGIVLKA 230 (243)
Q Consensus 198 ~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~vl~~ 230 (243)
.....+..+.+++.+|+ .+|.+|+ |+.++++.
T Consensus 267 ~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 267 SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 11234556888888876 5999999 89999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=242.12 Aligned_cols=196 Identities=21% Similarity=0.258 Sum_probs=155.8
Q ss_pred CcccC-CccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 3 SRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 3 ~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+.++| ++|+++.+++.++..+++||||+++|+|..++..... +++..+..++.|++.|+.|||+.+ +
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---i 122 (324)
T cd05587 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---------FKEPHAVFYAAEIAIGLFFLHSKG---I 122 (324)
T ss_pred HhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 44555 5688899999999999999999999999999876542 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+||++|+|++|..|
T Consensus 123 vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p 200 (324)
T cd05587 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200 (324)
T ss_pred EecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 9999999999999999999999999864322111 12234589999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM-----GIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~vl~ 229 (243)
|...... +....+.... ...+...+..+.+++.+||+.||.+|++. .++++
T Consensus 201 f~~~~~~---------------~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 201 FDGEDED---------------ELFQSIMEHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCCCHH---------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9644211 1111121111 12333456679999999999999999986 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=234.62 Aligned_cols=204 Identities=27% Similarity=0.378 Sum_probs=158.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++|+||+.+++|.+++..... ++...+..++.|++.|+.|||+.+ +
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 127 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP---------LSELQIAYVCRETLQGLAYLHSKG---K 127 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999998865432 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+|++|+||+++.++.++++|||+++........ .....++..|+|||.+. ...++.++|+||+|++++++++|
T Consensus 128 ~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g 205 (267)
T cd06646 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred cccCCCHHHEEECCCCCEEECcCccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999998765322111 12345788999999874 34467899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
..||....+......... .... .... ......+..+.+++.+||+.+|++|||++++++.+
T Consensus 206 ~~p~~~~~~~~~~~~~~~--~~~~--------~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 206 QPPMFDLHPMRALFLMSK--SNFQ--------PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCccccchhhhheeeec--CCCC--------CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 999864432211110000 0000 0000 01123456799999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=235.49 Aligned_cols=204 Identities=21% Similarity=0.301 Sum_probs=160.8
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++|+||+++.+++..+...++++||+.+++|..++...... .++...+..++.|++.|+.|||+.+
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~--- 122 (285)
T cd05632 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-------GFEEERALFYAAEILCGLEDLHREN--- 122 (285)
T ss_pred HHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 357889999999999999999999999999999999888654322 2889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||+|+||+++.++.++++|||++........ .....|+..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 123 iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 199 (285)
T cd05632 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199 (285)
T ss_pred eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998865432211 123458899999999988889999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~~ 230 (243)
||....+... .......... .....+...+..+.+++.+||+.||++||| +.++++.
T Consensus 200 P~~~~~~~~~------------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 200 PFRGRKEKVK------------REEVDRRVLE-TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCCCCCHHHH------------HHHHHHhhhc-cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 9974421100 0011111100 011223345567899999999999999999 7787774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=237.64 Aligned_cols=199 Identities=25% Similarity=0.381 Sum_probs=160.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++||||+++++|.+++.... ++...+..++.|++.|+.|||+.+ +
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~l~~~L~~LH~~~---i 136 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALDFLHSNQ---V 136 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999999999999999999999999999987543 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||++......... .....+++.|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 137 ~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~p 214 (297)
T cd06656 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (297)
T ss_pred ccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999988654322111 1234578899999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|....+......... ........+...+..+.+++.+||+.+|++|||+.++++
T Consensus 215 f~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 215 YLNENPLRALYLIAT--------------NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCcchheeeecc--------------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 965433211110000 000011123345567899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=241.29 Aligned_cols=218 Identities=24% Similarity=0.359 Sum_probs=163.5
Q ss_pred CCcc-cCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCC--------------------------------
Q 026115 2 VSRL-KNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKG-------------------------------- 47 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------------------------------- 47 (243)
+.++ +||||+++++++.. +...+++|||+++|+|.+++........
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (343)
T cd05103 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITS 143 (343)
T ss_pred HHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccc
Confidence 4566 68999999998764 4568999999999999999875421000
Q ss_pred --------------------------CCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceee
Q 026115 48 --------------------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 101 (243)
Q Consensus 48 --------------------------~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l 101 (243)
......++...+..++.|+++|+.|||+.+ ++|+||||+||+++.++.+++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl 220 (343)
T cd05103 144 SQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKI 220 (343)
T ss_pred ccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEE
Confidence 000113677888999999999999999998 999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCc
Q 026115 102 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180 (243)
Q Consensus 102 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 180 (243)
+|||++................++..|+|||.+.+..++.++|+||||++++++++ |..||......
T Consensus 221 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------ 288 (343)
T cd05103 221 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------------ 288 (343)
T ss_pred EecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------------
Confidence 99999876533222111222335677999999988888999999999999999997 88898643110
Q ss_pred CchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
......+........+...+..+.+++..||+.||++|||+.++++.|+.++..
T Consensus 289 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 289 ---EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ---HHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111111112222223445799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=240.91 Aligned_cols=188 Identities=23% Similarity=0.286 Sum_probs=154.2
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
+||+|+++.+++.....+++||||+++|+|..++..... +++..+..++.|++.|+.|||+.+ ++|||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 126 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRD 126 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEecC
Confidence 689999999999999999999999999999999876542 788999999999999999999998 99999
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 165 (243)
|||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...
T Consensus 127 lkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 127 LKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999864322111 123345899999999999888999999999999999999999999744
Q ss_pred CCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
... .....+.... ...+...+.++.+++.+||+.||++|++.
T Consensus 205 ~~~---------------~~~~~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 205 DED---------------ELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CHH---------------HHHHHHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 221 1111222221 12344556789999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=233.87 Aligned_cols=201 Identities=25% Similarity=0.357 Sum_probs=155.4
Q ss_pred CCcc-cCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 2 VSRL-KNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
++++ +||||+++++++... ...++++||+.+++|.+++...... .+++..+..++.|++.|++|||
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH 128 (272)
T cd06637 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLH 128 (272)
T ss_pred HHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH
Confidence 3455 699999999998753 4689999999999999998864332 2788899999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-----CCCCcccchHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFG 149 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG 149 (243)
+.+ ++|+|++|+||+++.++.++|+|||++........ ......|+..|+|||++.. ..++.++|+||+|
T Consensus 129 ~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 203 (272)
T cd06637 129 QHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203 (272)
T ss_pred HCC---CccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHH
Confidence 998 99999999999999999999999999875433211 1233458889999999862 3567899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|+++++++|..||....+... .................+..+.+++.+||+.||.+|||+.++++
T Consensus 204 v~l~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 204 ITAIEMAEGAPPLCDMHPMRA---------------LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHhCCCCccccCHHHH---------------HHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 999999999999864322111 11111111111112234567999999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=236.52 Aligned_cols=213 Identities=20% Similarity=0.245 Sum_probs=155.0
Q ss_pred CcccCCccceeeEEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 3 SRLKNENVVELVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
++++||||+++++++.. ....++++|++.+ +|.+++....... ++...+..++.|++.|+.|||+.+
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~-------~~~~~~~~~~~qi~~al~~lH~~~ 128 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPG-------LPAETIKDLMRQFLRGLDFLHANC 128 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35689999999999864 3468999999975 8999887654322 789999999999999999999998
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++|+||||+||+++.++.++|+|||+++....... .....++..|+|||++.+..++.++|+||+||++++|++
T Consensus 129 ---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 202 (288)
T cd07863 129 ---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 202 (288)
T ss_pred ---eecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHh
Confidence 99999999999999999999999999876543221 123457889999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhh-------hhhcccc---CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVK-------QCVDTKL---GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
|.+||...........+............. ....... ........+..+.+++.+||+.||++|||+.++
T Consensus 203 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 282 (288)
T cd07863 203 RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA 282 (288)
T ss_pred CCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH
Confidence 999996542211100000000000000000 0000000 001112345678999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
+.
T Consensus 283 l~ 284 (288)
T cd07863 283 LQ 284 (288)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=231.56 Aligned_cols=201 Identities=20% Similarity=0.311 Sum_probs=162.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++|+||+.+++|.+++....... ++...++.++.|++.|+.|||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~l~~~l~~lh~~~---i 122 (256)
T cd08218 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-------FPEDQILDWFVQICLALKHVHDRK---I 122 (256)
T ss_pred HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 578999999999999999999999999999999999987643321 778899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||.+......... .....|+..|+|||...+..++.++|+||||++++++++|..|
T Consensus 123 ~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~ 200 (256)
T cd08218 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200 (256)
T ss_pred ecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998765433221 1234578889999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|..... .+....+.. +.....+...+..+.+++.+||+.+|++||++.++++.
T Consensus 201 ~~~~~~---------------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 201 FEAGNM---------------KNLVLKIIR-GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccCCCH---------------HHHHHHHhc-CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 863311 111112211 11222344556789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=243.65 Aligned_cols=194 Identities=19% Similarity=0.166 Sum_probs=153.3
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
+||||+++++++.++...++||||+.+|+|..++..... ++...+..++.|++.|++|||+.+ ++|||
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qil~al~~LH~~~---ivHrD 121 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---------FSEDRAKFYIAELVLALEHLHKYD---IVYRD 121 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 699999999999999999999999999999998876542 888999999999999999999998 99999
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDH 164 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~ 164 (243)
|||+||+++.++.++|+|||+++........ .....|+..|+|||++.+. .++.++|+||+||++|+|++|..||..
T Consensus 122 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 122 LKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred CCHHHeEECCCCCEEEecCCcCcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 9999999999999999999998653322111 2334589999999998754 478899999999999999999999964
Q ss_pred CCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC----CHHHHHH
Q 026115 165 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP----NMGIVLK 229 (243)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~vl~ 229 (243)
.... +....+....... .....+..+.+++.+||+.||++|| ++.++++
T Consensus 200 ~~~~---------------~~~~~i~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 200 EDTQ---------------QMYRNIAFGKVRF-PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHH---------------HHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3211 1111111111111 1112456789999999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=231.33 Aligned_cols=195 Identities=25% Similarity=0.415 Sum_probs=154.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.. ...++|+||+++++|.+++..... .++...++.++.|++.|++|||+.+
T Consensus 54 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~--- 121 (259)
T cd05037 54 LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKK--- 121 (259)
T ss_pred HHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---
Confidence 3678999999999999988 778999999999999999986542 2788899999999999999999998
Q ss_pred eEeccCCCCceEecCCC-------ceeecccCCCCCCcccccccccccccccccccCchhhccC--CCCcccchHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDD-------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVV 151 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~ 151 (243)
++|+||||+||+++.++ .++++|||++...... ....++..|+|||.+... .++.++|+||||++
T Consensus 122 i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~ 195 (259)
T cd05037 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTT 195 (259)
T ss_pred eecccCccceEEEecCccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHH
Confidence 99999999999999877 7999999998765431 223456789999998876 67899999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 152 LLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 152 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
++++++ |..||........ ......... .+......+.+++.+||..+|.+|||+.++++.
T Consensus 196 ~~~l~~~~~~p~~~~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 196 LLEICSNGEEPLSTLSSSEK----------------ERFYQDQHR--LPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred HHHHHhCCCCCcccCCchhH----------------HHHHhcCCC--CCCCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 999999 5777754321100 000000000 011112579999999999999999999999987
Q ss_pred H
Q 026115 231 L 231 (243)
Q Consensus 231 l 231 (243)
|
T Consensus 258 l 258 (259)
T cd05037 258 L 258 (259)
T ss_pred c
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=232.23 Aligned_cols=202 Identities=28% Similarity=0.374 Sum_probs=156.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++..+...++++||+.+++|.+++..... ++..+++.++.|++.|+.|||+.+ +
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i 127 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---------LSESQIAYVSRETLQGLYYLHSKG---K 127 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999875442 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||+++.++.++++|||++........ ......|+..|+|||.+. ...++.++|+||+||+++++++|
T Consensus 128 ~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~ 205 (267)
T cd06645 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred ecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcC
Confidence 9999999999999999999999999765432211 123345889999999874 44578899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||....+.......... . ...... ......+..+.+++.+||+.+|++|||+.++++
T Consensus 206 ~~p~~~~~~~~~~~~~~~~--~--------~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 206 QPPMFDLHPMRALFLMTKS--N--------FQPPKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCcccccchhhHHhhhcc--C--------CCCCcc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 9998644321110000000 0 000000 001123456899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=233.53 Aligned_cols=201 Identities=23% Similarity=0.309 Sum_probs=157.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++++||+++++|..+.. ++...+..++.|++.|+.|||+.+ +
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~qi~~~l~~lH~~~---i 116 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRK-------------IPEHVLGRIAVAVVKGLTYLWSLK---I 116 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567899999999999999999999999999999976521 677888899999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|++++|..|
T Consensus 117 ~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 192 (279)
T cd06619 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192 (279)
T ss_pred eeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987554321 2234588899999999888899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|.......... ..........+...........+..+.+++.+||+.+|++||++.++++.
T Consensus 193 f~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 193 YPQIQKNQGSL--------MPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred chhhccccccc--------chHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 96532211110 00011111111111111112245578999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=239.21 Aligned_cols=220 Identities=20% Similarity=0.268 Sum_probs=159.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++|+||+. ++|.+++..... .++...+..++.|++.|+.|||+.+ +
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---i 125 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRRK---V 125 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 568899999999999999999999999997 499998876432 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++++|||++......... .....++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 126 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 203 (301)
T cd07873 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203 (301)
T ss_pred eCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998754332211 1223468899999998753 46889999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhh---------ccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCV---------DTKLGG----EYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
||..........................+. .+.... ......+..+.+++.+||+.||.+|||++++
T Consensus 204 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei 283 (301)
T cd07873 204 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283 (301)
T ss_pred CCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 997553321110000000000000000000 000000 0111235578999999999999999999999
Q ss_pred HH--HHHHHH
Q 026115 228 LK--ALQPLL 235 (243)
Q Consensus 228 l~--~l~~~~ 235 (243)
++ .++.+.
T Consensus 284 l~h~~f~~~~ 293 (301)
T cd07873 284 MKHPYFHCLG 293 (301)
T ss_pred hcCccccccc
Confidence 97 444433
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=244.41 Aligned_cols=211 Identities=22% Similarity=0.251 Sum_probs=153.9
Q ss_pred CCcccCCccceeeEEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGP------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++.... ..++||||+.+ +|...+... ++...+..++.|++.||.|||+
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~ 141 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHME-----------LDHERMSYLLYQMLCGIKHLHS 141 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhcc-----------CCHHHHHHHHHHHHHHHHHHHh
Confidence 56789999999999986543 57999999965 677766421 7788888999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.+ ++||||||+||+++.++.++|+|||+++...... ......|+..|+|||++.+..++.++|+|||||++|+|
T Consensus 142 ~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 215 (359)
T cd07876 142 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215 (359)
T ss_pred CC---cccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHH
Confidence 98 9999999999999999999999999987543221 12234578899999999988899999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCch-------hhhhhhhccccC------------------CCCCHHHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSE-------DKVKQCVDTKLG------------------GEYPPKAIAKMAAVA 210 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------------------~~~~~~~~~~~~~li 210 (243)
++|..||...+................. ............ .......+..+.+++
T Consensus 216 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (359)
T cd07876 216 VKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295 (359)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHH
Confidence 9999999865332110000000000000 000000000000 011112345789999
Q ss_pred HhhcCCCCCCCCCHHHHHHH
Q 026115 211 ALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 211 ~~~l~~~p~~Rps~~~vl~~ 230 (243)
.+||+.||++|||+.|+++.
T Consensus 296 ~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 296 SKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHhccCcccCCCHHHHhcC
Confidence 99999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=237.02 Aligned_cols=200 Identities=24% Similarity=0.407 Sum_probs=159.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++.+..+...++++||+++++|.+++.... ++...++.++.|++.|+.|||+.+ +
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~~---i 139 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIATVCLSVLRALSYLHNQG---V 139 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567899999999999999999999999999999999886543 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++........ ......|+..|+|||...+..++.++|+||+|++++++++|..|
T Consensus 140 vH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p 217 (292)
T cd06658 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217 (292)
T ss_pred eecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998865432221 12234578899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|....+... ............ ......+..+.+++.+||..||++|||++++++.
T Consensus 218 ~~~~~~~~~------------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 218 YFNEPPLQA------------MRRIRDNLPPRV--KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCCCHHHH------------HHHHHhcCCCcc--ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 864322100 000111111111 1112345578999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=243.85 Aligned_cols=200 Identities=18% Similarity=0.208 Sum_probs=156.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++.++...++||||+++|+|.+++.... ++...+..++.|++.||.|||+.+ +
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~---i 163 (371)
T cd05622 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---F 163 (371)
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567899999999999999999999999999999999997643 778888999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC----CCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~l~~ 157 (243)
+||||||+||+++.++.++|+|||+++........ ......||+.|+|||++.+.. ++.++|+|||||++|+|++
T Consensus 164 vHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~ 242 (371)
T cd05622 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242 (371)
T ss_pred EeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh
Confidence 99999999999999999999999998765432111 123456899999999987532 6889999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc--cCCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADF--RPNMGIVLKA 230 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~vl~~ 230 (243)
|..||...... .....+.... .........+..+.+++.+|++.++.. |+++.++++.
T Consensus 243 G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 243 GDTPFYADSLV---------------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCCCCCCCHH---------------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 99999744211 1112222211 111122245667999999999844433 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=239.05 Aligned_cols=160 Identities=24% Similarity=0.371 Sum_probs=127.2
Q ss_pred CCcccCCccceeeEEEE--eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++. .+...++++||+.+ +|.+++..............++...+..++.|++.|+.|||+.+
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-- 128 (317)
T cd07867 52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-- 128 (317)
T ss_pred HHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 57899999999999985 35678999999865 88888764432221122223788899999999999999999998
Q ss_pred CeEeccCCCCceEe----cCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccC-CCCcccchHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLL----FDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLL 153 (243)
Q Consensus 80 ~~~h~di~~~nil~----~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~ 153 (243)
++|+||||+||++ +.++.++|+|||+++......... ......++..|+|||.+.+. .++.++|+||+||+++
T Consensus 129 -ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 207 (317)
T cd07867 129 -VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207 (317)
T ss_pred -EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHH
Confidence 9999999999999 456789999999997664432211 12234578999999998764 5788999999999999
Q ss_pred HHHhCCCCCCCC
Q 026115 154 ELLTGRKPVDHT 165 (243)
Q Consensus 154 ~l~~g~~pf~~~ 165 (243)
+|++|.+||...
T Consensus 208 el~tg~~~f~~~ 219 (317)
T cd07867 208 ELLTSEPIFHCR 219 (317)
T ss_pred HHHhCCCCcccc
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=233.80 Aligned_cols=200 Identities=23% Similarity=0.311 Sum_probs=157.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+..+++||||+++++|..++..... .++...+..++.|++.++.|||+.+ +
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i 131 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHSMK---I 131 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 5688999999999999999999999999999999988765432 2788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~ 156 (243)
+|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+. ...++.++|+|||||++|+++
T Consensus 132 ~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~ 209 (292)
T cd06644 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 209 (292)
T ss_pred eecCCCcceEEEcCCCCEEEccCccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHh
Confidence 9999999999999999999999998765432211 123345788999999874 334677899999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||....+. ........... ....+...+..+.+++.+||+.||++||++.++++
T Consensus 210 ~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 210 QIEPPHHELNPM---------------RVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCCccccHH---------------HHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 999998643211 11111111110 11223345567999999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=231.66 Aligned_cols=200 Identities=22% Similarity=0.275 Sum_probs=163.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++++||+++++|.+++..... ++...+..++.|+++|+.|||+.+ +
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~~---~ 114 (262)
T cd05572 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL---------FDEYTARFYIACVVLAFEYLHNRG---I 114 (262)
T ss_pred HHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhCC---c
Confidence 5688999999999999999999999999999999999976542 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||++....... ......++..|++||.+.+..++.++|+||+|+++|++++|..|
T Consensus 115 ~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p 191 (262)
T cd05572 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191 (262)
T ss_pred ccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999987665432 12234578899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~ 229 (243)
|...... .................+...+..+.+++.+||+.||++||+ ++++++
T Consensus 192 ~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 192 FGEDDED-------------PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCCCCCC-------------HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 9755320 111222222222223344445778999999999999999999 788776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=246.34 Aligned_cols=198 Identities=22% Similarity=0.349 Sum_probs=164.2
Q ss_pred CCCcccCCccceeeEEEEeCCe--eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPL--RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
||+.|+||||+++++++.+... +.+|+|.+..|+|..|+.+... +++..+..|++||+.||.|||.+.
T Consensus 94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~~- 163 (632)
T KOG0584|consen 94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQD- 163 (632)
T ss_pred HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcCC-
Confidence 5789999999999999986554 8999999999999999998875 889999999999999999999984
Q ss_pred CCeEeccCCCCceEecCC-CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 79 PRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++|+|||||=+|||++.+ |.|||+|+|+|....... ....+|||.|||||+.. ..|.+..||||||+.+.||+|
T Consensus 164 PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 164 PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred CCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh
Confidence 789999999999999876 899999999997654432 34478999999999888 689999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE-YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+..||.. +...-.++..+..+.+.. ...-.-.++.++|.+|+.. ..+|||+.|+|+
T Consensus 239 ~eYPYsE---------------C~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 239 SEYPYSE---------------CTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ccCChhh---------------hCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 9999852 223334444444433321 1112234799999999999 999999999997
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=243.34 Aligned_cols=147 Identities=28% Similarity=0.426 Sum_probs=126.0
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++..+...++|+|++. ++|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~--- 177 (357)
T PHA03209 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLHAQR--- 177 (357)
T ss_pred HHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999995 589888865432 2889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||+++....... .....|+..|+|||++.+..++.++|+|||||++|+|+++..
T Consensus 178 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~ 254 (357)
T PHA03209 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPS 254 (357)
T ss_pred eecCCCCHHHEEECCCCCEEEecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999875332211 123458899999999998889999999999999999998555
Q ss_pred CC
Q 026115 161 PV 162 (243)
Q Consensus 161 pf 162 (243)
++
T Consensus 255 ~~ 256 (357)
T PHA03209 255 TI 256 (357)
T ss_pred cc
Confidence 44
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=231.95 Aligned_cols=201 Identities=24% Similarity=0.328 Sum_probs=160.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+||+++++++.++...++++||+.+++|.+++..... ++...+..++.|++.|++|||+.+ +
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 123 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP---------LPEPVFCKYTKQILDGVAYLHNNC---V 123 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5678999999999999999999999999999999999976432 778889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccc----ccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA----RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
+|+||+|+||+++.++.++++|||.+........ ........++..|+|||.+.+..++.++|+||||++++++++
T Consensus 124 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 203 (265)
T cd06631 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT 203 (265)
T ss_pred ccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999998865432111 111123457889999999988888999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhcc-ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||....... ........ ......+...+..+.+++.+||+.+|++|||+.++++
T Consensus 204 g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 204 GKPPLASMDRLA---------------AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCccccCChHH---------------HHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999996432110 11111111 1111233345667999999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=247.70 Aligned_cols=215 Identities=24% Similarity=0.300 Sum_probs=157.8
Q ss_pred CCcccCCccceeeEEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
++.++||||+++++++..+. ..++|+||+. ++|.+++..... ++...+..++.|++.||.|||+.
T Consensus 53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~ 122 (372)
T cd07853 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQP---------LSSDHVKVFLYQILRGLKYLHSA 122 (372)
T ss_pred HHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhC
Confidence 56789999999999998776 7899999996 588888765432 88999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l 155 (243)
+ ++||||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+. .++.++|+||+||++++|
T Consensus 123 ~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 198 (372)
T cd07853 123 G---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198 (372)
T ss_pred C---eeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHH
Confidence 8 999999999999999999999999998754332111 11223578899999998864 468899999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhh-------hhhh-ccccCC-------CCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKV-------KQCV-DTKLGG-------EYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
++|..||....+......+.........+.. ...+ ...... ......+.++.+++.+||+.||++
T Consensus 199 ~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 278 (372)
T cd07853 199 LGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDK 278 (372)
T ss_pred HcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhh
Confidence 9999999765432211111110011110100 0000 000000 111223567899999999999999
Q ss_pred CCCHHHHHHH
Q 026115 221 RPNMGIVLKA 230 (243)
Q Consensus 221 Rps~~~vl~~ 230 (243)
|||+.++++.
T Consensus 279 R~t~~e~l~h 288 (372)
T cd07853 279 RISAADALAH 288 (372)
T ss_pred CcCHHHHhcC
Confidence 9999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=229.71 Aligned_cols=211 Identities=21% Similarity=0.335 Sum_probs=160.2
Q ss_pred CCcccCCccceeeEEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGP------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++.... ..+++++|+.+|+|..++....... ....++...++.++.|++.|++|||+
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~ 131 (273)
T cd05074 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE---EPFTLPLQTLVRFMIDIASGMEYLSS 131 (273)
T ss_pred HhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 67899999999999886532 2478889999999998875432111 01127888899999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.+ ++|+||||+||+++.++.++++|||.++...............++..|++||.+....++.++|+||||+++|++
T Consensus 132 ~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el 208 (273)
T cd05074 132 KN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI 208 (273)
T ss_pred CC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHH
Confidence 98 999999999999999999999999998765432221111223345689999999888889999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
++ |..||..... ......+........+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 209 ~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 209 MTRGQTPYAGVEN----------------SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred hhCCCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99 8888864321 111111111111122234556899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=234.38 Aligned_cols=216 Identities=18% Similarity=0.194 Sum_probs=156.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++|+||+. ++|.+++...... ..++...++.++.|++.||.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---i 122 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKG------QYMDAELVKSYLYQILQGILFCHSRR---V 122 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCC------CcCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999997 5898888654321 12889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+. .++.++|+||||++++++++|..
T Consensus 123 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 200 (285)
T cd07861 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200 (285)
T ss_pred eecCCCHHHEEEcCCCcEEECcccceeecCCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999998654322111 1223467889999988754 46889999999999999999999
Q ss_pred CCCCCCCCCCccce--------eeccCcCch-hhhhhhhcc---ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 161 PVDHTLPRGQQSLV--------TWATPKLSE-DKVKQCVDT---KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 161 pf~~~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
||............ ...++.... ......... ..........+.++.+++.+||+.||++|||+.+++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll 280 (285)
T cd07861 201 LFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280 (285)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 99754321100000 000000000 000000000 000011112456788999999999999999999998
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
+
T Consensus 281 ~ 281 (285)
T cd07861 281 N 281 (285)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=228.76 Aligned_cols=199 Identities=21% Similarity=0.324 Sum_probs=160.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++.+..+...++|+||+++++|.+++...... .+++..++.++.+++.++.|||+++ +
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~---i 122 (256)
T cd08220 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-------LLDEDTILHFFVQILLALHHVHTKL---I 122 (256)
T ss_pred HhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 67889999999999999999999999999999999999765432 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCC-CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.+ +.++++|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 123 ~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 199 (256)
T cd08220 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199 (256)
T ss_pred ecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCC
Confidence 999999999999865 4679999999876543321 123457889999999988888999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||...... ........ ......+...+..+.+++.+||+.+|++|||+.++++
T Consensus 200 ~~~~~~~~---------------~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 200 AFEAANLP---------------ALVLKIMS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CcccCchH---------------HHHHHHHh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 98643211 11111111 1112233345667999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=230.25 Aligned_cols=204 Identities=24% Similarity=0.347 Sum_probs=160.7
Q ss_pred CcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCCe
Q 026115 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRI 81 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~~ 81 (243)
++++||||+++++++..+...++++||+++++|.+++....... ..++...++.++.|++.++.|||+ .+ +
T Consensus 64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~---i 135 (269)
T cd08528 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK-----QRFTEERIWNIFVQMVLALRYLHKEKR---I 135 (269)
T ss_pred hcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHhccCCc---e
Confidence 35799999999999999999999999999999999885422110 127888999999999999999996 56 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|.||+++.++.++++|||.+....... ......++..|++||.+.+..++.++|+||||+++|++++|..|
T Consensus 136 ~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 136 VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 999999999999999999999999987654332 12334578899999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
|...... .......+...........+..+.+++.+||+.||++|||+.++.+.+.
T Consensus 213 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 213 FYSTNML---------------SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccccCHH---------------HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 8643111 1111111111111111234567999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=230.42 Aligned_cols=204 Identities=24% Similarity=0.377 Sum_probs=163.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++|+||+.+++|.+++.... ++++..+..++.|++.|+.|||+.+ +
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~---i 124 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQ---I 124 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999999999999997643 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCC-ceeecccCCCCCCccccccc--ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||+++.++ .++|+|||.+.......... ......++..|+|||.+.+..++.++|+||+|++++++++|
T Consensus 125 ~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 204 (268)
T cd06630 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204 (268)
T ss_pred ecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhC
Confidence 9999999999998775 68999999987654332111 11234578899999999888889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||........ .....+..........+...+..+.+++.+||+.+|++|||+.++++
T Consensus 205 ~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 205 KPPWNAEKHSNH------------LALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCCCCcch------------HHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 999864321100 01111222222223455567788999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=235.81 Aligned_cols=203 Identities=22% Similarity=0.289 Sum_probs=161.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++.+.++...+++|||+.+++|.+++....... ++...+..++.|++.|++|||+.+ +
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------l~~~~~~~~~~qi~~~l~~lH~~~---i 124 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC-------LSEEVARFYAAEVLLALEYLHLLG---I 124 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCc-------cCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999987654322 888899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc---------------------------cccccccccccccCchhh
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR---------------------------LHSTRVLGTFGYHAPEYA 134 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~aPE~~ 134 (243)
+|+||||+||+++.++.++|+|||++......... .......|+..|+|||++
T Consensus 125 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 204 (316)
T cd05574 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI 204 (316)
T ss_pred eccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH
Confidence 99999999999999999999999987654322110 011123578899999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhc
Q 026115 135 MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCV 214 (243)
Q Consensus 135 ~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 214 (243)
.+..++.++|+||||+++|++++|..||...... ...................+..+.+++.+||
T Consensus 205 ~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 269 (316)
T cd05574 205 SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD---------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLL 269 (316)
T ss_pred cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH---------------HHHHHHhcCCccCCCccccCHHHHHHHHHHc
Confidence 9888899999999999999999999999644221 1122222222221222225678999999999
Q ss_pred CCCCCCCCC----HHHHHH
Q 026115 215 QYEADFRPN----MGIVLK 229 (243)
Q Consensus 215 ~~~p~~Rps----~~~vl~ 229 (243)
+.||++||| +.++++
T Consensus 270 ~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 270 VKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred cCCHhHCCCchhhHHHHHc
Confidence 999999999 777777
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=232.21 Aligned_cols=201 Identities=24% Similarity=0.339 Sum_probs=159.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++||||+.+++|.+++..... .++...++.++.|++.|+.|||+.+ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i 124 (280)
T cd06611 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLHSHK---V 124 (280)
T ss_pred HHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5788999999999999999999999999999999999876432 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~ 156 (243)
+|+||+|+||+++.++.++++|||.+........ ......++..|++||.+. ...++.++|+||||+++|+++
T Consensus 125 ~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~ 202 (280)
T cd06611 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202 (280)
T ss_pred ccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH
Confidence 9999999999999999999999998765433211 122345788999999875 234677899999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc-cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
+|..||...... .......... .....+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 203 ~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 203 QMEPPHHELNPM---------------RVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred hCCCCcccCCHH---------------HHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 999998644221 1111111110 0112233455679999999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=238.09 Aligned_cols=199 Identities=23% Similarity=0.284 Sum_probs=168.4
Q ss_pred CCCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
||++++ ||||+.+.++|++...+++|||++.||.|.+.+.... +++..+..++.|++.+++|||..|
T Consensus 88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~~----------~sE~da~~~~~~il~av~~lH~~g-- 155 (382)
T KOG0032|consen 88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKKH----------YSERDAAGIIRQILEAVKYLHSLG-- 155 (382)
T ss_pred HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHcc----------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 467888 9999999999999999999999999999999998761 889999999999999999999999
Q ss_pred CeEeccCCCCceEecCC----CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLLFDD----DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
++|||+||+|+++... +.++++|||++...... .......||+.|+|||++....|+...|+||+|+++|.|
T Consensus 156 -vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiL 231 (382)
T KOG0032|consen 156 -VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYIL 231 (382)
T ss_pred -ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHH
Confidence 9999999999999643 47999999999877662 223557799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc--cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
++|..||...... .....+.... .....-...+....+++..|+..||.+|+|+.++|+.
T Consensus 232 L~G~~PF~~~~~~---------------~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 232 LSGVPPFWGETEF---------------EIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred hhCCCCCcCCChh---------------HHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 9999999865322 1222222222 2233345567889999999999999999999999984
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=229.39 Aligned_cols=200 Identities=24% Similarity=0.331 Sum_probs=157.2
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.+ +...++++||+.+++|.+++..... ++....+.++.|++.|+.|||+.+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~-- 126 (266)
T cd06651 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---------LTESVTRKYTRQILEGMSYLHSNM-- 126 (266)
T ss_pred HHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 568899999999999875 4678999999999999999976432 778888999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccc-cccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|+||+++.++.++|+|||+++........ .......++..|+|||.+.+..++.++|+||+||+++++++|
T Consensus 127 -i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g 205 (266)
T cd06651 127 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTE 205 (266)
T ss_pred -eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHC
Confidence 999999999999999999999999998754322111 111223478899999999888889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||..... ................+......+.+++ +||..+|++|||++++++
T Consensus 206 ~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 206 KPPWAEYEA---------------MAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCccccch---------------HHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 999964311 1112222222222334445566778887 688889999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=229.94 Aligned_cols=203 Identities=27% Similarity=0.365 Sum_probs=156.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++++||+.+++|.+++....... ..+...+..++.|++.|+.|||+.+ +
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~~---i 129 (268)
T cd06624 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPL------KDNEQTIIFYTKQILEGLKYLHDNQ---I 129 (268)
T ss_pred HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccC------CCcHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 568899999999999999999999999999999999997643210 0267888889999999999999998 9
Q ss_pred EeccCCCCceEecC-CCceeecccCCCCCCcccccccccccccccccccCchhhccCC--CCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||+++. ++.++|+|||.+........ ......++..|+|||.+.... ++.++|+||+|++++++++|
T Consensus 130 ~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g 207 (268)
T cd06624 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207 (268)
T ss_pred eecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC
Confidence 99999999999976 67899999998865432211 112234788999999986543 68899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||........ ..............+...+..+.+++.+||+.+|++|||+.++++
T Consensus 208 ~~p~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 208 KPPFIELGEPQA--------------AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCccccChhh--------------hHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 999864321100 000010111112334456678999999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=222.90 Aligned_cols=200 Identities=18% Similarity=0.224 Sum_probs=161.1
Q ss_pred cCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 6 KNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 6 ~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
.|||||.++++|++ ...+.+|||.++||.|...++...... +++.++..+.+||..|+.|||+.+ |
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~a-------fTErea~eI~~qI~~Av~~lH~~n---I 182 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQA-------FTEREASEIMKQIGLAVRYLHSMN---I 182 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccccc-------chHHHHHHHHHHHHHHHHHHHhcc---h
Confidence 69999999999875 356899999999999999998887654 999999999999999999999998 9
Q ss_pred EeccCCCCceEecC---CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
.|||+||+|+|+.. |..+||+|||+++........ .....|+.|.|||++-..+|+..+|+||+||+.|-|++|
T Consensus 183 AHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L---~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCG 259 (400)
T KOG0604|consen 183 AHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDL---MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_pred hhccCChhheeeecCCCCcceEecccccccccCCCccc---cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcC
Confidence 99999999999964 567899999999876543221 233468899999999988999999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.+||.+...... +.+-...+..... ..+-=..+++...++|+++|..+|.+|.|+.++++
T Consensus 260 yPPFYS~hg~ai-----------spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 260 YPPFYSNHGLAI-----------SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCcccccCCccC-----------ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 999986643221 1111111211111 11222567889999999999999999999999876
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=229.49 Aligned_cols=202 Identities=24% Similarity=0.350 Sum_probs=159.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++..+...++|+||+.+++|.+++.... .++...+..++.|++.|+.|||+.+ +
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i 129 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKG---I 129 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 578899999999999999999999999999999999997653 2888899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC--CCcccchHHHHHHHHHHHhCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~ 159 (243)
+|+||+|+||+++.++.++++|||.++...............++..|+|||.+.... ++.++|+||||++++++++|.
T Consensus 130 ~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 209 (272)
T cd06629 130 LHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209 (272)
T ss_pred eecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCC
Confidence 999999999999999999999999987654322221222345788999999987654 788999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhcccc----CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL----GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
.||...... +...+...... ........+..+.+++.+||+.+|++|||+.++++.
T Consensus 210 ~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 210 RPWSDEEAI---------------AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCCcCcchH---------------HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 998533110 11111111111 111122346789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=233.30 Aligned_cols=200 Identities=25% Similarity=0.338 Sum_probs=154.7
Q ss_pred Ccc-cCCccceeeEEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 3 SRL-KNENVVELVGYYVD------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 3 ~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++ +||||+++++++.. +...+++|||+.+++|.+++....... ++...++.++.|+++|+.|||+
T Consensus 67 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~~~~qi~~al~~LH~ 139 (282)
T cd06636 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA-------LKEDWIAYICREILRGLAHLHA 139 (282)
T ss_pred HHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCC-------CCHHHHHHHHHHHHHHHHHHHH
Confidence 445 69999999999853 467899999999999999997654322 7788889999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGV 150 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ 150 (243)
.+ ++|+|++|+||+++.++.++|+|||++........ ......|+..|+|||.+. ...++.++|+||||+
T Consensus 140 ~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~ 214 (282)
T cd06636 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGI 214 (282)
T ss_pred CC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHH
Confidence 98 99999999999999999999999999875432211 122345788999999875 345678899999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++|++++|..||....+.. ..................+..+.+++.+||+.||.+|||+.++++
T Consensus 215 ~l~el~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 215 TAIEMAEGAPPLCDMHPMR---------------ALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHHHHHhCCCCccccCHHh---------------hhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 9999999999996442211 111111111111122235568999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=234.44 Aligned_cols=202 Identities=28% Similarity=0.443 Sum_probs=158.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...+++||++.+++|.+++.... .++...++.++.|++.||.+||+.+ +
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~~~---i 119 (260)
T PF00069_consen 52 LRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHSKG---I 119 (260)
T ss_dssp HHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---------ccccccccccccccccccccccccc---c
Confidence 457899999999999999999999999999999999998332 2899999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-cCCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+. +..++.++|+||+|+++++|++|..
T Consensus 120 ~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 197 (260)
T PF00069_consen 120 VHRDIKPENILLDENGEVKLIDFGSSVKLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKL 197 (260)
T ss_dssp EESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSS
T ss_pred ccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999986431111 1123445788999999998 7788999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE--YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||....... ................ ........+.+++.+||+.||++|||+.++++
T Consensus 198 p~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 198 PFEESNSDD------------QLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SSTTSSHHH------------HHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccchh------------hhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 987441000 0011111111111000 00111368999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=244.34 Aligned_cols=201 Identities=22% Similarity=0.318 Sum_probs=167.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||..|.||+||++++.|...+.++++.|||.||.+...+-.-.. ++...++..+++|++.||.|||+++
T Consensus 82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LHs~~--- 150 (1187)
T KOG0579|consen 82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLHSQN--- 150 (1187)
T ss_pred hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHhhcc---
Confidence 57899999999999999989999999999999999998877654 3999999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l 155 (243)
++|||+|..|||++.+|.++|.|||++...... ......++||+.|||||++. ..+|+.++||||||+.|.||
T Consensus 151 iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEM 228 (1187)
T KOG0579|consen 151 IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEM 228 (1187)
T ss_pred hhhhhccccceEEEecCcEeeecccccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHH
Confidence 999999999999999999999999998654433 23356788999999999885 45788899999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG-GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..+.+|.....+ ...+..+...... .-.|..-+..+.+++.+||.+||..||+++++++
T Consensus 229 AqiEPPHhelnp---------------MRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 229 AQIEPPHHELNP---------------MRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hccCCCccccch---------------HHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 999999753322 2233333222211 2344556678999999999999999999999987
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=228.74 Aligned_cols=198 Identities=23% Similarity=0.346 Sum_probs=160.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++..+++++||+++++|.+++..... ++...+..++.|++.|+++||+.+ +
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i 123 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS---------FPEPVIRLYTRQILLGLEYLHDRN---T 123 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999976532 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC-CCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++|+|||++....... ......++..|++||.+.... ++.++|+||+|++++++++|..
T Consensus 124 ~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~ 200 (258)
T cd06632 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200 (258)
T ss_pred ccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999887654332 123345788899999987666 8899999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||....+ ................+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 201 pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 201 PWSQLEG---------------VAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcccCcH---------------HHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 9964421 01111111111122333445678999999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=243.21 Aligned_cols=211 Identities=19% Similarity=0.222 Sum_probs=154.1
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
++.++||||+++++++... ...+++|||+.+ +|...+... ++...+..++.|++.||.|||+
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~ 137 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHS 137 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHh
Confidence 5678999999999998643 357999999966 777776532 7788899999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.| ++||||||+||+++.++.++|+|||+++....... .....|+..|+|||++.+..++.++|+|||||++++|
T Consensus 138 ~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el 211 (355)
T cd07874 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211 (355)
T ss_pred CC---cccCCCChHHEEECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence 98 99999999999999999999999999876543221 2234588999999999988899999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCch-------hhhhhhhcc---------------cc---CCCCCHHHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSE-------DKVKQCVDT---------------KL---GGEYPPKAIAKMAAVA 210 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~---------------~~---~~~~~~~~~~~~~~li 210 (243)
++|..||..................... .......+. .. ....+......+.+++
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 291 (355)
T cd07874 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291 (355)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHH
Confidence 9999999754321110000000000000 000000000 00 0011122345789999
Q ss_pred HhhcCCCCCCCCCHHHHHHH
Q 026115 211 ALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 211 ~~~l~~~p~~Rps~~~vl~~ 230 (243)
.+||+.||++|||+.++++.
T Consensus 292 ~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 292 SKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhcCCchhcCCHHHHhcC
Confidence 99999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=235.07 Aligned_cols=199 Identities=25% Similarity=0.353 Sum_probs=159.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++++||+++++|..++.... ++...++.++.|++.|+.|||+++ +
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---i 138 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG---V 138 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999999999999886533 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 139 vH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 216 (297)
T cd06659 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216 (297)
T ss_pred ecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998865433211 12234578899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccc-cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|....+.. ......... .........+..+.+++.+||+.+|++|||++++++.
T Consensus 217 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 217 YFSDSPVQ---------------AMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCCHHH---------------HHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 86432211 000000000 0001112334578999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=235.98 Aligned_cols=188 Identities=22% Similarity=0.301 Sum_probs=153.0
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
+|++|+++.+++.++..+++||||+++|+|.+++..... +++..+..++.|++.|+.|||+.+ ++|||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---ivHrD 126 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---------FKEPQAVFYAAEISVGLFFLHRRG---IIYRD 126 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 568888999999999999999999999999999876542 889999999999999999999998 99999
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 165 (243)
|||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+||++++|++|..||...
T Consensus 127 ikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 127 LKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875322211 122345899999999999888999999999999999999999999754
Q ss_pred CCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
.+ ......+..... ..+...+..+.+++.+||+++|.+|++.
T Consensus 205 ~~---------------~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 205 DE---------------DELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CH---------------HHHHHHHHhCCC--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 21 111222222111 2334456688999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=231.01 Aligned_cols=203 Identities=23% Similarity=0.292 Sum_probs=160.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++..++..++|+||+++++|.+++...... .++...+..++.|++.|+.|||+.+
T Consensus 46 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~--- 115 (277)
T cd05577 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP-------GFPEARAIFYAAQIICGLEHLHQRR--- 115 (277)
T ss_pred HHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367889999999999999999999999999999999998765432 2888999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||+|+||+++.++.++++|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 116 i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~ 192 (277)
T cd05577 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192 (277)
T ss_pred cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCC
Confidence 99999999999999999999999998865433111 122346788999999988888999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
||........ ......... ......+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 193 p~~~~~~~~~------------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 193 PFRQRKEKVE------------KEELKRRTL-EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCCCCccccc------------HHHHHhccc-cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 9965432111 011111100 111123334466899999999999999999 7777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=243.12 Aligned_cols=200 Identities=23% Similarity=0.277 Sum_probs=155.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+.+++||||+++++++.++..+++||||+++|+|.+++..... ++...+..++.|++.||.|||+.+ +
T Consensus 55 l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~~L~~lH~~g---i 122 (360)
T cd05627 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT---------LSEEATQFYIAETVLAIDAIHQLG---F 122 (360)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999976542 888999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc---------------------------------cccccccccccc
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR---------------------------------LHSTRVLGTFGY 128 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~ 128 (243)
+||||||+||+++.++.++|+|||++......... .......||+.|
T Consensus 123 vHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 202 (360)
T cd05627 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDY 202 (360)
T ss_pred EccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccc
Confidence 99999999999999999999999998644321100 001124689999
Q ss_pred cCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC--HHHHHHH
Q 026115 129 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKM 206 (243)
Q Consensus 129 ~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 206 (243)
+|||++.+..++.++|+|||||++|+|++|..||....+. .....+.........+ ...+..+
T Consensus 203 ~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~ 267 (360)
T cd05627 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ---------------ETYRKVMNWKETLVFPPEVPISEKA 267 (360)
T ss_pred cCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHH---------------HHHHHHHcCCCceecCCCCCCCHHH
Confidence 9999999989999999999999999999999999754221 1111111111000111 1235578
Q ss_pred HHHHHhhcCCCCCCCCC---HHHHHH
Q 026115 207 AAVAALCVQYEADFRPN---MGIVLK 229 (243)
Q Consensus 207 ~~li~~~l~~~p~~Rps---~~~vl~ 229 (243)
.+++.+|+ .||.+|++ +.++++
T Consensus 268 ~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 268 KDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred HHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 88888876 49999985 566665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=242.25 Aligned_cols=211 Identities=20% Similarity=0.248 Sum_probs=154.2
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
++.++||||+++++++... ...++||||+.+ +|..++... ++...+..++.|++.||+|||+
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~ 144 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHS 144 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhh
Confidence 5678999999999987543 457999999965 787777532 7788899999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
++ ++||||||+||+++.++.++|+|||+++....... .....++..|+|||++.+..++.++|+|||||++|+|
T Consensus 145 ~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 218 (364)
T cd07875 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218 (364)
T ss_pred CC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHH
Confidence 98 99999999999999999999999999876543211 2234588999999999988899999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchh-------hhhhhhccc---------------c---CCCCCHHHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSED-------KVKQCVDTK---------------L---GGEYPPKAIAKMAAVA 210 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~---------------~---~~~~~~~~~~~~~~li 210 (243)
++|..||.....................+ ......... . ...........+.+++
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298 (364)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence 99999997553221110000000000000 000000000 0 0011112245789999
Q ss_pred HhhcCCCCCCCCCHHHHHHH
Q 026115 211 ALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 211 ~~~l~~~p~~Rps~~~vl~~ 230 (243)
.+||+.||.+|||+.++++.
T Consensus 299 ~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 299 SKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhcCcCcccCCCHHHHhcC
Confidence 99999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=232.17 Aligned_cols=202 Identities=24% Similarity=0.362 Sum_probs=159.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-CCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~~~~ 80 (243)
+++++||||+++++++..+...++|+||+++++|..++...... ..+++..+..++.|++.|+.|||+. +
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~~--- 123 (286)
T cd06622 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVAT------EGIPEDVLRRITYAVVKGLKFLKEEHN--- 123 (286)
T ss_pred HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcccc------CCCCHHHHHHHHHHHHHHHHHHHhcCC---
Confidence 56789999999999999999999999999999999998764210 1288999999999999999999974 6
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC------CCcccchHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ------MSSKSDVYSFGVVLLE 154 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~~l~~ 154 (243)
++|+||+|+||+++.++.++++|||.+....... .....++..|+|||.+.+.. ++.++|+||+||++++
T Consensus 124 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~ 199 (286)
T cd06622 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199 (286)
T ss_pred EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHH
Confidence 9999999999999999999999999987653321 12234778899999885433 4778999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+++|..||....... .......+.. ......+...+..+.+++.+||+.+|++||++.++++
T Consensus 200 l~~g~~pf~~~~~~~------------~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 200 MALGRYPYPPETYAN------------IFAQLSAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHhCCCCCCCcchhh------------HHHHHHHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 999999996431100 0011111111 2222344557788999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=231.27 Aligned_cols=198 Identities=23% Similarity=0.373 Sum_probs=159.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++++||+.+++|.+++.... ++...+..++.|++.|+++||+.+ +
T Consensus 70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~~---i 136 (285)
T cd06648 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIATVCLAVLKALSFLHAQG---V 136 (285)
T ss_pred HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999999999999987632 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||.+........ ......|+..|+|||...+..++.++|+||+|++++++++|..|
T Consensus 137 ~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p 214 (285)
T cd06648 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214 (285)
T ss_pred ecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765433211 12234578899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccc-cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|....+. .......... .....+...+..+.+++.+||+.+|++|||+.++++
T Consensus 215 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 215 YFNEPPL---------------QAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CcCCCHH---------------HHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 8643211 0011111000 001112224567999999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=254.81 Aligned_cols=219 Identities=19% Similarity=0.204 Sum_probs=164.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCC--CCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK--PGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.+++..+++|||++|++|.+++.......... .....+...++.++.|++.|++|||+.+
T Consensus 56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-- 133 (932)
T PRK13184 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-- 133 (932)
T ss_pred HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 568899999999999999999999999999999999987532111000 0112567788999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccc----------------cccccccccccccCchhhccCCCCccc
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR----------------LHSTRVLGTFGYHAPEYAMTGQMSSKS 143 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~----------------~~~~~~~~~~~~~aPE~~~~~~~~~~~ 143 (243)
++||||||+||+++.++.++++|||+++........ .......||+.|+|||.+.+..++.++
T Consensus 134 -IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kS 212 (932)
T PRK13184 134 -VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST 212 (932)
T ss_pred -ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHh
Confidence 999999999999999999999999998765211100 001224689999999999988899999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-
Q 026115 144 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP- 222 (243)
Q Consensus 144 DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp- 222 (243)
|+||+||++++|++|..||.......... ................+..+.+++.+||+.||++||
T Consensus 213 DIWSLGVILyELLTG~~PF~~~~~~ki~~--------------~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 213 DIYALGVILYQMLTLSFPYRRKKGRKISY--------------RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred HHHHHHHHHHHHHHCCCCCCCcchhhhhh--------------hhhccChhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence 99999999999999999996532111000 000000000011123456789999999999999996
Q ss_pred CHHHHHHHHHHHHhh
Q 026115 223 NMGIVLKALQPLLNT 237 (243)
Q Consensus 223 s~~~vl~~l~~~~~~ 237 (243)
+++++++.|++.+..
T Consensus 279 s~eeLl~~Le~~lq~ 293 (932)
T PRK13184 279 SVQELKQDLEPHLQG 293 (932)
T ss_pred HHHHHHHHHHHHHhc
Confidence 667777788877664
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=229.03 Aligned_cols=198 Identities=28% Similarity=0.396 Sum_probs=161.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++|+||+++++|..++.... ++...+..++.|++.|+.+||+.+ +
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~----------~~~~~~~~~~~~l~~~l~~lh~~~---i 122 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---K 122 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHccCC---e
Confidence 567899999999999999999999999999999999987543 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 123 ~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 200 (277)
T cd06641 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred ecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999998865543211 12234578889999999888888999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|....+. .....+........+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 201 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 201 HSELHPM----------------KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCccchH----------------HHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 8643211 1111111111122333456679999999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=230.12 Aligned_cols=197 Identities=21% Similarity=0.275 Sum_probs=158.3
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
..+||||+.+++++..++..++||||+.+++|..++..... +++..+..++.|++.|+.|||+.+ ++|
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---ivH 120 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV---------FSEKEMRFYATEIILGLEHMHNRF---VVY 120 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cCC
Confidence 35799999999999999999999999999999998876542 889999999999999999999998 999
Q ss_pred ccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-cCCCCcccchHHHHHHHHHHHhCCCCC
Q 026115 84 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 84 ~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf 162 (243)
+||||+||+++.++.++++|||++....... .....|+..|+|||... +..++.++|+||+||+++++++|..||
T Consensus 121 ~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 196 (279)
T cd05633 121 RDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196 (279)
T ss_pred CCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 9999999999999999999999986543322 12235889999999886 455788999999999999999999999
Q ss_pred CCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 026115 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 230 (243)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~~ 230 (243)
........ ..... .........+...+..+.+++.+||+.||.+|| |++++++.
T Consensus 197 ~~~~~~~~-------------~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 197 RQHKTKDK-------------HEIDR-MTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCCCCcCH-------------HHHHH-HhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 74422110 11111 111112234445667899999999999999999 69999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=232.68 Aligned_cols=218 Identities=21% Similarity=0.286 Sum_probs=159.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...+++|||+.+++|.+++....... ++...+..++.|++.|+.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~-------~~~~~~~~~~~~l~~~L~~LH~~~---i 122 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-------LPELAIAFILKDVLNALDYIHSKG---F 122 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccC-------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999998653222 778889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc-----cccccccccccccCchhhcc--CCCCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~ 154 (243)
+|+||+|+||+++.++.++++||+.+......... .......++..|+|||.+.. ..++.++|+||+|+++++
T Consensus 123 vH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~e 202 (314)
T cd08216 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACE 202 (314)
T ss_pred ecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHH
Confidence 99999999999999999999999987644322111 01122346778999999875 357889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcc------ceeeccCc---Cchhhhh--------hhhccccCCCCCHHHHHHHHHHHHhhcCCC
Q 026115 155 LLTGRKPVDHTLPRGQQS------LVTWATPK---LSEDKVK--------QCVDTKLGGEYPPKAIAKMAAVAALCVQYE 217 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~------~~~~~~~~---~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (243)
+++|..||.......... ........ ....... ...............+..+.+++.+||+.|
T Consensus 203 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 282 (314)
T cd08216 203 LANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRD 282 (314)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcC
Confidence 999999997543211000 00000000 0000000 000001111233445678999999999999
Q ss_pred CCCCCCHHHHHH
Q 026115 218 ADFRPNMGIVLK 229 (243)
Q Consensus 218 p~~Rps~~~vl~ 229 (243)
|++|||+.++++
T Consensus 283 P~~Rpt~~~ll~ 294 (314)
T cd08216 283 PESRPSASQLLN 294 (314)
T ss_pred CCcCcCHHHHhc
Confidence 999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=228.49 Aligned_cols=203 Identities=26% Similarity=0.381 Sum_probs=174.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||+|+..|++|++||.|.....+++|||||-.|++.+.++.... ++++..+..++..-+.||+|||...
T Consensus 81 IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH~~~--- 149 (502)
T KOG0574|consen 81 IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLHDLK--- 149 (502)
T ss_pred HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHHHHH---
Confidence 57899999999999999999999999999999999999876653 3999999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
-+|||||..|||++.+|..||.|||++....+.... +....||+.|+|||++..-.|...+||||||+...||..|.+
T Consensus 150 KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 150 KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred HHHhhcccccEEEcccchhhhhhccccchhhhhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCC
Confidence 999999999999999999999999999776654433 456789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|+....+.....++.-.. .-.-..|..-+.++.+++++||.++|++|.||.++++.
T Consensus 228 PYsDIHPMRAIFMIPT~P--------------PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 228 PYSDIHPMRAIFMIPTKP--------------PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CcccccccceeEeccCCC--------------CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 998776655544432111 11113456667789999999999999999999999874
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=226.43 Aligned_cols=200 Identities=24% Similarity=0.318 Sum_probs=159.2
Q ss_pred CCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.++ ..+++++||+++++|.+++..... ++...+..++.|++.|+.|||+.+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~-- 126 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---------LTENVTRKYTRQILEGVSYLHSNM-- 126 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5688999999999998763 568899999999999999875432 778888999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccc-cccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|+||+++.++.++|+|||+++........ .......++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus 127 -i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g 205 (265)
T cd06652 127 -IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTE 205 (265)
T ss_pred -EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhC
Confidence 999999999999999999999999988755322111 111234578899999999888889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||..... .....+..........+...+..+.+++.+||. +|++|||++++++
T Consensus 206 ~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 206 KPPWAEFEA---------------MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCccch---------------HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 999864311 111222222222334556677789999999995 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=231.12 Aligned_cols=194 Identities=22% Similarity=0.314 Sum_probs=160.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...+++|||+.+++|.+++..... ++...+..++.|++.|+.|||+.+ +
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qil~~l~~lH~~~---i 122 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR---------FPEPVARFYAAQVVLALEYLHSLD---I 122 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5788999999999999999999999999999999999876542 888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|.||+++.++.++|+|||++...... .....+++.|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 123 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 197 (290)
T cd05580 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197 (290)
T ss_pred ecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765443 2233578899999999888888999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
|..... ........... ...+...+..+.+++.+||+.||.+|+ +++++++
T Consensus 198 ~~~~~~---------------~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 198 FFDDNP---------------IQIYEKILEGK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCCCCH---------------HHHHHHHhcCC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 864421 01111111111 123334467899999999999999999 7777774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=229.98 Aligned_cols=209 Identities=24% Similarity=0.326 Sum_probs=161.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~ 80 (243)
+++++||||+++++++.....+++|+||+++++|.+++.... .++...+..++.+++.|+.|||+ .+
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~~--- 124 (284)
T cd06620 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVHR--- 124 (284)
T ss_pred HHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhcC---
Confidence 567899999999999999999999999999999999887643 27889999999999999999997 46
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||+|+||+++.++.++++|||++....... .....|+..|+|||++.+..++.++|+||+||+++++++|..
T Consensus 125 i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~ 200 (284)
T cd06620 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKF 200 (284)
T ss_pred eeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876543221 123458889999999988888999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
||............ .....+..................+..+.+++.+||+.||++|||+.++++.
T Consensus 201 p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 201 PFAFSNIDDDGQDD----PMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CCcccchhhhhhhh----hhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 99754332110000 0000011111111111111112356689999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=228.07 Aligned_cols=202 Identities=29% Similarity=0.407 Sum_probs=161.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~ 80 (243)
+++++||||+++++++..+..+++++||+.+++|.+++..... .++...+..++.|++.|+.|||+ .+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~~--- 121 (265)
T cd06605 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQG--------RIPERILGKIAVAVLKGLTYLHEKHK--- 121 (265)
T ss_pred HHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHcCCCC---
Confidence 5678999999999999999999999999999999999986532 28889999999999999999999 87
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||+|+||+++.++.++++|||.+........ ....++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 122 i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 197 (265)
T cd06605 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRF 197 (265)
T ss_pred eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765533221 12457889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||........ ............. ....+.. .+..+.+++.+||..||++|||+.+++.
T Consensus 198 p~~~~~~~~~----------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 198 PYPPENDPPD----------GIFELLQYIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCccccccc----------cHHHHHHHHhcCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 9864421100 0011111111211 1122222 6678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=232.64 Aligned_cols=205 Identities=21% Similarity=0.260 Sum_probs=158.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...+++|||+++++|.+++.... .+++..+..++.|++.|+.|||+.+ +
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i 122 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYG---I 122 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999999999999999999999999999997653 2788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc-------------cccccccccccccCchhhccCCCCcccchHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSF 148 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl 148 (243)
+|+||+|.||+++.++.++++|||.++........ .......++..|+|||.+.+..++.++|+|||
T Consensus 123 ~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (305)
T cd05609 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202 (305)
T ss_pred cccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHH
Confidence 99999999999999999999999987632111000 00112346778999999988888999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG-GEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
|++++++++|..||.+.... +........... .......+..+.+++.+||+.||++||+...+
T Consensus 203 G~vl~el~~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 267 (305)
T cd05609 203 GIILYEFLVGCVPFFGDTPE---------------ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGA 267 (305)
T ss_pred HHHHHHHHhCCCCCCCCCHH---------------HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCH
Confidence 99999999999998643211 111111111110 11112356679999999999999999997666
Q ss_pred HHHHHH
Q 026115 228 LKALQP 233 (243)
Q Consensus 228 l~~l~~ 233 (243)
.+.|+.
T Consensus 268 ~~ll~~ 273 (305)
T cd05609 268 FEVKQH 273 (305)
T ss_pred HHHHhC
Confidence 655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=227.06 Aligned_cols=203 Identities=20% Similarity=0.256 Sum_probs=162.7
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh-----
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH----- 74 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh----- 74 (243)
+++++||||+++++++.. +...++++||+.+++|.+++...... ...+++..++.++.|++.|+.+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~ 127 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDP 127 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccc
Confidence 578899999999998763 45689999999999999998754210 112888999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 154 (243)
+.+ ++|+||+|+||+++.++.++++|||++......... .....++..|+|||.+.+..++.++|+||||+++++
T Consensus 128 ~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~ 202 (265)
T cd08217 128 GNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE 202 (265)
T ss_pred cCc---ceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHH
Confidence 776 999999999999999999999999998876543321 123457889999999988888999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
+++|..||..... ....+.+........+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus 203 l~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 203 LCALSPPFTARNQ----------------LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHCCCcccCcCH----------------HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999974421 12222222222234445566789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=243.95 Aligned_cols=206 Identities=23% Similarity=0.258 Sum_probs=157.0
Q ss_pred CccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 026115 8 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 87 (243)
Q Consensus 8 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~ 87 (243)
-|+|+++++|...+++|||+|.++. +|+++++.+.-.. ++...+..++.||+.||.+||+.+ ++|||||
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~f~G-------lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLK 316 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLST-NLYELLKNNKFRG-------LSLPLVRKFAQQILTALLFLHELG---IIHCDLK 316 (586)
T ss_pred eeEEEeeeccccccceeeeehhhhh-hHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCC
Confidence 4799999999999999999999955 9999999876433 889999999999999999999999 9999999
Q ss_pred CCceEecCC--CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026115 88 SSNVLLFDD--DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165 (243)
Q Consensus 88 ~~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 165 (243)
|+|||+... ..+||+|||.+....... ...+.+..|+|||++.+..|+.+.|||||||++.||++|.+.|.+.
T Consensus 317 PENILL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 317 PENILLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred hhheeeccCCcCceeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 999999654 378999999987654432 1344677899999999999999999999999999999999999876
Q ss_pred CCCCCccceeeccCcCc-------------------------h------------hhhhh--hhccccC-------CCCC
Q 026115 166 LPRGQQSLVTWATPKLS-------------------------E------------DKVKQ--CVDTKLG-------GEYP 199 (243)
Q Consensus 166 ~~~~~~~~~~~~~~~~~-------------------------~------------~~~~~--~~~~~~~-------~~~~ 199 (243)
.+.++-..+......++ . .+... ..+.+.. ....
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 55433221110000000 0 00000 0010010 0111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 200 PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 200 ~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
...-..+.+++.+||..||.+|+|+.+.++
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 233457899999999999999999999987
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=226.46 Aligned_cols=202 Identities=26% Similarity=0.350 Sum_probs=163.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~ 80 (243)
+++++||||+++++++..+...++++||+++++|.+++.... .++...++.++.|++.|+.|||+ .+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~--- 120 (264)
T cd06623 53 LRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRH--- 120 (264)
T ss_pred HHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCC---
Confidence 467889999999999999999999999999999999997653 28899999999999999999999 88
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+....++.++|+||||++++++++|..
T Consensus 121 ~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~ 198 (264)
T cd06623 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKF 198 (264)
T ss_pred CccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999988765433222 123457889999999988888999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
||...... ........+........+.. .+..+.+++.+||+.+|++|||+.++++.
T Consensus 199 p~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 199 PFLPPGQP-------------SFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccccc-------------CHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 99755320 00111111111121223333 56789999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=255.56 Aligned_cols=205 Identities=21% Similarity=0.306 Sum_probs=154.5
Q ss_pred CCCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 1 MVSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
++++++||||++++++|.+ ...+++||||+.+++|.+++....... ..+++..++.++.||+.||.|||..+.
T Consensus 65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~-----g~L~E~~Il~Ia~QIL~ALaYLHs~g~ 139 (1021)
T PTZ00266 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF-----GKIEEHAIVDITRQLLHALAYCHNLKD 139 (1021)
T ss_pred HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhccc
Confidence 3678999999999999864 457999999999999999987532110 128899999999999999999998431
Q ss_pred ----CCeEeccCCCCceEecC-----------------CCceeecccCCCCCCcccccccccccccccccccCchhhcc-
Q 026115 79 ----PRIIHRNIKSSNVLLFD-----------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT- 136 (243)
Q Consensus 79 ----~~~~h~di~~~nil~~~-----------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 136 (243)
.+++|+||||+|||++. .+.++|+|||++........ .....|++.|+|||++.+
T Consensus 140 ~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge 216 (1021)
T PTZ00266 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHE 216 (1021)
T ss_pred ccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhcc
Confidence 23999999999999964 23489999999876543221 233468999999999864
Q ss_pred -CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcC
Q 026115 137 -GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQ 215 (243)
Q Consensus 137 -~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 215 (243)
..++.++|||||||++|+|++|..||..... ...+...+....... ....+..+.+||..||+
T Consensus 217 ~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~---------------~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~ 280 (1021)
T PTZ00266 217 TKSYDDKSDMWALGCIIYELCSGKTPFHKANN---------------FSQLISELKRGPDLP-IKGKSKELNILIKNLLN 280 (1021)
T ss_pred CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc---------------HHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhc
Confidence 3478899999999999999999999964311 111111111111111 12235679999999999
Q ss_pred CCCCCCCCHHHHHH
Q 026115 216 YEADFRPNMGIVLK 229 (243)
Q Consensus 216 ~~p~~Rps~~~vl~ 229 (243)
.+|.+|||+.+++.
T Consensus 281 ~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 281 LSAKERPSALQCLG 294 (1021)
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999995
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=230.29 Aligned_cols=200 Identities=25% Similarity=0.374 Sum_probs=160.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++|+||+++++|.+++.... ++...+..++.|++.|+.|||+.+ +
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~g---i 136 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---V 136 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 567899999999999999999999999999999999997643 778889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+|++|+||+++.++.++|+|||++........ ......+++.|++||.+....++.++|+||||++++++++|..|
T Consensus 137 ~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~p 214 (293)
T cd06647 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (293)
T ss_pred eeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765543221 12334578889999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|............. .........+...+..+.+++.+||+.+|++||++.+++..
T Consensus 215 f~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 215 YLNENPLRALYLIA--------------TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCChhhheeehh--------------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 97543221110000 00000111223345679999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=245.57 Aligned_cols=200 Identities=28% Similarity=0.396 Sum_probs=165.0
Q ss_pred CcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCcc--CHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL--SWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++|+|.|||+++|++-+++++-|.||-++||+|.+++...=+. + ++.++--+..||++||+|||++.
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGP--------lKDNEstm~fYtkQILeGLkYLHen~--- 695 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGP--------LKDNESTMNFYTKQILEGLKYLHENK--- 695 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCC--------CccchhHHHHHHHHHHHHhhhhhhcc---
Confidence 5789999999999999999999999999999999999865431 4 67788889999999999999998
Q ss_pred eEeccCCCCceEecC-CCceeecccCCCCCCcccccccccccccccccccCchhhccC--CCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~ 157 (243)
|+|||||-+|++++. .|.+||+|||-++....-. .....+.||..|||||++..+ .|..++|||||||...||.|
T Consensus 696 IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT 773 (1226)
T KOG4279|consen 696 IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT 773 (1226)
T ss_pred eeeccccCCcEEEeeccceEEecccccchhhccCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc
Confidence 999999999999976 5899999999876554332 224456799999999999854 57889999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|++||...... .....+.--.+.-.+.|.+.+.+...+|.+|+..+|.+||+|.++|+
T Consensus 774 GrPPF~Elgsp--------------qAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 774 GRPPFVELGSP--------------QAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCCeeecCCh--------------hHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 99999643110 01111111122335788999999999999999999999999999987
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=228.71 Aligned_cols=214 Identities=21% Similarity=0.280 Sum_probs=157.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++++||+++++|..++..... +++..+..++.|++.|+.|||+.+ +
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~ql~~~l~~LH~~~---i 121 (286)
T cd07847 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---------VPEHLIKKIIWQTLQAVNFCHKHN---C 121 (286)
T ss_pred HHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5688999999999999999999999999999888887654432 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+ ..++.++|+||+|++++++++|..
T Consensus 122 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~ 199 (286)
T cd07847 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199 (286)
T ss_pred eecCCChhhEEEcCCCcEEECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765443211 122346788999999876 456889999999999999999999
Q ss_pred CCCCCCCCCCccceeec-cCc-------Cchhhh-hhhhccccCCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 161 PVDHTLPRGQQSLVTWA-TPK-------LSEDKV-KQCVDTKLGGE-----YPPKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~-~~~-------~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
||.+..+.......... ... ...... .....+..... .....+..+.+++.+||+.+|++|||+.+
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 279 (286)
T cd07847 200 LWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279 (286)
T ss_pred CCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence 99755332110000000 000 000000 00000000000 01123567999999999999999999999
Q ss_pred HHH
Q 026115 227 VLK 229 (243)
Q Consensus 227 vl~ 229 (243)
++.
T Consensus 280 il~ 282 (286)
T cd07847 280 LLE 282 (286)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=232.42 Aligned_cols=214 Identities=19% Similarity=0.219 Sum_probs=154.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++++||+.+ +|.+++..... .+++..++.++.|++.|+.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~---i 120 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCHSHN---V 120 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5678999999999999999999999999965 88888765432 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++|+|||+++........ .....++..|+|||.+.+. .++.++|+|||||++++|++|..
T Consensus 121 ~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~ 198 (284)
T cd07839 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198 (284)
T ss_pred ecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999998755432211 1223467899999998764 46889999999999999999988
Q ss_pred CCCCCCCCCCc-cceeeccCcCchh---hhhhhhccccC---------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 161 PVDHTLPRGQQ-SLVTWATPKLSED---KVKQCVDTKLG---------GEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 161 pf~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
|+....+.... ............. ......+.... .......+..+.+++.+||+.||.+|||++++
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i 278 (284)
T cd07839 199 PLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278 (284)
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence 86432211000 0000000000000 00000000000 01112345678999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 279 l~ 280 (284)
T cd07839 279 LQ 280 (284)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=240.81 Aligned_cols=209 Identities=24% Similarity=0.307 Sum_probs=152.5
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++... ...+++++++ +++|.+++.... ++...+..++.|++.||.|||+
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~ 136 (343)
T cd07878 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQK----------LSDEHVQFLIYQLLRGLKYIHS 136 (343)
T ss_pred HHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 6789999999999988643 4578999988 779998886543 8899999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
.+ ++||||||+||+++.++.++|+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++++
T Consensus 137 ~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 208 (343)
T cd07878 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208 (343)
T ss_pred CC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHH
Confidence 98 999999999999999999999999998765432 223458899999999876 467889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCch--------hhhhhhhcc--ccCC----CCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSE--------DKVKQCVDT--KLGG----EYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--~~~~----~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|++|..||..................... ......... .... .........+.+++.+||+.||++
T Consensus 209 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~ 288 (343)
T cd07878 209 LLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDK 288 (343)
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhh
Confidence 99999999754221100000000000000 000000000 0000 000112345789999999999999
Q ss_pred CCCHHHHHH
Q 026115 221 RPNMGIVLK 229 (243)
Q Consensus 221 Rps~~~vl~ 229 (243)
|||+.++++
T Consensus 289 R~s~~ell~ 297 (343)
T cd07878 289 RISASEALA 297 (343)
T ss_pred CCCHHHHhc
Confidence 999999997
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=226.84 Aligned_cols=196 Identities=21% Similarity=0.260 Sum_probs=156.7
Q ss_pred CcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 026115 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 82 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~ 82 (243)
.+.+|||++++++++..+...++++||+.+++|.+++..... ++...+..++.|++.|+.|||+.+ ++
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~---i~ 119 (260)
T cd05611 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG---------LPEDWAKQYIAEVVLGVEDLHQRG---II 119 (260)
T ss_pred hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 456899999999999999999999999999999999976542 788999999999999999999998 99
Q ss_pred eccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCC
Q 026115 83 HRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 83 h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 162 (243)
|+||+|+||+++.++.++++|||+++.... .....++..|++||.+.+..++.++|+||+|++++++++|..||
T Consensus 120 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 193 (260)
T cd05611 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF 193 (260)
T ss_pred cCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999998765432 12345778899999998877899999999999999999999999
Q ss_pred CCCCCCCCccceeeccCcCchhhhhhhhccc--cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
...... .......... .........+..+.+++.+||+.||++|||+..+.+.+
T Consensus 194 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 194 HAETPD---------------AVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCCCHH---------------HHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 643211 1111111111 11112224567899999999999999999776554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=229.80 Aligned_cols=204 Identities=25% Similarity=0.341 Sum_probs=154.3
Q ss_pred CCcc-cCCccceeeEEEE-----eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRL-KNENVVELVGYYV-----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
++++ +||||+++++++. ++...+++|||+++++|.+++...... ...++...+..++.|++.|+.|||+
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~ 142 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHV 142 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHh
Confidence 4556 6999999999884 456799999999999999987642211 0127888899999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-----CCCCcccchHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGV 150 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ 150 (243)
.+ ++|+|++|+||+++.++.++++|||.++....... ......|+..|+|||.+.. ..++.++|+||+||
T Consensus 143 ~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv 217 (286)
T cd06638 143 NK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217 (286)
T ss_pred CC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHH
Confidence 98 99999999999999999999999999875533211 1233458899999998753 34688999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcc-ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+++++++|..||....+.... ...... ......+...+..+.+++.+||+.||++|||+.++++
T Consensus 218 i~~el~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 218 TAIELGDGDPPLADLHPMRAL---------------FKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred HHHHHhcCCCCCCCCchhHHH---------------hhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 999999999998754221110 000000 0001112223457999999999999999999999987
Q ss_pred H
Q 026115 230 A 230 (243)
Q Consensus 230 ~ 230 (243)
.
T Consensus 283 ~ 283 (286)
T cd06638 283 H 283 (286)
T ss_pred c
Confidence 5
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=227.21 Aligned_cols=203 Identities=26% Similarity=0.386 Sum_probs=155.5
Q ss_pred CCcc-cCCccceeeEEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 2 VSRL-KNENVVELVGYYVDGP------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
++++ +||||+++++++.... ..+++|||+++++|.+++....... ..++...+..++.|++.|+.|||
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH 130 (275)
T cd06608 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-----KRLKEEWIAYILRETLRGLAYLH 130 (275)
T ss_pred HHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHh
Confidence 4556 6999999999997644 5899999999999999887543100 12888999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-----CCCCcccchHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFG 149 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG 149 (243)
+.+ ++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.. ..++.++|+||||
T Consensus 131 ~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 205 (275)
T cd06608 131 ENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205 (275)
T ss_pred cCC---cccCCCCHHHEEEccCCeEEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhH
Confidence 998 999999999999999999999999988654432211 233457889999998753 2457789999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
++++++++|..||....+. ....+...... ....+...+..+.+++.+||+.||++|||+.+++
T Consensus 206 ~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 206 ITAIELADGKPPLCDMHPM---------------RALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred HHHHHHHhCCCCccccchH---------------HHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 9999999999999643211 11111111111 1122233566899999999999999999999998
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
+
T Consensus 271 ~ 271 (275)
T cd06608 271 E 271 (275)
T ss_pred c
Confidence 6
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=226.09 Aligned_cols=201 Identities=24% Similarity=0.403 Sum_probs=160.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++.+.++...++++||+.+++|.+++...... .+++..+..++.|++.|+.|||+.+ +
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~---i 122 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGV-------LFSEDQILSWFVQISLGLKHIHDRK---I 122 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 56789999999999999999999999999999999999765432 2788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCC-ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+|++|+||+++.++ .++++|||.+......... .....|++.|+|||...+..++.++|+||+|++++++++|..
T Consensus 123 ~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08225 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKH 200 (257)
T ss_pred ccccCCHHHEEEcCCCCeEEecccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999998885 4699999988765433221 223457889999999988888999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
||..... .....+...... .......+..+.+++.+||+.+|++|||+.++++.
T Consensus 201 p~~~~~~---------------~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 201 PFEGNNL---------------HQLVLKICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCccH---------------HHHHHHHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 9864311 111112222111 12223445679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=225.56 Aligned_cols=206 Identities=31% Similarity=0.364 Sum_probs=161.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCC-CCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG-VKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++|+||+++++.+..+...++++|++.+++|.+++..... . .+++..+..++.|++.|+.+||+.+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~ql~~al~~lh~~~--- 122 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG-------GLDEAIIATVLKEVLKGLEYLHSNG--- 122 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5678999999999999999999999999999999999976432 1 2788999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccc--ccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~ 157 (243)
++|+|++|+||+++.++.++++|||++.......... ......|+..|+|||.+... .++.++|+||||+++++|++
T Consensus 123 i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~ 202 (267)
T cd06610 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202 (267)
T ss_pred eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh
Confidence 9999999999999999999999999886555433221 12334578899999998866 67899999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE-YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||....+..... ............. .....+..+.+++.+||+.||++|||+.++++
T Consensus 203 g~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 203 GAAPYSKYPPMKVLM------------LTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCCccccChhhhHH------------HHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 999997542211000 0000000011101 11245677999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=224.18 Aligned_cols=193 Identities=23% Similarity=0.281 Sum_probs=157.3
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
+||||+++++++..+...++||||+++++|.+++..... +++..+..++.|+++|+.+||+.+ ++|+|
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 134 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---------LSEAEVKKIIRQLVEALNDLHKHN---IIHND 134 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCC
Confidence 699999999999999999999999999999999976542 889999999999999999999998 99999
Q ss_pred CCCCceEecCCC-ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026115 86 IKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164 (243)
Q Consensus 86 i~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 164 (243)
|+|+||+++.++ .++++|||++...... ....++..|+|||++.+..++.++|+||+|++++++++|..||..
T Consensus 135 l~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 208 (267)
T PHA03390 135 IKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208 (267)
T ss_pred CCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999988 9999999988655322 223478899999999988889999999999999999999999974
Q ss_pred CCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 026115 165 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-MGIVLK 229 (243)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~vl~ 229 (243)
...... ........... ....+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus 209 ~~~~~~-----------~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 209 DEDEEL-----------DLESLLKRQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCcchh-----------hHHHHHHhhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 422110 00111111111 11233356678999999999999999996 588875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=261.64 Aligned_cols=218 Identities=28% Similarity=0.494 Sum_probs=165.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||++++|++.++...++||||+++|+|.++++. +++..+.+++.|++.|++|||.....++
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~i 804 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAV 804 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 5788999999999999999999999999999999999952 7788999999999999999995433349
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|||+||+||+++.++..++. ++....... .....++..|+|||++.+..++.++|||||||++||+++|..|
T Consensus 805 iH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred ecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 999999999999988877764 444322211 1223578899999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
|...... ......+............+.++.... ..+.....++.+++.+||+.||++|||++++++.|+++....+
T Consensus 878 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 878 ADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred CCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 8533221 111111211111111222333333322 2345566788999999999999999999999999999877543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=226.88 Aligned_cols=200 Identities=26% Similarity=0.385 Sum_probs=160.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+||+++++++..+...++++||+.+++|.+++..... .++...+..++.|++.|+.+||+.| +
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~i~~~i~~~L~~lH~~g---i 137 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV--------RMNEPQIAYVCREVLQGLEYLHSQN---V 137 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5688999999999999999999999999999999999987641 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+|++|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||++++++++|..|
T Consensus 138 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p 215 (286)
T cd06614 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215 (286)
T ss_pred eeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998764433221 12234477889999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG-GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|....+. ............ ...+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 216 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 216 YLREPPL---------------RALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCCHH---------------HHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 8643211 111111111111 1112235668999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=263.87 Aligned_cols=203 Identities=24% Similarity=0.304 Sum_probs=168.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+..++|||+|+++|+=.+.+..+|.||||++|+|.+.+..... .++.....+..|+++|+.|||+.| |
T Consensus 1288 lE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~g---I 1355 (1509)
T KOG4645|consen 1288 LEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEHG---I 1355 (1509)
T ss_pred HHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhcC---c
Confidence 5678999999999999999999999999999999999987763 566677778999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc--cccccccccccccCchhhccCC---CCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~l~ 156 (243)
|||||||.||+++.+|.+|++|||.|......... .......||+.|||||++.+.. --.++|||||||++.||+
T Consensus 1356 VHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~ 1435 (1509)
T KOG4645|consen 1356 VHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMA 1435 (1509)
T ss_pred eecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEee
Confidence 99999999999999999999999999887665322 1123467999999999998654 356899999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
||+.||...+.. =.+.-.+..+-....|...+.+-.+++..||..||..|.++.|+++.-
T Consensus 1436 tGkrPW~~~dne---------------~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1436 TGKRPWAELDNE---------------WAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred cCCCchhhccch---------------hHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 999999754332 112222334444567777888999999999999999999999888753
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=226.43 Aligned_cols=193 Identities=23% Similarity=0.362 Sum_probs=154.5
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
.|||++++++++.++...+++|||+.+++|.+++.... +++..++.++.|++.|+.|||+.+ ++|+|
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~---i~H~d 126 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----------IAEKYISVIIREVLVALKYIHKVG---VIHRD 126 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHccC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 49999999999999999999999999999999986542 889999999999999999999998 99999
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDH 164 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~ 164 (243)
|+|+||+++.++.++++|||++......... .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||..
T Consensus 127 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 127 IKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred cCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999988765433211 2234578899999988754 468899999999999999999999975
Q ss_pred CCCCCCccceeeccCcCchhhhhhhhccccCCCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 165 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP-KAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.......... ........+. ..+..+.+++.+||+.||++|||+.++++
T Consensus 205 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 205 VDAFRAMMLI----------------PKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CChhhhhhcc----------------ccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 4221111000 0000001111 14557999999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=227.30 Aligned_cols=198 Identities=26% Similarity=0.290 Sum_probs=161.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++|+||+.+++|.+++.... +++...+..++.|+++|+.|||+++ +
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~---i 121 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKG---I 121 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 578999999999999999999999999999999999997652 2888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||.+........ .....|+..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 122 ~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred eccCCCHHHeEEcCCCCEEEeecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence 9999999999999999999999999876544321 2334578889999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH--HHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM--GIVL 228 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~~vl 228 (243)
|....... .....+.... .....+...+..+.+++.+||+.||.+||++ .+++
T Consensus 199 ~~~~~~~~-------------~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 199 YRGHSRTI-------------RDQIRAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CCCCCccH-------------HHHHHHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 97543210 1111111111 2223444566789999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=230.16 Aligned_cols=215 Identities=21% Similarity=0.275 Sum_probs=158.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++++||+.++.+..+..... .++...++.++.|++.|+.|||+.+ +
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i 121 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSHN---I 121 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999998866666554432 2788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+|++|+||+++.++.++|+|||++......... ......++..|+|||++.+. .++.++|+||+|++++++++|..
T Consensus 122 ~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 200 (288)
T cd07833 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200 (288)
T ss_pred ecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998776544321 12234577889999999877 78899999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCc--------------Cchhhhhhhhcc-ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 161 PVDHTLPRGQQSLVTWATPK--------------LSEDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
||.................. ............ ......+...+..+.+++.+||+.+|++|||++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 280 (288)
T cd07833 201 LFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD 280 (288)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHH
Confidence 98754221100000000000 000000000000 000012223467899999999999999999999
Q ss_pred HHHH
Q 026115 226 IVLK 229 (243)
Q Consensus 226 ~vl~ 229 (243)
++++
T Consensus 281 ~il~ 284 (288)
T cd07833 281 ELLQ 284 (288)
T ss_pred HHhc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=229.37 Aligned_cols=215 Identities=21% Similarity=0.280 Sum_probs=154.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.++...++||||+.+ +|.+++..... .++...+..++.|+++|+.|||+.+
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~--- 123 (291)
T cd07844 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRR--- 123 (291)
T ss_pred HHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999975 99998876543 2788999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++|+||+|+||+++.++.++++|||+++........ .....++..|+|||.+.+ ..++.++|+||+|+++++|++|.
T Consensus 124 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~ 201 (291)
T cd07844 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201 (291)
T ss_pred eecccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998654322111 122245778999999875 45788999999999999999999
Q ss_pred CCCCCCCCCCCc-cceeeccCcCchhhhhhh------hc--------cccCCCC-CHHHHHHHHHHHHhhcCCCCCCCCC
Q 026115 160 KPVDHTLPRGQQ-SLVTWATPKLSEDKVKQC------VD--------TKLGGEY-PPKAIAKMAAVAALCVQYEADFRPN 223 (243)
Q Consensus 160 ~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~------~~--------~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps 223 (243)
.||......... ............+..... .. ....... .......+.+++.+||+.+|++|||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps 281 (291)
T cd07844 202 PLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281 (291)
T ss_pred CCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC
Confidence 999654311000 000000000000000000 00 0000000 0001256889999999999999999
Q ss_pred HHHHHH
Q 026115 224 MGIVLK 229 (243)
Q Consensus 224 ~~~vl~ 229 (243)
+.++++
T Consensus 282 ~~e~l~ 287 (291)
T cd07844 282 AAEAMK 287 (291)
T ss_pred HHHHhc
Confidence 999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=222.83 Aligned_cols=202 Identities=25% Similarity=0.334 Sum_probs=165.5
Q ss_pred CCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++.+.+. ...++++|++.+++|.+++..... +++..++.++.|++.|+.|||+.+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lh~~~-- 121 (260)
T cd06606 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK---------LPEPVIRKYTRQILEGLAYLHSNG-- 121 (260)
T ss_pred HHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5688999999999999988 899999999999999999986642 889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++|+|++|+||+++.++.++|+|||.+................++..|+|||.+.....+.++|+||||++++++++|.
T Consensus 122 -~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (260)
T cd06606 122 -IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200 (260)
T ss_pred -ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987665543211123345788999999998888899999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.||..... .................+...+..+.+++.+||+.||++||++.++++
T Consensus 201 ~p~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 201 PPWSELGN--------------PMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCCCCCc--------------hHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 99975431 111112222222223444555778999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=226.84 Aligned_cols=202 Identities=28% Similarity=0.332 Sum_probs=155.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-CCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~~~~ 80 (243)
++.++||||+++++++..+...++++||++ ++|.+++....... ..+++..++.++.|++.|+.|||++ +
T Consensus 54 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~~--- 124 (283)
T cd06617 54 MRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKG-----LTIPEDILGKIAVSIVKALEYLHSKLS--- 124 (283)
T ss_pred HHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---
Confidence 356789999999999999999999999996 58888876532111 1388999999999999999999997 7
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc----CCCCcccchHHHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~l~ 156 (243)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||+|+++++++
T Consensus 125 i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~ 201 (283)
T cd06617 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA 201 (283)
T ss_pred eecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHH
Confidence 99999999999999999999999999876543211 122357888999998864 34578999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||..... ..+..................+..+.+++.+||+.+|++|||+.++++
T Consensus 202 ~g~~p~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 202 TGRFPYDSWKT--------------PFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred hCCCCCCcccc--------------CHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999853211 111122222211111111234678999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=227.37 Aligned_cols=216 Identities=22% Similarity=0.299 Sum_probs=158.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++|+||+ +++|.+++..... +++...++.++.|++.|+.|||+.+ +
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 120 (286)
T cd07832 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEER--------PLPEAQVKSYMRMLLKGVAYMHANG---I 120 (286)
T ss_pred HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 56789999999999999999999999999 9999999875442 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+.+. .++.++|+||+|++++++++|.+
T Consensus 121 ~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 199 (286)
T cd07832 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSP 199 (286)
T ss_pred ecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCc
Confidence 99999999999999999999999998766443211 11234578899999988654 45889999999999999999988
Q ss_pred CCCCCCCCCCccceeeccCcCchh---------hhhhhhccccC----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSED---------KVKQCVDTKLG----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
+|.+..+................. ........... .......+..+.+++.+||+.+|++|||++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 279 (286)
T cd07832 200 LFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA 279 (286)
T ss_pred CcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH
Confidence 886543211100000000000000 00000000000 00111234789999999999999999999999
Q ss_pred HHH
Q 026115 228 LKA 230 (243)
Q Consensus 228 l~~ 230 (243)
++.
T Consensus 280 l~h 282 (286)
T cd07832 280 LRH 282 (286)
T ss_pred hhC
Confidence 863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=232.02 Aligned_cols=202 Identities=17% Similarity=0.168 Sum_probs=153.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+|+|.+++..... .++...+..++.|++.|++|||+.+ +
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 123 (331)
T cd05597 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVHQLG---Y 123 (331)
T ss_pred HHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4567999999999999999999999999999999999975332 1788899999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-----CCCCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~ 156 (243)
+||||||+||+++.++.++|+|||++......... ......|++.|+|||++.. ..++.++|+||+||++|+|+
T Consensus 124 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (331)
T cd05597 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202 (331)
T ss_pred EECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHh
Confidence 99999999999999999999999998654332211 1122458999999999863 34678999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC---CCCCHHHHHHHHHHHHhhcCCCC--CCCCCHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEA--DFRPNMGIVLKA 230 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p--~~Rps~~~vl~~ 230 (243)
+|..||...... +....+...... .......+..+.+++.+|+..++ ..||++.++++.
T Consensus 203 ~g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 203 YGETPFYAESLV---------------ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred hCCCCCCCCCHH---------------HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999643211 111111111100 11112246678899999886533 347899998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=232.94 Aligned_cols=202 Identities=16% Similarity=0.180 Sum_probs=156.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++|+||+++++++.++...++||||+.+|+|.+++..... .++...+..++.|++.|+.|||+.+ +
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~~---i 123 (332)
T cd05623 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQLH---Y 123 (332)
T ss_pred HhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 4578999999999999999999999999999999999976432 1788889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~ 156 (243)
+||||||+||+++.++.++|+|||++......... ......|++.|+|||++. ...++.++|+|||||++|+|+
T Consensus 124 iHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell 202 (332)
T cd05623 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202 (332)
T ss_pred EecCCCHHHEEECCCCCEEEeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh
Confidence 99999999999999999999999998654322111 112345899999999986 245788999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC---CCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEADF--RPNMGIVLKA 230 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~vl~~ 230 (243)
+|..||...... +....+.....+ .......+..+.+++.+|+..+++. |++++++++.
T Consensus 203 ~g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 203 YGETPFYAESLV---------------ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCCCCCCCHH---------------HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 999999643211 111111111111 1112345678999999998654443 7899999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=223.60 Aligned_cols=201 Identities=26% Similarity=0.386 Sum_probs=164.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++.+++.++...++++||+++++|.+++...... ...++...++.++.|++.|+.+||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh~~~---i 124 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALHEQK---I 124 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---c
Confidence 56889999999999999999999999999999999998763211 112788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||+++...... .....++..|++||.+.+..++.++|+||+|++++++++|..|
T Consensus 125 ~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p 200 (256)
T cd08530 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200 (256)
T ss_pred ccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987665431 2224478899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|..... ...............+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 201 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 201 FEARSM----------------QDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCH----------------HHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 964421 11222222223334445667789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=226.62 Aligned_cols=202 Identities=27% Similarity=0.363 Sum_probs=153.4
Q ss_pred Ccc-cCCccceeeEEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 3 SRL-KNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 3 ~~l-~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+++ +|||++++++++... ...++|+||+++++|.+++...... ...+++..++.++.|++.|+.+||+.
T Consensus 73 ~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~ 147 (291)
T cd06639 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHNN 147 (291)
T ss_pred HHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 455 799999999998753 4689999999999999988643210 01278889999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-----CCCcccchHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVV 151 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~ 151 (243)
+ ++|+||+|+||+++.++.++++|||++......... .....|+..|+|||.+... .++.++|+||+||+
T Consensus 148 ~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi 222 (291)
T cd06639 148 R---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222 (291)
T ss_pred C---eeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHH
Confidence 8 999999999999999999999999998765432211 2234578899999987543 25789999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcc-ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 152 LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 152 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++++++|..||....+. ......... ......+......+.+++.+||+.+|++|||+.++++
T Consensus 223 ~~el~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 223 AIELGDGDPPLFDMHPV---------------KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHhhCCCCCCCCcHH---------------HHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99999999998644221 111111111 0001112334557999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=227.33 Aligned_cols=197 Identities=24% Similarity=0.378 Sum_probs=158.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...+++|||+++++|.+++.... +++..+..++.|++.|++|||+.+ +
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~g---i 137 (292)
T cd06657 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG---V 137 (292)
T ss_pred HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999876543 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||++........ ......++..|++||...+..++.++|+||+|++++++++|..|
T Consensus 138 vH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p 215 (292)
T cd06657 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215 (292)
T ss_pred ecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765433211 12234578899999998887889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|...... .....+..... .......+..+.+++.+||+.+|.+||++.++++
T Consensus 216 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 216 YFNEPPL----------------KAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCCCCHH----------------HHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 8643211 00111111110 0111234557899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=230.00 Aligned_cols=214 Identities=23% Similarity=0.286 Sum_probs=157.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+ +++|.+++..... .+++..++.++.|+++||.|||+.+ +
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---i 123 (298)
T cd07841 56 LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSI--------VLTPADIKSYMLMTLRGLEYLHSNW---I 123 (298)
T ss_pred HhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 57889999999999999999999999999 8899999976541 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++|+|||+++........ .....++..|+|||.+.+ ..++.++|+||+||+++++++|.+
T Consensus 124 ~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~ 201 (298)
T cd07841 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201 (298)
T ss_pred eecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCc
Confidence 99999999999999999999999998766443211 122345778999998865 356889999999999999999988
Q ss_pred CCCCCCCCCCccceeeccCcCchh------hhhhhhccccC-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSED------KVKQCVDTKLG-----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|....+................. ........... .......+..+.+++.+||+.||++|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 202 FLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 876543211000000000000000 00000000000 0111234568999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=224.91 Aligned_cols=196 Identities=22% Similarity=0.306 Sum_probs=157.5
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
...||||+++.+++..+...++|+||+.+++|..++.... .+++..+..++.|++.|+.|||+.+ ++|
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H 120 (278)
T cd05606 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRF---VVY 120 (278)
T ss_pred hCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEc
Confidence 4579999999999999999999999999999999886543 2889999999999999999999998 999
Q ss_pred ccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCCCC
Q 026115 84 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 84 ~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf 162 (243)
+||+|+||+++.++.++++|||++....... .....|+..|+|||.+.+. .++.++|+||+|++++++++|..||
T Consensus 121 ~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~ 196 (278)
T cd05606 121 RDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196 (278)
T ss_pred CCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCC
Confidence 9999999999999999999999987553321 1234588999999998754 5788999999999999999999999
Q ss_pred CCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
........ ....... .......+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 197 ~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 197 RQHKTKDK-------------HEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCccch-------------HHHHHHh-hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 75422111 0111111 0111123333467899999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=220.48 Aligned_cols=198 Identities=30% Similarity=0.448 Sum_probs=160.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++..+...++++||+.+++|.+++..... .++...+..++.|++.|+.+||..+ +
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lh~~~---i 119 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--------TLTESQIAYVCKELLKGLEYLHSNG---I 119 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHhhcCC---E
Confidence 5678999999999999999999999999999999999877632 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||++++++++|..|
T Consensus 120 ~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 196 (253)
T cd05122 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196 (253)
T ss_pred ecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998876654321 2334578899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCC--CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEY--PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|...... ........ ...... ....+..+.+++.+||+.||++|||+.++++
T Consensus 197 ~~~~~~~---------------~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 197 YSELPPM---------------KALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCCchH---------------HHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 8643211 11111111 111111 1112567999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=222.46 Aligned_cols=201 Identities=24% Similarity=0.369 Sum_probs=158.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+||+++++++.+....++++||+.+++|.+++..... ++...+..++.|++.|+.|||+.+ +
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~---i 120 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI---------LDEHVIRVYTLQLLEGLAYLHSHG---I 120 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCC---------CChHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5688999999999999999999999999999999999876432 778888999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccc--cccccccccccCchhhccCC---CCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~l~ 156 (243)
+|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+.. ++.++|+||+|+++++++
T Consensus 121 ~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~ 200 (264)
T cd06626 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200 (264)
T ss_pred ccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHH
Confidence 9999999999999999999999999876544322211 11244778999999988665 788999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCH--HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP--KAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||....... .....+........+. ..+..+.+++.+||+.+|++|||+.+++.
T Consensus 201 ~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 201 TGKRPWSELDNEF---------------QIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hCCCCccCCcchH---------------HHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999996442110 0000011111111222 23667899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=225.43 Aligned_cols=205 Identities=29% Similarity=0.335 Sum_probs=156.9
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||++++++|.. +..+++||||+++++|.+++...... ...++...+..++.|++.|+.|||+.+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~-- 125 (287)
T cd06621 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHSRK-- 125 (287)
T ss_pred HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 578999999999999864 44789999999999999987643211 012788889999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++|+|++|+||+++.++.++++|||++........ ....++..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus 126 -i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (287)
T cd06621 126 -IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200 (287)
T ss_pred -cccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999765433221 1234678899999998888899999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhc----cccCCCCC--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD----TKLGGEYP--PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.||......... . ......+. ........ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 201 ~p~~~~~~~~~~----------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 201 FPFPPEGEPPLG----------P-IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCcccCCCCC----------h-HHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 999754221000 0 00111111 11111111 124567999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=229.81 Aligned_cols=214 Identities=21% Similarity=0.287 Sum_probs=157.2
Q ss_pred CCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++..+ ...++++||+.+ +|.+++..... .++...++.++.|++.|++|||+.+
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~-- 126 (293)
T cd07843 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNW-- 126 (293)
T ss_pred HHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5678999999999999877 889999999975 99998876442 2889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC-CCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|+||+++.++.++++|||++......... .....++..|+|||.+.+.. ++.++|+||+|++++++++|
T Consensus 127 -i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 203 (293)
T cd07843 127 -ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203 (293)
T ss_pred -eeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999998766543211 12334678899999987644 58899999999999999999
Q ss_pred CCCCCCCCCCCCccce-eecc-------------CcCchhhhhhhhccccCCCCCHH-HHHHHHHHHHhhcCCCCCCCCC
Q 026115 159 RKPVDHTLPRGQQSLV-TWAT-------------PKLSEDKVKQCVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPN 223 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~-~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps 223 (243)
..||............ .... +...................+.. .++.+.+++.+||+.||++|||
T Consensus 204 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t 283 (293)
T cd07843 204 KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283 (293)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC
Confidence 9999754321110000 0000 00000000000000111112221 3667899999999999999999
Q ss_pred HHHHHH
Q 026115 224 MGIVLK 229 (243)
Q Consensus 224 ~~~vl~ 229 (243)
+.|+++
T Consensus 284 ~~ell~ 289 (293)
T cd07843 284 AEDALK 289 (293)
T ss_pred HHHHhc
Confidence 999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=226.98 Aligned_cols=196 Identities=28% Similarity=0.382 Sum_probs=154.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++.+++.++...++|+||+. |++.+++..... .+++..+..++.|++.|+.|||+.+ +
T Consensus 69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~~~---i 136 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHSHE---R 136 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999999999999999999996 478777754332 2888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||+++.++.++|+|||++...... ....++..|+|||++. ...++.++|+||||+++|++++|
T Consensus 137 ~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg 210 (307)
T cd06607 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (307)
T ss_pred eecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence 99999999999999999999999987654322 2235778899999874 34578899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
..||....... ..............+...+..+.+++.+||+.+|++|||+.+++..
T Consensus 211 ~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 211 KPPLFNMNAMS---------------ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCCccHHH---------------HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 99986432111 0111111111111223456689999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=235.94 Aligned_cols=190 Identities=21% Similarity=0.289 Sum_probs=157.7
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
.-+||||+++.+.+.++.+.++|||.+.|+-+.+-+...+. .. ..+..|++++++|+.|||.+| ++|
T Consensus 372 ~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~---------~~-~e~~~w~~~lv~Av~~LH~~g---vvh 438 (612)
T KOG0603|consen 372 VRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE---------FC-SEASQWAAELVSAVDYLHEQG---VVH 438 (612)
T ss_pred hcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch---------hH-HHHHHHHHHHHHHHHHHHhcC---eee
Confidence 34799999999999999999999999999988777766652 33 677789999999999999999 999
Q ss_pred ccCCCCceEe-cCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCC
Q 026115 84 RNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 84 ~di~~~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 162 (243)
||+||+|||+ +..+.++|+|||.++..... .....-|..|.|||++....|++++|+||||++||+|++|..||
T Consensus 439 RDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~ 513 (612)
T KOG0603|consen 439 RDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLF 513 (612)
T ss_pred cCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcc
Confidence 9999999999 58899999999998776544 11223477899999999999999999999999999999999999
Q ss_pred CCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
... +....+...+ .........+....+|+.+||+.||.+||++.++..
T Consensus 514 ~~~---------------P~~~ei~~~i---~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 514 AAH---------------PAGIEIHTRI---QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccC---------------CchHHHHHhh---cCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 743 1111222222 223334778889999999999999999999999876
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=226.54 Aligned_cols=199 Identities=28% Similarity=0.371 Sum_probs=157.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++.++...++|+||+.+ +|.+.+..... .+++..+..++.|++.|+.|||+.+ +
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~---i 146 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---M 146 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999965 88777754332 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||+++.++.++++|||++...... ....++..|+|||.+. ...++.++|+||+|++++++++|
T Consensus 147 ~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g 220 (317)
T cd06635 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 220 (317)
T ss_pred ccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999987654321 2335788899999874 34578899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
..||..... ......+.............+..+.+++.+||+.+|.+||++.++++..-.
T Consensus 221 ~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 221 KPPLFNMNA---------------MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCCCCccH---------------HHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 999864311 111112222222122233455679999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=244.26 Aligned_cols=213 Identities=23% Similarity=0.352 Sum_probs=179.0
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCC-CCCCCCC----C--CccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKK-GVKGAKP----G--PVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~----~--~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
+||||+.++|++.+++..++|.||+..|+|..|++... ....... . ..++....+.++.||+.|++||++..
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~- 438 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP- 438 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 69999999999999999999999999999999999887 1111111 1 23889999999999999999999998
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccc-cccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV-LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++|||+..+|||+..+..+|++|||+++.............. .-+..|+|||.+....++.++|+||+|+++||+++
T Consensus 439 --~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 439 --CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFT 516 (609)
T ss_pred --ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhh
Confidence 999999999999999999999999999865544333211111 12456999999999999999999999999999998
Q ss_pred -CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 158 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
|..|+.+. .....+.+.+..+.+...|..++.+++++|..||+.+|++||+.+++.+.+..++.
T Consensus 517 LG~~PYp~~---------------~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 517 LGGTPYPGI---------------PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCC---------------CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 88888642 11345566888888889999999999999999999999999999999999999764
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=232.36 Aligned_cols=197 Identities=22% Similarity=0.331 Sum_probs=157.2
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
.|.+|+++++|-..++.+++|||+-+. +|..+|...... ...-.+..+..|++.|+.++|+.| |+|.|
T Consensus 418 g~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~g---IVHSD 485 (677)
T KOG0596|consen 418 GHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQHG---IVHSD 485 (677)
T ss_pred CCceEEEEeeeeccCceEEEEeecccc-cHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHhc---eeecC
Confidence 389999999999999999999998866 999999887643 222267789999999999999999 99999
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC-----------CCcccchHHHHHHHHH
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-----------MSSKSDVYSFGVVLLE 154 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------~~~~~DiwslG~~l~~ 154 (243)
+||.|+++ -.|.+||+|||+|...............+||..||+||.+.... .+.++|||||||+||+
T Consensus 486 LKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYq 564 (677)
T KOG0596|consen 486 LKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQ 564 (677)
T ss_pred CCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHH
Confidence 99999987 56889999999998887766655566788999999999986433 3568999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|+.|..||..... .-.++..+.++.-.-+++.- ...++.+++..||+.||++|||+.++|+
T Consensus 565 MvYgktPf~~~~n--------------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 565 MVYGKTPFGQIIN--------------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhcCCchHHHHH--------------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 9999999973311 11344445555332222211 1123999999999999999999999997
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=240.24 Aligned_cols=211 Identities=16% Similarity=0.221 Sum_probs=150.8
Q ss_pred cCCccceeeEEEEeC-CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCCeEe
Q 026115 6 KNENVVELVGYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIH 83 (243)
Q Consensus 6 ~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~~~h 83 (243)
+|+++++++++|..+ .++++||+++ +++|.+++..... ++...+..++.|++.||.|||. .+ ++|
T Consensus 189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~yLH~~~g---IiH 255 (467)
T PTZ00284 189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGP---------FSHRHLAQIIFQTGVALDYFHTELH---LMH 255 (467)
T ss_pred cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcCC---eec
Confidence 456789999998754 5789999988 7799998876532 8889999999999999999997 47 999
Q ss_pred ccCCCCceEecCCC----------------ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHH
Q 026115 84 RNIKSSNVLLFDDD----------------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYS 147 (243)
Q Consensus 84 ~di~~~nil~~~~~----------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws 147 (243)
|||||+||+++.++ .+||+|||.+...... .....||+.|+|||++.+..++.++||||
T Consensus 256 rDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 330 (467)
T PTZ00284 256 TDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330 (467)
T ss_pred CCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHH
Confidence 99999999998765 4899999987543221 23456899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCch--------hhhhhhhcc--ccC---------------CCCCHHH
Q 026115 148 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE--------DKVKQCVDT--KLG---------------GEYPPKA 202 (243)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--~~~---------------~~~~~~~ 202 (243)
|||++|||++|..||...........+......... .....+... .+. .......
T Consensus 331 lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (467)
T PTZ00284 331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR 410 (467)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhc
Confidence 999999999999999764332111111000000000 000000000 000 0000112
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHHHHH--HHHHH
Q 026115 203 IAKMAAVAALCVQYEADFRPNMGIVLK--ALQPL 234 (243)
Q Consensus 203 ~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~~~ 234 (243)
...+.+||.+||+.||.+|||++|+++ .+.+.
T Consensus 411 ~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 411 DDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 346889999999999999999999997 45443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=228.71 Aligned_cols=226 Identities=22% Similarity=0.304 Sum_probs=160.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||++++++|..+...++++||+.+++|.+++...... .++...+..++.|++.||+|||+.+ +
T Consensus 53 ~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~~~---i 122 (328)
T cd08226 53 SHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLHQNG---Y 122 (328)
T ss_pred HHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 45689999999999999999999999999999999998865322 1788889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc-----ccccccccccccCchhhccC--CCCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~ 154 (243)
+||||||+||+++.++.++++||+.+.......... ......++..|+|||++.+. .++.++|+||+||++++
T Consensus 123 vHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~e 202 (328)
T cd08226 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202 (328)
T ss_pred ecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHH
Confidence 999999999999999999999997543221111000 00112245679999998763 46889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcc-ce------eeccCcCc-h-----------------hhhh-----hhhccccCCCCCHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQS-LV------TWATPKLS-E-----------------DKVK-----QCVDTKLGGEYPPKAIA 204 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~-~~------~~~~~~~~-~-----------------~~~~-----~~~~~~~~~~~~~~~~~ 204 (243)
+++|..||.......... .. .+...... . .... ...............+.
T Consensus 203 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (328)
T cd08226 203 LATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSP 282 (328)
T ss_pred HHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhH
Confidence 999999997543211000 00 00000000 0 0000 00001111222345677
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHH--HHHHHHhh
Q 026115 205 KMAAVAALCVQYEADFRPNMGIVLK--ALQPLLNT 237 (243)
Q Consensus 205 ~~~~li~~~l~~~p~~Rps~~~vl~--~l~~~~~~ 237 (243)
.+.+++.+||+.||++|||+.++++ .+..+.+.
T Consensus 283 ~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 283 AFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 8999999999999999999999986 55555543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=226.51 Aligned_cols=214 Identities=17% Similarity=0.238 Sum_probs=155.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...+++|||+. ++|.+++....... +++..+..++.|++.|++|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~-------l~~~~~~~~~~~i~~~l~~lh~~~---i 121 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSG-------IPLPLIKSYLFQLLQGLAFCHSHR---V 121 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578899999999999999999999999996 58999887654332 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC-CCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++++|||++......... .....++..|+|||.+.+.. ++.++|+||||++++++++|..
T Consensus 122 ~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 199 (284)
T cd07860 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199 (284)
T ss_pred ecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999998755432111 12234677899999887644 5788999999999999999999
Q ss_pred CCCCCCCCCCccc-eeeccCc----Cch-h-------hhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 161 PVDHTLPRGQQSL-VTWATPK----LSE-D-------KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 161 pf~~~~~~~~~~~-~~~~~~~----~~~-~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
||........... ....... +.. . .......... .......+..+.+++.+||+.||.+|||++++
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 278 (284)
T cd07860 200 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278 (284)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence 9975432110000 0000000 000 0 0000000000 00011234568899999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 279 l~ 280 (284)
T cd07860 279 LA 280 (284)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=239.87 Aligned_cols=203 Identities=24% Similarity=0.368 Sum_probs=176.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|.+|+|||++++||+..+ ....+|||.+..|+|.+.|++.... .+-......++.||+.|+.||..++ +
T Consensus 165 M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~-------~llv~~Lcdya~QiA~aM~YLeskr---l 233 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKA-------ILLVSRLCDYAMQIAKAMQYLESKR---L 233 (1039)
T ss_pred HHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhcccc-------ceeHHHHHHHHHHHHHHHHHHhhhh---h
Confidence 568999999999999988 6788999999999999999884332 2778899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccc-cccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|||+...|+++.....+||+|||+.+-.+....... .....-...|.|||.+....++.++|+|++||.+|||++ |+
T Consensus 234 vHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGE 313 (1039)
T KOG0199|consen 234 VHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGE 313 (1039)
T ss_pred hhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCC
Confidence 9999999999999999999999999987765543321 112223567999999999999999999999999999998 88
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
-||.+. ....+.+.++.+-+...+..|++.+++++..||..+|++|||+..+.+.+
T Consensus 314 ePW~G~----------------~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 314 EPWVGC----------------RGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCC----------------CHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 898644 44677888888888899999999999999999999999999999997543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=220.70 Aligned_cols=202 Identities=23% Similarity=0.361 Sum_probs=163.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++.+.+..+...++++|++++++|.+++..... ....++...+..++.+++.|+.+||+.+ +
T Consensus 53 l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~ 124 (258)
T cd08215 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSRK---I 124 (258)
T ss_pred HHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 4678999999999999999999999999999999999977531 0012889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+|++|+||+++.++.++++|||.+........ ......|++.|+|||...+..++.++|+||+|++++++++|..|
T Consensus 125 ~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 202 (258)
T cd08215 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202 (258)
T ss_pred ecccCChHHeEEcCCCcEEECCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999876554331 12334578899999999888889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..... ...............+...+..+.+++.+||..+|++|||+.++++
T Consensus 203 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 203 FEGENL----------------LELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCcH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 864321 1111111111122333455678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=224.50 Aligned_cols=202 Identities=24% Similarity=0.328 Sum_probs=159.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++.+..+...++++||+.+++|.+++..... ++...++.++.|++.|++|||+.+ +
T Consensus 47 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~L~~lH~~~---i 114 (265)
T cd05579 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS---------LDEDVARIYIAEIVLALEYLHSNG---I 114 (265)
T ss_pred HHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHcC---e
Confidence 5678899999999999999999999999999999999976442 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccc------ccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
+|+||+|+||+++.++.++++|||++........ ........++..|++||.......+.++|+||||++++++
T Consensus 115 ~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l 194 (265)
T cd05579 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEF 194 (265)
T ss_pred ecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHH
Confidence 9999999999999999999999998765433211 0112234577889999999888888999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHH--HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK--AIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
++|..||...... +.......... ..+.. .+..+.+++.+||+.+|.+|||+..+.+.|.
T Consensus 195 ~~g~~p~~~~~~~---------------~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 195 LVGIPPFHGETPE---------------EIFQNILNGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HhCCCCCCCCCHH---------------HHHHHHhcCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 9999998644211 11111111111 12222 2678999999999999999999955554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=231.07 Aligned_cols=202 Identities=17% Similarity=0.171 Sum_probs=155.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+||+++++++.++...++||||+.+|+|.+++..... .++...+..++.|++.||.|||+.+ +
T Consensus 55 l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~~---i 123 (331)
T cd05624 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQLH---Y 123 (331)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 4567999999999999999999999999999999999976432 1788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-----CCCCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~ 156 (243)
+||||||+||+++.++.++|+|||++......... ......|++.|+|||++.+ ..++.++|+||+|+++|+|+
T Consensus 124 iHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell 202 (331)
T cd05624 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202 (331)
T ss_pred eeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhh
Confidence 99999999999999999999999998655432211 1122458999999999875 45688999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCC---CCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG---EYPPKAIAKMAAVAALCVQYEADF--RPNMGIVLKA 230 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~vl~~ 230 (243)
+|..||...... +....+.....+. ......+..+.+++.+|+..+++. |++++++++.
T Consensus 203 ~g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 203 YGETPFYAESLV---------------ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred hCCCCccCCCHH---------------HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 999999643211 1111111111111 111234668999999999866544 4688888763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=220.20 Aligned_cols=200 Identities=22% Similarity=0.278 Sum_probs=161.1
Q ss_pred CCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.+. ..+++++||+.+++|.+++..... ++...+..++.|+++|+.|||+.+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~~i~~al~~LH~~~-- 126 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA---------LTENVTRRYTRQILQGVSYLHSNM-- 126 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5688999999999998764 568899999999999999875432 778888999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccc-cccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|+||+++.++.++++|||+++........ .......++..|+|||.+.+..++.++|+||||++++++++|
T Consensus 127 -i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 205 (264)
T cd06653 127 -IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTE 205 (264)
T ss_pred -EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765332111 111234578899999999888889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||.... ......+..........+...++.+.+++.+||+ +|..|||+.+++.
T Consensus 206 ~~p~~~~~---------------~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 206 KPPWAEYE---------------AMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCccC---------------HHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 99996431 1122333333333345566777889999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=237.47 Aligned_cols=196 Identities=27% Similarity=0.369 Sum_probs=161.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++|||++.|-|+|..+...+||||||-| +..+++.-... ++.+..+..|+.+.+.||+|||+.+ .
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLHS~~---~ 147 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---R 147 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHHHhh---H
Confidence 6789999999999999999999999999955 88888766543 3889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|||||..|||+++.|.|||+|||.+..... ...++|||.|||||++. .+.|+.+.||||||++-.|+.-.
T Consensus 148 IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER 221 (948)
T KOG0577|consen 148 IHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 221 (948)
T ss_pred HhhhccccceEecCCCeeeeccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhc
Confidence 9999999999999999999999998765432 36688999999999985 56899999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
.+|...... ...++-+.......-...+-+..++.++..||++-|++|||.++++..
T Consensus 222 kPPlFnMNA---------------MSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 222 KPPLFNMNA---------------MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCccCchH---------------HHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 999653311 112222222222212234567789999999999999999999999874
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=239.75 Aligned_cols=220 Identities=17% Similarity=0.181 Sum_probs=153.5
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.++...+++++++. ++|..++....... ........+..++.|++.||.|||+.+
T Consensus 216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~----~~~~~~~~~~~i~~ql~~aL~yLH~~g--- 287 (501)
T PHA03210 216 ALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCAVEYIHDKK--- 287 (501)
T ss_pred HHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccc----cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3578899999999999999999999999985 48888775443110 001335677889999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||+++........ ......|+..|+|||++.+..++.++|||||||++|||++|..
T Consensus 288 IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~ 366 (501)
T PHA03210 288 LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366 (501)
T ss_pred eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999999766433221 1223468999999999998889999999999999999999875
Q ss_pred C-CCCCCCCCCccce---eec---cCc--CchhhhhhhhccccCCCCC---------HHHHHHHHHHHHhhcCCCCCCCC
Q 026115 161 P-VDHTLPRGQQSLV---TWA---TPK--LSEDKVKQCVDTKLGGEYP---------PKAIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 161 p-f~~~~~~~~~~~~---~~~---~~~--~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp 222 (243)
+ +..........+. ... ... .........+........+ ...+..+.+++.+||+.||++||
T Consensus 367 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp 446 (501)
T PHA03210 367 CPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP 446 (501)
T ss_pred CCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc
Confidence 4 4322111000000 000 000 0000111111110000000 01234577889999999999999
Q ss_pred CHHHHHH
Q 026115 223 NMGIVLK 229 (243)
Q Consensus 223 s~~~vl~ 229 (243)
|+.|+++
T Consensus 447 sa~elL~ 453 (501)
T PHA03210 447 GAAELLA 453 (501)
T ss_pred CHHHHhh
Confidence 9999987
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=224.29 Aligned_cols=197 Identities=26% Similarity=0.391 Sum_probs=155.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+|++++.+++..+...++|+||+. |++.+++..... .++...+..++.|++.|+.|||+.+ +
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~~~---i 136 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---M 136 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 578899999999999999999999999996 588887754332 2788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||+++.++.++++|||++...... ....++..|+|||.+. ...++.++|+|||||+++++++|
T Consensus 137 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 210 (308)
T cd06634 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (308)
T ss_pred ccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcC
Confidence 99999999999999999999999987654321 2335788999999975 34578899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
..||...... ...................+..+.+++.+||+.+|++||++.++++.-
T Consensus 211 ~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 211 KPPLFNMNAM---------------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCCCccccHH---------------HHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 9998643110 111111111111122334566799999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=216.55 Aligned_cols=199 Identities=25% Similarity=0.359 Sum_probs=157.2
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
....|+||+++|||..+...++.||.+.. .+..++....+ ++++..+-++...+++||.||-... +++|
T Consensus 147 s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH--~viH 215 (391)
T KOG0983|consen 147 SHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKH--GVIH 215 (391)
T ss_pred ccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceee
Confidence 34479999999999999999999999955 78888877664 2888888899999999999998775 4999
Q ss_pred ccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc---CCCCcccchHHHHHHHHHHHhCCC
Q 026115 84 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 84 ~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
||+||+|||+|..|++|++|||++...-+... .....|-+.|||||.+.- ..|+.++|+||||+.++|+.||+.
T Consensus 216 RDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~y 292 (391)
T KOG0983|consen 216 RDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQY 292 (391)
T ss_pred cccCccceEEccCCCEEeecccccceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccC
Confidence 99999999999999999999999755443322 233447889999999863 468889999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG-GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
||.+... ..+.+..+++..-. .......+..+.+++..||++|+.+||...++++.
T Consensus 293 Py~~c~t--------------dFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 293 PYKGCKT--------------DFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCCc--------------cHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 9986421 22333333332111 12222367889999999999999999999998863
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=223.16 Aligned_cols=211 Identities=24% Similarity=0.313 Sum_probs=153.9
Q ss_pred CCcc-cCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 2 VSRL-KNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
++++ +||||+++++++.++ +..++|+||+.+ +|.+++..... .+++..++.++.|++.|+.|||+.+
T Consensus 51 l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~- 120 (282)
T cd07831 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHRNG- 120 (282)
T ss_pred HhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3455 499999999999987 889999999975 88888865432 2889999999999999999999998
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHh
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~ 157 (243)
++|+||+|+||+++. +.++|+|||+++........ ....++..|+|||.+.. ..++.++|+||+||++++|++
T Consensus 121 --i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 121 --IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred --ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 999999999999999 99999999998765433221 22347889999998654 446889999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc--cC-----------CCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LG-----------GEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
|..||....+................ ...+..... .. .......+..+.+++.+||+.+|++|||+
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 273 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDA-EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCH-HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH
Confidence 99999754322110000000000000 000000000 00 00112346789999999999999999999
Q ss_pred HHHHH
Q 026115 225 GIVLK 229 (243)
Q Consensus 225 ~~vl~ 229 (243)
.++++
T Consensus 274 ~~~l~ 278 (282)
T cd07831 274 KQALR 278 (282)
T ss_pred HHHhh
Confidence 99986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=218.30 Aligned_cols=198 Identities=28% Similarity=0.427 Sum_probs=161.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++.++...++++|++++++|.+++.... .+++..+..++.|++.|+.+||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---i 120 (254)
T cd06627 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQG---V 120 (254)
T ss_pred HHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---c
Confidence 567899999999999999999999999999999999987653 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||.+......... .....++..|+|||...+..++.++|+|++|++++++++|..|
T Consensus 121 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p 198 (254)
T cd06627 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198 (254)
T ss_pred ccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998766543321 1234578899999998877788999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|....+. ....... .......+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 199 ~~~~~~~---------------~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 199 YYDLNPM---------------AALFRIV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCccHH---------------HHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 8643211 1111111 11112333445678999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=228.17 Aligned_cols=214 Identities=23% Similarity=0.333 Sum_probs=156.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++|+||+++++|..+...... +++..+..++.|++.|+.|||+.+ +
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~LH~~~---i 121 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---------LDESRVRKYLFQILRGIEFCHSHN---I 121 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999888887655432 789999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+|++|+||+++.++.++++|||++......... .....++..|+|||.+.+. .++.++|+||||++++++++|.+
T Consensus 122 ~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~ 199 (286)
T cd07846 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199 (286)
T ss_pred cccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999998765433211 1234578899999998753 46788999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchh--------hhh-hhhccccC-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSED--------KVK-QCVDTKLG-----GEYPPKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
||...................... ... ....+... .......+..+.+++.+||+.+|++|||+.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 279 (286)
T cd07846 200 LFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279 (286)
T ss_pred CCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence 986442211000000000000000 000 00000000 0011234567999999999999999999999
Q ss_pred HHH
Q 026115 227 VLK 229 (243)
Q Consensus 227 vl~ 229 (243)
+++
T Consensus 280 il~ 282 (286)
T cd07846 280 LLH 282 (286)
T ss_pred Hhc
Confidence 886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=218.92 Aligned_cols=183 Identities=22% Similarity=0.239 Sum_probs=148.8
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
...||||+++++++.++...+++|||+++++|.+++..... +++..+..++.|+++|+.|||+.+ ++|
T Consensus 41 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~ql~~~l~~lH~~~---i~H 108 (237)
T cd05576 41 PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN---------IPEECVKRWAAEMVVALDALHREG---IVC 108 (237)
T ss_pred hcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC---------CCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 34699999999999999999999999999999999876542 888999999999999999999998 999
Q ss_pred ccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026115 84 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163 (243)
Q Consensus 84 ~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 163 (243)
+||||+||+++.++.++++|||.+....... ....++..|+|||...+..++.++|+||+|++++++++|..|+.
T Consensus 109 ~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 109 RDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 9999999999999999999999876544321 12234667999999887788899999999999999999998875
Q ss_pred CCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 164 HTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
...... ........+...+..+.+++.+||+.||++|||+
T Consensus 184 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 184 CHPSGI---------------------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cCchhc---------------------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 321100 0000012233345679999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=230.51 Aligned_cols=210 Identities=19% Similarity=0.205 Sum_probs=154.2
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||++++++|... ...++|+||+.+ +|.+.+... ++...+..++.|++.|++|||+
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~ 136 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHS 136 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHh
Confidence 5678999999999998643 357999999965 888887542 6778888999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.| ++|+||||+||+++.++.++|+|||.++....... .....++..|+|||.+.+..++.++|+|||||++++|
T Consensus 137 ~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 210 (353)
T cd07850 137 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210 (353)
T ss_pred CC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHH
Confidence 98 99999999999999999999999999876543221 1223478899999999988899999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCch----------------------hhhhhhhccc----cCCCCCHHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSE----------------------DKVKQCVDTK----LGGEYPPKAIAKMAAV 209 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~----~~~~~~~~~~~~~~~l 209 (243)
++|..||...+.......+......... ....+..... .....+...+..+.++
T Consensus 211 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 211 IRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHH
Confidence 9999999754321110000000000000 0000000000 0001122346678999
Q ss_pred HHhhcCCCCCCCCCHHHHHH
Q 026115 210 AALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 210 i~~~l~~~p~~Rps~~~vl~ 229 (243)
+.+||+.||++|||+.++++
T Consensus 291 i~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHcCCChhhCcCHHHHhc
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=225.22 Aligned_cols=220 Identities=21% Similarity=0.277 Sum_probs=156.1
Q ss_pred CCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.+. ...++|+||+.+ +|.+++........ ..++...+..++.|++.|+.|||+.+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~-- 128 (316)
T cd07842 56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKR----VSIPPSMVKSLLWQILNGVHYLHSNW-- 128 (316)
T ss_pred HHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCC----cCcCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5678999999999999987 889999999965 78777654332110 13788999999999999999999998
Q ss_pred CeEeccCCCCceEecC----CCceeecccCCCCCCcccccc-cccccccccccccCchhhccC-CCCcccchHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLLFD----DDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLL 153 (243)
Q Consensus 80 ~~~h~di~~~nil~~~----~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~ 153 (243)
++|+||+|+||+++. ++.++++|||++......... .......++..|+|||.+.+. .++.++|+||||++++
T Consensus 129 -i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~ 207 (316)
T cd07842 129 -VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFA 207 (316)
T ss_pred -EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence 999999999999999 899999999998766443321 112234578889999988764 5788999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceee------c---cCcCchh---------hhhhhhccccCCCCC-----------HHHHH
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTW------A---TPKLSED---------KVKQCVDTKLGGEYP-----------PKAIA 204 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~------~---~~~~~~~---------~~~~~~~~~~~~~~~-----------~~~~~ 204 (243)
++++|..||.............. . ....... ......+.......+ ...+.
T Consensus 208 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (316)
T cd07842 208 ELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDS 287 (316)
T ss_pred HHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCH
Confidence 99999999976543321000000 0 0000000 000000000000000 02345
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 205 KMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 205 ~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.+.+++.+||+.||++|||+.++++
T Consensus 288 ~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 288 QGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 6899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=226.59 Aligned_cols=214 Identities=25% Similarity=0.274 Sum_probs=154.4
Q ss_pred CCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++|+||+++++++.+. +..++|+||+.+ +|.+++..... .+++..+..++.|++.|++|||+.+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~~-- 128 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT--------PFSESQVKCLMLQLLRGLQYLHENF-- 128 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5688999999999998755 568999999965 89888876432 2889999999999999999999999
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+ ..++.++|+||+|+++|++++|
T Consensus 129 -i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 205 (309)
T cd07845 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205 (309)
T ss_pred -eecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765433211 122235678999999875 4568899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhh-----------hhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKV-----------KQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
..||....+................... ......... .......++.+.+++.+||+.||++|||+.
T Consensus 206 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 285 (309)
T cd07845 206 KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE 285 (309)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHH
Confidence 9999754332111000000000000000 000000000 000112356788999999999999999999
Q ss_pred HHHH
Q 026115 226 IVLK 229 (243)
Q Consensus 226 ~vl~ 229 (243)
++++
T Consensus 286 ~il~ 289 (309)
T cd07845 286 EALE 289 (309)
T ss_pred HHhc
Confidence 9986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=226.14 Aligned_cols=214 Identities=19% Similarity=0.259 Sum_probs=158.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...++++||+.+ +|..++..... .++...++.++.|++.|+.|||+.+ +
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i 119 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHSHG---I 119 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999975 88888876432 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||+|++++++++|..
T Consensus 120 ~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 197 (283)
T cd05118 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197 (283)
T ss_pred eecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998866544321 11223467889999998776 67899999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhc---------cc-c---CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVD---------TK-L---GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~-~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
||............................. .. . ........+..+.+++.+||+.||.+||++.++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l 277 (283)
T cd05118 198 LFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA 277 (283)
T ss_pred CCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence 9965432111000000000000000000000 00 0 001123456789999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
+.
T Consensus 278 l~ 279 (283)
T cd05118 278 LA 279 (283)
T ss_pred hh
Confidence 86
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=222.77 Aligned_cols=196 Identities=27% Similarity=0.405 Sum_probs=153.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++.++...+++|||+. +++.+++..... ++++..++.++.|++.|+.|||+.+ +
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH~~g---i 142 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---M 142 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 568899999999999999999999999996 588887765432 2788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||+++.++.++++|||++..... .....|+..|+|||.+. ...++.++|+||||++++++++|
T Consensus 143 ~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999998754321 12345788999999974 35578899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
..||...... ...................+..+.+++.+||+.+|.+||++.+++..
T Consensus 217 ~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 217 KPPLFNMNAM---------------SALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCCCChH---------------HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9998644221 11111111111111122234568999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=220.45 Aligned_cols=201 Identities=22% Similarity=0.321 Sum_probs=159.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+....++++||+.+++|.+++...... ...+++..++.++.|++.|+.|||+.+ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i 127 (260)
T cd08222 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQRR---I 127 (260)
T ss_pred HHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHcC---c
Confidence 56789999999999999999999999999999999988653211 112889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+|++|+||+++. +.++++|||++......... .....|+..|+|||...+..++.++|+||+|++++++++|..|
T Consensus 128 ~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~ 204 (260)
T cd08222 128 LHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA 204 (260)
T ss_pred cccCCChhheEeec-CCEeecccCceeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999975 56999999988665432221 2234578899999998887888899999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..... ........ .......+...+..+.+++.+||+.+|++||++.++++
T Consensus 205 ~~~~~~---------------~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 205 FEGQNF---------------LSVVLRIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCccH---------------HHHHHHHH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 853211 01111111 12222344566778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=225.81 Aligned_cols=215 Identities=19% Similarity=0.220 Sum_probs=156.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++.++...++++||+. ++|.+++...... .+++..++.++.|++.|+.|||+.+ +
T Consensus 52 l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~~L~~lH~~~---~ 120 (283)
T cd07835 52 LKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLT-------GLDPPLIKSYLYQLLQGIAYCHSHR---V 120 (283)
T ss_pred HHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999995 5999998765532 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++++|||+++........ .....++..|+|||.+.+. .++.++|+||||++++++++|..
T Consensus 121 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 198 (283)
T cd07835 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198 (283)
T ss_pred eCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998754322111 1223457889999987654 46889999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchh---------hhhhhhcc---ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSED---------KVKQCVDT---KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
||...................... ........ ..........+..+.+++.+||+.+|.+|||+++++
T Consensus 199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 199 LFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 997543211000000000000000 00000000 000011122345789999999999999999999998
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
+
T Consensus 279 ~ 279 (283)
T cd07835 279 Q 279 (283)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=222.84 Aligned_cols=216 Identities=20% Similarity=0.240 Sum_probs=157.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++|+||+.+ +|.+++...... ..+++..+..++.|++.|+.|||+.+ +
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i 121 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCHENR---V 121 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCC------CCcCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999975 898888654321 12889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++++|||++......... .....++..|++||.+.+. .++.++|+||||++++++++|..
T Consensus 122 ~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (284)
T cd07836 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199 (284)
T ss_pred eeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998654332111 1223467889999998654 46889999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhc-----ccc-------CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVD-----TKL-------GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
||............................. ... ........+..+.+++.+||+.||.+||++.+++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 279 (284)
T cd07836 200 LFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279 (284)
T ss_pred CCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence 9975532211000000000000000000000 000 0011123456789999999999999999999998
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
+
T Consensus 280 ~ 280 (284)
T cd07836 280 Q 280 (284)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=219.95 Aligned_cols=214 Identities=20% Similarity=0.208 Sum_probs=152.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+||+++.+++.++...++|+||+. ++|.+++...... +....+..++.|++.|+.|||+.+ +
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~L~~lH~~~---i 124 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGG--------LHPYNVRLFMFQLLRGLAYIHGQH---I 124 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 567899999999999999999999999995 6887777554321 677788889999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||||+||+++.++.++|+|||+++........ .....++..|+|||.+.+. .++.++|+||||++++++++|..
T Consensus 125 ~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 202 (291)
T cd07870 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202 (291)
T ss_pred ccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999988754332111 1223468899999998753 47889999999999999999999
Q ss_pred CCCCCCCCCCccceeec-cCcCchhh----------hhhhhccccCCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 161 PVDHTLPRGQQSLVTWA-TPKLSEDK----------VKQCVDTKLGGE-----YPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~-~~~~~~~~----------~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
||....+........+. ........ ............ .....+..+.+++.+|++.||.+|||+
T Consensus 203 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~ 282 (291)
T cd07870 203 AFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA 282 (291)
T ss_pred CCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH
Confidence 99754321000000000 00000000 000000000000 000113568899999999999999999
Q ss_pred HHHHH
Q 026115 225 GIVLK 229 (243)
Q Consensus 225 ~~vl~ 229 (243)
.+++.
T Consensus 283 ~~~l~ 287 (291)
T cd07870 283 QDALL 287 (291)
T ss_pred HHHhc
Confidence 99875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=223.05 Aligned_cols=201 Identities=29% Similarity=0.350 Sum_probs=151.6
Q ss_pred CCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhc---cCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-
Q 026115 2 VSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILH---GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK- 76 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~- 76 (243)
+.++. ||||+++++++..+...+++|||+.. ++.++.. ..... .++...+..++.|++.|++|||+.
T Consensus 56 l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~~ 127 (288)
T cd06616 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKS-------VIPEEILGKIAVATVKALNYLKEEL 127 (288)
T ss_pred HHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 34554 99999999999999999999999854 6655432 21111 288899999999999999999975
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC---CCCcccchHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLL 153 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~ 153 (243)
+ ++|+||+|+||+++.++.++++|||+++....... .....|+..|+|||.+.+. .++.++|+||+|++++
T Consensus 128 ~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 201 (288)
T cd06616 128 K---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY 201 (288)
T ss_pred C---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHH
Confidence 6 99999999999999999999999999865433221 1223478889999998765 5788999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc---cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD---TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
++++|..||...... .+...+... +..........+..+.+++.+||+.+|++|||+.++++.
T Consensus 202 el~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 202 EVATGKFPYPKWNSV--------------FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHhCCCCchhcchH--------------HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999643210 011111111 111112223356689999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=228.90 Aligned_cols=215 Identities=23% Similarity=0.308 Sum_probs=155.6
Q ss_pred CCcc-cCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 2 VSRL-KNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
++++ +||||+++++++.. +...++|+||+.+ +|..++.... +++..+..++.|++.|++|||+.+
T Consensus 60 l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~- 127 (337)
T cd07852 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANI----------LEDVHKRYIMYQLLKALKYIHSGN- 127 (337)
T ss_pred HHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4577 99999999999864 4468999999974 9999887652 778888999999999999999998
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccc---cccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR---LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
++|+||+|+||+++.++.++++|||++......... .......|+..|+|||.+.+ ..++.++|+||||+++++
T Consensus 128 --i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~e 205 (337)
T cd07852 128 --VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGE 205 (337)
T ss_pred --eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHH
Confidence 999999999999999999999999998766443221 11223457889999998765 456889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhh--------hhhhc---cccC---CCCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV--------KQCVD---TKLG---GEYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~---~~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
+++|..||....+................... ....+ .... .......+..+.+++.+||+.||++
T Consensus 206 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~ 285 (337)
T cd07852 206 MLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNK 285 (337)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccc
Confidence 99999999754322111000000000000000 00000 0000 0111124567999999999999999
Q ss_pred CCCHHHHHHH
Q 026115 221 RPNMGIVLKA 230 (243)
Q Consensus 221 Rps~~~vl~~ 230 (243)
|||+.++++.
T Consensus 286 Rps~~~il~~ 295 (337)
T cd07852 286 RLTAEEALEH 295 (337)
T ss_pred ccCHHHHhhC
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=225.12 Aligned_cols=213 Identities=22% Similarity=0.307 Sum_probs=152.3
Q ss_pred CCcccCCccceeeEEEEeCC--------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRLKNENVVELVGYYVDGP--------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
+++++||||+++++++.... ..++|+||+.+ +|.+++..... .+++..++.++.|+++|+.||
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~l 135 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYI 135 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHH
Confidence 57889999999999987543 45999999965 88888765432 188999999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc--ccccccccccccCchhhccCC-CCcccchHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGV 150 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ 150 (243)
|+.+ ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+.. ++.++|+||+|+
T Consensus 136 H~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 212 (310)
T cd07865 136 HRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGC 212 (310)
T ss_pred HHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHH
Confidence 9998 9999999999999999999999999987654332211 112234678899999887643 678999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeeccCcCchh------------------hhhhhhccccCCCCCHHHHHHHHHHHHh
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED------------------KVKQCVDTKLGGEYPPKAIAKMAAVAAL 212 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~ 212 (243)
+++++++|..||....+................+ .........+. .......+.+++.+
T Consensus 213 ~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~ 289 (310)
T cd07865 213 IMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDK 289 (310)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHH
Confidence 9999999999997553321110000000000000 00000000000 00123457899999
Q ss_pred hcCCCCCCCCCHHHHHH
Q 026115 213 CVQYEADFRPNMGIVLK 229 (243)
Q Consensus 213 ~l~~~p~~Rps~~~vl~ 229 (243)
||+.||.+|||++++++
T Consensus 290 ~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 290 LLVLDPAKRIDADTALN 306 (310)
T ss_pred HhcCChhhccCHHHHhc
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=217.53 Aligned_cols=213 Identities=21% Similarity=0.257 Sum_probs=156.4
Q ss_pred CcccCCccceeeEEEEeCCe-----eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 3 SRLKNENVVELVGYYVDGPL-----RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
++++||||+++++++..... .++++|++.+ +|.+++...... .+++..++.++.|++.|+.+||+.+
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~~ 127 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLHSHR 127 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45679999999999987766 9999999975 899988765432 2888999999999999999999998
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++|+|++|+||+++.++.++++|||.+......... ....++..|+|||.+.+..++.++|+||+|+++++|++
T Consensus 128 ---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~ 201 (287)
T cd07838 128 ---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR 201 (287)
T ss_pred ---eeeccCChhhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHh
Confidence 999999999999999999999999998765433211 22346788999999998888999999999999999999
Q ss_pred CCCCCCCCCCCCCccceee-ccC----cCchhh--hhhhhcccc---CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTW-ATP----KLSEDK--VKQCVDTKL---GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~-~~~----~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
|.+||.............. ... .+.... ......... ........+..+.+++.+||+.||++||++.++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i 281 (287)
T cd07838 202 RRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281 (287)
T ss_pred CCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH
Confidence 9999875432211000000 000 000000 000000000 011122445678999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
+.
T Consensus 282 l~ 283 (287)
T cd07838 282 LQ 283 (287)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=222.54 Aligned_cols=199 Identities=23% Similarity=0.322 Sum_probs=161.3
Q ss_pred CCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++ ||||+++++++.++...+++||++.+++|.+++..... +++..++.++.|++.|+.+||+.+
T Consensus 55 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~i~~ql~~~l~~Lh~~~--- 122 (280)
T cd05581 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---------LDEKCTRFYAAEILLALEYLHSKG--- 122 (280)
T ss_pred HHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 45677 99999999999999999999999999999999987642 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccc------------------cccccccccccccCchhhccCCCCcc
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR------------------LHSTRVLGTFGYHAPEYAMTGQMSSK 142 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~ 142 (243)
++|+|++|+||+++.++.++++|||++......... .......++..|+|||......++.+
T Consensus 123 ~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~ 202 (280)
T cd05581 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS 202 (280)
T ss_pred eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh
Confidence 999999999999999999999999998765443221 11223457789999999988888999
Q ss_pred cchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 026115 143 SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 143 ~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (243)
+|+||||++++++++|..||..... ........ ......+...++.+.+++.+||+.+|++||
T Consensus 203 ~Di~slG~~l~~l~~g~~p~~~~~~---------------~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 265 (280)
T cd05581 203 SDLWALGCIIYQMLTGKPPFRGSNE---------------YLTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265 (280)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCccH---------------HHHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCC
Confidence 9999999999999999999974421 01111111 111233344567899999999999999999
Q ss_pred CH----HHHHH
Q 026115 223 NM----GIVLK 229 (243)
Q Consensus 223 s~----~~vl~ 229 (243)
|+ .++++
T Consensus 266 ~~~~~~~~ll~ 276 (280)
T cd05581 266 GVNEGYDELKA 276 (280)
T ss_pred CcccCHHHHhc
Confidence 99 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=221.57 Aligned_cols=206 Identities=20% Similarity=0.239 Sum_probs=159.1
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++ +||||+++.+.+..+...++||||+.+++|.+++..... +++..+..++.|++.|+.|||+.+
T Consensus 58 l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~ql~~~l~~lH~~~--- 125 (288)
T cd05583 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---------FTESEVRVYIAEIVLALDHLHQLG--- 125 (288)
T ss_pred HHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCC---------cCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4566 599999999999999999999999999999999875432 788899999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC--CCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|.||+++.++.++++|||+++........ ......|+..|++||.+.+.. .+.++|+||+|++++++++|
T Consensus 126 ~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg 204 (288)
T cd05583 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204 (288)
T ss_pred eeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence 999999999999999999999999998765433211 112235788999999987654 67899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
..||........ ........... ....+...+..+.+++.+||+.||++|||+.++.+.|..
T Consensus 205 ~~p~~~~~~~~~-----------~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 205 ASPFTVDGEQNS-----------QSEISRRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCcccCcccch-----------HHHHHHHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 999863311100 00111111111 112333455679999999999999999998877766553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=231.36 Aligned_cols=197 Identities=24% Similarity=0.291 Sum_probs=165.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|..++|||||+++++......+++||||+.+|.+.+++..... .....+..++.|+++|++|||+.+
T Consensus 108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~--- 175 (596)
T KOG0586|consen 108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKN--- 175 (596)
T ss_pred HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcc---
Confidence 46789999999999999999999999999999999999988765 556888889999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~ 159 (243)
++|||||.+|++++.+.+++|+|||++..+..... .....|++.|.|||++.+..| .+..|+||+|+++|-++.|.
T Consensus 176 ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~Gs 252 (596)
T KOG0586|consen 176 IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGS 252 (596)
T ss_pred eeccccchhhcccccccceeeeccccceeeccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecc
Confidence 99999999999999999999999999887764322 345668999999999998887 67899999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.||.+..-... ....+..++ ..+...+.++.++|+++|..+|.+|++.+++.+
T Consensus 253 LPFDG~~lk~L---------------r~rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 253 LPFDGQNLKEL---------------RPRVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cccCCcccccc---------------cchheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 99985422111 111222222 334445668999999999999999999999865
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=222.66 Aligned_cols=215 Identities=16% Similarity=0.196 Sum_probs=153.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++|+||+. ++|.+++....... .+...+..++.|++.|+.|||+++ +
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH~~~---i 123 (294)
T PLN00009 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFA-------KNPRLIKTYLYQILRGIAYCHSHR---V 123 (294)
T ss_pred HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCC-------cCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 578899999999999999999999999996 48888876544321 577888899999999999999998 9
Q ss_pred EeccCCCCceEecC-CCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCC
Q 026115 82 IHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~ 159 (243)
+|+||+|+||+++. ++.++++|||++......... .....++..|+|||.+.+. .++.++|+||+|++++++++|.
T Consensus 124 ~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~ 201 (294)
T PLN00009 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201 (294)
T ss_pred eCCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999985 567899999998755432111 1223467899999988754 4688999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhh------hhhh--hccccCCC----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDK------VKQC--VDTKLGGE----YPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~--~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
.||....................... .... ........ .....+..+.+++.+|++.+|++||++.++
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~ 281 (294)
T PLN00009 202 PLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281 (294)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence 99975432111000000000000000 0000 00000000 112235568999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 282 l~ 283 (294)
T PLN00009 282 LE 283 (294)
T ss_pred hc
Confidence 87
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=216.72 Aligned_cols=194 Identities=25% Similarity=0.305 Sum_probs=158.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++.+..+...+++||++.+++|.+++..... ++...+..++.|++.|+.|||+.+ +
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lh~~~---~ 114 (250)
T cd05123 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR---------FSEERARFYAAEIVLALEYLHSLG---I 114 (250)
T ss_pred HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5688999999999999999999999999999999999976642 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++++|||.+........ ......++..|++||...+...+.++|+||||++++++++|..|
T Consensus 115 ~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p 192 (250)
T cd05123 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192 (250)
T ss_pred eecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999998866543321 12334578899999999888888999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
|..... ......... .....+...+..+.+++.+||..||++|||+++
T Consensus 193 ~~~~~~---------------~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 193 FYAEDR---------------KEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCH---------------HHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 964321 011111111 112334444678999999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=220.35 Aligned_cols=207 Identities=16% Similarity=0.185 Sum_probs=151.4
Q ss_pred CcccCCccceeeEEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 3 SRLKNENVVELVGYYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
..++|+|++++++++.... ..+++++++.. ++.+.+..... .+...+..++.|++.|+.|||+.+
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~- 146 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC---------KNKKLIKNIMKDMLTTLEYIHEHG- 146 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhcc---------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4678999999999766443 34677777643 67666654321 556778899999999999999998
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccc-----cccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
++||||||+||+++.++.++|+|||+++........ .......||+.|+|||+..+..++.++|+|||||+++
T Consensus 147 --iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~ 224 (294)
T PHA02882 147 --ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCML 224 (294)
T ss_pred --eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 999999999999999999999999998765322111 0112235899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
++++|..||........ ... ....+.......... ....+++.+.+++..||+.+|++||+++++++.+
T Consensus 225 el~~g~~P~~~~~~~~~--~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 225 KWAGIKLPWKGFGHNGN--LIH----AAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhCCCCCCccccchH--HHH----HhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99999999975421110 000 000011111111111 1123467899999999999999999999999876
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=230.17 Aligned_cols=215 Identities=21% Similarity=0.320 Sum_probs=156.3
Q ss_pred CCcccCCccceeeEEEE----eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKNENVVELVGYYV----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
+++++||||+++.+++. .....++|+||+. ++|.+++..... ++...+..++.|++.|+.|||+.+
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~ 127 (334)
T cd07855 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQP---------LTEEHIRYFLYQLLRGLKYIHSAN 127 (334)
T ss_pred HHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCC---------CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 57889999999999886 3457899999995 589999875442 889999999999999999999998
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc--ccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+ ..++.++|+||+|+++++
T Consensus 128 ---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~e 204 (334)
T cd07855 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE 204 (334)
T ss_pred ---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHH
Confidence 9999999999999999999999999987654332211 1123457889999999865 457889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcC--------chhhhhhhhcc-ccCCCC-----CHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKL--------SEDKVKQCVDT-KLGGEY-----PPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|++|..||................... ......+.... ...... ....+..+.+++.+||+.+|++
T Consensus 205 l~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 284 (334)
T cd07855 205 MLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEE 284 (334)
T ss_pred HHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhh
Confidence 999999996543211100000000000 00111111110 000111 1234678999999999999999
Q ss_pred CCCHHHHHH
Q 026115 221 RPNMGIVLK 229 (243)
Q Consensus 221 Rps~~~vl~ 229 (243)
|||+++++.
T Consensus 285 Rpt~~~~l~ 293 (334)
T cd07855 285 RITVEQALQ 293 (334)
T ss_pred CcCHHHHHh
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=229.07 Aligned_cols=220 Identities=22% Similarity=0.267 Sum_probs=157.0
Q ss_pred CCcccCCccceeeEEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+++++||||+++++++... ...++++||+.+ +|...+.... ++...+..++.|++.|+.+||+.
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~ 125 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH----------LSNDHIQYFLYQILRGLKYIHSA 125 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC
Confidence 5678999999999987643 358999999965 8888876543 88999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
+ ++|+||+|+||+++.++.++++|||++.......... ......|+..|+|||.+.+ ..++.++|+||+|+++++
T Consensus 126 ~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~e 202 (336)
T cd07849 126 N---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAE 202 (336)
T ss_pred C---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999987654322211 1122457889999998754 457889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc---------CCCC-----CHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL---------GGEY-----PPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~-----~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|++|..||.....................+....+..... .... ....+..+.+++.+||+.+|++
T Consensus 203 l~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 282 (336)
T cd07849 203 MLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHK 282 (336)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhh
Confidence 9999999965422110000000000001111111111000 0000 1123567999999999999999
Q ss_pred CCCHHHHHHH--HHHHH
Q 026115 221 RPNMGIVLKA--LQPLL 235 (243)
Q Consensus 221 Rps~~~vl~~--l~~~~ 235 (243)
|||+.++++. +.+..
T Consensus 283 Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 283 RITVEEALAHPYLEQYH 299 (336)
T ss_pred CcCHHHHhcCccccccC
Confidence 9999999985 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=216.68 Aligned_cols=222 Identities=21% Similarity=0.281 Sum_probs=165.3
Q ss_pred CCCcccCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLKNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++.++||||+.++.+|.. +...++++||.+. +|...++.....+.. .++...+..++.||+.|+.|||++-
T Consensus 80 L~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~----~lp~~mvKsilwQil~Gv~YLH~NW-- 152 (438)
T KOG0666|consen 80 LLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAK----QLPRSMVKSILWQILDGVHYLHSNW-- 152 (438)
T ss_pred HHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhc----cCCHHHHHHHHHHHHhhhHHHhhhh--
Confidence 3578999999999999876 8889999999987 999998776654332 3788899999999999999999998
Q ss_pred CeEeccCCCCceEecCC----CceeecccCCCCCCccccccccc-ccccccccccCchhhccC-CCCcccchHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLLFDD----DIAKISDFDLSNQAPDAAARLHS-TRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLL 153 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~ 153 (243)
++|||+||.||++..+ |.|||+|+|+++.+.+...+..+ ...+-|..|+|||.+.+. -|+.+.|+|+.||++.
T Consensus 153 -vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfa 231 (438)
T KOG0666|consen 153 -VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFA 231 (438)
T ss_pred -eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHH
Confidence 9999999999999876 89999999999999887766533 445679999999999875 5899999999999999
Q ss_pred HHHhCCCCCCCCCCCCC-c-cce---------------eeccCcCch----hhhhhhhccccCCCC--C------HHHHH
Q 026115 154 ELLTGRKPVDHTLPRGQ-Q-SLV---------------TWATPKLSE----DKVKQCVDTKLGGEY--P------PKAIA 204 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~-~-~~~---------------~~~~~~~~~----~~~~~~~~~~~~~~~--~------~~~~~ 204 (243)
|+++.++.|.+.+.... . .+. ...|+.... .....-......... . ..-++
T Consensus 232 ElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~ 311 (438)
T KOG0666|consen 232 ELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDP 311 (438)
T ss_pred HHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCc
Confidence 99999999876533211 1 110 001111000 000000000000010 0 00122
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 205 KMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 205 ~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
.-.+|+.+||..||.+|.|+++.++.
T Consensus 312 ~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 312 SALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred hHHHHHHHHhccCchhhccHHHHhcc
Confidence 47889999999999999999998874
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=222.20 Aligned_cols=218 Identities=17% Similarity=0.185 Sum_probs=152.2
Q ss_pred CCcc-cCCccceeeEEEEeCCe-----eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRL-KNENVVELVGYYVDGPL-----RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
++++ +||||+++++++..... .+++|||+.+ +|.+++....... ...+++..++.++.|++.||.|||+
T Consensus 54 l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~ 128 (295)
T cd07837 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGP----GRPLPAKTIKSFMYQLLKGVAHCHK 128 (295)
T ss_pred HHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccC----CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456 46999999999987655 8999999986 8999886543210 1137899999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecC-CCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~ 153 (243)
.+ ++|+||+|+||+++. ++.++++|||.++........ .....+++.|+|||.+.+ ..++.++|+||+|++++
T Consensus 129 ~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~ 203 (295)
T cd07837 129 HG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFA 203 (295)
T ss_pred CC---eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHH
Confidence 98 999999999999998 889999999998755332111 122346778999998865 45688999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhh------hhhhc-cccC----CCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV------KQCVD-TKLG----GEYPPKAIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (243)
+|++|..||....+......+............ ..... .... .......+..+.+++.+||+.||.+||
T Consensus 204 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~ 283 (295)
T cd07837 204 EMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI 283 (295)
T ss_pred HHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC
Confidence 999999999754221100000000000000000 00000 0000 000123456799999999999999999
Q ss_pred CHHHHHH
Q 026115 223 NMGIVLK 229 (243)
Q Consensus 223 s~~~vl~ 229 (243)
|+.+++.
T Consensus 284 ~~~eil~ 290 (295)
T cd07837 284 SAKAALT 290 (295)
T ss_pred CHHHHhc
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=226.16 Aligned_cols=215 Identities=25% Similarity=0.286 Sum_probs=155.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+...+++|||+. ++|.+++..... ++...+..++.|++.|+.+||+.+ +
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~ql~~aL~~LH~~~---i 140 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR---------LTESQVKCILLQILNGLNVLHKWY---F 140 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 568899999999999999999999999996 599998865432 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccc------------ccccccccccccccCchhhccC-CCCcccchHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA------------RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSF 148 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Diwsl 148 (243)
+|+||+|+||+++.++.++++|||.++....... ........++..|+|||.+.+. .++.++|+|||
T Consensus 141 ~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 141 MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred ecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 9999999999999999999999999876542110 0011123457789999998764 46889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhh--------hcc---ccCCCCCHHHHHHHHHHHHhhcCCC
Q 026115 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC--------VDT---KLGGEYPPKAIAKMAAVAALCVQYE 217 (243)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~li~~~l~~~ 217 (243)
|++++++++|..||....+......+............... ... ..........+..+.+++.+||+.+
T Consensus 221 G~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 300 (335)
T PTZ00024 221 GCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLN 300 (335)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCC
Confidence 99999999999999755322110000000000000000000 000 0000011123567899999999999
Q ss_pred CCCCCCHHHHHH
Q 026115 218 ADFRPNMGIVLK 229 (243)
Q Consensus 218 p~~Rps~~~vl~ 229 (243)
|++|||+++++.
T Consensus 301 P~~R~s~~~~l~ 312 (335)
T PTZ00024 301 PLERISAKEALK 312 (335)
T ss_pred chhccCHHHHhc
Confidence 999999999986
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=222.36 Aligned_cols=215 Identities=20% Similarity=0.265 Sum_probs=156.2
Q ss_pred CCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++|||++++++++.+. ...++|+||+.+ +|.+++..... .+++..++.++.|++.|+++||+.+
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH~~~-- 120 (287)
T cd07840 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEV--------KFTESQIKCYMKQLLEGLQYLHSNG-- 120 (287)
T ss_pred HHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5678999999999999988 899999999975 89988876531 2889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|+||+++.++.++++|||++.......... .....++..|+|||.+.+ ..++.++|+||||++++++++|
T Consensus 121 -~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 121 -ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred -ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999987665432211 122346778999998765 4578899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhh--------hhhh------ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKV--------KQCV------DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
..||........................ .... ...........++..+.+++.+||+.+|.+|||+
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 278 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 9999754322110000000000000000 0000 0000000111136679999999999999999999
Q ss_pred HHHHH
Q 026115 225 GIVLK 229 (243)
Q Consensus 225 ~~vl~ 229 (243)
+++++
T Consensus 279 ~~~l~ 283 (287)
T cd07840 279 DQALQ 283 (287)
T ss_pred HHHhh
Confidence 99986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=228.20 Aligned_cols=218 Identities=23% Similarity=0.303 Sum_probs=157.7
Q ss_pred CCcccCCccceeeEEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
++.++||||+++++++... ...++++||+. ++|.+++..... ++...+..++.|++.|+.|||+.
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~ 127 (337)
T cd07858 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQT---------LSDDHCQYFLYQLLRGLKYIHSA 127 (337)
T ss_pred HHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhC
Confidence 5678999999999988644 35899999995 589988875432 88999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l 155 (243)
+ ++|+||+|+||+++.++.++|+|||+++....... ......++..|+|||.+.. ..++.++|+||||++++++
T Consensus 128 ~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 202 (337)
T cd07858 128 N---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202 (337)
T ss_pred C---EecCCCCHHHEEEcCCCCEEECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHH
Confidence 8 99999999999999999999999999876543321 1223357889999998864 4578999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeecc--------CcCchhhhhhhhcc---ccC---CCCCHHHHHHHHHHHHhhcCCCCCCC
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWAT--------PKLSEDKVKQCVDT---KLG---GEYPPKAIAKMAAVAALCVQYEADFR 221 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~li~~~l~~~p~~R 221 (243)
++|..||.+.............. .............. ... .......+..+.+++.+||+.+|++|
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 282 (337)
T cd07858 203 LGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282 (337)
T ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhc
Confidence 99999997542110000000000 00000011111100 000 01112356678999999999999999
Q ss_pred CCHHHHHHH--HHHH
Q 026115 222 PNMGIVLKA--LQPL 234 (243)
Q Consensus 222 ps~~~vl~~--l~~~ 234 (243)
||++++++. +..+
T Consensus 283 ps~~ell~h~~~~~~ 297 (337)
T cd07858 283 ITVEEALAHPYLASL 297 (337)
T ss_pred cCHHHHHcCcchhhh
Confidence 999999985 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=221.01 Aligned_cols=214 Identities=22% Similarity=0.243 Sum_probs=152.4
Q ss_pred CCcccCCccceeeEEEEeCC----------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYVDGP----------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 71 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~ 71 (243)
+++++||||+++++++.+.. .+++++||+.+ ++..++..... .+++..++.++.|++.|++
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~ 130 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLN 130 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHH
Confidence 56889999999999987654 79999999976 77777765422 2889999999999999999
Q ss_pred HhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHH
Q 026115 72 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGV 150 (243)
Q Consensus 72 ~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ 150 (243)
|||+.+ ++|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+. .++.++|+||+||
T Consensus 131 ~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 206 (302)
T cd07864 131 YCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 206 (302)
T ss_pred HHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHH
Confidence 999998 999999999999999999999999998765433211 11122356789999988643 4688999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhh--------------hccccCCCCCHHHHHHHHHHHHhhcCC
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC--------------VDTKLGGEYPPKAIAKMAAVAALCVQY 216 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~ 216 (243)
+++++++|..||........................... ...... ......+..+.+++.+||+.
T Consensus 207 ~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~ 285 (302)
T cd07864 207 ILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTL 285 (302)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccC
Confidence 999999999999754221100000000000000000000 000000 00112356799999999999
Q ss_pred CCCCCCCHHHHHH
Q 026115 217 EADFRPNMGIVLK 229 (243)
Q Consensus 217 ~p~~Rps~~~vl~ 229 (243)
+|.+|||+.++++
T Consensus 286 ~P~~Rp~~~~il~ 298 (302)
T cd07864 286 DPSKRCTAEEALN 298 (302)
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=217.09 Aligned_cols=202 Identities=22% Similarity=0.280 Sum_probs=156.1
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++ +||||+++++++..+...++|+||+++++|.+++..... ++...+..++.|++.|+.|||+.+
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~--- 125 (290)
T cd05613 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER---------FKEQEVQIYSGEIVLALEHLHKLG--- 125 (290)
T ss_pred HHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4566 589999999999999999999999999999999976542 778889999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC--CCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||+|+||+++.++.++|+|||++......... ......|+..|+|||.+... .++.++|+||+|++++++++|
T Consensus 126 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g 204 (290)
T cd05613 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204 (290)
T ss_pred eeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcC
Confidence 999999999999999999999999998765432211 11234578899999998753 457889999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
..||....... ............ ....+...+..+.+++.+||+.||++|| ++.++++
T Consensus 205 ~~p~~~~~~~~------------~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 205 ASPFTVDGEKN------------SQAEISRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCCCCcCCccc------------cHHHHHHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 99986321110 001111111111 1123334566799999999999999997 7788776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=218.45 Aligned_cols=204 Identities=16% Similarity=0.210 Sum_probs=155.5
Q ss_pred cceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCC
Q 026115 10 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 89 (243)
Q Consensus 10 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~ 89 (243)
++.+.++|...++.|+|+|.+ |-++.+|+..+...+ ++...+..++.|++++++|||+.+ ++|.|+||+
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~-------fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPE 221 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIP-------FPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPE 221 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccc-------cchHHHHHHHHHHHHHHHHHHhcc---eeecCCChh
Confidence 567777899999999999998 669999999987654 889999999999999999999999 999999999
Q ss_pred ceEecC--------------------CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHH
Q 026115 90 NVLLFD--------------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFG 149 (243)
Q Consensus 90 nil~~~--------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG 149 (243)
||++.. +..++++|||.+...... ....+.|..|+|||++.+-.++.++|+||+|
T Consensus 222 NILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiG 296 (415)
T KOG0671|consen 222 NILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIG 296 (415)
T ss_pred eEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeee
Confidence 999842 335789999998754332 3456789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhh-----h--------------------hhhhcccc----CCCCCH
Q 026115 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK-----V--------------------KQCVDTKL----GGEYPP 200 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~--------------------~~~~~~~~----~~~~~~ 200 (243)
|+|+|+++|...|++.+....-.+...+.+..+..- . ....+... ......
T Consensus 297 CIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d 376 (415)
T KOG0671|consen 297 CILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDD 376 (415)
T ss_pred eEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCc
Confidence 999999999999997764332222222211111100 0 00000000 001223
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 201 KAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 201 ~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.....+++|+.+||..||.+|+|+.|+|.
T Consensus 377 ~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 377 LEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 44557999999999999999999999987
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=226.74 Aligned_cols=222 Identities=22% Similarity=0.283 Sum_probs=162.6
Q ss_pred CCcccCCccceeeEEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+++++||||+++.+++.... .++++++|+.+ +|.+++.... .+++..++.++.|++.|+++||+.
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~ 122 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSA 122 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56789999999999998765 78999999974 8999887654 288999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc-cccccccccccccCchhhccC-CCCcccchHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~ 154 (243)
| ++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||+|+++++
T Consensus 123 g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~ 199 (330)
T cd07834 123 N---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAE 199 (330)
T ss_pred C---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHH
Confidence 8 999999999999999999999999998766543211 112234578889999999877 78999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcC--------chhhhhhhhcc---ccC---CCCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKL--------SEDKVKQCVDT---KLG---GEYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~---~~~---~~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
+++|..||...........+....... ........... ... .......+..+.+++.+||+.+|++
T Consensus 200 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 279 (330)
T cd07834 200 LLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKK 279 (330)
T ss_pred HHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhh
Confidence 999999997553221100000000000 00011111110 000 0011224667999999999999999
Q ss_pred CCCHHHHHH--HHHHHHh
Q 026115 221 RPNMGIVLK--ALQPLLN 236 (243)
Q Consensus 221 Rps~~~vl~--~l~~~~~ 236 (243)
|||+.++++ .+++...
T Consensus 280 Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 280 RITADEALAHPYLAQLHD 297 (330)
T ss_pred CCCHHHHHhCccHHhhcc
Confidence 999999998 3555444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=219.60 Aligned_cols=197 Identities=22% Similarity=0.297 Sum_probs=163.0
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||++++.+.||.+--+|+....+|+|+..|.||+|.-.|...... .+++..+.-++.+|+.||.+||..+
T Consensus 238 iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~-------gF~e~ra~FYAAEi~cGLehlH~~~--- 307 (591)
T KOG0986|consen 238 ILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNP-------GFDEQRARFYAAEIICGLEHLHRRR--- 307 (591)
T ss_pred HHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCC-------CCchHHHHHHHHHHHhhHHHHHhcc---
Confidence 467889999999888899999999999999999999988776531 3999999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
|++||+||+|||+|+.|+++|+|+|+|..+...... ...+||.+|||||++.+..|+.+.|.|+|||++|||+.|+.
T Consensus 308 iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~s 384 (591)
T KOG0986|consen 308 IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHS 384 (591)
T ss_pred eeeccCChhheeeccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccC
Confidence 999999999999999999999999999887665432 33479999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN 223 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (243)
||...-+ ....+.+.+.+.. -...++...+++..++....|++||.+|.-
T Consensus 385 PFr~~Ke------------Kvk~eEvdrr~~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 385 PFRQRKE------------KVKREEVDRRTLE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred chhhhhh------------hhhHHHHHHHHhc-chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 9963311 1111112111111 112456778889999999999999999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=217.08 Aligned_cols=196 Identities=26% Similarity=0.385 Sum_probs=150.3
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCCeEec
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHR 84 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~~~h~ 84 (243)
.||||+++++++.++...+++|||+. ++|.+++..... .+++..+..++.|++.|+.|||+ .+ ++|+
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~ 139 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKHG---VIHR 139 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EecC
Confidence 59999999999999999999999985 478877765432 28889999999999999999997 46 9999
Q ss_pred cCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC----CCcccchHHHHHHHHHHHhCCC
Q 026115 85 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 85 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~l~~g~~ 160 (243)
||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+.. ++.++|+||||++++++++|..
T Consensus 140 dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (296)
T cd06618 140 DVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216 (296)
T ss_pred CCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999865543221 12234678899999987543 6789999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG-GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
||...... .+........... .......+..+.+++.+||+.||++|||+.++++.
T Consensus 217 p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 217 PYKNCKTE--------------FEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCcchhH--------------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 98642110 0111111111110 01111245679999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=217.36 Aligned_cols=214 Identities=21% Similarity=0.325 Sum_probs=155.8
Q ss_pred CCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++ ||||+++++++.++...++||||+ +++|.+++....+. .++...++.++.|++.++.|||+++
T Consensus 51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~Lh~~~--- 119 (283)
T cd07830 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK-------PFSESVIRSIIYQILQGLAHIHKHG--- 119 (283)
T ss_pred HHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 35677 999999999999999999999999 77999988765422 2789999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.. ..++.++|+||||++++++++|.
T Consensus 120 i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~ 196 (283)
T cd07830 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196 (283)
T ss_pred cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC
Confidence 99999999999999999999999999875543221 122347788999998754 45788999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchh------hhhhhhccccC-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSED------KVKQCVDTKLG-------GEYPPKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
.||...................... ........... .......+..+.+++.+||+.||++|||+.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 197 PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred CccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 9996543211100000000000000 00000000000 0001112467999999999999999999999
Q ss_pred HHH
Q 026115 227 VLK 229 (243)
Q Consensus 227 vl~ 229 (243)
++.
T Consensus 277 i~~ 279 (283)
T cd07830 277 ALQ 279 (283)
T ss_pred Hhh
Confidence 976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=215.97 Aligned_cols=214 Identities=24% Similarity=0.277 Sum_probs=156.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|||++++++++.+....++|+||+.+ +|.+++..... .++...++.++.|++.|+.+||+.+ +
T Consensus 52 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i 119 (282)
T cd07829 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCHSHR---I 119 (282)
T ss_pred HHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999974 99999987531 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++|+|||+++........ .....++..|+|||.+.+. .++.++|+||||++++++++|..
T Consensus 120 ~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 197 (282)
T cd07829 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197 (282)
T ss_pred ccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765433211 1223356789999998766 77889999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhh------------hhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKV------------KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
||........................ ................+..+.+++.+||+.+|++||++.+++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 277 (282)
T cd07829 198 LFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277 (282)
T ss_pred CCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence 99654321100000000000000000 000000000001112256799999999999999999999998
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
.
T Consensus 278 ~ 278 (282)
T cd07829 278 K 278 (282)
T ss_pred h
Confidence 6
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=214.14 Aligned_cols=225 Identities=28% Similarity=0.401 Sum_probs=183.9
Q ss_pred cccCCccceeeEEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc---
Q 026115 4 RLKNENVVELVGYYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK--- 76 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~--- 76 (243)
.++|+||++|+++-+.+. .++||++|.+.|+|.+||..+. ++|....+++..++.||+|||+.
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~ 329 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPR 329 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCc
Confidence 689999999999887555 7999999999999999999987 99999999999999999999964
Q ss_pred ---CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC-CC-----cccchHH
Q 026115 77 ---AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MS-----SKSDVYS 147 (243)
Q Consensus 77 ---~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-----~~~Diws 147 (243)
-++.|+|||||+.|||+..+++.-|+|||++..+............+||..|||||++.+.. .. .+.||||
T Consensus 330 ~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYa 409 (534)
T KOG3653|consen 330 GDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYA 409 (534)
T ss_pred CCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHH
Confidence 26779999999999999999999999999998877555444445578999999999998642 22 2689999
Q ss_pred HHHHHHHHHhCCCCCC-CCCCCCCccceeeccCcCchhhhhhhhcccc-CCCCCH-----HHHHHHHHHHHhhcCCCCCC
Q 026115 148 FGVVLLELLTGRKPVD-HTLPRGQQSLVTWATPKLSEDKVKQCVDTKL-GGEYPP-----KAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 148 lG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~li~~~l~~~p~~ 220 (243)
+|.++||+++...-+. +..+..+-.+.+.+..++..+..++.+.... +...+. .....+.+.+.-||..||+.
T Consensus 410 mgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeA 489 (534)
T KOG3653|consen 410 MGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEA 489 (534)
T ss_pred HHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhh
Confidence 9999999999776654 4555556566666777788787777655433 333322 23557999999999999999
Q ss_pred CCCHHHHHHHHHHHHhhc
Q 026115 221 RPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 221 Rps~~~vl~~l~~~~~~~ 238 (243)
|.||.=+-+.+.++....
T Consensus 490 RLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 490 RLTAGCVEERMAELMMLW 507 (534)
T ss_pred hhhhHHHHHHHHHHhccC
Confidence 999999999888776544
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=208.21 Aligned_cols=209 Identities=22% Similarity=0.373 Sum_probs=161.2
Q ss_pred ccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 026115 4 RLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 82 (243)
Q Consensus 4 ~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~ 82 (243)
+++ |+||++++++|+++.++|||||.+.||.|...+.+... +++..+-.+..+|++||.|||..| |.
T Consensus 131 ~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~kg---IA 198 (463)
T KOG0607|consen 131 QCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH---------FNEREASRVVKDIASALDFLHTKG---IA 198 (463)
T ss_pred HhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhcC---cc
Confidence 444 99999999999999999999999999999999988775 999999999999999999999999 99
Q ss_pred eccCCCCceEecCCCc---eeecccCCCCCCcccccc--ccc---ccccccccccCchhhc-----cCCCCcccchHHHH
Q 026115 83 HRNIKSSNVLLFDDDI---AKISDFDLSNQAPDAAAR--LHS---TRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFG 149 (243)
Q Consensus 83 h~di~~~nil~~~~~~---~~l~df~~~~~~~~~~~~--~~~---~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG 149 (243)
|||+||+|||....+. +||+||++.......... ... ...+|+..|||||++. ...|+.++|.||||
T Consensus 199 HRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG 278 (463)
T KOG0607|consen 199 HRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG 278 (463)
T ss_pred cccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence 9999999999976554 699999886543322111 111 2346888999999875 23578899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccceeeccCcC---chhhhhhhhccccCCCCCHH----HHHHHHHHHHhhcCCCCCCCC
Q 026115 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKL---SEDKVKQCVDTKLGGEYPPK----AIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp 222 (243)
+++|-|++|.+||.+.-..+ +-|..... -...+.+.+..+.. .+|.. .+.+..+++...+.+++.+|-
T Consensus 279 vIlYImLsGYpPFvG~Cg~d----CGWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rl 353 (463)
T KOG0607|consen 279 VILYIMLSGYPPFVGHCGAD----CGWDRGEVCRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRL 353 (463)
T ss_pred HHHHHHHhCCCCccCccCCc----CCccCCCccHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhh
Confidence 99999999999998764322 22221111 12333343333332 34433 456788899999999999999
Q ss_pred CHHHHHH
Q 026115 223 NMGIVLK 229 (243)
Q Consensus 223 s~~~vl~ 229 (243)
++.++++
T Consensus 354 sa~~vln 360 (463)
T KOG0607|consen 354 SAAQVLN 360 (463)
T ss_pred hhhhccC
Confidence 9999987
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=221.20 Aligned_cols=210 Identities=22% Similarity=0.290 Sum_probs=152.9
Q ss_pred CCcccCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++||||+++.++|.. +...++++||+ +++|..++.... ++...+..++.|+++|+.|||+.+
T Consensus 63 l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~~--- 128 (328)
T cd07856 63 LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVHSAG--- 128 (328)
T ss_pred HHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 568899999999999865 56789999998 569998887543 777888889999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++|+||+|.||+++.++.++++|||.+...... .....++..|+|||.+.+ ..++.++|+||+|++++++++|.
T Consensus 129 iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~ 203 (328)
T cd07856 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203 (328)
T ss_pred cccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999988654321 122346788999998765 56789999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCch--------hhhhhhh-ccccCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSE--------DKVKQCV-DTKLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
.||..................... +...... ........+ ...+..+.+++.+||+.+|++|||+.
T Consensus 204 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 283 (328)
T cd07856 204 PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283 (328)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 999654321100000000000000 0000000 000001111 12356899999999999999999999
Q ss_pred HHHHH
Q 026115 226 IVLKA 230 (243)
Q Consensus 226 ~vl~~ 230 (243)
+++..
T Consensus 284 ell~~ 288 (328)
T cd07856 284 EALAH 288 (328)
T ss_pred HHhcC
Confidence 99863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=220.52 Aligned_cols=216 Identities=23% Similarity=0.271 Sum_probs=151.4
Q ss_pred CCcccCCccceeeEEEEeC--------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRLKNENVVELVGYYVDG--------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
+++++||||+++++++... ..++++++|+.+ +|...+..... .++...+..++.|+++|+.||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~l~~al~~l 131 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSV--------KLTESQIKCYMLQLLEGINYL 131 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHH
Confidence 5678999999999987543 346999999865 78777765432 288999999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccc---------cccccccccccCchhhccC-CCCccc
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH---------STRVLGTFGYHAPEYAMTG-QMSSKS 143 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~-~~~~~~ 143 (243)
|+.+ ++|+|++|+||+++.++.++++|||+++.......... .....++..|+|||.+.+. .++.++
T Consensus 132 H~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 208 (311)
T cd07866 132 HENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV 208 (311)
T ss_pred HhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchh
Confidence 9998 99999999999999999999999999875543222111 1123467889999988654 478899
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCch------hhhhhhh----ccccCC---CCCHHHHHHHHHHH
Q 026115 144 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE------DKVKQCV----DTKLGG---EYPPKAIAKMAAVA 210 (243)
Q Consensus 144 DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~----~~~~~~---~~~~~~~~~~~~li 210 (243)
|+||+|++++++++|.+||.+................... ....... ...... .........+.+++
T Consensus 209 Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 288 (311)
T cd07866 209 DIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLL 288 (311)
T ss_pred HhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHH
Confidence 9999999999999999999754332111000000000000 0000000 000000 00011235789999
Q ss_pred HhhcCCCCCCCCCHHHHHH
Q 026115 211 ALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 211 ~~~l~~~p~~Rps~~~vl~ 229 (243)
.+||+.||.+|||+.+++.
T Consensus 289 ~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 289 SKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHcccCcccCcCHHHHhc
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-33 Score=224.56 Aligned_cols=209 Identities=23% Similarity=0.305 Sum_probs=153.6
Q ss_pred CCcccCCccceeeEEEEeCCe------eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGPL------RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++.+++..++. .++|+||+ +++|.+++.... +++..+..++.|++.|+.|||+
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~ 136 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRGLKYIHS 136 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 567899999999998876554 89999998 669999987633 8899999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
.+ ++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++++
T Consensus 137 ~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~e 208 (343)
T cd07851 137 AG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208 (343)
T ss_pred CC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHH
Confidence 98 999999999999999999999999998765432 122346788999999865 356889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCc--------hhhhhhhhc---cccCCCC---CHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLS--------EDKVKQCVD---TKLGGEY---PPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~---~~~~~~~---~~~~~~~~~~li~~~l~~~p~~ 220 (243)
+++|..||................+... .+....... ....... ....+..+.+++.+||+.+|++
T Consensus 209 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~ 288 (343)
T cd07851 209 LLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK 288 (343)
T ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhh
Confidence 9999999975432111000000000000 000000000 0000000 0123568999999999999999
Q ss_pred CCCHHHHHH
Q 026115 221 RPNMGIVLK 229 (243)
Q Consensus 221 Rps~~~vl~ 229 (243)
|||+.++++
T Consensus 289 Rpt~~ell~ 297 (343)
T cd07851 289 RITAAEALA 297 (343)
T ss_pred CCCHHHHhc
Confidence 999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=221.71 Aligned_cols=214 Identities=24% Similarity=0.303 Sum_probs=154.9
Q ss_pred CCcccCCccceeeEEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGP------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++..+. ..++|++++ +++|.+++.... ++...+..++.|++.|+.|||+
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~al~~LH~ 136 (343)
T cd07880 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK----------LSEDRIQFLVYQMLKGLKYIHA 136 (343)
T ss_pred HHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHh
Confidence 67899999999999987553 468999998 779998886533 8889999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
.+ ++|+||+|+||+++.++.++++|||++...... .....++..|++||.+.+ ..++.++|+||+|+++++
T Consensus 137 ~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~ 208 (343)
T cd07880 137 AG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAE 208 (343)
T ss_pred CC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 98 999999999999999999999999998765332 122346788999999875 357889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCch--------hhhhhhhcc--ccC----CCCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSE--------DKVKQCVDT--KLG----GEYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--~~~----~~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
+++|..||..................... ......... ... .......+..+.+++.+|++.||++
T Consensus 209 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 288 (343)
T cd07880 209 MLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAES 288 (343)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhh
Confidence 99999999754321100000000000000 000000000 000 0011233456899999999999999
Q ss_pred CCCHHHHHH--HHHHH
Q 026115 221 RPNMGIVLK--ALQPL 234 (243)
Q Consensus 221 Rps~~~vl~--~l~~~ 234 (243)
|||+.++++ .++..
T Consensus 289 R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 289 RITAAEALAHPYFEEF 304 (343)
T ss_pred CCCHHHHhcCccHhhh
Confidence 999999995 44444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=220.68 Aligned_cols=210 Identities=25% Similarity=0.305 Sum_probs=151.9
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++... ...+++++++ +++|.+++.... +++..+..++.|++.|+.|||+
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~ 138 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHS 138 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 5688999999999988643 3467888876 779998886543 8889999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
.+ ++|+||+|+||+++.++.++++|||+++..... .....++..|+|||.+.+ ..++.++|+||+||++++
T Consensus 139 ~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 210 (345)
T cd07877 139 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 210 (345)
T ss_pred CC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHH
Confidence 98 999999999999999999999999998754322 123457889999998865 457889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCc--------Cchh---hhhhhhccccC---CCCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPK--------LSED---KVKQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
+++|..||...........+...... .... ........... .......+..+.+++.+|++.||.+
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 290 (345)
T cd07877 211 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 290 (345)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhh
Confidence 99999999654321100000000000 0000 00000000000 0001123557899999999999999
Q ss_pred CCCHHHHHHH
Q 026115 221 RPNMGIVLKA 230 (243)
Q Consensus 221 Rps~~~vl~~ 230 (243)
|||+.++++.
T Consensus 291 R~t~~e~l~h 300 (345)
T cd07877 291 RITAAQALAH 300 (345)
T ss_pred cCCHHHHhcC
Confidence 9999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=206.55 Aligned_cols=198 Identities=29% Similarity=0.373 Sum_probs=161.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+||+++++++..+...++++|++.+++|.+++..... ++...++.++.+++.++.+||+.+ +
T Consensus 41 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lh~~~---i 108 (244)
T smart00220 41 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR---------LSEDEARFYARQILSALEYLHSNG---I 108 (244)
T ss_pred HHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHHcC---e
Confidence 4678999999999999999999999999999999999876542 788899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|.||+++.++.++++|||.+....... ......++..|++||...+..++.++|+|++|++++++++|..|
T Consensus 109 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 185 (244)
T smart00220 109 IHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPP 185 (244)
T ss_pred ecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987665432 12334578899999999888888999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHH--HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK--AIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|.... ......+............. .+..+.+++.+||..+|++||++.++++
T Consensus 186 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 186 FPGDD---------------QLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCC---------------cHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 86421 11222222222221111111 5568999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=231.96 Aligned_cols=208 Identities=23% Similarity=0.361 Sum_probs=183.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|.++.|||+++++|++..+. +-||++|+++|+|.+|++..++. +.....+.|+.||++|+.|||++. +
T Consensus 752 masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~--------igsq~lLnw~~QIAkgM~YLe~qr---l 819 (1177)
T KOG1025|consen 752 MASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDN--------IGSQDLLNWCYQIAKGMKYLEEQR---L 819 (1177)
T ss_pred HhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhcc--------ccHHHHHHHHHHHHHHHHHHHhcc---h
Confidence 67899999999999998776 88899999999999999986653 888899999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||..+|+|+..-..+|++|||+++...............-.+-|+|-|.+....++.++||||+||++||++| |..
T Consensus 820 VHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~ 899 (1177)
T KOG1025|consen 820 VHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAK 899 (1177)
T ss_pred hhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCC
Confidence 9999999999999999999999999988766554443443445677999999999999999999999999999998 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
|+.+. +.+.+...++.+.+...|+.++.+++.++.+||..|++.||+++++.+.+.++...
T Consensus 900 Py~gi----------------~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 900 PYDGI----------------PAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccCCC----------------CHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 98643 44667777888888899999999999999999999999999999999999887654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=221.63 Aligned_cols=214 Identities=23% Similarity=0.296 Sum_probs=152.2
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++... ...++++||+.. +|..++.. . ++...+..++.|++.|++|||+
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~----------~~~~~~~~~~~qi~~aL~~LH~ 135 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGH-P----------LSEDKVQYLVYQMLCGLKYIHS 135 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHcC-C----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999998754 356999999864 77776531 1 7888999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
.+ ++||||+|+||+++.++.++++|||+++..... .....++..|+|||.+.+ ..++.++|+||||+++++
T Consensus 136 ~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~e 207 (342)
T cd07879 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAE 207 (342)
T ss_pred CC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHH
Confidence 98 999999999999999999999999998754321 123356788999999876 457889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhh--------hhhhcc--c-cCCC---CCHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV--------KQCVDT--K-LGGE---YPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~--~-~~~~---~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
+++|..||................+....... ...... . .... .....+..+.+++.+||+.||++
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 287 (342)
T cd07879 208 MLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDK 287 (342)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhh
Confidence 99999999754221100000000000000000 000000 0 0000 00123456889999999999999
Q ss_pred CCCHHHHHH--HHHHHH
Q 026115 221 RPNMGIVLK--ALQPLL 235 (243)
Q Consensus 221 Rps~~~vl~--~l~~~~ 235 (243)
|||+.+++. .+++..
T Consensus 288 R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 288 RLTATEALEHPYFDSFR 304 (342)
T ss_pred CcCHHHHhcCcchhhcc
Confidence 999999996 365543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=219.09 Aligned_cols=215 Identities=20% Similarity=0.228 Sum_probs=150.8
Q ss_pred CCcc-cCCccceeeEEEEeC----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRL-KNENVVELVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
++++ +||||+++++++... ...+++++++. ++|.+++..... ++...+..++.|++.||.|||+.
T Consensus 55 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~ 124 (332)
T cd07857 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQP---------LTDAHFQSFIYQILCGLKYIHSA 124 (332)
T ss_pred HHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhC
Confidence 3455 599999999975432 45788888885 599998865432 88899999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc--cccccccccccccCchhhcc-CCCCcccchHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~ 153 (243)
+ ++|+||||+||+++.++.++|+|||+++........ .......|+..|+|||.+.+ ..++.++|+||+|++++
T Consensus 125 g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~ 201 (332)
T cd07857 125 N---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILA 201 (332)
T ss_pred C---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHH
Confidence 8 999999999999999999999999998765432211 11123458889999998765 45788999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhh-----------hccccCC---CCCHHHHHHHHHHHHhhcCCCCC
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC-----------VDTKLGG---EYPPKAIAKMAAVAALCVQYEAD 219 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~ 219 (243)
++++|..||.....................+....+ ....... ......+..+.+++.+||+.||+
T Consensus 202 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 281 (332)
T cd07857 202 ELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT 281 (332)
T ss_pred HHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcc
Confidence 999999999754321100000000000000000000 0000000 00011245799999999999999
Q ss_pred CCCCHHHHHH
Q 026115 220 FRPNMGIVLK 229 (243)
Q Consensus 220 ~Rps~~~vl~ 229 (243)
+|||+.+++.
T Consensus 282 ~R~t~~~ll~ 291 (332)
T cd07857 282 KRISVEEALE 291 (332)
T ss_pred cCCCHHHHhc
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=221.84 Aligned_cols=214 Identities=20% Similarity=0.260 Sum_probs=149.5
Q ss_pred CCcccCCccceeeEEEEeC--------------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYVDG--------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 67 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~ 67 (243)
+++++||||+++++++... ...++++||+. ++|.+++.... ++...+..++.|++
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------l~~~~~~~~~~qi~ 124 (342)
T cd07854 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGP----------LSEEHARLFMYQLL 124 (342)
T ss_pred HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcCC----------CCHHHHHHHHHHHH
Confidence 5788999999999877643 35789999997 49998886543 88899999999999
Q ss_pred HHHHHhhhcCCCCeEeccCCCCceEecC-CCceeecccCCCCCCccccccc-ccccccccccccCchhhcc-CCCCcccc
Q 026115 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSD 144 (243)
Q Consensus 68 ~~l~~Lh~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~D 144 (243)
+|+.|||+.| ++|+||+|+||+++. ++.++++|||.++......... ......++..|+|||.+.+ ..++.++|
T Consensus 125 ~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 201 (342)
T cd07854 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAID 201 (342)
T ss_pred HHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhh
Confidence 9999999998 999999999999975 5678999999986543221111 1122346788999998754 45788999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhh--------hhccccCCC-----CCHHHHHHHHHHHH
Q 026115 145 VYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ--------CVDTKLGGE-----YPPKAIAKMAAVAA 211 (243)
Q Consensus 145 iwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~-----~~~~~~~~~~~li~ 211 (243)
+|||||+++++++|..||....+...........+......... ......... .....+.++.+++.
T Consensus 202 iwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 281 (342)
T cd07854 202 MWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLE 281 (342)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHH
Confidence 99999999999999999975432111000000000000000000 000000000 01123457889999
Q ss_pred hhcCCCCCCCCCHHHHHH
Q 026115 212 LCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 212 ~~l~~~p~~Rps~~~vl~ 229 (243)
+||+.||.+|||+.+++.
T Consensus 282 ~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 282 QILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhCCCchhccCHHHHhC
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=221.58 Aligned_cols=224 Identities=23% Similarity=0.315 Sum_probs=160.3
Q ss_pred CCCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 1 MVSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+|++|+|||||++++.=++. ....++||||.||||...+....-.. .+++...+.++.+++.|+.|||
T Consensus 64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~------GLpE~e~l~lL~d~~~al~~Lr 137 (732)
T KOG4250|consen 64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAY------GLPESEFLDLLSDLVSALRHLR 137 (732)
T ss_pred HHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCccccc------CCCHHHHHHHHHHHHHHHHHHH
Confidence 47899999999999976543 35799999999999999998754211 2889999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCC--C--ceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDD--D--IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFG 149 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~--~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG 149 (243)
++| |+||||||.||++-.+ | ..||+|||.|+...+... ....+||..|++||+... ..|+...|.||+|
T Consensus 138 En~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~G 211 (732)
T KOG4250|consen 138 ENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFG 211 (732)
T ss_pred HcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhh
Confidence 998 9999999999998433 3 469999999998877652 466789999999999994 7889999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCC-ccceeeccCcCchhhhh---h----hhc--ccc--CCCCCHHHHHHHHHHHHhhcCCC
Q 026115 150 VVLLELLTGRKPVDHTLPRGQ-QSLVTWATPKLSEDKVK---Q----CVD--TKL--GGEYPPKAIAKMAAVAALCVQYE 217 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~---~----~~~--~~~--~~~~~~~~~~~~~~li~~~l~~~ 217 (243)
|++|+++||..||........ +..........+..... + -++ ..+ .-.........+...+..+|..|
T Consensus 212 vtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~ 291 (732)
T KOG4250|consen 212 VTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWN 291 (732)
T ss_pred hHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhh
Confidence 999999999999975433221 11111000000000000 0 000 000 00111233345666777788888
Q ss_pred CCCCC--CHHHHHHHHHHHHh
Q 026115 218 ADFRP--NMGIVLKALQPLLN 236 (243)
Q Consensus 218 p~~Rp--s~~~vl~~l~~~~~ 236 (243)
|.+|- ...+.-..+.++++
T Consensus 292 ~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 292 PRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred HHHhCCCCcchHHHHHHHHHh
Confidence 88887 66666666666554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-33 Score=221.94 Aligned_cols=193 Identities=22% Similarity=0.303 Sum_probs=167.1
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||.+++.|.||++|-.|.+++..|++||.|-||.|+..+++... ++..++.-++..+++|+.|||..|
T Consensus 473 Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k~--- 540 (732)
T KOG0614|consen 473 IMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRKG--- 540 (732)
T ss_pred HHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhcC---
Confidence 46678899999999999999999999999999999999988764 888888889999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+++||+||+|.+++.+|-+||.|||+++....... ...+.||+.|.|||++.+...+.+.|.|+||++++|+++|.+
T Consensus 541 iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~p 617 (732)
T KOG0614|consen 541 IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSP 617 (732)
T ss_pred ceeccCChhheeeccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999998877654 356779999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN 223 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (243)
||.+.++....+. ++..--....|...++...+++.+.-..+|.+|.-
T Consensus 618 PFs~~dpmktYn~---------------ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 618 PFSGVDPMKTYNL---------------ILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred CCCCCchHHHHHH---------------HHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 9987755332222 22222223566777788999999999999999975
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=191.62 Aligned_cols=216 Identities=21% Similarity=0.261 Sum_probs=164.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|+.++|.|||++++....++.+.+|+|||.. +|..|.....+. ++.+.+..++.|++.++.|+|+.+
T Consensus 54 llkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~--------~d~~~~rsfmlqllrgl~fchshn--- 121 (292)
T KOG0662|consen 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGD--------LDPEIVRSFMLQLLRGLGFCHSHN--- 121 (292)
T ss_pred HHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCc--------CCHHHHHHHHHHHHhhhhhhhhhh---
Confidence 46789999999999999999999999999966 999998887765 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHh-C
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~-g 158 (243)
+.|||+||+|.+++.+|+.|+.|||+++-++-.... ....+-|..|++|.++.+. .|+++.|+||.||++.|+.. |
T Consensus 122 vlhrdlkpqnllin~ngelkladfglarafgipvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanag 199 (292)
T KOG0662|consen 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_pred hhhccCCcceEEeccCCcEEecccchhhhcCCceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcC
Confidence 999999999999999999999999999877644322 2334568899999999875 57999999999999999987 6
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhh---hhhccccCCCCC---------HHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVK---QCVDTKLGGEYP---------PKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
.+.|.+.+-.++-..+-+....+.+++.- ...+......++ +.....=.+++.+.+.-+|.+|.+|++
T Consensus 200 rplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaea 279 (292)
T KOG0662|consen 200 RPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEA 279 (292)
T ss_pred CCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHH
Confidence 77777654433322222222222222111 111111111111 222334678999999999999999998
Q ss_pred HHHH
Q 026115 227 VLKA 230 (243)
Q Consensus 227 vl~~ 230 (243)
.++.
T Consensus 280 alqh 283 (292)
T KOG0662|consen 280 ALQH 283 (292)
T ss_pred HhcC
Confidence 8763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=206.99 Aligned_cols=224 Identities=25% Similarity=0.317 Sum_probs=166.1
Q ss_pred cccCCccceeeEEEEeC----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh----
Q 026115 4 RLKNENVVELVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE---- 75 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~---- 75 (243)
-|+|+||+.|+++-..+ ..++||++|.+.|+|.+||.+.. ++....++++..+++||++||.
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~G 330 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVG 330 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhc
Confidence 37999999999986543 35899999999999999999975 9999999999999999999994
Q ss_pred -cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc--cccccccccccccCchhhccCCC------CcccchH
Q 026115 76 -KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQM------SSKSDVY 146 (243)
Q Consensus 76 -~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~------~~~~Diw 146 (243)
+|++.+.|||||+.||++.+++.+-|+|+|+|......... ...+..+||..|||||++...-. -..+|||
T Consensus 331 TqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIY 410 (513)
T KOG2052|consen 331 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIY 410 (513)
T ss_pred CCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHH
Confidence 46888999999999999999999999999998665544322 22345679999999999975321 2369999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc-cccCCCCC-----HHHHHHHHHHHHhhcCCCCCC
Q 026115 147 SFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD-TKLGGEYP-----PKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 147 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~ 220 (243)
|||.++||+.....- .+..++..-....++...+..+.....+. .+++...| ..+...+..+|+-||..||..
T Consensus 411 afgLVlWEiarRc~~-ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~a 489 (513)
T KOG2052|consen 411 AFGLVLWEIARRCES-GGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAA 489 (513)
T ss_pred HHHHHHHHHHHHhhc-CCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchh
Confidence 999999999863211 11111111222222223333333333221 22222222 356678999999999999999
Q ss_pred CCCHHHHHHHHHHHHhhc
Q 026115 221 RPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 221 Rps~~~vl~~l~~~~~~~ 238 (243)
|-||--+-+.|.++.+..
T Consensus 490 RltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 490 RLTALRIKKTLAKLSNSD 507 (513)
T ss_pred hhHHHHHHHHHHHHhcCh
Confidence 999999999999887643
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=207.18 Aligned_cols=190 Identities=21% Similarity=0.265 Sum_probs=160.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||.+..+--.|+...++|+||||..||.|.-.|.+... +++....-+...|++||.|||+++ +
T Consensus 222 L~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~---------FsE~RtRFYGaEIvsAL~YLHs~~---i 289 (516)
T KOG0690|consen 222 LQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERV---------FSEDRTRFYGAEIVSALGYLHSRN---I 289 (516)
T ss_pred HHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhc---------ccchhhhhhhHHHHHHhhhhhhCC---e
Confidence 6788999999988889999999999999999999988887653 888888889999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
++||+|.+|.++|++|.+||+|||+++.-...... .....||+.|+|||++....|..+.|.|.+|++.|||.+|+.|
T Consensus 290 vYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t--~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLP 367 (516)
T KOG0690|consen 290 VYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT--TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLP 367 (516)
T ss_pred eeeechhhhheeccCCceEeeecccchhcccccce--eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCc
Confidence 99999999999999999999999998765433222 3456799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (243)
|...+. +++.+.+--. ...+|...+++...|+...|.+||.+|.
T Consensus 368 Fyn~dh----------------~kLFeLIl~e-d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 368 FYNKDH----------------EKLFELILME-DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ccccch----------------hHHHHHHHhh-hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 985533 3333322211 1245666777899999999999999995
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=203.37 Aligned_cols=215 Identities=22% Similarity=0.286 Sum_probs=176.1
Q ss_pred CCcccCCccceeeEEEE-eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+....|||++++.+++. +....++++++..-|+|..|+.-.++.+ .+....++..+...++.|++.|+.+||..+
T Consensus 341 ly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~-~~~aqtvtt~qlV~masQla~am~hlh~~~--- 416 (563)
T KOG1024|consen 341 LYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDD-PSYAQTVTTIQLVLMASQLAMAMEHLHNHG--- 416 (563)
T ss_pred HhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCC-CccccchhHHHHHHHHHHHHHHHHHHHhcC---
Confidence 55778999999999875 4556888899999999999998444321 111223777788999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccccc-ccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-C
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 158 (243)
++|.||...|+++++..++|++|=.+++..-.. +..+- .....+..||+||.+.+..|+.++|+||||+++||+.| |
T Consensus 417 ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~-DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg 495 (563)
T KOG1024|consen 417 VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPG-DYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLG 495 (563)
T ss_pred cccchhhhhcceehhheeEEeccchhccccCcc-cccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcC
Confidence 999999999999999999999998887644222 11111 12234668999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
+.|+...+| ......+..+.+...|.+|+++++.+|.-||...|++||+.+++..-|.++...
T Consensus 496 ~~PyaeIDP----------------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 496 KLPYAEIDP----------------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred CCCccccCH----------------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 889864433 566777788888888999999999999999999999999999999988877543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=198.94 Aligned_cols=218 Identities=22% Similarity=0.317 Sum_probs=164.5
Q ss_pred CCCcccCCccceeeEEEEe--------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHH
Q 026115 1 MVSRLKNENVVELVGYYVD--------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 72 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~ 72 (243)
||..|+|+|++.+++.|.. ...+++||++|++ +|..++...... ++..++.++..++.+||.|
T Consensus 69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr--------~sls~Ikk~Mk~Lm~GL~~ 139 (376)
T KOG0669|consen 69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVR--------FSLSEIKKVMKGLMNGLYY 139 (376)
T ss_pred HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCcccc--------ccHHHHHHHHHHHHHHHHH
Confidence 4678899999999998752 3458999999987 999999877433 8899999999999999999
Q ss_pred hhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc--cccccccccccccCchhhccC-CCCcccchHHHH
Q 026115 73 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFG 149 (243)
Q Consensus 73 Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG 149 (243)
+|.+. ++|||+|+.|++++.++.++|+|||+++.+...... ......+-|..|++||.+.+. .|.++.|+|..|
T Consensus 140 iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 140 IHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred HHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 99998 999999999999999999999999999766433222 112234458899999998864 689999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccce--------eeccCcCchhhhhhhhccc-cCCC---CCHHH------HHHHHHHHH
Q 026115 150 VVLLELLTGRKPVDHTLPRGQQSLV--------TWATPKLSEDKVKQCVDTK-LGGE---YPPKA------IAKMAAVAA 211 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~------~~~~~~li~ 211 (243)
|++.+|+++.+.+++..+..+..++ ..+|+...+-.+.+.++.. +... ...+. -++..+++.
T Consensus 217 CimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle 296 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE 296 (376)
T ss_pred HHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH
Confidence 9999999999999877665433322 2233333333333333211 1111 01111 226789999
Q ss_pred hhcCCCCCCCCCHHHHHHH
Q 026115 212 LCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 212 ~~l~~~p~~Rps~~~vl~~ 230 (243)
+++..||.+|+++.+++..
T Consensus 297 ~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 297 KLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHhccCcccCcchHhhhch
Confidence 9999999999999998863
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=221.26 Aligned_cols=200 Identities=27% Similarity=0.383 Sum_probs=168.7
Q ss_pred cccCCccceeeEEEE-----eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 4 RLKNENVVELVGYYV-----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 4 ~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
...|||++.++|+|. .++.++||||||.+|+..++++...+.+ +.+..+.-+++.++.|+.+||.+.
T Consensus 72 ~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~r-------l~E~~IaYI~re~lrgl~HLH~nk- 143 (953)
T KOG0587|consen 72 YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNR-------LKEEWIAYILREILRGLAHLHNNK- 143 (953)
T ss_pred ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccc-------hhhHHHHHHHHHHHHHHHHHhhcc-
Confidence 347999999999986 3578999999999999999999887654 889999999999999999999998
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-----CCCcccchHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLL 153 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~ 153 (243)
++|||||-.|||++.++.||+.|||++...... ...+...+||+.|||||++... .|+.++|+||||++..
T Consensus 144 --viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaI 219 (953)
T KOG0587|consen 144 --VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAI 219 (953)
T ss_pred --eeeecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceee
Confidence 999999999999999999999999998766543 3345677899999999998643 4677999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||.-|.+|+....+...-..+. .++......+..-++++.++|..||.+|..+||+..++++
T Consensus 220 EladG~PPl~DmHPmraLF~Ip--------------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 220 EMAEGAPPLCDMHPMRALFLIP--------------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhcCCCCCccCcchhhhhccCC--------------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 9999999998765543322221 2233344567777889999999999999999999999886
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=236.26 Aligned_cols=197 Identities=19% Similarity=0.178 Sum_probs=141.2
Q ss_pred CcccC-CccceeeEEEE-------eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 3 SRLKN-ENVVELVGYYV-------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 3 ~~l~h-~niv~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
++++| +||++++++|. ....++.++|++ +++|.+++..... .++...++.++.||+.||.|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR--------SVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc--------cccHHHHHHHHHHHHHHHHHHH
Confidence 56778 79999999882 334677888887 5599999975432 2889999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCC-------------------CceeecccCCCCCCccccc--------c------ccccc
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDD-------------------DIAKISDFDLSNQAPDAAA--------R------LHSTR 121 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~-------------------~~~~l~df~~~~~~~~~~~--------~------~~~~~ 121 (243)
++| ++||||||+|||++.. +.++++|||+++....... . .....
T Consensus 98 ~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 SQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred hCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 998 9999999999999643 4456667766654221000 0 00011
Q ss_pred ccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHH
Q 026115 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK 201 (243)
Q Consensus 122 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (243)
..||+.|+|||++.+..++.++|||||||++|||++|..|+..... .......... ......
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----------------~~~~~~~~~~-~~~~~~ 236 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----------------TMSSLRHRVL-PPQILL 236 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----------------HHHHHHHhhc-Chhhhh
Confidence 3478889999999988899999999999999999998887642100 0000000001 111111
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 202 AIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 202 ~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.......++.+||+.+|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 2334668889999999999999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=223.81 Aligned_cols=95 Identities=28% Similarity=0.352 Sum_probs=87.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++......++||||+.+++|.+++..... ++...++.++.|++.||.|||..+ +
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~---------l~~~~~~~i~~qil~aL~yLH~~g---I 125 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY---------FDEEMAVKYISEVALALDYLHRHG---I 125 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 4578999999999999999999999999999999999976542 778889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
+||||||+||+++.++.++|+|||+++
T Consensus 126 iHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 126 IHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=223.56 Aligned_cols=181 Identities=24% Similarity=0.348 Sum_probs=135.5
Q ss_pred CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCce
Q 026115 20 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 99 (243)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~ 99 (243)
...+||-||||+..++.+++..+... -.....|+++++|++||.|+|++| ++||||||.|||++.++.|
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~V 736 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSV 736 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCe
Confidence 35689999999997777787776621 146789999999999999999999 9999999999999999999
Q ss_pred eecccCCCCCCc---cc-------------ccccccccccccccccCchhhccCC---CCcccchHHHHHHHHHHHhCCC
Q 026115 100 KISDFDLSNQAP---DA-------------AARLHSTRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 100 ~l~df~~~~~~~---~~-------------~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~l~~g~~ 160 (243)
||+|||++.... .. ......+..+||..|.|||++.+.. |+.+.|+||||++||||+.
T Consensus 737 KIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y--- 813 (1351)
T KOG1035|consen 737 KIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY--- 813 (1351)
T ss_pred eecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---
Confidence 999999997621 00 0111224567999999999997654 8999999999999999986
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhh-hhhccccCCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVK-QCVDTKLGGE--YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||.+. +..-... ...+..+..+ +.......-..+|.+|++.||.+||||.|+|+
T Consensus 814 PF~Ts---------------MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 814 PFGTS---------------MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cCCch---------------HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 45432 1111111 1111222111 23334455778999999999999999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=202.98 Aligned_cols=185 Identities=24% Similarity=0.304 Sum_probs=157.6
Q ss_pred CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC
Q 026115 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 86 (243)
Q Consensus 7 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di 86 (243)
-|.++++..+|+.-.++++||||+.||+|--.++.... +.+..+.-++..|+-||-|||+.| |++||+
T Consensus 409 ppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kg---IiYRDL 476 (683)
T KOG0696|consen 409 PPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDL 476 (683)
T ss_pred CchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCC---eeeeec
Confidence 46677888888899999999999999999998887664 777788889999999999999999 999999
Q ss_pred CCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 026115 87 KSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 166 (243)
Q Consensus 87 ~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 166 (243)
|.+||+++..|.+||+|||+++..-.... .....-||+.|+|||++....|..+.|.||+|++||||+.|++||.+.+
T Consensus 477 KLDNvmLd~eGHiKi~DFGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 477 KLDNVMLDSEGHIKIADFGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred cccceEeccCCceEeeecccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999876543322 2345679999999999999999999999999999999999999998663
Q ss_pred CCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 026115 167 PRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (243)
+ .+-...+.+... .+|...+.+..++....+.++|.+|.
T Consensus 555 E---------------~elF~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 555 E---------------DELFQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred H---------------HHHHHHHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 3 233344444443 67778888999999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=218.92 Aligned_cols=199 Identities=27% Similarity=0.362 Sum_probs=150.9
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
.|||||++++.=.+++..||..|.|.. +|.+++... +..... ..-...+.++.|+++|+++||+.+ ++|||
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~-~~d~~~----~~~i~~~~~l~q~~~GlaHLHsl~---iVHRD 631 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESS-GLDVEM----QSDIDPISVLSQIASGLAHLHSLK---IVHRD 631 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhcc-ccchhh----cccccHHHHHHHHHHHHHHHHhcc---ccccc
Confidence 699999999999999999999999966 999999875 211000 111345778899999999999998 99999
Q ss_pred CCCCceEecC---C--CceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-C
Q 026115 86 IKSSNVLLFD---D--DIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 86 i~~~nil~~~---~--~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 158 (243)
+||+|||++. + ..++|+|||+++......... +.....||.+|+|||++.....+.+.||||+||++|+.++ |
T Consensus 632 LkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG 711 (903)
T KOG1027|consen 632 LKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGG 711 (903)
T ss_pred CCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCC
Confidence 9999999976 2 467899999998776554332 2344569999999999998888889999999999999998 5
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||+.......... .-...-.......++ +..+||.+|++.+|..||+|.+|+.
T Consensus 712 ~HpFGd~~~R~~NIl--------------~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 712 SHPFGDSLERQANIL--------------TGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ccCCCchHHhhhhhh--------------cCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 899986533211110 000000001111122 7899999999999999999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-31 Score=200.18 Aligned_cols=210 Identities=19% Similarity=0.201 Sum_probs=159.1
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+..++|+||++++.+|.-. ...++|||++.. +|...+.- . ++=.++..++.|++.|+++||+
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~-e----------lDH~tis~i~yq~~~~ik~lhs 136 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILM-E----------LDHETISYILYQMLCGIKHLHS 136 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHH-h----------cchHHHHHHHHHHHHHHHHHHh
Confidence 4568999999999999633 457999999966 99998872 2 7778889999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.| ++|||+||+||++..+..+|+.|||+++..... ..-...+.+..|+|||++-+..+++..||||+||++.||
T Consensus 137 ~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEl 210 (369)
T KOG0665|consen 137 AG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 210 (369)
T ss_pred cc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHH
Confidence 99 999999999999999999999999999765433 122344578899999999998899999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhh----------------------hhhhcccc-C--CCCCHHHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKV----------------------KQCVDTKL-G--GEYPPKAIAKMAAVA 210 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~-~--~~~~~~~~~~~~~li 210 (243)
++|...|.+.+..++...+....+++..... .+...... . ...+.-......+++
T Consensus 211 i~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll 290 (369)
T KOG0665|consen 211 ILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLL 290 (369)
T ss_pred hhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHH
Confidence 9999999876554443332222222111100 00000000 0 011122344689999
Q ss_pred HhhcCCCCCCCCCHHHHHH
Q 026115 211 ALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 211 ~~~l~~~p~~Rps~~~vl~ 229 (243)
.+||..||++|.|+.++|+
T Consensus 291 ~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 291 SKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhhccChhhcccHHHHhc
Confidence 9999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=183.26 Aligned_cols=165 Identities=22% Similarity=0.211 Sum_probs=126.1
Q ss_pred CCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcc
Q 026115 33 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 112 (243)
Q Consensus 33 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~ 112 (243)
|+|.+++..... .+++..++.++.|++.|+.|||+.+ ||+||+++.++.+++ ||.+.....
T Consensus 1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 689999976432 2899999999999999999999985 999999999999998 998765433
Q ss_pred cccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcc
Q 026115 113 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 192 (243)
Q Consensus 113 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (243)
. ...|++.|+|||++.+..++.++||||+||++|||++|..||....... .........
T Consensus 62 ~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--------------~~~~~~~~~ 120 (176)
T smart00750 62 E-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--------------AILEILLNG 120 (176)
T ss_pred c-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--------------HHHHHHHHH
Confidence 2 1247899999999999899999999999999999999999986432110 111111111
Q ss_pred ccCC-----CCCHHHHH--HHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 193 KLGG-----EYPPKAIA--KMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 193 ~~~~-----~~~~~~~~--~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
.... ..+..... .+.+++.+||+.||.+|||+.++++.+..+..+
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0000 11223333 699999999999999999999999998776544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=201.97 Aligned_cols=158 Identities=25% Similarity=0.320 Sum_probs=133.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||..-.++=||+++-.|.+...+|+||+|++||++-.+|.+... +.+..+.-++..+..|+++.|+.|
T Consensus 682 ILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI---------FeE~LARFYIAEltcAiesVHkmG--- 749 (1034)
T KOG0608|consen 682 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI---------FEEDLARFYIAELTCAIESVHKMG--- 749 (1034)
T ss_pred hHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhcc---------CHHHHHHHHHHHHHHHHHHHHhcc---
Confidence 34555677899999999999999999999999999999988763 788888889999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCc---ccccc-------------------------------------cccc
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAP---DAAAR-------------------------------------LHST 120 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~---~~~~~-------------------------------------~~~~ 120 (243)
++||||||+|||+|.+|.+||+|||++.-+. +...+ -...
T Consensus 750 FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ah 829 (1034)
T KOG0608|consen 750 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAH 829 (1034)
T ss_pred ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhh
Confidence 9999999999999999999999999974221 11000 0011
Q ss_pred cccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 026115 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 170 (243)
Q Consensus 121 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 170 (243)
..+||+.|+|||++....++..+|.||.||+||||+.|++||-...+...
T Consensus 830 slvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 830 SLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred hhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 34689999999999999999999999999999999999999987655433
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=207.54 Aligned_cols=200 Identities=22% Similarity=0.251 Sum_probs=158.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
||++++||-||.+---|+..+..++|||.+.|.-|+-.|....+. +++..-.-+..||+.||+|||..+
T Consensus 616 ILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgR--------L~er~TkFlvtQIL~ALr~LH~kn--- 684 (888)
T KOG4236|consen 616 ILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGR--------LPERITKFLVTQILVALRYLHFKN--- 684 (888)
T ss_pred HHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhccc--------chHHHHHHHHHHHHHHHHHhhhcc---
Confidence 578999999999999999999999999999664455555544443 777777778899999999999998
Q ss_pred eEeccCCCCceEecCC---CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLFDD---DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
|+|||+||+|||+... ..+||+|||+++..+...- +...+||+.|+|||++.+..|..+-|+||.|+++|.-++
T Consensus 685 IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS 761 (888)
T KOG4236|consen 685 IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS 761 (888)
T ss_pred eeeccCCchheeeccCCCCCceeeccccceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEec
Confidence 9999999999999654 4789999999999876542 456789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||...++... .+ +...-......=.+.+....++|...|+..-.+|.|..+.+.
T Consensus 762 GTFPFNEdEdInd--------------QI-QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 762 GTFPFNEDEDIND--------------QI-QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ccccCCCccchhH--------------Hh-hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 9999974422110 00 000111111222456678899999999999999999887664
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=198.37 Aligned_cols=205 Identities=26% Similarity=0.370 Sum_probs=158.0
Q ss_pred CcccCCccceeeEEEE-eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 3 SRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+.|.||.||++++||. +...+|-|+|||+|.+|.-||+.... +++..+..|.-||+.||.||... +++|
T Consensus 522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl---------mSEKEARSIiMQiVnAL~YLNEi-kpPI 591 (775)
T KOG1151|consen 522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL---------MSEKEARSIIMQIVNALKYLNEI-KPPI 591 (775)
T ss_pred hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhh---------hhHHHHHHHHHHHHHHHHHHhcc-CCCe
Confidence 5789999999999996 55679999999999999999987763 88999999999999999999987 5679
Q ss_pred EeccCCCCceEecC---CCceeecccCCCCCCcccccccc-----cccccccccccCchhhccC----CCCcccchHHHH
Q 026115 82 IHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLH-----STRVLGTFGYHAPEYAMTG----QMSSKSDVYSFG 149 (243)
Q Consensus 82 ~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG 149 (243)
+|.|+||.|||+.. -|.+||+|||+++.+.+...... .....||++|++||.+.-. ..+.+.|+||+|
T Consensus 592 IHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvG 671 (775)
T KOG1151|consen 592 IHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVG 671 (775)
T ss_pred eeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeee
Confidence 99999999999954 47899999999988765443321 2234599999999988643 347789999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
|++|+++.|..||.....+.... . ...++...- .-+.-+.++.+...+|++||+..-++|....++.
T Consensus 672 VIFyQClYGrKPFGhnqsQQdIL---------q---eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 672 VIFYQCLYGRKPFGHNQSQQDIL---------Q---ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhhhhhhccCCCCCCchhHHHHH---------h---hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 99999999999998543221100 0 001111111 1122234566789999999999999998888775
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
.
T Consensus 740 ~ 740 (775)
T KOG1151|consen 740 C 740 (775)
T ss_pred c
Confidence 4
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=216.86 Aligned_cols=194 Identities=21% Similarity=0.274 Sum_probs=152.0
Q ss_pred CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC
Q 026115 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 86 (243)
Q Consensus 7 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di 86 (243)
.+=|+.+.-+|.++.++|+||||++||+|-.++..... +++.-+.-++..++.||.-+|+.| +|||||
T Consensus 134 s~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~---------~pE~~ArFY~aEiVlAldslH~mg---yVHRDi 201 (1317)
T KOG0612|consen 134 SEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDR---------LPEDWARFYTAEIVLALDSLHSMG---YVHRDI 201 (1317)
T ss_pred cHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCC---------ChHHHHHHHHHHHHHHHHHHHhcc---ceeccC
Confidence 44577777789999999999999999999999998873 888889999999999999999999 999999
Q ss_pred CCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-----CCCCcccchHHHHHHHHHHHhCCCC
Q 026115 87 KSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 87 ~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
||+|||+|..|.++|+|||.+-.....+.. .+...+|||-|.+||++.. +.|...+|.||+||++|||+.|.-|
T Consensus 202 KPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP 280 (1317)
T KOG0612|consen 202 KPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP 280 (1317)
T ss_pred CcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence 999999999999999999987665533222 2345689999999999862 4578899999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC--HHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADFRPN---MGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~vl~ 229 (243)
|....- -+..-.+.+-.-...+| ..++++..+||.+.+. +|+.|.. +.++-.
T Consensus 281 FYadsl---------------veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 281 FYADSL---------------VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred chHHHH---------------HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 974311 11222222222222233 4578889999988775 6667766 666543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-31 Score=195.25 Aligned_cols=202 Identities=25% Similarity=0.273 Sum_probs=152.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhcc---CCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHG---KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
++.-+.||||+|+|.+..++.+++.||.|+- +|..+... .... .+++..+-.+....+.||.||-..-
T Consensus 117 mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~-------~ipE~Ilg~ItvatV~AL~yLK~~l- 187 (361)
T KOG1006|consen 117 MKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKS-------RIPENILGHITVATVDALDYLKEEL- 187 (361)
T ss_pred HhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhc-------cCcHhhhhheeeeehhHHHHHHHHh-
Confidence 4556789999999999999999999999966 66654432 2111 1778888888999999999998875
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc--CCCCcccchHHHHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~ 156 (243)
.++|||+||+|||++..|.+||+|||.+....+.... ..-.|-..|+|||.+.. ..|+.++|+||||++++|+.
T Consensus 188 -kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvA 263 (361)
T KOG1006|consen 188 -KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVA 263 (361)
T ss_pred -hhhhccCChhheEEecCCCEeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeee
Confidence 4999999999999999999999999997655443221 22347788999999863 35899999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC-CCCC---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG-GEYP---PKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
||..|+..... ..+.+.+....... ...+ ...+..+..++..|+.+|-..||...++.++
T Consensus 264 tG~fPyr~w~s--------------vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 264 TGNFPYRKWDS--------------VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCCCCcchHHH--------------HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 99999865422 11222222211111 1111 3356789999999999999999999998763
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=189.87 Aligned_cols=77 Identities=27% Similarity=0.423 Sum_probs=69.0
Q ss_pred CCccceeeEEEE----eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 026115 7 NENVVELVGYYV----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 82 (243)
Q Consensus 7 h~niv~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~ 82 (243)
-.+||++++.|. ++.++|+|+|++ |.+|..+|.....+. ++...+.+|++||+.||.|||... +++
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYLH~ec--gII 210 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYLHREC--GII 210 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHHHHhc--Ccc
Confidence 357999999997 578999999999 779999998877654 888999999999999999999986 599
Q ss_pred eccCCCCceEe
Q 026115 83 HRNIKSSNVLL 93 (243)
Q Consensus 83 h~di~~~nil~ 93 (243)
|.||||+|||+
T Consensus 211 HTDlKPENvLl 221 (590)
T KOG1290|consen 211 HTDLKPENVLL 221 (590)
T ss_pred ccCCCcceeee
Confidence 99999999997
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=204.48 Aligned_cols=206 Identities=16% Similarity=0.155 Sum_probs=130.5
Q ss_pred EeCCeeEEEEeecCCCCHHHHhccCCCCC-----------CCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC
Q 026115 18 VDGPLRVLAYEHASKGSLHDILHGKKGVK-----------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 86 (243)
Q Consensus 18 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di 86 (243)
.++...++|+||+.+++|.+++....... ............+..++.|++.||.|||+.+ ++||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 35567999999999999999987543100 0000011223456679999999999999998 999999
Q ss_pred CCCceEecC-CCceeecccCCCCCCcccccccccccccccccccCchhhccC----------------------CCCccc
Q 026115 87 KSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG----------------------QMSSKS 143 (243)
Q Consensus 87 ~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~ 143 (243)
||+||+++. ++.++|+|||+++........ ......+++.|+|||.+... .+..++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 578999999999755332211 12345678999999966422 233456
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC------CCHHHHHHHHHHHHhhcCCC
Q 026115 144 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE------YPPKAIAKMAAVAALCVQYE 217 (243)
Q Consensus 144 DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~ 217 (243)
||||+||++|||+++..++..........+ .. ................... ..........+|+.+||+.|
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQL-KR--NDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHH-Hh--cCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 999999999999987665432100000000 00 0000001111111110000 00011224558999999999
Q ss_pred CCCCCCHHHHHHH
Q 026115 218 ADFRPNMGIVLKA 230 (243)
Q Consensus 218 p~~Rps~~~vl~~ 230 (243)
|++|||++++++.
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999973
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=184.57 Aligned_cols=194 Identities=22% Similarity=0.295 Sum_probs=157.0
Q ss_pred ccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 5 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
-+||.+|-+..+|...+++++|.||+.||+|--.++.... ++++.+.-+...++.||.|||+.| +++|
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~rg---iiyr 375 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHERG---IIYR 375 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhcC---eeee
Confidence 3789999999999999999999999999999766665543 889999999999999999999999 9999
Q ss_pred cCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026115 85 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164 (243)
Q Consensus 85 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 164 (243)
|+|.+|++++..|.+|++|+|.++........ .....||+.|.|||++.+..|..+.|.|+||++.+||..|..||..
T Consensus 376 dlkldnvlldaeghikltdygmcke~l~~gd~--tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 376 DLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred eccccceEEccCCceeecccchhhcCCCCCcc--cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 99999999999999999999998765544333 3456799999999999999999999999999999999999999973
Q ss_pred CCCCCCccceeeccCcCchhhhhh-hhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 026115 165 TLPRGQQSLVTWATPKLSEDKVKQ-CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (243)
.--. ......++-+.+ +++... ..|...+-....++...|++||.+|.
T Consensus 454 vgm~--------n~d~ntedylfqvilekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 454 VGMD--------NPDMNTEDYLFQVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ecCC--------CcccchhHHHHHHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 3110 001122222333 344443 34445556678889999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-27 Score=175.40 Aligned_cols=168 Identities=33% Similarity=0.526 Sum_probs=146.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|++|+++++++......++++|++.+++|.+++..... .++...++.++.+++.++.+||+.+ +
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~---~ 113 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLHSNG---I 113 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999998999999986531 2888999999999999999999998 9
Q ss_pred EeccCCCCceEecC-CCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCC
Q 026115 82 IHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~ 159 (243)
+|+|++|.||+++. ++.++++|||.+........ ......+...|.+||..... .++.+.|+|++|++++++
T Consensus 114 ~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---- 187 (215)
T cd00180 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---- 187 (215)
T ss_pred eccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----
Confidence 99999999999999 89999999998865544321 11223467789999998876 778899999999999998
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
..+.+++.+|++.||++||++.++++.
T Consensus 188 --------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 469999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=188.85 Aligned_cols=217 Identities=24% Similarity=0.308 Sum_probs=163.0
Q ss_pred CCCcccCCccceeeEEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 1 MVSRLKNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
||.-++|.|++..++...-.. .+++++|.+.. +|...+-.... ++...+..+++||+.|++|||+
T Consensus 105 mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~---------Ls~DHvKVFlYQILRGLKYLHs 174 (449)
T KOG0664|consen 105 MLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQA---------LTPDHVKVFVYQILRGLKYLHT 174 (449)
T ss_pred HHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCC---------CCcchhhhhHHHHHhhhHHHhh
Confidence 455679999999888776432 46778888855 88888765543 7888888899999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~ 154 (243)
.+ |.||||||.|.+++.|-..||+|||+++......... ....+-|..|+|||.+.+. .|+.+.||||.||++.|
T Consensus 175 A~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaE 250 (449)
T KOG0664|consen 175 AN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 250 (449)
T ss_pred cc---hhhccCCCccEEeccCceEEecccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHH
Confidence 98 9999999999999999999999999998765443332 2334457889999999974 58999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc--------cccCC---------CCCHHHHHHHHHHHHhhcCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD--------TKLGG---------EYPPKAIAKMAAVAALCVQYE 217 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~---------~~~~~~~~~~~~li~~~l~~~ 217 (243)
++..+..|+...+..+-.++......+..+.....-+ ...+. ..+.....+...++.+++..|
T Consensus 251 LLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d 330 (449)
T KOG0664|consen 251 LLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFD 330 (449)
T ss_pred HHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCC
Confidence 9999999987766655555544444444332222111 11111 122233456778889999999
Q ss_pred CCCCCCHHHHHHHH
Q 026115 218 ADFRPNMGIVLKAL 231 (243)
Q Consensus 218 p~~Rps~~~vl~~l 231 (243)
|++|.+.++.+...
T Consensus 331 ~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 331 PDKRISVEEALQHR 344 (449)
T ss_pred CcccccHhhhcccc
Confidence 99999999887643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=193.36 Aligned_cols=213 Identities=21% Similarity=0.206 Sum_probs=140.6
Q ss_pred cceeeEEEEe--------CCeeEEEEeecCCCCHHHHhccCCCCC---------------CCCCCCccCHHHHHHHHHHH
Q 026115 10 VVELVGYYVD--------GPLRVLAYEHASKGSLHDILHGKKGVK---------------GAKPGPVLSWAQRVKIAVGA 66 (243)
Q Consensus 10 iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------~~~~~~~~~~~~~~~~~~ql 66 (243)
+++++++|.. ....++|+||+.+++|.++++...+.. .......+++..+..++.|+
T Consensus 239 ~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql 318 (507)
T PLN03224 239 CAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQV 318 (507)
T ss_pred hhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHH
Confidence 4677887753 346799999999999999997532210 00011125677888999999
Q ss_pred HHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC--------
Q 026115 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-------- 138 (243)
Q Consensus 67 ~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------- 138 (243)
+.++.|||+.+ ++||||||+||+++.++.++|+|||++......... ......+++.|+|||.+....
T Consensus 319 ~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~ 394 (507)
T PLN03224 319 LTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELVMPQSCPRAPAP 394 (507)
T ss_pred HHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhhcCCCCCCccchh
Confidence 99999999998 999999999999999999999999998654322111 111223578999999875322
Q ss_pred --------------CCcccchHHHHHHHHHHHhCCC-CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHH
Q 026115 139 --------------MSSKSDVYSFGVVLLELLTGRK-PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAI 203 (243)
Q Consensus 139 --------------~~~~~DiwslG~~l~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (243)
.....|+||+||++++|+++.. ||.......... .. . .......................+
T Consensus 395 ~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~-~~-~--~~~~~~~r~~~~~~~~~~~~d~~s 470 (507)
T PLN03224 395 AMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL-RQ-Y--DNDLNRWRMYKGQKYDFSLLDRNK 470 (507)
T ss_pred hhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH-hh-c--cchHHHHHhhcccCCCcccccccC
Confidence 1234699999999999999875 664321110000 00 0 000001111111111112223456
Q ss_pred HHHHHHHHhhcCCCC---CCCCCHHHHHHH
Q 026115 204 AKMAAVAALCVQYEA---DFRPNMGIVLKA 230 (243)
Q Consensus 204 ~~~~~li~~~l~~~p---~~Rps~~~vl~~ 230 (243)
....+++.+||.++| .+|+|++|+|++
T Consensus 471 ~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 471 EAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 779999999999866 689999999863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-28 Score=195.14 Aligned_cols=147 Identities=23% Similarity=0.402 Sum_probs=129.8
Q ss_pred CCCccc---CCccceeeEEEEeCCeeEEEEeec-CCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 1 MVSRLK---NENVVELVGYYVDGPLRVLAYEHA-SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 1 ~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
||..|+ |+||++++++|++++.++|+||.. +|-+|.+++...+. +++..+..++.|++.|+++||++
T Consensus 619 Ila~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~ 689 (772)
T KOG1152|consen 619 ILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQ 689 (772)
T ss_pred HHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhcccccccc
Confidence 355566 999999999999999999999975 55699999988765 88999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLEL 155 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l 155 (243)
| |+|||||-+|+.++.+|-+|++|||.+....... -.-++||..|.|||++.+..| ....|||++|+++|.+
T Consensus 690 ~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillyti 762 (772)
T KOG1152|consen 690 G---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTI 762 (772)
T ss_pred C---ceecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEE
Confidence 9 9999999999999999999999999886554331 244679999999999999888 4568999999999999
Q ss_pred HhCCCCCC
Q 026115 156 LTGRKPVD 163 (243)
Q Consensus 156 ~~g~~pf~ 163 (243)
+....||.
T Consensus 763 vykenpyy 770 (772)
T KOG1152|consen 763 VYKENPYY 770 (772)
T ss_pred EeccCCCc
Confidence 99999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=169.70 Aligned_cols=153 Identities=30% Similarity=0.358 Sum_probs=125.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++...+|.+|+|+|.+......++.||.++. +|..|..+.-.. +..+++..+-+++..++.|+.|||++- .+
T Consensus 99 ~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~-----g~~ipE~vlGkIa~Svv~al~~L~~kL--~v 170 (282)
T KOG0984|consen 99 MRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKK-----GGTIPEDVLGKIAVSVVHALEFLHSKL--SV 170 (282)
T ss_pred ccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhc-----CCcCchHHhhHhHHHHHHHHHHHHHHh--hh
Confidence 3456789999999999999999999999976 888876543211 112788888999999999999999985 49
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc----CCCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~l~~ 157 (243)
+|||+||.|||++..|++|++|||.+-...+.... .-..|-..|+|||.+.. ..|+-++||||||+.+.||.+
T Consensus 171 IHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~ 247 (282)
T KOG0984|consen 171 IHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI 247 (282)
T ss_pred hhccCCcceEEEccCCcEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh
Confidence 99999999999999999999999998665544322 11236778999998853 368899999999999999999
Q ss_pred CCCCCCCC
Q 026115 158 GRKPVDHT 165 (243)
Q Consensus 158 g~~pf~~~ 165 (243)
+..|+...
T Consensus 248 lr~PY~~w 255 (282)
T KOG0984|consen 248 LRFPYESW 255 (282)
T ss_pred cccccccc
Confidence 99998744
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=192.38 Aligned_cols=206 Identities=19% Similarity=0.227 Sum_probs=150.8
Q ss_pred ccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 026115 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 88 (243)
Q Consensus 9 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~ 88 (243)
|.++++-.|...+++|||||.+.. +|.+.|.....- . .+....+..++.|+.-||..|-..| ++|+||||
T Consensus 495 Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~n----v--GL~ikaVRsYaqQLflALklLK~c~---vlHaDIKP 564 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRN----V--GLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKP 564 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcc----c--ceeehHHHHHHHHHHHHHHHHHhcC---eeecccCc
Confidence 678888889999999999999855 999999876531 1 1666788889999999999999998 99999999
Q ss_pred CceEecCC-CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 026115 89 SNVLLFDD-DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 167 (243)
Q Consensus 89 ~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 167 (243)
+|||++.+ ..+||||||.|........ .++. -+..|.|||++.+..|+...|+||+||.|||++||...|.+...
T Consensus 565 DNiLVNE~k~iLKLCDfGSA~~~~enei---tPYL-VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 565 DNILVNESKNILKLCDFGSASFASENEI---TPYL-VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cceEeccCcceeeeccCccccccccccc---cHHH-HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 99999887 4579999999866544332 1222 35679999999999999999999999999999999999885432
Q ss_pred CCC------------------------------ccceeeccCcCch-------------hhhhh-hhccccCCCCCHHHH
Q 026115 168 RGQ------------------------------QSLVTWATPKLSE-------------DKVKQ-CVDTKLGGEYPPKAI 203 (243)
Q Consensus 168 ~~~------------------------------~~~~~~~~~~~~~-------------~~~~~-~~~~~~~~~~~~~~~ 203 (243)
... ..+..... ...+ ..+.. ++.......-.....
T Consensus 641 N~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D-~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~ 719 (752)
T KOG0670|consen 641 NQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVD-KVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIV 719 (752)
T ss_pred HHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEecc-ccccceeEEEecccCcchhHHHHHhccCCCCchhHHHH
Confidence 210 00000000 0000 01111 111111112233456
Q ss_pred HHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 204 AKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 204 ~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..+.+|+.+||..||++|.|..+.|.
T Consensus 720 ~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 720 QQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHHHHHhccChhhcCCHHHHhc
Confidence 67999999999999999999999886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=194.66 Aligned_cols=203 Identities=26% Similarity=0.329 Sum_probs=162.4
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
|++.++||||+.++|.+.....+++.||||.+|+|.+.-+-.. ++++.++.-+++..+.+++|||..|
T Consensus 65 ~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs~g--- 132 (829)
T KOG0576|consen 65 MLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHSQG--- 132 (829)
T ss_pred eeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhcCC---
Confidence 5788999999999999999999999999999999999877665 3899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~ 157 (243)
-+|||||-.||++++.|.+++.|||.+-.+.... ..+..+.||+.|+|||+.. ...|...+|+|++|+...|+--
T Consensus 133 k~hRdiKGanilltd~gDvklaDfgvsaqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e 210 (829)
T KOG0576|consen 133 KIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE 210 (829)
T ss_pred cccccccccceeecccCceeecccCchhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh
Confidence 9999999999999999999999999986654332 2256678999999999874 4678899999999999999988
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.++|.....+.....+.+......+ . ..-...-.+.+.++++.++.++|++|||++.+|.
T Consensus 211 Lqpplfdlhpmr~l~LmTkS~~qpp----------~--lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 211 LQPPLFDLHPMRALFLMTKSGFQPP----------T--LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCcccccchHHHHHHhhccCCCCC----------c--ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 8888654433322222211111100 0 0112233557999999999999999999998875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=168.78 Aligned_cols=223 Identities=14% Similarity=0.210 Sum_probs=158.1
Q ss_pred CCCccc-CCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 1 MVSRLK-NENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 1 ~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
||..|+ ||||+++++...++ ....+|+|++.+.++..+... ++...+.-+..++++||.|+|+.|
T Consensus 85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCHS~G 152 (338)
T KOG0668|consen 85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCHSMG 152 (338)
T ss_pred HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHHhcC
Confidence 356676 99999999998764 568999999999887776543 667788889999999999999999
Q ss_pred CCCeEeccCCCCceEecCC-CceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHH
Q 026115 78 EPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l 155 (243)
+.|||+||.|++++.. -.++++|+|+|.......+. .-.+.+..|-.||.+.. ..|+-+-|+|||||++..|
T Consensus 153 ---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~m 226 (338)
T KOG0668|consen 153 ---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 226 (338)
T ss_pred ---cccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHH
Confidence 9999999999999865 57899999999877655433 22235667889999875 4578899999999999999
Q ss_pred HhCCCCCCCCCC-CCCccceeeccCcC------------chhhhhhhhccccCC--------CCCHHHHHHHHHHHHhhc
Q 026115 156 LTGRKPVDHTLP-RGQQSLVTWATPKL------------SEDKVKQCVDTKLGG--------EYPPKAIAKMAAVAALCV 214 (243)
Q Consensus 156 ~~g~~pf~~~~~-~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l 214 (243)
+...-||-...+ .++-..++.+.... .......++....+. ....-.+.+..+++.+.|
T Consensus 227 iFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklL 306 (338)
T KOG0668|consen 227 IFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLL 306 (338)
T ss_pred HhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHH
Confidence 998888754322 22211111111100 001111111111111 111112467899999999
Q ss_pred CCCCCCCCCHHHHHH--HHHHHHhhcCCC
Q 026115 215 QYEADFRPNMGIVLK--ALQPLLNTRSGP 241 (243)
Q Consensus 215 ~~~p~~Rps~~~vl~--~l~~~~~~~~~~ 241 (243)
..|-++|+||.|.+. .+...++..+.+
T Consensus 307 rYDHqeRlTakEam~HpyF~~~~~~~~~~ 335 (338)
T KOG0668|consen 307 RYDHQERLTAKEAMAHPYFAPVREAESSR 335 (338)
T ss_pred hhccccccchHHHhcCchHHHHHHHhhcc
Confidence 999999999999987 455555555443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=169.33 Aligned_cols=197 Identities=19% Similarity=0.277 Sum_probs=143.7
Q ss_pred cCCccceeeEE-EEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 6 KNENVVELVGY-YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 6 ~h~niv~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
.|.||+.-++. |+..+.+++++||++.|+|.+-+.... +.+....+++.|+++|+.|+|+.+ ++||
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHskn---lVHR 145 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSKN---LVHR 145 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhccc---hhhc
Confidence 48889987774 788889999999999999999988755 888888999999999999999998 9999
Q ss_pred cCCCCceEecC--CCceeecccCCCCCCcccccccccccccccccccCchhhc---cC--CCCcccchHHHHHHHHHHHh
Q 026115 85 NIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TG--QMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 85 di~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~--~~~~~~DiwslG~~l~~l~~ 157 (243)
|||.+|||+-. .-++|++|||..+..+..-. ....+..|.+||... +. ...+.+|+|+||+++|.+++
T Consensus 146 dlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt 220 (378)
T KOG1345|consen 146 DLKAENILIFDADFYRVKLCDFGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT 220 (378)
T ss_pred ccccceEEEecCCccEEEeeecccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeec
Confidence 99999999943 34799999999877654322 222345688998764 22 23678999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||+.....+.. .+.-.........+.. ......+.....+..+-|..+|++|=-..++-+
T Consensus 221 G~~PWQka~~~d~~--------Y~~~~~w~~rk~~~~P-~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 221 GKFPWQKASIMDKP--------YWEWEQWLKRKNPALP-KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred CCCcchhhhccCch--------HHHHHHHhcccCccCc-hhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 99999844222221 1111222222222221 122334556788888999999999944444433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=190.62 Aligned_cols=206 Identities=19% Similarity=0.211 Sum_probs=160.4
Q ss_pred CcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 026115 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 82 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~ 82 (243)
+.++|||++..+..+.+.....-.|||+++ +|..++..... +....+..++.|++.|++|+|..| +.
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~---------~~~~e~~c~fKqL~~Gv~y~h~~G---ia 442 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGK---------LTPLEADCFFKQLLRGVKYLHSMG---LA 442 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccc---------cchhhhhHHHHHHHHHHHHHHhcC---ce
Confidence 578999998888877665554445999999 99999987621 788889999999999999999999 99
Q ss_pred eccCCCCceEecCCCceeecccCCCCCCcccccc--cccccccccccccCchhhccCCCCc-ccchHHHHHHHHHHHhCC
Q 026115 83 HRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSS-KSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 83 h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~ 159 (243)
|||+|++|+++..++.++++|||.+..+....+. .......|+..|+|||++.+..|.+ ..||||.|+++..|++|+
T Consensus 443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 9999999999999999999999998766554443 3344567899999999999998865 589999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.||......+......... ................+.+...+|.+||+.||.+|.|+.++++
T Consensus 523 ~~Wk~a~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKTNNYS--------DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred Cccccccccccchhhhccc--------cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 9998665444332111000 0000011111233455778999999999999999999999987
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=169.69 Aligned_cols=208 Identities=21% Similarity=0.302 Sum_probs=148.6
Q ss_pred CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC
Q 026115 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 86 (243)
Q Consensus 7 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di 86 (243)
+.||+++.+++.+++..++|+||+++.+..++... ++...+..+++.++.|++++|.+| |+||||
T Consensus 94 ~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDi 158 (418)
T KOG1167|consen 94 SDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDI 158 (418)
T ss_pred chhhhcchhhhccCCeeEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCC
Confidence 78999999999999999999999999999998875 667889999999999999999999 999999
Q ss_pred CCCceEecCC-CceeecccCCCCCCcccc-------------cc-----------------------------ccccccc
Q 026115 87 KSSNVLLFDD-DIAKISDFDLSNQAPDAA-------------AR-----------------------------LHSTRVL 123 (243)
Q Consensus 87 ~~~nil~~~~-~~~~l~df~~~~~~~~~~-------------~~-----------------------------~~~~~~~ 123 (243)
||.|++++.. +...|+|||++....... .. .......
T Consensus 159 KpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrA 238 (418)
T KOG1167|consen 159 KPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRA 238 (418)
T ss_pred CccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccC
Confidence 9999999875 667899999986211000 00 0000123
Q ss_pred ccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCcc---------------------ceeec-cC-
Q 026115 124 GTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS---------------------LVTWA-TP- 179 (243)
Q Consensus 124 ~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---------------------~~~~~-~~- 179 (243)
||++|+|||++.. ...+++.||||.|+++..++++..||.......... ...|. ..
T Consensus 239 GT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~ 318 (418)
T KOG1167|consen 239 GTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNI 318 (418)
T ss_pred CCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccc
Confidence 8999999999874 456889999999999999999999986432221100 00000 00
Q ss_pred -cCc-----hhhh--hhhhcc----ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 180 -KLS-----EDKV--KQCVDT----KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 180 -~~~-----~~~~--~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
... .+.+ ..+... ..........+..+++++.+|+..||.+|.||++.|+
T Consensus 319 ~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 319 PTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000 0011 000000 0001112233457999999999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=159.28 Aligned_cols=151 Identities=34% Similarity=0.445 Sum_probs=128.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|+|++++++++..+...++++|++.+++|.+++...... ++...+..++.+++.++.+||+.+ +
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh~~~---i 119 (225)
T smart00221 51 LKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK--------LSEEEARFYLRQILEALEYLHSLG---I 119 (225)
T ss_pred HHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 45679999999999999999999999999999999999875421 678889999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhh-ccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA-MTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+|+++.|++++.++.++++|||.+......... ......++..|++||.. ....++.++|+|+||++++++++|..
T Consensus 120 ~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~ 198 (225)
T smart00221 120 VHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPE 198 (225)
T ss_pred ecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999988766443210 11233467789999998 56667789999999999999999999
Q ss_pred CCCC
Q 026115 161 PVDH 164 (243)
Q Consensus 161 pf~~ 164 (243)
||..
T Consensus 199 pf~~ 202 (225)
T smart00221 199 PFSG 202 (225)
T ss_pred Cccc
Confidence 9964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-24 Score=157.91 Aligned_cols=202 Identities=24% Similarity=0.366 Sum_probs=160.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|+-+.||||+.++|.|....++.++..|++.|+|+..++..... +++-.++.+++.+++.|.+|||+.. +-+
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~v-------vvd~sqav~faldiargmaflhsle-p~i 312 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSLE-PMI 312 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhcc-hhh
Confidence 45578999999999999999999999999999999999987654 3788899999999999999999985 223
Q ss_pred EeccCCCCceEecCCCceeec--ccCCCCCCcccccccccccccccccccCchhhccCCC---CcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKIS--DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~DiwslG~~l~~l~ 156 (243)
.-..+.+..++++++.+.+|. |--++.. .......+.|++||.+...+- -.++|+|||++++||+.
T Consensus 313 pr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~ 383 (448)
T KOG0195|consen 313 PRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELN 383 (448)
T ss_pred hhhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhh
Confidence 344688889999988776653 3222111 112234678999999875443 45799999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
|...||....+ .+--..+.-.+++...|+..+..+..++.-|+..||.+||.+..++-.|+++.
T Consensus 384 trevpfadlsp---------------mecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 384 TREVPFADLSP---------------MECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccccCCc---------------hhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999975533 23334445566777888888999999999999999999999999999988764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-23 Score=160.03 Aligned_cols=205 Identities=19% Similarity=0.229 Sum_probs=151.9
Q ss_pred cCCccceeeEEEEe---------------------------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHH
Q 026115 6 KNENVVELVGYYVD---------------------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 58 (243)
Q Consensus 6 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 58 (243)
+|||||++.++|.+ +..+++||..+.. +|..++.... .+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence 69999999998853 4568999999866 9999998876 77888
Q ss_pred HHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec--CCC--ceeecccCCCCCCcccc--ccccc--ccccccccccC
Q 026115 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDD--IAKISDFDLSNQAPDAA--ARLHS--TRVLGTFGYHA 130 (243)
Q Consensus 59 ~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~--~~~--~~~l~df~~~~~~~~~~--~~~~~--~~~~~~~~~~a 130 (243)
...++.|+++|+.|||++| +.|||+|++||++. +++ ...+.|||.+--..... ....+ ...-|.-..+|
T Consensus 343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 8999999999999999999 99999999999993 333 56889999764332211 11111 12336778899
Q ss_pred chhhccCC------CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHH
Q 026115 131 PEYAMTGQ------MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIA 204 (243)
Q Consensus 131 PE~~~~~~------~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (243)
||+..... .-.++|.|+.|.+.||+++...||...-+. .......++.--+ ..+..++.
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----------~L~~r~Yqe~qLP----alp~~vpp 484 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----------LLDTRTYQESQLP----ALPSRVPP 484 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-----------eechhhhhhhhCC----CCcccCCh
Confidence 99886432 135899999999999999999999863211 1111222222222 34555666
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 205 KMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 205 ~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
.+.+++...|+.||.+|+|+.-..+.|+=.++..+
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~ 519 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMG 519 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCc
Confidence 79999999999999999999888777775555543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-23 Score=167.55 Aligned_cols=216 Identities=23% Similarity=0.359 Sum_probs=164.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|+++.|.|+.+|+|.+.+++..++|.+||..|+|.+.+...... +++.-...+.++++.|+.|+|.... .
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~--------~d~~F~~s~~rdi~~Gl~ylh~s~i--~ 70 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK--------LDYFFILSFIRDISKGLAYLHNSPI--G 70 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC--------ccHHHHHHHHHHHHHHHHHHhcCcc--e
Confidence 67899999999999999999999999999999999999874432 8888999999999999999999861 3
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC-------CCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-------MSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~DiwslG~~l~~ 154 (243)
.|+.+++.|++++....+|++|||+.................-...|.|||.+.... .+.++|+||+|++++|
T Consensus 71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 999999999999999999999999976554311111111122345799999987631 3667999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc---cccCCCCC--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD---TKLGGEYP--PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+++...||........ ..+.+..+.+ ...+.... .+.+..+..++..||..+|.+||+++++-.
T Consensus 151 i~~r~~~~~~~~~~~~-----------~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVED-----------PDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HHhccCccccccccCC-----------hHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9999999975321111 0112222111 11111111 144557999999999999999999999999
Q ss_pred HHHHHHhhc
Q 026115 230 ALQPLLNTR 238 (243)
Q Consensus 230 ~l~~~~~~~ 238 (243)
.+..+....
T Consensus 220 ~~~~~~~~~ 228 (484)
T KOG1023|consen 220 KLLTINKGG 228 (484)
T ss_pred hhhhhcccc
Confidence 998887754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-20 Score=149.43 Aligned_cols=208 Identities=18% Similarity=0.221 Sum_probs=156.5
Q ss_pred CccceeeEEE-EeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC
Q 026115 8 ENVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 86 (243)
Q Consensus 8 ~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di 86 (243)
+++..+++.. ..+..-++||+.+ |.+|.++.......+ ++..+++.++.|++.+|+++|+.| ++||||
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~-------fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDi 148 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGR-------FSRKTVLRIAIQNLNALEDLHSKG---FIHRDI 148 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCC-------cCHhHHHHHHHHHHHHHHHHHhcC---cccCCc
Confidence 6888999998 4777889999988 779999886665332 899999999999999999999999 999999
Q ss_pred CCCceEecCC-----CceeecccCCCCCCcc--ccc----cc-c-cccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 87 KSSNVLLFDD-----DIAKISDFDLSNQAPD--AAA----RL-H-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 87 ~~~nil~~~~-----~~~~l~df~~~~~~~~--~~~----~~-~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
||.|+.+... ..+.+.|||+++.+.. ... .. . .....||..|.++....+...+.+.|+||++.++.
T Consensus 149 Kp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~ 228 (322)
T KOG1164|consen 149 KPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLL 228 (322)
T ss_pred CHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHH
Confidence 9999999865 3589999999983331 111 11 1 12355999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
++..|..||........ .....+..............+..+.++...+-..+..++|....+.+.+.+
T Consensus 229 el~~g~LPW~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 229 ELLKGSLPWEALEMTDL------------KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred HHhcCCCCCccccccch------------HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 99999999965432111 111111111111111222334566777777777999999999999999988
Q ss_pred HHhhc
Q 026115 234 LLNTR 238 (243)
Q Consensus 234 ~~~~~ 238 (243)
.....
T Consensus 297 ~~~~~ 301 (322)
T KOG1164|consen 297 VFDSE 301 (322)
T ss_pred HHHhc
Confidence 87764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-22 Score=174.18 Aligned_cols=198 Identities=18% Similarity=0.207 Sum_probs=145.0
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
.+++||.+++.-....++.-++|-+|..+ +|++.+...+- +...+..-++.|++.|+..+|..| ++|
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPF---------L~~iEKkWiaFQLL~al~qcH~~g---VcH 143 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPF---------LVLIEKKWIAFQLLKALSQCHKLG---VCH 143 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchH---------HHHHHHHHHHHHHHHHHHHHHHcC---ccc
Confidence 46899999988777778888888899966 99999887652 667778889999999999999999 999
Q ss_pred ccCCCCceEecCCCceeecccCCCCCCccccccccc-----ccccccccccCchhhccCC-----------CCcccchHH
Q 026115 84 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----TRVLGTFGYHAPEYAMTGQ-----------MSSKSDVYS 147 (243)
Q Consensus 84 ~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~-----------~~~~~Diws 147 (243)
||||.+|||++.=+.+.|+||..-+-..-..+.... .....-.+|.|||.+.... .+++.||||
T Consensus 144 GDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS 223 (1431)
T KOG1240|consen 144 GDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFS 223 (1431)
T ss_pred cccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhh
Confidence 999999999999999999999765433221111100 1112345899999886421 467889999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCCccceeeccC-cCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 148 FGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP-KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 148 lG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
+||+++|+++ |.++|+.. .+..+... ....+...+.++.. .++.++..|++.||.+|.||+
T Consensus 224 ~GCViaELf~Eg~PlF~LS------QL~aYr~~~~~~~e~~Le~Ied~-----------~~Rnlil~Mi~rdPs~RlSAe 286 (1431)
T KOG1240|consen 224 AGCVIAELFLEGRPLFTLS------QLLAYRSGNADDPEQLLEKIEDV-----------SLRNLILSMIQRDPSKRLSAE 286 (1431)
T ss_pred hhHHHHHHHhcCCCcccHH------HHHhHhccCccCHHHHHHhCcCc-----------cHHHHHHHHHccCchhccCHH
Confidence 9999999998 78888622 01111000 11222222222211 589999999999999999999
Q ss_pred HHHHHH
Q 026115 226 IVLKAL 231 (243)
Q Consensus 226 ~vl~~l 231 (243)
+.|+.-
T Consensus 287 dyL~~y 292 (1431)
T KOG1240|consen 287 DYLQKY 292 (1431)
T ss_pred HHHHhh
Confidence 999873
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-19 Score=144.62 Aligned_cols=208 Identities=28% Similarity=0.377 Sum_probs=157.3
Q ss_pred CCcccCC-ccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNE-NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++.+.|+ +++++.+++......+++++++.++++.+++...... ..+.......+..|++.++.++|..+
T Consensus 51 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~--- 121 (384)
T COG0515 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKG--- 121 (384)
T ss_pred HHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4567777 7999999998888889999999999999777665321 12888899999999999999999999
Q ss_pred eEeccCCCCceEecCCC-ceeecccCCCCCCccccccc----ccccccccccccCchhhcc---CCCCcccchHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARL----HSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVL 152 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l 152 (243)
++|||+||+||+++..+ .++++|||.++......... ......|+..|++||.+.+ ...+...|+|++|+++
T Consensus 122 ~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~ 201 (384)
T COG0515 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201 (384)
T ss_pred eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence 99999999999999988 79999999987554433221 1245568999999999987 5678899999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc----CCCCC----HHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL----GGEYP----PKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
+++++|..||...... .........+.... ..... ......+.+++..++..+|..|.+.
T Consensus 202 ~~~~~~~~p~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 269 (384)
T COG0515 202 YELLTGLPPFEGEKNS------------SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269 (384)
T ss_pred HHHHhCCCCCCCCCcc------------ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCH
Confidence 9999999997644321 00011111111111 00111 1223578999999999999999999
Q ss_pred HHHHHH
Q 026115 225 GIVLKA 230 (243)
Q Consensus 225 ~~vl~~ 230 (243)
.+....
T Consensus 270 ~~~~~~ 275 (384)
T COG0515 270 SSDLSH 275 (384)
T ss_pred HHHhhc
Confidence 887764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-20 Score=143.23 Aligned_cols=164 Identities=21% Similarity=0.267 Sum_probs=109.3
Q ss_pred eEEEEeecCCCCHHHHhcc---CCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCce
Q 026115 23 RVLAYEHASKGSLHDILHG---KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 99 (243)
Q Consensus 23 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~ 99 (243)
.+++|+-+.+ +|.+++.. .... ...+.....+.+..|++..+++||..| ++|+||+|+|++++.+|.+
T Consensus 114 ~~~l~P~~~~-dL~~~~~~l~~~~~~-----~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v 184 (288)
T PF14531_consen 114 RFLLMPRAQG-DLQDLVEALFSRAQT-----HSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGV 184 (288)
T ss_dssp EEEEEE--SE-EHHHHHHHHHHHTTT-----SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-E
T ss_pred hhhccchhhh-cHHHHHHHHhhcccc-----cchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCE
Confidence 3677887744 88887643 2211 112445566778899999999999999 9999999999999999999
Q ss_pred eecccCCCCCCcccccccccccccccccccCchhhccC--------CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 026115 100 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--------QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 171 (243)
Q Consensus 100 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~ 171 (243)
.|+||+.....+..... ...+..|.|||..... .++.+.|.|+||+++|.|+++..||....+....
T Consensus 185 ~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~ 259 (288)
T PF14531_consen 185 FLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADP 259 (288)
T ss_dssp EE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS
T ss_pred EEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccc
Confidence 99999877655543321 2234678899977532 3578899999999999999999999855332221
Q ss_pred cceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 026115 172 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFR 221 (243)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 221 (243)
.. ....+. +.++.+..||..+|+.||.+|
T Consensus 260 ~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 260 EW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 10 112444 778899999999999999988
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.3e-19 Score=135.78 Aligned_cols=208 Identities=20% Similarity=0.263 Sum_probs=159.4
Q ss_pred CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC
Q 026115 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 86 (243)
Q Consensus 7 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di 86 (243)
.+.|...+-+...+.+=.||+|.+ |.+|+++..-.... ++..+++.++.|++.-++++|+.. ++.|||
T Consensus 83 ~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~--------FSvKTV~miA~Qmi~rie~vH~k~---LIYRDI 150 (449)
T KOG1165|consen 83 TEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRR--------FSVKTVAMIAKQMITRIEYVHEKD---LIYRDI 150 (449)
T ss_pred CCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCc--------ccHHhHHHHHHHHHHHHHHHHhcc---eeeccc
Confidence 466777776667777888999998 77999987655443 999999999999999999999998 999999
Q ss_pred CCCceEecCC-----CceeecccCCCCCCcccccccc-----cccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 87 KSSNVLLFDD-----DIAKISDFDLSNQAPDAAARLH-----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 87 ~~~nil~~~~-----~~~~l~df~~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
||+|+|+... ..+.++|||+++.+.+.....+ .....||..||+--...+...+.+.|+-|||-++++.+
T Consensus 151 KPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL 230 (449)
T KOG1165|consen 151 KPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 230 (449)
T ss_pred CccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc
Confidence 9999999753 3578999999998876654433 23456999999988888888899999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE---YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
-|..||++.-..... ++...+-+.+.... .-...+.++...+.-.=..+..+-|..+.+...+.+
T Consensus 231 RGsLPWQGLKA~tnK------------~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 231 RGSLPWQGLKADTNK------------EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred cCCCccccccCcchH------------HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 999999976332222 22233323222211 112345567777766777788899999999998888
Q ss_pred HHhhc
Q 026115 234 LLNTR 238 (243)
Q Consensus 234 ~~~~~ 238 (243)
++...
T Consensus 299 vldr~ 303 (449)
T KOG1165|consen 299 VLDRL 303 (449)
T ss_pred HHHhc
Confidence 87643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-20 Score=150.25 Aligned_cols=176 Identities=26% Similarity=0.341 Sum_probs=127.6
Q ss_pred CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCcee
Q 026115 21 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 100 (243)
Q Consensus 21 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~ 100 (243)
..+++.|++|...+|.+|+....... ..++.....++.|++.|+.| ++ .+|+|+||.||++..+..++
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e------~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGE------ERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCccc------ccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhh
Confidence 36889999999999999997544221 16677888999999999999 66 99999999999999999999
Q ss_pred ecccCCCCCCcccc----cccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCcccee
Q 026115 101 ISDFDLSNQAPDAA----ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT 175 (243)
Q Consensus 101 l~df~~~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 175 (243)
|+|||+........ .........||..|++||.+.+..|+.+.|||+||++|+|++. =.-.|+..
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------- 466 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------- 466 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------
Confidence 99999976555443 1112344679999999999999999999999999999999987 11122100
Q ss_pred eccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 176 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
.....+.+..+....-.+ -+.=+.|+.+++...|.+||++.+.
T Consensus 467 --------~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 --------ATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --------HhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence 111111111111011111 1135689999999999999955443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-20 Score=150.17 Aligned_cols=178 Identities=26% Similarity=0.303 Sum_probs=151.3
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
+||.++++.-.++.+...+++.++..+|+|...+..... +.+.....+...++-|+.++|+.+ ++++|
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l~---iiyrd 122 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKLG---IAYRD 122 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchhH---HHHhc
Confidence 389999999999999999999999999999888877664 677777888999999999999999 99999
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 165 (243)
+|++||+++.+|.+++.|||+++..-..... .|+..|+|||++. ....+.|.||+|++.+++++|..||..
T Consensus 123 ~k~enilld~~Ghi~~tdfglske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~- 193 (612)
T KOG0603|consen 123 YKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG- 193 (612)
T ss_pred ccccceeecccCccccCCchhhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-
Confidence 9999999999999999999998766543322 5799999999998 557789999999999999999999963
Q ss_pred CCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
+....++... ...|...+....+++..++..+|..|--+
T Consensus 194 ------------------~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 ------------------DTMKRILKAE--LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ------------------HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2223333322 36777888899999999999999999755
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.7e-18 Score=125.84 Aligned_cols=205 Identities=20% Similarity=0.246 Sum_probs=152.8
Q ss_pred cceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCC
Q 026115 10 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 89 (243)
Q Consensus 10 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~ 89 (243)
|..+..|..+..+-.+||+.+ |.+|+++..-.... +++.+++.++-|++..++|+|..+ ++||||||+
T Consensus 73 iP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~--------ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPd 140 (341)
T KOG1163|consen 73 IPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRR--------FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPD 140 (341)
T ss_pred Cchhhhhccccccceeeeecc-CccHHHHHHHHhhh--------hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCcc
Confidence 344555667778889999998 77999977654432 899999999999999999999999 999999999
Q ss_pred ceEecCC---CceeecccCCCCCCccccccccc-----ccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 90 NVLLFDD---DIAKISDFDLSNQAPDAAARLHS-----TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 90 nil~~~~---~~~~l~df~~~~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
|+|..-+ ..+.++|||+++.+.+..+..+. ....||..|.+--...+-..+.+.|+-|+|.++...--|..|
T Consensus 141 NFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LP 220 (341)
T KOG1163|consen 141 NFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLP 220 (341)
T ss_pred ceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCc
Confidence 9998654 56789999999888765544332 234588889887777766778899999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEY---PPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
|++..... ..++...+.+.+..... -...|.++.-.+.-|=...-++-|....+-+.+.-++...
T Consensus 221 WQglka~t------------k~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 221 WQGLKAAT------------KKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred ccccchhh------------HHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 98763321 12333334343332211 1223556777777888888888899888887777665543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.5e-17 Score=130.33 Aligned_cols=113 Identities=22% Similarity=0.188 Sum_probs=84.6
Q ss_pred CCCcccCCccce-eeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLKNENVVE-LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+|++++|+|+++ +++ ....++||||+.|++|... . . .. ...++.|+++||.|||+.|
T Consensus 74 iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~--~----------~~---~~~~~~~i~~aL~~lH~~g-- 131 (365)
T PRK09188 74 ALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-R--P----------HG---DPAWFRSAHRALRDLHRAG-- 131 (365)
T ss_pred HHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-C--c----------cc---hHHHHHHHHHHHHHHHHCC--
Confidence 367899999985 443 2457999999999999632 1 1 11 1357889999999999998
Q ss_pred CeEeccC-CCCceEecCCCceeecccCCCCCCcccccccc------cccccccccccCchhhcc
Q 026115 80 RIIHRNI-KSSNVLLFDDDIAKISDFDLSNQAPDAAARLH------STRVLGTFGYHAPEYAMT 136 (243)
Q Consensus 80 ~~~h~di-~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~ 136 (243)
++|||| ||+||+++.++.++|+|||+++.......... .....++..|.+||.+..
T Consensus 132 -IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 132 -ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred -CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999 99999999999999999999986654332111 123456777889998753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=116.72 Aligned_cols=142 Identities=17% Similarity=0.133 Sum_probs=103.2
Q ss_pred CCCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+|++|+ |+++.+++++ ...+++|+|+.|.+|...+.. ....++.|++.++.++|+.|
T Consensus 54 iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~G-- 111 (218)
T PRK12274 54 ALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRCG-- 111 (218)
T ss_pred HHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHCc--
Confidence 356785 4889999886 346899999999888653211 11346789999999999999
Q ss_pred CeEeccC-CCCceEecCCCceeecccCCCCCCcccccc---cc--------cccccccccccCchhhccC-CCC-cccch
Q 026115 80 RIIHRNI-KSSNVLLFDDDIAKISDFDLSNQAPDAAAR---LH--------STRVLGTFGYHAPEYAMTG-QMS-SKSDV 145 (243)
Q Consensus 80 ~~~h~di-~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~--------~~~~~~~~~~~aPE~~~~~-~~~-~~~Di 145 (243)
++|+|| ||+||+++.++.++|+|||++......... .. ......++.++.|+...-. ..+ .+.+.
T Consensus 112 -IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w 190 (218)
T PRK12274 112 -VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELW 190 (218)
T ss_pred -CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHH
Confidence 999999 799999999999999999999855543310 00 0112356778888765432 334 35566
Q ss_pred HHHHHHHHHHHhCCCCCCCC
Q 026115 146 YSFGVVLLELLTGRKPVDHT 165 (243)
Q Consensus 146 wslG~~l~~l~~g~~pf~~~ 165 (243)
++.|+-+|.++|+..++.+.
T Consensus 191 ~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 191 FATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHhcchHHHHHhccCCcccc
Confidence 68899999999998886543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=6e-17 Score=121.90 Aligned_cols=119 Identities=16% Similarity=0.275 Sum_probs=89.8
Q ss_pred CCcccCCccceeeEEEEeC--------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRLKNENVVELVGYYVDG--------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
+.+++||+|..+.+++... ...+++|||++|.+|.++.. ++. ....+++.++..+
T Consensus 89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~l 151 (232)
T PRK10359 89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESL 151 (232)
T ss_pred HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHH
Confidence 4578999999999986643 35899999999999988732 332 2456899999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|..| ++|+|++|.|++++.++ ++++|||.......... .. ..+....+..++|+|+||+.+.
T Consensus 152 H~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a---~d-----------~~vler~y~~~~di~~lg~~~~ 213 (232)
T PRK10359 152 HQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA---KD-----------RIDLERHYGIKNEIKDLGYYLL 213 (232)
T ss_pred HHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhh---HH-----------HHHHHhHhcccccccceeEeeh
Confidence 9999 99999999999999888 99999998755421110 00 0222334556899999998876
Q ss_pred HH
Q 026115 154 EL 155 (243)
Q Consensus 154 ~l 155 (243)
..
T Consensus 214 ~~ 215 (232)
T PRK10359 214 IY 215 (232)
T ss_pred HH
Confidence 54
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.8e-17 Score=139.81 Aligned_cols=198 Identities=23% Similarity=0.234 Sum_probs=151.2
Q ss_pred CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh-hcCCCCeEecc
Q 026115 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-EKAEPRIIHRN 85 (243)
Q Consensus 7 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh-~~~~~~~~h~d 85 (243)
|+|++++++...+....++++++..++++...+...... ..+...+-.++.|+..++.|+| ..+ +.|+|
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~-------~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ 149 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDST-------GTSSSSASRYLPQLNSGLSYLHPENG---VTHRD 149 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCcc-------CCCCcchhhhhhhhccCccccCcccc---cccCC
Confidence 999999999999999999999999999998888422210 1445566678999999999999 887 99999
Q ss_pred CCCCceEecCCC-ceeecccCCCCCCcc-cccccccccccc-cccccCchhhccC-CCCcccchHHHHHHHHHHHhCCCC
Q 026115 86 IKSSNVLLFDDD-IAKISDFDLSNQAPD-AAARLHSTRVLG-TFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 86 i~~~nil~~~~~-~~~l~df~~~~~~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
++|+|.+++.++ ..++.|||++..+.. ...........| ++.|.|||...+. ...+..|+||.|+++.-+++|..|
T Consensus 150 ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 150 IKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP 229 (601)
T ss_pred CCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence 999999999999 999999999988776 333333334557 9999999999874 447789999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhcccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
+........... ...+... .............+++.+++..+|..|.+.+++-
T Consensus 230 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 230 WDFPSRKDGRYS--------------SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccccccccce--------------eecccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 876544332211 1111110 0122233344678888999999999999988764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.1e-15 Score=113.03 Aligned_cols=87 Identities=14% Similarity=0.067 Sum_probs=69.4
Q ss_pred cCCccceeeEEEEeCC---e-eEEEEee--cCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHH-HHhhhcCC
Q 026115 6 KNENVVELVGYYVDGP---L-RVLAYEH--ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL-EYLHEKAE 78 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l-~~Lh~~~~ 78 (243)
.||||++++|+++++. . +.+|+|| +.+++|.+++.... +++. ..++.+++.++ +|||+++
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~- 125 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNR- 125 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCC-
Confidence 6899999999999863 3 4478999 55789999997642 4444 35577888777 9999999
Q ss_pred CCeEeccCCCCceEecCC----CceeecccCCC
Q 026115 79 PRIIHRNIKSSNVLLFDD----DIAKISDFDLS 107 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~----~~~~l~df~~~ 107 (243)
++||||||+||+++.. ..++|+|++.+
T Consensus 126 --IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 126 --IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred --EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9999999999999743 37999996544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.5e-16 Score=135.30 Aligned_cols=141 Identities=24% Similarity=0.317 Sum_probs=105.4
Q ss_pred HHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc-------------cccccccccccccCch
Q 026115 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-------------LHSTRVLGTFGYHAPE 132 (243)
Q Consensus 66 l~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-------------~~~~~~~~~~~~~aPE 132 (243)
++.+++|||..+ ++|||+||+|.+++.-|.+|++|||+.+........ .......||+.|.|||
T Consensus 152 mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 378999999999 999999999999999999999999997654432111 1123346999999999
Q ss_pred hhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHh
Q 026115 133 YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAAL 212 (243)
Q Consensus 133 ~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 212 (243)
++....|....|.|++|+++|+.+.|..||.+..++..-..... ...++ .+.....+.+..+++.+
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis--------d~i~w------pE~dea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--------DDIEW------PEEDEALPPEAQDLIEQ 294 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh--------hhccc------cccCcCCCHHHHHHHHH
Confidence 99999999999999999999999999999987644321110000 00000 11122345579999999
Q ss_pred hcCCCCCCCCC
Q 026115 213 CVQYEADFRPN 223 (243)
Q Consensus 213 ~l~~~p~~Rps 223 (243)
.|+.+|.+|--
T Consensus 295 LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 295 LLRQNPLCRLG 305 (1205)
T ss_pred HHHhChHhhcc
Confidence 99999999953
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.8e-16 Score=118.83 Aligned_cols=201 Identities=22% Similarity=0.308 Sum_probs=137.2
Q ss_pred cccCCccceeeEEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 4 RLKNENVVELVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
++-|.|||++..|+.+ ..+..+++||++.|++..||++..... ..+....+.+|+.||++||.|||+..
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-----~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-----KALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-----hhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 5679999999998864 346888999999999999998865422 12667788899999999999999984
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcc---cccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD---AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
++++|+++.-+.|++..++-++++-- ....... ...........+.++|.+||.-...+.+.+.|||++|....+|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 67999999999999999998887532 1111111 1111111112356788999876666677899999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
..+..--....... . ......+....++.+ .-.+++.+|++-.|+.||+|.+++..
T Consensus 276 ailEiq~tnseS~~---~-----~ee~ia~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKV---E-----VEENIANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCccee---e-----hhhhhhhheeeccCc-----------cccCcCcccccCCCCCCcchhhhhcC
Confidence 87765422111000 0 000001111111111 23567788999999999999998753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-15 Score=112.39 Aligned_cols=93 Identities=16% Similarity=0.150 Sum_probs=69.6
Q ss_pred CcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHh-hhcCCCCe
Q 026115 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL-HEKAEPRI 81 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~L-h~~~~~~~ 81 (243)
.++.++++.....+.... .++||||+.++++........ .++...+..++.|++.++.++ |+.| +
T Consensus 74 ~~l~~~~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~g---i 139 (190)
T cd05147 74 KRLVTAGIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDCR---L 139 (190)
T ss_pred HHHHHCCCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 345555554333222222 379999998877665432222 178889999999999999999 6888 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQA 110 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~ 110 (243)
+||||||+||+++ ++.++++|||++...
T Consensus 140 iHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 140 VHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred ccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 9999999999998 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.9e-15 Score=129.40 Aligned_cols=194 Identities=18% Similarity=0.136 Sum_probs=136.7
Q ss_pred cceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCC
Q 026115 10 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 89 (243)
Q Consensus 10 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~ 89 (243)
|.++..++.-.+..++|++|.+.|+|.+++..... +++...+.+..|++..+..||..+ |+|+||||+
T Consensus 756 ~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~---------m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPD 823 (974)
T KOG1166|consen 756 IMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKV---------MDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPD 823 (974)
T ss_pred hHHHHHHHccCCcceeeeeccccccHHHhhccCCC---------CCchhhhHHHHHHHHHHHHHHhcc---eecccCCcc
Confidence 34444444556667899999999999999995543 888889999999999999999999 999999999
Q ss_pred ceEecC-------CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCC
Q 026115 90 NVLLFD-------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 90 nil~~~-------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 162 (243)
|+++.. +..++|+|||.+--..-......-...++|-.+--+|+..+..|+.++|.|.++.+++.|+.|...=
T Consensus 824 Nfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 824 NFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred eeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 999942 4468999999874332222211123345788899999999999999999999999999999987541
Q ss_pred CCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
...... .....++.+... -+-+..+...+|+.|...=|...++...+++.+..
T Consensus 904 --~~~g~~---------~~~~~~~~Ry~~-----------~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 904 --VKNGSS---------WMVKTNFPRYWK-----------RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred --hcCCcc---------eeccccchhhhh-----------HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 000000 000000111111 12355666677776666668888888877776654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=8e-15 Score=109.04 Aligned_cols=93 Identities=16% Similarity=0.158 Sum_probs=71.2
Q ss_pred CcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHH-hccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCC
Q 026115 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDI-LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPR 80 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~ 80 (243)
.++.|+++.....+.... .++||||+.++++... +.... ++...+..++.|++.++.++|. .|
T Consensus 74 ~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~g--- 138 (190)
T cd05145 74 KRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVP----------LEEEEAEELYEQVVEQMRRLYQEAG--- 138 (190)
T ss_pred HHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhcc----------CCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 456677764433333222 3799999988755433 33222 6778889999999999999999 88
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCc
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 111 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~ 111 (243)
++|+||||+||+++ ++.++++|||++....
T Consensus 139 ivHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 139 LVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999999998 8899999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.9e-13 Score=103.46 Aligned_cols=91 Identities=23% Similarity=0.353 Sum_probs=78.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+..++|++|.....++.+....+++|||++|++|.+++.... . ....++.+++.++.++|+.+ +
T Consensus 53 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~lH~~~---i 116 (211)
T PRK14879 53 MSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG------------M-EELELSREIGRLVGKLHSAG---I 116 (211)
T ss_pred HHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHHHHhCC---c
Confidence 345678888877777777888899999999999999986432 1 77889999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
+|+|++|.||+++ ++.++++|||.+..
T Consensus 117 ~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 117 IHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred ccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999999 78899999998754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.3e-13 Score=111.35 Aligned_cols=137 Identities=17% Similarity=0.267 Sum_probs=105.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|+.++||||++|++.++.+++.|+|+|.+. .|..++.+ +......-.+.||+.||.|||+.+ ++
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------------l~~~~v~~Gl~qIl~AL~FL~~d~--~l 126 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------------LGKEEVCLGLFQILAALSFLNDDC--NL 126 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------------hHHHHHHHHHHHHHHHHHHHhccC--Ce
Confidence 577999999999999999999999999883 56666664 334556668899999999998665 59
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+++.-+.|+++..|.-+|++|.++......... .......-.|..|+.+.... ...|.|.|||++++++.|
T Consensus 127 vHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 127 VHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99999999999999999999999887554433211 11122223456666544322 467999999999999998
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.4e-13 Score=100.50 Aligned_cols=89 Identities=25% Similarity=0.353 Sum_probs=73.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++|+++.....++......+++|||++|++|.+++.... . .++.+++.++.+||+.+ +
T Consensus 51 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~g---i 111 (199)
T TIGR03724 51 LSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKAG---I 111 (199)
T ss_pred HHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHCC---e
Confidence 345677776655556666777889999999999999875432 1 68899999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQA 110 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~ 110 (243)
+|+|++|.||+++ ++.++++|||.+...
T Consensus 112 ~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 112 VHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999999999 889999999987654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.8e-13 Score=102.35 Aligned_cols=92 Identities=17% Similarity=0.177 Sum_probs=71.4
Q ss_pred CCcccCCcc--ceeeEEEEeCC----eeEEEEeecCC-CCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 2 VSRLKNENV--VELVGYYVDGP----LRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 2 l~~l~h~ni--v~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+.+|+|++| ++.+++..... ..++|+|++++ .+|.+++.... ++.. .+.+++.++.+||
T Consensus 94 l~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH 159 (239)
T PRK01723 94 LAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFH 159 (239)
T ss_pred HHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHH
Confidence 456777774 67777654322 23599999997 69998886532 4433 3568999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCC
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~ 110 (243)
+.| ++|+||||.||+++.++.++++|||.+...
T Consensus 160 ~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 160 DAG---VYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HCC---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 999 999999999999999899999999987654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.1e-13 Score=114.50 Aligned_cols=88 Identities=24% Similarity=0.345 Sum_probs=76.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++|++++....++.++...++||||+++++|.+++. ....++.+++.++.+||+.+ +
T Consensus 390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~g---i 449 (535)
T PRK09605 390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAG---I 449 (535)
T ss_pred HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCC---C
Confidence 567899999988888887778899999999999999875 23568899999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQA 110 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~ 110 (243)
+|||+||+||++ .++.++++|||+++..
T Consensus 450 iHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 450 VHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999999 6788999999988653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.6e-12 Score=99.76 Aligned_cols=77 Identities=16% Similarity=0.150 Sum_probs=62.7
Q ss_pred eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeec
Q 026115 23 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 102 (243)
Q Consensus 23 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~ 102 (243)
.++||||+.+++|........ ......+..++.|++.++.+||+.| .++|+|+||+||+++ ++.++++
T Consensus 123 ~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~Li 190 (237)
T smart00090 123 NVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVII 190 (237)
T ss_pred ceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEE
Confidence 479999999988876543222 1555667889999999999999986 499999999999999 8889999
Q ss_pred ccCCCCCCc
Q 026115 103 DFDLSNQAP 111 (243)
Q Consensus 103 df~~~~~~~ 111 (243)
|||.+....
T Consensus 191 DFg~a~~~~ 199 (237)
T smart00090 191 DVSQSVELD 199 (237)
T ss_pred EChhhhccC
Confidence 999876443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1e-10 Score=93.73 Aligned_cols=207 Identities=16% Similarity=0.180 Sum_probs=132.9
Q ss_pred eEEEEeecCCC-CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceee
Q 026115 23 RVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 101 (243)
Q Consensus 23 ~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l 101 (243)
.-++|+.+++. -...++.... .+.+=+..+|...+.+++.++.+.+.||..| .+=+|+.++|+++++.+.+.+
T Consensus 85 iGflmP~v~g~~pI~~~y~p~t---RRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~L 158 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPAT---RRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVL 158 (637)
T ss_pred eEEecccCCCccchhhhcCchh---hcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEE
Confidence 56677777664 2233332211 1222234789999999999999999999999 999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCC-----C
Q 026115 102 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLPRG-----Q 170 (243)
Q Consensus 102 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g-~~pf~~~~~~~-----~ 170 (243)
.|-+.-....+... ....+|...|.+||... +...+...|.|.||+++|+++.| ..||.+..-.. .
T Consensus 159 VdsDsfqi~~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~ 235 (637)
T COG4248 159 VDSDSFQINANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL 235 (637)
T ss_pred EcccceeeccCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence 88654333322222 23456889999999765 33457789999999999999985 88987531110 0
Q ss_pred ccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCC--CCCCCCCHHHHHHHHHHHHhhcC
Q 026115 171 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQY--EADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
...+....-....+.... ..+.-....-.-.+..+..+..+|+.. ++.-|||++.++..|..+..+..
T Consensus 236 E~~Ia~g~f~ya~~~~~g-~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 236 ETDIAHGRFAYASDQRRG-LKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred hhhhhcceeeechhccCC-CCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 000000000000000000 000001111133456788889999954 57789999999999988776543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.9e-12 Score=103.90 Aligned_cols=195 Identities=21% Similarity=0.206 Sum_probs=141.2
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHH----HHHHhhhcCCCCe
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----GLEYLHEKAEPRI 81 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~----~l~~Lh~~~~~~~ 81 (243)
.|+|.++....++.++..++-+|.+. .+|..+....... ++...++..+.+... |+..+|..+ +
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~--------~p~~~l~~~~~~~~~~~~~al~~~hs~~---~ 243 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNF--------LPDNLLWNSLRDWLSRDVTALSHLHSNN---I 243 (524)
T ss_pred ccccccccCcccccCCcceeeecccc-chhHHhhhccccc--------CCchhhhhHHhhhhhcccccccccCCCc---c
Confidence 48889998889999999999999995 5888877655421 566777788888888 999999998 9
Q ss_pred EeccCCCCceEecCC-CceeecccCCCCCCccccccc---ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARL---HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
+|-|++|.||+...+ ...+++|||+...+....-.. ......|...|++||...+ .++...|++++|.++.+..+
T Consensus 244 ~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l 322 (524)
T KOG0601|consen 244 VHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAIL 322 (524)
T ss_pred cccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHh
Confidence 999999999999999 889999999987776543221 1122356778999998774 56889999999999999988
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+..+.-.. .. ..+.++.......++...-...+...+.+|++.+|-.|++++.+..
T Consensus 323 ~~~~~~~g------~~----------~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 323 GSHLPSVG------KN----------SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hcccccCC------CC----------CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 76654211 00 0011110100111122222335666899999999999999988765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.1e-11 Score=92.77 Aligned_cols=73 Identities=15% Similarity=0.096 Sum_probs=60.8
Q ss_pred CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCcee
Q 026115 21 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 100 (243)
Q Consensus 21 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~ 100 (243)
...+++|||+++++|...... .....++.+++.++.++|+.+ ++|+||+|.||+++.++.++
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEE
Confidence 345899999999998765321 223567889999999999998 99999999999999999999
Q ss_pred ecccCCCCCCc
Q 026115 101 ISDFDLSNQAP 111 (243)
Q Consensus 101 l~df~~~~~~~ 111 (243)
++|||.+....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999985543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-10 Score=82.89 Aligned_cols=91 Identities=21% Similarity=0.209 Sum_probs=73.5
Q ss_pred CcccC--CccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 3 SRLKN--ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 3 ~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+.++| .++.++++++..++..++++||+.++.+..+ +......++.+++.+++.+|.....+
T Consensus 46 ~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~ 109 (155)
T cd05120 46 QLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLV 109 (155)
T ss_pred HHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------------CHHHHHHHHHHHHHHHHHHhCCCceE
Confidence 34555 5888999888888889999999988777654 23455667889999999999863233
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
++|+|++|.|++++..+.++++||+.+..
T Consensus 110 i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999999999999989999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-09 Score=89.11 Aligned_cols=184 Identities=14% Similarity=0.129 Sum_probs=127.2
Q ss_pred CCcccCCccceeeEEEE----eCCeeEEEEeecCC-CCHHHHhccCCCCC------CCCCCCccCHHHHHHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYV----DGPLRVLAYEHASK-GSLHDILHGKKGVK------GAKPGPVLSWAQRVKIAVGAARGL 70 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~ql~~~l 70 (243)
++++.|+|||++-++|. .+..+++|++|.++ ++|.+......... ....+..+++..+|.++.|+..||
T Consensus 327 wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL 406 (655)
T KOG3741|consen 327 WKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAAL 406 (655)
T ss_pred HHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHH
Confidence 46889999999999886 45679999999876 48888665544322 122333477899999999999999
Q ss_pred HHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHH
Q 026115 71 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGV 150 (243)
Q Consensus 71 ~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ 150 (243)
.++|+.| +.-+-+.+.+|+++.+.+++|..+|......... . +.+. -..+.|.-.||.
T Consensus 407 ~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------~--~~le---~~Qq~D~~~lG~ 464 (655)
T KOG3741|consen 407 YSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------T--EPLE---SQQQNDLRDLGL 464 (655)
T ss_pred HHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC--------------C--cchh---HHhhhhHHHHHH
Confidence 9999999 8889999999999988899998887654432211 0 1111 123578999999
Q ss_pred HHHHHHhCCCC-CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 151 VLLELLTGRKP-VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 151 ~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+++.+.+|..- +.. +...+... .......+.+++.++.-....++++ -++.+++.
T Consensus 465 ll~aLAt~~~ns~~~-------------------d~~~~s~~----~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 465 LLLALATGTENSNRT-------------------DSTQSSHL----TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred HHHHHhhcccccccc-------------------cchHHHHH----HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 99999997532 111 11111100 0122345566777777777777776 77777776
Q ss_pred HH
Q 026115 230 AL 231 (243)
Q Consensus 230 ~l 231 (243)
++
T Consensus 521 ~~ 522 (655)
T KOG3741|consen 521 MI 522 (655)
T ss_pred HH
Confidence 43
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-10 Score=101.89 Aligned_cols=191 Identities=23% Similarity=0.236 Sum_probs=135.4
Q ss_pred CccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 026115 8 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 87 (243)
Q Consensus 8 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~ 87 (243)
|-++...-.+.......|+++|..+++|..-++.... .+..-.......+..+.++||... +.|+|++
T Consensus 864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~ 931 (1205)
T KOG0606|consen 864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSSL---RKHRDLK 931 (1205)
T ss_pred CceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccch---hhccccc
Confidence 4444444444556778999999999999999887662 343444455667788999999987 8999999
Q ss_pred CCceEecCCCceeecccCCCCCCccc---------------------c----c----ccccccccccccccCchhhccCC
Q 026115 88 SSNVLLFDDDIAKISDFDLSNQAPDA---------------------A----A----RLHSTRVLGTFGYHAPEYAMTGQ 138 (243)
Q Consensus 88 ~~nil~~~~~~~~l~df~~~~~~~~~---------------------~----~----~~~~~~~~~~~~~~aPE~~~~~~ 138 (243)
|.|.+...++...+.||+.....+.. . . ........+|+.|.+||...+..
T Consensus 932 p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~ 1011 (1205)
T KOG0606|consen 932 PDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR 1011 (1205)
T ss_pred ccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc
Confidence 99999999999999998732211110 0 0 00112345899999999999988
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC-CCCCHHHHHHHHHHHHhhcCCC
Q 026115 139 MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG-GEYPPKAIAKMAAVAALCVQYE 217 (243)
Q Consensus 139 ~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~ 217 (243)
....+|.|+.|+.+++.++|.+||....++..- ..++..... ...+...+.+..+++...+..+
T Consensus 1012 hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~ 1076 (1205)
T KOG0606|consen 1012 HGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEE 1076 (1205)
T ss_pred CCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccC
Confidence 899999999999999999999999866443221 111111111 1233444557888888889999
Q ss_pred CCCCCCHH
Q 026115 218 ADFRPNMG 225 (243)
Q Consensus 218 p~~Rps~~ 225 (243)
|.+|-.+.
T Consensus 1077 ~~qr~~a~ 1084 (1205)
T KOG0606|consen 1077 PTQRLGAK 1084 (1205)
T ss_pred chhccCcc
Confidence 99987765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.6e-10 Score=82.74 Aligned_cols=76 Identities=13% Similarity=0.072 Sum_probs=58.4
Q ss_pred eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCceEecCCCcee
Q 026115 22 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAK 100 (243)
Q Consensus 22 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~~~h~di~~~nil~~~~~~~~ 100 (243)
..+++|||+.++++........ .....+..++.+++.++.++|. .+ ++|+|++|+||+++ ++.++
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~----------~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDV----------RLLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhh----------hhcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEE
Confidence 4589999999865422111111 1115677899999999999999 87 99999999999999 88999
Q ss_pred ecccCCCCCCc
Q 026115 101 ISDFDLSNQAP 111 (243)
Q Consensus 101 l~df~~~~~~~ 111 (243)
++|||.+....
T Consensus 155 liDfg~a~~~~ 165 (187)
T cd05119 155 IIDVPQAVEID 165 (187)
T ss_pred EEECccccccc
Confidence 99999886443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.8e-10 Score=97.28 Aligned_cols=155 Identities=18% Similarity=0.290 Sum_probs=106.8
Q ss_pred HHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccccccc-------ccccccccCch
Q 026115 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-------VLGTFGYHAPE 132 (243)
Q Consensus 60 ~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~-------~~~~~~~~aPE 132 (243)
..=+.+++.|+.|+|... .++|+.|.|++|.++.++..|++.|+.+.............+ ......|.|||
T Consensus 102 f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred hhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 334456668999999885 499999999999999999999999998765554332221111 12345799999
Q ss_pred hhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHH
Q 026115 133 YAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAA 211 (243)
Q Consensus 133 ~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 211 (243)
.+.+.-.+.++|++|+|+++|.+.. |...+...... .........+......+....+.++.+-+.
T Consensus 180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-------------~~~~~~~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-------------LSYSFSRNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred hhccccccccccceeeeeEEEEEecCCcchhhccCCc-------------chhhhhhcccccccccccccCcHHHHHHHH
Confidence 9998778899999999999999984 55544422110 001111111111112233566778999999
Q ss_pred hhcCCCCCCCCCHHHHHH
Q 026115 212 LCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 212 ~~l~~~p~~Rps~~~vl~ 229 (243)
+++..++..||++..+..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999997776643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.2e-09 Score=90.80 Aligned_cols=190 Identities=16% Similarity=0.137 Sum_probs=133.7
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
.|.|++.++..+......++-.||+.++++...+.... .+++...+.+..|++.++.++|+.. .+|+|
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~---------~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d 391 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQ---------MLDEDPRLRLTAQILTALNVIHSKL---FVHLD 391 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhHHHH---------hcCcchhhhhHHHHHhccccccchh---hhccc
Confidence 47888888888877777778899999998887763322 1677788899999999999999998 99999
Q ss_pred CCCCceEecCC-CceeecccCCCCCCccccccccccccccccccc--CchhhccCCCCcccchHHHHHHHHHHHhCCCCC
Q 026115 86 IKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 86 i~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~--aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 162 (243)
++|.||++..+ +..+++||+.......... ...+.-.+. ++.......+-.++|+++||..+.+.+++...-
T Consensus 392 ~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 392 VKPSNILISNDGFFSKLGDFGCWTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ccccceeeccchhhhhccccccccccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 99999999876 7778999987653221111 111222333 444455667788999999999999999877643
Q ss_pred CCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
... .....+..... .........+..+...+...++.-||++.++.....
T Consensus 467 ~~~------------------~~~~~i~~~~~--p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 467 ESG------------------VQSLTIRSGDT--PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccc------------------ccceeeecccc--cCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 211 11111111111 111122367888889999999999999988776544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.1e-08 Score=75.65 Aligned_cols=85 Identities=18% Similarity=0.152 Sum_probs=61.0
Q ss_pred ccceeeEEEEeCCeeEEEEeecCCCCHHH-HhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHh-hhcCCCCeEeccC
Q 026115 9 NVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL-HEKAEPRIIHRNI 86 (243)
Q Consensus 9 niv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~L-h~~~~~~~~h~di 86 (243)
++...+++ ..-++||||+.+..+.. .+.... ++...+..+..+++.++..| |+.+ ++|+|+
T Consensus 89 ~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~----------~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 89 PCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAK----------LNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred CCCeEEEe----cCCEEEEEEcCCCCccchhhhccc----------cCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 34445543 35578999997643321 222211 44556677889999999998 8888 999999
Q ss_pred CCCceEecCCCceeecccCCCCCCc
Q 026115 87 KSSNVLLFDDDIAKISDFDLSNQAP 111 (243)
Q Consensus 87 ~~~nil~~~~~~~~l~df~~~~~~~ 111 (243)
++.||+++ ++.+.++|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.9e-08 Score=76.68 Aligned_cols=87 Identities=16% Similarity=0.053 Sum_probs=67.4
Q ss_pred eeeEEEEe-----CCeeEEEEeecCCC-CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 12 ELVGYYVD-----GPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 12 ~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
..+++.+. ...-++|+|++++. +|.+++...... +.+......++.+++..+.-||..| ++|+|
T Consensus 94 ~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~la~~i~~LH~~G---i~HgD 163 (268)
T PRK15123 94 TGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKRVATMVRDMHAAG---INHRD 163 (268)
T ss_pred CeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHHCc---CccCC
Confidence 44555543 23578999999886 899988532111 1456677789999999999999999 99999
Q ss_pred CCCCceEecC-------CCceeecccCCCC
Q 026115 86 IKSSNVLLFD-------DDIAKISDFDLSN 108 (243)
Q Consensus 86 i~~~nil~~~-------~~~~~l~df~~~~ 108 (243)
+++.||+++. +..+.++||+.++
T Consensus 164 L~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 164 CYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred CChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999999975 4578999999764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.2e-08 Score=72.15 Aligned_cols=76 Identities=24% Similarity=0.315 Sum_probs=61.7
Q ss_pred EEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec
Q 026115 15 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 94 (243)
Q Consensus 15 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~ 94 (243)
=+..+.....|+|||.+|..|.+++.... ..++..+-.-+.-||..| ++|+|+.++|+.+.
T Consensus 66 v~dvD~~~~~I~me~I~G~~lkd~l~~~~----------------~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~ 126 (204)
T COG3642 66 VYDVDPDNGLIVMEYIEGELLKDALEEAR----------------PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILS 126 (204)
T ss_pred EEEEcCCCCEEEEEEeCChhHHHHHHhcc----------------hHHHHHHHHHHHHHHhcC---eecCCCccceEEEe
Confidence 34556777789999999999998887652 346667777789999999 99999999999997
Q ss_pred CCCceeecccCCCCCC
Q 026115 95 DDDIAKISDFDLSNQA 110 (243)
Q Consensus 95 ~~~~~~l~df~~~~~~ 110 (243)
..+ +.++|||++...
T Consensus 127 ~~~-i~~IDfGLg~~s 141 (204)
T COG3642 127 GGR-IYFIDFGLGEFS 141 (204)
T ss_pred CCc-EEEEECCccccc
Confidence 665 889999997643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.4e-08 Score=84.84 Aligned_cols=79 Identities=23% Similarity=0.291 Sum_probs=60.0
Q ss_pred CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHH-HHHHhhhcCCCCeEeccCCCCceEecCCCc
Q 026115 20 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-GLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 98 (243)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~-~l~~Lh~~~~~~~~h~di~~~nil~~~~~~ 98 (243)
.+..++||||++|++|.++....... .+ ..+++..++. .+..+|..| ++|+|++|.||+++.++.
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~--------~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~ 295 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAG--------LD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGK 295 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcC--------CC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCc
Confidence 44578999999999998876532210 22 2334455554 467889888 999999999999999999
Q ss_pred eeecccCCCCCCcc
Q 026115 99 AKISDFDLSNQAPD 112 (243)
Q Consensus 99 ~~l~df~~~~~~~~ 112 (243)
++++|||++.....
T Consensus 296 i~liDfG~~~~l~~ 309 (437)
T TIGR01982 296 IIALDFGIVGRLSE 309 (437)
T ss_pred EEEEeCCCeeECCH
Confidence 99999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.9e-08 Score=72.08 Aligned_cols=88 Identities=27% Similarity=0.264 Sum_probs=70.2
Q ss_pred cceeeEEEEeC----CeeEEEEeecCCC-CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 10 VVELVGYYVDG----PLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 10 iv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
..+.+++.+.. ...++|+|++++. +|.+++..... .+......++.+++..++-||..| ++|+
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~~l~~~i~~lH~~g---i~H~ 142 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLRALARLIAKLHDAG---IYHG 142 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHHHHHHHHHHHHHCc---CCCC
Confidence 34556665542 2458999999884 89999886432 445567789999999999999999 9999
Q ss_pred cCCCCceEecCCC---ceeecccCCCCC
Q 026115 85 NIKSSNVLLFDDD---IAKISDFDLSNQ 109 (243)
Q Consensus 85 di~~~nil~~~~~---~~~l~df~~~~~ 109 (243)
|+++.|||++.++ .+.++||+.++.
T Consensus 143 Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 143 DLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999887 789999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.7e-08 Score=68.99 Aligned_cols=85 Identities=21% Similarity=0.272 Sum_probs=65.4
Q ss_pred EEEeCCeeEEEEeecCC-CCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec
Q 026115 16 YYVDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 94 (243)
Q Consensus 16 ~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~ 94 (243)
++.+...-.++|||++| .++.+|+....... ........++..+-+.+.-||.++ ++|+|+..+||++.
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~ 147 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLR 147 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEe
Confidence 45566667799999977 48888887765321 223333678899999999999999 99999999999997
Q ss_pred CCC---ceeecccCCCCCC
Q 026115 95 DDD---IAKISDFDLSNQA 110 (243)
Q Consensus 95 ~~~---~~~l~df~~~~~~ 110 (243)
..+ .+.++|||++...
T Consensus 148 ~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 148 SDGNQITPILIDFGLSSVS 166 (229)
T ss_pred cCCCcCceEEEeecchhcc
Confidence 654 3489999987544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.7e-08 Score=72.41 Aligned_cols=79 Identities=19% Similarity=0.114 Sum_probs=57.0
Q ss_pred ceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC--CCCeEeccCCC
Q 026115 11 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--EPRIIHRNIKS 88 (243)
Q Consensus 11 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~--~~~~~h~di~~ 88 (243)
.+++.+. ....++||||++|.++... .. .. ...+.+++.+++.||..+ ...++|+|++|
T Consensus 56 P~~~~~~--~~~~~lv~e~i~G~~l~~~---~~----------~~----~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~ 116 (170)
T cd05151 56 PKLYYFD--PETGVLITEFIEGSELLTE---DF----------SD----PENLEKIAKLLKKLHSSPLPDLVPCHNDLLP 116 (170)
T ss_pred CceEEEe--CCCCeEEEEecCCCccccc---cc----------cC----HHHHHHHHHHHHHHhCCCCCCceeecCCCCc
Confidence 3444443 3345799999999877543 00 11 234678999999999986 22259999999
Q ss_pred CceEecCCCceeecccCCCCC
Q 026115 89 SNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 89 ~nil~~~~~~~~l~df~~~~~ 109 (243)
.||+++ ++.++++||+.+..
T Consensus 117 ~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 117 GNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CcEEEE-CCeEEEEecccccC
Confidence 999998 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.9e-07 Score=66.03 Aligned_cols=94 Identities=28% Similarity=0.246 Sum_probs=73.2
Q ss_pred CCcccC-CccceeeEEEEeCCeeEEEEeecCCCCHHHH---hccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDI---LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
|+.+++ +++.+++|+| .-+++.|+...+++... +...- ..+|..+.+++.++++.+.+++...
T Consensus 13 l~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~---------~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 13 LQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFL---------QSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred HHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccccccc---------ccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 445565 6999999999 23567899987665432 11111 1679999999999999999999875
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCC
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
.+.+.-+|++++|+-++.++.++++|.+-+.
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 4559999999999999999999999997653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.6e-07 Score=67.32 Aligned_cols=82 Identities=21% Similarity=0.216 Sum_probs=49.7
Q ss_pred ccceeeEEEEeCCeeEEEEeecC--CCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHH-hhhcCCCCeEecc
Q 026115 9 NVVELVGYYVDGPLRVLAYEHAS--KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY-LHEKAEPRIIHRN 85 (243)
Q Consensus 9 niv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~-Lh~~~~~~~~h~d 85 (243)
++.+.+++. .-++||||+. |..+..+.. .. ++......++.+++..+.. +|..| ++|+|
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~-~~----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGD 132 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKD-VD----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGD 132 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHHH-CG----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHHh-cc----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecC
Confidence 344555442 2369999998 544443332 22 2223445567777775555 57888 99999
Q ss_pred CCCCceEecCCCceeecccCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~ 109 (243)
+++.||+++.+ .+.++|||.+..
T Consensus 133 Ls~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 133 LSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp -STTSEEEETT-CEEE--GTTEEE
T ss_pred CChhhEEeecc-eEEEEecCccee
Confidence 99999999887 899999997644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.9e-07 Score=79.38 Aligned_cols=78 Identities=12% Similarity=0.092 Sum_probs=53.2
Q ss_pred CCeeEEEEeecCCCCHHHHh--ccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCC
Q 026115 20 GPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 97 (243)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~ 97 (243)
.+.-++||||+.|+.+.++- .... . ....+....+..++.|+ ...| ++|+|++|.||+++.++
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g-~----d~~~la~~~v~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g 297 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAG-T----DMKLLAERGVEVFFTQV-------FRDG---FFHADMHPGNIFVSYDP 297 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcC-C----CHHHHHHHHHHHHHHHH-------HhCC---eeeCCCChHHeEEecCC
Confidence 45667999999999998742 2211 0 00013333333344444 3467 99999999999999887
Q ss_pred ----ceeecccCCCCCCcc
Q 026115 98 ----IAKISDFDLSNQAPD 112 (243)
Q Consensus 98 ----~~~l~df~~~~~~~~ 112 (243)
.++++|||++.....
T Consensus 298 ~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 298 PENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCCCeEEEEecceEEECCH
Confidence 899999999866544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.7e-06 Score=65.69 Aligned_cols=92 Identities=23% Similarity=0.299 Sum_probs=61.2
Q ss_pred CccceeeEEEEeC---CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc--------
Q 026115 8 ENVVELVGYYVDG---PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-------- 76 (243)
Q Consensus 8 ~niv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-------- 76 (243)
.++.+++.+.... +..++||||++|.++...+.... ++......++.+++.++..||+.
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 126 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLRPE----------LSPEERRALARALADTLAALHSVDPAAVGLG 126 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCCCC----------CCHHHHHHHHHHHHHHHHHHhCCChhhcCCc
Confidence 3456667766553 25689999999988877553111 44444455555555555555532
Q ss_pred ---------------------------------------------CCCCeEeccCCCCceEecC--CCceeecccCCCCC
Q 026115 77 ---------------------------------------------AEPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQ 109 (243)
Q Consensus 77 ---------------------------------------------~~~~~~h~di~~~nil~~~--~~~~~l~df~~~~~ 109 (243)
....++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 127 DLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1234799999999999998 56688999987654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=6e-06 Score=61.53 Aligned_cols=79 Identities=15% Similarity=0.073 Sum_probs=63.8
Q ss_pred eeEEEEeecCC-CCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCc--
Q 026115 22 LRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-- 98 (243)
Q Consensus 22 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~-- 98 (243)
.-+||+|-+.+ .+|.+++....-.+ .+......++.+++.+++-||+.| +.|+|+.+.||+++..+.
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~-------~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~ 168 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSP-------YSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAE 168 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCC-------cchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCee
Confidence 46899997754 49999886643211 567777889999999999999999 999999999999986666
Q ss_pred eeecccCCCCCC
Q 026115 99 AKISDFDLSNQA 110 (243)
Q Consensus 99 ~~l~df~~~~~~ 110 (243)
+.++||.-++..
T Consensus 169 v~lIDlEk~r~~ 180 (216)
T PRK09902 169 AGFLDLEKSRRR 180 (216)
T ss_pred EEEEEhhccchh
Confidence 899999865543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.4e-06 Score=63.12 Aligned_cols=68 Identities=21% Similarity=0.234 Sum_probs=52.7
Q ss_pred CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCcee
Q 026115 21 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 100 (243)
Q Consensus 21 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~ 100 (243)
...+++|||++|..|.++.. ++. .+...+.+++.-+|+.| +.|+|.+|.|++++.++ ++
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EE
Confidence 44678999999988877643 322 23456778899999999 99999999999998544 88
Q ss_pred ecccCCCCC
Q 026115 101 ISDFDLSNQ 109 (243)
Q Consensus 101 l~df~~~~~ 109 (243)
++|++..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999976543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.3e-05 Score=72.54 Aligned_cols=190 Identities=19% Similarity=0.227 Sum_probs=127.2
Q ss_pred CCcccCCccceeeEEEEeCCe----eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKNENVVELVGYYVDGPL----RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
+....|+|++.+++|...... ..+..+++...++...+..... ++..+...+..++.+++.++|...
T Consensus 236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---------i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---------IPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---------cCHHHHHHHHHHHhhhHHHHHHhc
Confidence 456789999999998764432 2334467888888888876653 788889899999999999999986
Q ss_pred CCCeEeccCCCC---ceEecCCCceeec--ccCCCCCCcccccccccccccccccccCchhhccCCCCc--ccchHHHHH
Q 026115 78 EPRIIHRNIKSS---NVLLFDDDIAKIS--DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS--KSDVYSFGV 150 (243)
Q Consensus 78 ~~~~~h~di~~~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~DiwslG~ 150 (243)
..|.-+... +...+..+.+..+ ||+.++........ .....+..+-++|.......+. ..|+|++|.
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 666665554 3334455556655 88776655443221 1122345567777776655443 479999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
.+..+..|..+-... ......+.. .......+...+|+..++++|+++.+++..
T Consensus 381 l~~~~~~~~~i~~~~------------------~~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS------------------AVPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCcccccc------------------cchhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 999998876653211 001111110 111157888899999999999999999986
Q ss_pred HH
Q 026115 231 LQ 232 (243)
Q Consensus 231 l~ 232 (243)
.-
T Consensus 435 ~f 436 (1351)
T KOG1035|consen 435 PF 436 (1351)
T ss_pred hh
Confidence 43
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.7e-06 Score=73.38 Aligned_cols=144 Identities=22% Similarity=0.238 Sum_probs=104.5
Q ss_pred CCCcccCCc-cceeeEEEEeCCeeEEEEeecCCC-CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 1 MVSRLKNEN-VVELVGYYVDGPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 1 ~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
||.+++||| .+.+++-+..+....+.++++.++ +.......... .+...+....++.-..+++++|+.-
T Consensus 286 LLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~--------~~~~~~~~~~~r~et~~l~~l~~~~- 356 (829)
T KOG0576|consen 286 LLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEI--------ALEQYQFAYPLRKETRPLAELHSSY- 356 (829)
T ss_pred HHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhH--------hhhhhhhhhhhhhhccccccccccc-
Confidence 467899999 777777777788899999999887 22211111110 1444455667777888899999875
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
-+|+| ||+. .++..+..||+......... ......+++.++|||+...+.+...-|.|++|.-..++.-|
T Consensus 357 --~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~ 426 (829)
T KOG0576|consen 357 --KVHRD----NILG-SEEEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG 426 (829)
T ss_pred --ccCcc----cccc-cccccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC
Confidence 57887 6644 44778899999876655443 23445689999999999998999999999999877777777
Q ss_pred CCCCC
Q 026115 159 RKPVD 163 (243)
Q Consensus 159 ~~pf~ 163 (243)
.+|-.
T Consensus 427 ~pPr~ 431 (829)
T KOG0576|consen 427 LPPRS 431 (829)
T ss_pred CCCCC
Confidence 77654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=7.9e-05 Score=57.38 Aligned_cols=72 Identities=14% Similarity=0.127 Sum_probs=53.2
Q ss_pred CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCcee
Q 026115 21 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 100 (243)
Q Consensus 21 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~ 100 (243)
++-++|||+++|--|...- ++....-.++..++..+.-+-..| ++|+|+++-||+++.+|.+.
T Consensus 180 nRHaVvMe~ieG~eL~~~r--------------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLR--------------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred ccceeeeehcccceeeccc--------------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEE
Confidence 4557999999886554432 223334445566666666666777 99999999999999999999
Q ss_pred ecccCCCCC
Q 026115 101 ISDFDLSNQ 109 (243)
Q Consensus 101 l~df~~~~~ 109 (243)
++||-.+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999976543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0025 Score=48.70 Aligned_cols=30 Identities=10% Similarity=0.100 Sum_probs=25.8
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
..++|+|+.|.|++++.++ +.++||+.+..
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 3479999999999999888 89999987653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00055 Score=52.24 Aligned_cols=75 Identities=16% Similarity=0.168 Sum_probs=53.4
Q ss_pred eEEEEeecCCC-CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCceEecCCCcee
Q 026115 23 RVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAK 100 (243)
Q Consensus 23 ~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~~~h~di~~~nil~~~~~~~~ 100 (243)
-.|||||+... .-...|.+.. +....+..+..+++..+.-|-. .+ ++|+|++.-|||+. .+.+.
T Consensus 141 nVLvMEfIg~~g~pAP~LkDv~----------~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 141 NVLVMEFIGDDGLPAPRLKDVP----------LELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CeEEEEeccCCCCCCCCcccCC----------cCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEE
Confidence 46899998443 1111222211 3333566777888888888877 55 99999999999999 88999
Q ss_pred ecccCCCCCCc
Q 026115 101 ISDFDLSNQAP 111 (243)
Q Consensus 101 l~df~~~~~~~ 111 (243)
++|++.+....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999876554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0046 Score=47.77 Aligned_cols=30 Identities=10% Similarity=0.114 Sum_probs=26.0
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
..++|+|+.|.|++++.++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 448999999999999987778899998654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0028 Score=54.14 Aligned_cols=82 Identities=21% Similarity=0.216 Sum_probs=56.5
Q ss_pred eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCc
Q 026115 19 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 98 (243)
Q Consensus 19 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~ 98 (243)
-.+.-.|+|||++|-.+.+...-.... .+...+.....++. +..+-..| +.|+|.+|.||+++.++.
T Consensus 237 ~t~~~VLtmE~i~Gi~i~d~~~l~~~g--------~d~k~ia~~~~~~f--~~q~~~dg---ffHaDpHpGNi~v~~~g~ 303 (517)
T COG0661 237 YTTRRVLTMEWIDGIKISDIAALKSAG--------IDRKELAELLVRAF--LRQLLRDG---FFHADPHPGNILVRSDGR 303 (517)
T ss_pred ccCCcEEEEEeeCCEecccHHHHHhcC--------CCHHHHHHHHHHHH--HHHHHhcC---ccccCCCccceEEecCCc
Confidence 356678999999998888874322211 55444333332221 33333356 999999999999999999
Q ss_pred eeecccCCCCCCccc
Q 026115 99 AKISDFDLSNQAPDA 113 (243)
Q Consensus 99 ~~l~df~~~~~~~~~ 113 (243)
+.+.|||........
T Consensus 304 i~~lDfGi~g~l~~~ 318 (517)
T COG0661 304 IVLLDFGIVGRLDPK 318 (517)
T ss_pred EEEEcCcceecCCHH
Confidence 999999998666543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.00031 Score=58.92 Aligned_cols=42 Identities=21% Similarity=0.339 Sum_probs=33.7
Q ss_pred CCCcccCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCC
Q 026115 1 MVSRLKNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKK 43 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~ 43 (243)
+++.++|+|...++++-.. ..+..+|+|++ +.+|++.+....
T Consensus 35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 4678899999999998764 34688999999 449999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0095 Score=44.46 Aligned_cols=82 Identities=17% Similarity=0.186 Sum_probs=60.0
Q ss_pred ccCCccceeeEEEEeCCeeEEEEeecCC------CCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 5 LKNENVVELVGYYVDGPLRVLAYEHASK------GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 5 l~h~niv~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
..+.+|.+++|..+++...-+|+|.+.. .+|.+++.... ++. .. ...+-.-.++|-+..
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~---~~~L~~f~~~l~~~~- 138 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-EL---RQALDEFKRYLLDHH- 138 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HH---HHHHHHHHHHHHHcC-
Confidence 4578999999999999888899986522 37888886554 544 33 333444566777777
Q ss_pred CCeEeccCCCCceEecCCC----ceeecc
Q 026115 79 PRIIHRNIKSSNVLLFDDD----IAKISD 103 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~----~~~l~d 103 (243)
|+.+|++|.||++..+. .+.++|
T Consensus 139 --Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 139 --IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred --CeecCCCcccEEEEecCCCceEEEEEe
Confidence 99999999999996432 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.0057 Score=52.30 Aligned_cols=79 Identities=19% Similarity=0.203 Sum_probs=53.2
Q ss_pred CCeeEEEEeecCCCCHHH--HhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecC--
Q 026115 20 GPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-- 95 (243)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~-- 95 (243)
...-+|+|||++|..+.+ .+.+.. ++...+...+.+... .-+=..| .+|+|=+|.||++..
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~l~~~~~--~qIf~~G---ffHaDPHPGNilv~~~~ 338 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNKLVEAYL--EQIFKTG---FFHADPHPGNILVRPNP 338 (538)
T ss_pred CcceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHHHHHHHH--HHHHhcC---CccCCCCCCcEEEecCC
Confidence 456789999999986666 444443 555544443333222 2222345 999999999999984
Q ss_pred --CCceeecccCCCCCCccc
Q 026115 96 --DDIAKISDFDLSNQAPDA 113 (243)
Q Consensus 96 --~~~~~l~df~~~~~~~~~ 113 (243)
+..+.+.|||+.......
T Consensus 339 ~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 339 EGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCCccEEEEcccccccccHH
Confidence 567889999997766544
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0051 Score=49.79 Aligned_cols=55 Identities=22% Similarity=0.239 Sum_probs=48.6
Q ss_pred cCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCc
Q 026115 54 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 111 (243)
Q Consensus 54 ~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~ 111 (243)
..++++..++.+.+..+.-+...- +.-||++...||+++ +|++.|+||.+++...
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~ 372 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSY 372 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeeccc
Confidence 668899999999999999888775 589999999999999 9999999999988443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.00021 Score=67.01 Aligned_cols=153 Identities=10% Similarity=-0.070 Sum_probs=101.8
Q ss_pred cccCCccceeeEEEE--eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc--CCC
Q 026115 4 RLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK--AEP 79 (243)
Q Consensus 4 ~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~--~~~ 79 (243)
...|+++.....=.. .+...+..++++.+|.+.+.+.+.-.. .+.++..-+...-.+.+.+..-.|.. +..
T Consensus 1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee-----~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~ 1359 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE-----SPDLDRSPVHLRHKVSVLNRNVILSLTNLGN 1359 (2724)
T ss_pred hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc-----CCcchhchHHHHHHHHHhccchhhhcccCCc
Confidence 346676665544333 234467788899999999988765422 11233222222222324444444433 223
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
..+|+++++.|.++..+-.++++++|+.+...... ...+...+++.|+.++....-.++.++|+|..|+.+|....|.
T Consensus 1360 T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred cchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 36899999999999999999999999988222211 1134556788888999888888888899999999999988887
Q ss_pred CCCC
Q 026115 160 KPVD 163 (243)
Q Consensus 160 ~pf~ 163 (243)
.+|-
T Consensus 1438 ~~fi 1441 (2724)
T KOG1826|consen 1438 AYFI 1441 (2724)
T ss_pred HHHH
Confidence 7764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.023 Score=51.99 Aligned_cols=32 Identities=25% Similarity=0.442 Sum_probs=24.7
Q ss_pred CeEeccCCCCceEecCC-Cc-eeecccCCCCCCc
Q 026115 80 RIIHRNIKSSNVLLFDD-DI-AKISDFDLSNQAP 111 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~-~~-~~l~df~~~~~~~ 111 (243)
.++|+|+++.|++++.. +. .-|.|++.+....
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 49999999999999853 33 4688998875443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.0089 Score=47.80 Aligned_cols=71 Identities=17% Similarity=0.164 Sum_probs=52.6
Q ss_pred CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCce
Q 026115 20 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 99 (243)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~ 99 (243)
..+-|+|||++.+..|...-+-.. .. .+...+..-+.-|..+| ++|||+.--||++..++.+
T Consensus 180 ~~RH~Vvmelv~g~Pl~~v~~v~d------------~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 180 HNRHCVVMELVDGYPLRQVRHVED------------PP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred ccceeeHHHhhcccceeeeeecCC------------hH---HHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCE
Confidence 346688999998877766543222 22 24445555566777788 9999999999999999999
Q ss_pred eecccCCCC
Q 026115 100 KISDFDLSN 108 (243)
Q Consensus 100 ~l~df~~~~ 108 (243)
+++||-...
T Consensus 242 ~vIDFPQmv 250 (465)
T KOG2268|consen 242 VVIDFPQMV 250 (465)
T ss_pred EEeechHhh
Confidence 999996543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.082 Score=42.21 Aligned_cols=30 Identities=20% Similarity=0.454 Sum_probs=26.0
Q ss_pred CCeEeccCCCCceEecCC----CceeecccCCCC
Q 026115 79 PRIIHRNIKSSNVLLFDD----DIAKISDFDLSN 108 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~----~~~~l~df~~~~ 108 (243)
..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 358999999999999875 789999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.057 Score=41.37 Aligned_cols=29 Identities=17% Similarity=0.420 Sum_probs=25.4
Q ss_pred CeEeccCCCCceEecC-CCceeecccCCCC
Q 026115 80 RIIHRNIKSSNVLLFD-DDIAKISDFDLSN 108 (243)
Q Consensus 80 ~~~h~di~~~nil~~~-~~~~~l~df~~~~ 108 (243)
.++|+|+.+.||+++. ++.+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 4999999999999998 5779999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.08 Score=41.62 Aligned_cols=48 Identities=19% Similarity=0.202 Sum_probs=35.2
Q ss_pred HHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCC
Q 026115 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110 (243)
Q Consensus 62 ~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~ 110 (243)
.+..+-.++.-.+..- -..+|+|+.|.|++.++.+.++|+||..+...
T Consensus 137 ~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 137 KLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 4444445555555440 13899999999999999999999999887543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.45 Score=38.06 Aligned_cols=29 Identities=17% Similarity=0.143 Sum_probs=22.4
Q ss_pred CCCeEeccCCCCceEecCC-Cc-eeecccCC
Q 026115 78 EPRIIHRNIKSSNVLLFDD-DI-AKISDFDL 106 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~-~~-~~l~df~~ 106 (243)
.+.++|+|+.+.|++++.+ +. +.++|...
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa~ 222 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPGL 222 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECchH
Confidence 3569999999999999865 43 56777653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.036 Score=41.76 Aligned_cols=29 Identities=24% Similarity=0.509 Sum_probs=20.5
Q ss_pred CeEeccCCCCceEe-cCCCceeecccCCCC
Q 026115 80 RIIHRNIKSSNVLL-FDDDIAKISDFDLSN 108 (243)
Q Consensus 80 ~~~h~di~~~nil~-~~~~~~~l~df~~~~ 108 (243)
.++|+|+.+.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 38999999999999 888999999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.093 Score=42.07 Aligned_cols=29 Identities=28% Similarity=0.474 Sum_probs=25.7
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
.++|+|+.+.|++++.++.+.++||+.+.
T Consensus 188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 188 GVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 49999999999999988877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=93.98 E-value=0.057 Score=41.48 Aligned_cols=31 Identities=23% Similarity=0.436 Sum_probs=25.6
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
..++|+|+.+.|++++.++..-++||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3489999999999998776667999997644
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.047 Score=40.24 Aligned_cols=30 Identities=10% Similarity=0.343 Sum_probs=25.4
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~ 110 (243)
..+|+|+.|.|++++.++ ++++|++.+...
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 369999999999998777 889999987543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.074 Score=40.34 Aligned_cols=39 Identities=15% Similarity=0.180 Sum_probs=32.9
Q ss_pred HHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCC
Q 026115 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 106 (243)
Q Consensus 67 ~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~ 106 (243)
+++|...|+. .++.+|+|..|+||+.|..|.+|+.|-+.
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 4667888855 24699999999999999999999999764
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.19 Score=40.29 Aligned_cols=28 Identities=29% Similarity=0.447 Sum_probs=24.0
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4899999999999987 667899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.09 Score=39.87 Aligned_cols=29 Identities=31% Similarity=0.537 Sum_probs=19.8
Q ss_pred CCeEeccCCCCceEec-CCCceeecccCCC
Q 026115 79 PRIIHRNIKSSNVLLF-DDDIAKISDFDLS 107 (243)
Q Consensus 79 ~~~~h~di~~~nil~~-~~~~~~l~df~~~ 107 (243)
..++|+|+.+.||+++ .++.+-++||+.+
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred cEEEEeccccccceeeeccceeEEEecccc
Confidence 3499999999999999 5566679999865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.52 E-value=0.12 Score=41.08 Aligned_cols=30 Identities=27% Similarity=0.490 Sum_probs=26.0
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
.++|+|+.|.|++++.++.+.++||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 399999999999999877778999987643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.081 Score=41.18 Aligned_cols=30 Identities=13% Similarity=0.376 Sum_probs=25.5
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~ 110 (243)
.++|+|+.+.||+++.++ +.++||+.+...
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence 489999999999998876 789999877543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.07 Score=42.99 Aligned_cols=30 Identities=27% Similarity=0.448 Sum_probs=25.2
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
+++|+|+.+.||+++.+...-++||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 399999999999998666568999987643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.67 E-value=0.21 Score=40.77 Aligned_cols=29 Identities=14% Similarity=0.413 Sum_probs=25.0
Q ss_pred CeEeccCCCCceEecC-CCceeecccCCCC
Q 026115 80 RIIHRNIKSSNVLLFD-DDIAKISDFDLSN 108 (243)
Q Consensus 80 ~~~h~di~~~nil~~~-~~~~~l~df~~~~ 108 (243)
.++|+|+++.||+++. ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 4899999999999986 4679999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=91.93 E-value=0.28 Score=39.38 Aligned_cols=31 Identities=16% Similarity=0.223 Sum_probs=27.2
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~ 110 (243)
+++|+|+.+.|++++.++.+.++||..+...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 4999999999999999988999999876543
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=91.58 E-value=1.4 Score=35.98 Aligned_cols=83 Identities=12% Similarity=0.101 Sum_probs=58.4
Q ss_pred cCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchh
Q 026115 54 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 133 (243)
Q Consensus 54 ~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 133 (243)
......++++.+.+..|.-+... ..|--+.|+||+++.++.+.+.-+|+-.... |.=+.||.
T Consensus 82 ~~k~~Klr~a~~~I~~l~e~~~t----r~~~~laPeNilf~~~l~p~~vH~Glk~~lp--------------Pye~tee~ 143 (434)
T COG4499 82 KEKTRKLRLALQNIATLSELNNT----RYTFFLAPENILFDGGLTPFFVHRGLKNSLP--------------PYEMTEER 143 (434)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcc----ceeEEecchheEEcCCCceEEEecchhccCC--------------CCCCCHHH
Confidence 44566777788888887776544 6788899999999999999998888753321 11133443
Q ss_pred hccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026115 134 AMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164 (243)
Q Consensus 134 ~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 164 (243)
+. -.+-+++..++.|..+|+.
T Consensus 144 f~----------~~ykA~~~~~fn~k~~Fe~ 164 (434)
T COG4499 144 FL----------KEYKALAIYAFNGKFSFES 164 (434)
T ss_pred HH----------HHHHHHHHHHHcCCccHHH
Confidence 22 1567778888889988863
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.39 E-value=0.61 Score=37.83 Aligned_cols=28 Identities=39% Similarity=0.559 Sum_probs=24.7
Q ss_pred eEeccCCCCceEecCCCc-eeecccCCCC
Q 026115 81 IIHRNIKSSNVLLFDDDI-AKISDFDLSN 108 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~-~~l~df~~~~ 108 (243)
++|+|+.|.||+++.+.. +.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8899998654
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=90.97 E-value=0.24 Score=36.93 Aligned_cols=30 Identities=27% Similarity=0.409 Sum_probs=24.5
Q ss_pred CeEeccCCCCceEecCCC-----ceeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDD-----IAKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~-----~~~l~df~~~~~ 109 (243)
.++|||+.+.|+++..++ .+.++||..++.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 489999999999997543 578999987643
|
subfamily of choline kinases |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.87 E-value=0.22 Score=39.30 Aligned_cols=32 Identities=13% Similarity=0.351 Sum_probs=25.6
Q ss_pred CCeEeccCCCCceEecCCCc-eeecccCCCCCC
Q 026115 79 PRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQA 110 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~-~~l~df~~~~~~ 110 (243)
..++|+|+.+.|++++.++. .-|+||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 34899999999999987454 569999876544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.60 E-value=0.82 Score=37.71 Aligned_cols=75 Identities=23% Similarity=0.242 Sum_probs=54.3
Q ss_pred EEEEeecCCC-CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeec
Q 026115 24 VLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 102 (243)
Q Consensus 24 ~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~ 102 (243)
+|||+|+... =....|.... ++...+..+-.+++.-+.-|.+.+ .+||.||+--|+|+. .|.+.++
T Consensus 240 VLVM~FlGrdgw~aPkLKd~~----------ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~lyiI 306 (520)
T KOG2270|consen 240 VLVMEFLGRDGWAAPKLKDAS----------LSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGKLYII 306 (520)
T ss_pred eEeeeeccCCCCcCccccccc----------CChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCEEEEE
Confidence 6889998432 1222333332 667778888888888888888776 599999999999884 5678888
Q ss_pred ccCCCCCCc
Q 026115 103 DFDLSNQAP 111 (243)
Q Consensus 103 df~~~~~~~ 111 (243)
|.+.+....
T Consensus 307 DVSQSVE~D 315 (520)
T KOG2270|consen 307 DVSQSVEHD 315 (520)
T ss_pred EccccccCC
Confidence 988765543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=90.12 E-value=0.26 Score=40.03 Aligned_cols=30 Identities=20% Similarity=0.364 Sum_probs=25.5
Q ss_pred CeEeccCCCCceEecC-CCceeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFD-DDIAKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~-~~~~~l~df~~~~~ 109 (243)
..+|+|+.+.||++++ ++.++++||.++..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4799999999999975 47899999987643
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=88.76 E-value=0.28 Score=39.76 Aligned_cols=37 Identities=24% Similarity=0.254 Sum_probs=21.8
Q ss_pred HHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEecC
Q 026115 59 RVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFD 95 (243)
Q Consensus 59 ~~~~~~ql~~~l~~Lh~~-~~~~~~h~di~~~nil~~~ 95 (243)
+.-++.|++.-.--.-.. +-.+.+|-||||+|||+-+
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 314 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFD 314 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEec
Confidence 344556654432112122 1235999999999999954
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.89 E-value=0.57 Score=37.77 Aligned_cols=35 Identities=14% Similarity=0.371 Sum_probs=29.7
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCcc
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 112 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~ 112 (243)
.+.++|+|+.+.|++++.++-+-+.||+.+.....
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 45699999999999999988888999998765443
|
|
| >PRK14559 putative protein serine/threonine phosphatase; Provisional | Back alignment and domain information |
|---|
Probab=87.01 E-value=2.6 Score=37.51 Aligned_cols=86 Identities=15% Similarity=0.151 Sum_probs=66.1
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCC-CCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
++.||.+++|++..+..-++++|+... .+|.+...... .+..+.+.++.|++.=..-|...+ ++..
T Consensus 178 ~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~~~----------~~~l~~l~Wl~q~~~LW~~l~~~~---~~~s 244 (645)
T PRK14559 178 FPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQDQT----------LPTLQILYWLNQMTQLWKALEPWG---CCQS 244 (645)
T ss_pred ccccCcchheeecCCCCcEEEeCCCCCCchHHHHhhhcC----------CcHHHHHHHHHHHHHHHHHHHhcC---eehh
Confidence 345699999999988877888887633 35555544432 567888999999999999999988 9999
Q ss_pred cCCCCceEecCCCceeeccc
Q 026115 85 NIKSSNVLLFDDDIAKISDF 104 (243)
Q Consensus 85 di~~~nil~~~~~~~~l~df 104 (243)
=+.++|+.++.+..+.+..|
T Consensus 245 ll~~~nlrv~~~~~~~l~~l 264 (645)
T PRK14559 245 LLELENLRVDEDQTLGLQQL 264 (645)
T ss_pred ccchhheeeCCCceehHhhh
Confidence 99999999987666655544
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=86.56 E-value=1.2 Score=41.92 Aligned_cols=30 Identities=30% Similarity=0.429 Sum_probs=24.7
Q ss_pred eEeccCCCCceEecCCC--ce-eecccCCCCCC
Q 026115 81 IIHRNIKSSNVLLFDDD--IA-KISDFDLSNQA 110 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~--~~-~l~df~~~~~~ 110 (243)
++|+|+.+.||+++.++ .+ -|+|||-+...
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 99999999999998775 44 49999976544
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=86.46 E-value=1.6 Score=36.42 Aligned_cols=31 Identities=13% Similarity=0.441 Sum_probs=25.6
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCc
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 111 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~ 111 (243)
.++|||+.+.||++..+ .++++|+..+....
T Consensus 224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~~G~ 254 (401)
T PRK09550 224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAFYGP 254 (401)
T ss_pred ceeeccCCcccEEeeCC-CcEEEeccccccCC
Confidence 49999999999999766 58899998766443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.84 E-value=1.6 Score=35.46 Aligned_cols=28 Identities=21% Similarity=0.259 Sum_probs=23.0
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
.++|+|+.+.||+++ + .+.++||+-+..
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 389999999999995 3 578899987643
|
|
| >PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria | Back alignment and domain information |
|---|
Probab=85.33 E-value=2.2 Score=34.98 Aligned_cols=84 Identities=12% Similarity=0.148 Sum_probs=43.7
Q ss_pred ccCCccceeeEEEEeCCeeEEEEeecCC-CCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 5 LKNENVVELVGYYVDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 5 l~h~niv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
-.||++++. ..-.+++.+.+.++.-+. .++... . . .+...+++++.+ +.++..+. .. -.|
T Consensus 20 ~~~~~f~~~-~i~~~ed~~~~~y~~~~~~~~f~~i-~--~----------~~~~eklr~~~n-i~~l~~~~-~~---~~~ 80 (359)
T PF10140_consen 20 EHDPYFLPQ-EIEEDEDELTFTYQIPESYQSFEEI-K--K----------LDKSEKLRLLIN-IAALKEHL-NS---RYT 80 (359)
T ss_dssp S--TTB--E-EEEE-SSEEEEEE---TTSEEGGGG-G--G----------S-HHHHHHHHHH-GGGGGGGG-GS---SEE
T ss_pred ccCcccCCc-eEEEeCCEEEEEEEcCcccCcHHHH-H--h----------cCHHHHHHHHHH-HHHHHHHh-cC---cee
Confidence 357888873 555566665555544332 233332 1 1 667788888888 44454322 23 688
Q ss_pred ccCCCCceEecCCCceeecccCCC
Q 026115 84 RNIKSSNVLLFDDDIAKISDFDLS 107 (243)
Q Consensus 84 ~di~~~nil~~~~~~~~l~df~~~ 107 (243)
--+.|+|++++.++.+++.-.|+-
T Consensus 81 f~l~P~Nl~fd~~~~p~i~hrGi~ 104 (359)
T PF10140_consen 81 FILHPENLVFDKNLMPKILHRGIK 104 (359)
T ss_dssp ---SGGGEEE-TTS-EEES--EET
T ss_pred EEEechheEEcCCCCEEEEEcCCc
Confidence 999999999999999999877754
|
This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=82.19 E-value=3.3 Score=33.72 Aligned_cols=40 Identities=25% Similarity=0.254 Sum_probs=25.0
Q ss_pred HHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEecCCC
Q 026115 58 QRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDD 97 (243)
Q Consensus 58 ~~~~~~~ql~~~l~~Lh~~-~~~~~~h~di~~~nil~~~~~ 97 (243)
-+.-++.|++.-.-..-.. +-.+.+|.||||+|||+-++.
T Consensus 280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 3444666776554233222 223599999999999995443
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=81.35 E-value=5.7 Score=33.50 Aligned_cols=63 Identities=19% Similarity=0.083 Sum_probs=41.9
Q ss_pred eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCC
Q 026115 23 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 97 (243)
Q Consensus 23 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~ 97 (243)
..++=+|..|-++..++.... .++....+++.-.+.|+--+---. +.+|.|+.|.||++..+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~----------~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS----------QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhccc----------ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEecC
Confidence 345556888889999998776 344455555555555544433222 399999999999996543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 243 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-34 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-30 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-107
Identities = 88/237 (37%), Positives = 138/237 (58%), Gaps = 10/237 (4%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+S ++ ++V L+G+ + +L Y++ G+L L+G P +SW QR+
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD-----LPTMSMSWEQRL 142
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-S 119
+I +GAARGL YLH +A IIHR++KS N+LL ++ + KI+DF +S + + + H S
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD-QTHLS 198
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
T V GT GY PEY + G+++ KSDVYSFGVVL E+L R + +LPR +L WA
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236
+ +++Q VD L + P+++ K A C+ ++ RP+MG VL L+ L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = e-105
Identities = 83/234 (35%), Positives = 130/234 (55%), Gaps = 10/234 (4%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
M+S + N++ L G+ + R+L Y + + GS+ L + + P L W +R
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQ 134
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-S 119
+IA+G+ARGL YLH+ +P+IIHR++K++N+LL ++ A + DF L+ H +
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVT 192
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS--LVTWA 177
T V GT G+ APEY TG+ S K+DV+ +GV+LLEL+TG++ D L+ W
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 178 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231
L E K++ VD L G Y + + ++ VA LC Q RP M V++ L
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = e-102
Identities = 88/238 (36%), Positives = 136/238 (57%), Gaps = 14/238 (5%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++++ ++EN+VEL+G+ DG L Y + GSL D L G P LSW R
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG------TPPLSWHMRC 136
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
KIA GAA G+ +LHE IHR+IKS+N+LL + AKISDF L+ + A + ++
Sbjct: 137 KIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
R++GT Y APE + G+++ KSD+YSFGVVLLE++TG VD R Q L+
Sbjct: 194 RIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDIKEEI 250
Query: 181 LSEDK-VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237
E+K ++ +D K+ ++ M +VA+ C+ + + RP++ V + LQ + +
Sbjct: 251 EDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 8e-63
Identities = 64/256 (25%), Positives = 102/256 (39%), Gaps = 32/256 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRV----LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 56
+ +K+EN+++ +G G L KGSL D L V+SW
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSW 120
Query: 57 AQRVKIAVGAARGLEYLHE-------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109
+ IA ARGL YLHE +P I HR+IKS NVLL ++ A I+DF L+ +
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 110 APDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDH 164
+ + +GT Y APE + D+Y+ G+VL EL + D
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 165 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK------AIAKMAAVAALCVQYEA 218
+ S + +++ V K +A + C ++A
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 219 DFRPNMGIVLKALQPL 234
+ R + G V + + +
Sbjct: 301 EARLSAGCVGERITQM 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-46
Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 28/244 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+SR+ + N+V+L G ++ P+ L E+A GSL+++LHG + P P + A +
Sbjct: 54 QLSRVNHPNIVKLYGACLN-PVC-LVMEYAEGGSLYNVLHGAE------PLPYYTAAHAM 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHS 119
+ ++G+ YLH +IHR++K N+LL + KI DF + H
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HM 160
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
T G+ + APE S K DV+S+G++L E++T RKP +
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--------------FDEI 206
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239
++ V + ++ C + RP+M ++K + L+
Sbjct: 207 GGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266
Query: 240 GPSK 243
G +
Sbjct: 267 GADE 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-45
Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 22/165 (13%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAY--EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ NV+ ++G P GSL+++LH V+ +Q V
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQSQAV 114
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
K A+ ARG+ +LH EP I + S +V++ +D A+IS D+ S
Sbjct: 115 KFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSP 166
Query: 121 RVLGTFGYHAPEYAMTGQMSS----KSDVYSFGVVLLELLTGRKP 161
+ + APE A+ + +D++SF V+L EL+T P
Sbjct: 167 GRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-44
Identities = 69/243 (28%), Positives = 109/243 (44%), Gaps = 36/243 (14%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ RL++ N+V +G P + E+ S+GSL+ +LH L +R+
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG------AREQLDERRRL 140
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A A+G+ YLH + P I+HRN+KS N+L+ K+ DF LS S
Sbjct: 141 SMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA--- 177
GT + APE + KSDVYSFGV+L EL T ++P + L Q V A
Sbjct: 200 A--GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQ---VVAAVGF 253
Query: 178 ---TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234
++ + P ++AA+ C E RP+ ++ L+PL
Sbjct: 254 KCKRLEIPRN----L---------NP----QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
Query: 235 LNT 237
+ +
Sbjct: 297 IKS 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-44
Identities = 65/247 (26%), Positives = 111/247 (44%), Gaps = 48/247 (19%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++S L + N+V+L G + P V+ E G L+ L K + W+ ++
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP--------IKWSVKL 125
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFDLSNQAPDAAA 115
++ + A G+EY+ + P I+HR+++S N+ L D AK++DF LS Q+ +
Sbjct: 126 RLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 172
+ +LG F + APE + + + K+D YSF ++L +LTG P D G+
Sbjct: 183 ---VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGKIK 237
Query: 173 LVTWA-----TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227
+ P + ED C PP ++ V LC + RP+ +
Sbjct: 238 FINMIREEGLRPTIPED----C---------PP----RLRNVIELCWSGDPKKRPHFSYI 280
Query: 228 LKALQPL 234
+K L L
Sbjct: 281 VKELSEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-43
Identities = 51/276 (18%), Positives = 90/276 (32%), Gaps = 47/276 (17%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRV-----LAYEHASKGSLHDILHGKKGVKGAKPGPVLS 55
V ++++N+ + L E+ GSL L
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------SD 109
Query: 56 WAQRVKIAVGAARGLEYLHE------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-- 107
W ++A RGL YLH +P I HR++ S NVL+ +D ISDF LS
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 108 ----NQAPDAAARLHSTRVLGTFGYHAPEYAM-------TGQMSSKSDVYSFGVVLLELL 156
+ +GT Y APE + D+Y+ G++ E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 157 TGRKPVDH--TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP---------KAIAK 205
+ ++P Q + T + + ++ V + + P A+
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE--KQRPKFPEAWKENSLAVRS 287
Query: 206 MAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGP 241
+ C +A+ R + + L+
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-42
Identities = 57/169 (33%), Positives = 83/169 (49%), Gaps = 22/169 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ + LK+ N++ L G + P L E A G L+ +L GK+ + V
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILV 108
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--------FDDDIAKISDFDLSNQAPD 112
AV ARG+ YLH++A IIHR++KSSN+L+ + I KI+DF L+ +
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 113 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
G + + APE S SDV+S+GV+L ELLTG P
Sbjct: 169 TT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-41
Identities = 50/253 (19%), Positives = 87/253 (34%), Gaps = 41/253 (16%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+ ++ENVV +G + P + +L+ ++ K VL + +I
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQI 135
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHS 119
A +G+ YLH K I+H+++KS NV D+ I+DF L
Sbjct: 136 AQEIVKGMGYLHAKG---ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKL 191
Query: 120 TRVLGTFGYHAPE---------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 170
G + APE S SDV++ G + EL P P
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEA 250
Query: 171 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAI-AKMAAVAALCVQYEADFRPNMGIVLK 229
+ W + T + + +++ + C +E + RP ++
Sbjct: 251 ---IIWQ------------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295
Query: 230 ALQPLLNTRSGPS 242
L+ L S
Sbjct: 296 MLEKLPKRNRRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-41
Identities = 59/238 (24%), Positives = 109/238 (45%), Gaps = 26/238 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ + ++ N++ +GY L ++ + SL+ LH + +
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLH--------ASETKFEMKKLI 123
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
IA ARG++YLH K IIHR++KS+N+ L +D+ KI DF L+ + +
Sbjct: 124 DIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 121 RVLGTFGYHAPE---YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
++ G+ + APE + S +SDVY+FG+VL EL+TG+ P + R Q +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM 237
Query: 178 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
+ + + + +M + A C++ + D RP+ +L ++ L
Sbjct: 238 ---VGRGSLSPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-40
Identities = 56/251 (22%), Positives = 90/251 (35%), Gaps = 37/251 (14%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
L++ NV++ +G E+ G+L I+ W+QRV
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK--------SMDSQYPWSQRVSF 113
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS------------NQA 110
A A G+ YLH IIHR++ S N L+ ++ ++DF L+ ++
Sbjct: 114 AKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 111 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 170
R V+G + APE K DV+SFG+VL E++ LPR
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 171 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230
+ V L PP + C + + RP+ +
Sbjct: 231 DFGLN--------------VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276
Query: 231 LQPLLNTRSGP 241
L+ L +G
Sbjct: 277 LETLRMHLAGH 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-39
Identities = 50/260 (19%), Positives = 95/260 (36%), Gaps = 40/260 (15%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSW 56
L++EN++ + + + GSL+D L L
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDT 104
Query: 57 AQRVKIAVGAARGLEYLHE-----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---N 108
++I + A GL +LH + +P I HR++KS N+L+ + I+D L+ +
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 109 QAPDAAARLHSTRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162
Q+ + ++ RV GT Y APE + D+++FG+VL E+ R
Sbjct: 165 QSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVS 222
Query: 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP--------KAIAKMAAVAALCV 214
+ + + S + +++ V + P + +A + C
Sbjct: 223 NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVD--QQRPNIPNRWFSDPTLTSLAKLMKECW 280
Query: 215 QYEADFRPNMGIVLKALQPL 234
R + K L +
Sbjct: 281 YQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-39
Identities = 51/262 (19%), Positives = 94/262 (35%), Gaps = 38/262 (14%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSW 56
+++EN++ + + G ++ GSL+D L L
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----------LDA 133
Query: 57 AQRVKIAVGAARGLEYLHE-----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS--NQ 109
+K+A + GL +LH + +P I HR++KS N+L+ + I+D L+
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193
Query: 110 APDAAARLHSTRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
+ + +GT Y PE Q +D+YSFG++L E+ R
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSG 252
Query: 164 HTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP--------KAIAKMAAVAALCVQ 215
+ Q S + +++ V K P + + +M + C
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIK--KLRPSFPNRWSSDECLRQMGKLMTECWA 310
Query: 216 YEADFRPNMGIVLKALQPLLNT 237
+ R V K L + +
Sbjct: 311 HNPASRLTALRVKKTLAKMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 56/266 (21%), Positives = 98/266 (36%), Gaps = 40/266 (15%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSW 56
L++EN++ + ++ GSL D L+ ++
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTV 138
Query: 57 AQRVKIAVGAARGLEYLHE-----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---N 108
+K+A+ A GL +LH + +P I HR++KS N+L+ + I+D L+ +
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198
Query: 109 QAPDAAARLHSTRVLGTFGYHAPE-----YAMTGQMSS-KSDVYSFGVVLLELLTGRKPV 162
A D + RV GT Y APE M S ++D+Y+ G+V E+ R +
Sbjct: 199 SATDTIDIAPNHRV-GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSI 256
Query: 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP--------KAIAKMAAVAALCV 214
Q S +++++ V + P +A+ MA + C
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVMAKIMRECW 314
Query: 215 QYEADFRPNMGIVLKALQPLLNTRSG 240
R + K L L
Sbjct: 315 YANGAARLTALRIKKTLSQLSQQEGI 340
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-27
Identities = 59/248 (23%), Positives = 92/248 (37%), Gaps = 58/248 (23%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+ + N+V L+G + E G L G L +++
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--------TEGARLRVKTLLQMV 219
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
AA G+EYL K IHR++ + N L+ + ++ KISDF +S R
Sbjct: 220 GDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMS-------------REE 263
Query: 124 GTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 169
Y APE G+ SS+SDV+SFG++L E + G P
Sbjct: 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY------- 316
Query: 170 QQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227
P LS + ++ V+ GG P + + C YE RP+ +
Sbjct: 317 ---------PNLSNQQTREFVEK--GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365
Query: 228 LKALQPLL 235
+ LQ +
Sbjct: 366 YQELQSIR 373
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 13/160 (8%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
S+L ++N+V ++ + L E+ +L + + GP LS +
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAIN 115
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
G+++ H+ RI+HR+IK N+L+ + KI DF ++ +A + +
Sbjct: 116 FTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNH 171
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
VLGT Y +PE A +D+YS G+VL E+L G P
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 47/166 (28%), Positives = 83/166 (50%), Gaps = 19/166 (11%)
Query: 2 VSRLKNENVVEL--VGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSW 56
+ L + +V + G + P L Y E+ +L DI+H + GP ++
Sbjct: 66 AAALNHPAIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTP 115
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 116
+ +++ A + L + H+ IIHR++K +N+++ + K+ DF ++ D+
Sbjct: 116 KRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 117 LHST-RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ T V+GT Y +PE A + ++SDVYS G VL E+LTG P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 42/175 (24%), Positives = 72/175 (41%), Gaps = 29/175 (16%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAY----------------EHASKGSLHDILHGKKGVK 46
++L + N+V G + E KG+L + ++G K
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 47 GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 106
L +++ +G++Y+H K ++I+R++K SN+ L D KI DF L
Sbjct: 119 -------LDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGL 168
Query: 107 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ R TR GT Y +PE + + D+Y+ G++L ELL
Sbjct: 169 VTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 6e-25
Identities = 41/166 (24%), Positives = 68/166 (40%), Gaps = 20/166 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 56
M+ L++ N+V + VL E + G+L L + +
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--------RFKV-MKI 128
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAA 115
+GL++LH + P IIHR++K N+ + KI D L+ + A
Sbjct: 129 KVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ V+GT + APE + DVY+FG+ +LE+ T P
Sbjct: 188 K----AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 8e-25
Identities = 37/159 (23%), Positives = 73/159 (45%), Gaps = 12/159 (7%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+ +K+ N+V+ + + + ++ G L ++ +KGV Q +
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDW 130
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
V L+++H++ +I+HR+IKS N+ L D ++ DF ++ +
Sbjct: 131 FVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--C 185
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT Y +PE ++KSD+++ G VL EL T +
Sbjct: 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-24
Identities = 40/172 (23%), Positives = 73/172 (42%), Gaps = 39/172 (22%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+ N +V L+G + ++++ + G L D + K + +
Sbjct: 73 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWC 123
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
V A+G+ YL ++ R++HR++ + NVL+ KI+DF L+ ++L
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLL 167
Query: 124 GTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
G A E + + +SDV+S+GV + EL+T G KP
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-24
Identities = 39/160 (24%), Positives = 63/160 (39%), Gaps = 13/160 (8%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
RL+ +VV + + + + L +L + GP L+ + V
Sbjct: 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR--------RQGP-LAPPRAVA 138
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
I L+ H HR++K N+L+ DD A + DF ++ A
Sbjct: 139 IVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGN 194
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT Y APE + ++D+Y+ VL E LTG P
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 4e-24
Identities = 57/240 (23%), Positives = 101/240 (42%), Gaps = 34/240 (14%)
Query: 4 RLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+K+ N+V+L+G V + P ++ E + G+L D L +S +
Sbjct: 272 EIKHPNLVQLLG--VCTREPPFYIIT-EFMTYGNLLDYLRECNR-------QEVSAVVLL 321
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A + +EYL +K IHRN+ + N L+ ++ + K++DF LS H+
Sbjct: 322 YMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP 179
+ APE + S KSDV++FGV+L E+ T G P P
Sbjct: 379 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------------P 421
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239
+ +V + ++ E P K+ + C Q+ RP+ + +A + + S
Sbjct: 422 GIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 4e-24
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 33/237 (13%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L++E +V+L + P+ ++ E+ SKGSL D L G+ G L Q V +A
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETG-------KYLRLPQLVDMA 286
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
A G+ Y+ +HR+++++N+L+ ++ + K++DF L+ D
Sbjct: 287 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 124 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 182
+ APE A+ G+ + KSDV+SFG++L EL T GR P P +
Sbjct: 344 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----------------PGMV 386
Query: 183 EDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237
+V V+ G PP+ + + C + E + RP + L+ +
Sbjct: 387 NREVLDQVER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-24
Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 13/164 (7%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
LK+ N+V +D L Y E+ G L ++ KG K L
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVI-----TKGTKERQYLDEEFV 113
Query: 60 VKIAVGAARGLEYLHEKAEP--RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 117
+++ L+ H +++ ++HR++K +NV L K+ DF L+ +
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ +GT Y +PE + KSD++S G +L EL P
Sbjct: 174 KT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-23
Identities = 44/179 (24%), Positives = 80/179 (44%), Gaps = 35/179 (19%)
Query: 3 SRLKNENVVELVGYYVDGP---------LRVLAY---EHASKGSLHDILHGKKGVKGAKP 50
++L++ +V +++ +V Y + K +L D ++G+ ++ +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 51 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS--- 107
L ++ A +E+LH K ++HR++K SN+ DD+ K+ DF L
Sbjct: 118 SVCLHIFLQI------AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
Query: 108 --------NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLT 157
P A H+ +V GT Y +PE + G S K D++S G++L ELL
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQV-GTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-23
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 33/237 (13%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L++E +V+L + P+ ++ E+ SKGSL D L G+ G L Q V +A
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETG-------KYLRLPQLVDMA 369
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
A G+ Y+ +HR+++++N+L+ ++ + K++DF L+ D
Sbjct: 370 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426
Query: 124 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 182
+ APE A+ G+ + KSDV+SFG++L EL T GR P P +
Sbjct: 427 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----------------PGMV 469
Query: 183 EDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237
+V V+ G PP+ + + C + E + RP + L+ +
Sbjct: 470 NREVLDQVER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 27/165 (16%)
Query: 4 RLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+L++ N+V+L+G V + + E+ +KGSL D L + VL +
Sbjct: 242 QLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLL 292
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHS 119
K ++ +EYL +HR++ + NVL+ +D++AK+SDF L + S
Sbjct: 293 KFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASS 341
Query: 120 TRVLGTFGYH--APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
T+ G APE + S+KSDV+SFG++L E+ + GR P
Sbjct: 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-23
Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 15/209 (7%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ + +V G + + EH GSL +L + P +L
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI----PEQILG----- 134
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
K+++ +GL YL EK +I+HR++K SN+L+ K+ DF +S Q D+ A +
Sbjct: 135 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---S 189
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
V GT Y +PE S +SD++S G+ L+E+ GR P+ + + +
Sbjct: 190 FV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAV 209
+ + + A+
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAI 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-23
Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+L + NV++ +++ + E A G L ++ K K ++ K
Sbjct: 87 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKY 141
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
V LE++H + R++HR+IK +NV + + K+ D L HS +
Sbjct: 142 FVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--L 196
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT Y +PE + KSD++S G +L E+ + P
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-23
Identities = 40/172 (23%), Positives = 73/172 (42%), Gaps = 39/172 (22%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+ N +V L+G + ++++ + G L D + K + +
Sbjct: 73 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWC 123
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
V A+G+ YL ++ R++HR++ + NVL+ KI+DF L+ ++L
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLL 167
Query: 124 GTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
G A E + + +SDV+S+GV + EL+T G KP
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 44/161 (27%), Positives = 81/161 (50%), Gaps = 17/161 (10%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
L+++ +V+L P+ ++ E +KGSL D L +G + + +
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEG-------SKQPLPKLIDFS 290
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
A G+ ++ ++ IHR+++++N+L+ + KI+DF L+ D ++ R
Sbjct: 291 AQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREG 344
Query: 124 GTFGYH--APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
F APE G + KSDV+SFG++L+E++T GR P
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-23
Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 24/171 (14%)
Query: 33 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 92
SL P +L KIAV + LE+LH K +IHR++K SNVL
Sbjct: 90 TSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKALEHLHSKL--SVIHRDVKPSNVL 142
Query: 93 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE----YAMTGQMSSKSDVYSF 148
+ K+ DF +S D A+ G Y APE S KSD++S
Sbjct: 143 INALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 199
Query: 149 GVVLLELLTGRKPVDHTLP--RGQQSLVTWATPKLSEDK--------VKQC 189
G+ ++EL R P D + + +V +P+L DK QC
Sbjct: 200 GITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQC 250
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 7e-23
Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 22/170 (12%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 58
+ R+ + VG +V Y + K +L D ++ + ++ + G L
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------DLSN 108
+IA +E+LH K ++HR++K SN+ DD+ K+ DF +
Sbjct: 172 --QIA----EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 109 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158
A T +GT Y +PE S K D++S G++L ELL
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-23
Identities = 51/173 (29%), Positives = 71/173 (41%), Gaps = 40/173 (23%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
L + N++ L G + P++++ E A GSL D L +G + A
Sbjct: 77 SLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH--------FLLGTLSRYA 127
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
V A G+ YL K R IHR++ + N+LL D+ KI DF L R L
Sbjct: 128 VQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM-------------RAL 171
Query: 124 GTFG--YH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
Y APE T S SD + FGV L E+ T G++P
Sbjct: 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-22
Identities = 41/172 (23%), Positives = 73/172 (42%), Gaps = 39/172 (22%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
L + ++V L+G L+++ ++ GSL D + +G L +
Sbjct: 71 SLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA--------LGPQLLLNWG 121
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
V A+G+ YL E ++HRN+ + NVLL +++DF ++ +L
Sbjct: 122 VQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA-------------DLL 165
Query: 124 GTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
A E G+ + +SDV+S+GV + EL+T G +P
Sbjct: 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-22
Identities = 51/255 (20%), Positives = 98/255 (38%), Gaps = 53/255 (20%)
Query: 1 MVSRLKNENVVELVG--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 58
++ + NV+ L+G +G V+ + G L + + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVV-LPYMKHGDLRNFIR--------NETHNPTVKD 129
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-L 117
+ + A+G++YL K + +HR++ + N +L + K++DF L+ R +
Sbjct: 130 LIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA--------RDM 178
Query: 118 HST---RVLGTFGYH------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 167
+ V G A E T + ++KSDV+SFGV+L EL+T G P
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----- 233
Query: 168 RGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMG 225
P ++ + + G P + V C +A+ RP+
Sbjct: 234 -----------PDVNTFDITVYLLQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 280
Query: 226 IVLKALQPLLNTRSG 240
++ + + +T G
Sbjct: 281 ELVSRISAIFSTFIG 295
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-22
Identities = 61/246 (24%), Positives = 102/246 (41%), Gaps = 27/246 (10%)
Query: 3 SRLKNENVVELVG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
L +E++++ G L+++ E+ GSL D L + AQ
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVM-EYVPLGSLRDYLPRHS----------IGLAQL 136
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA--RL 117
+ A G+ YLH + IHR++ + NVLL +D + KI DF L+ P+ R+
Sbjct: 137 LLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 193
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 176
F Y APE + SDV+SFGV L ELLT + +
Sbjct: 194 REDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252
Query: 177 ATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234
+++ ++ + ++ G P K A++ + C + EA FRP ++ L+ +
Sbjct: 253 --GQMTVLRLTELLER--GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
Query: 235 LNTRSG 240
G
Sbjct: 309 HEKYQG 314
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-22
Identities = 52/174 (29%), Positives = 78/174 (44%), Gaps = 40/174 (22%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+L N +V L+G L ++ E A G LH L GK+ + + ++
Sbjct: 65 HQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNVAEL 115
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
+ G++YL EK +HR++ + NVLL + AKISDF LS +
Sbjct: 116 LHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLS-------------KA 159
Query: 123 LGT--FGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
LG Y APE + SS+SDV+S+GV + E L+ G+KP
Sbjct: 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-22
Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 25/170 (14%)
Query: 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 65
++ ++ L Y + + E + L+ L KK + +R
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKN 116
Query: 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 125
+ +H+ I+H ++K +N L D + K+ DF ++NQ + +GT
Sbjct: 117 MLEAVHTIHQH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 126 FGYHAPE-----------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164
Y PE ++S KSDV+S G +L + G+ P
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-22
Identities = 55/257 (21%), Positives = 98/257 (38%), Gaps = 49/257 (19%)
Query: 4 RLKNENVVELVG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
L ++ +V+ G LR++ E+ G L D L + L ++ +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVM-EYLPSGCLRDFLQ--------RHRARLDASRLL 130
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ +G+EYL + R +HR++ + N+L+ + KI+DF L+
Sbjct: 131 LYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA------------- 174
Query: 121 RVLGTFG--YH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 165
++L Y APE S +SDV+SFGVVL EL T K +
Sbjct: 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CS 232
Query: 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPN 223
++ + ++ + ++ G PP A++ + LC RP+
Sbjct: 233 PSAEFLRMMGCERDVPALSRLLELLEE--GQRLPAPPACPAEVHELMKLCWAPSPQDRPS 290
Query: 224 MGIVLKALQPLLNTRSG 240
+ L L + G
Sbjct: 291 FSALGPQLDMLWSGSRG 307
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-22
Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+L + +V+L G ++ L E G L D L ++G+ + + +
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--------FAAETLLGM 109
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
+ G+ YL E +IHR++ + N L+ ++ + K+SDF ++ D +++
Sbjct: 110 CLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSST 163
Query: 123 LGTFGYH--APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
F +PE + SSKSDV+SFGV++ E+ + G+ P
Sbjct: 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 4e-22
Identities = 53/173 (30%), Positives = 78/173 (45%), Gaps = 40/173 (23%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L N +V L+G L ++ E A G LH L GK+ + + ++
Sbjct: 392 QLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNVAELL 442
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
+ G++YL EK +HRN+ + NVLL + AKISDF LS + L
Sbjct: 443 HQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS-------------KAL 486
Query: 124 GT--FGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
G Y APE + SS+SDV+S+GV + E L+ G+KP
Sbjct: 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-22
Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 25/170 (14%)
Query: 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 65
++ ++ L Y + + E + L+ L KK + +R
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKN 135
Query: 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 125
+ +H+ I+H ++K +N L D + K+ DF ++NQ + +GT
Sbjct: 136 MLEAVHTIHQH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 126 FGYHAPE-----------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164
Y PE ++S KSDV+S G +L + G+ P
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-22
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 27/165 (16%)
Query: 4 RLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+L++ N+V+L+G V + + E+ +KGSL D L + VL +
Sbjct: 70 QLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLL 120
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHS 119
K ++ +EYL +HR++ + NVL+ +D++AK+SDF L + S
Sbjct: 121 KFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASS 169
Query: 120 TRVLGTFGYH--APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
T+ G APE + S+KSDV+SFG++L E+ + GR P
Sbjct: 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-22
Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 17/161 (10%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L+++ +V L P+ ++ E+ GSL D L G L+ + + +A
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSG-------IKLTINKLLDMA 115
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
A G+ ++ E+ IHR+++++N+L+ D KI+DF L+ D ++ R
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREG 169
Query: 124 GTFGYH--APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
F APE G + KSDV+SFG++L E++T GR P
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-21
Identities = 53/245 (21%), Positives = 99/245 (40%), Gaps = 22/245 (8%)
Query: 3 SRLKNENVVELVG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
L+++N+V+ G L+++ E+ GSL D L K + +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER--------IDHIKL 147
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD--AAARL 117
++ +G+EYL K R IHR++ + N+L+ +++ KI DF L+ P ++
Sbjct: 148 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 204
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
F Y APE + S SDV+SFGVVL EL T + + +
Sbjct: 205 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
Query: 178 TPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
++ + + + G P ++ + C + RP+ + + +
Sbjct: 264 QGQMIVFHLIELLKN--NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
Query: 236 NTRSG 240
+ +G
Sbjct: 322 DQMAG 326
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-21
Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 42/174 (24%)
Query: 4 RLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+K+ N+V+L+G V + P ++ E + G+L D L +S +
Sbjct: 65 EIKHPNLVQLLG--VCTREPPFYIIT-EFMTYGNLLDYLRECNR-------QEVSAVVLL 114
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A + +EYL +K IHR++ + N L+ ++ + K++DF LS
Sbjct: 115 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS------------- 158
Query: 121 RVLGTFGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
R++ Y APE + S KSDV++FGV+L E+ T G P
Sbjct: 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-21
Identities = 53/245 (21%), Positives = 99/245 (40%), Gaps = 22/245 (8%)
Query: 3 SRLKNENVVELVG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
L+++N+V+ G L+++ E+ GSL D L K + +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER--------IDHIKL 116
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD--AAARL 117
++ +G+EYL K R IHR++ + N+L+ +++ KI DF L+ P ++
Sbjct: 117 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
F Y APE + S SDV+SFGVVL EL T + + +
Sbjct: 174 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 178 TPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
++ + + + G P ++ + C + RP+ + + +
Sbjct: 233 QGQMIVFHLIELLKN--NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
Query: 236 NTRSG 240
+ +G
Sbjct: 291 DNMAG 295
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-21
Identities = 34/170 (20%), Positives = 62/170 (36%), Gaps = 25/170 (14%)
Query: 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 65
++ ++ L Y + + E L+ L KK + +R
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKN 163
Query: 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 125
+ +H+ I+H ++K +N L D + K+ DF ++NQ + +G
Sbjct: 164 MLEAVHTIHQH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 126 FGYHAPE-----------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164
Y PE ++S KSDV+S G +L + G+ P
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-21
Identities = 43/187 (22%), Positives = 72/187 (38%), Gaps = 28/187 (14%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSW 56
M + N++ LV Y + +G+L + + + G L+
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTE 133
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 116
Q + + +G RGLE +H HR++K +N+LL D+ + D NQA
Sbjct: 134 DQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 117 LHSTRVL-------GTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
L T Y APE + + + ++DV+S G VL ++ G P D
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYD 247
Query: 164 HTLPRGQ 170
+G
Sbjct: 248 MVFQKGD 254
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-21
Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 41/173 (23%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L N +V ++G ++ E A G L+ L + + +++
Sbjct: 74 QLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRH---------VKDKNIIELV 123
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
+ G++YL E +HR++ + NVLL AKISDF LS + L
Sbjct: 124 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-------------KAL 167
Query: 124 GTFG--YH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
Y APE + SSKSDV+SFGV++ E + G+KP
Sbjct: 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-21
Identities = 36/172 (20%), Positives = 67/172 (38%), Gaps = 38/172 (22%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
L + ++V+L+G + P ++ E G L L + L V
Sbjct: 68 KNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLE--------RNKNSLKVLTLVLY 118
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
++ + + YL +HR+I N+L+ + K+ DF LS R
Sbjct: 119 SLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS-------------RY 162
Query: 123 LGTFGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ Y+ +PE + ++ SDV+ F V + E+L+ G++P
Sbjct: 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 64
+ ++V+L+G + P+ ++ E + G L L +K L A + A
Sbjct: 448 FDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASLILYAY 498
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 124
+ L YL K R +HR+I + NVL+ +D K+ DF LS D+ S L
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 125 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
APE + +S SDV+ FGV + E+L G KP
Sbjct: 556 IKWM-APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-21
Identities = 43/179 (24%), Positives = 76/179 (42%), Gaps = 37/179 (20%)
Query: 1 MVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKP-GPVLSW 56
++ +VV L+G V P V+ E ++G L L + P S
Sbjct: 81 VMKEFNCHHVVRLLG--VVSQGQPTLVI-MELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 116
++ +++A A G+ YL+ + +HR++ + N ++ +D KI DF ++
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT--------- 185
Query: 117 LHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
R + Y+ +PE G ++ SDV+SFGVVL E+ T +P
Sbjct: 186 ----RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-21
Identities = 38/177 (21%), Positives = 71/177 (40%), Gaps = 43/177 (24%)
Query: 3 SRLKNENVVELVG--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ NV+ L+G +G V+ + G L + + + +
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIR--------NETHNPTVKDLI 195
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ A+G+++L K + +HR++ + N +L + K++DF L+
Sbjct: 196 GFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA------------- 239
Query: 121 RVLGTFGYH---------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
R + + A E T + ++KSDV+SFGV+L EL+T G P
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-21
Identities = 52/258 (20%), Positives = 93/258 (36%), Gaps = 59/258 (22%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
S+L ++++V G V G +L E GSL L K ++ ++++
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK--------KNKNCINILWKLEV 118
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--------IAKISDFDLSNQAPDAA 114
A A + +L E +IH N+ + N+LL ++ K+SD +S
Sbjct: 119 AKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------- 168
Query: 115 ARLHSTRVLGTFGYH-------APEYAMTGQM-SSKSDVYSFGVVLLELLT-GRKPVDHT 165
+ PE + + +D +SFG L E+ + G KP+
Sbjct: 169 ------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--- 219
Query: 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225
L + Q + + P A++A + C+ YE D RP+
Sbjct: 220 -------------SALDSQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFR 264
Query: 226 IVLKALQPLLNTRSGPSK 243
+++ L L P
Sbjct: 265 AIIRDLNSLFTPDLVPRG 282
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-21
Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 43/185 (23%)
Query: 1 MVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDILHGK-------KGVKGAKP 50
+ +RL++ NVV L+G V D PL ++ + + S G LH+ L +
Sbjct: 65 LRARLQHPNVVCLLG--VVTKDQPLSMI-FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 51 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110
L V + A G+EYL ++H+++ + NVL++D KISD L
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF--- 175
Query: 111 PDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT 157
R + Y+ APE M G+ S SD++S+GVVL E+ +
Sbjct: 176 ----------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
Query: 158 -GRKP 161
G +P
Sbjct: 226 YGLQP 230
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-21
Identities = 33/176 (18%), Positives = 67/176 (38%), Gaps = 29/176 (16%)
Query: 2 VSRLKNENVVEL--VGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSW 56
++ + + ++V++ + D + Y E+ SL K L
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPV 181
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 116
A+ + + L YLH +++ ++K N++L ++ K+ D A +R
Sbjct: 182 AEAIAYLLEILPALSYLHSI---GLVYNDLKPENIML-TEEQLKLIDLG-------AVSR 230
Query: 117 LHST-RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 171
++S + GT G+ APE + +D+Y+ G L L + G
Sbjct: 231 INSFGYLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-21
Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 37/172 (21%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+L + +V+ G + E+ S G L + L G L +Q +++
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQLLEM 109
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
G+ +L + IHR++ + N L+ D K+SDF ++ R
Sbjct: 110 CYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT-------------RY 153
Query: 123 LGTFGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ Y APE + SSKSDV++FG+++ E+ + G+ P
Sbjct: 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-21
Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+ + N++ L G G L ++ E+ GSL L G + Q V +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGML 157
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 123
G G+ YL + +HR++ + NVL+ + + K+SDF LS RVL
Sbjct: 158 RGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS-------------RVL 201
Query: 124 G--TFGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ APE SS SDV+SFGVV+ E+L G +P
Sbjct: 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-21
Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 17/162 (10%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
L +E +V+L G + E+ + G L + L + Q +++
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEM 125
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
+EYL K + +HR++ + N L+ D + K+SDF LS D +++ V
Sbjct: 126 CKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSV 179
Query: 123 LGTFGYH--APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
F PE M + SSKSD+++FGV++ E+ + G+ P
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-21
Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 13/163 (7%)
Query: 3 SRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+ +KNE + G + V + YE+ S+ V +
Sbjct: 98 TDIKNEYCLTCEGIITN-YDEVYIIYEYMENDSILKFDE-YFFVLDKNYTCFIPIQVIKC 155
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
I Y+H + I HR++K SN+L+ + K+SDF S D ++ +R
Sbjct: 156 IIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSR 211
Query: 122 VLGTFGYHAPEYAMTGQMS---SKSDVYSFGVVLLELLTGRKP 161
GT+ + PE + + S +K D++S G+ L + P
Sbjct: 212 --GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-21
Identities = 45/172 (26%), Positives = 71/172 (41%), Gaps = 38/172 (22%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+ + ++V+L+G + P+ ++ E + G L L L A +
Sbjct: 71 RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--------VRKYSLDLASLILY 121
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 122
A + L YL K R +HR+I + NVL+ +D K+ DF LS R
Sbjct: 122 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RY 165
Query: 123 LGTFGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ Y+ APE + +S SDV+ FGV + E+L G KP
Sbjct: 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-21
Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 15/160 (9%)
Query: 3 SRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+LK+ +++EL Y+ D V L E G ++ L + S +
Sbjct: 66 CQLKHPSILELYNYFED-SNYVYLVLEMCHNGEMNRYLKNRVKP--------FSENEARH 116
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
G+ YLH I+HR++ SN+LL + KI+DF L+ Q + ++
Sbjct: 117 FMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL- 172
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT Y +PE A +SDV+S G + LL GR P
Sbjct: 173 -CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-21
Identities = 45/185 (24%), Positives = 84/185 (45%), Gaps = 43/185 (23%)
Query: 1 MVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKP 50
+++ L++E++V+ G V PL ++ +E+ G L+ L + +
Sbjct: 70 LLTNLQHEHIVKFYG--VCGDGDPLIMV-FEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 51 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110
L +Q + IA A G+ YL + +HR++ + N L+ + + KI DF +S
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS--- 180
Query: 111 PDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT 157
R + + Y+ PE M + +++SDV+SFGV+L E+ T
Sbjct: 181 ----------RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
Query: 158 -GRKP 161
G++P
Sbjct: 231 YGKQP 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-21
Identities = 34/163 (20%), Positives = 62/163 (38%), Gaps = 21/163 (12%)
Query: 8 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 67
NV+ D + +A E + +L + + + + + +
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQKDFAHLGLEPITLLQQTT 128
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFDLSNQ-APDAAARLHSTR 121
GL +LH I+HR++K N+L+ + A ISDF L + A + +
Sbjct: 129 SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 122 VLGTFGYHAPEY---AMTGQMSSKSDVYSFGVVLLELLTGRKP 161
V GT G+ APE + D++S G V +++
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-21
Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 41/176 (23%)
Query: 3 SRLKNENVVELVGYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
L + NV+ L+G + L + + G L + P + +
Sbjct: 77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKDLIS 128
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
+ ARG+EYL E+ + +HR++ + N +L + K++DF L+ R
Sbjct: 129 FGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLA-------------R 172
Query: 122 VLGTFGYH---------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ Y+ A E T + ++KSDV+SFGV+L ELLT G P
Sbjct: 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-21
Identities = 42/165 (25%), Positives = 76/165 (46%), Gaps = 21/165 (12%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+ + N++ L G ++ E+ GSL L K + Q V +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--------KHDAQFTVIQLVGM 152
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR- 121
G A G++YL + +HR++ + N+L+ + + K+SDF L D ++TR
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 122 ----VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ T +PE + +S SDV+S+G+VL E+++ G +P
Sbjct: 210 GKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-21
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 21/165 (12%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+ + N++ L G ++ E+ G+L L K G S Q V +
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGM 152
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR- 121
G A G++YL +HR++ + N+L+ + + K+SDF LS D ++T
Sbjct: 153 LRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 122 ----VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ T APE + +S SDV+SFG+V+ E++T G +P
Sbjct: 210 GKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 1e-20
Identities = 20/174 (11%), Positives = 53/174 (30%), Gaps = 14/174 (8%)
Query: 16 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75
+V + ++ + ++L + L R+++ + R L LH
Sbjct: 175 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----LVHHARLQLTLQVIRLLASLHH 229
Query: 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE--- 132
++H ++ +++L ++ F+ A+A R A
Sbjct: 230 Y---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAVSPIGRGFAPPETTAERMLP 285
Query: 133 --YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 184
M+ D ++ G+ + + P G + + + +
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP 339
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-20
Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 43/181 (23%)
Query: 3 SRLKNENVVELVG--------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 54
+ +V +LVG + P+ +L G LH L + + L
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVIL--PFMKHGDLHAFL---LASRIGENPFNL 134
Query: 55 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 114
V+ V A G+EYL + IHR++ + N +L +D ++DF LS
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS------- 184
Query: 115 ARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160
R + + Y+ A E + SDV++FGV + E++T G+
Sbjct: 185 ------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238
Query: 161 P 161
P
Sbjct: 239 P 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-20
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 43/177 (24%)
Query: 3 SRLKNENVVELVG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
L +EN+V+ G ++++ E GSL + L K ++ Q+
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIM-EFLPSGSLKEYLPKNKNK--------INLKQQ 128
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
+K AV +G++YL + + +HR++ + NVL+ + KI DF L+
Sbjct: 129 LKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT------------ 173
Query: 120 TRVL--GTFGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ + Y APE M + SDV+SFGV L ELLT
Sbjct: 174 -KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-20
Identities = 42/180 (23%), Positives = 69/180 (38%), Gaps = 42/180 (23%)
Query: 3 SRLKNENVVELVG-------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 55
+ NV+ L+G + P+ +L G LH L + +
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVIL--PFMKYGDLHTYL---LYSRLETGPKHIP 145
Query: 56 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 115
+K V A G+EYL + +HR++ + N +L DD ++DF LS
Sbjct: 146 LQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS-------- 194
Query: 116 RLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ + + Y+ A E +SKSDV++FGV + E+ T G P
Sbjct: 195 -----KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-20
Identities = 50/163 (30%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 33 GSLHDILHGKKGVKGAK-PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 91
S V P +L KI + + L +L E +IIHR+IK SN+
Sbjct: 105 TSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHLKENL--KIIHRDIKPSNI 157
Query: 92 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE----YAMTGQMSSKSDVYS 147
LL K+ DF +S Q D+ A+ TR G Y APE A +SDV+S
Sbjct: 158 LLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWS 214
Query: 148 FGVVLLELLTGRKPVD--HTLPRGQQSLVTWATPKLSEDKVKQ 188
G+ L EL TGR P +++ +V P+LS + ++
Sbjct: 215 LGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-20
Identities = 47/163 (28%), Positives = 72/163 (44%), Gaps = 16/163 (9%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
+ L + +V L G +GP + E GSL ++ K L + +
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---------KQMGCLPEDRALYY 155
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQ-APDAAARLHST 120
A GLEYLH + RI+H ++K+ NVLL D A + DF + PD + T
Sbjct: 156 LGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 121 R--VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ GT + APE M +K D++S ++L +L G P
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-20
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 14/162 (8%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
LK++N+V+ +G + + + E GSL +L K G + + +++
Sbjct: 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI-- 131
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTR 121
GL+YLH+ +I+HR+IK NVL+ + KISDF S + +
Sbjct: 132 ----LEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-- 182
Query: 122 VLGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKP 161
GT Y APE G +D++S G ++E+ TG+ P
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-20
Identities = 61/265 (23%), Positives = 109/265 (41%), Gaps = 63/265 (23%)
Query: 1 MVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKP 50
M K++N++ L+G DGPL V+ E+ASKG+L + L P
Sbjct: 140 MKMIGKHKNIINLLG--ACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 51 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110
+++ V ARG+EYL + + IHR++ + NVL+ ++++ KI+DF L+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA--- 250
Query: 111 PDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT 157
R + Y+ APE + +SDV+SFGV++ E+ T
Sbjct: 251 ----------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
Query: 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCV 214
G P P + +++ + + K G + P ++ + C
Sbjct: 301 LGGSP----------------YPGIPVEELFKLL--KEGHRMDKPANCTNELYMMMRDCW 342
Query: 215 QYEADFRPNMGIVLKALQPLLNTRS 239
RP +++ L +L +
Sbjct: 343 HAVPSQRPTFKQLVEDLDRILTLTT 367
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-20
Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 37/182 (20%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAY-------------EHASKGSLHDILHGKKGVKGAK 49
+ L ++ VV +++ V E+ G+L+D++ +
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQ 114
Query: 50 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109
+++ L Y+H + IIHR++K N+ + + KI DF L+
Sbjct: 115 RDEYWRLFRQI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 110 APDAAARLHS------------TRVLGTFGYHAPE-YAMTGQMSSKSDVYSFGVVLLELL 156
+ L T +GT Y A E TG + K D+YS G++ E++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 157 TG 158
Sbjct: 226 YP 227
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-20
Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 26/175 (14%)
Query: 1 MVSRLKNENVVELVGY-YVDGPLRVLAYEHASKGSLHDILHGKK-------GVKGAKPGP 52
+ + N++ L+G G L + E+A G+L D L +
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 53 VLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 112
LS Q + A ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS----- 189
Query: 113 AAARLHSTRVLGTFG-----YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
R V T G + A E ++ SDV+S+GV+L E+++ G P
Sbjct: 190 ---RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-20
Identities = 43/184 (23%), Positives = 78/184 (42%), Gaps = 42/184 (22%)
Query: 1 MVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDIL------HGKKGVKGAKPG 51
+++ L+++++V G V PL ++ +E+ G L+ L
Sbjct: 96 LLTMLQHQHIVRFFG--VCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 52 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 111
L Q + +A A G+ YL +HR++ + N L+ + KI DF +S
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS---- 205
Query: 112 DAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT- 157
R + + Y+ PE + + +++SDV+SFGVVL E+ T
Sbjct: 206 ---------RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY 256
Query: 158 GRKP 161
G++P
Sbjct: 257 GKQP 260
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-20
Identities = 61/266 (22%), Positives = 109/266 (40%), Gaps = 59/266 (22%)
Query: 1 MVSRLKNENVVELVGY-YVDGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGP 52
M K++N++ L+G DGPL V+ E+ASKG+L + L P
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 53 VLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 112
+++ V ARG+EYL + + IHR++ + NVL+ ++++ KI+DF L+
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA----- 204
Query: 113 AAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-G 158
R + Y+ APE + +SDV+SFGV++ E+ T G
Sbjct: 205 --------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQY 216
P P + +++ + + K G + P ++ + C
Sbjct: 257 GSP----------------YPGIPVEELFKLL--KEGHRMDKPANCTNELYMMMRDCWHA 298
Query: 217 EADFRPNMGIVLKALQPLLNTRSGPS 242
RP +++ L +L +
Sbjct: 299 VPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 50/162 (30%), Positives = 70/162 (43%), Gaps = 22/162 (13%)
Query: 3 SRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQR 59
S L++ N++ L GY+ D RV L E+A G+++ L K +
Sbjct: 64 SHLRHPNILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLSKFDEQRTA---------- 112
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
A L Y H K R+IHR+IK N+LL KI+DF S AP +
Sbjct: 113 -TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRT 165
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ GT Y PE K D++S GV+ E L G+ P
Sbjct: 166 D-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-19
Identities = 47/173 (27%), Positives = 71/173 (41%), Gaps = 29/173 (16%)
Query: 33 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 92
+ KK ++G P +L K+ V + L YL EK +IHR++K SN+L
Sbjct: 108 TCAEKL---KKRMQGPIPERILG-----KMTVAIVKALYYLKEKH--GVIHRDVKPSNIL 157
Query: 93 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-----YAMTGQMSSKSDVYS 147
L + K+ DF +S + D A+ R G Y APE ++DV+S
Sbjct: 158 LDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 148 FGVVLLELLTGRKPVDHTLP--RGQQSLVTWATPKLSEDK---------VKQC 189
G+ L+EL TG+ P + ++ P L VK C
Sbjct: 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDC 267
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-19
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 40/184 (21%)
Query: 1 MVSRLKNENVVELVG--YYVDGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPG 51
++ + NVV L+G GPL V+ E G+L L K+
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 52 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 111
L+ + + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA---- 195
Query: 112 DAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT- 157
R + + APE + +SDV+SFGV+L E+ +
Sbjct: 196 ---------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 158 GRKP 161
G P
Sbjct: 247 GASP 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-19
Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 55/253 (21%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
S+ ++N+V +G + R + E + G L L + L+ + +
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHV 145
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHS 119
A A G +YL E IHR+I + N LL +AKI DF ++
Sbjct: 146 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------------ 190
Query: 120 TRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 165
R + Y+ PE M G +SK+D +SFGV+L E+ + G P
Sbjct: 191 -RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--- 246
Query: 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPN 223
P S +V + V + GG + P + + C Q++ + RPN
Sbjct: 247 -------------PSKSNQEVLEFVTS--GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN 291
Query: 224 MGIVLKALQPLLN 236
I+L+ ++
Sbjct: 292 FAIILERIEYCTQ 304
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-19
Identities = 36/161 (22%), Positives = 60/161 (37%), Gaps = 16/161 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ V L + +G + L E SL G L AQ
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--------AWGASLPEAQVW 160
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
L +LH + ++H ++K +N+ L K+ DF L + A A
Sbjct: 161 GYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EV 215
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ G Y APE + G + +DV+S G+ +LE+ +
Sbjct: 216 QE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-19
Identities = 67/265 (25%), Positives = 109/265 (41%), Gaps = 63/265 (23%)
Query: 1 MVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKP 50
M K++N++ L+G DGPL V+ E+ASKG+L + L P
Sbjct: 128 MKMIGKHKNIINLLG--ACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 51 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110
LS V A ARG+EYL K + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA--- 238
Query: 111 PDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT 157
R + Y+ APE + +SDV+SFGV+L E+ T
Sbjct: 239 ----------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
Query: 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCV 214
G P P + +++ + + K G + P ++ + C
Sbjct: 289 LGGSP----------------YPGVPVEELFKLL--KEGHRMDKPSNCTNELYMMMRDCW 330
Query: 215 QYEADFRPNMGIVLKALQPLLNTRS 239
RP +++ L ++ S
Sbjct: 331 HAVPSQRPTFKQLVEDLDRIVALTS 355
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-19
Identities = 47/191 (24%), Positives = 90/191 (47%), Gaps = 47/191 (24%)
Query: 1 MVSRLKNENVVELVGY-YVDGPLRVLAYEHASKGSLHDIL---------------HGKKG 44
+++ N N+V+L+G V P+ +L +E+ + G L++ L +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 45 VKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 104
+ P LS A+++ IA A G+ YL E+ + +HR++ + N L+ ++ + KI+DF
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADF 218
Query: 105 DLSNQAPDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVV 151
LS R + + Y+ PE + +++SDV+++GVV
Sbjct: 219 GLS-------------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 265
Query: 152 LLELLT-GRKP 161
L E+ + G +P
Sbjct: 266 LWEIFSYGLQP 276
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-19
Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 1 MVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
++ KN N+V + Y V L V+ E+ + GSL D++ + Q
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETC----------MDEGQI 118
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
+ + LE+LH ++IHR+IKS N+LL D K++DF Q ++ +
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
++GT + APE K D++S G++ +E++ G P
Sbjct: 176 --MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-19
Identities = 49/182 (26%), Positives = 77/182 (42%), Gaps = 39/182 (21%)
Query: 1 MVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGV-----KGAKPGP 52
M ++EN+V L+G GP+ V+ E+ G L + L K V A
Sbjct: 103 MSHLGQHENIVNLLG--ACTHGGPVLVIT-EYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 53 VLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 112
S + + A+G+ +L K IHR++ + NVLL + +AKI DF L
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL------ 210
Query: 113 AAARLHSTRVLGTFGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159
AR ++ Y APE + +SDV+S+G++L E+ + G
Sbjct: 211 --ARD----IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264
Query: 160 KP 161
P
Sbjct: 265 NP 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 4e-19
Identities = 24/197 (12%), Positives = 62/197 (31%), Gaps = 25/197 (12%)
Query: 1 MVSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 58
+V + + ++ + D R Y +L G+ + + L
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTF--GEVLLSHSSTHKSLVHHA 207
Query: 59 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 118
R+++ + R L LH ++H ++ +++L ++ F+ +
Sbjct: 208 RLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------A 258
Query: 119 STRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 167
+ G+ PE M+ D ++ G+V+ + P+
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318
Query: 168 RGQQSLVTWATPKLSED 184
G + + + +
Sbjct: 319 LGGSEWIFRSCKNIPQP 335
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 4e-19
Identities = 20/168 (11%), Positives = 40/168 (23%), Gaps = 15/168 (8%)
Query: 9 NVVELVGYYVDGPL--RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 66
+L D + +L AS L + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQL 203
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 126
R L K ++H + N+ + D + D +
Sbjct: 204 IRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPV 255
Query: 127 GYHAPEYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 172
Y E+ T + + + G+ + + P P + S
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-19
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 15/161 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++S+ + V + G Y+ + E+ GS D+L +PGP L Q
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIA 122
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
I +GL+YLH + + IHR+IK++NVLL + K++DF ++ Q D + ++
Sbjct: 123 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT- 178
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT + APE SK+D++S G+ +EL G P
Sbjct: 179 -FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-19
Identities = 60/253 (23%), Positives = 99/253 (39%), Gaps = 55/253 (21%)
Query: 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 62
S+ ++N+V +G + R + E + G L L + L+ + +
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR--PRPSQPSSLAMLDLLHV 186
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHS 119
A A G +YL E IHR+I + N LL +AKI DF ++
Sbjct: 187 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------------ 231
Query: 120 TRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 165
R + GY+ PE M G +SK+D +SFGV+L E+ + G P
Sbjct: 232 -RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--- 287
Query: 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPN 223
P S +V + V + GG + P + + C Q++ + RPN
Sbjct: 288 -------------PSKSNQEVLEFVTS--GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN 332
Query: 224 MGIVLKALQPLLN 236
I+L+ ++
Sbjct: 333 FAIILERIEYCTQ 345
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 5e-19
Identities = 48/170 (28%), Positives = 71/170 (41%), Gaps = 21/170 (12%)
Query: 4 RLKNENVVELV------GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWA 57
+L + NVV L +LA E+ G L L+ + G K GP+ +
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 58 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAA 114
+ + L YLHE RIIHR++K N++L I KI D + +
Sbjct: 128 SDI------SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG- 177
Query: 115 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164
L + V GT Y APE + + D +SFG + E +TG +P
Sbjct: 178 -ELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-19
Identities = 46/162 (28%), Positives = 84/162 (51%), Gaps = 15/162 (9%)
Query: 1 MVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
++ + + +VV+ G Y+ + L ++ E+ GS+ DI+ + L+ +
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVM-EYCGAGSVSDIIRLRNKT--------LTEDEI 127
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
I +GLEYLH R IHR+IK+ N+LL + AK++DF ++ Q D A+ ++
Sbjct: 128 ATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
V+GT + APE + +D++S G+ +E+ G+ P
Sbjct: 185 --VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-19
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 17/227 (7%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+S+ + N+V +V L + S GS+ DI+ K G L +
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIA 124
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
I GLEYLH+ IHR++K+ N+LL +D +I+DF +S +
Sbjct: 125 TILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 121 R---VLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVT 175
+GT + APE + K+D++SFG+ +EL TG P P + +
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ 241
Query: 176 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222
P L + + K G K+ KM +LC+Q + + RP
Sbjct: 242 NDPPSLETGVQDKEMLKKYG-----KSFRKM---ISLCLQKDPEKRP 280
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 8e-19
Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 16/162 (9%)
Query: 3 SRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
L +++VV G++ D V + E + SL ++ +K + + A+
Sbjct: 70 RSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRRKALTEPE-------ARY-- 119
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
G +YLH R+IHR++K N+ L +D KI DF L+ + R
Sbjct: 120 YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL- 175
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
GT Y APE S + DV+S G ++ LL G+ P +
Sbjct: 176 -CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 16/160 (10%)
Query: 3 SRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
L +++VV G++ D V + E + SL ++ +K + + A+
Sbjct: 96 RSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRRKALTEPE-------ARY-- 145
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
G +YLH R+IHR++K N+ L +D KI DF L+ + R
Sbjct: 146 YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL- 201
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT Y APE S + DV+S G ++ LL G+ P
Sbjct: 202 -CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-18
Identities = 43/185 (23%), Positives = 70/185 (37%), Gaps = 41/185 (22%)
Query: 1 MVSRLKNENVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVK---------GAKP 50
+ + N+V L+G + GP V+ E+ G L + L K+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVIT-EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 51 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110
L + + A+G+ +L K IHR++ + N+LL I KI DF L+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA--- 192
Query: 111 PDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT 157
R + + APE + +SDV+S+G+ L EL +
Sbjct: 193 ----------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 158 -GRKP 161
G P
Sbjct: 243 LGSSP 247
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-18
Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 22/162 (13%)
Query: 3 SRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQR 59
S L++ N++ + Y+ D R+ L E A +G L+ L HG+ + +
Sbjct: 69 SHLRHPNILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSA---------- 117
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
A L Y HE+ ++IHR+IK N+L+ KI+DF S AP R +
Sbjct: 118 -TFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRT 171
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT Y PE K D++ GV+ E L G P
Sbjct: 172 M--CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 5e-18
Identities = 30/168 (17%), Positives = 58/168 (34%), Gaps = 17/168 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ + N+V ++ + + GS D++ ++
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI------CTHFMDG-MNELAIA 131
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
I G + L+Y+H +HR++K+S++L+ D +S + R
Sbjct: 132 YILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 121 RVL-----GTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKP 161
+ +PE +KSD+YS G+ EL G P
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-18
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 1 MVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
++ ++ NVVE+ Y V L VL E G+L DI+ + L+ Q
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQVR----------LNEEQI 143
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
+ + L YLH + +IHR+IKS ++LL D K+SDF Q + S
Sbjct: 144 ATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
++GT + APE +++ D++S G++++E++ G P
Sbjct: 201 --LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-18
Identities = 45/191 (23%), Positives = 78/191 (40%), Gaps = 51/191 (26%)
Query: 3 SRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHDIL---------------HGKKG 44
++ + +V++L G DGPL ++ E+A GSL L
Sbjct: 81 KQVNHPHVIKLYG--ACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 45 VKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 104
L+ + A ++G++YL E +++HR++ + N+L+ + KISDF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDF 194
Query: 105 DLSNQAPDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVV 151
LS R + + A E +++SDV+SFGV+
Sbjct: 195 GLS-------------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 152 LLELLT-GRKP 161
L E++T G P
Sbjct: 242 LWEIVTLGGNP 252
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 46/190 (24%), Positives = 82/190 (43%), Gaps = 46/190 (24%)
Query: 1 MVSRLKNENVVELVGY-YVDGPLRVLAYEHASKGSLHDIL--------------HGKKGV 45
M +EN+V L+G + GP+ ++ E+ G L + L +K +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIF-EYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 46 KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 105
+ + VL++ + A A+G+E+L K +HR++ + NVL+ + KI DF
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 106 LSNQAPDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVL 152
L+ R + + + APE G + KSDV+S+G++L
Sbjct: 218 LA-------------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
Query: 153 LELLT-GRKP 161
E+ + G P
Sbjct: 265 WEIFSLGVNP 274
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-17
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 1 MVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
+++ + +V+L+G YY DG L ++ E G++ I+ L+ Q
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRG--------LTEPQI 119
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
+ L +LH K RIIHR++K+ NVL+ + +++DF +S + + S
Sbjct: 120 QVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
Query: 120 TRVLGTFGYHAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKP 161
+GT + APE M M K+D++S G+ L+E+ P
Sbjct: 177 --FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 35/175 (20%), Positives = 65/175 (37%), Gaps = 28/175 (16%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68
NV+ +A E + +L D++ K + + + + A
Sbjct: 70 NVIRYYCSETTDRFLYIALELCN-LNLQDLVESKN--VSDENLKLQKEYNPISLLRQIAS 126
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLL-------------FDDDIAKISDFDLSNQAPDAAA 115
G+ +LH +IIHR++K N+L+ ++ ISDF L + +
Sbjct: 127 GVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 116 RLHSTR--VLGTFGYHAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ GT G+ APE +++ D++S G V +L+ K
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-17
Identities = 43/185 (23%), Positives = 71/185 (38%), Gaps = 27/185 (14%)
Query: 4 RLKNENVVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+L ++N+V+L + R VL E GSL+ +L G L + V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV- 121
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF----DDDIAKISDFDLSNQAPDAAARL 117
G+ +L E I+HRNIK N++ + K++DF + + D +
Sbjct: 122 -----VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QF 172
Query: 118 HSTRVLGTFGYHAPE--------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPR 168
S + GT Y P+ + + D++S GV TG P PR
Sbjct: 173 VS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 169 GQQSL 173
+ +
Sbjct: 231 RNKEV 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 6e-17
Identities = 43/185 (23%), Positives = 71/185 (38%), Gaps = 27/185 (14%)
Query: 4 RLKNENVVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+L ++N+V+L + R VL E GSL+ +L G L + V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV- 121
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF----DDDIAKISDFDLSNQAPDAAARL 117
G+ +L E I+HRNIK N++ + K++DF + + D +
Sbjct: 122 -----VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QF 172
Query: 118 HSTRVLGTFGYHAPE--------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPR 168
S + GT Y P+ + + D++S GV TG P PR
Sbjct: 173 VS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 169 GQQSL 173
+ +
Sbjct: 231 RNKEV 235
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-17
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
G+EYLH + +IIHR+IK SN+L+ +D KI+DF +SN+ + A L +T GT +
Sbjct: 149 GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV--GTPAF 203
Query: 129 HAPEYAMTGQMS---SKSDVYSFGVVLLELLTGRKP-VDHTLP 167
APE + DV++ GV L + G+ P +D +
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-16
Identities = 28/177 (15%), Positives = 58/177 (32%), Gaps = 28/177 (15%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ ++ ++ VL E S G+L + ++ K P V+ +
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK----NTPEKVMPQGLVI 175
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA-----------KISDF----D 105
A+ +E +H+ IIH +IK N +L + + + D D
Sbjct: 176 SFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 106 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS-KSDVYSFGVVLLELLTGRKP 161
+ T T G+ E ++ + + + D + + +L G
Sbjct: 233 MKLFPKGTIF----TAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-16
Identities = 43/183 (23%), Positives = 66/183 (36%), Gaps = 31/183 (16%)
Query: 1 MVSRLKNENVVELVGYYVDGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPV 53
M + N+V+ G L KG L + L K +
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL------KKMESRGP 132
Query: 54 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF--------- 104
LS +KI R ++++H + +P IIHR++K N+LL + K+ DF
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 105 -DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-----SKSDVYSFGVVLLELLTG 158
D S A A T Y PE + S K D+++ G +L L
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFR 249
Query: 159 RKP 161
+ P
Sbjct: 250 QHP 252
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-16
Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 38/207 (18%)
Query: 6 KNENVVELVGYYVDGPLRVLAY------EHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
+ N+ G ++ + E GS+ D+ +K K L
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL------IKNTKGNT-LKEEW- 130
Query: 60 VKIAV---GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 116
IA RGL +LH+ ++IHR+IK NVLL ++ K+ DF +S Q R
Sbjct: 131 --IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 117 LHSTRVLGTFGYHAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKPVDHTLP-RGQ 170
++ +GT + APE + KSD++S G+ +E+ G P+ P R
Sbjct: 186 RNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243
Query: 171 QSLVTWATPKLSEDK--------VKQC 189
+ P+L K ++ C
Sbjct: 244 FLIPRNPAPRLKSKKWSKKFQSFIESC 270
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-15
Identities = 27/171 (15%), Positives = 59/171 (34%), Gaps = 22/171 (12%)
Query: 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 64
++ +VV + + ++ E+ + GSL D + + L + +
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLLL 122
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA----------- 113
RGL Y+H ++H +IK SN+ + I + + +
Sbjct: 123 QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 114 -AARLHSTRVL-GTFGYHAPE-YAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
R+ S +V G + A E K+D+++ + ++
Sbjct: 180 HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 4/113 (3%)
Query: 50 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109
L+ + + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 110 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 161
+ + APE + +SDV+SFGV+L E+ + G P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-14
Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 30/201 (14%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ +L++ N ++ G Y+ L E+ GS D+L K L +
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIA 157
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ GA +GL YLH +IHR++K+ N+LL + + K+ DF ++ A
Sbjct: 158 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------N 208
Query: 121 RVLGTFGYHAPEYAMTGQMS---SKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTW 176
+GT + APE + K DV+S G+ +EL + P+ + +
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 268
Query: 177 ATPKLSEDK--------VKQC 189
+P L V C
Sbjct: 269 ESPALQSGHWSEYFRNFVDSC 289
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 5e-14
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GLE++H + +++R++K +N+LL + +ISD L+ V GT GY
Sbjct: 304 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV-GTHGY 356
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE G S D +S G +L +LL G P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 48/163 (29%), Positives = 69/163 (42%), Gaps = 23/163 (14%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 61
L + N+++L ++ D L E G L D I K A A +K
Sbjct: 92 LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA--------AVIIK 143
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLH 118
+ + YLH+ I+HR++K N+LL + + KI DF LS +
Sbjct: 144 QVLSG---VTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-- 195
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
LGT Y APE + + K DV+S GV+L LL G P
Sbjct: 196 -KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 23/163 (14%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 61
+L + N+++L ++ D L E + G L D I + A A+ ++
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA--------ARIIR 133
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLH 118
+ + Y+H+ +I+HR++K N+LL +I DF LS +
Sbjct: 134 QVLSG---ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-- 185
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT Y APE + G K DV+S GV+L LL+G P
Sbjct: 186 -KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA--RLHSTRVLGTF 126
GLEYLH + I+H++IK N+LL KIS ++ AA +++ G+
Sbjct: 121 GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSP 175
Query: 127 GYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKPVDH 164
+ PE A K D++S GV L + TG P +
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 48/163 (29%), Positives = 71/163 (43%), Gaps = 23/163 (14%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 61
L + N+++L + D L E G L + I K A A +K
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA--------ANIMK 153
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLH 118
+ + YLH+ I+HR+IK N+LL + + KI DF LS+ +L
Sbjct: 154 QILSG---ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLR 206
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
LGT Y APE + + + K DV+S GV++ LL G P
Sbjct: 207 D--RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-13
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GLE+LH++ II+R++K NVLL DD +ISD L+ + + GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYA-GTPGF 355
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + G+ S D ++ GV L E++ R P
Sbjct: 356 MAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 18/106 (16%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
++Y H+K RI+HR++K+ N+LL D KI+DF SN+ G Y
Sbjct: 126 AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPY 179
Query: 129 HAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLP 167
APE Y + DV+S GV+L L++G P L
Sbjct: 180 AAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-12
Identities = 37/102 (36%), Positives = 48/102 (47%), Gaps = 16/102 (15%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRVLGTFG 127
G+ YLH I HR+IK N+LL + D KISDF L+ RL + GT
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 128 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
Y APE + + DV+S G+VL +L G P D
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-12
Identities = 45/195 (23%), Positives = 59/195 (30%), Gaps = 40/195 (20%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L + N+ L Y D L E G L D L+ K + Q
Sbjct: 84 KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 64 VG------------------------AAR-------GLEYLHEKAEPRIIHRNIKSSNVL 92
+ L YLH + I HR+IK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFL 200
Query: 93 LFDDDIA--KISDFDLSN--QAPDAAARLHSTRVLGTFGYHAPE--YAMTGQMSSKSDVY 146
+ K+ DF LS + T GT + APE K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 147 SFGVVLLELLTGRKP 161
S GV+L LL G P
Sbjct: 261 SAGVLLHLLLMGAVP 275
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L+YL + RIIHR++K N+LL + I+DF+++ P +T + GT Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180
Query: 129 HAPE--YAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + G S + D +S GV ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-12
Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 12/99 (12%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGT 125
++YLHE IIHR++K NVLL + + KI+DF S + + L T GT
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-GT 304
Query: 126 FGYHAPE---YAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
Y APE T + D +S GV+L L+G P
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-12
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GLE LH + RI++R++K N+LL D +ISD L+ P+ + RV GT GY
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 351
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + + + S D ++ G +L E++ G+ P
Sbjct: 352 MAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-12
Identities = 37/102 (36%), Positives = 48/102 (47%), Gaps = 16/102 (15%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRVLGTFG 127
G+ YLH I HR+IK N+LL + D KISDF L+ RL + GT
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 128 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
Y APE + + DV+S G+VL +L G P D
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-12
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 23/163 (14%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 61
+L + N+++L D + E + G L D I + A A+ +K
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIK 128
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLH 118
+ Y+H+ I+HR++K N+LL + KI DF LS ++
Sbjct: 129 QVFSG---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMK 181
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+GT Y APE + G K DV+S GV+L LL+G P
Sbjct: 182 D--RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-12
Identities = 35/104 (33%), Positives = 47/104 (45%), Gaps = 21/104 (20%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGT 125
G+ Y H +I HR++K N LL D A KI DF S + + + ST +GT
Sbjct: 128 GVSYCHSM---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS-QPKST--VGT 180
Query: 126 FGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
Y APE Y +DV+S GV L +L G P +
Sbjct: 181 PAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 24/98 (24%), Positives = 44/98 (44%), Gaps = 9/98 (9%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+++ H + ++HR+IK N+L+ AK+ DF D GT
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDF--DGTRV 203
Query: 128 YHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDH 164
Y PE+ Q + + V+S G++L +++ G P +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 23/98 (23%), Positives = 42/98 (42%), Gaps = 9/98 (9%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+ + H ++HR+IK N+L+ + K+ DF D GT
Sbjct: 161 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF--DGTRV 213
Query: 128 YHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDH 164
Y PE+ + + V+S G++L +++ G P +H
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 38/101 (37%), Positives = 53/101 (52%), Gaps = 17/101 (16%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
+EY H +I+HR++K N+LL D+ KI+DF LSN D L ++ G+ Y
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTS--CGSPNY 173
Query: 129 HAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
APE YA + DV+S G+VL +L GR P D
Sbjct: 174 AAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-11
Identities = 22/160 (13%), Positives = 38/160 (23%), Gaps = 43/160 (26%)
Query: 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 61
+SR+ V ++ ++ E GSL ++ P P ++
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSP----VGAIR 133
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 121
A + H + S V + D
Sbjct: 134 AMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVV--------------------- 169
Query: 122 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
L + + D+ G L LL R P
Sbjct: 170 -LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWP 201
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 44/165 (26%), Positives = 67/165 (40%), Gaps = 13/165 (7%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
LK+ ++VEL+ Y + + +E L + VK A G V S A
Sbjct: 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYM 136
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHST 120
L Y H+ IIHR++K VLL + + K+ F ++ Q ++
Sbjct: 137 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG- 192
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165
+GT + APE DV+ GV+L LL+G P T
Sbjct: 193 -RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-11
Identities = 29/101 (28%), Positives = 43/101 (42%), Gaps = 17/101 (16%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
+ YL K IIHR+IK N+++ +D K+ DF + +L T GT Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFC-GTIEY 195
Query: 129 HAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
APE Y + +++S GV L L+ P
Sbjct: 196 CAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFC 231
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-11
Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 17/101 (16%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
++Y H ++HR++K NVLL AKI+DF LSN D L ++ G+ Y
Sbjct: 123 AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNY 176
Query: 129 HAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
APE YA + D++S GV+L LL G P D
Sbjct: 177 AAPEVISGRLYA-----GPEVDIWSCGVILYALLCGTLPFD 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 5e-11
Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 27/165 (16%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQR 59
++K+EN+V L Y L + S G L D IL ++GV K A +
Sbjct: 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGVYTEKDA--------SLV 111
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAAR 116
++ + A ++YLHE I+HR++K N+L ++ I+DF LS +
Sbjct: 112 IQQVLSA---VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM- 164
Query: 117 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ GT GY APE S D +S GV+ LL G P
Sbjct: 165 ---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 8e-11
Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
LEYLH K IIHR++K N+LL +D +I+DF + + + + +GT Y
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 130 APEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
+PE +T + + KS D+++ G ++ +L+ G P
Sbjct: 200 SPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-11
Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
G+++LH IIHR++K SN+++ D KI DF L A A T + T
Sbjct: 138 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRY 191
Query: 128 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
Y APE + D++S G ++ E++ G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-10
Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 26/165 (15%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQR 59
RL + N+++L + L E + G L D I+ +KG + A A
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV--EKGYYSERDA--------ADA 153
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAAR 116
VK + A + YLHE I+HR++K N+L D KI+DF LS
Sbjct: 154 VKQILEA---VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QV 205
Query: 117 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
L T GT GY APE + D++S G++ LL G +P
Sbjct: 206 LMKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-10
Identities = 37/101 (36%), Positives = 51/101 (50%), Gaps = 17/101 (16%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
G++Y H ++HR++K NVLL AKI+DF LSN D L ++ G+ Y
Sbjct: 128 GVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNY 181
Query: 129 HAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
APE YA + D++S GV+L LL G P D
Sbjct: 182 AAPEVISGRLYA-----GPEVDIWSSGVILYALLCGTLPFD 217
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-10
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D +TR
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE + +++ D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 31/102 (30%), Positives = 44/102 (43%), Gaps = 12/102 (11%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
+ LH+ I+HR++K N+LL DD K++DF S Q GT Y
Sbjct: 136 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVC-GTPSY 189
Query: 129 HAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164
APE + D++S GV++ LL G P H
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 35/99 (35%), Positives = 47/99 (47%), Gaps = 12/99 (12%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGT 125
++YLHE IIHR++K NVLL + + KI+DF S + L T GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLC-GT 179
Query: 126 FGYHAPE---YAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
Y APE T + D +S GV+L L+G P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 38/161 (23%), Positives = 64/161 (39%), Gaps = 15/161 (9%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
L + N++++ + D + E G L + + + LS ++
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELM 130
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHST 120
L Y H + ++H+++K N+L D KI DF L+ +
Sbjct: 131 KQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTN 185
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT Y APE ++ K D++S GVV+ LLTG P
Sbjct: 186 AA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-10
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 34/174 (19%)
Query: 5 LKNENVVELVGYYVDGPLR--VLAYEHASKGSLHD---ILHGKKGVKGAKPGPVLSWAQR 59
LK+ NV+ L ++ R L +++A HD I+ + K K L
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAA 115
+ G+ YLH ++HR++K +N+L+ + KI+D A
Sbjct: 131 KSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------A 179
Query: 116 RL---------HSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
RL V+ TF Y APE + + +K+ D+++ G + ELLT
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L+YLH + +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + ++ D + GVV+ E++ GR P
Sbjct: 316 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-10
Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 23/163 (14%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 61
L + N++ L + D L E + G L + + A A+ +K
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMK 113
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLH 118
+ A + Y H+ + HR++K N L D K+ DF L+ + ++
Sbjct: 114 DVLSA---VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMM 165
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
T+V GT Y +P+ + G + D +S GV++ LL G P
Sbjct: 166 RTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-10
Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
L++ +V L + D V+ YE S G L + + + +S + V+
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYM 261
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQ-APDAAARLHST 120
+GL ++HE +H ++K N++ + K+ DF L+ P + ++
Sbjct: 262 RQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--- 315
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT + APE A + +D++S GV+ LL+G P
Sbjct: 316 -TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-10
Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 8/96 (8%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGT 125
+ ++H+ ++HR++K N+L D++ KI DF + P L + T
Sbjct: 118 AVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
Query: 126 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
Y APE D++S GV+L +L+G+ P
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 6e-10
Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
G+++LH IIHR++K SN+++ D KI DF L+ A + T + T
Sbjct: 175 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRY 228
Query: 128 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
Y APE + D++S G ++ E++ +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 7e-10
Identities = 36/96 (37%), Positives = 58/96 (60%), Gaps = 11/96 (11%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTF 126
L++LH II+R++K N+LL D++ I K++DF LS ++ D + +S GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILL-DEEGHI-KLTDFGLSKESIDHEKKAYS--FCGTV 190
Query: 127 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
Y APE + + ++S D +SFGV++ E+LTG P
Sbjct: 191 EYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-10
Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
+L + ++ L + D VL E S G L D + + +S A+ +
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYM 155
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQA-PDAAARLHST 120
A GL+++HE I+H +IK N++ + KI DF L+ + PD ++
Sbjct: 156 RQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--- 209
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
T + APE + +D+++ GV+ LL+G P
Sbjct: 210 -TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-10
Identities = 24/102 (23%), Positives = 46/102 (45%), Gaps = 20/102 (19%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHST------ 120
+ L+Y H I+HR++K NV++ + ++ D+ L A +
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL--------AEFYHPGQEYNV 189
Query: 121 RVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
RV + + PE + QM S D++S G +L ++ ++P
Sbjct: 190 RV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-10
Identities = 37/165 (22%), Positives = 66/165 (40%), Gaps = 25/165 (15%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQR 59
LK+ N+V L + L ++ + G L + I+ + A +
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADA--------SHC 115
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAAR 116
++ + A + + H+ ++HRN+K N+LL K++DF L+ +
Sbjct: 116 IQQILEA---VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 117 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT GY +PE D+++ GV+L LL G P
Sbjct: 170 WFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
GL LHE ++HR++ N+LL D++ I DF+L+ + A + T +
Sbjct: 145 LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRW 198
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE M + +K D++S G V+ E+ +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-09
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+GL Y+H IIHR++K N+ + +D KI DF L+ QA TR
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE + +++ D++S G ++ E++TG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
LEYLH + +++R+IK N++L D KI+DF L + A + + GT Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + ++ D + GVV+ E++ GR P
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-09
Identities = 28/96 (29%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTF 126
L +LH+K II+R++K N++L + + K++DF L ++ H+ GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIML-NHQGHV-KLTDFGLCKESIHDGTVTHT--FCGTI 185
Query: 127 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
Y APE + +++ D +S G ++ ++LTG P
Sbjct: 186 EYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTF 126
RGL+Y+H A ++HR++K SN+LL KI DF L+ PD T + T
Sbjct: 139 RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 127 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE + + +KS D++S G +L E+L+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L YLHE+ II+R++K NVLL + K++D+ + + + GT Y
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 176
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 44/170 (25%), Positives = 68/170 (40%), Gaps = 33/170 (19%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV---KGAKPGPVLSWAQRVKIAVG 65
NV+EL+ ++ + L +E GS+ +H K+ A + V+
Sbjct: 72 NVLELIEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEA--------SVVVQDVAS 122
Query: 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLS------NQAPDAAAR 116
A L++LH K I HR++K N+L + KI DFDL +
Sbjct: 123 A---LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 117 LHSTRVLGTFGYHAPEYAMTGQMSSKS-----DVYSFGVVLLELLTGRKP 161
T G+ Y APE + D++S GV+L LL+G P
Sbjct: 177 ELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 23/163 (14%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 61
+L + N+++L D + E + G L D I + A A+ +K
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIK 128
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLH 118
+ Y+H+ I+HR++K N+LL + KI DF LS
Sbjct: 129 QVFSG---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKM 180
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
R+ GT Y APE + G K DV+S GV+L LL+G P
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 29/99 (29%), Positives = 43/99 (43%), Gaps = 12/99 (12%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
+ +LH I+HR++K N+LL D+ ++SDF S GT GY
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELC-GTPGY 265
Query: 129 HAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
APE + D+++ GV+L LL G P
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 12/101 (11%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
R ++ LH +IHR++K SN+L+ + K+ DF L+ ++AA +
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 128 --------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE +T S++ DV+S G +L EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-09
Identities = 28/102 (27%), Positives = 51/102 (50%), Gaps = 20/102 (19%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLG 124
GL Y+H +I+HR++K++NVL+ D + K++DF L+ + A ++ ++ RV+
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190
Query: 125 TFGYHAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGR 159
T Y PE Y D++ G ++ E+ T
Sbjct: 191 TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-09
Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+GL+Y+H ++HR++K N+ + +D KI DF L+ A TR
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----- 188
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE ++ +++ D++S G ++ E+LTG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-09
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L +LH+K II+R++K NVLL + K++DF + + + GT Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDY 190
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + + + D ++ GV+L E+L G P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L YLHE+ II+R++K NVLL + K++D+ + + + GT Y
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 219
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.4 bits (132), Expect = 5e-09
Identities = 26/97 (26%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHSTRVLGT 125
+GL + H + ++HR++K N+L+ + K+++F L+ P R +S V+ T
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVV-T 164
Query: 126 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
Y P+ ++ S S D++S G + EL +P
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-09
Identities = 28/95 (29%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLS-NQAPDAAARLHSTRVLGT 125
RGL+Y+H ++HR++K +N+ + +D + KI DF L+ P + + H + L T
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 126 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y +P ++ +K+ D+++ G + E+LTG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 5e-09
Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 16/97 (16%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----TRV 122
RGL++LH R++HR++K N+L+ K++DF L AR++S T V
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSV 179
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
+ T Y APE + ++ D++S G + E+ +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL +L K II+R++K NV+L + KI+DF + + + GT Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 508
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 509 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-09
Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL++LH K I++R++K N+LL D KI+DF + + A+ ++ GT Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + GQ + S D +SFGV+L E+L G+ P
Sbjct: 185 IAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-09
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
++ +H+ +HR+IK N+L+ + +++DF + + S V GT Y
Sbjct: 187 AIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 242
Query: 129 HAPEYAMTGQMSSKS-----DVYSFGVVLLELLTGRKP 161
+PE + D +S GV + E+L G P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-09
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
L YLH I++R++K N+LL ++DF L + + + + GT Y
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEY 205
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + Q ++ D + G VL E+L G P
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-09
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 22/163 (13%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 61
+L++ N+V L + L ++ + G L + + A + ++
Sbjct: 84 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA--------SHCIQ 135
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLH 118
+ + + Y H I+HRN+K N+LL K++DF L+ + D +
Sbjct: 136 QILES---IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAW 187
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT GY +PE S D+++ GV+L LL G P
Sbjct: 188 HGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 7e-09
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 16/97 (16%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----TRV 122
RGL++LH I+HR++K N+L+ K++DF L AR++S T V
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQMALTPV 179
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
+ T Y APE + ++ D++S G + E+ +
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-09
Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 10/98 (10%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVL 123
+++LH I HR++K N+L + + K++DF + + A + T
Sbjct: 138 GTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ---TPC- 190
Query: 124 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
T Y APE + D++S GV++ LL G P
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 30/111 (27%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAARLHSTRV 122
+ +EYLH + ++HR++K SN+L D+ +I DF + Q L T
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-TPC 181
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
T + APE + D++S GV+L +LTG P + + +
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 39/162 (24%), Positives = 69/162 (42%), Gaps = 20/162 (12%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKI 62
+L + N+++L + VL E+ G L D I+ + L+ +
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--DESYN-------LTELDTILF 192
Query: 63 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQ-APDAAARLHS 119
G+ ++H+ I+H ++K N+L D KI DF L+ + P ++
Sbjct: 193 MKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV-- 247
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT + APE +S +D++S GV+ LL+G P
Sbjct: 248 --NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 33/161 (20%), Positives = 65/161 (40%), Gaps = 18/161 (11%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
++ N++ L + V+ +E S + + ++ L+ + V
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS--------AFELNEREIVSYV 108
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQ-APDAAARLHST 120
L++LH I H +I+ N++ + KI +F + Q P RL
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--- 162
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ Y+APE +S+ +D++S G ++ LL+G P
Sbjct: 163 -LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 28/96 (29%), Positives = 40/96 (41%), Gaps = 8/96 (8%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 129
L+ +H IHR++K N+LL K++DF + T V GT Y
Sbjct: 181 LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYI 236
Query: 130 APEYAMTGQMSSK----SDVYSFGVVLLELLTGRKP 161
+PE + D +S GV L E+L G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 23/100 (23%), Positives = 40/100 (40%), Gaps = 11/100 (11%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
++ +H +HR+IK N+LL +++DF + A + S +GT Y
Sbjct: 174 AIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVAVGTPDY 229
Query: 129 HAPEYAMTGQMSSKSDVY-------SFGVVLLELLTGRKP 161
+PE + Y + GV E+ G+ P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 128
GL +L K II+R++K NV+L + KI+DF + + + GT Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 187
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 12/96 (12%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLH--STRVLG 124
R + ++H I HR+IK N+L+ D+ K+ DF + + + + +R
Sbjct: 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-- 206
Query: 125 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE + + S D++S G V EL+ G+
Sbjct: 207 ---YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 25/96 (26%), Positives = 44/96 (45%), Gaps = 10/96 (10%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLH--STRVLG 124
R + LH + + HR+IK NVL+ + D K+ DF + + + + +R
Sbjct: 140 RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-- 196
Query: 125 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE Q + + D++S G + E++ G
Sbjct: 197 ---YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 33/104 (31%), Positives = 43/104 (41%), Gaps = 28/104 (26%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHS------- 119
R L Y+H I HR+IK N+LL D + K+ DF A+
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRGEPNVS 215
Query: 120 ---TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
+R Y APE + S DV+S G VL ELL G+
Sbjct: 216 YICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-08
Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 26/165 (15%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQR 59
+L++ N+V L + L ++ + G L + I+ + A +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AREFYSEADA--------SHC 110
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAAR 116
++ + + + Y H I+HRN+K N+LL K++DF L+ + D +
Sbjct: 111 IQQILES---IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SE 162
Query: 117 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT GY +PE S D+++ GV+L LL G P
Sbjct: 163 AWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-08
Identities = 39/164 (23%), Positives = 70/164 (42%), Gaps = 23/164 (14%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 61
+++ NV+ L Y + +L E + G L D + A + +K
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA--------TEFLK 121
Query: 62 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARL 117
+ + YLH +I H ++K N++L D ++ KI DF L+++ D
Sbjct: 122 QILNG---VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEF 174
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ GT + APE + ++D++S GV+ LL+G P
Sbjct: 175 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
++ + N++ L Y + VL E S G L D L K+ LS +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFI 121
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHS 119
G+ YLH K +I H ++K N++L D +I K+ DF L+++ D
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ GT + APE + ++D++S GV+ LL+G P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-08
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQA-PDAAARLHSTRVLGT 125
LE+LH+ II+R+IK N+LL D + + ++DF LS + D R + GT
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILL-DSNGHV-VLTDFGLSKEFVADETERAYD--FCGT 223
Query: 126 FGYHAPEYAMTGQMS-SKS-DVYSFGVVLLELLTGRKP 161
Y AP+ G K+ D +S GV++ ELLTG P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 5e-08
Identities = 31/93 (33%), Positives = 54/93 (58%), Gaps = 6/93 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
RG+ + H+ RI+HR++K N+L+ D K++DF L+ +A R ++ V+ T
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEVV-TLW 184
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y AP+ M + S S D++S G + E++TG+
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-08
Identities = 27/96 (28%), Positives = 42/96 (43%), Gaps = 12/96 (12%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLH--STRVLG 124
R L Y+H I HR+IK N+LL + K+ DF + + +R
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-- 206
Query: 125 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE + + D++S G V+ EL+ G+
Sbjct: 207 ---YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-08
Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 26/163 (15%)
Query: 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVG 65
V+ L Y + +L E+A+ G + L + ++S +
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCL--------PELAEMVS----ENDVIR 135
Query: 66 AAR----GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLH 118
+ G+ YLH+ I+H ++K N+LL KI DF +S + A L
Sbjct: 136 LIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELR 191
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
++GT Y APE +++ +D+++ G++ LLT P
Sbjct: 192 E--IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 8e-08
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+GL + HE +I+HR++K N+L+ K+ DF L+ +A S+ V+ T
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVNTFSSEVV-TLW 173
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y AP+ M + S S D++S G +L E++TG+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 8e-08
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 27/166 (16%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQR 59
+++ N++ L + + VL E S G L D + +K A Q
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA--EKESLTEDEA--------TQF 113
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAA 115
+K + G+ YLH K RI H ++K N++L D ++ K+ DF ++++ +A
Sbjct: 114 LKQILD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGN 166
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ + GT + APE + ++D++S GV+ LL+G P
Sbjct: 167 EFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 9e-08
Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+GLEYLH+ I+HR++K +N+LL ++ + K++DF L+ R ++ +V+ T
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVV-TRW 177
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE +M D+++ G +L ELL
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-07
Identities = 27/95 (28%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHSTRVLGT 125
G+ Y H++ R++HR++K N+L+ + KI+DF L+ P R ++ ++ T
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIV-T 163
Query: 126 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y AP+ M + S + D++S G + E++ G
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 21/163 (12%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
++ + NV+ L Y + VL E S G L D L K+ LS +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFI 121
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQ-APDAAARLH 118
G+ YLH K +I H ++K N++L D +I K+ DF L+++ +
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN- 177
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ GT + APE + ++D++S GV+ LL+G P
Sbjct: 178 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 26/93 (27%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
RGL Y H + +++HR++K N+L+ + K++DF L+ +A + + V+ T
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYDNEVV-TLW 165
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y P+ + S D++ G + E+ TGR
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 13/97 (13%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA------KISDFDLSNQAPDAAARLHSTRV 122
GL+Y+H + IIH +IK NVL+ D KI+D + + H T
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNS 195
Query: 123 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
+ T Y +PE + +D++S ++ EL+TG
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 9/98 (9%)
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVL 123
++YLH I HR++K N+L I K++DF + + +T
Sbjct: 171 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC- 224
Query: 124 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
T Y APE + D++S GV++ LL G P
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 25/94 (26%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-GTFGY 128
EYLH +I+R++K N+L+ +++DF + + T L GT
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEA 204
Query: 129 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
APE + + +K+ D ++ GV++ E+ G P
Sbjct: 205 LAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-07
Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 12/95 (12%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-GTFG 127
LEYLH K II+R++K N+LL + KI+DF + PD T L GT
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPD 168
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
Y APE ++ + +KS D +SFG+++ E+L G P
Sbjct: 169 YIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 5e-07
Identities = 23/93 (24%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+ + + H+ IHR++K N+L+ + K+ DF + + + + V T
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA-RLLTGPSDYYDDEVA-TRW 167
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y +PE + DV++ G V ELL+G
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-07
Identities = 28/115 (24%), Positives = 44/115 (38%), Gaps = 24/115 (20%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
G ++HE + IIHR++K +N LL D K+ DF L+ +
Sbjct: 140 LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 128 --------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
Y APE + + +KS D++S G + ELL +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-07
Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
G+ + H IIHR+IK N+L+ + K+ DF + + A ++ V T
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAPGEVYDDEVA-TRW 189
Query: 128 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE + K+ DV++ G ++ E+ G
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 27/112 (24%), Positives = 49/112 (43%), Gaps = 23/112 (20%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 127
+ ++YLH ++HR++K SN+LL + K++DF LS + ++ +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 128 -------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
Y APE + +K D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 27/101 (26%), Positives = 43/101 (42%), Gaps = 17/101 (16%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA------KISDFDL--SNQAPDAAARLHS 119
G+ + H + R +HR++K N LL A KI DF L + P R +
Sbjct: 143 NGVNFCHSR---RCLHRDLKPQN-LLLSVSDASETPVLKIGDFGLARAFGIPI---RQFT 195
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 159
++ T Y PE + + S S D++S + E+L
Sbjct: 196 HEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-06
Identities = 31/111 (27%), Positives = 46/111 (41%), Gaps = 13/111 (11%)
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK---ISDFDLSNQAPDAAAR 116
+ +A +EY+H K IHR++K N L+ I DF L+ + DA
Sbjct: 108 LLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
Query: 117 LH-----STRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 161
H + + GT Y A G + S + D+ S G VL+ G P
Sbjct: 165 QHIPYRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 6e-06
Identities = 27/129 (20%), Positives = 49/129 (37%), Gaps = 29/129 (22%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLG 124
G++Y+H I+HR++K +N L+ D K+ DF L+ + + ++L +
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 125 TFG----------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 161
Y APE + + +++ DV+S G + ELL K
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 162 VDHTLPRGQ 170
Sbjct: 284 NVAYHADRG 292
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 10/93 (10%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQAPDAAARLHSTRVLGTF 126
L+ LH+ RIIH ++K N+LL + K+ DF S +R F
Sbjct: 212 CLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F 264
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
Y APE + + D++S G +L ELLTG
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQAPDAAARLHSTRVLGTF 126
L +L E IIH ++K N+LL + + KI DF S Q + F
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRF 223
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159
Y +PE + D++S G +L+E+ TG
Sbjct: 224 -YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 23/103 (22%), Positives = 42/103 (40%), Gaps = 15/103 (14%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK-----ISDFDLSNQAPDAAARLH-----S 119
++ +HEK+ +++R+IK N L+ + + DF + D + H
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 120 TRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 161
+ GT Y G + S + D+ + G V + L G P
Sbjct: 176 KNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-05
Identities = 29/135 (21%), Positives = 45/135 (33%), Gaps = 46/135 (34%)
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDI------------------------------ 98
GL+YLH K RIIH +IK N+LL ++
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 99 -----------AKISDFDLSNQAPDAAARL---HSTRVLGTFGYHAPEYAMTGQMSSKSD 144
K ++ A A H T + T Y + E + ++ +D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 145 VYSFGVVLLELLTGR 159
++S + EL TG
Sbjct: 276 IWSTACMAFELATGD 290
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 7e-05
Identities = 24/104 (23%), Positives = 41/104 (39%), Gaps = 20/104 (19%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI--SDFDLSNQAPDAAARLH-----STRV 122
LEY+HE +H +IK+SN+LL + ++ D+ L+ +
Sbjct: 165 LEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 123 LGTFGYHAPEYA-----MTGQMSSKSDVYSFGVVLLELLTGRKP 161
GT E+ S + D+ G +++ LTG P
Sbjct: 222 DGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 9e-05
Identities = 27/100 (27%), Positives = 45/100 (45%), Gaps = 12/100 (12%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI--SDFDLSNQAPDAAARLH----STRVL 123
LEY+HE +H +IK++N+LL + ++ +D+ LS + +
Sbjct: 164 LEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 124 -GTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 161
GT + A G +S +SDV G +L L G+ P
Sbjct: 221 NGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 29/101 (28%), Positives = 46/101 (45%), Gaps = 13/101 (12%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARLH-----STR 121
+E++H K+ +HR+IK N L+ + I DF L+ + D + H +
Sbjct: 116 VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
Query: 122 VLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 161
+ GT Y A G + S + D+ S G VL+ L G P
Sbjct: 173 LTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 15/103 (14%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLL-----FDDDIAKISDFDLSNQAPDAAARLH-----S 119
+EY+H K +I+R++K N L+ + I DF L+ + D + H
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 120 TRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 161
+ GT Y G + S + D+ + G + + L G P
Sbjct: 175 KSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 39.9 bits (92), Expect = 4e-04
Identities = 18/109 (16%), Positives = 32/109 (29%), Gaps = 15/109 (13%)
Query: 53 VLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 112
+ S A I L R HR++ NVLL + K+
Sbjct: 157 LSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGK---- 210
Query: 113 AAARLHSTRVLGTFGYHAP--EYAMTGQMSSKSDVYSFGVVLLELLTGR 159
+ + + G +Y ++ V+ + +L TG
Sbjct: 211 -------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 5e-04
Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 20/104 (19%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI--SDFDLSNQAPDA----AARLHSTRVL 123
LE+LHE +H N+ + N+ + +D +++ + + + + + A S
Sbjct: 172 LEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPH 228
Query: 124 -GTFGYHAPEYA-----MTGQMSSKSDVYSFGVVLLELLTGRKP 161
G E+ S +SD+ S G +L+ L G P
Sbjct: 229 EGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 7e-04
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 30/95 (31%)
Query: 70 LEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTF 126
++YLH I HR++K N+L I K++DF A + G
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE---------TTGE- 173
Query: 127 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
Y D++S GV++ LL G P
Sbjct: 174 KY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 7e-04
Identities = 28/117 (23%), Positives = 38/117 (32%), Gaps = 35/117 (29%)
Query: 68 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV---LG 124
+ L YL + + H ++K N+LL D K + L
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 125 TFG-----------------YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTG 158
FG Y APE + SD++SFG VL EL TG
Sbjct: 205 DFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 243 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.64 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.4 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.12 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.75 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.35 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.71 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.5 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.81 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.66 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.62 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.87 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.8 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.15 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 90.94 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.36 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.3 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 90.04 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 89.47 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 88.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 87.95 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 87.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.5 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 81.59 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=335.68 Aligned_cols=218 Identities=25% Similarity=0.417 Sum_probs=180.1
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCC----CCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG----VKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+|++++|||||+++|+|.+++.+++||||+++|+|.+++..... .........+++.+++.++.|++.|++|||++
T Consensus 68 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 68 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 47899999999999999999999999999999999999976431 00011112389999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
+ ++||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+
T Consensus 148 ~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 148 H---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224 (299)
T ss_dssp T---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 8 9999999999999999999999999997654433322233456899999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 157 T-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 157 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
| |..||... ....+...+..+.+...|..++.++.+++.+||+.||++|||+++|++.|+++.
T Consensus 225 t~G~~Pf~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 225 TYGKQPWYQL----------------SNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp TTTCCTTTTS----------------CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCCC----------------CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 8 89999743 223333444444445566778889999999999999999999999999999887
Q ss_pred hh
Q 026115 236 NT 237 (243)
Q Consensus 236 ~~ 237 (243)
+.
T Consensus 289 ~~ 290 (299)
T 4asz_A 289 KA 290 (299)
T ss_dssp HH
T ss_pred hc
Confidence 54
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=335.58 Aligned_cols=218 Identities=24% Similarity=0.363 Sum_probs=173.2
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC------CCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG------AKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+|++++|||||+++|+|.++..+++||||+++|+|.+++........ .....++++.+++.++.|++.|++|||
T Consensus 96 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 47899999999999999999999999999999999999987543210 111124899999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 154 (243)
+.+ ++||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++||
T Consensus 176 ~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~E 252 (329)
T 4aoj_A 176 GLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252 (329)
T ss_dssp HTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHH
Confidence 998 99999999999999999999999999987654433333344568999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
|+| |..||.... ...+...+..+.+...|..+++++.+++.+||+.||++|||++||++.|+.
T Consensus 253 llt~G~~Pf~~~~----------------~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 253 IFTYGKQPWYQLS----------------NTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHTTSCCTTCSSC----------------HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHcCCCCCCCCCC----------------HHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 999 899996431 223333333444456667778899999999999999999999999999999
Q ss_pred HHhh
Q 026115 234 LLNT 237 (243)
Q Consensus 234 ~~~~ 237 (243)
+.+.
T Consensus 317 l~~~ 320 (329)
T 4aoj_A 317 LAQA 320 (329)
T ss_dssp HHHS
T ss_pred HhhC
Confidence 8764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=330.28 Aligned_cols=212 Identities=28% Similarity=0.415 Sum_probs=167.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++|++.+ +.++|||||+++|+|.+++..... .+++..++.++.|++.|++|||+++
T Consensus 85 il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~~~--- 152 (307)
T 3omv_A 85 VLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHAKN--- 152 (307)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4689999999999999865 468999999999999999976543 2899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc---CCCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+|||++.++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||+|
T Consensus 153 IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt 232 (307)
T 3omv_A 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232 (307)
T ss_dssp CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH
Confidence 99999999999999999999999999987654333322345679999999999964 358999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc----CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL----GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
|..||...... ..+...+.... ....+..++..+.+++.+||+.||++|||+++|++.|+.
T Consensus 233 g~~Pf~~~~~~---------------~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 233 GELPYSHINNR---------------DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp SSCTTTTCCCH---------------HHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCChH---------------HHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99999744221 11122221111 123345667789999999999999999999999999998
Q ss_pred HHhhcC
Q 026115 234 LLNTRS 239 (243)
Q Consensus 234 ~~~~~~ 239 (243)
+..+.-
T Consensus 298 l~~~lp 303 (307)
T 3omv_A 298 LQHSLP 303 (307)
T ss_dssp HHTTCC
T ss_pred HhccCC
Confidence 876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=333.54 Aligned_cols=215 Identities=26% Similarity=0.347 Sum_probs=179.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC-------CCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
+|++++|||||+++|+|.+++.+++||||+++|+|.++|........ ......+++..++.++.|++.|++||
T Consensus 82 il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 161 (308)
T 4gt4_A 82 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161 (308)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 36789999999999999999999999999999999999975432110 01112388999999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|
T Consensus 162 H~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~ 238 (308)
T 4gt4_A 162 SSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238 (308)
T ss_dssp HHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHH
Confidence 9998 9999999999999999999999999998765544333344567899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
||+| |..||.+. ....+.+.+..+.+.+.+..++..+.+++.+||+.||++|||+++|++.|+
T Consensus 239 El~t~g~~Pf~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 239 EVFSYGLQPYCGY----------------SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp HHHTTTCCTTTTC----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhCCCCCCCCC----------------CHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9998 89999644 223344444444555667778889999999999999999999999999998
Q ss_pred HH
Q 026115 233 PL 234 (243)
Q Consensus 233 ~~ 234 (243)
..
T Consensus 303 a~ 304 (308)
T 4gt4_A 303 AW 304 (308)
T ss_dssp TS
T ss_pred hc
Confidence 64
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=330.37 Aligned_cols=212 Identities=24% Similarity=0.273 Sum_probs=172.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++++|.+++.++|||||++||+|.+++..... +++..+..++.|++.||+|||+++
T Consensus 103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~--- 170 (336)
T 4g3f_A 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---------LPEDRALYYLGQALEGLEYLHTRR--- 170 (336)
T ss_dssp TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 57899999999999999999999999999999999999986542 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCC-ceeecccCCCCCCcccccc---cccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAAR---LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
++||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 171 IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml 250 (336)
T 4g3f_A 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250 (336)
T ss_dssp EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999887 6999999999866432211 1123356999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
+|..||........ ...+..... ....+..++..+.+++.+||++||++|||+.|+++.|...+
T Consensus 251 tG~~Pf~~~~~~~~---------------~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 251 NGCHPWTQYFRGPL---------------CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp HSSCSSTTTCCSCC---------------HHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HCcCCCCCCCHHHH---------------HHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 99999975432211 111111110 01234456678999999999999999999999999999887
Q ss_pred hhcC
Q 026115 236 NTRS 239 (243)
Q Consensus 236 ~~~~ 239 (243)
....
T Consensus 316 ~~~~ 319 (336)
T 4g3f_A 316 QEVG 319 (336)
T ss_dssp HHTT
T ss_pred hhhh
Confidence 6543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=332.58 Aligned_cols=201 Identities=20% Similarity=0.331 Sum_probs=169.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++|+|||||+++++|.+++.+++||||++||+|.+++....... +++..++.++.|++.||+|||+++
T Consensus 76 il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~-------~~e~~~~~~~~qi~~aL~ylH~~~--- 145 (350)
T 4b9d_A 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDWFVQICLALKHVHDRK--- 145 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999999999999997654432 788999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
|+||||||+|||++.++.+||+|||+++........ .....||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 146 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~ 223 (350)
T 4b9d_A 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223 (350)
T ss_dssp CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eeeccCCHHHEEECCCCCEEEcccccceeecCCccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999999877543322 234569999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||.+... .+....+..... ...+...+.++.+||.+||++||++|||++|+++
T Consensus 224 PF~~~~~---------------~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 224 AFEAGSM---------------KNLVLKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp SCCCSSH---------------HHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCcCH---------------HHHHHHHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9975421 112222222221 2334456778999999999999999999999987
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=327.64 Aligned_cols=199 Identities=25% Similarity=0.370 Sum_probs=167.1
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++++|.+++.++|||||++||+|.+++.... +++..+..++.|++.||+|||+++
T Consensus 124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~--- 190 (346)
T 4fih_A 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG--- 190 (346)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4678999999999999999999999999999999999998654 899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+|||++.++.+||+|||+++........ .....||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 191 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 268 (346)
T 4fih_A 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 268 (346)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999999766443221 345679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccc-cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||.+.... +....+.+.. .........+.++.+||.+||++||++|||++|+++
T Consensus 269 PF~~~~~~---------------~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 269 PYFNEPPL---------------KAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp TTTTSCHH---------------HHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCcCHH---------------HHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99754221 1111111111 112233456778999999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=325.62 Aligned_cols=199 Identities=22% Similarity=0.308 Sum_probs=168.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++++|.+++.+++||||++||+|.+++..... +++..+..++.|++.||+|||+++
T Consensus 85 il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~--- 152 (311)
T 4aw0_A 85 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG--- 152 (311)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 47889999999999999999999999999999999999987542 899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..|+.++||||+||++|+|++|..
T Consensus 153 IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 232 (311)
T 4aw0_A 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232 (311)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999987654333333445679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
||.+... .+....+..... ..+...+.++.+|+.+||++||++|||++|++
T Consensus 233 PF~~~~~---------------~~~~~~i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 233 PFRAGNE---------------GLIFAKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp SSCCSSH---------------HHHHHHHHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCCCCH---------------HHHHHHHHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 9974421 112222222222 34445677899999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=328.73 Aligned_cols=220 Identities=23% Similarity=0.345 Sum_probs=179.9
Q ss_pred CCcccC-CccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHH
Q 026115 2 VSRLKN-ENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEY 72 (243)
Q Consensus 2 l~~l~h-~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~ 72 (243)
|++++| ||||+++|+|.+ +..+++||||+++|+|.++|+...... .......+++..++.++.|++.|++|
T Consensus 121 l~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 456755 999999999976 467899999999999999997643210 00112238999999999999999999
Q ss_pred hhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHH
Q 026115 73 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 152 (243)
Q Consensus 73 Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 152 (243)
||+++ ++||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++
T Consensus 201 LH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 201 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 99998 999999999999999999999999999876544333333455689999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 153 LELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 153 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
|||+| |..||.+.. ..+.+...+..+.+...|..++.++.+++.+||+.||++|||+++|++.|
T Consensus 278 ~El~t~G~~Pf~~~~---------------~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 278 WEIFSLGASPYPGVK---------------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp HHHTTTSCCSSTTCC---------------CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCCCCCCCC---------------HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 99998 899997431 11334444445555566677788999999999999999999999999999
Q ss_pred HHHHhhcC
Q 026115 232 QPLLNTRS 239 (243)
Q Consensus 232 ~~~~~~~~ 239 (243)
+++++..+
T Consensus 343 ~~llq~~~ 350 (353)
T 4ase_A 343 GNLLQANA 350 (353)
T ss_dssp HHHHHHTC
T ss_pred HHHHHHhh
Confidence 99987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=316.45 Aligned_cols=227 Identities=22% Similarity=0.300 Sum_probs=169.3
Q ss_pred CCcccCCccceeeEEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKNENVVELVGYYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
+.+++|||||+++|++.++. .++|||||+++|+|.++++... +++..+++++.|++.|++|||+++
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~ 120 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhh
Confidence 56899999999999998653 5899999999999999998764 899999999999999999999871
Q ss_pred -----CCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc--ccccccccccccCchhhccC------CCCcccc
Q 026115 78 -----EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTG------QMSSKSD 144 (243)
Q Consensus 78 -----~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~~~D 144 (243)
..+++||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|
T Consensus 121 ~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~D 200 (303)
T 3hmm_A 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200 (303)
T ss_dssp CSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHH
T ss_pred hhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHh
Confidence 1239999999999999999999999999987654433221 12335699999999999754 3567899
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhh-hhccccCCCCC-----HHHHHHHHHHHHhhcCCCC
Q 026115 145 VYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ-CVDTKLGGEYP-----PKAIAKMAAVAALCVQYEA 218 (243)
Q Consensus 145 iwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p 218 (243)
||||||++|||+||..||........ ................. ......+...+ .++++.+.+++.+||+.||
T Consensus 201 VwS~Gvvl~El~tg~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP 279 (303)
T 3hmm_A 201 IYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSG
T ss_pred hhhHHHHHHHHHHCCCCCCccccccc-cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCH
Confidence 99999999999999988764422111 11111111111122222 22333333332 3567789999999999999
Q ss_pred CCCCCHHHHHHHHHHHHhhcC
Q 026115 219 DFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 219 ~~Rps~~~vl~~l~~~~~~~~ 239 (243)
++|||+++|++.|+++..+.+
T Consensus 280 ~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 280 AARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp GGSCCHHHHHHHHHHHHHC--
T ss_pred hHCcCHHHHHHHHHHHHHHcC
Confidence 999999999999999887653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=317.81 Aligned_cols=198 Identities=21% Similarity=0.278 Sum_probs=165.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++++|.+++.+++||||++||+|.+++..... +++..+..++.|++.||+|||+++
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~--- 146 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSLG--- 146 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 57899999999999999999999999999999999999987542 899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+|||++.++.+||+|||+++........ .....||+.|+|||++.+..|+.++||||+||++|||++|..
T Consensus 147 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 224 (304)
T 3ubd_A 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224 (304)
T ss_dssp CCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCC
Confidence 999999999999999999999999999765443222 234579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM-----GIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~vl~ 229 (243)
||.+... .+....+.... ...+...+.++.+++.+||++||++|||+ +|+++
T Consensus 225 PF~~~~~---------------~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 225 PFQGKDR---------------KETMTMILKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp SSCCSSH---------------HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCcCH---------------HHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 9975421 11222222222 23445567789999999999999999985 57765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=329.06 Aligned_cols=199 Identities=25% Similarity=0.370 Sum_probs=166.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++++|.+++.++|||||++||+|.+++.... +++..+..++.|++.||+|||++|
T Consensus 201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~~--- 267 (423)
T 4fie_A 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG--- 267 (423)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4678999999999999999999999999999999999997654 899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
|+||||||+|||++.++.+||+|||+++........ .....||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 268 IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 345 (423)
T 4fie_A 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 345 (423)
T ss_dssp EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999999765433221 345679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccc-cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||.+..+. +....+.... .........+..+.+||.+||+.||++|||++|+++
T Consensus 346 PF~~~~~~---------------~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 346 PYFNEPPL---------------KAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTTTSCHH---------------HHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCcCHH---------------HHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99754221 1111111111 111223345678999999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=315.27 Aligned_cols=199 Identities=24% Similarity=0.393 Sum_probs=159.0
Q ss_pred CCCcccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 1 MVSRLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+|++|+|||||+++++|.+ +..+++||||+++|+|.+++..... +++..+..++.|++.||+|||++
T Consensus 78 il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~ylH~~ 148 (290)
T 3fpq_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTR 148 (290)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 3678999999999999975 3568999999999999999987542 88999999999999999999987
Q ss_pred CCCCeEeccCCCCceEecC-CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
+ .+++||||||+|||++. ++.+||+|||+++..... ......||+.|+|||++.+ .|+.++|||||||++|||
T Consensus 149 ~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyel 222 (290)
T 3fpq_A 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 222 (290)
T ss_dssp S-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred C-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHH
Confidence 4 24999999999999974 789999999999754322 1234579999999998865 699999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG-GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++|..||..... ...+...+..... ...+...+.++.+++.+||+.||++|||++|+++
T Consensus 223 ltg~~Pf~~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 223 ATSEYPYSECQN---------------AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHSSCTTTTCSS---------------HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCCCc---------------HHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999964321 1111122211111 1122234457999999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=309.56 Aligned_cols=196 Identities=22% Similarity=0.268 Sum_probs=155.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+++.+++||||+ +|+|.+++..... +++..+..++.|++.||+|||+++
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~--- 132 (275)
T 3hyh_A 66 YLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDK---------MSEQEARRFFQQIISAVEYCHRHK--- 132 (275)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 367899999999999999999999999999 6799999876542 899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus 133 IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~ 209 (275)
T 3hyh_A 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209 (275)
T ss_dssp CCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccCChHHeEECCCCCEEEeecCCCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCC
Confidence 99999999999999999999999999976544322 234579999999999998776 57999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.||..... ......+.... ...+...+.++.+++.+||+.||++|||++|+++
T Consensus 210 ~PF~~~~~---------------~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 210 LPFDDESI---------------PVLFKNISNGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CSSCCSSH---------------HHHHHHHHHTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCH---------------HHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 99974311 11111122221 1334456678999999999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=300.25 Aligned_cols=202 Identities=21% Similarity=0.338 Sum_probs=149.6
Q ss_pred CCCcccCCccceeeEEEEeCC------------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHH
Q 026115 1 MVSRLKNENVVELVGYYVDGP------------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 68 (243)
+|++|+|||||+++++|.+.+ .+++||||+++|+|.+++...... .......++.++.|+++
T Consensus 56 il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~ 129 (299)
T 4g31_A 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI------EERERSVCLHIFLQIAE 129 (299)
T ss_dssp HHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSG------GGSCHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC------ChhHHHHHHHHHHHHHH
Confidence 468999999999999987543 479999999999999999865421 12456678899999999
Q ss_pred HHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc----------ccccccccccccCchhhccCC
Q 026115 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL----------HSTRVLGTFGYHAPEYAMTGQ 138 (243)
Q Consensus 69 ~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~ 138 (243)
||+|||+++ ++||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+..
T Consensus 130 al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 206 (299)
T 4g31_A 130 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206 (299)
T ss_dssp HHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC
T ss_pred HHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC
Confidence 999999999 9999999999999999999999999998765432211 112346999999999999999
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCC
Q 026115 139 MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEA 218 (243)
Q Consensus 139 ~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 218 (243)
|+.++|||||||++|||++ ||.+..+ ............. .......+....+++.+||+.||
T Consensus 207 y~~~~DiwSlGvilyell~---Pf~~~~~--------------~~~~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP 268 (299)
T 4g31_A 207 YSHKVDIFSLGLILFELLY---PFSTQME--------------RVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSP 268 (299)
T ss_dssp CCTHHHHHHHHHHHHHHHS---CCSSHHH--------------HHHHHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSG
T ss_pred CCCHHHHHHHHHHHHHHcc---CCCCccH--------------HHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCCh
Confidence 9999999999999999996 6642200 0011111111111 11223344567889999999999
Q ss_pred CCCCCHHHHHH
Q 026115 219 DFRPNMGIVLK 229 (243)
Q Consensus 219 ~~Rps~~~vl~ 229 (243)
++|||+.|+++
T Consensus 269 ~~Rps~~eil~ 279 (299)
T 4g31_A 269 MERPEAINIIE 279 (299)
T ss_dssp GGSCCHHHHHT
T ss_pred hHCcCHHHHhc
Confidence 99999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=286.76 Aligned_cols=231 Identities=37% Similarity=0.629 Sum_probs=186.8
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.+++..++||||+++++|.+++...... ...+++..++.++.|++.|+.|||+.+
T Consensus 88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~--- 159 (321)
T 2qkw_B 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLHTRA--- 159 (321)
T ss_dssp GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhcCCC---
Confidence 367899999999999999999999999999999999999765421 113889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++|+||||+||+++.++.++|+|||+++...............|++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 160 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 239 (321)
T 2qkw_B 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239 (321)
T ss_dssp EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCT
T ss_pred eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCC
Confidence 99999999999999999999999999875443222222233458999999999998889999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
||....+........+..............++......+...+..+.+++.+||+.||++|||+.++++.|+.++....
T Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp TCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 9986655443332222211122223334445555566778899999999999999999999999999999999886543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=300.61 Aligned_cols=216 Identities=21% Similarity=0.323 Sum_probs=159.2
Q ss_pred CCCcccCCccceeeEEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 1 MVSRLKNENVVELVGYYVD------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+|++++|||||++++++.. ...+++||||+. |+|.+++..... +++..+..++.|++.||.|||
T Consensus 106 il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~---------l~~~~~~~~~~qil~al~ylH 175 (398)
T 4b99_A 106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQP---------LTLEHVRYFLYQLLRGLKYMH 175 (398)
T ss_dssp HHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSC---------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999764 367899999996 589999976543 899999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc--cccccccccccccCchhhccC-CCCcccchHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVV 151 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~ 151 (243)
++| ++||||||+|||++.++.+|++|||+++........ .......||+.|+|||++.+. .++.++||||+||+
T Consensus 176 ~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~i 252 (398)
T 4b99_A 176 SAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCI 252 (398)
T ss_dssp HTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred HCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHH
Confidence 999 999999999999999999999999999876443211 123346799999999998875 45899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCccceeeccCcCc--------hhhhhhhhccc-cCCCCC-----HHHHHHHHHHHHhhcCCC
Q 026115 152 LLELLTGRKPVDHTLPRGQQSLVTWATPKLS--------EDKVKQCVDTK-LGGEYP-----PKAIAKMAAVAALCVQYE 217 (243)
Q Consensus 152 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~~l~~~ 217 (243)
+|||++|.+||.+.........+........ ........... .....+ ...+.++.+||.+||+.|
T Consensus 253 l~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d 332 (398)
T 4b99_A 253 FGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFE 332 (398)
T ss_dssp HHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCC
Confidence 9999999999986543221111110000000 00001110000 000111 123557899999999999
Q ss_pred CCCCCCHHHHHH
Q 026115 218 ADFRPNMGIVLK 229 (243)
Q Consensus 218 p~~Rps~~~vl~ 229 (243)
|++|||++|+|+
T Consensus 333 P~~R~ta~e~L~ 344 (398)
T 4b99_A 333 PSARISAAAALR 344 (398)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhHCcCHHHHhc
Confidence 999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=308.02 Aligned_cols=198 Identities=22% Similarity=0.270 Sum_probs=164.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++|||||+++++|.++..+++||||+.||+|.+++..... +++..+..++.||+.||.|||++| |
T Consensus 246 l~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~---------l~E~~a~~y~~qIl~aL~yLH~~g---I 313 (689)
T 3v5w_A 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---V 313 (689)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 4678999999999999999999999999999999999987542 899999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+|||++.+|.+||+|||+++...... .....||+.|+|||++.. ..|+.++|+|||||++|||++|..
T Consensus 314 iHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~ 389 (689)
T 3v5w_A 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389 (689)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999997654332 234579999999999964 578999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~ 229 (243)
||........ ......+.... ...+...+.++.+||.+||++||.+|++ ++|+++
T Consensus 390 PF~~~~~~~~------------~~i~~~i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 390 PFRQHKTKDK------------HEIDRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TTCGGGCCCH------------HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCCChHHH------------HHHHHhhcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 9975422110 01111122222 2345556778999999999999999998 688775
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=290.54 Aligned_cols=149 Identities=26% Similarity=0.391 Sum_probs=126.7
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
|+++ +||||++++++|.+++++++||||+++|+|.+++.. +++..+..++.|++.||+|||++|
T Consensus 73 l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH~~g--- 137 (361)
T 4f9c_A 73 LTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIHQFG--- 137 (361)
T ss_dssp HHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3445 699999999999999999999999999999999841 888999999999999999999999
Q ss_pred eEeccCCCCceEecCC-CceeecccCCCCCCcccccc--------------------------cccccccccccccCchh
Q 026115 81 IIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAAR--------------------------LHSTRVLGTFGYHAPEY 133 (243)
Q Consensus 81 ~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~aPE~ 133 (243)
++||||||+|||++.+ +.+||+|||+++........ .......||+.|+|||+
T Consensus 138 IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~ 217 (361)
T 4f9c_A 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEV 217 (361)
T ss_dssp EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHH
T ss_pred eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHH
Confidence 9999999999999877 79999999999754322110 01123469999999999
Q ss_pred hccC-CCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026115 134 AMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 165 (243)
Q Consensus 134 ~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~ 165 (243)
+.+. .++.++||||+||++|+|++|..||...
T Consensus 218 l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 218 LTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp HTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred HcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 9875 4789999999999999999999999643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=307.95 Aligned_cols=200 Identities=20% Similarity=0.274 Sum_probs=164.8
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++|+||||++++++|.++..+++||||++||+|.+++....+. +++..+..++.||+.||+|||+++
T Consensus 207 il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~--------l~e~~~~~~~~qi~~al~ylH~~~--- 275 (573)
T 3uto_A 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYMRQVCKGLCHMHENN--- 275 (573)
T ss_dssp HHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSC--------EEHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCC--------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 367899999999999999999999999999999999999755432 899999999999999999999999
Q ss_pred eEeccCCCCceEecCC--CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLFDD--DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++||||||+||+++.+ +.+||+|||+++....... .....||+.|+|||++.+..|+.++||||+||++|+|++|
T Consensus 276 iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G 352 (573)
T 3uto_A 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352 (573)
T ss_dssp EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999999854 8899999999987644322 2345699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||.+.... +....+..... ........+..+.+||.+||+.||.+|||+.|+++
T Consensus 353 ~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 353 LSPFGGENDD---------------ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCSSCCSSHH---------------HHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCcCHH---------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999754221 11111211111 11222345668999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=283.44 Aligned_cols=225 Identities=28% Similarity=0.352 Sum_probs=175.0
Q ss_pred CCCcccCCccceeeEEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 1 MVSRLKNENVVELVGYYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
++++++||||+++++++.++. .+++||||+++|+|.+++.... +++..++.++.|++.|++|||+.
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~ 140 (322)
T 3soc_A 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHED 140 (322)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhh
Confidence 478899999999999998744 4799999999999999998754 89999999999999999999998
Q ss_pred ----------CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-----CCCc
Q 026115 77 ----------AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSS 141 (243)
Q Consensus 77 ----------~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~ 141 (243)
+ ++||||||+||+++.++.++|+|||+++...............||+.|+|||++.+. .++.
T Consensus 141 ~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 217 (322)
T 3soc_A 141 IPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217 (322)
T ss_dssp EEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHH
T ss_pred ccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCc
Confidence 8 999999999999999999999999999765443332223345689999999999863 3456
Q ss_pred ccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc-cccCCCC-----CHHHHHHHHHHHHhhcC
Q 026115 142 KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD-TKLGGEY-----PPKAIAKMAAVAALCVQ 215 (243)
Q Consensus 142 ~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~~l~ 215 (243)
++|||||||++|+|++|..||.+........................... ....... ....+..+.+++.+||+
T Consensus 218 ~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (322)
T 3soc_A 218 RIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297 (322)
T ss_dssp HHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTC
T ss_pred cchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHcc
Confidence 78999999999999999999987654433333222222222222222222 1111111 23456779999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHhhc
Q 026115 216 YEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 216 ~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
.||++|||+.++++.|+++....
T Consensus 298 ~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 298 HDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CChhhCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999987643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=287.34 Aligned_cols=220 Identities=23% Similarity=0.380 Sum_probs=177.5
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
|+++ +||||+++++++.+++.+++||||+.+|+|.+++....... .......+++..++.++.|++.||.||
T Consensus 140 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp HHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4567 89999999999999999999999999999999998754210 001112378999999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++||||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|+|||||++|
T Consensus 220 H~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 220 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred HhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 9998 9999999999999999999999999987654433222233345778999999999989999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+|++ |..||.... .......+........+..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus 297 ellt~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 297 EIFTLGGSPYPGIP----------------VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp HHHTTSCCSSTTCC----------------GGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHcCCCCCCCCCC----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999 999996431 12233333333344455566778999999999999999999999999999
Q ss_pred HHHhhcCC
Q 026115 233 PLLNTRSG 240 (243)
Q Consensus 233 ~~~~~~~~ 240 (243)
+++...+.
T Consensus 361 ~il~~~~~ 368 (370)
T 2psq_A 361 RILTLTTN 368 (370)
T ss_dssp HHHHHHC-
T ss_pred HHHHHhcc
Confidence 99876554
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=288.86 Aligned_cols=210 Identities=25% Similarity=0.403 Sum_probs=174.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+++..++||||+++|+|.+++..... .++...++.++.|++.|++|||+.+
T Consensus 165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~--- 233 (377)
T 3cbl_A 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLESKC--- 233 (377)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999976432 2889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |.
T Consensus 234 ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~ 313 (377)
T 3cbl_A 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGA 313 (377)
T ss_dssp EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999875443222211122235678999999998889999999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
.||... ......+.+....+...+..++..+.+++.+||+.||++|||++++++.|+++.+.
T Consensus 314 ~p~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 314 SPYPNL----------------SNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CSSTTS----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCC----------------CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 998643 22333344444444455566777899999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=280.89 Aligned_cols=213 Identities=26% Similarity=0.406 Sum_probs=174.5
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.++...++||||+++++|.+++...... +++..++.++.|++.||.|||+.+
T Consensus 103 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~L~~LH~~~--- 171 (325)
T 3kul_A 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLRGVGAGMRYLSDLG--- 171 (325)
T ss_dssp HHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTC--------SCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 367899999999999999999999999999999999999765432 889999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-C
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 158 (243)
++||||||+||+++.++.++|+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|++++ |
T Consensus 172 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g 251 (325)
T 3kul_A 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251 (325)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999987664432211 1122345778999999998889999999999999999999 9
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
..||... ........+........+..++..+.+++.+||+.||++|||+.++++.|+.++...
T Consensus 252 ~~p~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 252 ERPYWNM----------------TNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCTTTTS----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCcccC----------------CHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 9999643 223333333334444555566778999999999999999999999999999998765
Q ss_pred CC
Q 026115 239 SG 240 (243)
Q Consensus 239 ~~ 240 (243)
..
T Consensus 316 ~~ 317 (325)
T 3kul_A 316 ES 317 (325)
T ss_dssp C-
T ss_pred cc
Confidence 43
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=275.23 Aligned_cols=198 Identities=25% Similarity=0.378 Sum_probs=164.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+.+++|.+++.... ++...+..++.|++.|+.|||+.+ +
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i 137 (297)
T 3fxz_A 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---V 137 (297)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 567899999999999999999999999999999999998764 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 138 ~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 215 (297)
T 3fxz_A 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (297)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998655433221 2345689999999999998999999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhh-ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCV-DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|....+. ....... ........+...+..+.+++.+||+.||++|||++++++
T Consensus 216 f~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 216 YLNENPL---------------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp TTTSCHH---------------HHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCHH---------------HHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9644221 1111111 111112334456678999999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=276.84 Aligned_cols=213 Identities=26% Similarity=0.400 Sum_probs=171.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... .+++..++.++.|++.|++|||+.+ +
T Consensus 61 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---i 129 (310)
T 3s95_A 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSMN---I 129 (310)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 6789999999999999999999999999999999999987443 2889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc------------ccccccccccccCchhhccCCCCcccchHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL------------HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFG 149 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG 149 (243)
+|+||||+||+++.++.++|+|||+++......... ......||+.|+|||++.+..++.++||||||
T Consensus 130 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 209 (310)
T 3s95_A 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209 (310)
T ss_dssp ECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHH
T ss_pred cCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHH
Confidence 999999999999999999999999987654332211 01134689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+++|++++|..||....+...... .......... .+..++..+.+++.+||+.||++|||+.++++
T Consensus 210 ~~l~el~~g~~~~~~~~~~~~~~~----------~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 210 IVLCEIIGRVNADPDYLPRTMDFG----------LNVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHHHTCCSSTTTSCBCTTSS----------BCHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCcchhhhHHHHh----------hhhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999875433222111 0111111111 12234457999999999999999999999999
Q ss_pred HHHHHHhhcC
Q 026115 230 ALQPLLNTRS 239 (243)
Q Consensus 230 ~l~~~~~~~~ 239 (243)
.|+++.....
T Consensus 276 ~L~~l~~~~~ 285 (310)
T 3s95_A 276 WLETLRMHLA 285 (310)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHhcc
Confidence 9999876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=276.41 Aligned_cols=217 Identities=32% Similarity=0.446 Sum_probs=165.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++...... ..+++..++.++.|++.||+|||+.+ .++
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-~~i 160 (309)
T 3p86_A 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNRN-PPI 160 (309)
T ss_dssp HHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCC-CCE
Confidence 56789999999999999999999999999999999999865321 12788999999999999999999985 239
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 161 vH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P 238 (309)
T 3p86_A 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238 (309)
T ss_dssp CCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCT
T ss_pred ECCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875443221 12345689999999999998899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGP 241 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~~~ 241 (243)
|..... .+..............+...+..+.+++.+||+.||.+|||++++++.|+.++++..++
T Consensus 239 f~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 239 WGNLNP---------------AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp TTTSCH---------------HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred CCCCCH---------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 974421 11111111122223445556678999999999999999999999999999999887665
Q ss_pred C
Q 026115 242 S 242 (243)
Q Consensus 242 ~ 242 (243)
+
T Consensus 304 ~ 304 (309)
T 3p86_A 304 P 304 (309)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=276.98 Aligned_cols=217 Identities=25% Similarity=0.373 Sum_probs=176.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC---------------CCCCCCccCHHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---------------GAKPGPVLSWAQRVKIAVGA 66 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------~~~~~~~~~~~~~~~~~~ql 66 (243)
+++++||||+++++++.++...++||||+.+++|.+++....... .......+++..++.++.|+
T Consensus 80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 678999999999999999999999999999999999998754310 00112238899999999999
Q ss_pred HHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchH
Q 026115 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY 146 (243)
Q Consensus 67 ~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw 146 (243)
+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++|+|
T Consensus 160 ~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 236 (314)
T 2ivs_A 160 SQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236 (314)
T ss_dssp HHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHH
Confidence 99999999998 999999999999999999999999998765443322223334577889999999988889999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
|||+++++|++ |..||..... ......+........+...+..+.+++.+||+.||++|||+.
T Consensus 237 slG~il~el~t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 300 (314)
T 2ivs_A 237 SFGVLLWEIVTLGGNPYPGIPP----------------ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300 (314)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCG----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999 9999964422 222333333333344555677899999999999999999999
Q ss_pred HHHHHHHHHHhh
Q 026115 226 IVLKALQPLLNT 237 (243)
Q Consensus 226 ~vl~~l~~~~~~ 237 (243)
++++.|++++..
T Consensus 301 ~l~~~l~~~~~~ 312 (314)
T 2ivs_A 301 DISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHhh
Confidence 999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=283.34 Aligned_cols=220 Identities=26% Similarity=0.384 Sum_probs=180.0
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
++++ +||||+++++++.+++..++||||+.+|+|.+++....... .......+++..++.++.|++.||.||
T Consensus 128 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 207 (382)
T 3tt0_A 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207 (382)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4456 89999999999999999999999999999999998754210 111122489999999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++||||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||+++
T Consensus 208 H~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 208 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp HHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred HhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHH
Confidence 9998 9999999999999999999999999998765443322233445788999999999989999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+|++ |..||.... .....+.+........+..++..+.+++.+||+.||++|||++++++.|+
T Consensus 285 ellt~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 285 EIFTLGGSPYPGVP----------------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp HHHTTSCCSSTTCC----------------HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhCCCCCCCCCC----------------HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999 999986431 23333334444344445556778999999999999999999999999999
Q ss_pred HHHhhcCC
Q 026115 233 PLLNTRSG 240 (243)
Q Consensus 233 ~~~~~~~~ 240 (243)
+++...+.
T Consensus 349 ~~~~~~~~ 356 (382)
T 3tt0_A 349 RIVALTSN 356 (382)
T ss_dssp HHHHHSCS
T ss_pred HHHHHHhc
Confidence 99877654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=271.05 Aligned_cols=208 Identities=25% Similarity=0.426 Sum_probs=173.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... .++...++.++.|++.|+.|||+.+ +
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i 127 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---V 127 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5689999999999999999999999999999999999976543 2889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..
T Consensus 128 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~ 206 (269)
T 4hcu_A 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 206 (269)
T ss_dssp CCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ecCCcchheEEEcCCCCEEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999998765433221 1223446778999999998899999999999999999999 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
||..... ......+........+...+..+.+++.+||+.||++|||++++++.|+++.++
T Consensus 207 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 207 PYENRSN----------------SEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TTTTCCH----------------HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCH----------------HHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 9964321 222222223333344445567899999999999999999999999999999865
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=272.66 Aligned_cols=210 Identities=25% Similarity=0.393 Sum_probs=174.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++...... +++..++.++.|++.|+.|||+.+ +
T Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~---i 141 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESKQ---F 141 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGC--------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccC--------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 56889999999999999999999999999999999999874322 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 142 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~ 220 (283)
T 3gen_A 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220 (283)
T ss_dssp CCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765443222 1223346778999999998889999999999999999998 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
||.... .......+........+...+..+.+++.+||+.||++|||++++++.|++++.+.|
T Consensus 221 p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~es 283 (283)
T 3gen_A 221 PYERFT----------------NSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283 (283)
T ss_dssp TTTTSC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CccccC----------------hhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhccC
Confidence 996442 122223333333334444556789999999999999999999999999999998765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=276.13 Aligned_cols=225 Identities=36% Similarity=0.598 Sum_probs=181.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc---C
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK---A 77 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~---~ 77 (243)
++++++||||+++++++.++...++||||+.+|+|.+++...... ...+++..+..++.|++.|++|||+. +
T Consensus 80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ 154 (326)
T 3uim_A 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPK 154 (326)
T ss_dssp GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 467899999999999999999999999999999999999876432 12388999999999999999999999 7
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++|+||||+||+++.++.++|+|||+++........ ......||+.|+|||.+.+..++.++||||||+++++|++
T Consensus 155 ---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 230 (326)
T 3uim_A 155 ---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230 (326)
T ss_dssp ---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH
T ss_pred ---eEeCCCchhhEEECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh
Confidence 999999999999999999999999998765432221 1233458999999999988889999999999999999999
Q ss_pred CCCCCCCCCC--CCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 158 GRKPVDHTLP--RGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 158 g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
|..||..... ........+..............+.......+...+..+.+++.+||+.||.+|||++++++.|+..
T Consensus 231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred CCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 9999963211 1111122222223333444455555566677888999999999999999999999999999999853
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=284.96 Aligned_cols=216 Identities=25% Similarity=0.389 Sum_probs=175.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+|+|.+++........ ....+++..++.++.|++.||+|||+.+ +
T Consensus 128 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 202 (367)
T 3l9p_A 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQYLEENH---F 202 (367)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccC--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999999999999987653221 1123889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCC---ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-
Q 026115 82 IHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT- 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 157 (243)
+||||||+||+++.++ .++|+|||+++...............||+.|+|||++.+..++.++|||||||++++|++
T Consensus 203 vHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~ 282 (367)
T 3l9p_A 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 282 (367)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999998554 599999999865433322222334567889999999999899999999999999999998
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
|..||... ........+........+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 283 g~~pf~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 283 GYMPYPSK----------------SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp SCCSSTTC----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCC----------------CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 99999643 12333333333333444556677899999999999999999999999999988765
Q ss_pred c
Q 026115 238 R 238 (243)
Q Consensus 238 ~ 238 (243)
.
T Consensus 347 ~ 347 (367)
T 3l9p_A 347 P 347 (367)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=277.81 Aligned_cols=208 Identities=23% Similarity=0.362 Sum_probs=170.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++. .+++++++.+|+|.+++...... ++...++.++.|++.||.|||+.+ +
T Consensus 71 l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~~---i 138 (327)
T 3poz_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYLEDRR---L 138 (327)
T ss_dssp HHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTS--------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 56789999999999998765 67889999999999999875432 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|++++ |..
T Consensus 139 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 218 (327)
T 3poz_A 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218 (327)
T ss_dssp CCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred eCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999999999865543332222233456889999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
||.... .......+........+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 219 p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 219 PYDGIP----------------ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTTTCC----------------GGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CccCCC----------------HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 996432 2233344444444445556677899999999999999999999999999988753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=279.83 Aligned_cols=220 Identities=25% Similarity=0.366 Sum_probs=172.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC---------------CCCCCCccCHHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---------------GAKPGPVLSWAQRVKIAVGA 66 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------~~~~~~~~~~~~~~~~~~ql 66 (243)
+++++||||+++++++.+++..++||||+.+++|.+++....... .......+++..++.++.|+
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 568899999999999999999999999999999999998743210 00011248899999999999
Q ss_pred HHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchH
Q 026115 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY 146 (243)
Q Consensus 67 ~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw 146 (243)
+.|+.|||+.+ ++|+||||+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++|+|
T Consensus 184 ~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 260 (343)
T 1luf_A 184 AAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260 (343)
T ss_dssp HHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccH
Confidence 99999999998 999999999999999999999999998654433222222344578899999999988899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
|||+++|+|++ |..||..... ......+........+..++..+.+++.+||+.||++|||+.
T Consensus 261 slG~il~el~t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 324 (343)
T 1luf_A 261 AYGVVLWEIFSYGLQPYYGMAH----------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC 324 (343)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHhcCCCcCCCCCh----------------HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 99999999999 9999964311 222222222222334455667899999999999999999999
Q ss_pred HHHHHHHHHHhhcCC
Q 026115 226 IVLKALQPLLNTRSG 240 (243)
Q Consensus 226 ~vl~~l~~~~~~~~~ 240 (243)
++++.|+++......
T Consensus 325 ~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 325 SIHRILQRMCERAEG 339 (343)
T ss_dssp HHHHHHHHTTC----
T ss_pred HHHHHHHHHHhhhhh
Confidence 999999999876553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=277.43 Aligned_cols=208 Identities=23% Similarity=0.361 Sum_probs=169.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+ ...++|+||+.+|+|.+++....+ .+++..++.++.|++.||.|||+.+ +
T Consensus 69 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 136 (325)
T 3kex_A 69 IGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEHG---M 136 (325)
T ss_dssp HHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 467899999999999874 568899999999999999986532 2788899999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus 137 vH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 216 (325)
T 3kex_A 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216 (325)
T ss_dssp CCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654433322344557889999999998899999999999999999999 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
||..... ......+........+..++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 217 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 217 PYAGLRL----------------AEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTTTSCT----------------THHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CccccCH----------------HHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9975421 222233333333334444566799999999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=274.65 Aligned_cols=221 Identities=23% Similarity=0.343 Sum_probs=177.5
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC---------CCCCCCccCHHHHHHHHHHHHHHHH
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---------GAKPGPVLSWAQRVKIAVGAARGLE 71 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~~~~~~ql~~~l~ 71 (243)
++++ +||||+++++++.+++..++||||+++|+|.+++....... .......+++..++.++.|++.||.
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 4567 89999999999999999999999999999999998764310 0011123889999999999999999
Q ss_pred HhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHH
Q 026115 72 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 151 (243)
Q Consensus 72 ~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~ 151 (243)
|||+.+ ++|+||||+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++|+||||++
T Consensus 160 ~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 236 (313)
T 1t46_A 160 FLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (313)
T ss_dssp HHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHH
Confidence 999998 99999999999999999999999999987655433222334457788999999998899999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 152 LLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 152 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
+++|++ |..||..... ................+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 237 l~ellt~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPV---------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHTTTCCSSTTCCS---------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCcccc---------------hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999998 9999865421 122222333333333344556789999999999999999999999999
Q ss_pred HHHHHhhcCC
Q 026115 231 LQPLLNTRSG 240 (243)
Q Consensus 231 l~~~~~~~~~ 240 (243)
|++++.+..+
T Consensus 302 L~~~~~~~~~ 311 (313)
T 1t46_A 302 IEKQISESTN 311 (313)
T ss_dssp HHHHHHHTCC
T ss_pred HHHHHHHhhc
Confidence 9999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=277.66 Aligned_cols=227 Identities=21% Similarity=0.271 Sum_probs=171.3
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.. ....++||||+++++|.+++..... .++...++.++.|++.|++|||+.+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~-- 134 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR-- 134 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcCC--
Confidence 578899999999999864 4568999999999999999987643 2889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||||+||+++.++.++|+|||+++......... ......++..|+|||.+.+..++.++||||||++++++++|
T Consensus 135 -ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 213 (295)
T 3ugc_A 135 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213 (295)
T ss_dssp -CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred -cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998765432221 12223467789999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
..||.........................+.+........+..++..+.+++.+||+.||++|||++++++.|+++....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 214 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 99986432110000000000001111233333344444556667788999999999999999999999999999998775
Q ss_pred C
Q 026115 239 S 239 (243)
Q Consensus 239 ~ 239 (243)
+
T Consensus 294 ~ 294 (295)
T 3ugc_A 294 A 294 (295)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=280.14 Aligned_cols=211 Identities=23% Similarity=0.382 Sum_probs=164.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.++...++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+
T Consensus 99 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~--- 167 (373)
T 2qol_A 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMKYLSDMG--- 167 (373)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999986542 2889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-C
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 158 (243)
++||||||+||+++.++.++|+|||+++......... ......++..|+|||.+.+..++.++||||||+++|++++ |
T Consensus 168 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g 247 (373)
T 2qol_A 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247 (373)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC
T ss_pred eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999997665432211 1112235678999999999899999999999999999998 9
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
..||.... .......+........+..++..+.+++.+||+.||.+|||+.++++.|++++...
T Consensus 248 ~~P~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 248 ERPYWEMS----------------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -CTTTTCC----------------HHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCCCCC----------------HHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 99996431 22333333333334445566778999999999999999999999999999997653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=274.23 Aligned_cols=208 Identities=23% Similarity=0.361 Sum_probs=166.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++. .+++++++.+|+|.+++...... ++...++.++.|++.||.|||+.+ +
T Consensus 71 l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~---i 138 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYLEDRR---L 138 (327)
T ss_dssp HTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHhhCC---C
Confidence 67899999999999998765 77889999999999999875432 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||||+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 139 vH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 218 (327)
T 3lzb_A 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218 (327)
T ss_dssp CCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999987654433332333456788999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
||..... ......+........+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 219 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 219 PYDGIPA----------------SEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTTTCCG----------------GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 9975422 233334444444445556677899999999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=277.25 Aligned_cols=220 Identities=23% Similarity=0.354 Sum_probs=174.5
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC--------------CCCCCCccCHHHHHHHHHHH
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIAVGA 66 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--------------~~~~~~~~~~~~~~~~~~ql 66 (243)
++++ +||||+++++++.+++..++||||+++|+|.+++....... .......+++..++.++.|+
T Consensus 102 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 4567 89999999999999999999999999999999998754310 00011237889999999999
Q ss_pred HHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchH
Q 026115 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY 146 (243)
Q Consensus 67 ~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw 146 (243)
+.||.|||+.+ ++|+||||+||+++.++.++|+|||++................|++.|+|||.+.+..++.++|||
T Consensus 182 ~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 258 (344)
T 1rjb_A 182 AKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258 (344)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHH
Confidence 99999999998 999999999999999999999999999866544332223344578899999999988899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
|||+++++|++ |..||..... .......+........+...+..+.+++.+||+.||.+|||+.
T Consensus 259 slG~il~el~t~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 323 (344)
T 1rjb_A 259 SYGILLWEIFSLGVNPYPGIPV---------------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 323 (344)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCC---------------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHcCCCCCcccCCc---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 99999999998 9999975421 1223333333333444555677899999999999999999999
Q ss_pred HHHHHHHHHHhhcC
Q 026115 226 IVLKALQPLLNTRS 239 (243)
Q Consensus 226 ~vl~~l~~~~~~~~ 239 (243)
++++.|+.++....
T Consensus 324 ~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 324 NLTSFLGCQLADAE 337 (344)
T ss_dssp HHHHHHHHHC----
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999887643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=269.29 Aligned_cols=208 Identities=25% Similarity=0.385 Sum_probs=160.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++. ++..++||||+.+++|.+++..... .+++..++.++.|++.|+.|||+.+ +
T Consensus 70 l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 137 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---F 137 (281)
T ss_dssp HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 56789999999999985 4568899999999999999976542 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++|+|||+++........ ......+++.|+|||++.+..++.++|+||||++++++++ |..
T Consensus 138 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~ 216 (281)
T 1mp8_A 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216 (281)
T ss_dssp CCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred ecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCC
Confidence 99999999999999999999999998766443221 1222346778999999998889999999999999999997 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
||..... ......+........+...+..+.+++.+||+.||++|||+.++++.|++++++.
T Consensus 217 pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 217 PFQGVKN----------------NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp TTTTCCG----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCcCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 9975422 1112222222223344556678999999999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=273.11 Aligned_cols=216 Identities=21% Similarity=0.315 Sum_probs=163.2
Q ss_pred CCcccCCccceeeEEEEeCCee------EEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGPLR------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++...... ++||||+.+++|.+++....... ....+++..++.++.|++.|++|||+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~ 155 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLSS 155 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHHc
Confidence 5789999999999999876654 99999999999999996543211 01128899999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.+ ++|+||||+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++||||||++++++
T Consensus 156 ~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (323)
T 3qup_A 156 RN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232 (323)
T ss_dssp TT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHH
Confidence 99 999999999999999999999999999766543322222334467889999999998999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
++ |..||..... ......+........+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 233 l~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 233 MTRGQTPYAGIEN----------------AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HTTSCCTTTTCCG----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCccccCh----------------HHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99 8999975422 122222222222344445667899999999999999999999999999999
Q ss_pred HhhcC
Q 026115 235 LNTRS 239 (243)
Q Consensus 235 ~~~~~ 239 (243)
+....
T Consensus 297 l~~~~ 301 (323)
T 3qup_A 297 LGHLS 301 (323)
T ss_dssp HHC--
T ss_pred HHHhh
Confidence 87654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=268.54 Aligned_cols=208 Identities=24% Similarity=0.311 Sum_probs=170.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... .+++..++.++.|++.|++|||+.+ +
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 125 (268)
T 3sxs_A 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLESHQ---F 125 (268)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999976532 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++|+|||++.......... .....+++.|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 126 ~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 204 (268)
T 3sxs_A 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204 (268)
T ss_dssp EESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999987554332221 122346678999999998888999999999999999999 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
||..... ...............+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 205 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 205 PYDLYTN----------------SEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TTTTSCH----------------HHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CccccCh----------------HHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 9964321 122222222222333444566899999999999999999999999999988654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=290.08 Aligned_cols=210 Identities=25% Similarity=0.376 Sum_probs=176.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++.++..+++||||+.+|+|.+++....... ++...++.++.|++.|++|||+.+ +
T Consensus 270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~---i 339 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAMEYLEKKN---F 339 (495)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTT-------SCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCC-------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 568899999999999999999999999999999999998654332 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..
T Consensus 340 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~ 418 (495)
T 1opk_A 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 418 (495)
T ss_dssp ECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432211 1222346778999999998889999999999999999999 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
||.... ...+.+.+....+...+..++..+.+++.+||+.||++|||+.++++.|++++...
T Consensus 419 p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 419 PYPGID----------------LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp SSTTCC----------------GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 986442 12333444445555556667788999999999999999999999999999887543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=274.08 Aligned_cols=202 Identities=27% Similarity=0.302 Sum_probs=164.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... ++...+..++.|++.||+|||+.| +
T Consensus 59 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~g---i 126 (323)
T 3tki_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIG---I 126 (323)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||++................||+.|+|||++.+..+ +.++|||||||++++|++|..
T Consensus 127 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 206 (323)
T 3tki_A 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 206 (323)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999976544333322344568999999999987765 678999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||....... ...................+..+.+++.+||+.||++|||+.|+++
T Consensus 207 pf~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 207 PWDQPSDSC--------------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp SCSSSCTTS--------------HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCchHH--------------HHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 997542211 1111112222222222345667899999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=273.97 Aligned_cols=196 Identities=24% Similarity=0.300 Sum_probs=163.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++.+++..++||||+++++|.+++..... ++...+..++.|++.|++|||+.+ +
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---i 135 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR---------MKEKEARSKFRQIVSAVQYCHQKR---I 135 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5678999999999999999999999999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCC-cccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||++........ .....||+.|+|||++.+..+. .++||||+||++++|++|..
T Consensus 136 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 212 (328)
T 3fe3_A 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212 (328)
T ss_dssp CCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSC
T ss_pred eccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence 9999999999999999999999999875543221 2345689999999999987775 78999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||.+... ......+..... ..+...+..+.+++.+||+.||.+|||++++++
T Consensus 213 pf~~~~~---------------~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 213 PFDGQNL---------------KELRERVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp SSCCSSH---------------HHHHHHHHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCH---------------HHHHHHHHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9975421 111111222211 233345668999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=279.31 Aligned_cols=219 Identities=22% Similarity=0.330 Sum_probs=173.9
Q ss_pred CCcc-cCCccceeeEEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCC--------------------------------
Q 026115 2 VSRL-KNENVVELVGYYVDGP-LRVLAYEHASKGSLHDILHGKKGVKG-------------------------------- 47 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~-------------------------------- 47 (243)
++++ +||||+++++++.+.. ..++||||+.+|+|.+++........
T Consensus 79 l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (359)
T 3vhe_A 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITS 158 (359)
T ss_dssp HHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------
T ss_pred HHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCc
Confidence 3456 7899999999998754 48999999999999999987643100
Q ss_pred -------------------------CCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeec
Q 026115 48 -------------------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 102 (243)
Q Consensus 48 -------------------------~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~ 102 (243)
......+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~ 235 (359)
T 3vhe_A 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKIC 235 (359)
T ss_dssp -------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEE
Confidence 000122888999999999999999999998 9999999999999999999999
Q ss_pred ccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCcC
Q 026115 103 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL 181 (243)
Q Consensus 103 df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 181 (243)
|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 236 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------------- 301 (359)
T 3vhe_A 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------------- 301 (359)
T ss_dssp CCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--------------
T ss_pred eccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch--------------
Confidence 9999986644333323344567889999999999899999999999999999998 9999964421
Q ss_pred chhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 182 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
.......+........+...+..+.+++.+||+.||.+|||++++++.|+++++..
T Consensus 302 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 302 -DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp -SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 12222333333333444556678999999999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=275.60 Aligned_cols=213 Identities=21% Similarity=0.331 Sum_probs=163.0
Q ss_pred CCCcccCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLKNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
++++++||||+++++++.+ ++..++||||+.+|+|.+++..... .+++..++.++.|++.|++|||+.+
T Consensus 143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~-- 212 (373)
T 3c1x_A 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK-- 212 (373)
T ss_dssp TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5789999999999998754 5678999999999999999976543 2788999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCccccccc--ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+||+++.++.++|+|||+++......... ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 213 -ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt 291 (373)
T 3c1x_A 213 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291 (373)
T ss_dssp -CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999997654332111 1123346788999999999899999999999999999999
Q ss_pred -CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 158 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
|.+||...... .....+........+..++..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 292 ~~~~p~~~~~~~----------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 292 RGAPPYPDVNTF----------------DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp TSCCSCTTSCSS----------------CHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCCCCCCCHH----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 67777644221 1111111222223344556789999999999999999999999999999988
Q ss_pred hcCC
Q 026115 237 TRSG 240 (243)
Q Consensus 237 ~~~~ 240 (243)
+...
T Consensus 356 ~~~~ 359 (373)
T 3c1x_A 356 TFIG 359 (373)
T ss_dssp TCCS
T ss_pred hccc
Confidence 7654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=283.19 Aligned_cols=205 Identities=28% Similarity=0.422 Sum_probs=170.8
Q ss_pred CCcccCCccceeeEEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
|++++||||+++++++.+.. ..++||||+.+|+|.+++...... .++...++.++.|++.|++|||+.+
T Consensus 240 l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~--- 309 (450)
T 1k9a_A 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN--- 309 (450)
T ss_dssp HHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTT-------TCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 67899999999999987665 799999999999999999875432 2688999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++||||||+||+++.++.++|+|||+++...... ....++..|+|||++.+..++.++||||||+++|||++ |.
T Consensus 310 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 384 (450)
T 1k9a_A 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384 (450)
T ss_dssp EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987543221 22346789999999999899999999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
.||..... ..+...+..+.+...+..++..+.++|.+||+.||++|||+.++++.|+++...
T Consensus 385 ~P~~~~~~----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 385 VPYPRIPL----------------KDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CSSTTSCT----------------TTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCH----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 99974421 222333334444455666778899999999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=267.06 Aligned_cols=222 Identities=23% Similarity=0.305 Sum_probs=165.7
Q ss_pred cccCCccceeeEEEEeC----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc---
Q 026115 4 RLKNENVVELVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK--- 76 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~--- 76 (243)
.++||||+++++++.++ ...++||||+++|+|.+++.... +++..++.++.|++.|++|||+.
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~ 156 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFS 156 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCS
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 46999999999999887 78999999999999999997654 89999999999999999999998
Q ss_pred -----CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccc--cccccccccccCchhhccCCCCcc------c
Q 026115 77 -----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQMSSK------S 143 (243)
Q Consensus 77 -----~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~------~ 143 (243)
+ ++||||||+||+++.++.++|+|||+++.......... .....||+.|+|||++.+...... +
T Consensus 157 ~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 233 (337)
T 3mdy_A 157 TQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233 (337)
T ss_dssp TTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHH
T ss_pred hccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCcccc
Confidence 7 99999999999999999999999999865543322211 123468999999999987666554 9
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhh-ccccCCCCC-----HHHHHHHHHHHHhhcCCC
Q 026115 144 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV-DTKLGGEYP-----PKAIAKMAAVAALCVQYE 217 (243)
Q Consensus 144 DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~li~~~l~~~ 217 (243)
|||||||++|+|++|..|+.......... ................. ........+ ..++..+.+++.+||+.|
T Consensus 234 DiwslG~il~el~tg~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 312 (337)
T 3mdy_A 234 DMYSFGLILWEVARRCVSGGIVEEYQLPY-HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312 (337)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTT-TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSS
T ss_pred chHHHHHHHHHHHhccCcccccccccccH-hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhC
Confidence 99999999999999954443211100000 00000011111122211 122222222 377889999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhhcC
Q 026115 218 ADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 218 p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
|++|||+.++++.|+++..+..
T Consensus 313 P~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 313 PASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp GGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhhCCCHHHHHHHHHHHHhhcc
Confidence 9999999999999999988764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=266.69 Aligned_cols=204 Identities=32% Similarity=0.481 Sum_probs=160.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+++++|.+++.... +++..++.++.|++.|+.|||+.+..++
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~~~~i 129 (271)
T 3dtc_A 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHDEAIVPI 129 (271)
T ss_dssp HHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHSSSSCC
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 467899999999999999999999999999999999996543 8899999999999999999999874458
Q ss_pred EeccCCCCceEecC--------CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFD--------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 82 ~h~di~~~nil~~~--------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
+|+||||+||+++. ++.++|+|||.+........ ....|++.|+|||.+.+..++.++|+||||++++
T Consensus 130 ~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 205 (271)
T 3dtc_A 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLW 205 (271)
T ss_dssp CCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHH
T ss_pred eecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHH
Confidence 89999999999986 67899999999876543322 2345899999999999988999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
++++|..||..... ................+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 206 ~l~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 206 ELLTGEVPFRGIDG---------------LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHCCCTTTTSCH---------------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHhCCCCCCCCCH---------------HHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 99999999974421 112222222333334445566789999999999999999999999999986
Q ss_pred H
Q 026115 234 L 234 (243)
Q Consensus 234 ~ 234 (243)
+
T Consensus 271 l 271 (271)
T 3dtc_A 271 I 271 (271)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=266.53 Aligned_cols=213 Identities=22% Similarity=0.326 Sum_probs=172.3
Q ss_pred CCcccCCccceeeEEEEeCCee-EEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLR-VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++||||+++++++.+.+.. ++++||+.+++|.+++..... .+++..++.++.|++.|++|||+.+
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~--- 144 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARGMEYLAEQK--- 144 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5678999999999999866554 999999999999999986432 2889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccc--cccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||||+||+++.++.++|+|||+++........ .......+++.|+|||.+.+..++.++|+||||+++++|++|
T Consensus 145 i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 224 (298)
T 3pls_A 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224 (298)
T ss_dssp CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHT
T ss_pred cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhC
Confidence 999999999999999999999999999866543321 112334578899999999998999999999999999999995
Q ss_pred CCC-CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 159 RKP-VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 159 ~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
..| |.... .......+........+...+..+.+++.+||+.||.+|||+.++++.|++++..
T Consensus 225 ~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 225 GAPPYRHID----------------PFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp SCCTTTTSC----------------GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccCC----------------HHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 555 43221 1222233333333344445567899999999999999999999999999999987
Q ss_pred cCCC
Q 026115 238 RSGP 241 (243)
Q Consensus 238 ~~~~ 241 (243)
....
T Consensus 289 l~~~ 292 (298)
T 3pls_A 289 LLGD 292 (298)
T ss_dssp CCSC
T ss_pred Hhcc
Confidence 7543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=267.95 Aligned_cols=213 Identities=28% Similarity=0.421 Sum_probs=174.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++ +.+..++||||+.+++|.+++..... .+++..++.++.|++.|+.|||+.+ +
T Consensus 64 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 131 (287)
T 1u59_A 64 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---F 131 (287)
T ss_dssp HHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5678999999999999 55678999999999999999975432 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|+||+|+||+++.++.++|+|||++.......... ......+++.|+|||++.+..++.++|+||||+++++|++ |.
T Consensus 132 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 211 (287)
T 1u59_A 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211 (287)
T ss_dssp ECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred eeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999987654332211 1223346789999999988888999999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
.||..... ......+........+...+..+.+++.+||+.||++|||+.++++.|+++..+..
T Consensus 212 ~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 212 KPYKKMKG----------------PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CTTTTCCT----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCcccCCH----------------HHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 99964421 22223333333334455667789999999999999999999999999999988776
Q ss_pred CCC
Q 026115 240 GPS 242 (243)
Q Consensus 240 ~~~ 242 (243)
+++
T Consensus 276 ~~~ 278 (287)
T 1u59_A 276 SKV 278 (287)
T ss_dssp TTC
T ss_pred Ccc
Confidence 554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=268.23 Aligned_cols=210 Identities=25% Similarity=0.374 Sum_probs=175.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++....... ++...++.++.|++.|+.|||+.+ +
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~---i 132 (288)
T 3kfa_A 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAMEYLEKKN---F 132 (288)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTT-------SCHHHHHHHHHHHHHHHHHHHHHT---C
T ss_pred HHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCC-------ccHhHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999999999999999999999999999998754332 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus 133 ~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~ 211 (288)
T 3kfa_A 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211 (288)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCCcceEEEcCCCCEEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765433221 1223346788999999998899999999999999999999 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
||..... ....+.+........+...+..+.+++.+||+.||.+|||++++++.|++++.+.
T Consensus 212 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 212 PYPGIDL----------------SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp SSTTCCG----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCH----------------HHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9864421 2233333333344455566778999999999999999999999999999988754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=286.07 Aligned_cols=210 Identities=23% Similarity=0.404 Sum_probs=173.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++. +...++||||+.+|+|.+++....... ++...++.++.|++.|++|||+.+
T Consensus 236 ~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~~--- 304 (454)
T 1qcf_A 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK-------QPLPKLIDFSAQIAEGMAFIEQRN--- 304 (454)
T ss_dssp HHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367899999999999986 567899999999999999998653221 788899999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++||||||+||+++.++.++|+|||+++......... .....++..|+|||++....++.++||||||+++|||++ |.
T Consensus 305 ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~ 383 (454)
T 1qcf_A 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383 (454)
T ss_dssp CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCC
Confidence 9999999999999999999999999997654332211 122346778999999998899999999999999999999 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
.||... ........+....+...+..++..+.+++.+||+.||++|||+++|++.|+++....
T Consensus 384 ~P~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 384 IPYPGM----------------SNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CSSTTC----------------CHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCCC----------------CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 999643 122333333444444556667788999999999999999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=266.35 Aligned_cols=211 Identities=21% Similarity=0.336 Sum_probs=166.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+++++|.+++..... +++..++.++.|++.|+.|||+.+ +
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 132 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDGIKHAHDMR---I 132 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5789999999999999999999999999999999999976542 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||||+||+++.++.++|+|||++......... ......||+.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 133 ~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p 211 (294)
T 4eqm_A 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211 (294)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999866433221 12334589999999999998899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccC---CCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHHHHHhh
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEADFRP-NMGIVLKALQPLLNT 237 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~vl~~l~~~~~~ 237 (243)
|...... ......+..... .......+..+.+++.+||+.||++|| +++++.+.|.+++.+
T Consensus 212 f~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 212 FNGETAV---------------SIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SCSSCHH---------------HHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred CCCCChH---------------HHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 9754211 111111111110 011223456799999999999999998 999999999988766
Q ss_pred cCC
Q 026115 238 RSG 240 (243)
Q Consensus 238 ~~~ 240 (243)
...
T Consensus 277 ~~~ 279 (294)
T 4eqm_A 277 NRA 279 (294)
T ss_dssp SST
T ss_pred ccC
Confidence 543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=264.29 Aligned_cols=208 Identities=25% Similarity=0.415 Sum_probs=171.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... .++...++.++.|++.|+.|||+.+ +
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 125 (267)
T 3t9t_A 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---V 125 (267)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5678999999999999999999999999999999999986543 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||+|+||+++.++.++|+|||++......... ......++..|+|||++.+..++.++|+||||+++++|++ |..
T Consensus 126 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 204 (267)
T 3t9t_A 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204 (267)
T ss_dssp CCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCchheEEECCCCCEEEccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCC
Confidence 99999999999999999999999998765432211 1223446788999999998889999999999999999999 899
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
||..... ......+........+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 205 p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 205 PYENRSN----------------SEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TTTTCCH----------------HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCH----------------HHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9864311 122222222222233444567899999999999999999999999999998864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=266.60 Aligned_cols=213 Identities=22% Similarity=0.327 Sum_probs=169.6
Q ss_pred CCcccCCccceeeEEEE-eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++||||+++++++. .+...++||||+.+++|.+++..... .++...++.++.|++.|++|||+.+
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~ql~~~l~~lH~~~--- 148 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKYLASKK--- 148 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 56889999999999865 55678999999999999999976443 2788999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccc--ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT- 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 157 (243)
++|+||||+||+++.++.++|+|||+++......... ......+++.|+|||.+.+..++.++|+||||++++++++
T Consensus 149 i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 228 (298)
T 3f66_A 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 228 (298)
T ss_dssp CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998665433221 1223457788999999999899999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
+.+||..... ...............+...+..+.+++.+||+.||++|||+.++++.|++++..
T Consensus 229 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 229 GAPPYPDVNT----------------FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp SCCSSTTSCT----------------TTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCccCCH----------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 5566653321 111111122222233344566899999999999999999999999999999987
Q ss_pred cCCC
Q 026115 238 RSGP 241 (243)
Q Consensus 238 ~~~~ 241 (243)
..+.
T Consensus 293 ~~~~ 296 (298)
T 3f66_A 293 FIGE 296 (298)
T ss_dssp SCCS
T ss_pred hccC
Confidence 6553
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=267.00 Aligned_cols=223 Identities=37% Similarity=0.567 Sum_probs=173.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++...... .++++..++.++.|++.||.|||+.+ +
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i 154 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLHENH---H 154 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 56789999999999999999999999999999999999754321 13889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++................|++.|+|||.+.+ .++.++|+||||+++++|++|..|
T Consensus 155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999875543322222234568999999998865 478899999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
|................ ......+...++... ...+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 234 VDEHREPQLLLDIKEEI-EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BCTTBSSSBTTHHHHHH-HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cccCcchHHHHHHHHHh-hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 97643321111000000 000011222223322 34567888999999999999999999999999999998864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=270.12 Aligned_cols=216 Identities=22% Similarity=0.352 Sum_probs=171.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-CCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++||||+++++++.++...++||||+.+++|.+++....... .......++...++.++.|++.||.|||+.+
T Consensus 82 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--- 158 (322)
T 1p4o_A 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--- 158 (322)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 678999999999999999999999999999999999997632100 0000012688999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|+||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|+||||+++++|++ |.
T Consensus 159 i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 238 (322)
T 1p4o_A 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238 (322)
T ss_dssp CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999876554433222333456889999999998889999999999999999999 88
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
.||..... ......+........+...+..+.+++.+||+.||.+|||+.++++.|++++.
T Consensus 239 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 239 QPYQGLSN----------------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CTTTTSCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CccccCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 99864311 22222222222223344566789999999999999999999999999988754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=269.97 Aligned_cols=217 Identities=26% Similarity=0.358 Sum_probs=172.7
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
++++ +||||+++++++.+++..++||||+++++|.+++....... .......++...++.++.|++.||.||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 5678 89999999999999999999999999999999997653000 000011288999999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++|+||||+||+++.++.++|+|||+++....... .....+++.|+|||.+.+..++.++|+||||++++
T Consensus 159 H~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 159 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp HHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 9998 99999999999999999999999999864432211 12334678899999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+|++ |..||..... ....+.+........+...+..+.+++.+||+.||.+|||++++++.|+
T Consensus 233 ellt~g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTC----------------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp HHHTTSCCTTTTCCH----------------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHcCCCCCCCCCcH----------------HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9998 9999964421 2222222233333344456678999999999999999999999999999
Q ss_pred HHHhhcCC
Q 026115 233 PLLNTRSG 240 (243)
Q Consensus 233 ~~~~~~~~ 240 (243)
+++.+..+
T Consensus 297 ~~~~~~~~ 304 (327)
T 1fvr_A 297 RMLEERKT 304 (327)
T ss_dssp HHHHSSSC
T ss_pred HHHHhhcC
Confidence 99987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=270.75 Aligned_cols=211 Identities=25% Similarity=0.385 Sum_probs=167.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+....++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---i 168 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---Y 168 (333)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5688999999999999999999999999999999999976533 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|+||||+||+++.++.++|+|||+++......... ......++..|+|||++.+..++.++|+||||++++++++ |.
T Consensus 169 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 248 (333)
T 1mqb_A 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 248 (333)
T ss_dssp CCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 999999999999999999999999987665432211 1122345778999999998889999999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
.||.... .......+........+..++..+.+++.+||+.||++|||+.++++.|++++....
T Consensus 249 ~pf~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 249 RPYWELS----------------NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CTTTTCC----------------HHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCcccCC----------------HHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 9996431 122223333333334445567789999999999999999999999999999886543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=275.32 Aligned_cols=219 Identities=26% Similarity=0.366 Sum_probs=173.3
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCC-----CCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
++++ +||||+++++++.++...++||||+++|+|.+++...... ........++...++.++.|++.||.|||+
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 4567 8999999999999999999999999999999999754210 000001137899999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.+ ++|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++++|
T Consensus 183 ~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 183 KN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp TT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 98 999999999999999999999999999866543332223334567889999999988899999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
++ |..||..... ................+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 260 ~t~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 260 FSLGLNPYPGILV---------------NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp TTTSCCSSTTCCS---------------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCCcccch---------------hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 98 8999864421 1222233333333333444567899999999999999999999999999988
Q ss_pred Hhhc
Q 026115 235 LNTR 238 (243)
Q Consensus 235 ~~~~ 238 (243)
..+.
T Consensus 325 ~~~~ 328 (333)
T 2i1m_A 325 AQED 328 (333)
T ss_dssp HHHH
T ss_pred HHhh
Confidence 7653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=267.62 Aligned_cols=217 Identities=21% Similarity=0.296 Sum_probs=164.4
Q ss_pred CCcccCCccceeeEEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+++++||||+++++++.+.. ..++||||+.+++|.+++....... ....+++..++.++.|++.||.|||+.
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~ 166 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLSNR 166 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56889999999999998654 4599999999999999985432111 111388999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
+ ++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++++|+
T Consensus 167 ~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 243 (313)
T 3brb_A 167 N---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243 (313)
T ss_dssp T---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred C---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence 8 9999999999999999999999999987665433222223345778999999999888999999999999999999
Q ss_pred h-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 157 T-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 157 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
+ |..||..... ......+........+...+..+.+++.+||+.||.+|||+.++++.|++++
T Consensus 244 ~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 244 TRGMTPYPGVQN----------------HEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp TTSCCSSTTCCG----------------GGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCccCCH----------------HHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9 8889864422 1122222222223344556678999999999999999999999999999998
Q ss_pred hhcCC
Q 026115 236 NTRSG 240 (243)
Q Consensus 236 ~~~~~ 240 (243)
.+..+
T Consensus 308 ~~lp~ 312 (313)
T 3brb_A 308 ESLPD 312 (313)
T ss_dssp HHC--
T ss_pred HhcCC
Confidence 87643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=271.81 Aligned_cols=219 Identities=23% Similarity=0.375 Sum_probs=174.5
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC-------CCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
++++ +||||+++++++.+++..++||||+.+++|.+++........ ......+++..++.++.|++.||.||
T Consensus 94 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 173 (334)
T 2pvf_A 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173 (334)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4456 899999999999999999999999999999999987542110 01112378899999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++|+||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++||||||++++
T Consensus 174 H~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 174 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250 (334)
T ss_dssp HHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence 9998 9999999999999999999999999987654433222223345678899999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
+|++ |..||.... .......+........+..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus 251 ellt~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 251 EIFTLGGSPYPGIP----------------VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp HHHTTSCCSSTTCC----------------HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhCCCCCcCcCC----------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9999 999986431 12222223233333444556678999999999999999999999999999
Q ss_pred HHHhhcC
Q 026115 233 PLLNTRS 239 (243)
Q Consensus 233 ~~~~~~~ 239 (243)
+++....
T Consensus 315 ~l~~~~~ 321 (334)
T 2pvf_A 315 RILTLTT 321 (334)
T ss_dssp HHHHHHC
T ss_pred HHHhccc
Confidence 9987554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=271.65 Aligned_cols=196 Identities=23% Similarity=0.361 Sum_probs=162.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.|+.|||+.| +
T Consensus 69 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---i 136 (361)
T 2yab_A 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---------LSEEEATSFIKQILDGVNYLHTKK---I 136 (361)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSC---------CBHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 6789999999999999999999999999999999999976542 899999999999999999999998 9
Q ss_pred EeccCCCCceEecCCC----ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
+||||||+||+++.++ .++|+|||++........ .....||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 137 vHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~ 213 (361)
T 2yab_A 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213 (361)
T ss_dssp ECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHh
Confidence 9999999999998776 799999999876544321 234568999999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP----PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||.+.... +....+..... ..+ ...+..+.+++.+||+.||.+|||+.++++
T Consensus 214 g~~Pf~~~~~~---------------~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 214 GASPFLGDTKQ---------------ETLANITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp SCCSSCCSSHH---------------HHHHHHHTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCHH---------------HHHHHHHhcCC--CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999644211 11111111111 112 123567999999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=269.21 Aligned_cols=198 Identities=21% Similarity=0.279 Sum_probs=164.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+...+++||||+++|+|..++..... ++...+..++.|++.||.|||+.+ +
T Consensus 59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---i 126 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---V 126 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 127 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 204 (337)
T 1o6l_A 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204 (337)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCC
Confidence 9999999999999999999999999875432221 12345689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~~ 230 (243)
|..... ......+..... ..+...+..+.+++.+||+.||++|| +++++++.
T Consensus 205 f~~~~~---------------~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 205 FYNQDH---------------ERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SCCSSH---------------HHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCH---------------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 964321 111111222221 23445567899999999999999999 89999873
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=287.82 Aligned_cols=212 Identities=28% Similarity=0.428 Sum_probs=172.8
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+ +..++||||+.+|+|.+++..... .+++..++.++.|++.||+|||+.+
T Consensus 389 il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~--- 456 (613)
T 2ozo_A 389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN--- 456 (613)
T ss_dssp HHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999976 568999999999999999975432 2889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-C
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 158 (243)
++||||||+||+++.++.++|+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |
T Consensus 457 iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G 536 (613)
T 2ozo_A 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536 (613)
T ss_dssp CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999998764332211 1122335678999999998899999999999999999998 9
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
..||.... ...+...+..+.+...+..++..+.+++.+||+.||++|||+.++++.|+++..+.
T Consensus 537 ~~Pf~~~~----------------~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 537 QKPYKKMK----------------GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCTTTTCC----------------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCC----------------HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 99997442 12334444444445566677889999999999999999999999999999987765
Q ss_pred CC
Q 026115 239 SG 240 (243)
Q Consensus 239 ~~ 240 (243)
+.
T Consensus 601 ~~ 602 (613)
T 2ozo_A 601 AS 602 (613)
T ss_dssp SC
T ss_pred cc
Confidence 54
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=277.38 Aligned_cols=199 Identities=20% Similarity=0.228 Sum_probs=163.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~---------~~e~~~~~i~~qil~aL~~lH~~g---i 131 (444)
T 3soa_A 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---------YSEADASHCIQQILEAVLHCHQMG---V 131 (444)
T ss_dssp HHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999887643 889999999999999999999999 9
Q ss_pred EeccCCCCceEec---CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+||||||+||+++ .++.++|+|||++......... .....||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 132 vHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G 209 (444)
T 3soa_A 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209 (444)
T ss_dssp BCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhC
Confidence 9999999999998 4678999999999766543221 2335689999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||..... .+....+...... .......+..+.+++.+||+.||++|||+.++++
T Consensus 210 ~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 210 YPPFWDEDQ---------------HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp SCSCCCSSH---------------HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCccH---------------HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999964321 1111112211111 1111245668999999999999999999999997
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=265.89 Aligned_cols=209 Identities=27% Similarity=0.394 Sum_probs=171.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++ +.+..++||||+.+++|.+++..... ++...++.++.|++.|+.|||+.+ +
T Consensus 72 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i 138 (291)
T 1xbb_A 72 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---F 138 (291)
T ss_dssp HHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999 56678999999999999999987542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|+||||+||+++.++.++|+|||++.......... ......+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 139 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 218 (291)
T 1xbb_A 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 218 (291)
T ss_dssp ECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred EcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCC
Confidence 999999999999999999999999987654332211 1122346788999999988888999999999999999999 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
.||..... ......+........+...+..+.+++.+||+.||++|||+.++++.|++++....
T Consensus 219 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 219 KPYRGMKG----------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CSSTTCCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 99964421 22333333333334455667789999999999999999999999999999987643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=272.85 Aligned_cols=220 Identities=18% Similarity=0.211 Sum_probs=168.6
Q ss_pred CCcccCCccceeeEEEEeC----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKNENVVELVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
+++++||||+++++++... ...++||||+ +++|.+++..... .+++..++.++.|++.||+|||+.+
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~~~ 172 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHEHE 172 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3578999999999998764 5689999999 9999999987532 2899999999999999999999998
Q ss_pred CCCeEeccCCCCceEec--CCCceeecccCCCCCCcccccccc-----cccccccccccCchhhccCCCCcccchHHHHH
Q 026115 78 EPRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGV 150 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ 150 (243)
++||||||+||+++ .++.++|+|||+++.......... .....||+.|+|||++.+..++.++|||||||
T Consensus 173 ---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 249 (364)
T 3op5_A 173 ---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGY 249 (364)
T ss_dssp ---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHH
Confidence 99999999999999 889999999999976544322111 12344899999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
++|+|++|..||......... ..... ..........++..+. ....+..+.+++..||+.||.+|||+.++++.
T Consensus 250 ~l~el~~g~~Pf~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 250 CMIQWLTGHLPWEDNLKDPKY--VRDSK-IRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHHSCCTTGGGTTCHHH--HHHHH-HHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHhCCCCccccccCHHH--HHHHH-HHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 999999999999743211000 00000 0000111112211111 01235579999999999999999999999999
Q ss_pred HHHHHhhcC
Q 026115 231 LQPLLNTRS 239 (243)
Q Consensus 231 l~~~~~~~~ 239 (243)
|++++....
T Consensus 324 l~~~~~~~~ 332 (364)
T 3op5_A 324 LLQGLKAIG 332 (364)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHcC
Confidence 999987654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=273.54 Aligned_cols=225 Identities=27% Similarity=0.363 Sum_probs=177.7
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.+ ...+++||||+++++|.+++.... +++..++.++.|++.|+.|||+.+
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~-- 154 (318)
T 3lxp_A 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQH-- 154 (318)
T ss_dssp HHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 567899999999999987 467899999999999999998764 889999999999999999999999
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||||+||+++.++.++|+|||++.......... ......++..|+|||++.+..++.++||||||+++++|++|
T Consensus 155 -ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g 233 (318)
T 3lxp_A 155 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233 (318)
T ss_dssp -EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred -ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999987665432211 12234578889999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
..||......... ...............+.+........+..++..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 234 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 234 CDSSQSPPTKFLE-LIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TCGGGSHHHHHHH-HHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCcccccchhhhh-hhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 9998643111000 000000111122334444445555566667788999999999999999999999999999998765
Q ss_pred CC
Q 026115 239 SG 240 (243)
Q Consensus 239 ~~ 240 (243)
..
T Consensus 313 ~~ 314 (318)
T 3lxp_A 313 QG 314 (318)
T ss_dssp HC
T ss_pred cc
Confidence 44
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=260.98 Aligned_cols=206 Identities=23% Similarity=0.347 Sum_probs=167.9
Q ss_pred CCCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 1 MVSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
++++++||||+++++++.++ ...++||||+++|+|.+++...... .+++..++.++.|++.|+.|||+.+
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~- 131 (271)
T 3kmu_A 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMARGMAFLHTLE- 131 (271)
T ss_dssp GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSC-------CCCHHHHHHHHHHHHHHHHHHTTSS-
T ss_pred HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 46789999999999999877 7889999999999999999876532 2899999999999999999999874
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCc---ccchHHHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS---KSDVYSFGVVLLEL 155 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~DiwslG~~l~~l 155 (243)
..++|+||||+||+++.++.++++|||+...... ....||+.|+|||.+.+..++. ++||||||+++|++
T Consensus 132 ~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 204 (271)
T 3kmu_A 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWEL 204 (271)
T ss_dssp SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHH
T ss_pred CceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHH
Confidence 3499999999999999999999998887654222 2345789999999998755444 79999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
++|..||..... ................+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus 205 ~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 205 VTREVPFADLSN---------------MEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHCSCTTTTSCH---------------HHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HhCCCCccccCh---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 999999964311 12222333333334455566778999999999999999999999999999886
Q ss_pred h
Q 026115 236 N 236 (243)
Q Consensus 236 ~ 236 (243)
+
T Consensus 270 ~ 270 (271)
T 3kmu_A 270 D 270 (271)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=283.61 Aligned_cols=211 Identities=27% Similarity=0.443 Sum_probs=169.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++.+ +..++||||+.+|+|.+++....+. .++...++.++.|++.|++|||+.+ +
T Consensus 233 l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~---i 301 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN---Y 301 (452)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 578899999999999876 6789999999999999999754322 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 302 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~ 380 (452)
T 1fmk_A 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380 (452)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCC
Confidence 99999999999999999999999999866432211 1122346788999999998899999999999999999999 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~~ 240 (243)
||.... .......+..+.+...+..++..+.+++.+||+.||++|||++++++.|+++..+...
T Consensus 381 P~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 381 PYPGMV----------------NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp SSTTCC----------------HHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 996431 1233333344444455666778899999999999999999999999999998865543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=269.28 Aligned_cols=199 Identities=17% Similarity=0.205 Sum_probs=162.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... .+++..++.++.|++.|+.|||+.+ +
T Consensus 55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~g---i 123 (321)
T 1tki_A 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---I 123 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 5678999999999999999999999999999999999976542 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecC--CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 82 IHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
+||||||+||+++. ++.++|+|||+++....... .....|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 124 vH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 200 (321)
T 1tki_A 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999987 78999999999876543321 23345899999999999888899999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE--YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.||..... .+....+........ .....+..+.+++.+||+.||.+|||+.++++
T Consensus 201 ~pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 201 NPFLAETN---------------QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CTTCCSSH---------------HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcCCCH---------------HHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99964321 111122222211100 00123567999999999999999999999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=265.30 Aligned_cols=208 Identities=29% Similarity=0.490 Sum_probs=156.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++ .....++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 74 l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~~---i 141 (289)
T 3og7_A 74 LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLHAKS---I 141 (289)
T ss_dssp HTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 6789999999999965 45668999999999999999975543 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||||+||+++.++.++|+|||++................|++.|+|||.+. +..++.++||||||+++++|++|
T Consensus 142 ~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 221 (289)
T 3og7_A 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221 (289)
T ss_dssp CCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHS
T ss_pred ccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHC
Confidence 999999999999999999999999987654332222233456899999999986 55678899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
..||...... ....+....... ......++..+.+++.+||+.||.+|||++++++.|+++
T Consensus 222 ~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 222 QLPYSNINNR---------------DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp SCTTSSCCCH---------------HHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCccccchH---------------HHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 9999643211 111221111111 122234567899999999999999999999999999988
Q ss_pred Hh
Q 026115 235 LN 236 (243)
Q Consensus 235 ~~ 236 (243)
..
T Consensus 287 ~~ 288 (289)
T 3og7_A 287 AR 288 (289)
T ss_dssp TC
T ss_pred hh
Confidence 65
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=265.90 Aligned_cols=198 Identities=24% Similarity=0.355 Sum_probs=162.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..++..++||||+++++|.+++.... +++..+..++.|++.|+.|||+.+ +
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------l~~~~~~~i~~qi~~~L~~LH~~~---i 162 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQG---V 162 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578999999999999999999999999999999999987543 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||||+||+++.++.++|+|||++......... .....||+.|+|||++.+..++.++|+||||+++++|++|..|
T Consensus 163 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 240 (321)
T 2c30_A 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240 (321)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998655432211 2345689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhcccc-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|...... .....+..... ........+..+.+++.+||+.||++|||+.++++
T Consensus 241 f~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 241 YFSDSPV---------------QAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp TTTSCHH---------------HHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCHH---------------HHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9644211 11111111110 01122334567999999999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=270.65 Aligned_cols=223 Identities=23% Similarity=0.330 Sum_probs=173.6
Q ss_pred CCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.+. ...++||||+++++|.+++..... .++...++.++.|++.|++|||+.+
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~-- 146 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGSRQ-- 146 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcCC--
Confidence 5688999999999999876 678999999999999999965442 2889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccc-cccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||||+||+++.++.++|+|||++......... .......|+..|+|||.+.+..++.++|+||||+++++|++|
T Consensus 147 -i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 225 (302)
T 4e5w_A 147 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225 (302)
T ss_dssp -EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred -cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHc
Confidence 999999999999999999999999998765543221 112334578889999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
..|+............ .......................+...+..+.+++.+||+.||.+|||+.++++.|+++++
T Consensus 226 ~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 226 CDSDSSPMALFLKMIG-PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp TCGGGSHHHHHHHHHC-SCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred cCCCcchhhHHhhccC-CcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 9886432110000000 0001112223333444444445556677889999999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=269.45 Aligned_cols=198 Identities=23% Similarity=0.328 Sum_probs=161.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 68 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---i 135 (326)
T 2y0a_A 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSLQ---I 135 (326)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSC---------CBHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCC---------cCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999976542 899999999999999999999998 9
Q ss_pred EeccCCCCceEecCCC----ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
+|+||||+||+++.++ .++|+|||+++....... .....||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 136 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 212 (326)
T 2y0a_A 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212 (326)
T ss_dssp ECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred EcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999998877 799999999876543221 233468999999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||...... +....+...... .......+..+.+++.+||+.||++|||+.++++
T Consensus 213 g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 213 GASPFLGDTKQ---------------ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp SCCSSCCSSHH---------------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCCCCCCCHH---------------HHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999643211 111111111110 0001123567999999999999999999999997
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=265.42 Aligned_cols=194 Identities=24% Similarity=0.369 Sum_probs=163.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++..+++||||+.+|+|.+++..... ++...+..++.|++.||.|||+.+ +
T Consensus 60 l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---i 127 (318)
T 1fot_A 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---I 127 (318)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999987542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++..... .....||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 128 vHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 202 (318)
T 1fot_A 128 IYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202 (318)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred cccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 99999999999999999999999998755432 2335689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
|..... ......+..... ..+...+..+.+++.+||+.||.+|| +++++++
T Consensus 203 f~~~~~---------------~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 203 FYDSNT---------------MKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TCCSSH---------------HHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCH---------------HHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 964311 122222332222 23444567899999999999999999 8898885
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=268.32 Aligned_cols=206 Identities=24% Similarity=0.392 Sum_probs=161.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... .++...++.++.|++.||.|||+.+ +
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---i 134 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEENT---L 134 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 5688999999999999999999999999999999999987543 2888999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCc--------eeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDI--------AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVL 152 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l 152 (243)
+||||||+||+++.++. ++|+|||++...... ....|++.|+|||++.+ ..++.++||||||+++
T Consensus 135 vH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 208 (289)
T 4fvq_A 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208 (289)
T ss_dssp CCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred ECCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence 99999999999988876 999999998655432 22347889999999987 6689999999999999
Q ss_pred HHHHhCCCC-CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 153 LELLTGRKP-VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 153 ~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
++|++|..| |..... ........... ..+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 209 ~el~~g~~~~~~~~~~----------------~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 209 WEICSGGDKPLSALDS----------------QRKLQFYEDRH--QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp HHHHTTTCCTTTTSCH----------------HHHHHHHHTTC--CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCccccch----------------HHHHHHhhccC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999996544 432211 11111111111 11222245699999999999999999999999999
Q ss_pred HHHHhhcCCCC
Q 026115 232 QPLLNTRSGPS 242 (243)
Q Consensus 232 ~~~~~~~~~~~ 242 (243)
++++....+++
T Consensus 271 ~~l~~p~~~~~ 281 (289)
T 4fvq_A 271 NSLFTPDLVPR 281 (289)
T ss_dssp HTCC-------
T ss_pred HHhcCCCCCCC
Confidence 99988766543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=290.25 Aligned_cols=209 Identities=27% Similarity=0.387 Sum_probs=172.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++.+ +..++||||+.+|+|.+++..... +++..++.++.|++.||+|||+.+ +
T Consensus 424 l~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~yLH~~~---i 490 (635)
T 4fl3_A 424 MQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---F 490 (635)
T ss_dssp HHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 568899999999999975 457899999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccc-cccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+||||||+||+++.++.++|+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 491 iHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp CCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998755433221 11222346788999999999899999999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
.||... ....+.+.+........+..++..+.+++.+||+.||++|||+++|++.|+++..+..
T Consensus 571 ~Pf~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 571 KPYRGM----------------KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CSSTTC----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCC----------------CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 999644 2234444555555556666778899999999999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=262.44 Aligned_cols=207 Identities=20% Similarity=0.306 Sum_probs=165.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++ ..++||||+.+++|.+++..... .++...++.++.|++.|+.|||+.+ +
T Consensus 67 l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 134 (281)
T 3cc6_A 67 MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLESIN---C 134 (281)
T ss_dssp HHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999998754 56899999999999999976542 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++|+|||++......... ......+++.|+|||++.+..++.++|+||||+++++|++ |..
T Consensus 135 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~ 213 (281)
T 3cc6_A 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213 (281)
T ss_dssp CCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765443221 1223346788999999998889999999999999999998 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
||..... ......+........+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 214 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 214 PFFWLEN----------------KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TTTTSCG----------------GGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccCCh----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 9964322 112222222222233444567899999999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=261.88 Aligned_cols=207 Identities=24% Similarity=0.346 Sum_probs=160.2
Q ss_pred cccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh-----
Q 026115 4 RLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH----- 74 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh----- 74 (243)
+++||||+++++++.+ +...++||||+++|+|.+++.... +++..++.++.|++.|++|||
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~ 127 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFG 127 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCS
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 4899999999999764 356899999999999999996543 899999999999999999999
Q ss_pred ---hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc--ccccccccccccCchhhccC------CCCccc
Q 026115 75 ---EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTG------QMSSKS 143 (243)
Q Consensus 75 ---~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~~~ 143 (243)
+.+ ++||||||+||+++.++.++|+|||+++......... ......||+.|+|||++.+. .++.++
T Consensus 128 ~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 204 (301)
T 3q4u_A 128 TQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204 (301)
T ss_dssp TTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHH
T ss_pred ccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchh
Confidence 777 9999999999999999999999999986544332211 12234689999999999876 344689
Q ss_pred chHHHHHHHHHHHhC----------CCCCCCCCCCCCccceeeccCcCchhhhhhhh-ccccCCC-----CCHHHHHHHH
Q 026115 144 DVYSFGVVLLELLTG----------RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV-DTKLGGE-----YPPKAIAKMA 207 (243)
Q Consensus 144 DiwslG~~l~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~ 207 (243)
||||||+++|+|++| ..||....+... ......... ....... .....+..+.
T Consensus 205 DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 273 (301)
T 3q4u_A 205 DIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP-----------SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLA 273 (301)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHH
T ss_pred hHHHHHHHHHHHHhhhcCccccccccccccccCCCCc-----------chhhhhHHHhccCCCCCCChhhccCccHHHHH
Confidence 999999999999999 666654322111 111111111 1111111 1235778899
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 208 AVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 208 ~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
+++.+||+.||++|||+.++++.|+++
T Consensus 274 ~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 274 KLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=263.92 Aligned_cols=213 Identities=17% Similarity=0.183 Sum_probs=169.0
Q ss_pred Ccc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 3 SRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 3 ~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++ +|+|++++++++.++...++||||+ +++|.+++..... .++...++.++.|++.|+.|||+.+ +
T Consensus 60 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 127 (298)
T 1csn_A 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---L 127 (298)
T ss_dssp HHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 455 7999999999999999999999999 8899999986542 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCc-----eeecccCCCCCCccccccc-----ccccccccccccCchhhccCCCCcccchHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDI-----AKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 151 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~-----~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~ 151 (243)
+|+||||+||+++.++. ++|+|||+++......... ......||+.|+|||++.+..++.++||||||++
T Consensus 128 vH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 207 (298)
T 1csn_A 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 207 (298)
T ss_dssp ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHH
Confidence 99999999999987765 9999999987655432211 1234568999999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 152 LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE---YPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 152 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
+++|++|..||......... .....+........ .....+..+.+++.+||+.||++|||+++|+
T Consensus 208 l~el~~g~~pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~ 275 (298)
T 1csn_A 208 FMYFLRGSLPWQGLKAATNK------------QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 275 (298)
T ss_dssp HHHHHHSSCTTSSCCSCCHH------------HHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HHHHHcCCCCcchhhccccH------------HHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 99999999999764321111 11111111110000 1113456799999999999999999999999
Q ss_pred HHHHHHHhhcC
Q 026115 229 KALQPLLNTRS 239 (243)
Q Consensus 229 ~~l~~~~~~~~ 239 (243)
+.|++++....
T Consensus 276 ~~l~~~~~~~~ 286 (298)
T 1csn_A 276 GLFSKVLERLN 286 (298)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHhcC
Confidence 99999988754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=269.68 Aligned_cols=199 Identities=22% Similarity=0.291 Sum_probs=161.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---i 149 (362)
T 2bdw_A 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNG---I 149 (362)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999876542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCC---ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+||||||+||+++.++ .++|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 150 vH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 226 (362)
T 2bdw_A 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226 (362)
T ss_dssp BCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999998654 599999999976653321 2335689999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
..||...... .....+...... .......+..+.+++.+||+.||++|||+.++++.
T Consensus 227 ~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 227 YPPFWDEDQH---------------RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp SCSSCCSSHH---------------HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCHH---------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999643211 111111111111 11112346689999999999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=272.29 Aligned_cols=196 Identities=21% Similarity=0.298 Sum_probs=158.3
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
+||||++++++|.++..+++||||+.+|+|..++..... +++..+..++.|++.||.|||+.+ ++|||
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 178 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRD 178 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEecc
Confidence 899999999999999999999999999999999987542 899999999999999999999999 99999
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 165 (243)
|||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||...
T Consensus 179 LKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred CCHHHEEECCCCCEEEeecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999975332221 133456899999999999999999999999999999999999999643
Q ss_pred CCCCCccceeeccCcCchhhhh-hhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 166 LPRGQQSLVTWATPKLSEDKVK-QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
....... ........ .+.... ...+...+..+.+++.+||+.||.+||++
T Consensus 257 ~~~~~~~-------~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 257 GSSDNPD-------QNTEDYLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp TC-------------CCHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccccccc-------hhhHHHHHHHHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 2211100 00111111 222222 23444567789999999999999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=270.95 Aligned_cols=203 Identities=21% Similarity=0.246 Sum_probs=153.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+|+|.+++..... ++...+..++.|++.||+|||+.| +
T Consensus 70 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~ql~~~L~~LH~~~---i 137 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR---------FSEDEARFFFQQLLSGVSYCHSMQ---I 137 (361)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999976542 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCc--eeecccCCCCCCcccccccccccccccccccCchhhccCCCCcc-cchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDI--AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK-SDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g 158 (243)
+||||||+||+++.++. ++|+|||+++....... .....||+.|+|||++.+..++.+ +|||||||++|+|++|
T Consensus 138 vH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 214 (361)
T 3uc3_A 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214 (361)
T ss_dssp CSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHS
T ss_pred ccCCCCHHHEEEcCCCCceEEEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhC
Confidence 99999999999987765 99999999874332221 233468999999999988777665 8999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
..||........ .......+.............+..+.+++.+||+.||++|||+.++++.
T Consensus 215 ~~Pf~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 215 AYPFEDPEEPRD-----------YRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp SCSCC----CCC-----------HHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCCccHHH-----------HHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 999975432111 1111222222222222222345679999999999999999999999873
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=269.15 Aligned_cols=216 Identities=25% Similarity=0.383 Sum_probs=170.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++........ ....+++..++.++.|++.|+.|||+.+ +
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~---i 161 (327)
T 2yfx_A 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQYLEENH---F 161 (327)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSS--STTSCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhccccc--ccccccHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 5678999999999999999999999999999999999987653221 1123889999999999999999999998 9
Q ss_pred EeccCCCCceEecC---CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-
Q 026115 82 IHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT- 157 (243)
Q Consensus 82 ~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 157 (243)
+|+||||+||+++. +..++|+|||++................+++.|+|||.+.+..++.++|+||||+++++|++
T Consensus 162 ~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 241 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241 (327)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999984 44699999998764433222222234457889999999998889999999999999999998
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
|..||.... .......+........+..++..+.+++.+||+.||.+|||+.++++.|..+...
T Consensus 242 g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 242 GYMPYPSKS----------------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp SCCSSTTCC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCcC----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 999986431 1222222333323334445667899999999999999999999999999988764
Q ss_pred c
Q 026115 238 R 238 (243)
Q Consensus 238 ~ 238 (243)
.
T Consensus 306 ~ 306 (327)
T 2yfx_A 306 P 306 (327)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=263.89 Aligned_cols=198 Identities=25% Similarity=0.298 Sum_probs=157.3
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.+ +...++||||+++++|.+++.... +++..+..++.|++.||.|||+.+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~-- 157 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP----------LSEDQARFYFQDLIKGIEYLHYQK-- 157 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSC----------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 568899999999999986 678999999999999988654432 899999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC---CCcccchHHHHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~l~ 156 (243)
++|+||||+||+++.++.++|+|||+++........ .....||+.|+|||++.+.. ++.++|+||||+++|+|+
T Consensus 158 -ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 158 -IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred -eeccCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 999999999999999999999999998765433211 23346899999999997654 367899999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||...... .....+.............+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 235 FGQCPFMDERIM---------------CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HSSCSSCCSSHH---------------HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HCCCCCCCccHH---------------HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999643110 1111111111111222234567999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=267.46 Aligned_cols=220 Identities=22% Similarity=0.331 Sum_probs=172.8
Q ss_pred CCcc-cCCccceeeEEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCCC-------CCCCccCHHHHHHHHHHHHHHHHH
Q 026115 2 VSRL-KNENVVELVGYYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEY 72 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~~~~ql~~~l~~ 72 (243)
++++ +||||+++++++...+ ..++||||+.+++|.+++......... .....++...++.++.|++.|+.|
T Consensus 84 l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 3456 7999999999988654 599999999999999999876431000 001127889999999999999999
Q ss_pred hhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHH
Q 026115 73 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 152 (243)
Q Consensus 73 Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 152 (243)
||+.+ ++|+||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|+||||+++
T Consensus 164 lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 240 (316)
T 2xir_A 164 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240 (316)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHH
Confidence 99998 999999999999999999999999999866543332223344578899999999998999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 153 LELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 153 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
++|++ |..||..... .......+........+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus 241 ~~l~t~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 241 WEIFSLGASPYPGVKI---------------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HHHHTTSCCSSTTCCC---------------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCCCCcccch---------------hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99998 9999964321 1122222222222333444566899999999999999999999999999
Q ss_pred HHHHhhcC
Q 026115 232 QPLLNTRS 239 (243)
Q Consensus 232 ~~~~~~~~ 239 (243)
++++....
T Consensus 306 ~~~~~~~~ 313 (316)
T 2xir_A 306 GNLLQANA 313 (316)
T ss_dssp HHHHHHHC
T ss_pred HHHHhhhc
Confidence 99987643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=267.29 Aligned_cols=195 Identities=25% Similarity=0.300 Sum_probs=160.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+ +|+|.+++..... +++..+..++.|++.|+.|||+.| +
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---i 129 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR---------MTEDEGRRFFQQIICAIEYCHRHK---I 129 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHT---C
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 57899999999999999999999999999 6799998876542 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|..
T Consensus 130 vH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 206 (336)
T 3h4j_B 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206 (336)
T ss_dssp CCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSC
T ss_pred EecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876544322 233468999999999987766 689999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||............ ... ....+...+..+.+++.+||+.||.+|||++++++
T Consensus 207 Pf~~~~~~~~~~~i----------------~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 207 PFDDEFIPNLFKKV----------------NSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSBCSSSTTCBCCC----------------CSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCccHHHHHHHH----------------HcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 99754222111100 000 11223344567999999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=261.23 Aligned_cols=228 Identities=18% Similarity=0.233 Sum_probs=168.9
Q ss_pred CCcccCCccceeeEEEEeCC--eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDGP--LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.... ..++||||+++++|.+++....... .+++..++.++.|++.||+|||+.+
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~-- 132 (319)
T 4euu_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY------GLPESEFLIVLRDVVGGMNHLRENG-- 132 (319)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTT------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhcccc------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 56789999999999998655 7899999999999999998754211 2789999999999999999999999
Q ss_pred CeEeccCCCCceEe----cCCCceeecccCCCCCCcccccccccccccccccccCchhhc--------cCCCCcccchHH
Q 026115 80 RIIHRNIKSSNVLL----FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--------TGQMSSKSDVYS 147 (243)
Q Consensus 80 ~~~h~di~~~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Diws 147 (243)
++|+||||+||++ +.++.++|+|||+++....... .....|++.|+|||++. +..++.++||||
T Consensus 133 -ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diws 208 (319)
T 4euu_A 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS 208 (319)
T ss_dssp -EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHH
T ss_pred -EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHH
Confidence 9999999999999 7778899999999876544322 22345899999999986 467789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcc-ceeeccCcCch----------hhhhhh-hccccCCCCCHHHHHHHHHHHHhhcC
Q 026115 148 FGVVLLELLTGRKPVDHTLPRGQQS-LVTWATPKLSE----------DKVKQC-VDTKLGGEYPPKAIAKMAAVAALCVQ 215 (243)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~----------~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~ 215 (243)
|||++|+|++|..||.......... ........... ...... .............+..+.+++.+||+
T Consensus 209 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 288 (319)
T 4euu_A 209 IGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288 (319)
T ss_dssp HHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhcc
Confidence 9999999999999996432211100 00000000000 000000 00111124567888999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHhhcCCC
Q 026115 216 YEADFRPNMGIVLKALQPLLNTRSGP 241 (243)
Q Consensus 216 ~~p~~Rps~~~vl~~l~~~~~~~~~~ 241 (243)
.||++|||++|+++..++-.....++
T Consensus 289 ~dP~~R~s~~ell~h~~d~~~~~~~~ 314 (319)
T 4euu_A 289 ADQEKCWGFDQFFAETSDILHRGNSH 314 (319)
T ss_dssp CCTTTSCCHHHHHHHHHHHTC-----
T ss_pred CChhhhccHHHhhhccHHHhhcCCcc
Confidence 99999999999999998766554443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=271.43 Aligned_cols=196 Identities=21% Similarity=0.297 Sum_probs=159.4
Q ss_pred Ccc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 3 SRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 3 ~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++ +||||+++++++.++..+++||||+.+|+|..++..... +++..+..++.|++.||+|||+.+ +
T Consensus 78 ~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---i 145 (353)
T 3txo_A 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEIISALMFLHDKG---I 145 (353)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 344 799999999999999999999999999999999987543 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++........ .....||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 146 vHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P 223 (353)
T 3txo_A 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223 (353)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCCHHHEEECCCCCEEEccccceeecccCCcc--ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCC
Confidence 99999999999999999999999998754332211 2345689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM------GIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~vl~ 229 (243)
|..... .+....+..... ..+...+..+.+++.+||+.||.+||++ .++++
T Consensus 224 f~~~~~---------------~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 224 FEAENE---------------DDLFEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp SCCSSH---------------HHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCH---------------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 974421 112222222222 3344456789999999999999999998 77765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=270.07 Aligned_cols=207 Identities=21% Similarity=0.260 Sum_probs=164.8
Q ss_pred CCcccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
+++++||||+++++++.. +...++||||+ +++|.+++..... +++..++.++.|++.||+|||+.+
T Consensus 102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~ 171 (345)
T 2v62_A 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT---------FKKSTVLQLGIRMLDVLEYIHENE 171 (345)
T ss_dssp HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGB---------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 356799999999999987 78899999999 9999999987642 899999999999999999999998
Q ss_pred CCCeEeccCCCCceEecCCC--ceeecccCCCCCCccccccc-----ccccccccccccCchhhccCCCCcccchHHHHH
Q 026115 78 EPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGV 150 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~--~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ 150 (243)
++||||||+||+++.++ .++|+|||+++......... ......|++.|+|||++.+..++.++|||||||
T Consensus 172 ---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 248 (345)
T 2v62_A 172 ---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGY 248 (345)
T ss_dssp ---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHH
T ss_pred ---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHH
Confidence 99999999999998877 99999999997654332111 113346899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCH---------HHHHHHHHHHHhhcCCCCCCC
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP---------KAIAKMAAVAALCVQYEADFR 221 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~R 221 (243)
++|+|++|..||........ ... ..........+. ..+..+.+++.+||+.||++|
T Consensus 249 il~ell~g~~pf~~~~~~~~--------------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 313 (345)
T 2v62_A 249 CMLRWLCGKLPWEQNLKDPV--------------AVQ-TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEK 313 (345)
T ss_dssp HHHHHHHSSCTTGGGTTCHH--------------HHH-HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCC
T ss_pred HHHHHHhCCCCccccccccH--------------HHH-HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccC
Confidence 99999999999964211100 000 000000001111 345579999999999999999
Q ss_pred CCHHHHHHHHHHHHh
Q 026115 222 PNMGIVLKALQPLLN 236 (243)
Q Consensus 222 ps~~~vl~~l~~~~~ 236 (243)
||+.+|++.|+++..
T Consensus 314 ps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 314 PNYQALKKILNPHGI 328 (345)
T ss_dssp CCHHHHHHHHCTTCC
T ss_pred CCHHHHHHHHhccCC
Confidence 999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=270.64 Aligned_cols=200 Identities=21% Similarity=0.260 Sum_probs=162.5
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.++...++||||+.+++|.+++..... .+++..++.++.|++.||+|||+.+
T Consensus 101 il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g--- 169 (387)
T 1kob_A 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS--- 169 (387)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999999999999976542 2899999999999999999999998
Q ss_pred eEeccCCCCceEecC--CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++||||||+||+++. .+.++|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 170 ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 246 (387)
T 1kob_A 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246 (387)
T ss_dssp EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred eeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhC
Confidence 999999999999974 46799999999876543221 2234589999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhcc--ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT--KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||...... .....+... ..........+..+.+++.+||+.||++|||+.++++
T Consensus 247 ~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 247 LSPFAGEDDL---------------ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCSSCCSSHH---------------HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCHH---------------HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 9999754211 111111111 1111222345668999999999999999999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=264.99 Aligned_cols=212 Identities=19% Similarity=0.253 Sum_probs=168.9
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++ +||||+++++++.++...++||||+ +++|.+++..... .+++..++.++.|++.||+|||+.+
T Consensus 58 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~--- 125 (330)
T 2izr_A 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVHSKN--- 125 (330)
T ss_dssp HHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4567 8999999999999999999999999 8999999986532 2899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCc-----eeecccCCCCCCccccccc-----ccccccccccccCchhhccCCCCcccchHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDI-----AKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGV 150 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~-----~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ 150 (243)
++||||||+||+++.++. ++|+|||+++......... ......||+.|+|||++.+..++.++|+||||+
T Consensus 126 iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 205 (330)
T 2izr_A 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGH 205 (330)
T ss_dssp EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHH
Confidence 999999999999998887 9999999997654332211 123456899999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEY---PPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
++|+|++|..||......... +....+......... ....+ .+.+++..||+.||.+||++.+|
T Consensus 206 il~ell~g~~Pf~~~~~~~~~------------~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l 272 (330)
T 2izr_A 206 MFMYFLRGSLPWQGLKADTLK------------ERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYL 272 (330)
T ss_dssp HHHHHHHSSCTTTTCCCSSHH------------HHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred HHHHHhcCCCCccccccccHH------------HHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHH
Confidence 999999999999764221110 111111111110000 01123 79999999999999999999999
Q ss_pred HHHHHHHHhhc
Q 026115 228 LKALQPLLNTR 238 (243)
Q Consensus 228 l~~l~~~~~~~ 238 (243)
.+.|+++....
T Consensus 273 ~~~l~~~~~~~ 283 (330)
T 2izr_A 273 RKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHc
Confidence 99999988764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=274.15 Aligned_cols=198 Identities=20% Similarity=0.269 Sum_probs=164.0
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~ 79 (243)
++++++||||+++++++.+++.+++||||+.+|+|..++..... ++...+..++.|++.||+|||+ .+
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~g-- 269 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKN-- 269 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHHTC--
T ss_pred HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHhhcCC--
Confidence 47889999999999999999999999999999999999976542 8899999999999999999998 88
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.++|+|||+++........ .....||+.|+|||++.+..++.++|+|||||++++|++|.
T Consensus 270 -iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 346 (446)
T 4ejn_A 270 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346 (446)
T ss_dssp -CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred -EEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCC
Confidence 999999999999999999999999998764332221 23456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
.||...... .....+..... ..+...+..+.+++.+||+.||.+|| |++++++
T Consensus 347 ~Pf~~~~~~---------------~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 347 LPFYNQDHE---------------KLFELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CSSCCSSHH---------------HHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCHH---------------HHHHHHHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 999643211 11111122211 23344567899999999999999999 9999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=269.46 Aligned_cols=200 Identities=20% Similarity=0.237 Sum_probs=163.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||+++++++.++..+++||||+.+|+|.+++..... ++...+..++.|++.||.|||+.+ +
T Consensus 93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---i 160 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---I 160 (373)
T ss_dssp BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5778999999999999999999999999999999999986542 888999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|||++|..|
T Consensus 161 vHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P 238 (373)
T 2r5t_A 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238 (373)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eecCCCHHHEEECCCCCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999875332211 13345689999999999998999999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
|..... .+....+..... ..+...+..+.+++.+||+.||.+||++.+.++.+.
T Consensus 239 f~~~~~---------------~~~~~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 239 FYSRNT---------------AEMYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp TCCSBH---------------HHHHHHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred CCCCCH---------------HHHHHHHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 964311 112222222222 233345668999999999999999999865444443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=263.16 Aligned_cols=217 Identities=19% Similarity=0.293 Sum_probs=161.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+.+++|.+++....... ..++...++.++.|++.|+.|||+.+ +
T Consensus 86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i 157 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-----RLIPERTVWKYFVQLCSALEHMHSRR---V 157 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 568899999999999999999999999999999999987532100 12889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++......... .....|++.|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 158 ~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 235 (310)
T 2wqm_A 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235 (310)
T ss_dssp CCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765433221 2234588999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGP 241 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~~~ 241 (243)
|...... .....................+..+.+++.+||+.||++|||+.++++.|+++......+
T Consensus 236 ~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 236 FYGDKMN-------------LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp TC---CC-------------HHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred Ccccchh-------------HHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 9643110 001111111111111112345667999999999999999999999999999998776554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=267.11 Aligned_cols=194 Identities=19% Similarity=0.252 Sum_probs=163.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++..+++||||+.+|+|.+++..... ++...+..++.|++.||.|||+.+ +
T Consensus 95 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---i 162 (350)
T 1rdq_E 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD---L 162 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 6788999999999999999999999999999999999986542 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++..... .....||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 163 vHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 237 (350)
T 1rdq_E 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCC
Confidence 99999999999999999999999998765432 2334689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~ 229 (243)
|..... .+....+..... ..+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 238 f~~~~~---------------~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 238 FFADQP---------------IQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SCCSSH---------------HHHHHHHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCH---------------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 964321 111222222222 334455678999999999999999998 888876
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=268.90 Aligned_cols=202 Identities=22% Similarity=0.249 Sum_probs=160.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ +
T Consensus 80 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---i 151 (351)
T 3c0i_A 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNN---I 151 (351)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 56789999999999999999999999999999999887653211 012789999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCc---eeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDI---AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+||||||+||+++.++. ++|+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 152 vHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (351)
T 3c0i_A 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229 (351)
T ss_dssp ECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred eeccCChHHeEEecCCCCCcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHC
Confidence 99999999999987654 999999998765443211 2345689999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCC--CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEY--PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||..... .....+......... ....+..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~pf~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 230 CLPFYGTKE----------------RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp SCSSCSSHH----------------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCcHH----------------HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999974311 111111111111000 0123567999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=261.33 Aligned_cols=210 Identities=25% Similarity=0.392 Sum_probs=169.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+ +..++||||+.+++|.+++...... .++...++.++.|++.|+.|||+.+ +
T Consensus 62 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i 130 (279)
T 1qpc_A 62 MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERN---Y 130 (279)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999874 4588999999999999999764321 1889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus 131 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 209 (279)
T 1qpc_A 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209 (279)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred eccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765433221 1223346778999999998888999999999999999999 899
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
||..... ......+........+...+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 210 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 210 PYPGMTN----------------PEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp SSTTCCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCcccCH----------------HHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 9864321 12222222233333444566789999999999999999999999999999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=263.31 Aligned_cols=208 Identities=28% Similarity=0.437 Sum_probs=160.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh---cCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE---KAE 78 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~---~~~ 78 (243)
+++++||||+++++++.+ ..++||||+++++|.+++...... +.++...++.++.|++.|+.|||+ .+
T Consensus 55 l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~- 125 (307)
T 2eva_A 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKA- 125 (307)
T ss_dssp HHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSC-
T ss_pred HhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCC-
Confidence 567899999999998874 478999999999999999865421 126788999999999999999999 66
Q ss_pred CCeEeccCCCCceEecCCCc-eeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 79 PRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++|+||||+||+++.++. ++|+|||++...... .....|++.|+|||++.+..++.++||||||+++++|++
T Consensus 126 --ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 198 (307)
T 2eva_A 126 --LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 198 (307)
T ss_dssp --CCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred --eecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999988876 799999998755432 123358999999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
|..||...... ................+...+..+.+++.+||+.||++|||++++++.|+++...
T Consensus 199 g~~p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 199 RRKPFDEIGGP--------------AFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp TCCTTTTTCSS--------------HHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred CCCCchhhCcc--------------HHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 99999643211 0111111112222233344566899999999999999999999999999998765
Q ss_pred cC
Q 026115 238 RS 239 (243)
Q Consensus 238 ~~ 239 (243)
..
T Consensus 265 ~~ 266 (307)
T 2eva_A 265 FP 266 (307)
T ss_dssp CC
T ss_pred cc
Confidence 53
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=258.04 Aligned_cols=202 Identities=26% Similarity=0.285 Sum_probs=162.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++|+||+++++|.+++.... .++...++.++.|++.|+.|||+.+ +
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i 126 (276)
T 2yex_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---I 126 (276)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 467899999999999999999999999999999999987643 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++|+|||.+................|++.|+|||.+.+..+ +.++|+||||++++++++|..
T Consensus 127 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 206 (276)
T 2yex_A 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 206 (276)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred eccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876543332222334568999999999987665 678999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||....... ...................+..+.+++.+||+.||++|||++++++
T Consensus 207 p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 207 PWDQPSDSC--------------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CCSCSCTTS--------------HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCchHH--------------HHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 997542211 1111111111111222344567999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=259.03 Aligned_cols=204 Identities=29% Similarity=0.509 Sum_probs=163.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+.. ++||||+.+++|.+++..... .+++..++.++.|++.|++|||+.+ .++
T Consensus 77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~-~~i 145 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH--------PIKWSVKLRLMLDIALGIEYMQNQN-PPI 145 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccC--------CccHHHHHHHHHHHHHHHHHHHhCC-CCe
Confidence 57889999999999997665 589999999999998876543 2899999999999999999999985 239
Q ss_pred EeccCCCCceEecCCCc-----eeecccCCCCCCcccccccccccccccccccCchhhc--cCCCCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDI-----AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~ 154 (243)
+|+||||+||+++.++. ++|+|||+++..... .....|++.|+|||++. ...++.++|+||||+++|+
T Consensus 146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~ 220 (287)
T 4f0f_A 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220 (287)
T ss_dssp BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHH
Confidence 99999999999988776 999999998754432 23356899999999984 4456889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
|++|..||...... .................+...+..+.+++.+||+.||++|||++++++.|+++
T Consensus 221 l~~g~~pf~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 221 ILTGEGPFDEYSYG-------------KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHSSCTTTTCCCC-------------HHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHcCCCCCcccccc-------------HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 99999999644211 11112222333333445556677899999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=269.86 Aligned_cols=219 Identities=17% Similarity=0.249 Sum_probs=160.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+.+++|.+++....... +++..+..++.|++.||+|||+.+ +
T Consensus 80 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~~---i 149 (389)
T 3gni_B 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-------MNELAIAYILQGVLKALDYIHHMG---Y 149 (389)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccC-------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999999999999998764322 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc-----ccccccccccccCchhhcc--CCCCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~ 154 (243)
+||||||+||+++.++.++|+|||.+.......... ......|++.|+|||++.+ ..++.++|||||||++++
T Consensus 150 vHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~e 229 (389)
T 3gni_B 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229 (389)
T ss_dssp ECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHH
Confidence 999999999999999999999999875443221111 1122468889999999987 578999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceee-ccCc------Cchhh-------------hhhhh---------ccccCCCCCHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTW-ATPK------LSEDK-------------VKQCV---------DTKLGGEYPPKAIAK 205 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~-~~~~------~~~~~-------------~~~~~---------~~~~~~~~~~~~~~~ 205 (243)
|++|..||.............. ..+. ..... ..... ........+...+..
T Consensus 230 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 309 (389)
T 3gni_B 230 LANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309 (389)
T ss_dssp HHHSSCTTTTCCSTTHHHHC--------------------------------------------------------CCHH
T ss_pred HHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHH
Confidence 9999999976433221100000 0000 00000 00000 000001123345667
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 206 MAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 206 ~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
+.+|+.+||+.||++|||++++++.
T Consensus 310 ~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 310 FHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHhhcCcccCCCHHHHhcC
Confidence 9999999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=261.23 Aligned_cols=206 Identities=28% Similarity=0.427 Sum_probs=163.4
Q ss_pred CCcccCCccceeeEEEEeC-CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++||||+++++++.+. ...++||||+++++|.+++...... .++...++.++.|++.|+.|||+.+
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~--- 137 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN--- 137 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5789999999999997654 5789999999999999999765321 2678899999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++|+||||+||+++.++.++|+|||++....... ....+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 138 i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 212 (278)
T 1byg_A 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212 (278)
T ss_dssp CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987554321 22346788999999998889999999999999999998 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
.||..... ......+........+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 213 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 213 VPYPRIPL----------------KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CSCTTSCG----------------GGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCCH----------------HHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 99964321 1222222222333444556678999999999999999999999999999987654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=266.57 Aligned_cols=227 Identities=22% Similarity=0.269 Sum_probs=166.2
Q ss_pred CCcccCCccceeeEEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
++.++||||+++++.+.. ...+++||||+++|+|.+++.... .++..++.++.|++.||+|||+.
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~ 130 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTE 130 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhh
Confidence 456899999999986642 336799999999999999997665 78889999999999999999998
Q ss_pred ---------CCCCeEeccCCCCceEecCCCceeecccCCCCCCccccc------ccccccccccccccCchhhcc-----
Q 026115 77 ---------AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA------RLHSTRVLGTFGYHAPEYAMT----- 136 (243)
Q Consensus 77 ---------~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~----- 136 (243)
+ ++||||||+||+++.++.++|+|||+++....... ........||+.|+|||++.+
T Consensus 131 ~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (336)
T 3g2f_A 131 LPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207 (336)
T ss_dssp BCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG
T ss_pred hccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc
Confidence 8 99999999999999999999999999875543211 111223458999999999976
Q ss_pred --CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCcc--ceeeccCcCchhhhhhhhc-cccCCC------CCHHHHHH
Q 026115 137 --GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS--LVTWATPKLSEDKVKQCVD-TKLGGE------YPPKAIAK 205 (243)
Q Consensus 137 --~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~------~~~~~~~~ 205 (243)
..++.++|||||||++|+|++|..||.......... ................... ...+.. .....+..
T Consensus 208 ~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
T 3g2f_A 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287 (336)
T ss_dssp GHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHH
T ss_pred cccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHH
Confidence 345678999999999999999977765432221111 0000111111111111111 111111 22346778
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 026115 206 MAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGP 241 (243)
Q Consensus 206 ~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~~~ 241 (243)
+.+++.+||+.||++|||++++++.|++++......
T Consensus 288 l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999765543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=268.79 Aligned_cols=199 Identities=24% Similarity=0.308 Sum_probs=162.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||++++++|.+....++||||+.+|+|..++..... ++...+..++.|++.||.|||+.| +
T Consensus 69 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---i 136 (384)
T 4fr4_A 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH---------FKEETVKLFICELVMALDYLQNQR---I 136 (384)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5688999999999999999999999999999999999986542 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc---CCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g 158 (243)
+||||||+||+++.++.++|+|||++........ .....||+.|+|||++.+ ..++.++|+|||||++|+|++|
T Consensus 137 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG 213 (384)
T 4fr4_A 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213 (384)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred eeccCcHHHeEECCCCCEEEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhC
Confidence 9999999999999999999999999976543221 234569999999999874 4578899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-MGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~vl~ 229 (243)
..||....... .......+... ....+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 214 ~~Pf~~~~~~~-------------~~~~~~~~~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 214 RRPYHIRSSTS-------------SKEIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SCSSCCCTTSC-------------HHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCCCCCCcc-------------HHHHHHHHhhc-ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 99997442211 11111111111 12344456678999999999999999998 676654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=285.59 Aligned_cols=210 Identities=28% Similarity=0.448 Sum_probs=173.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++.+ ...++||||+.+|+|.+++...... .+++..++.++.|++.||+|||+.+ +
T Consensus 316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---i 384 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN---Y 384 (535)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 678999999999999876 6789999999999999999754322 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..
T Consensus 385 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~ 463 (535)
T 2h8h_A 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 463 (535)
T ss_dssp CCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCC
T ss_pred eCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876543211 1222346788999999998899999999999999999999 899
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
||.... ...+...+....+...+..++..+.++|.+||+.||++|||+++|++.|+++..+..
T Consensus 464 P~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 464 PYPGMV----------------NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp SSTTCC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 986431 123333344444445556677889999999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=265.22 Aligned_cols=214 Identities=20% Similarity=0.247 Sum_probs=159.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+ +|.+++...... ++...+..++.|++.||.|||+.+ +
T Consensus 73 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~~---i 140 (311)
T 3niz_A 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG--------LQDSQIKIYLYQLLRGVAHCHQHR---I 140 (311)
T ss_dssp HHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTC--------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999975 888888765432 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ .....||+.|+|||++.+ ..++.++||||+||++++|++|..
T Consensus 141 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 218 (311)
T 3niz_A 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218 (311)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCchHhEEECCCCCEEEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765432211 233458999999999876 457999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchh------hhhhhhcccc--CCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSED------KVKQCVDTKL--GGE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~--~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
||...........+.......... .......... ... .....+.++.+++.+||+.||++|||++|+
T Consensus 219 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 298 (311)
T 3niz_A 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298 (311)
T ss_dssp SCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 998654432211110000000000 0000000000 000 011234578999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 299 l~ 300 (311)
T 3niz_A 299 MN 300 (311)
T ss_dssp HT
T ss_pred hc
Confidence 87
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=264.25 Aligned_cols=197 Identities=23% Similarity=0.322 Sum_probs=159.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++.+++..++||||+.+++|.+++..... ++...+..++.|++.||.|||+.+ +
T Consensus 75 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---i 142 (327)
T 3a62_A 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI---------FMEDTACFYLAEISMALGHLHQKG---I 142 (327)
T ss_dssp HHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5678999999999999999999999999999999999976542 788999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++........ .....|++.|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 143 vH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 220 (327)
T 3a62_A 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220 (327)
T ss_dssp CCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EcccCCHHHeEECCCCcEEEEeCCcccccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCC
Confidence 99999999999999999999999998754332211 2334689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
|..... ......+..... ..+...+..+.+++.+||+.||++|| ++.++++
T Consensus 221 f~~~~~---------------~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 221 FTGENR---------------KKTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCCSSH---------------HHHHHHHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCH---------------HHHHHHHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 974421 111222222221 23344567899999999999999999 7888876
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=265.59 Aligned_cols=199 Identities=23% Similarity=0.282 Sum_probs=154.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... +++..++.++.|++.|+.|||+.+ +
T Consensus 102 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~L~~LH~~~---i 169 (349)
T 2w4o_A 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---------YSERDAADAVKQILEAVAYLHENG---I 169 (349)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecC---CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+||||||+||+++. ++.++|+|||+++....... .....|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 170 vH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 246 (349)
T 2w4o_A 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246 (349)
T ss_dssp CCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 99999999999975 78999999999876543221 2334589999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||...... ......+...... .......+..+.+++.+||+.||++|||+.++++
T Consensus 247 ~~pf~~~~~~--------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 247 FEPFYDERGD--------------QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp SCTTCCTTCH--------------HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCccc--------------HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999643211 0011111111111 1122345668999999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=260.51 Aligned_cols=206 Identities=23% Similarity=0.362 Sum_probs=164.3
Q ss_pred CCcccCCccceeeEEEEe----------------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYVD----------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 65 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~q 65 (243)
+++++||||+++++++.. ....++||||+++++|.+++...... .+++..++.++.|
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~q 130 (284)
T 2a19_B 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------KLDKVLALELFEQ 130 (284)
T ss_dssp HHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGS-------CCCHHHHHHHHHH
T ss_pred HHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCC-------CCCHHHHHHHHHH
Confidence 567899999999999864 45589999999999999999765322 2889999999999
Q ss_pred HHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccch
Q 026115 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDV 145 (243)
Q Consensus 66 l~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 145 (243)
++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....|++.|+|||.+.+..++.++|+
T Consensus 131 i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (284)
T 2a19_B 131 ITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDL 204 (284)
T ss_dssp HHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHH
T ss_pred HHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhh
Confidence 999999999998 99999999999999999999999999876543321 233458999999999998889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 146 YSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 146 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
||||+++++|++|..|+... ........... .+...+..+.+++.+||+.||.+|||+.
T Consensus 205 ~slG~il~~l~~~~~~~~~~-----------------~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ 263 (284)
T 2a19_B 205 YALGLILAELLHVCDTAFET-----------------SKFFTDLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTS 263 (284)
T ss_dssp HHHHHHHHHHHSCCSSHHHH-----------------HHHHHHHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHHhcCCcchhH-----------------HHHHHHhhccc----ccccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999999886421 01111111111 1223345689999999999999999999
Q ss_pred HHHHHHHHHHhhcCCC
Q 026115 226 IVLKALQPLLNTRSGP 241 (243)
Q Consensus 226 ~vl~~l~~~~~~~~~~ 241 (243)
++++.|..+.++...+
T Consensus 264 e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 264 EILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHHHHHHHHTC-----
T ss_pred HHHHHHHHHhhCCCcc
Confidence 9999999988776554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=270.29 Aligned_cols=226 Identities=22% Similarity=0.271 Sum_probs=174.5
Q ss_pred CCcccCCccceeeEEEE--eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++. +....++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~-- 147 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGSRR-- 147 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 56889999999999987 55679999999999999999976432 2889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||||+||+++.++.++|+|||++.......... ......++..|+|||++.+..++.++||||||+++++|++|
T Consensus 148 -ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g 226 (327)
T 3lxl_A 148 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 226 (327)
T ss_dssp -EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred -ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999987654332211 12234578889999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
..||........... .............+.+........+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 227 ~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 227 CDKSCSPSAEFLRMM-GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TCGGGSHHHHHHHHC-C----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred CCCCccccchhhhhc-ccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 999864422110000 0000111123334444444555566677788999999999999999999999999999887654
Q ss_pred C
Q 026115 239 S 239 (243)
Q Consensus 239 ~ 239 (243)
.
T Consensus 306 ~ 306 (327)
T 3lxl_A 306 R 306 (327)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=270.13 Aligned_cols=227 Identities=21% Similarity=0.272 Sum_probs=172.3
Q ss_pred CCcccCCccceeeEEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++... ...++||||+++++|.+++..... .++...++.++.|++.||.+||+.+
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~-- 165 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR-- 165 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5688999999999998754 378999999999999999987643 2889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++++|++|
T Consensus 166 -ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg 244 (326)
T 2w1i_A 166 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244 (326)
T ss_dssp -EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHT
T ss_pred -EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987654332211 11223467789999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
..||.........................+.+........+..++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 245 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp TCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 99876331100000000000000111222333333333445566778999999999999999999999999999998764
Q ss_pred C
Q 026115 239 S 239 (243)
Q Consensus 239 ~ 239 (243)
+
T Consensus 325 ~ 325 (326)
T 2w1i_A 325 A 325 (326)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=272.96 Aligned_cols=196 Identities=23% Similarity=0.308 Sum_probs=162.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+++|+|.+++..... +++..+..++.|++.|+.|||+.+ +
T Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---i 137 (476)
T 2y94_A 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---------LDEKESRRLFQQILSGVDYCHRHM---V 137 (476)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSS---------CCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 5789999999999999999999999999999999999976542 899999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||++........ .....|++.|+|||++.+..+ +.++|+|||||++|+|++|..
T Consensus 138 vHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~ 214 (476)
T 2y94_A 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTL 214 (476)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred CcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCC
Confidence 9999999999999999999999999876543221 233468999999999988765 679999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||..... ......+..... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 215 Pf~~~~~---------------~~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 215 PFDDDHV---------------PTLFKKICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp SSCCSSS---------------HHHHHHHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCH---------------HHHHHHHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 9974321 111112222211 223345567999999999999999999999997
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=267.67 Aligned_cols=204 Identities=21% Similarity=0.254 Sum_probs=164.1
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.++...++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 139 ~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~--- 207 (373)
T 2x4f_A 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY--------NLTELDTILFMKQICEGIRHMHQMY--- 207 (373)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999998875432 2889999999999999999999999
Q ss_pred eEeccCCCCceEe--cCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLL--FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++||||||+||++ +.++.++|+|||+++....... .....||+.|+|||++.+..++.++|||||||++++|++|
T Consensus 208 ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 284 (373)
T 2x4f_A 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284 (373)
T ss_dssp EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHS
T ss_pred cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhC
Confidence 9999999999999 5678899999999876543322 2234589999999999888889999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQP 233 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~~ 233 (243)
..||...... +....+...... .......+..+.+++.+||+.||.+|||+.++++ .+.+
T Consensus 285 ~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 285 LSPFLGDNDA---------------ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp SCTTCCSSHH---------------HHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred CCCCCCCCHH---------------HHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 9999754221 111112111111 1111234567999999999999999999999998 4443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=264.34 Aligned_cols=219 Identities=25% Similarity=0.220 Sum_probs=163.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCC-------------------------------CCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG-------------------------------AKP 50 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------------------------------~~~ 50 (243)
+++++||||+++++++.++...++||||+++|+|.+++........ ...
T Consensus 82 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (345)
T 3hko_A 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161 (345)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred HHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 5678999999999999999999999999999999999963211000 000
Q ss_pred CCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCC--ceeecccCCCCCCccccccc--ccccccccc
Q 026115 51 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARL--HSTRVLGTF 126 (243)
Q Consensus 51 ~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~--~~~l~df~~~~~~~~~~~~~--~~~~~~~~~ 126 (243)
...+++..++.++.|++.|++|||+.+ ++|+||||+||+++.++ .++|+|||+++......... ......|++
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 238 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCG
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCc
Confidence 112467788899999999999999998 99999999999998776 89999999987553322111 123456899
Q ss_pred cccCchhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCC--CHHH
Q 026115 127 GYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEY--PPKA 202 (243)
Q Consensus 127 ~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 202 (243)
.|+|||++.+ ..++.++||||||+++|+|++|..||..... .+.............. ....
T Consensus 239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~ 303 (345)
T 3hko_A 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND---------------ADTISQVLNKKLCFENPNYNVL 303 (345)
T ss_dssp GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HHHHHHHHHCCCCTTSGGGGGS
T ss_pred cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh---------------HHHHHHHHhcccccCCcccccC
Confidence 9999999875 5678999999999999999999999964422 1222222222222111 1234
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHHHHH--HHHHHHhhc
Q 026115 203 IAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLNTR 238 (243)
Q Consensus 203 ~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~~~~~~~ 238 (243)
+..+.+++.+||+.||.+|||+.++++ .+.++.+..
T Consensus 304 ~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHhh
Confidence 668999999999999999999999998 555554443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=264.06 Aligned_cols=197 Identities=21% Similarity=0.269 Sum_probs=162.2
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++ +||||+++++++.+...+++||||+++|+|.+++..... +++..+..++.|++.||.|||+.|
T Consensus 74 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g--- 141 (353)
T 2i0e_A 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG--- 141 (353)
T ss_dssp HTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3445 799999999999999999999999999999999986542 889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 142 ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 219 (353)
T 2i0e_A 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219 (353)
T ss_dssp CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCC
Confidence 99999999999999999999999999875432221 1234568999999999998889999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~ 229 (243)
||..... .+....+..... ..+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 220 Pf~~~~~---------------~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 220 PFEGEDE---------------DELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp SSCCSSH---------------HHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCH---------------HHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9974321 112222222222 334456678999999999999999995 577765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=267.58 Aligned_cols=203 Identities=18% Similarity=0.238 Sum_probs=155.2
Q ss_pred cccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 4 RLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
..+||||++++++|.. +..+++||||+.+|+|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~-- 181 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN-- 181 (400)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4589999999999876 56799999999999999999875432 2899999999999999999999998
Q ss_pred CeEeccCCCCceEecC---CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 80 ~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
++||||||+||+++. ++.++|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 182 -ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 257 (400)
T 1nxk_A 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_dssp -EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHH
T ss_pred -ccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHH
Confidence 999999999999987 78899999999875543221 23446899999999999889999999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
+|..||.......... .....+..... ........+..+.+++.+||+.||++|||+.++++.
T Consensus 258 ~g~~pf~~~~~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 258 CGYPPFYSNHGLAISP-----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HSSCSCCCCTTCSSCC-----------SHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCCCCCCCCccccccH-----------HHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999997553321100 01111111111 111113456689999999999999999999999983
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=262.56 Aligned_cols=191 Identities=20% Similarity=0.294 Sum_probs=159.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCC-CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++||||+++++++.+++..++||||+.+| +|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 83 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~--- 150 (335)
T 3dls_A 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---------LDEPLASYIFRQLVSAVGYLRLKD--- 150 (335)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 57889999999999999999999999998776 99999987643 889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.++|+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|.
T Consensus 151 ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 227 (335)
T 3dls_A 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227 (335)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred eEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCC
Confidence 99999999999999999999999999876543321 233458999999999988776 78899999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
.||....... .... ..+...+..+.+++.+||+.||++|||++++++.
T Consensus 228 ~pf~~~~~~~---------------------~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 228 NPFCELEETV---------------------EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CSCSSGGGGT---------------------TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CchhhHHHHH---------------------hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9996431110 0000 1112245579999999999999999999999984
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=265.68 Aligned_cols=201 Identities=22% Similarity=0.392 Sum_probs=156.7
Q ss_pred CCcccC--CccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
|++++| |||+++++++.++...++|||+ .+++|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 61 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~-- 128 (343)
T 3dbq_A 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG-- 128 (343)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCC---------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 456666 9999999999999999999994 57799999987543 889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-----------CCCCcccchHHH
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSF 148 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Diwsl 148 (243)
++||||||+||+++ ++.++|+|||+++...............||+.|+|||++.+ ..++.++|||||
T Consensus 129 -iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diwsl 206 (343)
T 3dbq_A 129 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206 (343)
T ss_dssp -CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHH
T ss_pred -eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHH
Confidence 99999999999997 67899999999987654433322344569999999999865 567889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
||++++|++|..||..... .................+...+..+.+++.+||+.||.+|||+.+++
T Consensus 207 G~il~ell~g~~pf~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l 272 (343)
T 3dbq_A 207 GCILYYMTYGKTPFQQIIN--------------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272 (343)
T ss_dssp HHHHHHHHHSSCTTTTCCS--------------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHhCCCcchhhhh--------------HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHH
Confidence 9999999999999964311 11223333333333344444556799999999999999999999998
Q ss_pred HH
Q 026115 229 KA 230 (243)
Q Consensus 229 ~~ 230 (243)
+.
T Consensus 273 ~h 274 (343)
T 3dbq_A 273 AH 274 (343)
T ss_dssp TS
T ss_pred hC
Confidence 73
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=264.77 Aligned_cols=204 Identities=21% Similarity=0.282 Sum_probs=161.4
Q ss_pred Ccc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 3 SRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 3 ~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++ +||||+++++++.++..+++||||+.+|+|..++..... +++..+..++.|++.||.|||+.+ +
T Consensus 64 ~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---i 131 (345)
T 3a8x_A 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---I 131 (345)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 344 899999999999999999999999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 132 vHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 209 (345)
T 3a8x_A 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209 (345)
T ss_dssp BCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eecCCCHHHEEECCCCCEEEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875432221 12345689999999999998899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhh-hhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVK-QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM------GIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~vl~ 229 (243)
|.......... ........ .+.... ...+...+..+.+++.+||+.||.+||++ +++++
T Consensus 210 f~~~~~~~~~~-------~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 210 FDIVGSSDNPD-------QNTEDYLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp TTTTTC--------------CHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred cCCcccccccc-------cccHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 96432111000 00111111 122222 23344566789999999999999999996 56654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=262.73 Aligned_cols=213 Identities=22% Similarity=0.266 Sum_probs=159.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.++...++++||+.+++|.+++..... .++...++.++.|++.|++|||+.+
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~--- 150 (319)
T 2y4i_B 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--------VLDVNKTRQIAQEIVKGMGYLHAKG--- 150 (319)
T ss_dssp GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCC--------CCCSHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999999999999976542 2888999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccc---cccccccccccccCchhhcc---------CCCCcccchHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR---LHSTRVLGTFGYHAPEYAMT---------GQMSSKSDVYSF 148 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Diwsl 148 (243)
++|+||||+||+++ ++.++|+|||++......... .......|++.|+|||++.+ ..++.++|||||
T Consensus 151 i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~sl 229 (319)
T 2y4i_B 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229 (319)
T ss_dssp CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHH
T ss_pred ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHH
Confidence 99999999999998 679999999998755322111 11223458899999999874 346889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
|+++++|++|..||...... ...................+..+.+++.+||+.||++|||+.+++
T Consensus 230 G~il~el~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~ 294 (319)
T 2y4i_B 230 GTIWYELHAREWPFKTQPAE---------------AIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294 (319)
T ss_dssp HHHHHHHHHSSCSSSSCCHH---------------HHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHH---------------HHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 99999999999999744211 111111111111111123445799999999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 026115 229 KALQPLLNTRSG 240 (243)
Q Consensus 229 ~~l~~~~~~~~~ 240 (243)
+.|+++......
T Consensus 295 ~~l~~l~~~~~~ 306 (319)
T 2y4i_B 295 DMLEKLPKRNRR 306 (319)
T ss_dssp HHHTTC------
T ss_pred HHHHHHHHhhcc
Confidence 999998876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=267.47 Aligned_cols=194 Identities=21% Similarity=0.271 Sum_probs=160.3
Q ss_pred ccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 5 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
.+||||+++++++.++..+++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.| ++||
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHr 142 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IVYR 142 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCC
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeC
Confidence 3899999999999999999999999999999999986542 889999999999999999999998 9999
Q ss_pred cCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026115 85 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164 (243)
Q Consensus 85 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 164 (243)
||||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 143 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999875432211 12345689999999999998899999999999999999999999974
Q ss_pred CCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 026115 165 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG-IVLK 229 (243)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~vl~ 229 (243)
.... +....+.... ...+...+..+.+++.+||+.||++||++. ++++
T Consensus 221 ~~~~---------------~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 221 QDEE---------------ELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp SSHH---------------HHHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCHH---------------HHHHHHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 4211 1111121111 123444567899999999999999999997 6653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=256.04 Aligned_cols=195 Identities=27% Similarity=0.392 Sum_probs=160.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... ++...++.++.|++.|+.|||+.+ +
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---i 130 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR---V 130 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---C
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5788999999999999999999999999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++....... .....|++.|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 131 ~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 206 (279)
T 3fdn_A 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206 (279)
T ss_dssp EECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred ecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCC
Confidence 999999999999999999999999886544322 2334589999999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..... ......+... ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 207 ~~~~~~---------------~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 207 FEANTY---------------QETYKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp TCCSSH---------------HHHHHHHHHT--CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcH---------------HHHHHHHHhC--CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 964311 1111111111 11233445667999999999999999999999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=260.37 Aligned_cols=215 Identities=20% Similarity=0.277 Sum_probs=156.8
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.+++..++||||+.+ +|.+++....+. ++...+..++.|++.||.|||+.+
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~--- 120 (288)
T 1ob3_A 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--------LESVTAKSFLLQLLNGIAYCHDRR--- 120 (288)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTC--------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 46789999999999999999999999999976 999998765432 888999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.++|+|||+++....... ......||+.|+|||++.+. .++.++|+|||||++++|++|.
T Consensus 121 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 198 (288)
T 1ob3_A 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (288)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999998865432211 12234579999999999764 5799999999999999999999
Q ss_pred CCCCCCCCCCCccceeec-----cCcCchhhhhhhhccccC-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWA-----TPKLSEDKVKQCVDTKLG-------GEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
.||...........+... ...+.........+.... .......+..+.+++.+||+.||++|||++++
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 278 (288)
T 1ob3_A 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278 (288)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 999754321110000000 000000000000000000 01112345678999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 279 l~ 280 (288)
T 1ob3_A 279 LE 280 (288)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=263.31 Aligned_cols=205 Identities=20% Similarity=0.236 Sum_probs=143.4
Q ss_pred CCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++ ||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 59 l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~--- 126 (325)
T 3kn6_A 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH---------FSETEASYIMRKLVSAVSHMHDVG--- 126 (325)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 34565 99999999999999999999999999999999987642 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCC---ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+||+++.++ .++|+|||+++........ .....||+.|+|||++.+..++.++||||||+++++|++
T Consensus 127 ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 204 (325)
T 3kn6_A 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204 (325)
T ss_dssp EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHh
Confidence 99999999999997765 8999999998754432221 233457999999999999899999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP---PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||......... .........+......... ...+..+.+++.+||+.||++|||++++++
T Consensus 205 g~~pf~~~~~~~~~---------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 205 GQVPFQSHDRSLTC---------TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SSCTTC-------C---------CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCCCCCCcccccc---------ccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 99999754321110 0111111211111111111 234678999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=259.75 Aligned_cols=212 Identities=25% Similarity=0.358 Sum_probs=166.2
Q ss_pred cccCCccceeeEEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh-----
Q 026115 4 RLKNENVVELVGYYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH----- 74 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh----- 74 (243)
+++||||+++++++..+. ..++||||+.+|+|.+++.... +++..++.++.|++.|+.|||
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~ 161 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVG 161 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 379999999999998775 8999999999999999997654 889999999999999999999
Q ss_pred ---hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc--ccccccccccccCchhhccCC------CCccc
Q 026115 75 ---EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQ------MSSKS 143 (243)
Q Consensus 75 ---~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~------~~~~~ 143 (243)
+.+ ++|+||||+||+++.++.++|+|||++.......... ......|++.|+|||++.+.. ++.++
T Consensus 162 ~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 238 (342)
T 1b6c_B 162 TQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238 (342)
T ss_dssp TTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHH
T ss_pred hcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcc
Confidence 777 9999999999999999999999999986554332211 123346899999999987652 23689
Q ss_pred chHHHHHHHHHHHhC----------CCCCCCCCCCCCccceeeccCcCchhhhhhh-hccccCCCCC-----HHHHHHHH
Q 026115 144 DVYSFGVVLLELLTG----------RKPVDHTLPRGQQSLVTWATPKLSEDKVKQC-VDTKLGGEYP-----PKAIAKMA 207 (243)
Q Consensus 144 DiwslG~~l~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~ 207 (243)
||||||+++|+|++| ..||....... ......... .........+ ..++..+.
T Consensus 239 Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (342)
T 1b6c_B 239 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD-----------PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 307 (342)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS-----------CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCcCCcccccccCccccCcCc-----------ccHHHHHHHHHHHHhCCCCcccccchhHHHHHH
Confidence 999999999999999 56665432211 111112221 2222222222 36778899
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 208 AVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 208 ~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
+++.+||+.||++|||+.++++.|+++..+..
T Consensus 308 ~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 308 KIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred HHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=259.62 Aligned_cols=214 Identities=19% Similarity=0.229 Sum_probs=156.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+ ++.+++....+ .+++..+..++.|++.|++|||+.| +
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i 122 (292)
T 3o0g_A 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHSRN---V 122 (292)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 6789999999999999999999999999976 66666654332 2899999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC-CCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ .....||+.|+|||++.+.. ++.++||||+||++++|++|..
T Consensus 123 vH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~ 200 (292)
T 3o0g_A 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred ecCCCCHHHEEEcCCCCEEEeecccceecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999998765432211 23346899999999998765 7999999999999999999888
Q ss_pred CCCCCCCC-CCccceeeccCcCchhh---hhhhhc---------cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 161 PVDHTLPR-GQQSLVTWATPKLSEDK---VKQCVD---------TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 161 pf~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
||...... .....+........... .....+ ...........+..+.+++.+||+.||++|||++|+
T Consensus 201 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 280 (292)
T 3o0g_A 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH
Confidence 75422111 00000000000000000 000000 000011223455679999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 281 l~ 282 (292)
T 3o0g_A 281 LQ 282 (292)
T ss_dssp HT
T ss_pred hc
Confidence 87
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=256.03 Aligned_cols=198 Identities=26% Similarity=0.367 Sum_probs=142.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... .++...++.++.|++.|+.|||+.+ +
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 133 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--------PFSENEARHFMHQIITGMLYLHSHG---I 133 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5788999999999999999999999999999999999986532 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||.+......... .....|++.|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 134 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 211 (278)
T 3cok_A 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211 (278)
T ss_dssp ECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred ecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432211 1234588999999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|......... ....... ...+...+..+.+++.+||+.||++|||++++++
T Consensus 212 ~~~~~~~~~~---------------~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 212 FDTDTVKNTL---------------NKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCCCSCC--------------------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCChhHHHHH---------------HHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 9754221110 0000000 1122334567999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=256.79 Aligned_cols=215 Identities=19% Similarity=0.276 Sum_probs=167.4
Q ss_pred CCcccCCccceeeEEE-EeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++|++++..++.+ .++...++||||+ +++|.+++..... .+++..++.++.|++.|+.|||+.+
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~--- 125 (296)
T 4hgt_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN--- 125 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4567888877766665 6788899999999 8899999985432 2899999999999999999999999
Q ss_pred eEeccCCCCceEe---cCCCceeecccCCCCCCccccccc-----ccccccccccccCchhhccCCCCcccchHHHHHHH
Q 026115 81 IIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 152 (243)
Q Consensus 81 ~~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 152 (243)
++|+||||+||++ +.++.++|+|||+++......... ......|++.|+|||.+.+..++.++|||||||++
T Consensus 126 ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 205 (296)
T 4hgt_A 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 205 (296)
T ss_dssp EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHH
Confidence 9999999999999 788999999999987654432211 12245689999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE---YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+++++|..||........... ............ .....+..+.+++.+||+.||++|||++++++
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 206 MYFNLGSLPWQGLKAATKRQK------------YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSH------------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHhcCCCCCcccchhhhhhh------------hhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 999999999976533222111 111111111000 00122567999999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 026115 230 ALQPLLNTRSG 240 (243)
Q Consensus 230 ~l~~~~~~~~~ 240 (243)
.|+++..+...
T Consensus 274 ~l~~~~~~~~~ 284 (296)
T 4hgt_A 274 LFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHHTC
T ss_pred HHHHHHHHhCC
Confidence 99999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=260.15 Aligned_cols=209 Identities=22% Similarity=0.278 Sum_probs=159.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++++||+++++|.+++..... ++...++.++.|++.|+.|||+.+ +
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---i 155 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---------LAPPRAVAIVRQIGSALDAAHAAG---A 155 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence 5788999999999999999999999999999999999986542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++......... ......|++.|+|||.+.+..++.++|+||||++++++++|..|
T Consensus 156 ~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 234 (309)
T 2h34_A 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234 (309)
T ss_dssp CCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCS
T ss_pred CcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999998765433211 12234588999999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHHHHHhhc
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRP-NMGIVLKALQPLLNTR 238 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~vl~~l~~~~~~~ 238 (243)
|...... .....+..... ...+...+..+.+++.+||+.||++|| |++++++.|++++...
T Consensus 235 f~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 235 YQGDQLS----------------VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp SCSCHHH----------------HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCCchHH----------------HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 9743211 11111111110 112234456799999999999999999 9999999999887655
Q ss_pred C
Q 026115 239 S 239 (243)
Q Consensus 239 ~ 239 (243)
.
T Consensus 299 ~ 299 (309)
T 2h34_A 299 D 299 (309)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=270.87 Aligned_cols=199 Identities=18% Similarity=0.210 Sum_probs=162.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||++++++|.++..+++||||+++|+|.+++.... +++..+..++.|++.||.|||+.+ +
T Consensus 123 l~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~g---i 189 (410)
T 3v8s_A 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---F 189 (410)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999997654 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC----CCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~l~~ 157 (243)
+||||||+||+++.++.++|+|||+++........ ......||+.|+|||++.+.. ++.++|+|||||++|+|++
T Consensus 190 vHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~ 268 (410)
T 3v8s_A 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268 (410)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred EeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence 99999999999999999999999998765433211 123456999999999998655 6789999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc--cCCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADF--RPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~vl~ 229 (243)
|..||..... .+....+.... .........+..+.+++.+||+.+|.+ ||+++++++
T Consensus 269 G~~Pf~~~~~---------------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 269 GDTPFYADSL---------------VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp SSCTTCCSSH---------------HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred CCCCCCCCCh---------------hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 9999974421 12222222211 111111235668999999999999988 999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=261.61 Aligned_cols=196 Identities=24% Similarity=0.363 Sum_probs=161.1
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... ++...++.++.|++.|+.|||+.+ +
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~---i 136 (321)
T 2a2a_A 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---------LSEEEATSFIKQILDGVNYLHTKK---I 136 (321)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---------EEHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCC----ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
+|+||||+||+++.++ .++|+|||++........ .....|++.|+|||++.+..++.++|+||||+++++|++
T Consensus 137 vH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 213 (321)
T 2a2a_A 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213 (321)
T ss_dssp ECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH
Confidence 9999999999999887 799999999876544321 233458999999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP----PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||...... +....+..... ..+ ...+..+.+++.+||+.||++|||+.++++
T Consensus 214 g~~pf~~~~~~---------------~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 214 GASPFLGDTKQ---------------ETLANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp SCCSSCCSSHH---------------HHHHHHHTTCC--CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCHH---------------HHHHHHHhccc--ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 99999643211 11111111111 111 123457999999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=261.47 Aligned_cols=214 Identities=20% Similarity=0.268 Sum_probs=156.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|..++..... ++...+..++.|++.|+.|||+.| +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~i~~~l~~~l~~lH~~~---i 123 (311)
T 4agu_A 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG---------VPEHLVKSITWQTLQAVNFCHKHN---C 123 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSC---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 5678999999999999999999999999999999998876543 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||||+||+++.++.++|+|||++......... .....|++.|+|||.+.+ ..++.++|+||+|++++++++|..
T Consensus 124 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 201 (311)
T 4agu_A 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201 (311)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765433221 233468899999999976 567999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhh-----hhc-cccC---CCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQ-----CVD-TKLG---GEY-----PPKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-~~~~---~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
||.......................... ... .... ... ....+..+.+++.+||+.||++|||+++
T Consensus 202 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 281 (311)
T 4agu_A 202 LWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281 (311)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHH
Confidence 9976533211111000000000000000 000 0000 000 0124557899999999999999999999
Q ss_pred HHH
Q 026115 227 VLK 229 (243)
Q Consensus 227 vl~ 229 (243)
+++
T Consensus 282 ll~ 284 (311)
T 4agu_A 282 LLH 284 (311)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=263.78 Aligned_cols=196 Identities=26% Similarity=0.397 Sum_probs=159.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+. |+|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 108 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---i 175 (348)
T 1u5q_A 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---M 175 (348)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999997 588888864432 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+||||||+||+++.++.++|+|||++...... ....||+.|+|||++. ...++.++|||||||++++|++|
T Consensus 176 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g 249 (348)
T 1u5q_A 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249 (348)
T ss_dssp BCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred eeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999998765432 2346899999999985 45678999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
..||..... ......+.........+...+..+.+++.+||+.||++|||++++++.
T Consensus 250 ~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 250 KPPLFNMNA---------------MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp SCTTTTSCH---------------HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCh---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 999864321 111112222222112223445679999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=261.61 Aligned_cols=181 Identities=21% Similarity=0.282 Sum_probs=139.2
Q ss_pred eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceee
Q 026115 22 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 101 (243)
Q Consensus 22 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l 101 (243)
..++||||+++++|.+++...... .......++.++.|++.||+|||+.+ ++||||||+||+++.++.++|
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL 205 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSL------EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 205 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSG------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEEecCCCCHHHHHhcccCc------cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEE
Confidence 389999999999999999875431 12566678999999999999999998 999999999999999999999
Q ss_pred cccCCCCCCcccccc----------cccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 026115 102 SDFDLSNQAPDAAAR----------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 171 (243)
Q Consensus 102 ~df~~~~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~ 171 (243)
+|||+++........ .......||+.|+|||++.+..++.++|+||||+++++|++|..|+...
T Consensus 206 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------ 279 (332)
T 3qd2_B 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------ 279 (332)
T ss_dssp CCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------
T ss_pred eecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------
Confidence 999998765543211 1122346899999999999989999999999999999999987664211
Q ss_pred cceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 172 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
...................+..+.+++.+||+.||++|||++++++
T Consensus 280 ------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 280 ------------VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ------------HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ------------HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 1111111111111222345567899999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=258.14 Aligned_cols=198 Identities=28% Similarity=0.394 Sum_probs=163.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++.... ++...++.++.|++.|+.|||+.+ +
T Consensus 74 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i 140 (303)
T 3a7i_A 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---K 140 (303)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 567899999999999999999999999999999999997543 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 141 ~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (303)
T 3a7i_A 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218 (303)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCC
Confidence 9999999999999999999999999866543321 12345689999999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
|..... ......+........+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 219 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 219 HSELHP----------------MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp TTTSCH----------------HHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCcCH----------------HHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 964321 11111111112222333445679999999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=267.08 Aligned_cols=201 Identities=21% Similarity=0.393 Sum_probs=156.6
Q ss_pred CCccc--CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLK--NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
|++++ ||||+++++++..+..+++||| +.+++|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 108 l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~-- 175 (390)
T 2zmd_A 108 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG-- 175 (390)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 34565 5999999999999999999999 567899999987642 788899999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-----------CCCCcccchHHH
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSF 148 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Diwsl 148 (243)
++||||||+||+++ ++.++|+|||+++...............||+.|+|||++.+ ..++.++|||||
T Consensus 176 -ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 176 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp -CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred -eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 99999999999995 58899999999987654433222334569999999999865 357889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
||++|+|++|..||..... .......++........+...+..+.+++.+||+.||.+|||+.+++
T Consensus 254 Gvil~ell~G~~Pf~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 254 GCILYYMTYGKTPFQQIIN--------------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp HHHHHHHHHSSCTTTTCCC--------------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHCCCcchhhhH--------------HHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 9999999999999964311 11223333333333333334456799999999999999999999998
Q ss_pred HH
Q 026115 229 KA 230 (243)
Q Consensus 229 ~~ 230 (243)
+.
T Consensus 320 ~h 321 (390)
T 2zmd_A 320 AH 321 (390)
T ss_dssp TS
T ss_pred hC
Confidence 63
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=261.88 Aligned_cols=215 Identities=21% Similarity=0.257 Sum_probs=160.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+. ++|.+++....... ....++...+..++.|++.||.|||+.| +
T Consensus 57 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i 129 (317)
T 2pmi_A 57 MKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHENK---I 129 (317)
T ss_dssp HTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 678999999999999999999999999997 59999887543211 1112888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ .....||+.|+|||++.+. .++.++|||||||++++|++|..
T Consensus 130 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (317)
T 2pmi_A 130 LHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207 (317)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeCCCChHHeEEcCCCCEEECcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765432211 2334689999999999764 57999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccC-----cC----------------chhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCC
Q 026115 161 PVDHTLPRGQQSLVTWATP-----KL----------------SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEAD 219 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~-----~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 219 (243)
||...........+..... .+ ......+.+..... ...+..+.+++.+||+.||+
T Consensus 208 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dP~ 283 (317)
T 2pmi_A 208 LFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK----EPLDGNLMDFLHGLLQLNPD 283 (317)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCS----SCCCHHHHHHHHHHSCSSGG
T ss_pred CCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhccccc----ccCCHHHHHHHHHHCCCCcc
Confidence 9975532211000000000 00 00011111111111 12345799999999999999
Q ss_pred CCCCHHHHHH
Q 026115 220 FRPNMGIVLK 229 (243)
Q Consensus 220 ~Rps~~~vl~ 229 (243)
+|||++++++
T Consensus 284 ~Rpt~~e~l~ 293 (317)
T 2pmi_A 284 MRLSAKQALH 293 (317)
T ss_dssp GSCCHHHHTT
T ss_pred cCCCHHHHhC
Confidence 9999999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=255.57 Aligned_cols=198 Identities=22% Similarity=0.287 Sum_probs=161.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... ++...+..++.|++.|+.|||+.+ +
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i 126 (284)
T 3kk8_A 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNG---I 126 (284)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999998876542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCc---eeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDDI---AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||||+||+++.++. ++|+|||.+........ .....|++.|+|||.+.+..++.++|+||||+++++|++|
T Consensus 127 ~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 203 (284)
T 3kk8_A 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203 (284)
T ss_dssp ECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHC
Confidence 99999999999986655 99999999865543322 2335689999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||...... ........... ........+..+.+++.+||+.||++|||+.++++
T Consensus 204 ~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 204 YPPFWDEDQH---------------RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp SCSSCCSSHH---------------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCchh---------------HHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9999643211 11111111111 11112244567999999999999999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=259.07 Aligned_cols=191 Identities=21% Similarity=0.240 Sum_probs=152.6
Q ss_pred ccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 5 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
.+||||+++++++.++...++||||+ +++|.+++..... .+++..++.++.|++.||+|||+.+ ++||
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 181 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHSQG---LVHL 181 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 48999999999999999999999999 6699998876542 2899999999999999999999998 9999
Q ss_pred cCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 026115 85 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 164 (243)
Q Consensus 85 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 164 (243)
||||+||+++.++.++|+|||++........ .....||+.|+|||++.+ .++.++|||||||++++|++|..|+..
T Consensus 182 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876543322 233458999999998876 789999999999999999999776542
Q ss_pred CCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 165 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
. ...............+...+..+.+++.+||+.||++|||++++++
T Consensus 258 ~------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 258 G------------------EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp H------------------HHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c------------------cHHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2 1111111111111111234567999999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=264.05 Aligned_cols=197 Identities=23% Similarity=0.359 Sum_probs=157.9
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
+||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.| ++|||
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---ivHrD 141 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHAQG---VVHRD 141 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEecc
Confidence 799999999999999999999999999999999976542 889999999999999999999999 99999
Q ss_pred CCCCceEecCC----CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 86 IKSSNVLLFDD----DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 86 i~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
|||+||++... +.++|+|||+++........ .....||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 142 lkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 219 (342)
T 2qr7_A 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219 (342)
T ss_dssp CCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCC
Confidence 99999998543 35999999998765432211 2334689999999999887788999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhh-hhcccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQ-CVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|...... ....+.. +..... ........+..+.+++.+||+.||++|||+.++++
T Consensus 220 f~~~~~~-------------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 220 FANGPDD-------------TPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp SCSSTTS-------------CHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCcC-------------CHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9743211 1111111 111111 11222345678999999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=253.27 Aligned_cols=202 Identities=19% Similarity=0.263 Sum_probs=163.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... +++..++.++.|++.|+.|||+.+ +
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~---i 127 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV---------FRESDAARIMKDVLSAVAYCHKLN---V 127 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5688999999999999999999999999999999998876542 889999999999999999999999 9
Q ss_pred EeccCCCCceEe---cCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||||+||++ +.++.++|+|||++........ .....|++.|+|||.+.+. ++.++|+||||+++++|++|
T Consensus 128 ~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g 203 (277)
T 3f3z_A 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCG 203 (277)
T ss_dssp ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHS
T ss_pred cCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHC
Confidence 999999999999 7788999999999865543221 2334589999999998754 89999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCH----HHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQ 232 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~ 232 (243)
..||..... .+....+..... ..+. ..+..+.+++.+||+.||++|||+.++++ .++
T Consensus 204 ~~p~~~~~~---------------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 204 YPPFSAPTD---------------SEVMLKIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp SCSSCCSSH---------------HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred CCCCCCCCH---------------HHHHHHHHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 999964321 111112222111 1222 24568999999999999999999999997 455
Q ss_pred HHHh
Q 026115 233 PLLN 236 (243)
Q Consensus 233 ~~~~ 236 (243)
+...
T Consensus 267 ~~~~ 270 (277)
T 3f3z_A 267 KQLS 270 (277)
T ss_dssp HHHC
T ss_pred cccc
Confidence 4443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=258.82 Aligned_cols=209 Identities=24% Similarity=0.362 Sum_probs=155.5
Q ss_pred CCCcccCCccceeeEEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 1 MVSRLKNENVVELVGYYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
++++++||||+++++++.... ..++||||+++++|.+++..... ++...++.++.|++.||.|||+.
T Consensus 65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~ 135 (311)
T 3ork_A 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQN 135 (311)
T ss_dssp TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 467899999999999987654 34999999999999999976542 88999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
+ ++|+||||+||+++.++.++|+|||+++......... ......|++.|+|||++.+..++.++||||||+++|+|
T Consensus 136 ~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 212 (311)
T 3ork_A 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212 (311)
T ss_dssp T---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred C---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHH
Confidence 8 9999999999999999999999999997665432221 12234589999999999998999999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH-HHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK-ALQ 232 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~-~l~ 232 (243)
++|..||....+. ............. ......+..+.+++.+||+.||++||++.+++. .+.
T Consensus 213 l~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 213 LTGEPPFTGDSPV---------------SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp HHSSCSCCCSSHH---------------HHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HhCCCCCCCCChH---------------HHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 9999999754221 1111111111100 001124567999999999999999997666554 555
Q ss_pred HHHh
Q 026115 233 PLLN 236 (243)
Q Consensus 233 ~~~~ 236 (243)
+...
T Consensus 278 ~~~~ 281 (311)
T 3ork_A 278 RVHN 281 (311)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 5544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=282.15 Aligned_cols=208 Identities=25% Similarity=0.383 Sum_probs=167.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++. ++..++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 445 l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g---i 512 (656)
T 2j0j_A 445 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLESKR---F 512 (656)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 56789999999999985 4568999999999999999986532 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 513 vHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~ 591 (656)
T 2j0j_A 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591 (656)
T ss_dssp CCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999876543221 1223346789999999998899999999999999999997 999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
||.+... ......+........+..++..+.+++.+||+.||++|||+.++++.|++++.+.
T Consensus 592 Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 592 PFQGVKN----------------NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp TTTTCCH----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 9974421 2222222223333445566778999999999999999999999999999998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=258.98 Aligned_cols=210 Identities=27% Similarity=0.356 Sum_probs=165.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++. .++|+||+.+++|.+++..... .++...++.++.|++.|+.|||+.+ +
T Consensus 75 l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 142 (291)
T 1u46_A 75 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---F 142 (291)
T ss_dssp HHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 46789999999999998765 8899999999999999976532 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
+|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 143 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 222 (291)
T 1u46_A 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222 (291)
T ss_dssp ECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654332211 1223446778999999988888999999999999999999 99
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
.||..... .+..............+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 223 ~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 223 EPWIGLNG---------------SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp CTTTTCCH---------------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCcccCCH---------------HHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 99964421 11122222222223334456678999999999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=260.66 Aligned_cols=211 Identities=23% Similarity=0.313 Sum_probs=155.4
Q ss_pred ccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 5 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
++||||+++++++.+++..++||||+++++|.+++..... ++...+..++.|++.||+|||+.+ ++|+
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 135 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNKG---IAHR 135 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeC
Confidence 4799999999999999999999999999999999976542 889999999999999999999998 9999
Q ss_pred cCCCCceEecCCCc---eeecccCCCCCCcccccc-----cccccccccccccCchhhcc-----CCCCcccchHHHHHH
Q 026115 85 NIKSSNVLLFDDDI---AKISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVV 151 (243)
Q Consensus 85 di~~~nil~~~~~~---~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~ 151 (243)
||||+||+++.++. ++|+|||++......... .......|++.|+|||++.+ ..++.++|||||||+
T Consensus 136 dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 215 (316)
T 2ac3_A 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215 (316)
T ss_dssp CCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHH
T ss_pred CCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHH
Confidence 99999999988776 899999998765422111 01123458999999999875 457889999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCH----HHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 152 LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 152 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
+++|++|..||..........................+..... ..+. ..+..+.+++.+||+.||++|||++++
T Consensus 216 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 293 (316)
T 2ac3_A 216 LYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293 (316)
T ss_dssp HHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence 9999999999986543322111100000000011111111111 2222 245679999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 294 l~ 295 (316)
T 2ac3_A 294 LQ 295 (316)
T ss_dssp HH
T ss_pred hc
Confidence 98
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=258.94 Aligned_cols=212 Identities=21% Similarity=0.260 Sum_probs=158.5
Q ss_pred cccCCccceeeEEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 4 RLKNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
+++||||+++++++.... ..+++||++. ++|.+++....... +++..+..++.|++.||+|||+.+
T Consensus 70 ~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~-------~~~~~~~~i~~qi~~al~~lH~~~- 140 (308)
T 3g33_A 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPG-------LPAETIKDLMRQFLRGLDFLHANC- 140 (308)
T ss_dssp HHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTC-------SCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCC-------CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 345999999999998765 5899999996 59999998765432 889999999999999999999999
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++||||||+||+++.++.++|+|||+++....... .....||+.|+|||++.+..++.++|||||||++++|++|
T Consensus 141 --ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 215 (308)
T 3g33_A 141 --IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215 (308)
T ss_dssp --CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTS
T ss_pred --cccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999976543322 2345689999999999988999999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhh---hhhccccC--CC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVK---QCVDTKLG--GE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
..||...........+............. ........ .. .....+..+.+++.+||+.||++|||+.+++
T Consensus 216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 216 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 99997543221110000000000000000 00000000 00 0112346789999999999999999999998
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
+
T Consensus 296 ~ 296 (308)
T 3g33_A 296 Q 296 (308)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=254.95 Aligned_cols=215 Identities=20% Similarity=0.281 Sum_probs=166.7
Q ss_pred CCcccCCccceeeEEE-EeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++|++++..++++ .++...++||||+ +++|.+++..... .+++..++.++.|++.|+.|||+.+
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~--- 125 (296)
T 3uzp_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN--- 125 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4567888877666655 6778899999999 8899999975432 2899999999999999999999998
Q ss_pred eEeccCCCCceEec---CCCceeecccCCCCCCccccccc-----ccccccccccccCchhhccCCCCcccchHHHHHHH
Q 026115 81 IIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 152 (243)
Q Consensus 81 ~~h~di~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 152 (243)
++|+||||+||+++ .++.++|+|||++.......... ......|++.|+|||.+.+..++.++||||||+++
T Consensus 126 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 205 (296)
T 3uzp_A 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 205 (296)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHH
Confidence 99999999999994 78899999999987655432211 12344689999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE---YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++|++|..||.......... ....+........ .....+..+.+++.+||+.||++|||++++++
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 206 MYFNLGSLPWQGLKAATKRQ------------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSS------------HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhCCCCCCCcCchhhhh------------hhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 99999999997643221111 1111111111000 01223467999999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 026115 230 ALQPLLNTRSG 240 (243)
Q Consensus 230 ~l~~~~~~~~~ 240 (243)
.|+++..+...
T Consensus 274 ~l~~~~~~~~~ 284 (296)
T 3uzp_A 274 LFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHTTC
T ss_pred HHHHHHHhcCC
Confidence 99999887654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=275.65 Aligned_cols=202 Identities=23% Similarity=0.321 Sum_probs=165.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++.++..+++||||+.+|+|.+++....... +++..++.++.|++.||.|||+.+ +
T Consensus 238 L~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~-------l~e~~~~~i~~qIl~aL~yLH~~g---I 307 (576)
T 2acx_A 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-------FPEARAVFYAAEICCGLEDLHRER---I 307 (576)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCC-------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567899999999999999999999999999999999998654322 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++....... .....||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 308 vHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~P 384 (576)
T 2acx_A 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384 (576)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCS
T ss_pred eccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999976543321 2334689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
|....... ....+...+.. .....+...+..+.+++.+||+.||.+|| +++++++
T Consensus 385 F~~~~~~~------------~~~~i~~~i~~-~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 385 FQQRKKKI------------KREEVERLVKE-VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SSCSSSCC------------CHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred Ccccccch------------hHHHHHHHhhc-ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 97542211 11112221111 11233445667899999999999999999 7899886
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=263.65 Aligned_cols=210 Identities=21% Similarity=0.272 Sum_probs=157.5
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
.++||||+++++++......++||||+ +++|.+++....... ++...+..++.|++.||+|||+.+ ++|
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~~~---ivH 160 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNG-------FHIEDIKLYCIEILKALNYLRKMS---LTH 160 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 345999999999999999999999999 889999998765332 889999999999999999999999 999
Q ss_pred ccCCCCceEecC-------------------------CCceeecccCCCCCCcccccccccccccccccccCchhhccCC
Q 026115 84 RNIKSSNVLLFD-------------------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 138 (243)
Q Consensus 84 ~di~~~nil~~~-------------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 138 (243)
|||||+||+++. ++.++|+|||++...... .....||+.|+|||++.+..
T Consensus 161 rDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 235 (360)
T 3llt_A 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLG 235 (360)
T ss_dssp SCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCC
T ss_pred CCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCC
Confidence 999999999975 788999999998654322 23456899999999999999
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc---------cc----cC----------
Q 026115 139 MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD---------TK----LG---------- 195 (243)
Q Consensus 139 ~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~----~~---------- 195 (243)
++.++|||||||++|+|++|..||...........+................. .. ..
T Consensus 236 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 315 (360)
T 3llt_A 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315 (360)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHH
T ss_pred CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhh
Confidence 99999999999999999999999975432211111100000000000000000 00 00
Q ss_pred ------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 196 ------GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 196 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..........+.+++.+||+.||++|||++++++
T Consensus 316 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000011256889999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=269.97 Aligned_cols=201 Identities=16% Similarity=0.182 Sum_probs=161.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||++++++|.++..+++||||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 128 l~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH~~g---i 196 (437)
T 4aw2_A 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVHQLH---Y 196 (437)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4578999999999999999999999999999999999987432 2899999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~ 156 (243)
+||||||+||+++.++.++|+|||+++........ ......||+.|+|||++. ...++.++|+|||||++|||+
T Consensus 197 iHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell 275 (437)
T 4aw2_A 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275 (437)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH
T ss_pred EecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH
Confidence 99999999999999999999999998655432221 122356999999999987 456789999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC---CCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEADF--RPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~vl~ 229 (243)
+|..||..... .+....+...... .......+..+.++|.+||..+|+. ||+++++++
T Consensus 276 tG~~Pf~~~~~---------------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 276 YGETPFYAESL---------------VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HSSCTTCCSSH---------------HHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hCCCCCCCCCh---------------hHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 99999975421 1112222221111 1111235668999999999988888 999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=263.26 Aligned_cols=218 Identities=19% Similarity=0.259 Sum_probs=167.7
Q ss_pred CCcccCCccce---------------eeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHH
Q 026115 2 VSRLKNENVVE---------------LVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 65 (243)
Q Consensus 2 l~~l~h~niv~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~q 65 (243)
+++++||||++ +++++.. +...++||||+ +++|.+++...... .+++..++.++.|
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~-------~l~~~~~~~i~~q 167 (352)
T 2jii_A 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH-------VLSERSVLQVACR 167 (352)
T ss_dssp HHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGG-------CCCHHHHHHHHHH
T ss_pred HHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcC-------CCCHHHHHHHHHH
Confidence 45678888876 7788876 78899999999 99999999876322 2899999999999
Q ss_pred HHHHHHHhhhcCCCCeEeccCCCCceEecCCC--ceeecccCCCCCCccccccc-----ccccccccccccCchhhccCC
Q 026115 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQ 138 (243)
Q Consensus 66 l~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~--~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~ 138 (243)
++.||.|||+.+ ++||||||+||+++.++ .++|+|||+++......... ......|++.|+|||++.+..
T Consensus 168 i~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 244 (352)
T 2jii_A 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG 244 (352)
T ss_dssp HHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC
T ss_pred HHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC
Confidence 999999999998 99999999999999988 89999999997765433211 112346899999999999888
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc--cCCC--CCHHHHHHHHHHHHhhc
Q 026115 139 MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LGGE--YPPKAIAKMAAVAALCV 214 (243)
Q Consensus 139 ~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~li~~~l 214 (243)
++.++||||||+++|+|++|..||....+..... ........... .... .....+..+.+++.+||
T Consensus 245 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 314 (352)
T 2jii_A 245 PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI----------MKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVM 314 (352)
T ss_dssp CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH----------HHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH----------HHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHH
Confidence 9999999999999999999999997542110000 00000000000 0000 00123467999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhhcCC
Q 026115 215 QYEADFRPNMGIVLKALQPLLNTRSG 240 (243)
Q Consensus 215 ~~~p~~Rps~~~vl~~l~~~~~~~~~ 240 (243)
+.||++|||++++++.|++++.....
T Consensus 315 ~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 315 ALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999877643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=262.13 Aligned_cols=213 Identities=22% Similarity=0.354 Sum_probs=162.5
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-CCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~~~ 79 (243)
++++++||||+++++++.+++..++||||+++++|.+++..... ++...+..++.|++.|+.|||+. +
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~~-- 152 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK-- 152 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC--
T ss_pred HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 46789999999999999999999999999999999999987542 88999999999999999999985 7
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++|+||||+||+++.++.++|+|||++...... ......|++.|+|||++.+..++.++||||||+++++|++|.
T Consensus 153 -i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 227 (360)
T 3eqc_A 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227 (360)
T ss_dssp -CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTS
T ss_pred -EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999988544322 123356899999999999988999999999999999999999
Q ss_pred CCCCCCCCCCCcccee-----------------------e---ccCcCc-hhhhhhhhccccCCCCCHHHHHHHHHHHHh
Q 026115 160 KPVDHTLPRGQQSLVT-----------------------W---ATPKLS-EDKVKQCVDTKLGGEYPPKAIAKMAAVAAL 212 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~-----------------------~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 212 (243)
.||............. . ...... ......+.............+..+.+++.+
T Consensus 228 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 307 (360)
T 3eqc_A 228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 307 (360)
T ss_dssp CCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHH
Confidence 9997543211100000 0 000000 011111111111111222346679999999
Q ss_pred hcCCCCCCCCCHHHHHH
Q 026115 213 CVQYEADFRPNMGIVLK 229 (243)
Q Consensus 213 ~l~~~p~~Rps~~~vl~ 229 (243)
||+.||++|||++++++
T Consensus 308 ~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 308 CLIKNPAERADLKQLMV 324 (360)
T ss_dssp HHCSSTTTSCCHHHHHT
T ss_pred HhhcChhhCCCHHHHhh
Confidence 99999999999999997
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=253.68 Aligned_cols=195 Identities=26% Similarity=0.386 Sum_probs=162.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... ++...++.++.|++.|+.|||+.+ +
T Consensus 68 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 135 (284)
T 2vgo_A 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---------FDEQRSATFMEELADALHYCHERK---V 135 (284)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999976542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++....... .....|++.|+|||.+.+..++.++|+||||++++++++|..|
T Consensus 136 ~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 211 (284)
T 2vgo_A 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211 (284)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred eecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCC
Confidence 999999999999999999999999875443221 2334589999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|...... +....+.... ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus 212 f~~~~~~---------------~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 212 FDSPSHT---------------ETHRRIVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TCCSSHH---------------HHHHHHHTTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCHh---------------HHHHHHhccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 9643211 1111111111 1233445668999999999999999999999997
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=253.06 Aligned_cols=199 Identities=23% Similarity=0.310 Sum_probs=153.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+....++||||+++++|.+++....... ..++...++.++.|++.||.|||+.+ +
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i 145 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARG-----KALSEGYVAELMKQMMNALAYFHSQH---V 145 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 578899999999999999999999999999999999886532100 12889999999999999999999998 9
Q ss_pred EeccCCCCceEe---cCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||||+||++ +.++.++|+|||++........ .....|++.|+|||++. ..++.++|+||||+++++|++|
T Consensus 146 vH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g 221 (285)
T 3is5_A 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221 (285)
T ss_dssp CCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHS
T ss_pred EECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhC
Confidence 999999999999 4567899999999976544322 23445899999999886 4678999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhh---ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV---DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||...... ...... ..... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~pf~~~~~~----------------~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 222 CLPFTGTSLE----------------EVQQKATYKEPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp SCSSCCSSHH----------------HHHHHHHHCCCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCCCCCCCHH----------------HHHhhhccCCcccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999754211 111111 11110 001113457899999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=262.78 Aligned_cols=220 Identities=20% Similarity=0.276 Sum_probs=158.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+ +|.+++..... .++...+..++.|++.||.|||+.| +
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---i 121 (324)
T 3mtl_A 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHRQK---V 121 (324)
T ss_dssp HSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 6789999999999999999999999999975 99998876543 2889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ .....|++.|+|||++.+ ..++.++|||||||++++|++|..
T Consensus 122 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (324)
T 3mtl_A 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199 (324)
T ss_dssp EESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcCHHHEEECCCCCEEEccCcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998755433221 233457999999999876 567999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCc-----Cc----hhhhhhhhccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPK-----LS----EDKVKQCVDTKLGG----EYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~-----~~----~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
||.+.........+...... +. .............. ......+..+.+++.+||+.||++|||++|+
T Consensus 200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 279 (324)
T 3mtl_A 200 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279 (324)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence 99765322111110000000 00 00000000000000 0011234578999999999999999999999
Q ss_pred HH--HHHHHH
Q 026115 228 LK--ALQPLL 235 (243)
Q Consensus 228 l~--~l~~~~ 235 (243)
++ .+.++.
T Consensus 280 l~hp~f~~~~ 289 (324)
T 3mtl_A 280 MKHPFFLSLG 289 (324)
T ss_dssp TTSGGGGGGC
T ss_pred hcChhhhhcc
Confidence 88 444443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=255.43 Aligned_cols=200 Identities=25% Similarity=0.355 Sum_probs=162.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... .++...++.++.|++.|+.|||+.+ +
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i 146 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK--------TLTEDEIATILQSTLKGLEYLHFMR---K 146 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 5678999999999999999999999999999999999874322 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||.+......... .....|++.|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 147 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (314)
T 3com_A 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224 (314)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred cCCCcCHHHEEECCCCCEEEeecccchhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998655432211 2334689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhc-cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVD-TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|...... ........ .......+...+..+.+++.+||+.||.+|||+.++++
T Consensus 225 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 225 YADIHPM---------------RAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp TTTSCHH---------------HHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCChH---------------HHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9743211 01111100 11111223334567999999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=268.08 Aligned_cols=215 Identities=20% Similarity=0.278 Sum_probs=156.0
Q ss_pred CCccc-CCccceeeEEEEeCC--eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 2 VSRLK-NENVVELVGYYVDGP--LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
+++++ ||||+++++++..++ .+++||||+. ++|..++.... ++...+..++.|++.||+|||+.|
T Consensus 62 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~- 129 (388)
T 3oz6_A 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSGG- 129 (388)
T ss_dssp HHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45666 999999999997543 7899999997 59999998653 889999999999999999999999
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCccccc-------------------ccccccccccccccCchhhcc-CC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA-------------------RLHSTRVLGTFGYHAPEYAMT-GQ 138 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-------------------~~~~~~~~~~~~~~aPE~~~~-~~ 138 (243)
++||||||+||+++.++.++|+|||+++....... ........||+.|+|||++.+ ..
T Consensus 130 --ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 207 (388)
T 3oz6_A 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK 207 (388)
T ss_dssp --EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCC
T ss_pred --EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCC
Confidence 99999999999999999999999999875432110 111223468999999999986 57
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhh-----------hhhhc------cccCCCC---
Q 026115 139 MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV-----------KQCVD------TKLGGEY--- 198 (243)
Q Consensus 139 ~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~------~~~~~~~--- 198 (243)
++.++||||+||++++|++|..||.+.........+......+..+.. .+.+. .......
T Consensus 208 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (388)
T 3oz6_A 208 YTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK 287 (388)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHH
T ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcc
Confidence 899999999999999999999999765332111111000000000000 00000 0000000
Q ss_pred ----------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 199 ----------PPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 199 ----------~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
....+..+.+|+.+||+.||++|||++++++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 01234579999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=255.11 Aligned_cols=197 Identities=24% Similarity=0.373 Sum_probs=162.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+.+++|.+++..... ++...++.++.|++.|+.|||+.+ +
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---i 136 (294)
T 2rku_A 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNR---V 136 (294)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999876542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++......... .....|++.|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 137 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 214 (294)
T 2rku_A 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214 (294)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred cccCCChHhEEEcCCCCEEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432211 2334589999999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..... .+......... ...+...+..+.+++.+||+.||++|||++++++
T Consensus 215 ~~~~~~---------------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 215 FETSCL---------------KETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TCCSSH---------------HHHHHHHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCCH---------------HHHHHHHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 964321 11111111111 1223344567999999999999999999999997
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=269.82 Aligned_cols=203 Identities=24% Similarity=0.340 Sum_probs=162.4
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 89 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~--- 156 (494)
T 3lij_A 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK---------FNEVDAAVIIKQVLSGVTYLHKHN--- 156 (494)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999998876542 889999999999999999999998
Q ss_pred eEeccCCCCceEecCC---CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLFDD---DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+||+++.. +.++|+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++
T Consensus 157 ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~ 232 (494)
T 3lij_A 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232 (494)
T ss_dssp EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH
T ss_pred ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh
Confidence 9999999999999764 4599999999876543322 23456899999999886 468999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE--YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQP 233 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~~ 233 (243)
|..||...... +....+........ .....+..+.+++.+||+.||.+|||+.++++ .+.+
T Consensus 233 g~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 233 GYPPFGGQTDQ---------------EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp SSCSSCCSSHH---------------HHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred CCCCCCCCCHH---------------HHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 99999754221 11111111111111 11234567999999999999999999999997 3554
Q ss_pred H
Q 026115 234 L 234 (243)
Q Consensus 234 ~ 234 (243)
.
T Consensus 298 ~ 298 (494)
T 3lij_A 298 M 298 (494)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=260.42 Aligned_cols=197 Identities=24% Similarity=0.379 Sum_probs=162.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~---i 162 (335)
T 2owb_A 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNR---V 162 (335)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 5678999999999999999999999999999999999876542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+|+||+|+||+++.++.++|+|||++......... .....|+..|+|||++.+..++.++|+||||+++++|++|..|
T Consensus 163 vH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 240 (335)
T 2owb_A 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240 (335)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EecCCCchhEEEcCCCCEEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCC
Confidence 99999999999999999999999998765432211 2334589999999999988889999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..... .+....+..... ..+...+..+.+++.+||+.||++|||++++++
T Consensus 241 f~~~~~---------------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 241 FETSCL---------------KETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TCCSSH---------------HHHHHHHHHTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCCH---------------HHHHHHHhcCCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 964311 111111111111 223344567999999999999999999999997
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=269.11 Aligned_cols=197 Identities=25% Similarity=0.310 Sum_probs=159.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++..+++||||+.+++|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 75 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---i 142 (486)
T 3mwu_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---I 142 (486)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5788999999999999999999999999999999998876542 889999999999999999999999 9
Q ss_pred EeccCCCCceEec---CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+||||||+||+++ .++.++|+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|
T Consensus 143 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 218 (486)
T 3mwu_A 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218 (486)
T ss_dssp CCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHS
T ss_pred EeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhC
Confidence 9999999999995 456799999999976543322 233468999999999876 589999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||...... +....+....... ......+..+.+++.+||+.||.+|||+.++++
T Consensus 219 ~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 219 TPPFYGKNEY---------------DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SCSSCCSSHH---------------HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCHH---------------HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9999754211 1111121111111 111345668999999999999999999999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=252.37 Aligned_cols=198 Identities=24% Similarity=0.375 Sum_probs=156.5
Q ss_pred CCcccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
+++++||||+++++++.. +...++||||+++++|.+++..... ++...++.++.|++.|+.|||+.+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~ 149 (290)
T 1t4h_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRT 149 (290)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred HHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccC---------CCHHHHHHHHHHHHHHHHHHHcCC
Confidence 678999999999999875 4568999999999999999987542 889999999999999999999984
Q ss_pred CCCeEeccCCCCceEec-CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 78 EPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
.+++|+||||+||+++ .++.++|+|||++....... .....|++.|+|||++.+ .++.++|+||||+++++|+
T Consensus 150 -~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~ 223 (290)
T 1t4h_A 150 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA 223 (290)
T ss_dssp -SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHH
T ss_pred -CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHH
Confidence 2399999999999997 78899999999986443321 233458999999998874 5899999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc-cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||...... .......... .....+...+..+.+++.+||+.||.+|||++++++
T Consensus 224 ~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 224 TSEYPYSECQNA---------------AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HSSCTTTTCSSH---------------HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCcCcH---------------HHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 999999643211 1111111111 111122223457999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=253.55 Aligned_cols=203 Identities=27% Similarity=0.373 Sum_probs=160.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+++++|.+++...... ..++...+..++.|++.|+.|||+.+ +
T Consensus 73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i 143 (295)
T 2clq_A 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDNQ---I 143 (295)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 56789999999999999999999999999999999999865321 12678889999999999999999998 9
Q ss_pred EeccCCCCceEecC-CCceeecccCCCCCCcccccccccccccccccccCchhhccCC--CCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||+++. ++.++|+|||.+......... .....|++.|+|||++.+.. ++.++|+||||+++++|++|
T Consensus 144 ~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 221 (295)
T 2clq_A 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221 (295)
T ss_dssp ECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT
T ss_pred EccCCChhhEEEECCCCCEEEeecccccccCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999987 899999999998765432211 23345899999999987643 78899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||...... ................+...+..+.+++.+||+.||++|||+.++++
T Consensus 222 ~~pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 222 KPPFYELGEP--------------QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp SCTTGGGSSH--------------HHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCCccCCCch--------------hHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999643110 01111111112222344455678999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=271.58 Aligned_cols=198 Identities=26% Similarity=0.351 Sum_probs=161.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.+....++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 79 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~--- 146 (484)
T 3nyv_A 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGITYMHKNK--- 146 (484)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---------CBHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999876543 889999999999999999999998
Q ss_pred eEeccCCCCceEe---cCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+||++ +.++.++|+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++
T Consensus 147 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~ 222 (484)
T 3nyv_A 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS 222 (484)
T ss_dssp CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHH
T ss_pred eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHH
Confidence 9999999999999 4678899999999865433221 233468999999999876 68999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||...... +....+....... +.....+..+.+++.+||+.||.+|||+.++++
T Consensus 223 g~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 223 GCPPFNGANEY---------------DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SSCSSCCSSHH---------------HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCHH---------------HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 99999754221 1111222221111 111345678999999999999999999999997
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=258.28 Aligned_cols=199 Identities=21% Similarity=0.275 Sum_probs=158.2
Q ss_pred Ccc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 3 SRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 3 ~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++ +||||+++++++.++...++||||+.+|+|.+++....... +++..++.++.|++.||+|||+.+ +
T Consensus 83 ~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~i~~ql~~~L~~LH~~g---i 152 (327)
T 3lm5_A 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM-------VSENDVIRLIKQILEGVYYLHQNN---I 152 (327)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CC-------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccC-------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 345 57999999999999999999999999999999986643322 889999999999999999999998 9
Q ss_pred EeccCCCCceEecC---CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+||||||+||+++. ++.++|+|||+++....... .....|++.|+|||++.+..++.++|+||||+++++|++|
T Consensus 153 vH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (327)
T 3lm5_A 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229 (327)
T ss_dssp ECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999987 78999999999876543322 2334689999999999988999999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhh--ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV--DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||...... +....+. ............+..+.+++.+||+.||++|||++++++
T Consensus 230 ~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 230 TSPFVGEDNQ---------------ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp SCSSCCSSHH---------------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCch---------------HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 9999654221 1111111 111122223345668999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=264.98 Aligned_cols=225 Identities=19% Similarity=0.238 Sum_probs=169.8
Q ss_pred CCcccCCccceeeEEEEeCC--eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVDGP--LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++.+.. ..++||||+++|+|.+++...... ..+++..++.++.|++.|++|||+.+
T Consensus 61 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~-- 132 (396)
T 4eut_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG-- 132 (396)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 56789999999999998755 789999999999999999865421 12789999999999999999999999
Q ss_pred CeEeccCCCCceEe----cCCCceeecccCCCCCCcccccccccccccccccccCchhhcc--------CCCCcccchHH
Q 026115 80 RIIHRNIKSSNVLL----FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--------GQMSSKSDVYS 147 (243)
Q Consensus 80 ~~~h~di~~~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Diws 147 (243)
++||||||+||++ +.++.++|+|||+++....... .....|++.|+|||++.+ ..++.++||||
T Consensus 133 -ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwS 208 (396)
T 4eut_A 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS 208 (396)
T ss_dssp -EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHH
T ss_pred -EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHH
Confidence 9999999999999 7778899999999976544322 233458999999999864 45677899999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcc-ceeeccCcCchhh---h-------hhh-hccccCCCCCHHHHHHHHHHHHhhcC
Q 026115 148 FGVVLLELLTGRKPVDHTLPRGQQS-LVTWATPKLSEDK---V-------KQC-VDTKLGGEYPPKAIAKMAAVAALCVQ 215 (243)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~---~-------~~~-~~~~~~~~~~~~~~~~~~~li~~~l~ 215 (243)
|||++|+|++|..||.......... ............. . ..+ .............+..+.+++.+||+
T Consensus 209 lG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~ 288 (396)
T 4eut_A 209 IGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288 (396)
T ss_dssp HHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhc
Confidence 9999999999999997543221110 0000000000000 0 000 00011123457888899999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHhhc
Q 026115 216 YEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 216 ~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
.||++|||+.++++.+.+++...
T Consensus 289 ~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 289 ADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cChhhhccHHHHHHHHHHHhhce
Confidence 99999999999999999988753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=253.90 Aligned_cols=207 Identities=21% Similarity=0.335 Sum_probs=162.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... ++...++.++.|++.|+.|||+.+ +
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i 129 (283)
T 3bhy_A 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---------LTEDEATQFLKQILDGVHYLHSKR---I 129 (283)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5678999999999999999999999999999999999976432 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCC----ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
+|+||+|+||+++.++ .++|+|||++........ .....|++.|+|||.+.+..++.++|+||||++++++++
T Consensus 130 ~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 206 (283)
T 3bhy_A 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206 (283)
T ss_dssp ECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH
Confidence 9999999999998876 799999999876543322 123458899999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQP 233 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~~ 233 (243)
|..||...... .....+...... .......+..+.+++.+||+.||++|||+.++++ .+++
T Consensus 207 g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 207 GASPFLGETKQ---------------ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp SSCTTCCSSHH---------------HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCCCCCCcchH---------------HHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 99999644211 111111111100 0001123557999999999999999999999998 5666
Q ss_pred HHhhc
Q 026115 234 LLNTR 238 (243)
Q Consensus 234 ~~~~~ 238 (243)
+....
T Consensus 272 ~~~~~ 276 (283)
T 3bhy_A 272 IRRRN 276 (283)
T ss_dssp HHHCC
T ss_pred HHHHh
Confidence 65443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=261.39 Aligned_cols=214 Identities=17% Similarity=0.197 Sum_probs=153.1
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.++...++||||+.+ +|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~---------~~~~~~~~i~~ql~~~l~~LH~~~--- 152 (329)
T 3gbz_A 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSRR--- 152 (329)
T ss_dssp HGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999975 99999987653 889999999999999999999998
Q ss_pred eEeccCCCCceEec-----CCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLF-----DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 81 ~~h~di~~~nil~~-----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~ 154 (243)
++|+||||+||+++ ..+.++|+|||+++........ .....||+.|+|||++.+. .++.++|||||||++++
T Consensus 153 ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 230 (329)
T 3gbz_A 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAE 230 (329)
T ss_dssp CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999994 4556999999998654322111 2334579999999999874 47999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccC-----cCchh-hhhhhh--ccccCCC-----CCHHHHHHHHHHHHhhcCCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATP-----KLSED-KVKQCV--DTKLGGE-----YPPKAIAKMAAVAALCVQYEADFR 221 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~--~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R 221 (243)
|++|..||...........+..... .+... ...... .+..... .+...+..+.+++.+||+.||++|
T Consensus 231 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 310 (329)
T 3gbz_A 231 MLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR 310 (329)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhC
Confidence 9999999975432211000000000 00000 000000 0000000 011134678999999999999999
Q ss_pred CCHHHHHH
Q 026115 222 PNMGIVLK 229 (243)
Q Consensus 222 ps~~~vl~ 229 (243)
||++++++
T Consensus 311 ~t~~e~l~ 318 (329)
T 3gbz_A 311 ISAKNALE 318 (329)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhC
Confidence 99999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=258.47 Aligned_cols=215 Identities=25% Similarity=0.374 Sum_probs=163.9
Q ss_pred CCcccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
+++++||||+++++++.. ....++|+||+.+++|.+++...... ...+++..++.++.|++.||.|||+.+
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ 154 (317)
T 2buj_A 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAKG 154 (317)
T ss_dssp HHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 567899999999999872 34789999999999999999763211 012889999999999999999999998
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc-------ccccccccccccCchhhccCC---CCcccchHH
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-------HSTRVLGTFGYHAPEYAMTGQ---MSSKSDVYS 147 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~---~~~~~Diws 147 (243)
++|+||||+||+++.++.++|+|||.+.......... ......|++.|+|||.+.+.. ++.++||||
T Consensus 155 ---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s 231 (317)
T 2buj_A 155 ---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWS 231 (317)
T ss_dssp ---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHH
T ss_pred ---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHH
Confidence 9999999999999999999999999876553221110 011234789999999987543 688999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 148 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
||+++|+|++|..||....... ...............+...+..+.+++.+||+.||.+|||+.++
T Consensus 232 lG~il~el~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 297 (317)
T 2buj_A 232 LGCVLYAMMFGEGPYDMVFQKG--------------DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297 (317)
T ss_dssp HHHHHHHHHHSSCTTHHHHHTT--------------SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhCCCChhhhhccc--------------chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 9999999999999985321110 01111111122222233455689999999999999999999999
Q ss_pred HHHHHHHHhhc
Q 026115 228 LKALQPLLNTR 238 (243)
Q Consensus 228 l~~l~~~~~~~ 238 (243)
++.|+++....
T Consensus 298 l~~L~~~~~~~ 308 (317)
T 2buj_A 298 LSQLEALQPPA 308 (317)
T ss_dssp HHHHHHTCCCC
T ss_pred HHHhhhcCCCC
Confidence 99999876443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=264.90 Aligned_cols=200 Identities=18% Similarity=0.176 Sum_probs=159.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+.+++||||++++++|.+++.+++||||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 115 l~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~g---i 183 (412)
T 2vd5_A 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHRLG---Y 183 (412)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 4568999999999999999999999999999999999976432 1889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-------cCCCCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-------TGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~DiwslG~~l~~ 154 (243)
+||||||+||+++.++.++|+|||+++........ ......||+.|+|||++. ...++.++|+|||||++||
T Consensus 184 iHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilye 262 (412)
T 2vd5_A 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262 (412)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHH
T ss_pred eecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHH
Confidence 99999999999999999999999998765432211 122356999999999987 3457899999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc--c-CCCCCHHHHHHHHHHHHhhcCCCCCCC---CCHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--L-GGEYPPKAIAKMAAVAALCVQYEADFR---PNMGIVL 228 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~~vl 228 (243)
|++|..||..... .+....+.... . ....+...+..+.++|.+||. +|.+| |++++++
T Consensus 263 lltG~~Pf~~~~~---------------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~ 326 (412)
T 2vd5_A 263 MFYGQTPFYADST---------------AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR 326 (412)
T ss_dssp HHHSSCTTCCSSH---------------HHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH
T ss_pred HHhCCCCCCCCCH---------------HHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 9999999975421 11112222111 1 111123456789999999999 99998 5899987
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
+
T Consensus 327 ~ 327 (412)
T 2vd5_A 327 T 327 (412)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=250.75 Aligned_cols=209 Identities=25% Similarity=0.275 Sum_probs=154.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-CCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~~~~ 80 (243)
++.++||||+++++++.+++..++||||+.+ +|.+++...... ...+++..++.++.|++.|++|||+. +
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~--- 130 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLHSKLS--- 130 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHSC---
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---
Confidence 4678999999999999999999999999975 888877642110 01289999999999999999999998 8
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhh----ccCCCCcccchHHHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA----MTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~~l~~l~ 156 (243)
++|+||||+||+++.++.++|+|||++........ .....|++.|+|||.+ .+..++.++|+||+|+++++++
T Consensus 131 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 207 (290)
T 3fme_A 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 207 (290)
T ss_dssp CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999876544322 2234589999999996 4556788999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPL 234 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~~~ 234 (243)
+|..||..... .....................+..+.+++.+||+.||++|||+.++++ .++..
T Consensus 208 ~g~~p~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 208 ILRFPYDSWGT--------------PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HTSCSSCCCSC--------------HHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HCCCCccccCc--------------hHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 99999964311 112222222322222223345668999999999999999999999998 55544
Q ss_pred Hh
Q 026115 235 LN 236 (243)
Q Consensus 235 ~~ 236 (243)
..
T Consensus 274 ~~ 275 (290)
T 3fme_A 274 ES 275 (290)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=252.99 Aligned_cols=197 Identities=22% Similarity=0.303 Sum_probs=161.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+++++|.+++..... ++...+..++.|++.|+.|||+.+ +
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 127 (304)
T 2jam_A 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV---------YTEKDASLVIQQVLSAVKYLHENG---I 127 (304)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999876542 889999999999999999999998 9
Q ss_pred EeccCCCCceEe---cCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||++ +.++.++|+|||++....... .....|++.|+|||.+.+..++.++|+||||+++++|++|
T Consensus 128 ~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 203 (304)
T 2jam_A 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203 (304)
T ss_dssp CCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHS
T ss_pred cccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999 778899999999987543321 2234589999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||...... .....+..... ........+..+.+++.+||+.||++|||+.++++
T Consensus 204 ~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 204 YPPFYEETES---------------KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp SCTTTTSCHH---------------HHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCHH---------------HHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9999643211 11111111111 11222345668999999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=266.52 Aligned_cols=210 Identities=20% Similarity=0.214 Sum_probs=152.4
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
|++++||||+++++++... ...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+
T Consensus 115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~~-----------l~~~~~~~~~~qil~aL~~lH~ 182 (464)
T 3ttj_A 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHS 182 (464)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999754 467999999976 577766432 7889999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.| ++||||||+||+++.++.++|+|||+++...... ......||+.|+|||++.+..++.++|||||||++++|
T Consensus 183 ~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 256 (464)
T 3ttj_A 183 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256 (464)
T ss_dssp TT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred CC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHH
Confidence 98 9999999999999999999999999997654321 12345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCch-------hhhhhhhccc---------------cCC---CCCHHHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSE-------DKVKQCVDTK---------------LGG---EYPPKAIAKMAAVA 210 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~---------------~~~---~~~~~~~~~~~~li 210 (243)
++|..||.+.........+......... .......... ... ......+..+.+|+
T Consensus 257 l~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 336 (464)
T 3ttj_A 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 336 (464)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHH
Confidence 9999999765322111110000000000 0001111100 000 01112366799999
Q ss_pred HhhcCCCCCCCCCHHHHHH
Q 026115 211 ALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 211 ~~~l~~~p~~Rps~~~vl~ 229 (243)
.+||+.||++|||++|+++
T Consensus 337 ~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 337 SKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHSCSSTTTSCCHHHHHT
T ss_pred HHHcCCChhhCCCHHHHhc
Confidence 9999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=269.65 Aligned_cols=197 Identities=26% Similarity=0.358 Sum_probs=159.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++.++...++||||+.+|+|.+++..... +++..++.++.|++.||+|||+.+ +
T Consensus 100 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---i 167 (504)
T 3q5i_A 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---------FDECDAANIMKQILSGICYLHKHN---I 167 (504)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5688999999999999999999999999999999998876542 899999999999999999999998 9
Q ss_pred EeccCCCCceEecCCC---ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+||||||+||+++.++ .++|+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|
T Consensus 168 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 243 (504)
T 3q5i_A 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243 (504)
T ss_dssp ECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHS
T ss_pred EeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhC
Confidence 9999999999998776 689999999876543321 234468999999999874 689999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||...... +....+.........+ ...+..+.+++.+||+.||.+|||++++++
T Consensus 244 ~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 244 YPPFGGQNDQ---------------DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp SCSSCCSSHH---------------HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCHH---------------HHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999754221 1111121111111100 123567999999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=262.49 Aligned_cols=197 Identities=23% Similarity=0.330 Sum_probs=150.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||+++++++. .+..++||||+.+|+|.+++..... +++..+..++.|++.||+|||+.+ +
T Consensus 194 l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i 260 (419)
T 3i6u_A 194 LKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR---------LKEATCKLYFYQMLLAVQYLHENG---I 260 (419)
T ss_dssp HHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 56789999999999985 4567899999999999998876542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCC---ceeecccCCCCCCcccccccccccccccccccCchhhcc---CCCCcccchHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 82 ~h~di~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l 155 (243)
+||||||+||+++.++ .++|+|||+++....... .....||+.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 261 vHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~l 337 (419)
T 3i6u_A 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337 (419)
T ss_dssp CCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHH
T ss_pred cccCCChHhEEEecCCCcceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHH
Confidence 9999999999997654 599999999987654321 234568999999999863 5678899999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP---PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++|..||....... .....+........+ ...+..+.+++.+||+.||++|||++++++
T Consensus 338 ltg~~pf~~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 338 LSGYPPFSEHRTQV---------------SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHSSCSSCCCSSSC---------------CHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHCCCCCCCCcchH---------------HHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 99999997432211 111111111111111 123567999999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.78 Aligned_cols=205 Identities=20% Similarity=0.298 Sum_probs=164.3
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++..+++||||+.||+|..++...... ...+++..++.++.|++.||.|||+.+ +
T Consensus 239 L~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~g---I 310 (543)
T 3c4z_A 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQRN---I 310 (543)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHcC---C
Confidence 56789999999999999999999999999999999998765321 112889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|+|||+++........ .....||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 311 vHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~P 388 (543)
T 3c4z_A 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388 (543)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCC
Confidence 99999999999999999999999999765433211 2334699999999999998899999999999999999999999
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM-----GIVLK 229 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~vl~ 229 (243)
|........ .......+.... ...+...+..+.+++.+||+.||.+||++ +++++
T Consensus 389 F~~~~~~~~-----------~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 389 FRARGEKVE-----------NKELKQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp SCCTTCCCC-----------HHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCCccchh-----------HHHHHHHHhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 975422110 111111222222 13344567789999999999999999965 66664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=262.87 Aligned_cols=209 Identities=22% Similarity=0.283 Sum_probs=158.9
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++..+ ..+++||||+ +++|.+++.... ++...+..++.|++.||+|||+
T Consensus 78 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~ 146 (367)
T 1cm8_A 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHA 146 (367)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999865 3469999999 779999998643 8899999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
.| ++||||||+||+++.++.++|+|||+++..... .....+|+.|+|||++.+ ..++.++|+||+||++++
T Consensus 147 ~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 218 (367)
T 1cm8_A 147 AG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218 (367)
T ss_dssp TT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHH
T ss_pred CC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHH
Confidence 99 999999999999999999999999998765432 233468999999999887 678999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhh--------hhhhhc---c---ccCCCCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDK--------VKQCVD---T---KLGGEYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~---~---~~~~~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|++|..||.+.........+.........+. ....+. . ..........+..+.+++.+||+.||++
T Consensus 219 ll~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~ 298 (367)
T 1cm8_A 219 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 298 (367)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhH
Confidence 9999999976533211111100000111000 000000 0 0000112234567999999999999999
Q ss_pred CCCHHHHHH
Q 026115 221 RPNMGIVLK 229 (243)
Q Consensus 221 Rps~~~vl~ 229 (243)
|||++++++
T Consensus 299 R~t~~e~l~ 307 (367)
T 1cm8_A 299 RVTAGEALA 307 (367)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=260.52 Aligned_cols=214 Identities=21% Similarity=0.305 Sum_probs=156.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|..++..... +++..+..++.|++.|+.|||+.+ +
T Consensus 78 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---i 145 (331)
T 4aaa_A 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---------LDYQVVQKYLFQIINGIGFCHSHN---I 145 (331)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5678999999999999999999999999999999888765543 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||||+||+++.++.++|+|||+++........ .....|++.|+|||.+.+. .++.++||||||+++++|++|..
T Consensus 146 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (331)
T 4aaa_A 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223 (331)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EccCcChheEEEcCCCcEEEEeCCCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765433221 2334589999999999875 67899999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhh---------hhhhhccccCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDK---------VKQCVDTKLGGEY-----PPKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
||...........+........... ......+...... ....+..+.+++.+||+.||++|||+++
T Consensus 224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 303 (331)
T 4aaa_A 224 LFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303 (331)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred CCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH
Confidence 9976532211100000000000000 0000000000011 1134567999999999999999999999
Q ss_pred HHH
Q 026115 227 VLK 229 (243)
Q Consensus 227 vl~ 229 (243)
+++
T Consensus 304 ll~ 306 (331)
T 4aaa_A 304 LLH 306 (331)
T ss_dssp GGG
T ss_pred Hhc
Confidence 987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=258.66 Aligned_cols=203 Identities=20% Similarity=0.248 Sum_probs=160.5
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++ +||||+++++++.++...++||||+.+++|.+++..... ++...+..++.|++.||.|||+.+
T Consensus 112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~--- 179 (355)
T 1vzo_A 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG--- 179 (355)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3456 699999999999999999999999999999999986542 889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc--CCCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g 158 (243)
++||||||+||+++.++.++|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 180 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g 258 (355)
T 1vzo_A 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258 (355)
T ss_dssp CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999999999998765433221 1233568999999999985 3468899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 230 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~~ 230 (243)
..||........ ...+...+.. .....+...+..+.+++.+||+.||++|| |++++++.
T Consensus 259 ~~pf~~~~~~~~------------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 259 ASPFTVDGEKNS------------QAEISRRILK-SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp SCTTSCTTSCCC------------HHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCccCCccch------------HHHHHHHHhc-cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 999974422111 0111111111 11233445567899999999999999999 99999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=254.41 Aligned_cols=208 Identities=15% Similarity=0.109 Sum_probs=164.6
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
...|+||+++++++..++..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ ++|
T Consensus 123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivH 195 (365)
T 3e7e_A 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIH 195 (365)
T ss_dssp GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EEC
T ss_pred hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCC---eec
Confidence 445999999999999999999999999999999999753211 0012899999999999999999999998 999
Q ss_pred ccCCCCceEecC-----------CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHH
Q 026115 84 RNIKSSNVLLFD-----------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 152 (243)
Q Consensus 84 ~di~~~nil~~~-----------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 152 (243)
|||||+||+++. ++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++
T Consensus 196 rDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 275 (365)
T 3e7e_A 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275 (365)
T ss_dssp CCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHH
T ss_pred CCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHH
Confidence 999999999988 899999999999654322222223445699999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCC-CCHHHHHHHH
Q 026115 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFR-PNMGIVLKAL 231 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R-ps~~~vl~~l 231 (243)
|+|++|..||........ . +..... .. ...+.+.+++..|++.+|.+| |+++++.+.|
T Consensus 276 ~elltg~~pf~~~~~~~~--------------~----~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 276 YCMLFGTYMKVKNEGGEC--------------K----PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp HHHHHSSCCCEEEETTEE--------------E----ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred HHHHhCCCccccCCCCce--------------e----echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 999999999854321100 0 001111 11 124578899999999999999 6888888899
Q ss_pred HHHHhhcC
Q 026115 232 QPLLNTRS 239 (243)
Q Consensus 232 ~~~~~~~~ 239 (243)
++++....
T Consensus 335 ~~~l~~~~ 342 (365)
T 3e7e_A 335 KKVFQQHY 342 (365)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHhh
Confidence 88877643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=248.88 Aligned_cols=196 Identities=22% Similarity=0.278 Sum_probs=153.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+++|.+++..... ++...+..++.|++.|+.|||+.+ +
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 132 (276)
T 2h6d_A 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---------VEEMEARRLFQQILSAVDYCHRHM---V 132 (276)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHC---S
T ss_pred HhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 5678999999999999999999999999999999999976542 889999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~ 160 (243)
+|+||+|+||+++.++.++|+|||++........ .....|++.|+|||.+.+..+ +.++|+||||+++++|++|..
T Consensus 133 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 209 (276)
T 2h6d_A 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTL 209 (276)
T ss_dssp SCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876543321 123458899999999987665 579999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||..... ....+.+.... ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 210 p~~~~~~----------------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 210 PFDDEHV----------------PTLFKKIRGGV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp SSCCSSH----------------HHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcH----------------HHHHHHhhcCc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 9964311 11111111111 1223344567999999999999999999999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=255.17 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=152.8
Q ss_pred CCcc-cCCccceeeEEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 2 VSRL-KNENVVELVGYYVD------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
++++ +||||+++++++.. +...++||||+.+++|.+++...... .++...++.++.|++.||.|||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH 146 (326)
T 2x7f_A 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLH 146 (326)
T ss_dssp HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHH
Confidence 3455 79999999999986 56899999999999999999875422 2889999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFG 149 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG 149 (243)
+.+ ++|+||+|+||+++.++.++|+|||++......... .....|++.|+|||++. +..++.++||||||
T Consensus 147 ~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG 221 (326)
T 2x7f_A 147 QHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221 (326)
T ss_dssp HTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHH
T ss_pred HCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHH
Confidence 998 999999999999999999999999998765432211 23346899999999987 45678899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+++++|++|..||...... .....+.............+..+.+++.+||+.||.+|||++++++
T Consensus 222 ~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 222 ITAIEMAEGAPPLCDMHPM---------------RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHHSSCTTTTSCHH---------------HHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCCCCCCcHH---------------HHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 9999999999999644211 1111111111111112234567999999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=263.04 Aligned_cols=202 Identities=14% Similarity=0.184 Sum_probs=153.8
Q ss_pred CCcccCCccceee-------EEEEeCC-----------------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHH
Q 026115 2 VSRLKNENVVELV-------GYYVDGP-----------------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWA 57 (243)
Q Consensus 2 l~~l~h~niv~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 57 (243)
+++++||||++++ +++.+++ ..+++|||+ +|+|.+++....... .....+++.
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~--~~~~~l~~~ 206 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHH 206 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT--TTTHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc--cccccccHH
Confidence 5678999999998 7776553 388999999 679999998653211 111125568
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC
Q 026115 58 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 137 (243)
Q Consensus 58 ~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 137 (243)
.++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++..... .....| +.|+|||++.+.
T Consensus 207 ~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 207 ARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhccc
Confidence 88899999999999999999 999999999999999999999999998754331 233456 899999999877
Q ss_pred -----------CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHH
Q 026115 138 -----------QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKM 206 (243)
Q Consensus 138 -----------~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (243)
.++.++|||||||++|+|++|..||.......... .... . ....+..+
T Consensus 278 ~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~---------------~~~~-~-----~~~~~~~~ 336 (377)
T 3byv_A 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE---------------WIFR-S-----CKNIPQPV 336 (377)
T ss_dssp TSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG---------------GGGS-S-----CCCCCHHH
T ss_pred ccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh---------------hhhh-h-----ccCCCHHH
Confidence 78999999999999999999999997543221110 0000 0 01234579
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHH--HHHHHHh
Q 026115 207 AAVAALCVQYEADFRPNMGIVLK--ALQPLLN 236 (243)
Q Consensus 207 ~~li~~~l~~~p~~Rps~~~vl~--~l~~~~~ 236 (243)
.+++.+||+.||++|||+.++++ .++++..
T Consensus 337 ~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 337 RALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 99999999999999999999997 5555443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=256.63 Aligned_cols=198 Identities=23% Similarity=0.371 Sum_probs=158.1
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++ +||||+++++++......++||||+++++|.+++..... ++...+..++.|++.||.|||+.|
T Consensus 153 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~g--- 220 (365)
T 2y7j_A 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA---------LSEKETRSIMRSLLEAVSFLHANN--- 220 (365)
T ss_dssp HHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 799999999999999999999999999999999976532 889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC------CCCcccchHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG------QMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~ 154 (243)
++|+||||+||+++.++.++|+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+
T Consensus 221 i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 297 (365)
T 2y7j_A 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297 (365)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHH
Confidence 99999999999999999999999999865543221 2335689999999998642 57889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|++|..||...... .....+.........+ ...+..+.+++.+||+.||++|||+.++++
T Consensus 298 ll~g~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 298 LLAGSPPFWHRRQI---------------LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHSSCSSCCSSHH---------------HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHCCCCCCCCCHH---------------HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99999999643110 1111111111110100 123457999999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=275.30 Aligned_cols=193 Identities=22% Similarity=0.279 Sum_probs=162.2
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
+||||+++++++.+...+++||||+.+|+|..++..... +++..+..++.|++.||.|||+.+ ++|||
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---IiHrD 467 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRD 467 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTS---EECCC
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEecc
Confidence 799999999999999999999999999999999987542 889999999999999999999998 99999
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 165 (243)
|||+|||++.++.++|+|||+++....... ......||+.|+|||++.+..++.++|+||||+++|||++|..||...
T Consensus 468 LKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp CCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999875332221 134456999999999999999999999999999999999999999754
Q ss_pred CCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 026115 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM-----GIVLK 229 (243)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~vl~ 229 (243)
.. .+....+..... ..+...+.++.+||.+||+.||++||++ +++++
T Consensus 546 ~~---------------~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 546 DE---------------DELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SH---------------HHHHHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CH---------------HHHHHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 21 122223333222 3445567789999999999999999997 66654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=254.03 Aligned_cols=207 Identities=19% Similarity=0.263 Sum_probs=160.1
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC--
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-- 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~-- 77 (243)
+++++||||+++++++.+ +...++||||+++++|.+++...... ...+++..++.++.|++.|++|||+.+
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 133 (279)
T 2w5a_A 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDG 133 (279)
T ss_dssp HHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHC--
T ss_pred HHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcccCC
Confidence 567899999999998854 67899999999999999999764311 012889999999999999999999975
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
..+++|+||+|+||+++.++.++|+|||.++........ .....|++.|+|||.+.+..++.++|+||||+++++|++
T Consensus 134 ~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 211 (279)
T 2w5a_A 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211 (279)
T ss_dssp ----CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH
T ss_pred CCeeEEeccchhhEEEcCCCCEEEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 223999999999999999999999999998654432211 123458899999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l 231 (243)
|..||..... ....+.+........+...+..+.+++.+||+.||++|||+.++++.+
T Consensus 212 g~~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 212 LMPPFTAFSQ----------------KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp SSCSSCCSSH----------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CCCCCcccCH----------------HHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 9999974421 112222222222233445567899999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=249.13 Aligned_cols=193 Identities=17% Similarity=0.252 Sum_probs=153.6
Q ss_pred cc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 026115 4 RL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 82 (243)
Q Consensus 4 ~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~ 82 (243)
++ +||||+++++++.+++..++||||+++++|.+++....... ..+++..++.++.|++.||.|||+.+ ++
T Consensus 66 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---iv 137 (289)
T 1x8b_A 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-----SYFKEAELKDLLLQVGRGLRYIHSMS---LV 137 (289)
T ss_dssp HSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 45 89999999999999999999999999999999997642100 02889999999999999999999998 99
Q ss_pred eccCCCCceEecCC-------------------CceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcc
Q 026115 83 HRNIKSSNVLLFDD-------------------DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSK 142 (243)
Q Consensus 83 h~di~~~nil~~~~-------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~ 142 (243)
|+||||+||+++.+ ..++++|||.+...... ....|++.|+|||++.+. .++.+
T Consensus 138 H~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~ 211 (289)
T 1x8b_A 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPK 211 (289)
T ss_dssp CSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHH
T ss_pred ecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCch
Confidence 99999999999844 47899999988655432 223489999999999865 55679
Q ss_pred cchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 026115 143 SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 222 (243)
Q Consensus 143 ~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (243)
+||||||++++++++|.+++... .....+.. ......+...+..+.+++.+||+.||++||
T Consensus 212 ~Di~slG~il~~l~~~~~~~~~~------------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 272 (289)
T 1x8b_A 212 ADIFALALTVVCAAGAEPLPRNG------------------DQWHEIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRP 272 (289)
T ss_dssp HHHHHHHHHHHHHTTCCCCCSSS------------------HHHHHHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhHHHHHHHHHHHhcCCCCCcch------------------hHHHHHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCC
Confidence 99999999999999998876422 11111111 111233344566899999999999999999
Q ss_pred CHHHHHH
Q 026115 223 NMGIVLK 229 (243)
Q Consensus 223 s~~~vl~ 229 (243)
|+.++++
T Consensus 273 s~~~ll~ 279 (289)
T 1x8b_A 273 SAMALVK 279 (289)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=257.39 Aligned_cols=215 Identities=21% Similarity=0.247 Sum_probs=159.6
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++||||+.+ +|..++..... .+++..+..++.|++.|+.|||+.+ +
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 133 (346)
T 1ua2_A 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLHQHW---I 133 (346)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5678999999999999999999999999976 89998876542 2778889999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.++|+|||+++........ .....||+.|+|||++.+. .++.++|||||||++++|++|.+
T Consensus 134 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp CCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ECCCCCHHHEEEcCCCCEEEEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999999999999999999866433221 2335689999999999754 47889999999999999999999
Q ss_pred CCCCCCCCCCccceeecc-----CcCch-hhhhhhhccccCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWAT-----PKLSE-DKVKQCVDTKLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||.+.........+.... ..+.. ...............+ ...+..+.+++.+||+.||++|||++|+++
T Consensus 212 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 212 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 987543211100000000 00000 0000000000000111 233467999999999999999999999987
Q ss_pred H
Q 026115 230 A 230 (243)
Q Consensus 230 ~ 230 (243)
.
T Consensus 292 h 292 (346)
T 1ua2_A 292 M 292 (346)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=249.88 Aligned_cols=200 Identities=23% Similarity=0.304 Sum_probs=155.9
Q ss_pred CCcccCCccceeeEEEE--eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++||||+++++++. ++...++||||+.++ |.+++....... ++...++.++.|++.|+.|||+.+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~-------~~~~~~~~~~~qi~~al~~LH~~~-- 129 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKR-------FPVCQAHGYFCQLIDGLEYLHSQG-- 129 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCS-------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccc-------cCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 67899999999999984 456899999999875 777776644322 889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC--CcccchHHHHHHHHHHHh
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~DiwslG~~l~~l~~ 157 (243)
++|+||||+||+++.++.++|+|||++................|++.|+|||++.+... +.++|+||||+++++|++
T Consensus 130 -i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 208 (305)
T 2wtk_C 130 -IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208 (305)
T ss_dssp -EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH
T ss_pred -eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999876543222222234458999999999886443 779999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||..... ....+.+.... ...+...+..+.+++.+||+.||.+|||++++++
T Consensus 209 g~~p~~~~~~----------------~~~~~~i~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 209 GLYPFEGDNI----------------YKLFENIGKGS-YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp SSCSCCCSSH----------------HHHHHHHHHCC-CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCchH----------------HHHHHHHhcCC-CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999974311 11111111111 1223345667999999999999999999999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=255.95 Aligned_cols=214 Identities=19% Similarity=0.212 Sum_probs=159.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHH------hccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDI------LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++.+++..++||||+++++|.++ +...... .+++..++.++.|++.|+.|||+
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~ 169 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC-------FIPIQVIKCIIKSVLNSFSYIHN 169 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCC-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcccc-------CCCHHHHHHHHHHHHHHHHHHhc
Confidence 5789999999999999999999999999999999999 5442222 38999999999999999999999
Q ss_pred -cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCc-ccchHHHHHHH
Q 026115 76 -KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSS-KSDVYSFGVVL 152 (243)
Q Consensus 76 -~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~DiwslG~~l 152 (243)
.| ++|+||+|+||+++.++.++|+|||.+...... ......|+..|+|||++.+. .++. ++|+||||+++
T Consensus 170 ~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 242 (348)
T 2pml_X 170 EKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242 (348)
T ss_dssp TSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHH
T ss_pred cCC---EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHH
Confidence 88 999999999999999999999999998765433 12345689999999999876 5555 99999999999
Q ss_pred HHHHhCCCCCCCCCCCCC-ccceeec-cCcCc-hhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 153 LELLTGRKPVDHTLPRGQ-QSLVTWA-TPKLS-EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~-~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++|++|..||........ ....... ..... ....................+..+.+++.+||+.||.+|||++++++
T Consensus 243 ~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 243 YVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999999975533100 0000000 00000 00000000000000111345668999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=255.82 Aligned_cols=210 Identities=20% Similarity=0.208 Sum_probs=150.1
Q ss_pred CCcccCCccceeeEEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGP------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++.... ..++||||+.+ +|.+++... ++...+..++.|++.||.|||+
T Consensus 78 l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~lH~ 145 (371)
T 2xrw_A 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHS 145 (371)
T ss_dssp HHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhhc-----------cCHHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999998654 78999999975 888888532 7889999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.+ ++||||||+||+++.++.++|+|||+++....... .....||+.|+|||++.+..++.++|||||||++++|
T Consensus 146 ~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 219 (371)
T 2xrw_A 146 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219 (371)
T ss_dssp TT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred CC---eecccCCHHHEEEcCCCCEEEEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHH
Confidence 98 99999999999999999999999999876543221 2334689999999999998899999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCch-------hh---------------hhhhhccccCC---CCCHHHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSE-------DK---------------VKQCVDTKLGG---EYPPKAIAKMAAVA 210 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~---------------~~~~~~~~~~~---~~~~~~~~~~~~li 210 (243)
++|..||.+.........+......... .. ........... ......+..+.+++
T Consensus 220 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 299 (371)
T 2xrw_A 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299 (371)
T ss_dssp HHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHH
Confidence 9999999765332110000000000000 00 00000000000 01123467899999
Q ss_pred HhhcCCCCCCCCCHHHHHH
Q 026115 211 ALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 211 ~~~l~~~p~~Rps~~~vl~ 229 (243)
.+||+.||++|||++++++
T Consensus 300 ~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 300 SKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHSCSSGGGSCCHHHHHH
T ss_pred HHHCcCChhhCCCHHHHhC
Confidence 9999999999999999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=253.74 Aligned_cols=218 Identities=26% Similarity=0.326 Sum_probs=157.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++..++..++||||+++++|.+++......... ....++...++.++.|++.|+.|||+.+
T Consensus 66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~--- 141 (303)
T 2vwi_A 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEH-KSGVLDESTIATILREVLEGLEYLHKNG--- 141 (303)
T ss_dssp CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTT-TTCSSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 467899999999999999999999999999999999998752111000 0113889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccc---cccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR---LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~ 156 (243)
++|+||+|+||+++.++.++|+|||++......... .......|++.|+|||.+.+ ..++.++|+||||+++++|+
T Consensus 142 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 221 (303)
T 2vwi_A 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221 (303)
T ss_dssp CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999987654332111 11223458999999999875 56789999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||............. ..... ......... ......+..+.+++.+||+.||.+|||+.++++
T Consensus 222 ~g~~pf~~~~~~~~~~~~~--~~~~~-~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 222 TGAAPYHKYPPMKVLMLTL--QNDPP-SLETGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HSSCTTTTSCGGGHHHHHH--TSSCC-CTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCCccCchhhHHHHHh--ccCCC-ccccccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 9999997543221100000 00000 000000000 111223457999999999999999999999997
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=253.48 Aligned_cols=200 Identities=22% Similarity=0.320 Sum_probs=156.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+++++|.+++..... .++...+..++.|++.|+.|||+.+ +
T Consensus 70 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 138 (302)
T 2j7t_A 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHSKR---I 138 (302)
T ss_dssp HHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhcCC---c
Confidence 4678999999999999999999999999999999999876432 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~ 156 (243)
+|+||+|+||+++.++.++|+|||++........ ......|++.|+|||.+. +..++.++|+||||+++++|+
T Consensus 139 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 216 (302)
T 2j7t_A 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216 (302)
T ss_dssp CCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEECCCCCEEEEECCCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHh
Confidence 9999999999999999999999998643222111 123345899999999984 566788999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||...... ........... ....+...+..+.+++.+||+.||++|||++++++
T Consensus 217 ~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 217 QIEPPHHELNPM---------------RVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HSSCTTTTSCHH---------------HHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCCCCccCCHH---------------HHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 999999754221 11111111111 11223345667999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=256.88 Aligned_cols=216 Identities=19% Similarity=0.264 Sum_probs=156.7
Q ss_pred CCcccCCccceeeEEEEe--------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRLKNENVVELVGYYVD--------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
+++++||||+++++++.. ++..++||||+.+ +|.+.+...... ++...+..++.|++.||+||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~L 140 (351)
T 3mi9_A 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK--------FTLSEIKRVMQMLLNGLYYI 140 (351)
T ss_dssp HHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSC--------CCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCC--------CCHHHHHHHHHHHHHHHHHH
Confidence 567899999999999986 4578999999976 888877665432 88999999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc--cccccccccccccCchhhcc-CCCCcccchHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGV 150 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ 150 (243)
|+.| ++||||||+||+++.++.++|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||
T Consensus 141 H~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 217 (351)
T 3mi9_A 141 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 217 (351)
T ss_dssp HHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred HHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHH
Confidence 9999 999999999999999999999999998755422211 11233468999999999876 45799999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeec--------cCcCchhhhhhhhccccCCCCC-HH------HHHHHHHHHHhhcC
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWA--------TPKLSEDKVKQCVDTKLGGEYP-PK------AIAKMAAVAALCVQ 215 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~-~~------~~~~~~~li~~~l~ 215 (243)
++++|++|..||...........+... .+.................... .. .+..+.+++.+||+
T Consensus 218 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 297 (351)
T 3mi9_A 218 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 297 (351)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSC
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhc
Confidence 999999999999865332111110000 0000000000000000000000 00 13468899999999
Q ss_pred CCCCCCCCHHHHHH
Q 026115 216 YEADFRPNMGIVLK 229 (243)
Q Consensus 216 ~~p~~Rps~~~vl~ 229 (243)
.||++|||++|+++
T Consensus 298 ~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 298 LDPAQRIDSDDALN 311 (351)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHhC
Confidence 99999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=261.39 Aligned_cols=206 Identities=11% Similarity=0.052 Sum_probs=144.3
Q ss_pred cCCccceee-------EEEEeC-----------------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHH--
Q 026115 6 KNENVVELV-------GYYVDG-----------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR-- 59 (243)
Q Consensus 6 ~h~niv~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~-- 59 (243)
+||||++++ +++..+ ..+++||||+. ++|.+++...... +....+
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~ 192 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--------YVFRGDEG 192 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--------CCCCHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--------cchhhhhh
Confidence 699987755 555433 34899999998 7999999865321 333333
Q ss_pred ----HHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc
Q 026115 60 ----VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 135 (243)
Q Consensus 60 ----~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 135 (243)
..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++...... ....+++.|+|||++.
T Consensus 193 ~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~ 264 (371)
T 3q60_A 193 ILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLN 264 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHT
T ss_pred hhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhcc
Confidence 667799999999999999 9999999999999999999999999987654321 1344679999999998
Q ss_pred c--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhh
Q 026115 136 T--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALC 213 (243)
Q Consensus 136 ~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 213 (243)
+ ..++.++|||||||++|+|++|..||....+........ ...................+..+.+++.+|
T Consensus 265 ~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 336 (371)
T 3q60_A 265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR--------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336 (371)
T ss_dssp CSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCB--------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHH
T ss_pred CCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhh--------hhhhhccccccchhhccCCCHHHHHHHHHH
Confidence 7 678999999999999999999999998664432211110 000001111111122224466899999999
Q ss_pred cCCCCCCCCCHHHHHH--HHHHHHh
Q 026115 214 VQYEADFRPNMGIVLK--ALQPLLN 236 (243)
Q Consensus 214 l~~~p~~Rps~~~vl~--~l~~~~~ 236 (243)
|+.||++|||+.++++ .++++.+
T Consensus 337 L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 337 LNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp TCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred cCCChhhCCCHHHHhcCHHHHHHHH
Confidence 9999999999999986 4444433
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=249.26 Aligned_cols=198 Identities=24% Similarity=0.296 Sum_probs=159.2
Q ss_pred CCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++ ||||+++++++.++...++||||+.+++|.+++..... ++...++.++.|++.|+.|||+.+
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~--- 144 (298)
T 1phk_A 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLN--- 144 (298)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 34564 99999999999999999999999999999999986532 889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc------cCCCCcccchHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~~l~~ 154 (243)
++|+||+|+||+++.++.++|+|||++........ .....|++.|+|||++. ...++.++|+||||+++++
T Consensus 145 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~ 221 (298)
T 1phk_A 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221 (298)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred cccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHH
Confidence 99999999999999999999999999875543221 23345889999999985 3457889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|++|..||...... .....+...... .......+..+.+++.+||+.||++|||+.++++
T Consensus 222 l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 222 LLAGSPPFWHRKQM---------------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHSSCSSCCSSHH---------------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCcCccHH---------------HHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 99999999643110 111111111111 1112345678999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=261.23 Aligned_cols=222 Identities=19% Similarity=0.242 Sum_probs=155.8
Q ss_pred CCcccCCccceeeEEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGP------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
|++++||||+++++++.... .+++||||+.++ +...+...... ...++...+..++.|++.||+|||+
T Consensus 86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (394)
T 4e7w_A 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIHS 159 (394)
T ss_dssp HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57899999999999996433 388999999874 44433321100 0028899999999999999999999
Q ss_pred cCCCCeEeccCCCCceEec-CCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLL 153 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~ 153 (243)
.+ ++||||||+||+++ .++.++|+|||+++....... .....|++.|+|||++.+. .++.++||||+||++|
T Consensus 160 ~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 233 (394)
T 4e7w_A 160 IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233 (394)
T ss_dssp TT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred CC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHH
Confidence 98 99999999999999 789999999999876543322 2334689999999998764 5899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhh----hcccc---CC-----CCCHHHHHHHHHHHHhhcCCCCCCC
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC----VDTKL---GG-----EYPPKAIAKMAAVAALCVQYEADFR 221 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~---~~-----~~~~~~~~~~~~li~~~l~~~p~~R 221 (243)
+|++|..||.+.........+.........+.+... ..... .. ..+...+..+.+++.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (394)
T 4e7w_A 234 ELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313 (394)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhC
Confidence 999999999765322111111000001111111000 00000 00 0112245679999999999999999
Q ss_pred CCHHHHHHH--HHHHH
Q 026115 222 PNMGIVLKA--LQPLL 235 (243)
Q Consensus 222 ps~~~vl~~--l~~~~ 235 (243)
||+.++++. ++++.
T Consensus 314 ~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 314 LTAIEALCHPFFDELR 329 (394)
T ss_dssp CCHHHHHTSGGGSTTT
T ss_pred CCHHHHhcChhhhhhc
Confidence 999999973 44443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=250.54 Aligned_cols=201 Identities=22% Similarity=0.396 Sum_probs=154.1
Q ss_pred CCccc--CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLK--NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+++++ ||||+++++++.++...+++|| +.+++|.+++..... ++...++.++.|++.||.|||+.+
T Consensus 80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~-- 147 (313)
T 3cek_A 80 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG-- 147 (313)
T ss_dssp HHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 34565 5999999999999999999999 557799999987542 889999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-----------CCCCcccchHHH
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSF 148 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Diwsl 148 (243)
++|+||||+||+++. +.++|+|||++................|++.|+|||.+.+ ..++.++|||||
T Consensus 148 -ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 148 -IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp -CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred -ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 999999999999964 8999999999987654433222234568999999999875 367889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
|+++++|++|..||..... .................+...+..+.+++.+||+.||.+|||+.+++
T Consensus 226 G~il~el~~g~~pf~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 291 (313)
T 3cek_A 226 GCILYYMTYGKTPFQQIIN--------------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291 (313)
T ss_dssp HHHHHHHHHSSCTTTTCCS--------------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHhCCCchhhHHH--------------HHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence 9999999999999964311 11222333333333333334456899999999999999999999999
Q ss_pred HH
Q 026115 229 KA 230 (243)
Q Consensus 229 ~~ 230 (243)
+.
T Consensus 292 ~h 293 (313)
T 3cek_A 292 AH 293 (313)
T ss_dssp TS
T ss_pred cC
Confidence 73
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=249.90 Aligned_cols=197 Identities=24% Similarity=0.326 Sum_probs=154.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++..+. .++||||+.+++|.+++..... ++...+..++.|++.||.|||+.+ +
T Consensus 69 l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 135 (322)
T 2ycf_A 69 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR---------LKEATCKLYFYQMLLAVQYLHENG---I 135 (322)
T ss_dssp HHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 56789999999999997665 8999999999999999876542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCc---eeecccCCCCCCcccccccccccccccccccCchhhc---cCCCCcccchHHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDI---AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l 155 (243)
+|+||||+||+++.++. ++|+|||++........ .....|++.|+|||++. ...++.++|+||||+++|+|
T Consensus 136 vH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l 212 (322)
T 2ycf_A 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212 (322)
T ss_dssp ECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHH
T ss_pred eccCCCHHHEEEecCCCCCeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHH
Confidence 99999999999987664 99999999876543221 12345899999999974 45678899999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP---PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++|..||........ ....+........+ ...+..+.+++.+||+.||++|||+.++++
T Consensus 213 ~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 213 LSGYPPFSEHRTQVS---------------LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHSSCSSCSTTCSSC---------------HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCCCCCcccchHHH---------------HHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 999999975422110 11111111100011 123567999999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=259.82 Aligned_cols=224 Identities=18% Similarity=0.220 Sum_probs=149.5
Q ss_pred CCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 2 VSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
|++++||||+++++++.. +...++||||+.+ +|.+++..............+++..++.++.|++.||+|||+.+
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-- 148 (405)
T 3rgf_A 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 148 (405)
T ss_dssp HHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 578899999999999964 6789999999965 88888764321111111113889999999999999999999999
Q ss_pred CeEeccCCCCceEe----cCCCceeecccCCCCCCcccccc-cccccccccccccCchhhccC-CCCcccchHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLL----FDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLL 153 (243)
Q Consensus 80 ~~~h~di~~~nil~----~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~ 153 (243)
++||||||+||++ +.++.++|+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|
T Consensus 149 -ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 227 (405)
T 3rgf_A 149 -VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 227 (405)
T ss_dssp -CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred -EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence 9999999999999 67789999999999876543221 112345689999999999874 4899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcccee---------eccC-----cCc-------hhhhhhhhccccCCCCC---------HHHH
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVT---------WATP-----KLS-------EDKVKQCVDTKLGGEYP---------PKAI 203 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~---------~~~~-----~~~-------~~~~~~~~~~~~~~~~~---------~~~~ 203 (243)
+|++|..||............. .... .+. ................. ...+
T Consensus 228 ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (405)
T 3rgf_A 228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307 (405)
T ss_dssp HHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTT
T ss_pred HHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCC
Confidence 9999999997553321000000 0000 000 00000000000000000 0013
Q ss_pred HHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 204 AKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 204 ~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..+.+|+.+||+.||.+|||++|+++
T Consensus 308 ~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 308 SKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp SHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 46889999999999999999999997
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=259.50 Aligned_cols=149 Identities=25% Similarity=0.334 Sum_probs=123.5
Q ss_pred CCcccCCccceeeEEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
|++++||||+++++++... ...++||||+. ++|.+++..... ++...+..++.|++.||+|||+.
T Consensus 79 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~i~~qil~aL~~LH~~ 148 (432)
T 3n9x_A 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIF---------LTEEHIKTILYNLLLGENFIHES 148 (432)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 5678999999999999866 57999999986 599999976542 89999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc--------------------cccccccccccccCchhh-c
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--------------------LHSTRVLGTFGYHAPEYA-M 135 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--------------------~~~~~~~~~~~~~aPE~~-~ 135 (243)
+ ++||||||+||+++.++.++|+|||+++........ .......||+.|+|||++ .
T Consensus 149 g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 225 (432)
T 3n9x_A 149 G---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225 (432)
T ss_dssp T---EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT
T ss_pred C---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence 9 999999999999999999999999999765433211 112345689999999986 4
Q ss_pred cCCCCcccchHHHHHHHHHHHhCCCCCC
Q 026115 136 TGQMSSKSDVYSFGVVLLELLTGRKPVD 163 (243)
Q Consensus 136 ~~~~~~~~DiwslG~~l~~l~~g~~pf~ 163 (243)
...++.++||||+||+++||++|..||.
T Consensus 226 ~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 226 QENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCCCCcccccchHHHHHHHHHhcccccc
Confidence 5668999999999999999998666654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=263.05 Aligned_cols=213 Identities=21% Similarity=0.291 Sum_probs=164.9
Q ss_pred CCcccC-CccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++.++| +++..+..++..+...++||||+ +++|.+++..... .+++..++.++.||+.||.|||+.+
T Consensus 56 l~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g--- 123 (483)
T 3sv0_A 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHSKS--- 123 (483)
T ss_dssp HHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 456666 55666666677888999999999 8899999985432 2899999999999999999999998
Q ss_pred eEeccCCCCceEe---cCCCceeecccCCCCCCccccccc-----ccccccccccccCchhhccCCCCcccchHHHHHHH
Q 026115 81 IIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 152 (243)
Q Consensus 81 ~~h~di~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 152 (243)
++||||||+||++ +.++.++|+|||+++......... ......||..|+|||++.+..++.++|||||||++
T Consensus 124 IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil 203 (483)
T 3sv0_A 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL 203 (483)
T ss_dssp EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHH
Confidence 9999999999999 578899999999997665433211 11245689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE---YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|+|++|..||......... .....+........ ....++.++.+++..||+.||++||++.+|++
T Consensus 204 ~elltG~~Pf~~~~~~~~~------------~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 204 MYFLRGSLPWQGLKAGTKK------------QKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHSSCTTSSCCCSSHH------------HHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhCCCCCccccchhHH------------HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999764322111 11111111111000 00123467999999999999999999999999
Q ss_pred HHHHHHhhc
Q 026115 230 ALQPLLNTR 238 (243)
Q Consensus 230 ~l~~~~~~~ 238 (243)
.|++++...
T Consensus 272 ~L~~l~~~~ 280 (483)
T 3sv0_A 272 LFRDLFIRE 280 (483)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHc
Confidence 999997654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=248.09 Aligned_cols=212 Identities=18% Similarity=0.250 Sum_probs=158.8
Q ss_pred cccCCccceeeEEEE-----eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 4 RLKNENVVELVGYYV-----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 4 ~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
+++||||+++++++. .....++||||+. |+|.+++....... ++...++.++.|++.||.|||+.|
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~g- 140 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG-------VPTETIKDMMFQLLRGLDFLHSHR- 140 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTC-------SCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCC-------CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 348999999999987 5567999999997 59999998765332 889999999999999999999999
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++|+||||+||+++.++.++|+|||+++....... .....|+..|+|||++.+..++.++|+||||+++++|++|
T Consensus 141 --i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 215 (326)
T 1blx_A 141 --VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215 (326)
T ss_dssp --CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred --ceeccCCHHHeEEcCCCCEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999987654322 2335689999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccC-----cCch-----hhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATP-----KLSE-----DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
..||...........+..... .+.. ...................+..+.+++.+||+.||++|||+.+++
T Consensus 216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 216 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 999975432111000000000 0000 000000000000011223456799999999999999999999998
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
+
T Consensus 296 ~ 296 (326)
T 1blx_A 296 S 296 (326)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=258.00 Aligned_cols=224 Identities=19% Similarity=0.261 Sum_probs=159.8
Q ss_pred CCCcccCCccceeeEEEEe--------------------------------------CCeeEEEEeecCCCCHHHHhccC
Q 026115 1 MVSRLKNENVVELVGYYVD--------------------------------------GPLRVLAYEHASKGSLHDILHGK 42 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~--------------------------------------~~~~~lv~e~~~~~~L~~~l~~~ 42 (243)
+|++++||||++++++|.. +..+++||||+.+ +|.+.+...
T Consensus 53 il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~ 131 (383)
T 3eb0_A 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSF 131 (383)
T ss_dssp HHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHH
T ss_pred HHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHH
Confidence 3678999999999999843 3458999999975 887777642
Q ss_pred CCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec-CCCceeecccCCCCCCccccccccccc
Q 026115 43 KGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTR 121 (243)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~ 121 (243)
.... ..+++..+..++.|++.||+|||+.| ++||||||+||+++ .++.++|+|||+++....... ...
T Consensus 132 ~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 200 (383)
T 3eb0_A 132 IRSG-----RSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVA 200 (383)
T ss_dssp HHTT-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCC
T ss_pred HhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcC
Confidence 1100 12889999999999999999999998 99999999999997 678999999999875543321 233
Q ss_pred ccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhh----------
Q 026115 122 VLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV---------- 190 (243)
Q Consensus 122 ~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 190 (243)
..|++.|+|||++.+. .++.++||||+||++++|++|..||.+.........+.........+......
T Consensus 201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 280 (383)
T 3eb0_A 201 YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT 280 (383)
T ss_dssp CCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCC
T ss_pred cccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCc
Confidence 4578999999998865 48999999999999999999999997653321111110000011111000000
Q ss_pred --ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHHHHHh
Q 026115 191 --DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLN 236 (243)
Q Consensus 191 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~~~~~ 236 (243)
........+...+..+.+++.+||+.||++|||+.|+++ .++++..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred cCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 000000122234567999999999999999999999996 4555543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=253.70 Aligned_cols=208 Identities=16% Similarity=0.226 Sum_probs=140.6
Q ss_pred CcccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 3 SRLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
+.++||||+++++++.. +...++||||+++|+|.+++....... +++..++.++.|++.||.|||+.+
T Consensus 77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~-------l~~~~~~~i~~ql~~~l~~LH~~~- 148 (336)
T 3fhr_A 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-------FTEREAAEIMRDIGTAIQFLHSHN- 148 (336)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCC-------CBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45789999999999976 456899999999999999998764322 899999999999999999999998
Q ss_pred CCeEeccCCCCceEecCC---CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDD---DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
++|+||||+||+++.+ +.++|+|||+++...... .....|++.|+|||++.+..++.++|+||||+++++|
T Consensus 149 --ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (336)
T 3fhr_A 149 --IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222 (336)
T ss_dssp --EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHH
T ss_pred --eecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999764 459999999987544321 2334578999999999888888999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQP 233 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~~ 233 (243)
++|..||............. ..................+..+.+++.+||+.||++|||++++++ .+.+
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 223 LCGFPPFYSNTGQAISPGMK---------RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp HHSSCCC------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHCCCCCCCccchhhhhhHH---------HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 99999997543321100000 000000011111112344667999999999999999999999998 4444
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=260.90 Aligned_cols=144 Identities=24% Similarity=0.340 Sum_probs=119.4
Q ss_pred CCcccCCccceeeEEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
|++++||||+++++++.. ...+++|||++ +++|.+++..... +++..+..++.|++.||+|||+.
T Consensus 106 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~ 175 (458)
T 3rp9_A 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY---------LTELHIKTLLYNLLVGVKYVHSA 175 (458)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCC---------CCHHHHHHHHHHHHHHHHHHHhC
Confidence 567899999999999953 35799999998 5699999976542 89999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc-------------------------cccccccccccccCc
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-------------------------LHSTRVLGTFGYHAP 131 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~aP 131 (243)
+ ++||||||+||+++.++.++|+|||+++........ .......||+.|+||
T Consensus 176 ~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 252 (458)
T 3rp9_A 176 G---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252 (458)
T ss_dssp T---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCH
T ss_pred C---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccCh
Confidence 8 999999999999999999999999999866432111 011234689999999
Q ss_pred hhh-ccCCCCcccchHHHHHHHHHHHhC
Q 026115 132 EYA-MTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 132 E~~-~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
|++ ....++.++|||||||++|||++|
T Consensus 253 E~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 253 ELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred HHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 986 456789999999999999999993
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=254.41 Aligned_cols=147 Identities=24% Similarity=0.294 Sum_probs=129.4
Q ss_pred cccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 026115 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 83 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h 83 (243)
..+|+||+++++++......++|||++. ++|.+++....... +++..+..++.|++.||+|||+.+ ++|
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~~~---ivH 223 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQG-------FSLPLVRKFAHSILQCLDALHKNR---IIH 223 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHHHT---EEC
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 3478999999999999999999999996 59999998765432 889999999999999999999998 999
Q ss_pred ccCCCCceEecCCCc--eeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 84 RNIKSSNVLLFDDDI--AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 84 ~di~~~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
|||||+||+++.++. ++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 224 rDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p 298 (429)
T 3kvw_A 224 CDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298 (429)
T ss_dssp SCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCC
Confidence 999999999999887 999999998644322 2335689999999999998899999999999999999999999
Q ss_pred CCCCC
Q 026115 162 VDHTL 166 (243)
Q Consensus 162 f~~~~ 166 (243)
|....
T Consensus 299 f~~~~ 303 (429)
T 3kvw_A 299 LPGED 303 (429)
T ss_dssp SCCSS
T ss_pred CCCCC
Confidence 97653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=253.60 Aligned_cols=213 Identities=21% Similarity=0.263 Sum_probs=147.0
Q ss_pred CCccc-CCccceeeEEEE--------eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHH
Q 026115 2 VSRLK-NENVVELVGYYV--------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 72 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~ 72 (243)
++++. ||||+++++++. ....+++++||+. |+|.+++...... ..+++..++.++.|++.||.|
T Consensus 79 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~ 151 (337)
T 3ll6_A 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQH 151 (337)
T ss_dssp HHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHH
Confidence 34564 999999999994 3445899999996 6999988652211 028899999999999999999
Q ss_pred hhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc----------ccccccccccccCchhh---ccCCC
Q 026115 73 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL----------HSTRVLGTFGYHAPEYA---MTGQM 139 (243)
Q Consensus 73 Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~---~~~~~ 139 (243)
||+.+ .+++|+||||+||+++.++.++|+|||+++......... ......|++.|+|||++ .+..+
T Consensus 152 LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 230 (337)
T 3ll6_A 152 MHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230 (337)
T ss_dssp HHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCS
T ss_pred HHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC
Confidence 99874 239999999999999999999999999997665432211 01133488999999998 45667
Q ss_pred CcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCC
Q 026115 140 SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEAD 219 (243)
Q Consensus 140 ~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 219 (243)
+.++||||||+++|+|++|..||....... ..............+..+.+++.+||+.||.
T Consensus 231 ~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 291 (337)
T 3ll6_A 231 GEKQDIWALGCILYLLCFRQHPFEDGAKLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPE 291 (337)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCCC-------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGG
T ss_pred ChHHhHHHHHHHHHHHHhCCCCCcchhHHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChh
Confidence 889999999999999999999996432211 0111111111122234588999999999999
Q ss_pred CCCCHHHHHHHHHHHHhhcCCC
Q 026115 220 FRPNMGIVLKALQPLLNTRSGP 241 (243)
Q Consensus 220 ~Rps~~~vl~~l~~~~~~~~~~ 241 (243)
+|||+.++++.|+++......+
T Consensus 292 ~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 292 ERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp GSCCHHHHHHHHHHHHHHTTCC
T ss_pred hCcCHHHHHHHHHHHHhccCCC
Confidence 9999999999999998765544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=257.88 Aligned_cols=214 Identities=21% Similarity=0.253 Sum_probs=159.1
Q ss_pred CCcccCCccceeeEEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+++++||||+++++++... ...++|+|++.+ +|.+++.... ++...+..++.|++.||+|||+.
T Consensus 79 l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~ 147 (364)
T 3qyz_A 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSA 147 (364)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 5678999999999999754 468999999975 9999997654 88999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
+ ++||||||+||+++.++.++|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++++
T Consensus 148 ~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 224 (364)
T 3qyz_A 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224 (364)
T ss_dssp T---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHH
T ss_pred C---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHH
Confidence 9 9999999999999999999999999997665433221 1233468999999998764 457999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhh--------hhcc-ccCCCC-----CHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ--------CVDT-KLGGEY-----PPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-~~~~~~-----~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|++|..||.+.........+.........+.... .... ...... ....+..+.+++.+||+.||++
T Consensus 225 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 304 (364)
T 3qyz_A 225 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 304 (364)
T ss_dssp HHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTT
T ss_pred HHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhh
Confidence 9999999976543222111110000111110000 0000 000000 1123457999999999999999
Q ss_pred CCCHHHHHH
Q 026115 221 RPNMGIVLK 229 (243)
Q Consensus 221 Rps~~~vl~ 229 (243)
|||++++++
T Consensus 305 R~t~~e~l~ 313 (364)
T 3qyz_A 305 RIEVEQALA 313 (364)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=244.90 Aligned_cols=202 Identities=25% Similarity=0.305 Sum_probs=159.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.++...++|+|++.+++|.+++..... ++...++.++.|++.|+.|||+.+ +
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i 142 (287)
T 2wei_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---I 142 (287)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5688999999999999999999999999999999998876542 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCC---CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 82 IHRNIKSSNVLLFDD---DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 82 ~h~di~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
+|+||+|+||+++.+ +.++|+|||++........ .....|++.|+|||.+.+ .++.++|+||||++++++++|
T Consensus 143 ~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g 218 (287)
T 2wei_A 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218 (287)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred eccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhC
Confidence 999999999999764 4699999999876543321 123347889999999875 488999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCC--CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEY--PPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPL 234 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~~~ 234 (243)
..||...... .....+......... ....+..+.+++.+||+.||++|||+.++++ .+++.
T Consensus 219 ~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 219 TPPFYGKNEY---------------DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp SCSSCCSSHH---------------HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred CCCCCCCCHH---------------HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999754211 111111111111111 1234567999999999999999999999998 44443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=247.20 Aligned_cols=208 Identities=17% Similarity=0.237 Sum_probs=158.0
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
.|++++++++++.+++..++||||+ +++|.+++....... ++...+..++.|++.||+|||+.+ ++|+|
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 143 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLP-------FRLDHIRKMAYQICKSVNFLHSNK---LTHTD 143 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCC-------CcHHHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 3456999999999999999999999 889999998765322 889999999999999999999998 99999
Q ss_pred CCCCceEecC-------------------CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchH
Q 026115 86 IKSSNVLLFD-------------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY 146 (243)
Q Consensus 86 i~~~nil~~~-------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw 146 (243)
|||+||+++. ++.++|+|||++...... .....||+.|+|||++.+..++.++|+|
T Consensus 144 lkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 218 (339)
T 1z57_A 144 LKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVW 218 (339)
T ss_dssp CCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHH
T ss_pred CCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhH
Confidence 9999999987 667999999998654322 2334689999999999988899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchh--------------------------hhhhhhcc-ccCCCCC
Q 026115 147 SFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED--------------------------KVKQCVDT-KLGGEYP 199 (243)
Q Consensus 147 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~-~~~~~~~ 199 (243)
|||++++++++|..||...................+.. ........ .......
T Consensus 219 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (339)
T 1z57_A 219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298 (339)
T ss_dssp HHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccc
Confidence 99999999999999997543221111000000000000 00000000 0011234
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 200 PKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 200 ~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
...+..+.+++.+||+.||.+|||++|+++
T Consensus 299 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 299 DVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp SHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 456788999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=260.36 Aligned_cols=209 Identities=24% Similarity=0.307 Sum_probs=144.8
Q ss_pred CCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++... ...++++|++ +++|.+++.... ++...+..++.|++.||+|||+
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~ 150 (367)
T 2fst_X 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHS 150 (367)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----CC----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999754 5689999999 679999887633 8999999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
.| ++||||||+||+++.++.++|+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++++
T Consensus 151 ~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 222 (367)
T 2fst_X 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222 (367)
T ss_dssp TT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHH
T ss_pred CC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHH
Confidence 98 999999999999999999999999998765432 233468999999999886 678999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCc--------hhhhhhhhccccC-CCC-----CHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLS--------EDKVKQCVDTKLG-GEY-----PPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-~~~-----~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|++|..||.+.........+........ .......+..... ... ....+..+.+|+.+||+.||++
T Consensus 223 ll~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~ 302 (367)
T 2fst_X 223 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302 (367)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCccc
Confidence 9999999976543211111100000000 0111111110000 000 0123457899999999999999
Q ss_pred CCCHHHHHH
Q 026115 221 RPNMGIVLK 229 (243)
Q Consensus 221 Rps~~~vl~ 229 (243)
|||+.++++
T Consensus 303 R~t~~e~L~ 311 (367)
T 2fst_X 303 RITAAQALA 311 (367)
T ss_dssp SCCHHHHHT
T ss_pred CcCHHHHhc
Confidence 999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=248.71 Aligned_cols=208 Identities=15% Similarity=0.241 Sum_probs=156.0
Q ss_pred CCccc-CCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 2 VSRLK-NENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
+++++ ||||+++++++.+ ....++||||+.+++|.+++.. ++...+..++.|++.|++|||+.+
T Consensus 84 l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~~- 150 (330)
T 3nsz_A 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMG- 150 (330)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45676 9999999999997 6779999999999999999852 778899999999999999999999
Q ss_pred CCeEeccCCCCceEecCCC-ceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~ 156 (243)
++||||||+||+++.++ .++|+|||+++....... .....|+..|+|||.+.+ ..++.++|||||||++++|+
T Consensus 151 --ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 225 (330)
T 3nsz_A 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225 (330)
T ss_dssp --EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred --eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHH
Confidence 99999999999999776 899999999875543322 233458899999999886 56899999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhh---------------hhhc--------cccCCCCCHHHHHHHHHHHHhh
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVK---------------QCVD--------TKLGGEYPPKAIAKMAAVAALC 213 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~--------~~~~~~~~~~~~~~~~~li~~~ 213 (243)
+|..||............ ........... .... .......+...+..+.+++.+|
T Consensus 226 ~g~~p~~~~~~~~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 303 (330)
T 3nsz_A 226 FRKEPFFHGHDNYDQLVR--IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 303 (330)
T ss_dssp HTCSSSSCCSSHHHHHHH--HHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTT
T ss_pred hCCCCcccCCchHHHHHH--HHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHH
Confidence 999999543211000000 00000000000 0000 0011112223466899999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 026115 214 VQYEADFRPNMGIVLK 229 (243)
Q Consensus 214 l~~~p~~Rps~~~vl~ 229 (243)
|+.||++|||++++++
T Consensus 304 L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 304 LRYDHQSRLTAREAME 319 (330)
T ss_dssp SCSSGGGSCCHHHHHT
T ss_pred hcCCcccCCCHHHHhc
Confidence 9999999999999997
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=259.90 Aligned_cols=222 Identities=20% Similarity=0.251 Sum_probs=155.9
Q ss_pred CCCcccCCccceeeEEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 1 MVSRLKNENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+|++++||||++++++|... ..+++||||+.+ +|...+...... ...+++..+..++.|++.||+|||
T Consensus 100 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH 173 (420)
T 1j1b_A 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIH 173 (420)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 36789999999999998532 247799999976 777666432100 012889999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCC-CceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVL 152 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l 152 (243)
+.+ ++||||||+||+++.+ +.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 174 ~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 247 (420)
T 1j1b_A 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247 (420)
T ss_dssp TTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHH
Confidence 998 9999999999999965 6789999999976543221 2334689999999998764 689999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc-------cccCC-----CCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD-------TKLGG-----EYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|||++|..||.+.........+.........+.+..... +.... ..+...+..+.+|+.+||+.||.+
T Consensus 248 ~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 327 (420)
T 1j1b_A 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327 (420)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhH
Confidence 999999999976532211110000000111111111000 00000 011233567999999999999999
Q ss_pred CCCHHHHHH--HHHHH
Q 026115 221 RPNMGIVLK--ALQPL 234 (243)
Q Consensus 221 Rps~~~vl~--~l~~~ 234 (243)
|||+.++++ .++++
T Consensus 328 R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 328 RLTPLEACAHSFFDEL 343 (420)
T ss_dssp SCCHHHHHTSGGGGGG
T ss_pred CCCHHHHhCCHhhccc
Confidence 999999986 44444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=249.38 Aligned_cols=206 Identities=27% Similarity=0.296 Sum_probs=139.4
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-CCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~~~~ 80 (243)
++.++||||+++++++.+++..++||||+.+ +|.+++....... ...++...+..++.|++.|+.|||+. +
T Consensus 75 ~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~--- 146 (327)
T 3aln_A 75 MRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVL----DDVIPEEILGKITLATVKALNHLKENLK--- 146 (327)
T ss_dssp HSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTT----CCCCCHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred HHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhh----cccCcHHHHHHHHHHHHHHHHHHhccCC---
Confidence 4678999999999999999999999999976 8888776311000 01288999999999999999999998 8
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhh----ccCCCCcccchHHHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA----MTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~~l~~l~ 156 (243)
++|+||||+||+++.++.++|+|||+++....... .....|++.|+|||++ .+..++.++|+||||+++++|+
T Consensus 147 ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 223 (327)
T 3aln_A 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223 (327)
T ss_dssp CCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHH
T ss_pred EeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999876644322 1233588999999998 4556889999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||.......... ... ................+..+.+++.+||+.||++|||+.++++
T Consensus 224 ~g~~pf~~~~~~~~~~-~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 224 TGRFPYPKWNSVFDQL-TQV----------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HSCCCSSCC--------CCC----------CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HCCCCCCCcchHHHHH-HHH----------hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 9999997532211000 000 0000001111111234557999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=244.44 Aligned_cols=200 Identities=21% Similarity=0.363 Sum_probs=150.8
Q ss_pred CCcccCCccceeeEEEEe-------------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYVD-------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 68 (243)
+++++||||+++++++.+ +...++||||+++++|.+++..... .++...++.++.|++.
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~ 127 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILE 127 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHH
Confidence 578999999999999865 4568999999999999999986432 2778899999999999
Q ss_pred HHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCccccc------------ccccccccccccccCchhhcc
Q 026115 69 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA------------RLHSTRVLGTFGYHAPEYAMT 136 (243)
Q Consensus 69 ~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~ 136 (243)
|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ........|++.|+|||++.+
T Consensus 128 ~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 128 ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp HHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS
T ss_pred HHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 999999998 99999999999999999999999999876543211 011223458899999999986
Q ss_pred C-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhh--hccccCCCCCHHHHHHHHHHHHhh
Q 026115 137 G-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC--VDTKLGGEYPPKAIAKMAAVAALC 213 (243)
Q Consensus 137 ~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~ 213 (243)
. .++.++|+||||+++|+|++ ||..... ........ .........+...+..+.+++.+|
T Consensus 205 ~~~~~~~~Di~slG~il~~l~~---p~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 267 (303)
T 1zy4_A 205 TGHYNEKIDMYSLGIIFFEMIY---PFSTGME--------------RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLL 267 (303)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--------------HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHH
T ss_pred CCCCcchhhHHHHHHHHHHHHh---ccCCchh--------------HHHHHHhccccccccCccccccchHHHHHHHHHH
Confidence 4 68999999999999999998 5432100 00001111 111222234445566799999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 026115 214 VQYEADFRPNMGIVLK 229 (243)
Q Consensus 214 l~~~p~~Rps~~~vl~ 229 (243)
|+.||++|||+.++++
T Consensus 268 l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 268 IDHDPNKRPGARTLLN 283 (303)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred HhcCcccCcCHHHHhC
Confidence 9999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=249.50 Aligned_cols=206 Identities=20% Similarity=0.212 Sum_probs=156.4
Q ss_pred cCCccceeeEEEE----eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-CCCC
Q 026115 6 KNENVVELVGYYV----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPR 80 (243)
Q Consensus 6 ~h~niv~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~~~~ 80 (243)
+||||+++++++. ++...++||||+ +++|.+++...... .+++..++.++.|++.||.|||++ +
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~g--- 167 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQ-------GLPLPCVKKIIQQVLQGLDYLHTKCR--- 167 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4899999999998 566899999999 55777776654322 288999999999999999999998 8
Q ss_pred eEeccCCCCceEecCCC-------------------------------------------------ceeecccCCCCCCc
Q 026115 81 IIHRNIKSSNVLLFDDD-------------------------------------------------IAKISDFDLSNQAP 111 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~-------------------------------------------------~~~l~df~~~~~~~ 111 (243)
++||||||+||+++.++ .++|+|||++....
T Consensus 168 ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~ 247 (397)
T 1wak_A 168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247 (397)
T ss_dssp EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT
T ss_pred EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc
Confidence 99999999999998775 79999999987654
Q ss_pred ccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCccce------eeccCcCchh-
Q 026115 112 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV------TWATPKLSED- 184 (243)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~------~~~~~~~~~~- 184 (243)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ..........
T Consensus 248 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 322 (397)
T 1wak_A 248 KH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322 (397)
T ss_dssp BC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHH
T ss_pred cc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHH
Confidence 32 23346899999999999988999999999999999999999999765332211000 0000000000
Q ss_pred --------------------------hhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 185 --------------------------KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 185 --------------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
...+.+.. ....+...+..+.+|+.+||+.||++|||++++++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhcccccccccCCccccccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000 11346778889999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=251.85 Aligned_cols=222 Identities=18% Similarity=0.210 Sum_probs=156.1
Q ss_pred CCcccCCccceeeEEEEeCCe-------eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 2 VSRLKNENVVELVGYYVDGPL-------RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+++++||||+++++++..... .++||||+.+ +|...+...... ...++...+..++.|++.|+.|||
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH 146 (360)
T 3e3p_A 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLH 146 (360)
T ss_dssp HHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred HHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHh
Confidence 356799999999999975332 8899999976 555544321100 012788999999999999999999
Q ss_pred --hcCCCCeEeccCCCCceEecC-CCceeecccCCCCCCcccccccccccccccccccCchhhccCC-CCcccchHHHHH
Q 026115 75 --EKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGV 150 (243)
Q Consensus 75 --~~~~~~~~h~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ 150 (243)
+.+ ++||||||+||+++. ++.++|+|||+++....... .....||+.|+|||++.+.. ++.++|||||||
T Consensus 147 ~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 220 (360)
T 3e3p_A 147 LPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGC 220 (360)
T ss_dssp STTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred CCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHH
Confidence 888 999999999999997 89999999999986654322 23345899999999987654 799999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhh---------c------cccCCCCCHHHHHHHHHHHHhhcC
Q 026115 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV---------D------TKLGGEYPPKAIAKMAAVAALCVQ 215 (243)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~------~~~~~~~~~~~~~~~~~li~~~l~ 215 (243)
++|+|++|..||...........+.........+...... . ...........+..+.+++.+||+
T Consensus 221 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 300 (360)
T 3e3p_A 221 IFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300 (360)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTC
T ss_pred HHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhc
Confidence 9999999999997643221111100000000000000000 0 000111222356789999999999
Q ss_pred CCCCCCCCHHHHHH--HHHHHH
Q 026115 216 YEADFRPNMGIVLK--ALQPLL 235 (243)
Q Consensus 216 ~~p~~Rps~~~vl~--~l~~~~ 235 (243)
.||.+|||+.++++ .++++.
T Consensus 301 ~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 301 YLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGGGGG
T ss_pred cCccccCCHHHHhcCccccccC
Confidence 99999999999997 354443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=254.60 Aligned_cols=200 Identities=22% Similarity=0.287 Sum_probs=147.6
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
|+++ +||||+++++++.++...++|||++. |+|.+++...... .....++.++.|++.||.|||+.+
T Consensus 71 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~--- 138 (432)
T 3p23_A 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLHSLN--- 138 (432)
T ss_dssp HHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHHHCc---
Confidence 4556 79999999999999999999999996 5999999876532 333455789999999999999998
Q ss_pred eEeccCCCCceEecC---C--CceeecccCCCCCCcccccc-cccccccccccccCchhhc---cCCCCcccchHHHHHH
Q 026115 81 IIHRNIKSSNVLLFD---D--DIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVV 151 (243)
Q Consensus 81 ~~h~di~~~nil~~~---~--~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~ 151 (243)
++||||||+||+++. + ..++|+|||+++........ .......||+.|+|||++. ...++.++|||||||+
T Consensus 139 ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~i 218 (432)
T 3p23_A 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218 (432)
T ss_dssp CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHH
T ss_pred CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHH
Confidence 999999999999953 2 35779999998766533211 1123356899999999997 4566789999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhcc-cc-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 152 LLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT-KL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 152 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
++++++ |..||...... ........ .. ........+..+.+++.+||+.||.+|||+++++
T Consensus 219 l~ellt~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 219 FYYVISEGSHPFGKSLQR----------------QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp HHHHHTTSCBTTBSTTTH----------------HHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHcCCCCCcchhhHH----------------HHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 999999 89998533111 00011110 00 0112234566789999999999999999999998
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
+
T Consensus 283 ~ 283 (432)
T 3p23_A 283 K 283 (432)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=250.38 Aligned_cols=213 Identities=20% Similarity=0.275 Sum_probs=149.9
Q ss_pred CCcccCCccceeeEEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+++++||||+++++++.. ...+++||||+. |+|.+++..... .++...+..++.|++.||.|||+.
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~ 153 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLHEA 153 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 567899999999999854 346899999997 588888876542 288999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l 155 (243)
+ ++|+||||+||+++.++.++|+|||++........ .....|++.|+|||++.+ ..++.++|+|||||++++|
T Consensus 154 ~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 227 (362)
T 3pg1_A 154 G---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227 (362)
T ss_dssp T---CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHH
T ss_pred c---CEecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHH
Confidence 8 99999999999999999999999999875433222 233458899999999886 6689999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCch--------hhhhhhhccccCC-------CCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSE--------DKVKQCVDTKLGG-------EYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
++|..||...........+......... ............. ......+..+.+++.+||+.||++
T Consensus 228 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 307 (362)
T 3pg1_A 228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307 (362)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence 9999999754321110000000000000 0000011010000 011123457999999999999999
Q ss_pred CCCHHHHHH
Q 026115 221 RPNMGIVLK 229 (243)
Q Consensus 221 Rps~~~vl~ 229 (243)
|||+.++++
T Consensus 308 Rpt~~ell~ 316 (362)
T 3pg1_A 308 RISTEQALR 316 (362)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHHc
Confidence 999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=255.24 Aligned_cols=205 Identities=21% Similarity=0.292 Sum_probs=147.8
Q ss_pred ccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 5 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 5 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
.+||||+++++++.++...++||||+. |+|.+++......... ....+...++.++.|++.||+|||+.+ ++||
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 139 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHSLK---IIHR 139 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHHCC---cccc
Confidence 389999999999999999999999996 5999999875432100 000123346789999999999999998 9999
Q ss_pred cCCCCceEecCC-------------CceeecccCCCCCCccccccc--ccccccccccccCchhhcc-------CCCCcc
Q 026115 85 NIKSSNVLLFDD-------------DIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMT-------GQMSSK 142 (243)
Q Consensus 85 di~~~nil~~~~-------------~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-------~~~~~~ 142 (243)
||||+||+++.+ +.++|+|||+++......... ......||+.|+|||++.+ ..++.+
T Consensus 140 DLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 219 (434)
T 2rio_A 140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219 (434)
T ss_dssp CCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTH
T ss_pred CCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchh
Confidence 999999999754 479999999987665432211 1223468999999999975 567899
Q ss_pred cchHHHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhh-hhc-cccCCCCCHHHHHHHHHHHHhhcCCCCC
Q 026115 143 SDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ-CVD-TKLGGEYPPKAIAKMAAVAALCVQYEAD 219 (243)
Q Consensus 143 ~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 219 (243)
+|||||||++++|++ |..||....... ..+.. ... ...........+..+.+++.+||+.||.
T Consensus 220 ~DiwSlG~il~ellt~g~~Pf~~~~~~~--------------~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 285 (434)
T 2rio_A 220 IDIFSMGCVFYYILSKGKHPFGDKYSRE--------------SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPL 285 (434)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTCSTTTHH--------------HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGG
T ss_pred hhhHhHHHHHHHHHhCCCCCCCCchhhH--------------HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChh
Confidence 999999999999999 999996432110 00000 000 1111223456788999999999999999
Q ss_pred CCCCHHHHHH
Q 026115 220 FRPNMGIVLK 229 (243)
Q Consensus 220 ~Rps~~~vl~ 229 (243)
+|||+.++++
T Consensus 286 ~Rps~~eil~ 295 (434)
T 2rio_A 286 KRPTAMKVLR 295 (434)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHHh
Confidence 9999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=243.08 Aligned_cols=214 Identities=19% Similarity=0.281 Sum_probs=154.4
Q ss_pred CCcccCCccceeeEEEE--------------eCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHH
Q 026115 2 VSRLKNENVVELVGYYV--------------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 67 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~ 67 (243)
+++++||||+++++++. +....++||||+. |+|.+++.... ++...++.++.|++
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~ 130 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP----------LLEEHARLFMYQLL 130 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCC----------CCHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcCC----------ccHHHHHHHHHHHH
Confidence 56889999999999874 4468899999997 59999997543 88999999999999
Q ss_pred HHHHHhhhcCCCCeEeccCCCCceEec-CCCceeecccCCCCCCcccccc-cccccccccccccCchhhcc-CCCCcccc
Q 026115 68 RGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMT-GQMSSKSD 144 (243)
Q Consensus 68 ~~l~~Lh~~~~~~~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~D 144 (243)
.|++|||+.+ ++|+||||+||+++ .++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|
T Consensus 131 ~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 207 (320)
T 2i6l_A 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAID 207 (320)
T ss_dssp HHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHH
T ss_pred HHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhh
Confidence 9999999998 99999999999997 5679999999999866432211 11223457889999998875 67899999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhc-------cccC-CC-----CCHHHHHHHHHHHH
Q 026115 145 VYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD-------TKLG-GE-----YPPKAIAKMAAVAA 211 (243)
Q Consensus 145 iwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~-----~~~~~~~~~~~li~ 211 (243)
+||||+++++|++|..||...........+....+....+...+... .... .. .....+..+.+++.
T Consensus 208 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 287 (320)
T 2i6l_A 208 MWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE 287 (320)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHH
T ss_pred hHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHH
Confidence 99999999999999999975532111100000000000011000000 0000 00 01124567999999
Q ss_pred hhcCCCCCCCCCHHHHHH
Q 026115 212 LCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 212 ~~l~~~p~~Rps~~~vl~ 229 (243)
+||+.||++|||++++++
T Consensus 288 ~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 288 QILTFSPMDRLTAEEALS 305 (320)
T ss_dssp TTSCSSGGGSCCHHHHHT
T ss_pred HHcCCCccccCCHHHHhC
Confidence 999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=246.74 Aligned_cols=206 Identities=17% Similarity=0.228 Sum_probs=154.7
Q ss_pred cCCccceeeEEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-CCCC
Q 026115 6 KNENVVELVGYYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPR 80 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~~~~ 80 (243)
.||||+++++++.... ..+++||++ +++|.+++....... ++...++.++.|++.||+|||+. +
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-------~~~~~~~~i~~qi~~aL~~lH~~~~--- 152 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-------IPLIYVKQISKQLLLGLDYMHRRCG--- 152 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSC-------CCHHHHHHHHHHHHHHHHHHHHTTC---
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccC-------CcHHHHHHHHHHHHHHHHHHHhcCC---
Confidence 4899999999998644 789999999 889999998754332 88999999999999999999998 8
Q ss_pred eEeccCCCCceEec------CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLF------DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 81 ~~h~di~~~nil~~------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 154 (243)
++|+||||+||+++ ..+.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 153 ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 227 (373)
T 1q8y_A 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227 (373)
T ss_dssp EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHH
T ss_pred EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHH
Confidence 99999999999994 3447999999998755432 233468999999999999889999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcccee------eccCcCch---------------------------hhhhhhhccccCCCCCHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVT------WATPKLSE---------------------------DKVKQCVDTKLGGEYPPK 201 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~------~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~ 201 (243)
|++|..||............. ......+. ......... ....+..
T Consensus 228 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 305 (373)
T 1q8y_A 228 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKD 305 (373)
T ss_dssp HHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHH
T ss_pred HHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcc
Confidence 999999997543211100000 00000000 000001111 1245678
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 202 AIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 202 ~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.+..+.+++.+||+.||++|||++++++
T Consensus 306 ~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 306 EAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred hHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 8899999999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=247.39 Aligned_cols=206 Identities=16% Similarity=0.211 Sum_probs=153.8
Q ss_pred CccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 026115 8 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 87 (243)
Q Consensus 8 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~ 87 (243)
++++.+++++......++||||+ +++|.+++....... +++..++.++.|++.||+|||+.+ ++|+|||
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-------~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlk 150 (355)
T 2eu9_A 82 FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQP-------YPLPHVRHMAYQLCHALRFLHENQ---LTHTDLK 150 (355)
T ss_dssp SCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCC
T ss_pred eeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 34999999999999999999999 667888776654322 889999999999999999999998 9999999
Q ss_pred CCceEe-------------------cCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHH
Q 026115 88 SSNVLL-------------------FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSF 148 (243)
Q Consensus 88 ~~nil~-------------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl 148 (243)
|+||++ +.++.++|+|||+++..... .....||+.|+|||++.+..++.++|+|||
T Consensus 151 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 225 (355)
T 2eu9_A 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSI 225 (355)
T ss_dssp GGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHH
Confidence 999999 56788999999998653322 233568999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchh--------------------------hhhhhhc-cccCCCCCHH
Q 026115 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED--------------------------KVKQCVD-TKLGGEYPPK 201 (243)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~-~~~~~~~~~~ 201 (243)
||++|+|++|..||...................+.. ....... ..........
T Consensus 226 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (355)
T 2eu9_A 226 GCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305 (355)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccch
Confidence 999999999999997543221100000000000000 0000000 0001122335
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 202 AIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 202 ~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.+..+.+++.+||+.||++|||++++++
T Consensus 306 ~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 306 EHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 5678999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=244.23 Aligned_cols=199 Identities=23% Similarity=0.324 Sum_probs=146.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-CCCC
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPR 80 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~-~~~~ 80 (243)
++.++||||+++++++.++...++||||+ ++.+..+...... .++...++.++.|++.|+.|||+. +
T Consensus 78 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~--- 145 (318)
T 2dyl_A 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLKEKHG--- 145 (318)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHHHC---
T ss_pred HHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhhCC---
Confidence 45679999999999999999999999999 5566666554322 288999999999999999999995 8
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l 155 (243)
++|+||+|+||+++.++.++|+|||++........ .....|++.|+|||++. ...++.++||||||+++++|
T Consensus 146 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l 222 (318)
T 2dyl_A 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222 (318)
T ss_dssp CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHH
T ss_pred EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHH
Confidence 99999999999999999999999999876543321 22345899999999984 45678899999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc-CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++|..||..... ............. ........+..+.+++.+||+.||.+|||++++++
T Consensus 223 ~~g~~pf~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 223 ATGQFPYKNCKT--------------DFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHSSCTTTTCCS--------------HHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HhCCCCCCCCCc--------------cHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 999999964311 0111111111111 01111234567999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=247.83 Aligned_cols=208 Identities=22% Similarity=0.310 Sum_probs=152.0
Q ss_pred CCcccCCccceeeEEEEeCCee------EEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGPLR------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++...... ++||||+. ++|.+++... ++...+..++.|++.||+|||+
T Consensus 95 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~ 162 (371)
T 4exu_A 95 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGME-----------FSEEKIQYLVYQMLKGLKYIHS 162 (371)
T ss_dssp HHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTSC-----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999876654 99999997 5898887432 8899999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
.+ ++||||||+||+++.++.++|+|||+++..... .....||+.|+|||++.+ ..++.++|+|||||++++
T Consensus 163 ~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (371)
T 4exu_A 163 AG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE 234 (371)
T ss_dssp TT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHH
T ss_pred CC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHH
Confidence 98 999999999999999999999999998765432 233468999999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCc--------hhhhhhhhc---cccCCC---CCHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLS--------EDKVKQCVD---TKLGGE---YPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~---~~~~~~---~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|++|..||...........+........ ......... ...... .....+..+.+++.+||+.||++
T Consensus 235 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 314 (371)
T 4exu_A 235 MLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 314 (371)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTT
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhh
Confidence 9999999975432111000000000000 000000000 000000 01123567999999999999999
Q ss_pred CCCHHHHHH
Q 026115 221 RPNMGIVLK 229 (243)
Q Consensus 221 Rps~~~vl~ 229 (243)
|||++++++
T Consensus 315 Rpt~~ell~ 323 (371)
T 4exu_A 315 RLTAAQALT 323 (371)
T ss_dssp SCCHHHHHT
T ss_pred cCCHHHHhc
Confidence 999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=250.06 Aligned_cols=208 Identities=22% Similarity=0.299 Sum_probs=152.6
Q ss_pred CCcccCCccceeeEEEEeCCe------eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVDGPL------RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++..... .++||||+. ++|.+++... ++...+..++.|++.||.|||+
T Consensus 77 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~LH~ 144 (353)
T 3coi_A 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLK-----------FSEEKIQYLVYQMLKGLKYIHS 144 (353)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTSC-----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcCC-----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 567899999999999987654 499999997 5888877421 8899999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ 154 (243)
.| ++|+||||+||+++.++.++|+|||+++..... .....+++.|+|||++.+ ..++.++|+||||+++++
T Consensus 145 ~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~e 216 (353)
T 3coi_A 145 AG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE 216 (353)
T ss_dssp TT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHH
T ss_pred CC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHH
Confidence 98 999999999999999999999999998765432 223458999999999886 577899999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCc--------hhh---hhhhhccccC---CCCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLS--------EDK---VKQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|++|..||.+.........+........ ... ....+..... .......+..+.+++.+||+.||++
T Consensus 217 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 296 (353)
T 3coi_A 217 MLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 296 (353)
T ss_dssp HHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCccc
Confidence 9999999975432111000000000000 000 0000000000 1122345678999999999999999
Q ss_pred CCCHHHHHH
Q 026115 221 RPNMGIVLK 229 (243)
Q Consensus 221 Rps~~~vl~ 229 (243)
|||++++++
T Consensus 297 Rpt~~e~l~ 305 (353)
T 3coi_A 297 RLTAAQALT 305 (353)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=245.61 Aligned_cols=144 Identities=25% Similarity=0.282 Sum_probs=124.5
Q ss_pred CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh--cCCCCeEec
Q 026115 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE--KAEPRIIHR 84 (243)
Q Consensus 7 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~--~~~~~~~h~ 84 (243)
|++|+++++++..+...++||||+.+ +|.+++....... +++..+..++.|++.|+.|||. .+ ++||
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~al~~lH~~~~~---ivHr 183 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRG-------VSLNLTRKFAQQMCTALLFLATPELS---IIHC 183 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSC-------CCHHHHHHHHHHHHHHHHHHTSTTTC---EECC
T ss_pred ceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCC-------CCHHHHHHHHHHHHHHHHHhccCCCC---EEcC
Confidence 44699999999999999999999964 9999998764322 8899999999999999999994 56 9999
Q ss_pred cCCCCceEec--CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCC
Q 026115 85 NIKSSNVLLF--DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 85 di~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 162 (243)
||||+||+++ .++.++|+|||+++..... .....||+.|+|||++.+..++.++|||||||++++|++|..||
T Consensus 184 Dlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 258 (382)
T 2vx3_A 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258 (382)
T ss_dssp CCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999995 4678999999998765432 23356899999999999989999999999999999999999999
Q ss_pred CCCC
Q 026115 163 DHTL 166 (243)
Q Consensus 163 ~~~~ 166 (243)
....
T Consensus 259 ~~~~ 262 (382)
T 2vx3_A 259 SGAN 262 (382)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 8643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=253.41 Aligned_cols=214 Identities=21% Similarity=0.244 Sum_probs=156.2
Q ss_pred CCcccCCccceeeEEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 2 VSRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+++++||||+++++++..+ ...++||||+. ++|.+++.... ++...+..++.|++.||.|||+.
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~ 131 (353)
T 2b9h_A 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM----------LSDDHIQYFIYQTLRAVKVLHGS 131 (353)
T ss_dssp HHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 5678999999999998754 67899999997 59999988643 88999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc--------ccccccccccccCchhhcc-CCCCcccchHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--------HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYS 147 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~-~~~~~~~Diws 147 (243)
+ ++||||||+||+++.++.++|+|||+++......... ......|++.|+|||++.+ ..++.++|+||
T Consensus 132 ~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 208 (353)
T 2b9h_A 132 N---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWS 208 (353)
T ss_dssp T---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHH
T ss_pred C---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHH
Confidence 8 9999999999999999999999999987654322111 1122458999999998764 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCccceee---------ccCcCchhhhhhhhccccC-CC-----CCHHHHHHHHHHHHh
Q 026115 148 FGVVLLELLTGRKPVDHTLPRGQQSLVTW---------ATPKLSEDKVKQCVDTKLG-GE-----YPPKAIAKMAAVAAL 212 (243)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~li~~ 212 (243)
|||++++|++|..||.+.........+.. ...........+....... .. .....+..+.+++.+
T Consensus 209 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (353)
T 2b9h_A 209 CGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288 (353)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHH
Confidence 99999999999999976532111000000 0000000111111110000 00 012345678999999
Q ss_pred hcCCCCCCCCCHHHHHH
Q 026115 213 CVQYEADFRPNMGIVLK 229 (243)
Q Consensus 213 ~l~~~p~~Rps~~~vl~ 229 (243)
||+.||++|||++++++
T Consensus 289 ~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 289 MLVFDPAKRITAKEALE 305 (353)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred hcCcCcccCCCHHHHhc
Confidence 99999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=244.87 Aligned_cols=188 Identities=19% Similarity=0.321 Sum_probs=154.3
Q ss_pred Cccc--CCccceeeEEEEeCCeeEEEEeecCC-CCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 3 SRLK--NENVVELVGYYVDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 3 ~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
++++ ||||+++++++.+++..++|+|++.+ ++|.+++..... ++...++.++.|++.||.|||+.+
T Consensus 101 ~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~-- 169 (320)
T 3a99_A 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCG-- 169 (320)
T ss_dssp HHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4454 69999999999999999999999976 899999976542 889999999999999999999998
Q ss_pred CeEeccCCCCceEec-CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHh
Q 026115 80 RIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 80 ~~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~ 157 (243)
++|+||||+||+++ .++.++|+|||+++...... .....|++.|+|||++.+..+ +.++|+||||+++++|++
T Consensus 170 -ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~ 244 (320)
T 3a99_A 170 -VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244 (320)
T ss_dssp -EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred -cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH
Confidence 99999999999999 67899999999987654321 223458999999999987665 678899999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||..... ...... ..+...+..+.+++.+||+.||++|||++++++
T Consensus 245 g~~pf~~~~~---------------------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 245 GDIPFEHDEE---------------------IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp SSCSCCSHHH---------------------HHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCChhh---------------------hhcccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999964311 000000 111223457999999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=243.23 Aligned_cols=185 Identities=21% Similarity=0.344 Sum_probs=149.9
Q ss_pred cCCccceeeEEEEeCCeeEEEEee-cCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEH-ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 84 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~ 84 (243)
+||||+++++++.+++..++|+|+ +.+++|.+++..... +++..++.++.|++.||.|||+.+ ++|+
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 163 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---------LGEGPSRCFFGQVVAAIQHCHSRG---VVHR 163 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHT---EECC
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 899999999999999999999999 788999999986542 889999999999999999999998 9999
Q ss_pred cCCCCceEec-CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCC-cccchHHHHHHHHHHHhCCCCC
Q 026115 85 NIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 85 di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~pf 162 (243)
||+|+||+++ .++.++|+|||++....... .....|+..|+|||++.+..+. .++|+||||++++++++|..||
T Consensus 164 dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 239 (312)
T 2iwi_A 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF 239 (312)
T ss_dssp CCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCC
Confidence 9999999999 78999999999987654322 2334589999999999876664 4899999999999999999999
Q ss_pred CCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.... . ..... ...+...+..+.+++.+||+.||++|||++++++
T Consensus 240 ~~~~------------------~---~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 240 ERDQ------------------E---ILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CSHH------------------H---HHHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CChH------------------H---Hhhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6321 0 11111 1222344567999999999999999999999997
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=255.78 Aligned_cols=223 Identities=23% Similarity=0.265 Sum_probs=162.6
Q ss_pred CCcccCCccceeeEEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 2 VSRLKNENVVELVGYYVD------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+++++||||+++++++.. +...++||||+++|+|.+++...... ..+++..++.++.|++.|+.|||+
T Consensus 66 L~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs 139 (676)
T 3qa8_A 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHE 139 (676)
T ss_dssp HHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 567899999999998765 67789999999999999999875421 127778899999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCc---eeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDI---AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 152 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 152 (243)
.| ++|+||+|+||+++.++. ++|+|||++........ .....|++.|+|||.+.+..++.++|+||||+++
T Consensus 140 ~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviL 213 (676)
T 3qa8_A 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213 (676)
T ss_dssp TT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHH
T ss_pred CC---CccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHH
Confidence 98 999999999999987664 89999999986644322 2345689999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCc--ccee------eccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 153 LELLTGRKPVDHTLPRGQQ--SLVT------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~--~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
|++++|..||......... .... ....... +..................+..+.+++.+||+.||++|||+
T Consensus 214 yeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~-g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa 292 (676)
T 3qa8_A 214 FECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT-GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD 292 (676)
T ss_dssp HHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS-SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC
T ss_pred HHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc-cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH
Confidence 9999999999653111000 0000 0000000 00000000011123445578899999999999999999999
Q ss_pred HH-----HHHHHHHHHhh
Q 026115 225 GI-----VLKALQPLLNT 237 (243)
Q Consensus 225 ~~-----vl~~l~~~~~~ 237 (243)
++ +.+.++++++.
T Consensus 293 ~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 293 PQNPNVGCFQALDSILSL 310 (676)
T ss_dssp TTCCCCTTHHHHHHHHCC
T ss_pred HHHhcCHHHHHHHHHHhc
Confidence 88 55666666553
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=255.24 Aligned_cols=191 Identities=18% Similarity=0.248 Sum_probs=150.9
Q ss_pred CCCcccCCccceeeEEEEeCCe-----eEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 1 MVSRLKNENVVELVGYYVDGPL-----RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
++++++||||+++++++.+... .++||||+++++|.+++.. . +++..++.++.|++.||.|||+
T Consensus 132 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-~----------l~~~~~~~~~~qi~~aL~~lH~ 200 (681)
T 2pzi_A 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-K----------LPVAEAIAYLLEILPALSYLHS 200 (681)
T ss_dssp GGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-C----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-C----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999987654 7999999999999887754 2 8899999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
.| ++||||||+||+++.+ .++|+|||+++..... ....||+.|+|||++.+. ++.++|||||||++++|
T Consensus 201 ~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 201 IG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL 269 (681)
T ss_dssp TT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHH
T ss_pred CC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHH
Confidence 98 9999999999999875 8999999998755432 334689999999998765 48899999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-MGIVLKALQPL 234 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~vl~~l~~~ 234 (243)
++|..||....... ... .......+..+.+++.+||+.||.+||+ ++++...+..+
T Consensus 270 ~~g~~~~~~~~~~~----------~~~-------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 270 TLDLPTRNGRYVDG----------LPE-------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HSCCCEETTEECSS----------CCT-------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HhCCCCCccccccc----------ccc-------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 99988876421100 000 0111223467999999999999999995 66666677665
Q ss_pred Hh
Q 026115 235 LN 236 (243)
Q Consensus 235 ~~ 236 (243)
+.
T Consensus 327 ~~ 328 (681)
T 2pzi_A 327 LR 328 (681)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=230.11 Aligned_cols=186 Identities=17% Similarity=0.278 Sum_probs=142.5
Q ss_pred CcccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 3 SRLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
+.++||||+++++++.+ +...++||||+++++|.+++....... +++..++.++.|++.|+.|||+.+
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~- 137 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-------FTEREASEIMKSIGEAIQYLHSIN- 137 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCC-------CBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45689999999999987 678999999999999999998764322 899999999999999999999999
Q ss_pred CCeEeccCCCCceEecC---CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
++|+||||+||+++. ++.++|+|||++.... +..++.++|+|||||++|+|
T Consensus 138 --i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el 191 (299)
T 3m2w_A 138 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYIL 191 (299)
T ss_dssp --EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHH
T ss_pred --cccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHH
Confidence 999999999999998 7889999999874322 12356789999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP----PKAIAKMAAVAALCVQYEADFRPNMGIVLK-- 229 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~vl~-- 229 (243)
++|..||.............. ...... ...+ ...+..+.+++.+||+.||.+|||+.++++
T Consensus 192 ~tg~~pf~~~~~~~~~~~~~~-----------~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 192 LCGYPPFYSNHGLAISPGMKT-----------RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HHSSCSCCC-------CCSCC-----------SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHCCCCCCCCcchhhhHHHHH-----------HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 999999975432211100000 000000 0111 124567999999999999999999999998
Q ss_pred HHHHHH
Q 026115 230 ALQPLL 235 (243)
Q Consensus 230 ~l~~~~ 235 (243)
.+.+..
T Consensus 259 ~~~~~~ 264 (299)
T 3m2w_A 259 WIMQST 264 (299)
T ss_dssp HHHTGG
T ss_pred hhcccc
Confidence 444433
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=226.38 Aligned_cols=183 Identities=17% Similarity=0.142 Sum_probs=141.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++++++.+++..++||||+++++|.+++... .....+..++.|++.||+|||+.| +
T Consensus 85 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~g---i 150 (286)
T 3uqc_A 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAG---V 150 (286)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCC---C
Confidence 46789999999999999999999999999999999999542 345578889999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.++|++++. ++ .++.++|||||||++|+|++|..|
T Consensus 151 vH~Dikp~NIll~~~g~~kl~~~~~----------------------~~-------~~~~~~Di~slG~il~elltg~~P 201 (286)
T 3uqc_A 151 ALSIDHPSRVRVSIDGDVVLAYPAT----------------------MP-------DANPQDDIRGIGASLYALLVNRWP 201 (286)
T ss_dssp CCCCCSGGGEEEETTSCEEECSCCC----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEEC
T ss_pred ccCCCCcccEEEcCCCCEEEEeccc----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999975432 22 257889999999999999999999
Q ss_pred CCCCCCCCCccce-eeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcC
Q 026115 162 VDHTLPRGQQSLV-TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239 (243)
Q Consensus 162 f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 239 (243)
|............ ......... . .......+..+.+++.+||+.||++| |+.++++.|+++.....
T Consensus 202 f~~~~~~~~~~~~~~~~~~~~~~--~---------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 202 LPEAGVRSGLAPAERDTAGQPIE--P---------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp SCCCSBCCCSEECCBCTTSCBCC--H---------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CCcCCcchhhHHHHHHhccCCCC--h---------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 9865432211000 000000000 0 00112345579999999999999999 99999999999876544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=223.40 Aligned_cols=175 Identities=14% Similarity=0.181 Sum_probs=131.9
Q ss_pred eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceee
Q 026115 22 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 101 (243)
Q Consensus 22 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l 101 (243)
..+++|+++ +++|.+++....... .....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL 252 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFL 252 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEE
T ss_pred ceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEE
Confidence 467777766 569999885221000 00113778899999999999999999999 999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccCchhh----------ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 026115 102 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA----------MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 171 (243)
Q Consensus 102 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~ 171 (243)
+|||+++..... .....| +.|+|||++ ....++.++|||||||++|+|++|..||.........
T Consensus 253 ~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~ 326 (413)
T 3dzo_A 253 TGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326 (413)
T ss_dssp CCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS
T ss_pred EeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH
Confidence 999998765433 233456 899999999 4445788999999999999999999999754322110
Q ss_pred cceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 172 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
....... . ..+..+.+++.+||+.||++|||+.++++
T Consensus 327 ---------------~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 327 ---------------EWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp ---------------GGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------------HHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111100 1 22357999999999999999999888754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-33 Score=224.95 Aligned_cols=169 Identities=15% Similarity=0.062 Sum_probs=129.7
Q ss_pred CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh-hcCCCCeEeccCCCCceEecCCC-
Q 026115 20 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-EKAEPRIIHRNIKSSNVLLFDDD- 97 (243)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh-~~~~~~~~h~di~~~nil~~~~~- 97 (243)
+...++||||+.+|++.+.+.... +++..+..++.|++.||.||| +.+ ++||||||+||+++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~~~----------~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~ 200 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRTKL----------SSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSL 200 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTTTC----------CCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSC
T ss_pred cCeEEEEEEecCCCccHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCC
Confidence 678999999999997766664422 889999999999999999999 898 99999999999999887
Q ss_pred -------------------ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHH-HHHHHh
Q 026115 98 -------------------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV-LLELLT 157 (243)
Q Consensus 98 -------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~-l~~l~~ 157 (243)
.++|+|||+++.... ....||+.|+|||++.+.. +.++||||++++ .+++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~ 272 (336)
T 2vuw_A 201 KKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWG 272 (336)
T ss_dssp SEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTT
T ss_pred cceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCccccc
Confidence 899999999975542 2346899999999998766 889999998766 777888
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhh---c--cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV---D--TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
|..||... .+......... . ...........+.++.+|+.+||+.| |+++++
T Consensus 273 g~~p~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 273 EYHPYSNV--------------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp SCCTHHHH--------------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ccCCCcch--------------hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 88887421 00000111111 0 11111223467889999999999977 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=221.46 Aligned_cols=140 Identities=17% Similarity=0.142 Sum_probs=103.5
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
|+++ +|+||+++++++++++..||||||++|++|.+.+..... ++.. +++.||+.||+|+|++|
T Consensus 295 l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~---------l~~~---~I~~QIl~AL~ylH~~G--- 359 (569)
T 4azs_A 295 LTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE---------IDRE---KILGSLLRSLAALEKQG--- 359 (569)
T ss_dssp HHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC---------CCHH---HHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC---------CCHH---HHHHHHHHHHHHHHHCC---
Confidence 5677 699999999999999999999999999999999987542 5544 47899999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
|+||||||+|||++.++.+||+|||+++........ .....||+.|+|||++.+ .+..++|+|++|+.++++.++.
T Consensus 360 IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 360 FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CEESCCCGGGEEECTTSCEEECCCTTEESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred ceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 999999999999999999999999999766543221 234569999999999976 4567899999999877665543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-24 Score=181.26 Aligned_cols=139 Identities=17% Similarity=0.150 Sum_probs=116.0
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||+++..++......++||||+++++|.+++.. +..++.|+++|+.|||+++ +
T Consensus 393 l~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~g---I 452 (540)
T 3en9_A 393 LALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKND---V 452 (540)
T ss_dssp HHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCc---C
Confidence 5688999999777777788888999999999999999875 3468999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCccccccc-----ccccccccccccCchhhcc--CCCCcccchHHHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~ 154 (243)
+||||||+||+++. .++|+|||+++......... ......||+.|+|||++.. ..|+...|+|+..+-..+
T Consensus 453 iHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~ 530 (540)
T 3en9_A 453 IHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMK 530 (540)
T ss_dssp ECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHH
T ss_pred ccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHH
Confidence 99999999999998 99999999998776543221 1124568999999999986 567888899999988888
Q ss_pred HHhCCCCC
Q 026115 155 LLTGRKPV 162 (243)
Q Consensus 155 l~~g~~pf 162 (243)
-+.++.+|
T Consensus 531 ~v~~r~rY 538 (540)
T 3en9_A 531 DVERRARY 538 (540)
T ss_dssp HHHTCSCC
T ss_pred HHHhcccc
Confidence 77766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=7.8e-17 Score=126.10 Aligned_cols=83 Identities=16% Similarity=0.158 Sum_probs=66.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++ | +++.+++.. +..++||||+++++|.+ +... ....++.|++.|+.+||+.| +
T Consensus 158 l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~---------------~~~~i~~qi~~~l~~lH~~g---i 214 (282)
T 1zar_A 158 LQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRVE---------------NPDEVLDMILEEVAKFYHRG---I 214 (282)
T ss_dssp HHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCCS---------------CHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cchh---------------hHHHHHHHHHHHHHHHHHCC---C
Confidence 34555 4 556665544 45699999999999998 4211 12368999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
+||||||+||+++ ++.++|+|||+++
T Consensus 215 iHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 215 VHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp ECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred EeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 9999999999999 9999999999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=9.6e-14 Score=107.20 Aligned_cols=88 Identities=18% Similarity=0.211 Sum_probs=65.7
Q ss_pred CCcccCCcc--ceeeEEEEeCCeeEEEEeecCC-C----CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 2 VSRLKNENV--VELVGYYVDGPLRVLAYEHASK-G----SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 2 l~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
|++++|+++ ...+++ ...++||||+.+ | +|.++... .+...+..++.|++.|+.+||
T Consensus 124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHH
Confidence 345666653 333432 256899999942 3 67766432 223456788999999999999
Q ss_pred -hcCCCCeEeccCCCCceEecCCCceeecccCCCCCC
Q 026115 75 -EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110 (243)
Q Consensus 75 -~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~ 110 (243)
+.| ++||||||+||+++. .++|+|||++...
T Consensus 188 ~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 888 999999999999988 8999999998543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.12 E-value=2.1e-11 Score=98.49 Aligned_cols=69 Identities=10% Similarity=0.135 Sum_probs=55.9
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCC------
Q 026115 24 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD------ 97 (243)
Q Consensus 24 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~------ 97 (243)
+|||||+.|++|..+... .....++.|++.++.+||+.| ++||||||.|||++.++
T Consensus 187 ~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp EEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTT
T ss_pred eEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCccccc
Confidence 699999999888655321 123467899999999999998 99999999999998776
Q ss_pred ----ceeecccCCCCCC
Q 026115 98 ----IAKISDFDLSNQA 110 (243)
Q Consensus 98 ----~~~l~df~~~~~~ 110 (243)
.+.|+||+.+...
T Consensus 249 ~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 249 SITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECCCTTCEET
T ss_pred ccccceEEEEeCCcccC
Confidence 3789999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=2.1e-08 Score=77.16 Aligned_cols=87 Identities=16% Similarity=0.136 Sum_probs=67.9
Q ss_pred CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc----------
Q 026115 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK---------- 76 (243)
Q Consensus 7 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~---------- 76 (243)
+.++.++++++.+++..++|||+++|.+|.+.+... .....++.+++.++..||+.
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~--------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~ 134 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--------------QSPEKIIELYAECIRLFHSIDISDCPYTNS 134 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCTT--------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCC
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCCc--------------ccHHHHHHHHHHHHHHHhCCCcccCCCcch
Confidence 567888999999999999999999999998763211 11235778888999999981
Q ss_pred ----------------------------------------------CCCCeEeccCCCCceEecCCCceeecccCCC
Q 026115 77 ----------------------------------------------AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 107 (243)
Q Consensus 77 ----------------------------------------------~~~~~~h~di~~~nil~~~~~~~~l~df~~~ 107 (243)
....++|+|+++.||+++.+..+.++||+.+
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 135 LDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 0134899999999999987656679999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.48 E-value=3.6e-07 Score=73.61 Aligned_cols=93 Identities=19% Similarity=0.195 Sum_probs=70.6
Q ss_pred CCccceeeEEEEeC---CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC------
Q 026115 7 NENVVELVGYYVDG---PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA------ 77 (243)
Q Consensus 7 h~niv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~------ 77 (243)
+..+.+++.++.+. +..++|||+++|..+.+.... .++......++.+++.+|..||...
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~ 165 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSLP-----------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGL 165 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTCT-----------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTC
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCccc-----------cCCHHHHHHHHHHHHHHHHHHhCCCchhccc
Confidence 45678888888776 458899999998776442111 1667788889999999999999731
Q ss_pred -------------------------------------------------CCCeEeccCCCCceEecCCCc--eeecccCC
Q 026115 78 -------------------------------------------------EPRIIHRNIKSSNVLLFDDDI--AKISDFDL 106 (243)
Q Consensus 78 -------------------------------------------------~~~~~h~di~~~nil~~~~~~--~~l~df~~ 106 (243)
...++|+|+++.||+++.++. +.++||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~ 245 (359)
T 3dxp_A 166 GDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWEL 245 (359)
T ss_dssp TTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTT
T ss_pred cccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccc
Confidence 135999999999999987653 58999998
Q ss_pred CCCC
Q 026115 107 SNQA 110 (243)
Q Consensus 107 ~~~~ 110 (243)
+...
T Consensus 246 a~~g 249 (359)
T 3dxp_A 246 STLG 249 (359)
T ss_dssp CEEE
T ss_pred cccC
Confidence 7543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.35 E-value=1e-06 Score=67.39 Aligned_cols=82 Identities=11% Similarity=0.064 Sum_probs=58.5
Q ss_pred cceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC------------
Q 026115 10 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA------------ 77 (243)
Q Consensus 10 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~------------ 77 (243)
+.+++++...++..++||||++|.+|. ... ... ..++.+++.++..||...
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~ 139 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKH 139 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC------------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc------------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 556888888888899999999998874 211 111 134556666666666532
Q ss_pred -------------------------------------------CCCeEeccCCCCceEecCCCceeecccCCCC
Q 026115 78 -------------------------------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 78 -------------------------------------------~~~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
...++|+|++|.||+++.++.+.++||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 140 RIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1229999999999999877666799999753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.33 E-value=1.4e-07 Score=74.20 Aligned_cols=127 Identities=18% Similarity=0.166 Sum_probs=77.1
Q ss_pred eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-------------------------
Q 026115 22 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK------------------------- 76 (243)
Q Consensus 22 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~------------------------- 76 (243)
..++||++++|.+|....... ++..+...++.+++..++.||..
T Consensus 90 ~~~~vm~~i~G~~l~~~~~~~-----------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLLNN-----------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIK 158 (304)
T ss_dssp CSCEEEECCCCEECCHHHHHT-----------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHH
T ss_pred cceEEEcccCCeECCcccccc-----------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHH
Confidence 357889999998876533211 55566666677777777777641
Q ss_pred ------------------------------CCCCeEeccCCCCceEecC--CCceeecccCCCCCCcccccccccccccc
Q 026115 77 ------------------------------AEPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHSTRVLG 124 (243)
Q Consensus 77 ------------------------------~~~~~~h~di~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 124 (243)
....++|+|+++.||+++. ...+.++||+.+.......+.......
T Consensus 159 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~-- 236 (304)
T 3sg8_A 159 KLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED-- 236 (304)
T ss_dssp HHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT--
T ss_pred HHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh--
Confidence 1234899999999999988 456789999987543221111000000
Q ss_pred cccccCchhhc----cC-CC---------CcccchHHHHHHHHHHHhCCCCC
Q 026115 125 TFGYHAPEYAM----TG-QM---------SSKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 125 ~~~~~aPE~~~----~~-~~---------~~~~DiwslG~~l~~l~~g~~pf 162 (243)
. .-..|+... .. .. ....+.|+++.+++.+.+|..+|
T Consensus 237 ~-~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 237 D-EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp T-TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred c-cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 001222111 11 00 11257899999999999998775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.14 E-value=1e-05 Score=59.52 Aligned_cols=98 Identities=15% Similarity=0.181 Sum_probs=64.6
Q ss_pred CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCccc
Q 026115 34 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 113 (243)
Q Consensus 34 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~ 113 (243)
+|.+.|....+ ++++.++|.++.|.+.++.-+-.... -..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~--------PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----- 97 (229)
T 2yle_A 34 SLEEILRLYNQ--------PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----- 97 (229)
T ss_dssp EHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------
T ss_pred cHHHHHHHcCC--------CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-----
Confidence 79999987765 49999999999999999887732210 11233457889999999888764 1110
Q ss_pred ccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 114 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 114 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
.....+.|||... ...+.+.-|+|||+++|..+-
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122456777653 234567789999999999886
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00011 Score=56.33 Aligned_cols=86 Identities=12% Similarity=0.076 Sum_probs=57.2
Q ss_pred cceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc-------------
Q 026115 10 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK------------- 76 (243)
Q Consensus 10 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~------------- 76 (243)
+.++++++.+++..++||++++|.++.+...... .....++.++...+..||..
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~ 148 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVF 148 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCccccc
Confidence 5678888999999999999999987766543221 01112223333333333321
Q ss_pred ------------------------------------------CCCCeEeccCCCCceEecCCCceeecccCCCC
Q 026115 77 ------------------------------------------AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 77 ------------------------------------------~~~~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
....++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 149 RLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 12237999999999999987777799998653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00045 Score=54.21 Aligned_cols=30 Identities=23% Similarity=0.292 Sum_probs=24.2
Q ss_pred CeEeccCCCCceEecC---CCc-eeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFD---DDI-AKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~---~~~-~~l~df~~~~~ 109 (243)
.++|+|+++.|++++. ++. +.|+||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4799999999999987 344 57999987643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.001 Score=53.22 Aligned_cols=31 Identities=19% Similarity=0.335 Sum_probs=25.2
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
..++|+|+.+.||+++.+..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 3499999999999998644578999987643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.014 Score=46.10 Aligned_cols=29 Identities=21% Similarity=0.359 Sum_probs=25.8
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
.++|+|+++.||+++.++.+.++||+.+.
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 49999999999999888889999998653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.66 E-value=0.038 Score=45.14 Aligned_cols=31 Identities=23% Similarity=0.495 Sum_probs=26.5
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCc
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 111 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~ 111 (243)
.++|+|+++.||+++.++ +.++||+.+....
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 399999999999998776 9999998876543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.62 E-value=0.2 Score=39.31 Aligned_cols=31 Identities=19% Similarity=0.408 Sum_probs=26.0
Q ss_pred CeEeccCCCCceEecCC----CceeecccCCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDD----DIAKISDFDLSNQA 110 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~----~~~~l~df~~~~~~ 110 (243)
.++|+|+.+.||+++.+ +.+.++||+.+...
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 49999999999999874 67899999876543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.87 E-value=0.19 Score=39.31 Aligned_cols=28 Identities=21% Similarity=0.264 Sum_probs=23.8
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
.++|+|+++.||+++ + .+.++||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 489999999999998 4 789999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.80 E-value=0.067 Score=41.80 Aligned_cols=29 Identities=24% Similarity=0.559 Sum_probs=24.7
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
.++|+|+.+.||+++.++.+.++||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 48999999999999877666899998653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.15 E-value=0.52 Score=34.57 Aligned_cols=115 Identities=8% Similarity=0.084 Sum_probs=74.4
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeEecc
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 85 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~h~d 85 (243)
.||+.++. ..-.+++.+.+.++. ..+..+|-.-.. .+....++++.+|+....+++. -+|--
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~~ik~----------~~~~eKlr~l~ni~~l~~~~~~-----r~tf~ 104 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDI--NDNHTPFDNIKS----------FTKNEKLRYLLNIKNLEEVNRT-----RYTFV 104 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECC--CTTSEEGGGGGG----------SCHHHHHHHHHHGGGGGGGGGS-----SEECC
T ss_pred cCCcccce-EEEEcccEEEEEEEc--CcccCCHHHHHh----------cCHHHHHHHHHHHHHHHHHhcC-----ceEEE
Confidence 57888765 455556655554443 333344433222 7788999999999887744432 57889
Q ss_pred CCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccch-HHHHHHHHHHHhCCCCCC
Q 026115 86 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDV-YSFGVVLLELLTGRKPVD 163 (243)
Q Consensus 86 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di-wslG~~l~~l~~g~~pf~ 163 (243)
+.|+|++++.++.+++.-.|+.. -++|. ..+ ..|. -++-|++..++++...|.
T Consensus 105 L~P~NL~f~~~~~p~i~~RGik~-------------------~l~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 105 LAPDELFFTRDGLPIAKTRGLQN-------------------VVDPL-----PVS-EAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CSGGGEEECTTSCEEESCCEETT-------------------TBSCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EecceEEEcCCCCEEEEEccCcc-------------------CCCCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999999987655421 12232 111 2233 367788888888888775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=90.94 E-value=0.29 Score=40.53 Aligned_cols=15 Identities=27% Similarity=0.341 Sum_probs=14.1
Q ss_pred CeEeccCCCCceEec
Q 026115 80 RIIHRNIKSSNVLLF 94 (243)
Q Consensus 80 ~~~h~di~~~nil~~ 94 (243)
.++|+|+.+.||+++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 489999999999998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.36 E-value=0.26 Score=39.00 Aligned_cols=30 Identities=27% Similarity=0.374 Sum_probs=26.2
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
.++|+|+.+.|++++.++.+.++||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 499999999999998878899999987643
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.30 E-value=1.3 Score=32.66 Aligned_cols=113 Identities=11% Similarity=0.065 Sum_probs=72.9
Q ss_pred cCCccceeeEEEEeCCeeEEEEeecCCC-CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHH-HhhhcCCCCeEe
Q 026115 6 KNENVVELVGYYVDGPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE-YLHEKAEPRIIH 83 (243)
Q Consensus 6 ~h~niv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~-~Lh~~~~~~~~h 83 (243)
.||++ -...-.+++.+.+.++.-+++ ++... . . .+....++++.+++.... +++. -+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~--~----------~~~~eKlrll~nl~~L~~~~~~~-----r~t 107 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-R--K----------TTLLSRIRAAIHLVSKVKHHSAR-----RLI 107 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-H--T----------SCHHHHHHHHHHHHHHHSSCCSS-----SEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-H--h----------cCHHHHHHHHHHHHHHHHHhhhC-----cee
Confidence 56776 233445666766666654333 44433 2 1 778889999999877666 4432 688
Q ss_pred ccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchH-HHHHHHHHHHhCCCCC
Q 026115 84 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY-SFGVVLLELLTGRKPV 162 (243)
Q Consensus 84 ~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw-slG~~l~~l~~g~~pf 162 (243)
--+.|+|++++.++.+++.-.|+. ..++|... ...|.| ++-|++..++.+...|
T Consensus 108 f~l~P~NL~f~~~~~p~i~hRGi~-------------------~~lpP~e~------~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 108 FIVCPENLMFNRALEPFFLHVGVK-------------------ESLPPDEW------DDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CCCCGGGEEECTTCCEEESCCEET-------------------TTBSSCSC------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred EEEeCceEEEeCCCcEEEEEcCCc-------------------ccCCCCCC------CHHHHHHHHHHHHHHHHcCCCCH
Confidence 899999999999999999866642 22333211 123333 6677888888877766
Q ss_pred C
Q 026115 163 D 163 (243)
Q Consensus 163 ~ 163 (243)
.
T Consensus 163 e 163 (219)
T 4ano_A 163 D 163 (219)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=90.04 E-value=0.35 Score=37.34 Aligned_cols=30 Identities=20% Similarity=0.135 Sum_probs=24.8
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
..++|+|+.+.|++ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 34899999999999 5666789999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.74 E-value=0.17 Score=40.42 Aligned_cols=28 Identities=18% Similarity=0.421 Sum_probs=23.3
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
.++|+|+.+.||+++.++ +.++||+.+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 489999999999997655 8899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=89.47 E-value=0.15 Score=41.85 Aligned_cols=30 Identities=20% Similarity=0.380 Sum_probs=23.7
Q ss_pred CeEeccCCCCceEecCC----------------------------CceeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDD----------------------------DIAKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~----------------------------~~~~l~df~~~~~ 109 (243)
.++|+|+.+.||+++.+ +.+.++||+.+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 48999999999999875 5688889887643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=88.11 E-value=0.65 Score=37.40 Aligned_cols=29 Identities=14% Similarity=0.391 Sum_probs=24.3
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
.++|+|+.+.||+++.++ +.++||..+..
T Consensus 228 ~L~HGDl~~~Nil~~~~~-~~lID~e~a~~ 256 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 256 (397)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence 499999999999997654 88999977653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=87.95 E-value=0.26 Score=39.71 Aligned_cols=30 Identities=30% Similarity=0.561 Sum_probs=25.7
Q ss_pred CCeEeccCCCCceEecCC----CceeecccCCCC
Q 026115 79 PRIIHRNIKSSNVLLFDD----DIAKISDFDLSN 108 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~----~~~~l~df~~~~ 108 (243)
..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 348999999999999876 688999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.50 E-value=0.37 Score=39.05 Aligned_cols=28 Identities=25% Similarity=0.470 Sum_probs=23.6
Q ss_pred eEeccCCCCceEe------cCCCceeecccCCCC
Q 026115 81 IIHRNIKSSNVLL------FDDDIAKISDFDLSN 108 (243)
Q Consensus 81 ~~h~di~~~nil~------~~~~~~~l~df~~~~ 108 (243)
++|+|+.+.||++ +....+.++||.++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 345678999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=81.59 E-value=0.69 Score=37.87 Aligned_cols=29 Identities=17% Similarity=0.398 Sum_probs=25.2
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 109 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~ 109 (243)
.++|+|+.+.|++ +.++.+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 7778899999987643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 243 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-37 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-30 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-27 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-21 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-52
Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 26/240 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ + ++ N++ +GY L + + SL+ LH + + +
Sbjct: 57 VLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETK--------FEMIKLI 107
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
IA A+G++YLH K IIHR++KS+N+ L +D KI DF L+ +
Sbjct: 108 DIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 121 RVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
++ G+ + APE S +SDVY+FG+VL EL+TG+ P + R Q
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------ 218
Query: 178 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237
V + + + M + A C++ + D RP +L +++ L +
Sbjct: 219 -----IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 4e-48
Identities = 52/235 (22%), Positives = 100/235 (42%), Gaps = 27/235 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L+++ +V L P+ + E+ GSL D L G+K L+ + +
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLL 112
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A A G+ ++ E+ IHR+++++N+L+ D KI+DF L+ D
Sbjct: 113 DMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-ARE 168
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ APE G + KSDV+SFG++L E++T + P
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY---------------PG 213
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
++ +V Q ++ P ++ + LC + + RP + L+
Sbjct: 214 MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 9e-48
Identities = 50/246 (20%), Positives = 93/246 (37%), Gaps = 27/246 (10%)
Query: 1 MVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG---------VKGAKP 50
++S L N N+V L+G G ++ E+ G L + L K+
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 51 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110
L + + A+G+ +L K IHR++ + N+LL I KI DF L+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 111 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 170
+ + + + APE + +SDV+S+G+ L EL + +P
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--- 252
Query: 171 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230
+ K + + P A A+M + C + RP +++
Sbjct: 253 -----------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 231 LQPLLN 236
++ ++
Sbjct: 302 IEKQIS 307
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-46
Identities = 51/258 (19%), Positives = 97/258 (37%), Gaps = 32/258 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRV----LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 56
L++EN++ + L ++ GSL D L+ ++
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTV 99
Query: 57 AQRVKIAVGAARGLEYLHEKA-----EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 111
+K+A+ A GL +LH + +P I HR++KS N+L+ + I+D L+ +
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159
Query: 112 DAAARLH--STRVLGTFGYHAPEYAMT------GQMSSKSDVYSFGVVLLELLTGRKP-- 161
A + +GT Y APE + ++D+Y+ G+V E+
Sbjct: 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219
Query: 162 --VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEY-PPKAIAKMAAVAALCVQYEA 218
D+ LP + ++ + +Q + + + +A+ MA + C
Sbjct: 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279
Query: 219 DFRPNMGIVLKALQPLLN 236
R + K L L
Sbjct: 280 AARLTALRIKKTLSQLSQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 1e-45
Identities = 52/250 (20%), Positives = 100/250 (40%), Gaps = 33/250 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------------- 46
+++ N N+V+L+G G L +E+ + G L++ L
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 47 -GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 105
+ P LS A+++ IA A G+ YL E + +HR++ + N L+ ++ + KI+DF
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 106 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165
LS A + PE + +++SDV+++GVVL E+ + +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY- 244
Query: 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225
++ ++V V P ++ + LC RP+
Sbjct: 245 --------------GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC 290
Query: 226 IVLKALQPLL 235
+ + LQ +
Sbjct: 291 SIHRILQRMC 300
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-45
Identities = 51/250 (20%), Positives = 99/250 (39%), Gaps = 32/250 (12%)
Query: 1 MVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG--------------V 45
M+++L + EN+V L+G L +E+ G L + L K+ +
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 46 KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 105
+ + VL++ + A A+G+E+L K +HR++ + NVL+ + KI DF
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 106 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 165
L+ + + + APE G + KSDV+S+G++L E+ +
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 166 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225
+P + + + P A ++ + C +++ RP+
Sbjct: 270 IPVDAN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 226 IVLKALQPLL 235
+ L L
Sbjct: 316 NLTSFLGCQL 325
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-45
Identities = 53/236 (22%), Positives = 97/236 (41%), Gaps = 27/236 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ + + N++ L G ++ E+ G+L L K G S Q V
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLV 113
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ G A G++YL +HR++ + N+L+ + + K+SDF LS D ++T
Sbjct: 114 GMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 121 -RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ APE + +S SDV+SFG+V+ E++T +
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--------------- 215
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
+LS +V + ++ P + + + C Q E RP ++ L L+
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-44
Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 15/173 (8%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ + +V G + + EH GSL +L +
Sbjct: 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILG 107
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
K+++ +GL YL EK +I+HR++K SN+L+ K+ DF +S Q D+ +
Sbjct: 108 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 161
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
+GT Y +PE S +SD++S G+ L+E+ GR P+ + + +
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (373), Expect = 5e-44
Identities = 53/239 (22%), Positives = 98/239 (41%), Gaps = 26/239 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +K+ N+V+L+G P + E + G+L D L + +S +
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLL 118
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A + +EYL +K IHR++ + N L+ ++ + K++DF LS H
Sbjct: 119 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-A 174
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ APE + S KSDV++FGV+L E+ T P
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------------PG 219
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 239
+ +V + ++ E P K+ + C Q+ RP+ + +A + + S
Sbjct: 220 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-43
Identities = 55/237 (23%), Positives = 105/237 (44%), Gaps = 31/237 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
++++L++ N+V+L+G V+ + + E+ +KGSL D L + VL
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCL 105
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
+K ++ +EYL +HR++ + NVL+ +D++AK+SDF L+ +A
Sbjct: 106 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQ 157
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ APE + S+KSDV+SFG++L E+ + + P
Sbjct: 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY---------------P 202
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236
++ V V+ + P + V C +A RP+ + + L+ +
Sbjct: 203 RIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-43
Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 28/238 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L N +V L+G L +L E A G LH L GK+ + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--------IPVSNVA 112
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHS 119
++ + G++YL EK +HR++ + NVLL + AKISDF LS D +
Sbjct: 113 ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ ++APE + SS+SDV+S+GV + E L+ +
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---------------PYK 214
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237
K+ +V ++ E PP+ ++ A+ + C Y+ + RP+ V + ++ +
Sbjct: 215 KMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-43
Identities = 51/232 (21%), Positives = 92/232 (39%), Gaps = 27/232 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ L +E +V+L G + E+ + G L + L + Q +
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLL 103
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
++ +EYL K + +HR++ + N L+ D + K+SDF LS D S
Sbjct: 104 EMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSV 159
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ PE M + SSKSD+++FGV++ E+ + K +
Sbjct: 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY---------------ER 204
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232
+ + + + L P A K+ + C +AD RP I+L +
Sbjct: 205 FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-43
Identities = 50/237 (21%), Positives = 95/237 (40%), Gaps = 27/237 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L + +V+L G ++ L +E G L D L + + +
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--------TQRGLFAAETLL 104
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ + G+ YL E +IHR++ + N L+ ++ + K+SDF ++ D ST
Sbjct: 105 GMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SST 160
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ +PE + SSKSDV+SFGV++ E+ + K
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------------- 205
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237
S +V + + T P A + + C + + RP +L+ L + +
Sbjct: 206 RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-43
Identities = 57/243 (23%), Positives = 106/243 (43%), Gaps = 27/243 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L++E +V+L + P+ + E+ SKGSL D L G+ G L Q V
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETG-------KYLRLPQLV 116
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+A A G+ Y+ +HR+++++N+L+ ++ + K++DF L+ D
Sbjct: 117 DMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQ 172
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ APE A+ G+ + KSDV+SFG++L EL T + P
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---------------PG 217
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240
+ +V V+ PP+ + + C + E + RP + L+ +
Sbjct: 218 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
Query: 241 PSK 243
+
Sbjct: 278 QYQ 280
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-43
Identities = 54/246 (21%), Positives = 105/246 (42%), Gaps = 29/246 (11%)
Query: 1 MVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGP 52
++ +L + N++ L+G LA E+A G+L D L + ++
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 53 VLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 112
LS Q + A ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179
Query: 113 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 172
+ T + A E ++ SDV+S+GV+L E+++
Sbjct: 180 ---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--------- 227
Query: 173 LVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232
++ ++ + + E P ++ + C + + RP+ +L +L
Sbjct: 228 ------CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 233 PLLNTR 238
+L R
Sbjct: 282 RMLEER 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 7e-43
Identities = 47/243 (19%), Positives = 96/243 (39%), Gaps = 29/243 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
++ + NV+ L+G + + + G L + + + +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------PTVKDL 132
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD--AAARL 117
+ + A+G+++L K + +HR++ + N +L + K++DF L+ D +
Sbjct: 133 IGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
+ T + A E T + ++KSDV+SFGV+L EL+T P P +
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDIT 244
Query: 178 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237
L ++ Q P + V C +A+ RP+ ++ + + +T
Sbjct: 245 VYLLQGRRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
Query: 238 RSG 240
G
Sbjct: 295 FIG 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (364), Expect = 1e-42
Identities = 50/238 (21%), Positives = 96/238 (40%), Gaps = 29/238 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ + + NV+ L G ++ E GSL L G + Q V
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--------TVIQLV 131
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ G A G++YL + +HR++ + N+L+ + + K+SDF LS D + T
Sbjct: 132 GMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188
Query: 121 RVLG---TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
LG + APE + +S SDV+S+G+V+ E+++ +
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---------------P 233
Query: 178 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
++ V ++ P + + + C Q + + RP G ++ L ++
Sbjct: 234 YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-42
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 31/235 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +L N +V ++G +L E A G L+ L + + +
Sbjct: 61 VMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH---------VKDKNII 110
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHS 119
++ + G++YL E +HR++ + NVLL AKISDF LS D
Sbjct: 111 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 178
T ++APE + SSKSDV+SFGV++ E + G+KP
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-------------- 213
Query: 179 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233
+ +V ++ P +M + LC Y+ + RP V L+
Sbjct: 214 --MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 1e-41
Identities = 53/229 (23%), Positives = 87/229 (37%), Gaps = 33/229 (14%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ S L++ N++ L GY+ D L E+A G+++ L +
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTA 109
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
A L Y H K R+IHR+IK N+LL KI+DF S AP + T
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRT 162
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ GT Y PE K D++S GV+ E L G+ P + + ++
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 222
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
+ + D + + +++ RP + VL+
Sbjct: 223 FPDFVTEGARD-----------------LISRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-41
Identities = 43/236 (18%), Positives = 89/236 (37%), Gaps = 27/236 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+++ + N +V L+G + ++++ + G L D + K +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQYLL 114
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
V A+G+ YL ++ R++HR++ + NVL+ KI+DF L+ H+
Sbjct: 115 NWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ A E + + +SDV+S+GV + EL+T
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDG 216
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236
+ ++ ++ PP + + C +AD RP ++ +
Sbjct: 217 IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 5e-41
Identities = 56/242 (23%), Positives = 100/242 (41%), Gaps = 25/242 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPV 53
M K++N++ L+G + E+ASKG+L + L ++ P
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 54 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 113
LS V A ARG+EYL K + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
+T + APE + +SDV+SFGV+L E+ T
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY---------- 238
Query: 174 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233
P + +++ + + + P ++ + C RP +++ L
Sbjct: 239 -----PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 234 LL 235
++
Sbjct: 294 IV 295
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-40
Identities = 51/243 (20%), Positives = 89/243 (36%), Gaps = 25/243 (10%)
Query: 1 MVSRLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGP 52
++ + NVV L+G G ++ E G+L L K+
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 53 VLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 112
L+ + + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 113 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 172
+ + APE + +SDV+SFGV+L E+ + P
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVK 241
Query: 173 LVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232
+ +L E P +M C E RP +++ L
Sbjct: 242 IDEEFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 233 PLL 235
LL
Sbjct: 293 NLL 295
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-40
Identities = 49/236 (20%), Positives = 98/236 (41%), Gaps = 19/236 (8%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP-GPVLSWAQR 59
++ +VV L+G G ++ E ++G L L + P S ++
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
+++A A G+ YL+ + +HR++ + N ++ +D KI DF ++ +
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ L + +PE G ++ SDV+SFGVVL E+ T +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---------------Q 237
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
LS ++V + V + P + + +C QY RP+ ++ +++ +
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 1e-39
Identities = 44/233 (18%), Positives = 86/233 (36%), Gaps = 27/233 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 58
++ LK+ N+V +D L E+ G L ++ KG K L
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEF 110
Query: 59 RVKIAVGAARGLEYLHEK--AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 116
+++ L+ H + ++HR++K +NV L K+ DF L+ +
Sbjct: 111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS- 169
Query: 117 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 176
+ +GT Y +PE + KSD++S G +L EL P +
Sbjct: 170 -FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA----- 223
Query: 177 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
K+++ ++ Y + + + + RP++ +L+
Sbjct: 224 -------GKIREGKFRRIPYRYSDELN----EIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-39
Identities = 49/234 (20%), Positives = 86/234 (36%), Gaps = 34/234 (14%)
Query: 1 MVSRLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 56
M+ L++ N+V + VL E + G+L L K V+
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------VMKI 111
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAA 115
+GL++LH + P IIHR++K N+ + KI D L+ +
Sbjct: 112 KVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
+ V+GT + APE + DVY+FG+ +LE+ T P Q
Sbjct: 169 --FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---- 221
Query: 176 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
++ + AI ++ + C++ D R ++ +L
Sbjct: 222 ----------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-38
Identities = 46/234 (19%), Positives = 89/234 (38%), Gaps = 32/234 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+++ + N+V+L+ + + E + G++ ++ + L+ +Q
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQ 113
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ L YLH+ +IIHR++K+ N+L D K++DF +S + R S
Sbjct: 114 VVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS- 169
Query: 121 RVLGTFGYHAPEYAMTGQM-----SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
+GT + APE M K+DV+S G+ L+E+ P P +
Sbjct: 170 -FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228
Query: 176 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
+ P P + + C++ D R +L+
Sbjct: 229 KSEPPTL--------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-38
Identities = 51/235 (21%), Positives = 92/235 (39%), Gaps = 28/235 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ + + ++V+L+G + P+ ++ E + G L L +K L A +
Sbjct: 61 TMRQFDHPHIVKLIGVITENPVWII-MELCTLGELRSFLQVRKYS--------LDLASLI 111
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
A + L YL K R +HR+I + NVL+ +D K+ DF LS D+ ++
Sbjct: 112 LYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KAS 167
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ + APE + +S SDV+ FGV + E+L
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ---------------G 212
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235
+ + V ++ PP + ++ C Y+ RP + L +L
Sbjct: 213 VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (331), Expect = 1e-37
Identities = 49/232 (21%), Positives = 88/232 (37%), Gaps = 36/232 (15%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ +L++ N ++ G Y+ L E+ + + KK L +
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVEIA 118
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ GA +GL YLH +IHR++K+ N+LL + + K+ DF ++ +
Sbjct: 119 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169
Query: 121 RVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
+GT + APE + GQ K DV+S G+ +EL + P+ +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------ 223
Query: 178 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
+ Q L + + C+Q RP ++LK
Sbjct: 224 ------YHIAQNESPALQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-37
Identities = 56/230 (24%), Positives = 87/230 (37%), Gaps = 27/230 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ L +ENVV+ G+ +G ++ L E+ S G L D + G +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQ 106
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ G+ YLH I HR+IK N+LL + D KISDF L+
Sbjct: 107 RFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163
Query: 121 RVLGTFGYHAPEYAMTGQMSS-KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
++ GT Y APE + + DV+S G+VL +L G P D Q+ W
Sbjct: 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK 222
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
K + K+ +A + + R + + K
Sbjct: 223 KTYLNPWKKI---------DSAPLALLHK----ILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-36
Identities = 56/233 (24%), Positives = 83/233 (35%), Gaps = 27/233 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ L + N++ L G + P++ + E A GSL D L +G
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLS 114
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-S 119
+ AV A G+ YL K R IHR++ + N+LL D+ KI DF L P
Sbjct: 115 RYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171
Query: 120 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
F + APE T S SD + FGV L E+ T + L Q
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------- 223
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232
+ + P + V C ++ + RP + L
Sbjct: 224 ------LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-36
Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 31/230 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ KN N+V + Y+ G + E+ + GSL D++ Q
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQIA 119
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ + LE+LH ++IHR+IKS N+LL D K++DF Q + +
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRS 174
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSLVTWATP 179
++GT + APE K D++S G++ +E++ G P ++ R + T TP
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 180 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
+L + P K A C+ + + R + +L+
Sbjct: 235 EL---------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 6e-33
Identities = 39/191 (20%), Positives = 67/191 (35%), Gaps = 12/191 (6%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++SRL + V+L + D +A G L +
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTR 111
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
LEYLH IIHR++K N+LL +D +I+DF + + + +
Sbjct: 112 FYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+GT Y +PE SD+++ G ++ +L+ G P +
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 228
Query: 181 LSEDKVKQCVD 191
E + D
Sbjct: 229 FPEKFFPKARD 239
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 117 bits (294), Expect = 7e-32
Identities = 42/231 (18%), Positives = 81/231 (35%), Gaps = 29/231 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+S L++ +V L + D V+ YE S G L + + + +S + V
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAV 127
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLH 118
+ +GL ++HE +H ++K N++ K+ DF L+ +
Sbjct: 128 EYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 184
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
+T GT + APE A + +D++S GV+ LL+G P V
Sbjct: 185 TT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 241
Query: 179 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
+ + + + + + R + L+
Sbjct: 242 WNMDDSAFSGI---------SEDGKDFIRK----LLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (293), Expect = 9e-32
Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 29/231 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++++L + ++ L + D VL E S G L D + + +S A+ +
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--------MSEAEVI 130
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--FDDDIAKISDFDLSNQAPDAAARLH 118
A GL+++HE I+H +IK N++ KI DF L+ +
Sbjct: 131 NYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
+T T + APE + +D+++ GV+ LL+G P V
Sbjct: 188 TT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244
Query: 179 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
+ ED P+A + +Q E R + L+
Sbjct: 245 WEFDEDAFSSV---------SPEAKDFIKN----LLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 114 bits (286), Expect = 2e-31
Identities = 49/229 (21%), Positives = 78/229 (34%), Gaps = 34/229 (14%)
Query: 7 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 66
+ N+++L Y L ++ KG L D L K LS + KI
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRAL 119
Query: 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 126
+ LH+ I+HR++K N+LL DD K++DF S Q V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 127 GYHAPEYAMTGQM------SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
Y APE + D++S GV++ LL G P H ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 181 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
+ +Y ++ + + R L
Sbjct: 234 FGSPEWD---------DYSDTVKDLVSR----FLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-31
Identities = 40/191 (20%), Positives = 72/191 (37%), Gaps = 14/191 (7%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+ ++ + + + E+ + G L + ++
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRAT 106
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
A GL++LH K I++R++K N+LL D KI+DF + + A+ +
Sbjct: 107 FYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TN 161
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
GT Y APE + + + D +SFGV+L E+L G+ P + P
Sbjct: 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 221
Query: 181 LSEDKVKQCVD 191
K+ D
Sbjct: 222 YPRWLEKEAKD 232
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 112 bits (280), Expect = 2e-30
Identities = 52/242 (21%), Positives = 93/242 (38%), Gaps = 31/242 (12%)
Query: 1 MVSRLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 56
+ L + +V + GPL + E+ +L DI+H + ++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTP 110
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 116
+ +++ A + L + H+ IIHR++K +N+++ + K+ DF ++ D+
Sbjct: 111 KRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167
Query: 117 LHST-RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
+ T V+GT Y +PE A + ++SDVYS G VL E+LTG P P
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
Query: 176 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-NMGIVLKALQPL 234
P A + AV + + R + L +
Sbjct: 228 REDPIPPS-------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
Query: 235 LN 236
N
Sbjct: 275 HN 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 4e-30
Identities = 37/231 (16%), Positives = 81/231 (35%), Gaps = 29/231 (12%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+++ ++ N++ L + V+ +E S + + ++ L+ + V
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIV 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLH 118
L++LH I H +I+ N++ KI +F + Q +
Sbjct: 106 SYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---N 159
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
+ Y+APE +S+ +D++S G ++ LL+G P + + A
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219
Query: 179 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
E+ K+ +A+ + + E R L+
Sbjct: 220 YTFDEEAFKEI---------SIEAMDFVDR----LLVKERKSRMTASEALQ 257
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-29
Identities = 40/244 (16%), Positives = 80/244 (32%), Gaps = 29/244 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLR-----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 55
+ ++ NVV L L +EH + + P P +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--------VPEPGVP 114
Query: 56 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 115
+ RGL++LH R++HR++K N+L+ K++DF L+
Sbjct: 115 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--- 168
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV- 174
++ T V+ T Y APE + ++ D++S G + E+ + + Q +
Sbjct: 169 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228
Query: 175 ---------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225
W + + ++ + C+ + R +
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
Query: 226 IVLK 229
L
Sbjct: 289 SALS 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 110 bits (277), Expect = 2e-29
Identities = 39/175 (22%), Positives = 66/175 (37%), Gaps = 17/175 (9%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
+VS +V + + + + G LH L A
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADMR 110
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
A GLE++H + +++R++K +N+LL + +ISD L+
Sbjct: 111 FYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPH 163
Query: 121 RVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
+GT GY APE G S +D +S G +L +LL G P + + +
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (263), Expect = 1e-27
Identities = 44/191 (23%), Positives = 75/191 (39%), Gaps = 17/191 (8%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
M+S + + ++ + G + D + ++ G L +L +
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAK 107
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
A LEYLH K II+R++K N+LL + KI+DF + PD +
Sbjct: 108 FYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTY 159
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ GT Y APE T + D +SFG+++ E+L G P + + A +
Sbjct: 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR 219
Query: 181 LSEDKVKQCVD 191
+ D
Sbjct: 220 FPPFFNEDVKD 230
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (262), Expect = 2e-27
Identities = 48/232 (20%), Positives = 79/232 (34%), Gaps = 31/232 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ ++K+ N+V L Y G L + S G L D + K +
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDAS 110
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARL 117
++ ++YLH+ I+HR++K N+L + +D ISDF LS +
Sbjct: 111 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL- 166
Query: 118 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
+ GT GY APE S D +S GV+ LL G P + A
Sbjct: 167 --STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 224
Query: 178 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
+ Y ++ + + R L+
Sbjct: 225 EYEFDS-------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 104 bits (259), Expect = 2e-27
Identities = 32/240 (13%), Positives = 70/240 (29%), Gaps = 31/240 (12%)
Query: 9 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 68
+ + + +G VL + + G S A
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---------LCGRKFSVKTVAMAAKQMLA 112
Query: 69 GLEYLHEKAEPRIIHRNIKSSNVLL-----FDDDIAKISDFDLSNQAPDAAARLH----- 118
++ +HEK +++R+IK N L+ + ++ + DF + D + H
Sbjct: 113 RVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 119 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
+ GT Y + + + S + D+ + G V + L G P +
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---- 225
Query: 179 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238
+++ + + E + D P+ + +L
Sbjct: 226 -----ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 103 bits (258), Expect = 3e-27
Identities = 39/247 (15%), Positives = 80/247 (32%), Gaps = 30/247 (12%)
Query: 1 MVSRLKNENVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
+ ++ + + + +G V+ E + S
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---------FSLKTV 105
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAAR 116
+ +A +EY+H K IHR++K N L+ + I DF L+ + DA
Sbjct: 106 LLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 117 LH-----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 171
H + + GT Y + + + S + D+ S G VL+ G P ++
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222
Query: 172 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 231
+ K ++ ++ A C D +P+ + +
Sbjct: 223 QKYERISEKKMSTPIE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273
Query: 232 QPLLNTR 238
+ L + +
Sbjct: 274 RNLFHRQ 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 6e-27
Identities = 51/249 (20%), Positives = 92/249 (36%), Gaps = 33/249 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSW 56
++ R ++EN++ + + + H L+ +L + LS
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSN 108
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAA 115
RGL+Y+H ++HR++K SN+LL KI DF L+ A PD
Sbjct: 109 DHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
T + T Y APE + + +KS D++S G +L E+L+ R Q + +
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
Query: 175 TWATPKLSEDKVKQCVDTKLGG--------------EYPPKAIAKMAAVAALCVQYEADF 220
S++ + ++ K P A +K + + +
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285
Query: 221 RPNMGIVLK 229
R + L
Sbjct: 286 RIEVEQALA 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.9 bits (248), Expect = 3e-25
Identities = 45/248 (18%), Positives = 78/248 (31%), Gaps = 30/248 (12%)
Query: 1 MVSRLKNENVVELVGYYV------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 54
++ +L + N+V L ++ D L ++ + H + L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------KQTL 119
Query: 55 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDA 113
R L Y+H I HR+IK N+LL D + K+ DF + Q
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
+ + + + +S DV+S G VL ELL G+ Q
Sbjct: 177 --EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 174 VTWA------------TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFR 221
+ P +E K Q + P+ + A+ + ++Y R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 222 PNMGIVLK 229
Sbjct: 295 LTPLEACA 302
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 9e-25
Identities = 46/233 (19%), Positives = 88/233 (37%), Gaps = 32/233 (13%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +++ NV+ L Y + +L E + G L D L K+ L+ +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEAT 116
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAAR 116
+ G+ YLH +I H ++K N++L D ++ KI DF L+++
Sbjct: 117 EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-- 171
Query: 117 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 176
+ GT + APE + ++D++S GV+ LL+G P + + V+
Sbjct: 172 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 177 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229
+ + EY A + + R + L+
Sbjct: 231 VNYEFED-------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 1e-24
Identities = 50/254 (19%), Positives = 90/254 (35%), Gaps = 28/254 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ L + N++ L+ + L ++ I L+ +
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIK 103
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ +GLEYLH+ I+HR++K +N+LL ++ + K++DF L+ T
Sbjct: 104 AYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYT 158
Query: 121 RVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ T Y APE +M D+++ G +L ELL + Q + +
Sbjct: 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218
Query: 180 KLSED------KVKQCVDTKLGGEYPPKAIAKMAAVAAL-----CVQYEADFRPNMGIVL 228
+E+ + V K P I A L + R L
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
Query: 229 KALQPLLNTRSGPS 242
K + R GP+
Sbjct: 279 K--MKYFSNRPGPT 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 2e-24
Identities = 33/168 (19%), Positives = 61/168 (36%), Gaps = 20/168 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 56
+ ++V +V Y + ++ E G L + + +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-------DRGDQAFTE 110
Query: 57 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDA 113
+ +I ++YLH I HR++K N+L + I K++DF + +
Sbjct: 111 REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
+ T Y APE + D++S GV++ LL G P
Sbjct: 168 NSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 3e-24
Identities = 38/191 (19%), Positives = 68/191 (35%), Gaps = 14/191 (7%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ ++ + L + E+A+ G L L ++ + +
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERAR 108
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
LEYLH + +++R+IK N++L D KI+DF L + A +
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-- 163
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
GT Y APE D + GVV+ E++ GR P + L+ +
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223
Query: 181 LSEDKVKQCVD 191
+
Sbjct: 224 FPRTLSPEAKS 234
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.7 bits (237), Expect = 4e-24
Identities = 35/241 (14%), Positives = 80/241 (33%), Gaps = 25/241 (10%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ LK+ N+V+L VL +EH + + + G L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAK 103
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ G+ Y H++ R++HR++K N+L+ + KI+DF L+ +
Sbjct: 104 SFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-H 159
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
++ + + + S+ D++S G + E++ G Q +
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
Query: 181 LSE------------DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228
+ D + + + + ++ + + R L
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 229 K 229
+
Sbjct: 280 E 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 4e-24
Identities = 29/161 (18%), Positives = 62/161 (38%), Gaps = 12/161 (7%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ L + N+V+L+ L +E + + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--------IPLPLIK 105
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+GL + H R++HR++K N+L+ + K++DF L+ +A R ++
Sbjct: 106 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTH 161
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
V+ + S+ D++S G + E++T R
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 7e-24
Identities = 32/163 (19%), Positives = 57/163 (34%), Gaps = 17/163 (10%)
Query: 4 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 63
V+ L+ ++ VL E ++G L
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQEELARSFF 116
Query: 64 VGAARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRV 122
+ + H ++HR+IK N+L+ + K+ DF D T
Sbjct: 117 WQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDF 169
Query: 123 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 164
GT Y PE+ + +S V+S G++L +++ G P +H
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 91.8 bits (227), Expect = 2e-22
Identities = 32/191 (16%), Positives = 65/191 (34%), Gaps = 17/191 (8%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ + +V+L + D + E+ + G + L S
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHAR 144
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
A EYLH +I+R++K N+L+ +++DF + + +
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTW 196
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ GT APE ++ + D ++ GV++ E+ G P P + +
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256
Query: 181 LSEDKVKQCVD 191
D
Sbjct: 257 FPSHFSSDLKD 267
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 4e-21
Identities = 29/161 (18%), Positives = 60/161 (37%), Gaps = 13/161 (8%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ LK++N+V L L +E + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVK 104
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+GL + H + ++HR++K N+L+ + K+++F L+ +A R +S
Sbjct: 105 SFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSA 160
Query: 121 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161
V+ + S+ D++S G + EL +P
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 6e-21
Identities = 37/202 (18%), Positives = 81/202 (40%), Gaps = 7/202 (3%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ LK+ENVV L+ + + H G+ + ++
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIK 120
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLH 118
++ GL Y+H +I+HR++K++NVL+ D + K++DF L+ +
Sbjct: 121 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 119 STRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
T + T Y PE + + D++ G ++ E+ T + + Q +L++
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 178 TPKLSEDKVKQCVDTKLGGEYP 199
++ + + +L +
Sbjct: 238 CGSITPEVWPNVDNYELYEKLE 259
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 2e-20
Identities = 40/190 (21%), Positives = 74/190 (38%), Gaps = 14/190 (7%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 60
++ +++ENV+ L+ + + GK L +
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQ 124
Query: 61 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 120
+ +GL Y+H IIHR++K N+ + +D KI DF L+ QA T
Sbjct: 125 FLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMT 176
Query: 121 RVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ T Y APE + + D++S G ++ E++TG+ + Q + T
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 180 KLSEDKVKQC 189
+ V++
Sbjct: 237 TPPAEFVQRL 246
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.6 bits (190), Expect = 2e-17
Identities = 40/177 (22%), Positives = 70/177 (39%), Gaps = 16/177 (9%)
Query: 1 MVSRLKNE-NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 59
++ ++ +V L + L ++ + G L L ++ + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEV 131
Query: 60 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 119
LE+LH+ II+R+IK N+LL + ++DF LS + A +
Sbjct: 132 QIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERA 187
Query: 120 TRVLGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
GT Y AP+ G D +S GV++ ELLTG P + Q+ +
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 76.4 bits (187), Expect = 5e-17
Identities = 28/159 (17%), Positives = 57/159 (35%), Gaps = 22/159 (13%)
Query: 7 NENVVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 64
N++ L D R L +EH + + L+
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMY 136
Query: 65 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVL 123
+ L+Y H I+HR++K NV++ + ++ D+ L+ +
Sbjct: 137 EILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRV 190
Query: 124 GTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 161
+ + PE + QM D++S G +L ++ ++P
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 75.8 bits (185), Expect = 1e-16
Identities = 31/171 (18%), Positives = 65/171 (38%), Gaps = 10/171 (5%)
Query: 1 MVSRLKNENVVELVGYYVDGPLRVLAY--EHASKGSLHDILHGKKGVKG-----AKPGPV 53
++ R+ + + + + L++L + G ++ G
Sbjct: 62 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121
Query: 54 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPD 112
+ +I+ GL+Y+H + IIH +IK NVL+ D + +++
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 179
Query: 113 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 163
H T + T Y +PE + +D++S ++ EL+TG +
Sbjct: 180 CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 3e-16
Identities = 44/194 (22%), Positives = 76/194 (39%), Gaps = 22/194 (11%)
Query: 1 MVSRLKNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 55
++ +K+ENV+ L+ + V H L++I+ +K L+
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LT 119
Query: 56 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 115
+ RGL+Y+H IIHR++K SN+ + +D KI DF L+ D
Sbjct: 120 DDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
+ V + + D++S G ++ ELLTGR T Q L+
Sbjct: 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 176 WATPKLSEDKVKQC 189
+ +K+
Sbjct: 233 RLVGTPGAELLKKI 246
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.7 bits (177), Expect = 2e-15
Identities = 36/198 (18%), Positives = 70/198 (35%), Gaps = 24/198 (12%)
Query: 1 MVSRLKNENVVELVGYYV------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 54
++ + ++N++ L+ + + L E I
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------ 116
Query: 55 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 114
+ + G+++LH IIHR++K SN+++ D KI DF L+ A
Sbjct: 117 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 171
Query: 115 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
T + T Y APE + D++S G ++ E++ + Q + V
Sbjct: 172 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
Query: 175 TWATPKLSEDKVKQCVDT 192
+ +K+ T
Sbjct: 231 IEQLGTPCPEFMKKLQPT 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 41.3 bits (96), Expect = 3e-05
Identities = 10/52 (19%), Positives = 21/52 (40%), Gaps = 4/52 (7%)
Query: 56 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 107
++ + + + I+H ++ NVL+ ++ I I DF S
Sbjct: 102 VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 243 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.59 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.46 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.91 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 89.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 84.63 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.3e-51 Score=319.49 Aligned_cols=211 Identities=23% Similarity=0.412 Sum_probs=169.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++|++.+++.+++||||+++|+|.+++....+. +++..+..++.|++.||+|||+++
T Consensus 80 ~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~--------l~~~~~~~i~~qia~gl~yLH~~~--- 148 (299)
T d1jpaa_ 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYLADMN--- 148 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTC--------SCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCC--------CCHHHHHHHHHHHHHHHHHHhhCC---
Confidence 368899999999999999999999999999999999998865432 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccc---cccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH---STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+||+++.++.+||+|||+++.......... .....||+.|+|||.+.+..++.++|||||||++|||+|
T Consensus 149 iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t 228 (299)
T d1jpaa_ 149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228 (299)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHh
Confidence 99999999999999999999999999987654332211 112347889999999999999999999999999999998
Q ss_pred -CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 158 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
|..||... ....+...+....+...+..++..+.+++.+||+.||++|||+++|++.|++++.
T Consensus 229 ~g~~Pf~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 229 YGERPYWDM----------------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TSCCTTTTC----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCC----------------CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 89999643 2233344444445555666778889999999999999999999999999999887
Q ss_pred hc
Q 026115 237 TR 238 (243)
Q Consensus 237 ~~ 238 (243)
..
T Consensus 293 ~p 294 (299)
T d1jpaa_ 293 NP 294 (299)
T ss_dssp SG
T ss_pred Ch
Confidence 54
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=314.42 Aligned_cols=203 Identities=27% Similarity=0.304 Sum_probs=167.1
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+++..++||||+++|+|.+++..... +++..+..++.|+++||+|||++|
T Consensus 56 ~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~ylH~~~--- 123 (271)
T d1nvra_ 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIG--- 123 (271)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHHcC---
Confidence 36789999999999999999999999999999999999976542 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus 124 IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~ 203 (271)
T d1nvra_ 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203 (271)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCC
Confidence 99999999999999999999999999987654443333445679999999999988776 56799999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.||....... ...................+.++.+++.+||+.||++|||++|+++
T Consensus 204 ~pf~~~~~~~--------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 204 LPWDQPSDSC--------------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp CSCSSSSTTS--------------HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCChHH--------------HHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9997542211 1111112222222223345678899999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=312.40 Aligned_cols=210 Identities=28% Similarity=0.439 Sum_probs=165.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+ +.+++||||+++|+|.+++...... +++..+..++.|++.|++|||+++
T Consensus 57 ~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~gl~yLH~~~--- 124 (276)
T d1uwha_ 57 VLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGMDYLHAKS--- 124 (276)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCC--------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCC--------CCHHHHHHHHHHHHHHHHHHhcCC---
Confidence 3688999999999998754 5689999999999999999765432 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc---CCCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 125 ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~t 204 (276)
T d1uwha_ 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204 (276)
T ss_dssp CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHH
Confidence 99999999999999999999999999987654433333345679999999999864 347889999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
|..||.+..+. ......+..... ...+..+++.+.+++.+||+.||++|||++++++.|+.
T Consensus 205 g~~Pf~~~~~~---------------~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 205 GQLPYSNINNR---------------DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp SSCTTTTCCCH---------------HHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCChH---------------HHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99999754221 111111111111 12334556789999999999999999999999999998
Q ss_pred HHhh
Q 026115 234 LLNT 237 (243)
Q Consensus 234 ~~~~ 237 (243)
+..+
T Consensus 270 l~~~ 273 (276)
T d1uwha_ 270 LARS 273 (276)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 8764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=310.85 Aligned_cols=208 Identities=25% Similarity=0.424 Sum_probs=165.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||++++|++.+++..++||||+++|+|.+++..... .+++..++.++.|++.|++|||+++ +
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~~~---i 122 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---V 122 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhhccc---e
Confidence 5789999999999999999999999999999999999876543 2889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC-CC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g-~~ 160 (243)
+||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+++ .+
T Consensus 123 iHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~ 201 (263)
T d1sm2a_ 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201 (263)
T ss_dssp CCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred eecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCC
Confidence 99999999999999999999999999766543222 12234689999999999999999999999999999999995 55
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
||... ....+.+.+....+...+..++.++.+++.+||+.||++|||++++++.|+++.++
T Consensus 202 ~~~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 202 PYENR----------------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTCSC----------------CHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC----------------CHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 55322 22333344444444555666778899999999999999999999999999999765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-50 Score=313.66 Aligned_cols=212 Identities=24% Similarity=0.349 Sum_probs=178.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++|+|.++...++||||+++|+|.+++....... +++..+..++.|++.||+|||+++
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~-------~~~~~~~~i~~qi~~gL~yLH~~~--- 135 (287)
T d1opja_ 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAMEYLEKKN--- 135 (287)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTT-------SCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccc-------hHHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999999999999997654332 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+|||++.++.+||+|||+++......... .....|++.|+|||++.+..++.++|||||||++|||++|..
T Consensus 136 iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~ 214 (287)
T d1opja_ 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214 (287)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCccccCeEEECCCCcEEEccccceeecCCCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence 9999999999999999999999999998765432221 223347889999999999999999999999999999999776
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
||... .....+.+.+....+...+..++..+.+++.+||+.||++|||++++++.|+.+.++.
T Consensus 215 p~~~~---------------~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 215 SPYPG---------------IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CSSTT---------------CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred CCCCc---------------chHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 65422 1223444555555556666777889999999999999999999999999999887654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=307.12 Aligned_cols=196 Identities=27% Similarity=0.398 Sum_probs=166.5
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++||||+++++++.+++..++||||+++|+|.+++..... +++..+..++.|+++||+|||+++
T Consensus 59 il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~~lH~~~--- 126 (263)
T d2j4za1 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR--- 126 (263)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999986542 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 127 ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~ 202 (263)
T d2j4za1 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 202 (263)
T ss_dssp CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred eeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCC
Confidence 9999999999999999999999999997654332 234569999999999999889999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||...... +....+.... ...+...++++.+++.+||+.||++|||++|+++
T Consensus 203 Pf~~~~~~---------------~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 203 PFEANTYQ---------------ETYKRISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTCCSSHH---------------HHHHHHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCHH---------------HHHHHHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 99744211 1111111211 2334456778999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=317.54 Aligned_cols=214 Identities=23% Similarity=0.362 Sum_probs=176.6
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC--------------CCCCCCccCHHHHHHHHHHH
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIAVGA 66 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--------------~~~~~~~~~~~~~~~~~~ql 66 (243)
|+++ +|||||++++++.+.+.+++||||+++|+|.+++....... .......+++..++.++.|+
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 4566 89999999999999999999999999999999997654311 01112248899999999999
Q ss_pred HHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchH
Q 026115 67 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY 146 (243)
Q Consensus 67 ~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw 146 (243)
+.|++|||+++ ++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||
T Consensus 174 ~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Diw 250 (325)
T d1rjba_ 174 AKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250 (325)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceecc
Confidence 99999999998 999999999999999999999999999876554433333445689999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 026115 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 225 (243)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (243)
||||++|||++ |..||.+.. ....+.+++....+.+.+..+++.+.+|+.+||+.||++|||++
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~---------------~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ 315 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIP---------------VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCC---------------CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred chhHHHHHHHhCCCCCCCCCC---------------HHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999997 899997431 12334445555555566677788999999999999999999999
Q ss_pred HHHHHHHH
Q 026115 226 IVLKALQP 233 (243)
Q Consensus 226 ~vl~~l~~ 233 (243)
||++.|..
T Consensus 316 ei~~~L~~ 323 (325)
T d1rjba_ 316 NLTSFLGC 323 (325)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhC
Confidence 99999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=310.85 Aligned_cols=199 Identities=25% Similarity=0.376 Sum_probs=166.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+++.+++||||+++|+|.+++.... +++..+..++.|++.||+|||++|
T Consensus 70 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~~--- 136 (293)
T d1yhwa1 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ--- 136 (293)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999999999999887654 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.+||+|||+++........ .....||+.|+|||++.+..++.++||||+||++|+|++|..
T Consensus 137 iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CcccCCcHHHeEECCCCcEeeccchhheeecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 999999999999999999999999999765432221 234569999999999999889999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhcc-ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||.+.... ......... ......+...+..+.+++.+||+.||++|||++|+++
T Consensus 215 Pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 215 PYLNENPL---------------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp TTTTSCHH---------------HHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCHH---------------HHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99644211 111111111 1122334556778999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=311.14 Aligned_cols=211 Identities=28% Similarity=0.427 Sum_probs=175.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++|++.++ .+++||||+++|+|.+++..... .+++..+..++.|++.|++|||+++
T Consensus 62 il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~--- 129 (285)
T d1u59a_ 62 IMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN--- 129 (285)
T ss_dssp HHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999754 57899999999999999865543 2899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-C
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 158 (243)
++||||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 130 iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G 209 (285)
T d1u59a_ 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 209 (285)
T ss_dssp EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCC
Confidence 9999999999999999999999999998665433221 2233458899999999998899999999999999999998 8
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
..||.... ...+...+..+.+...+..++.++.+++.+||+.||++|||+.+|++.|+....+.
T Consensus 210 ~~Pf~~~~----------------~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 210 QKPYKKMK----------------GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCTTTTCC----------------THHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCC----------------HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99997431 12334444444555666777889999999999999999999999999998776654
Q ss_pred C
Q 026115 239 S 239 (243)
Q Consensus 239 ~ 239 (243)
.
T Consensus 274 ~ 274 (285)
T d1u59a_ 274 A 274 (285)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=309.50 Aligned_cols=208 Identities=27% Similarity=0.399 Sum_probs=173.2
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||++++|++.++ ..++||||+++|+|.+++..... +++..++.++.|++.|++|||+++
T Consensus 61 il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~---------l~~~~~~~i~~qi~~gl~ylH~~~--- 127 (277)
T d1xbba_ 61 VMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN--- 127 (277)
T ss_dssp HHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccC---------CCHHHHHHHHHHHHHHHhhHHhCC---
Confidence 36789999999999999654 56899999999999999987653 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-C
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 158 (243)
++||||||+||+++.++.++++|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 128 iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g 207 (277)
T d1xbba_ 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 207 (277)
T ss_dssp EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCC
Confidence 9999999999999999999999999997654332221 1233468999999999999889999999999999999998 8
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
..||.+. ....+...+..+.+...+..++.++.+++.+||+.||++|||+++|++.|+....+
T Consensus 208 ~~Pf~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 208 QKPYRGM----------------KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCSSTTC----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC----------------CHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999743 22334444444455566667788999999999999999999999999988876554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=305.36 Aligned_cols=212 Identities=25% Similarity=0.368 Sum_probs=171.5
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||+++|++.++...++||||+.++++.+++..... .+++..++.++.|++.|++|||+.+
T Consensus 62 il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~~--- 130 (283)
T d1mqba_ 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN--- 130 (283)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhccccc---
Confidence 36789999999999999999999999999999999998876643 2899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||+++.
T Consensus 131 iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~ 210 (283)
T d1mqba_ 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 210 (283)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCC
Confidence 9999999999999999999999999998765432221 122345889999999999999999999999999999999966
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
.|+... .....+.+.+..+.+...+..++..+.+++.+||+.||++|||+.+|++.|++++...
T Consensus 211 ~~~~~~---------------~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 211 ERPYWE---------------LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp CCTTTT---------------CCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CCcccc---------------CCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 655322 1223444555555566667777889999999999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=306.12 Aligned_cols=209 Identities=24% Similarity=0.378 Sum_probs=172.2
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++|||||+++|++.+ +..++||||+++|+|.+++......+ +++..++.++.|++.|++|||+++ +
T Consensus 62 l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~-------l~~~~~~~i~~qi~~gl~~lH~~~---i 130 (272)
T d1qpca_ 62 MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN---Y 130 (272)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 678999999999998865 46789999999999999887654322 889999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.+||+|||+++........ ......|++.|+|||++.+..++.++|||||||++|||+||..|
T Consensus 131 vHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~ 209 (272)
T d1qpca_ 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209 (272)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccCccchhheeeecccceeeccccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCC
Confidence 99999999999999999999999999866543222 12335688999999999988899999999999999999996555
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
+... .......+.+....+...+..+++.+.+++.+||+.||++|||+++|++.|+++..+
T Consensus 210 ~~~~---------------~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 210 PYPG---------------MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp SSTT---------------CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC---------------CCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 4322 122333344444455556667778899999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=306.45 Aligned_cols=201 Identities=22% Similarity=0.332 Sum_probs=164.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+++.+++||||+++|+|.+++..... ++++..+..++.|++.||.|||+++
T Consensus 62 il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH~~~--- 130 (288)
T d2jfla1 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHDNK--- 130 (288)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999865432 2899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhc-----cCCCCcccchHHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l 155 (243)
++||||||+||+++.++.+||+|||+++........ .....||+.|+|||++. ...++.++|||||||++|+|
T Consensus 131 ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~--~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyem 208 (288)
T d2jfla1 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208 (288)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH--HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHH
T ss_pred EEEeecChhheeECCCCCEEEEechhhhccCCCccc--ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHH
Confidence 999999999999999999999999998765443221 23456999999999984 34578899999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccc-cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++|..||....+. +....+.... .....+...+.++.+++.+||+.||++|||++|+++
T Consensus 209 ltg~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 209 AEIEPPHHELNPM---------------RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHSSCTTTTSCGG---------------GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhCCCCCCCCCHH---------------HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999754221 1112222211 112334556778999999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=308.69 Aligned_cols=200 Identities=22% Similarity=0.300 Sum_probs=163.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+++.+++||||+++|+|.+++..... +++..+..++.|++.||+|||+.+
T Consensus 61 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~--- 128 (288)
T d1uu3a_ 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG--- 128 (288)
T ss_dssp HHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCC---------CCHHHHHHHHHHHHHHHHhhcccc---
Confidence 36789999999999999999999999999999999999886653 899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.++|+|||+++...............||+.|+|||++.+..++.++||||+||++|+|++|..
T Consensus 129 iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (288)
T d1uu3a_ 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208 (288)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCC
Confidence 99999999999999999999999999987654433333345579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
||....+. .....+.... ...+...+..+.+||.+||+.||++|||++|+++
T Consensus 209 Pf~~~~~~---------------~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 209 PFRAGNEY---------------LIFQKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp SSCCSSHH---------------HHHHHHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCcCHH---------------HHHHHHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 99744211 1112222221 2334456678999999999999999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=308.42 Aligned_cols=221 Identities=21% Similarity=0.322 Sum_probs=167.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~ 79 (243)
+|++++|||||+++++|.++..+++||||+++|+|.+++.+... +++..+..++.|++.||.|||+ ++
T Consensus 57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~---------l~~~~~~~~~~qil~aL~yLH~~~~-- 125 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK-- 125 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC--
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 57899999999999999999999999999999999999976542 8899999999999999999997 57
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.+||+|||+++...... .....||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus 126 -IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~ 200 (322)
T d1s9ja_ 126 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200 (322)
T ss_dssp -CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -EEccccCHHHeeECCCCCEEEeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999987543321 23457999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccee-e----------------------c---cCcCch-hhhhhhhccccCCCCCHHHHHHHHHHHHh
Q 026115 160 KPVDHTLPRGQQSLVT-W----------------------A---TPKLSE-DKVKQCVDTKLGGEYPPKAIAKMAAVAAL 212 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~-~----------------------~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 212 (243)
.||............. . . .+.... +..................+.++.+++.+
T Consensus 201 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 280 (322)
T d1s9ja_ 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280 (322)
T ss_dssp CCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHH
Confidence 9997643221100000 0 0 000000 00001111100001111235679999999
Q ss_pred hcCCCCCCCCCHHHHHH--HHHHHHhh
Q 026115 213 CVQYEADFRPNMGIVLK--ALQPLLNT 237 (243)
Q Consensus 213 ~l~~~p~~Rps~~~vl~--~l~~~~~~ 237 (243)
||+.||.+|||++|+++ ++++.-++
T Consensus 281 ~L~~dP~~R~ta~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 281 CLIKNPAERADLKQLMVHAFIKRSDAE 307 (322)
T ss_dssp HTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred HcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence 99999999999999998 56654443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=305.94 Aligned_cols=206 Identities=19% Similarity=0.278 Sum_probs=153.8
Q ss_pred CCCcccCCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC-
Q 026115 1 MVSRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA- 77 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~- 77 (243)
+|++++||||+++++++.+ +..+++||||+++|+|.+++....... ..+++..++.++.|++.||+|||+.+
T Consensus 56 il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~~ 130 (269)
T d2java1 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-----QYLDEEFVLRVMTQLTLALKECHRRSD 130 (269)
T ss_dssp HTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccC-----CCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4789999999999999864 456899999999999999986532100 12899999999999999999999864
Q ss_pred -CCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 78 -EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 78 -~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
..+++||||||+||+++.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 131 ~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~ 208 (269)
T d2java1 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208 (269)
T ss_dssp ---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHh
Confidence 234999999999999999999999999998765433221 23456899999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||..... ......+........+...++++.+++.+||+.||++|||++|+++
T Consensus 209 tg~~Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 209 ALMPPFTAFSQ----------------KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HSSCSCCCSSH----------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCCH----------------HHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 99999964421 1222222222222344456778999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=298.86 Aligned_cols=205 Identities=25% Similarity=0.395 Sum_probs=174.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+++++||||++++|++.+++.+++||||+++|+|..++...... +++..++.++.|+++|++|||+.+ +
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~--------~~~~~~~~i~~qi~~gl~~LH~~~---i 121 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESKQ---F 121 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGC--------CCHHHHHHHHHHHHHHHHHHHHTT---B
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccC--------CcHHHHHHHHHHHHHHHHHHhhcC---c
Confidence 57899999999999999999999999999999999997765532 888999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |..
T Consensus 122 iH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~ 200 (258)
T d1k2pa_ 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200 (258)
T ss_dssp CCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCC
Confidence 99999999999999999999999999765543222 2233568899999999999999999999999999999998 899
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
||... ....+...+....+...+...++.+.+++.+||+.||++|||++++++.|.++
T Consensus 201 Pf~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 201 PYERF----------------TNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTTTS----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCC----------------CHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 99644 22334444444555566667778999999999999999999999999998753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-48 Score=305.02 Aligned_cols=199 Identities=24% Similarity=0.335 Sum_probs=154.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+++.+++||||++||+|.+++..... +++..+..++.|++.||+|||+++
T Consensus 60 il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~--- 127 (307)
T d1a06a_ 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---------YTERDASRLIFQVLDAVKYLHDLG--- 127 (307)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccC---------CCHHHHHHHHHHHHHHHHhhhhce---
Confidence 36789999999999999999999999999999999999976542 899999999999999999999998
Q ss_pred eEeccCCCCceEec---CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+||++. .++.++|+|||+++....... .....||+.|+|||++.+..++.++||||+||++|+|++
T Consensus 128 iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~ 204 (307)
T d1a06a_ 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204 (307)
T ss_dssp CCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred eeeEEecccceeecccCCCceEEEeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHh
Confidence 99999999999995 478899999999976543322 234569999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||.+... .+....+..... ........+..+.+++.+||+.||++|||++|+++
T Consensus 205 g~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 205 GYPPFYDEND---------------AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp SSCSCCCSSH---------------HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCH---------------HHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 9999974321 111122222211 12233455678999999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-48 Score=304.85 Aligned_cols=196 Identities=24% Similarity=0.367 Sum_probs=163.0
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++|||||++++++.+++.+++||||+.+|+|..++..... +++..++.++.|++.||.|||++|
T Consensus 68 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~--- 135 (309)
T d1u5ra_ 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVEIAAVTHGALQGLAYLHSHN--- 135 (309)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 46899999999999999999999999999999999877665442 899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc---CCCCcccchHHHHHHHHHHHh
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+||+++.++.+||+|||+++..... ....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 136 iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~ 209 (309)
T d1u5ra_ 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (309)
T ss_dssp CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred EeccCCCcceEEECCCCCEEEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH
Confidence 999999999999999999999999999765432 33569999999999864 457899999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||.+... .+....+.........+...++.+.+++.+||+.||++|||++++++
T Consensus 210 g~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 210 RKPPLFNMNA---------------MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SSCTTTTSCH---------------HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCH---------------HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 9999964311 12222222222222233345678999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=301.00 Aligned_cols=208 Identities=25% Similarity=0.385 Sum_probs=163.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||++++|++. ++.+++||||+++|+|.+++...... +++..++.++.|+++|+.|||+++ +
T Consensus 62 l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~--------l~~~~~~~~~~qi~~gl~ylH~~~---i 129 (273)
T d1mp8a_ 62 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLESKR---F 129 (273)
T ss_dssp HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTT--------SCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCC--------CCHHHHHHHHHHHHHHhhhhcccC---e
Confidence 67899999999999996 45789999999999999988765432 899999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 160 (243)
+||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 130 iHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~ 208 (273)
T d1mp8a_ 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 208 (273)
T ss_dssp CCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred eccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCC
Confidence 99999999999999999999999999865543222 2234558899999999999999999999999999999998 899
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhc
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 238 (243)
||..... ..+...+....+...+..+++.+.+++.+||+.||++|||+.+|++.|++++++.
T Consensus 209 P~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 209 PFQGVKN----------------NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp TTTTCCG----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 9875422 2222222333334556667788999999999999999999999999999988753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=298.61 Aligned_cols=199 Identities=24% Similarity=0.392 Sum_probs=158.7
Q ss_pred CCCcccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 1 MVSRLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
+|++++||||+++++++.+ +..+++||||+++|+|.+++..... +++..+..++.|+++||+|||++
T Consensus 61 il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~gl~yLH~~ 131 (270)
T d1t4ha_ 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTR 131 (270)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcccc---------ccHHHHHHHHHHHHHHHHHHHHC
Confidence 4789999999999999875 4568999999999999999977542 88999999999999999999987
Q ss_pred CCCCeEeccCCCCceEec-CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 155 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 155 (243)
+ .+++||||||+||+++ .++.+||+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 132 ~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel 205 (270)
T d1t4ha_ 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 205 (270)
T ss_dssp S-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred C-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHH
Confidence 4 2499999999999996 5789999999999754322 1234579999999998875 589999999999999999
Q ss_pred HhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG-GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
++|..||..... .....+.+..... ...+...++++.+++.+||+.||++|||++|+++
T Consensus 206 ~~g~~Pf~~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 206 ATSEYPYSECQN---------------AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHSSCTTTTCSS---------------HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCccc---------------HHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 999999964321 1111122111111 1122234557999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=298.53 Aligned_cols=217 Identities=26% Similarity=0.387 Sum_probs=180.7
Q ss_pred Ccc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 3 SRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 3 ~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+++ +||||++++++|.++...++||||+++|+|.+++....... .......+++.+++.++.|++.|++|||
T Consensus 73 ~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH 152 (299)
T d1fgka_ 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152 (299)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh
Confidence 345 79999999999999999999999999999999997654211 1112223899999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 154 (243)
+.+ ++||||||+||+++.++.+||+|||+++...............|++.|+|||.+.+..++.++||||||+++||
T Consensus 153 ~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~e 229 (299)
T d1fgka_ 153 SKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 229 (299)
T ss_dssp HTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHH
Confidence 999 99999999999999999999999999987766544443445668999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 026115 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 233 (243)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~ 233 (243)
|++ |.+||... ....+.+.+..+.+...+..++..+.+++.+||+.||++|||+.||++.|++
T Consensus 230 ll~~g~~p~~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 230 IFTLGGSPYPGV----------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp HHTTSCCSSTTC----------------CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCCCCCCCCC----------------CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 998 78888643 2233444455555556666777889999999999999999999999999999
Q ss_pred HHhhc
Q 026115 234 LLNTR 238 (243)
Q Consensus 234 ~~~~~ 238 (243)
+++-.
T Consensus 294 i~a~~ 298 (299)
T d1fgka_ 294 IVALT 298 (299)
T ss_dssp HHHHC
T ss_pred HhhcC
Confidence 97654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=295.58 Aligned_cols=206 Identities=28% Similarity=0.432 Sum_probs=166.2
Q ss_pred CCCcccCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLKNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
++++++||||++++|++.+ +..+++||||+++|+|.+++...... .+++..+++++.|++.|+.|||+.+
T Consensus 53 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~~~-- 123 (262)
T d1byga_ 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN-- 123 (262)
T ss_dssp HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHhhccccccCc--
Confidence 3688999999999999865 45689999999999999999764322 2789999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-C
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 158 (243)
++||||||+||+++.++.++++|||+++..... .....++..|+|||.+.+..++.++||||||+++|||++ |
T Consensus 124 -ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~ 197 (262)
T d1byga_ 124 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197 (262)
T ss_dssp -CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -eeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCC
Confidence 999999999999999999999999998765432 223457889999999999999999999999999999998 6
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
.+||... ....+...+....+...+...+.++.+++.+||+.||++|||+.++++.|+++...
T Consensus 198 ~~p~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 198 RVPYPRI----------------PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCSCTTS----------------CGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC----------------CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 8777533 22233333444455566666778899999999999999999999999999998653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=302.45 Aligned_cols=208 Identities=23% Similarity=0.369 Sum_probs=171.2
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
++++++|||||+++|++.++. .+++++++.+|+|.+++...... +++..++.++.|++.|++|||+++
T Consensus 64 ~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~--------~~~~~~~~i~~qi~~gl~yLH~~~--- 131 (317)
T d1xkka_ 64 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYLEDRR--- 131 (317)
T ss_dssp HHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSS--------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccC--------CCHHHHHHHHHHHHHHHHHHHHcC---
Confidence 357899999999999998764 56778999999999988766432 889999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-CC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 159 (243)
++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 132 iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~ 211 (317)
T d1xkka_ 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211 (317)
T ss_dssp CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCC
Confidence 99999999999999999999999999876654333322334568999999999999999999999999999999998 78
Q ss_pred CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
.||... ....+...+..+.+...+..++..+.+++.+||+.||.+|||+.++++.|.++..
T Consensus 212 ~p~~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 212 KPYDGI----------------PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CTTTTS----------------CGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC----------------CHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 888643 1233444555555556667778899999999999999999999999999988754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=297.86 Aligned_cols=212 Identities=26% Similarity=0.406 Sum_probs=168.8
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++|||||+++|++.+ +..++||||+++|+|..++....... +++..++.++.|++.|++|||+++ +
T Consensus 66 l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~-------l~~~~~~~i~~~i~~gl~~LH~~~---i 134 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY-------LRLPQLVDMAAQIASGMAYVERMN---Y 134 (285)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhccccc-------chHHHHHHHHHHHHHHHHHHhhhh---e
Confidence 678999999999999965 45789999999999999887654322 899999999999999999999998 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 161 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 161 (243)
+||||||+||+++.++.+||+|||+++........ ......||+.|+|||.+....++.++|||||||++|||++|..|
T Consensus 135 vH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p 213 (285)
T d1fmka3 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213 (285)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecccccceEEEECCCCcEEEcccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCC
Confidence 99999999999999999999999999866433222 12335689999999999999999999999999999999997666
Q ss_pred CCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 026115 162 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 240 (243)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~~ 240 (243)
+... .........+....+...+..+++++.+++.+||+.||++|||+++|++.|++.+.+..+
T Consensus 214 ~~~~---------------~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 214 PYPG---------------MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp SSTT---------------CCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCC---------------CCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 5422 112333343444445556677788999999999999999999999999999988766543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=298.89 Aligned_cols=217 Identities=23% Similarity=0.323 Sum_probs=168.9
Q ss_pred ccCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHhhhc
Q 026115 5 LKNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEK 76 (243)
Q Consensus 5 l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~ 76 (243)
.+|+||+.+++++.. +..+++||||+++|+|.+++....... .......+++..+..++.|++.|++|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 478999999999865 456899999999999999997653210 001112388999999999999999999999
Q ss_pred CCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 77 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 77 ~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
+ ++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ell 230 (299)
T d1ywna1 154 K---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230 (299)
T ss_dssp T---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHH
Confidence 8 9999999999999999999999999998765544443344567999999999999999999999999999999999
Q ss_pred hC-CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 026115 157 TG-RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 235 (243)
Q Consensus 157 ~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 235 (243)
+| ..||.... ....+...+..+.+...+...+.++.+++.+||+.||++|||++++++.|++++
T Consensus 231 t~~~~p~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 231 SLGASPYPGVK---------------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp TTSCCSSTTCC---------------CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hCCCCCCCCCC---------------HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 86 45775331 112333444444445556667778999999999999999999999999999998
Q ss_pred hhcC
Q 026115 236 NTRS 239 (243)
Q Consensus 236 ~~~~ 239 (243)
++.|
T Consensus 296 q~n~ 299 (299)
T d1ywna1 296 QANA 299 (299)
T ss_dssp HHHT
T ss_pred hCCC
Confidence 7654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-47 Score=303.34 Aligned_cols=201 Identities=20% Similarity=0.272 Sum_probs=164.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+++.+++||||+++|+|.+++....+ .+++..+..++.||+.||+|||++|
T Consensus 76 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~--- 144 (350)
T d1koaa2 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN--- 144 (350)
T ss_dssp HHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhcC---
Confidence 36789999999999999999999999999999999999965443 2899999999999999999999999
Q ss_pred eEeccCCCCceEecC--CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++||||||+||+++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 145 iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred CeeeeechhHeeeccCCCCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhC
Confidence 999999999999964 57899999999876543322 2345689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
..||.+.... +....+..... ........++.+.+||.+||+.||++|||++|+++.
T Consensus 222 ~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 222 LSPFGGENDD---------------ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCSSCCSSHH---------------HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCHH---------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999744211 11122221111 112223456689999999999999999999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.3e-47 Score=302.37 Aligned_cols=200 Identities=21% Similarity=0.260 Sum_probs=165.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||++++++|.++..+++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.|
T Consensus 79 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~--- 147 (352)
T d1koba_ 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS--- 147 (352)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 46899999999999999999999999999999999998765542 2899999999999999999999998
Q ss_pred eEeccCCCCceEec--CCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLF--DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++||||||+|||++ .++.++|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 148 iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG 224 (352)
T d1koba_ 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224 (352)
T ss_dssp EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred eeecccccccccccccCCCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhC
Confidence 99999999999997 568999999999976644321 2345689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccc--cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
..||.+.... .....+.... .........+.++.+|+.+||+.||.+|||++|+++
T Consensus 225 ~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 225 LSPFAGEDDL---------------ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSCCSSHH---------------HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCHH---------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999754221 1111221111 112233455678999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=297.93 Aligned_cols=221 Identities=23% Similarity=0.344 Sum_probs=181.9
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC---------CCCCCCccCHHHHHHHHHHHHHHHH
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---------GAKPGPVLSWAQRVKIAVGAARGLE 71 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~~~~~~ql~~~l~ 71 (243)
++++ +|||||+++|++.++...+++|||+++|+|.+++....... .......+++..+..++.|++.|++
T Consensus 80 ~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 3456 69999999999999999999999999999999997654311 0111223889999999999999999
Q ss_pred HhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHH
Q 026115 72 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 151 (243)
Q Consensus 72 ~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~ 151 (243)
|||+++ ++||||||+||+++.++.++++|||.++...............||+.|+|||.+.+..++.++|||||||+
T Consensus 160 ~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~ 236 (311)
T d1t46a_ 160 FLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (311)
T ss_dssp HHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHH
Confidence 999999 99999999999999999999999999987765544443445678999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 026115 152 LLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 230 (243)
Q Consensus 152 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~ 230 (243)
+|||++ |.+||... ...+.+.+++..+.+...+...+..+.+||.+||+.||.+|||++++++.
T Consensus 237 l~ellt~g~p~~~~~---------------~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 237 LWELFSLGSSPYPGM---------------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp HHHHHTTTCCSSTTC---------------CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCCC---------------CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999 55555432 12234455555666666666677889999999999999999999999999
Q ss_pred HHHHHhhcCC
Q 026115 231 LQPLLNTRSG 240 (243)
Q Consensus 231 l~~~~~~~~~ 240 (243)
|++++.+.++
T Consensus 302 L~~~i~~~~~ 311 (311)
T d1t46a_ 302 IEKQISESTN 311 (311)
T ss_dssp HHHHHHHTCC
T ss_pred HHHhhccCCC
Confidence 9999888653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=294.74 Aligned_cols=217 Identities=25% Similarity=0.350 Sum_probs=175.3
Q ss_pred CCcc-cCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-------CCCCCCccCHHHHHHHHHHHHHHHHHh
Q 026115 2 VSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYL 73 (243)
Q Consensus 2 l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~ql~~~l~~L 73 (243)
|+++ +||||++++|++.+++.+++||||+++|+|.+++....... .......+++..++.++.|++.|+.||
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 5677 79999999999999999999999999999999997652100 000011289999999999999999999
Q ss_pred hhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHH
Q 026115 74 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 74 h~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~ 153 (243)
|+.+ ++||||||+|||++.++.+||+|||+++........ ....||..|+|||.+.+..++.++|||||||++|
T Consensus 144 H~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 144 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp HHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred hcCC---ccccccccceEEEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 9998 999999999999999999999999998765443222 2345889999999999999999999999999999
Q ss_pred HHHhCC-CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 026115 154 ELLTGR-KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 232 (243)
Q Consensus 154 ~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~ 232 (243)
||++|. +||... ....+...+..+.+...+..+++++.++|.+||+.||++|||+++|++.|+
T Consensus 218 ell~~~~~p~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 281 (309)
T d1fvra_ 218 EIVSLGGTPYCGM----------------TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281 (309)
T ss_dssp HHHTTSCCTTTTC----------------CHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcCCCCCCCC----------------CHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999965 566533 223333444444445566667789999999999999999999999999999
Q ss_pred HHHhhcCC
Q 026115 233 PLLNTRSG 240 (243)
Q Consensus 233 ~~~~~~~~ 240 (243)
+++++..+
T Consensus 282 ~i~~~~~~ 289 (309)
T d1fvra_ 282 RMLEERKT 289 (309)
T ss_dssp HHHHSSSC
T ss_pred HHHhcCcC
Confidence 99876543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=293.59 Aligned_cols=213 Identities=20% Similarity=0.305 Sum_probs=172.6
Q ss_pred CCCcccCCccceeeEEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLKNENVVELVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
+|++++||||++++|++.+ +...++||||+++|+|.+++...... .++..++.++.|++.|+.|||+.+
T Consensus 81 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~--------~~~~~~~~i~~qia~gL~~lH~~~-- 150 (311)
T d1r0pa_ 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------PTVKDLIGFGLQVAKGMKFLASKK-- 150 (311)
T ss_dssp HHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCC--------CBHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcccccc--------chHHHHHHHHHHHHHhhhhhcccC--
Confidence 3678999999999999876 56899999999999999998866532 778889999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCccccccc--ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
++||||||+||+++.++.+||+|||+++......... ......||..|+|||.+....++.++||||||+++|||++
T Consensus 151 -iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t 229 (311)
T d1r0pa_ 151 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229 (311)
T ss_dssp -CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHH
Confidence 9999999999999999999999999998765443221 1223468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHhh
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 237 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 237 (243)
|..||...... ..+...+..+.+...+..+++.+.+++.+||+.||++|||+.||++.|++++++
T Consensus 230 ~~~p~~~~~~~---------------~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 230 RGAPPYPDVNT---------------FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TSCCSCC---------------------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCCCH---------------HHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 88887533111 111122222223344455677899999999999999999999999999999876
Q ss_pred cC
Q 026115 238 RS 239 (243)
Q Consensus 238 ~~ 239 (243)
..
T Consensus 295 ~~ 296 (311)
T d1r0pa_ 295 FI 296 (311)
T ss_dssp CC
T ss_pred hh
Confidence 43
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=296.43 Aligned_cols=198 Identities=21% Similarity=0.262 Sum_probs=167.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||++++++|.++..+++||||+++|+|.+++..... +++..+..++.|++.||.|||++|
T Consensus 58 il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~---------~~e~~~~~~~~qil~al~ylH~~~--- 125 (337)
T d1o6la_ 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD--- 125 (337)
T ss_dssp HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccC---------CcHHHHHHHHHHHhhhhhhhhhcC---
Confidence 36789999999999999999999999999999999999987653 889999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.+|.+||+|||+++........ .....||+.|+|||++.+..++.++|+|||||++|||++|..
T Consensus 126 iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~ 203 (337)
T d1o6la_ 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCHHHeEecCCCCEEEeecccccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCC
Confidence 999999999999999999999999999865443222 334569999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~ 229 (243)
||.+.... +....+.... ...+...+.++.+||.+||++||.+||+ +.++++
T Consensus 204 pf~~~~~~---------------~~~~~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 204 PFYNQDHE---------------RLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SSCCSSHH---------------HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCcCHH---------------HHHHHHhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 99754221 1111222222 2345556778999999999999999995 888887
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=296.75 Aligned_cols=217 Identities=24% Similarity=0.352 Sum_probs=173.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCC---------------CCCCCCccCHHHHHHHHHH
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---------------GAKPGPVLSWAQRVKIAVG 65 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------~~~~~~~~~~~~~~~~~~q 65 (243)
+|++++||||+++++++.++...+++|||+.+|+|.+++....... .......+++..++.++.|
T Consensus 69 il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred HHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence 3678999999999999999999999999999999999997543210 1111223788999999999
Q ss_pred HHHHHHHhhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccch
Q 026115 66 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDV 145 (243)
Q Consensus 66 l~~~l~~Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 145 (243)
++.|++|||+.+ ++||||||+||+++.++.+||+|||+++...............|++.|+|||.+.+..++.++||
T Consensus 149 i~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDV 225 (301)
T d1lufa_ 149 VAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225 (301)
T ss_dssp HHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhh
Confidence 999999999998 99999999999999999999999999875544333333334568889999999999999999999
Q ss_pred HHHHHHHHHHHhCC-CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 026115 146 YSFGVVLLELLTGR-KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 224 (243)
Q Consensus 146 wslG~~l~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (243)
|||||++|||++|. +||....+ ......+..+.....+..++.++.+++.+||+.||++|||+
T Consensus 226 wS~Gvvl~ell~~~~~p~~~~~~----------------~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~ 289 (301)
T d1lufa_ 226 WAYGVVLWEIFSYGLQPYYGMAH----------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF 289 (301)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccchhhHHHHHccCCCCCCCCCH----------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence 99999999999985 56754311 22233333333445566677889999999999999999999
Q ss_pred HHHHHHHHHHHh
Q 026115 225 GIVLKALQPLLN 236 (243)
Q Consensus 225 ~~vl~~l~~~~~ 236 (243)
.+|++.|+++.+
T Consensus 290 ~ev~~~L~~i~~ 301 (301)
T d1lufa_ 290 CSIHRILQRMCE 301 (301)
T ss_dssp HHHHHHHHHTTC
T ss_pred HHHHHHHHHhcC
Confidence 999999998863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=296.30 Aligned_cols=198 Identities=23% Similarity=0.328 Sum_probs=162.5
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
|++++||||++++++|.++..+++||||+++|+|.+++..... +++..+..++.|++.||+|||+.+ +
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~---------l~~~~~~~~~~qi~~al~yLH~~~---i 134 (293)
T d1jksa_ 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSLQ---I 134 (293)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccc---------cchhHHHHHHHHHHHHHHhhhhcc---e
Confidence 5789999999999999999999999999999999999977542 899999999999999999999999 9
Q ss_pred EeccCCCCceEecCCC----ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh
Q 026115 82 IHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 157 (243)
Q Consensus 82 ~h~di~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 157 (243)
+||||||+||+++.++ .++++|||++........ .....||+.|+|||++.+..++.++||||+||++|+|++
T Consensus 135 vHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~ 211 (293)
T d1jksa_ 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211 (293)
T ss_dssp ECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred eecccccceEEEecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc
Confidence 9999999999998776 489999999876543322 233468999999999999889999999999999999999
Q ss_pred CCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|..||.+.... +....+...... ...+...+..+.++|.+||+.||++|||++|+++
T Consensus 212 g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 212 GASPFLGDTKQ---------------ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp SSCSSCCSSHH---------------HHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHH---------------HHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999754221 111111111111 0111234567999999999999999999999987
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-46 Score=293.28 Aligned_cols=195 Identities=24% Similarity=0.374 Sum_probs=165.8
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.++..+++||||+.||+|..++..... ++...+..++.|++.|++|||+++
T Consensus 57 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~--- 124 (316)
T d1fota_ 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD--- 124 (316)
T ss_dssp HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhccCc---
Confidence 36789999999999999999999999999999999999987764 788888999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 125 iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~ 199 (316)
T d1fota_ 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199 (316)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred EEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCC
Confidence 999999999999999999999999999765433 234569999999999999899999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
||.+... .+....+..... ..+...+.++.+++.+||+.||.+|+ |++++++
T Consensus 200 Pf~~~~~---------------~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 200 PFYDSNT---------------MKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTCCSSH---------------HHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCcCH---------------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 9974321 122222222222 33445667899999999999999996 8999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=291.53 Aligned_cols=207 Identities=26% Similarity=0.344 Sum_probs=169.0
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||++++|++.++ ..++||||+++|++.+++..... .+++..++.++.|++.|+.|||+++
T Consensus 64 ~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~--- 131 (273)
T d1u46a_ 64 AMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR--- 131 (273)
T ss_dssp HHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhhCC---
Confidence 36789999999999999764 67899999999999998776543 2899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhccCCCCcccchHHHHHHHHHHHh-C
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-G 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 158 (243)
++||||||+||+++.++.+|++|||+++......... ......|+..|+|||.+.+..++.++||||||+++|||++ |
T Consensus 132 iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G 211 (273)
T d1u46a_ 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211 (273)
T ss_dssp EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTS
T ss_pred EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCC
Confidence 9999999999999999999999999998765443322 1233457889999999999889999999999999999998 8
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 234 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~ 234 (243)
..||..... .+....+.....+.+.+...+..+.+++.+||+.||++|||+++|++.|+++
T Consensus 212 ~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 212 QEPWIGLNG---------------SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCTTTTCCH---------------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCH---------------HHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999964411 1223333344444555666778899999999999999999999999988864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=288.84 Aligned_cols=226 Identities=23% Similarity=0.274 Sum_probs=169.0
Q ss_pred CCcccCCccceeeEEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKNENVVELVGYYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
+++++||||+++++++.+.. .+++||||+++|+|.+++.... +++..++.++.|++.|+.|||...
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~ 120 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhh
Confidence 56789999999999997543 6899999999999999998764 889999999999999999999730
Q ss_pred -----CCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc--ccccccccccccCchhhccCC------CCcccc
Q 026115 78 -----EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQ------MSSKSD 144 (243)
Q Consensus 78 -----~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~------~~~~~D 144 (243)
..+++||||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+.. ++.++|
T Consensus 121 ~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~D 200 (303)
T d1vjya_ 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200 (303)
T ss_dssp CSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHH
T ss_pred hhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchh
Confidence 1139999999999999999999999999987664433221 223456999999999987543 466899
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCCccceeeccCcCchhhh-hhhhccccCCCC-----CHHHHHHHHHHHHhhcCCCC
Q 026115 145 VYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV-KQCVDTKLGGEY-----PPKAIAKMAAVAALCVQYEA 218 (243)
Q Consensus 145 iwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p 218 (243)
||||||++|||++|..||............ ........... ........+... .......+.+++.+||+.||
T Consensus 201 i~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp 279 (303)
T d1vjya_ 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSG
T ss_pred hhhhHHHHHHHhhCCCCCCcccccccchhh-cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCH
Confidence 999999999999999887644322211111 00111111111 122223332222 23456779999999999999
Q ss_pred CCCCCHHHHHHHHHHHHhhc
Q 026115 219 DFRPNMGIVLKALQPLLNTR 238 (243)
Q Consensus 219 ~~Rps~~~vl~~l~~~~~~~ 238 (243)
++|||+.||++.|+++....
T Consensus 280 ~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 280 AARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp GGSCCHHHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHHHhc
Confidence 99999999999999988654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-45 Score=296.52 Aligned_cols=198 Identities=22% Similarity=0.284 Sum_probs=162.7
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++.++||||++++++|.+++.+++||||+++|+|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~ylH~~~---i 128 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---V 128 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678899999999999999999999999999999999976543 788999999999999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHHHHHHhCCC
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
+||||||+||+++.++.+||+|||+++...... .....||+.|+|||++.. ..++.++|||||||++|+|++|..
T Consensus 129 iHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~ 204 (364)
T d1omwa3 129 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 204 (364)
T ss_dssp ECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCC
Confidence 999999999999999999999999997654332 234569999999999974 568999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~vl~ 229 (243)
||........ ..+.... .......+...+.++.++|.+||+.||++||| |+++++
T Consensus 205 Pf~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 205 PFRQHKTKDK-------------HEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSCSSCSSCH-------------HHHHHHS-SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCHHHH-------------HHHHHhc-ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 9975422111 1111111 11112333445678999999999999999999 788876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=293.80 Aligned_cols=202 Identities=18% Similarity=0.242 Sum_probs=159.4
Q ss_pred cccCCccceeeEEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 4 RLKNENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
..+||||++++++|.+ +..+++||||++||+|.+++...... .+++..+..++.|++.||+|||+.|
T Consensus 61 ~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~-------~l~e~~~~~i~~qi~~al~ylH~~~-- 131 (335)
T d2ozaa1 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN-- 131 (335)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCC-------CEEHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCC-------CcCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 4589999999999976 46799999999999999999865332 2999999999999999999999999
Q ss_pred CeEeccCCCCceEecC---CCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 80 RIIHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 80 ~~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
++||||||+||+++. .+.++|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 132 -iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll 207 (335)
T d2ozaa1 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 207 (335)
T ss_dssp -EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT
T ss_pred -CccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHh
Confidence 999999999999986 45799999999976544322 23456999999999999888999999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||.+........... ..+...... .......++++.+|+.+||+.||++|||+.++++
T Consensus 208 tg~~Pf~~~~~~~~~~~~~-----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 208 CGYPPFYSNHGLAISPGMK-----------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp TSSCSCEETTCC-------------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHH-----------HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 9999997543321111000 000001111 1112345678999999999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-45 Score=285.37 Aligned_cols=198 Identities=25% Similarity=0.308 Sum_probs=163.1
Q ss_pred CCccc-CCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
|++++ ||||+++++++.++...++||||+++|+|.+++..... +++..+..++.|++.||+|||+++
T Consensus 63 l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~--- 130 (277)
T d1phka_ 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLN--- 130 (277)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHcC---
Confidence 45676 99999999999999999999999999999999976542 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhcc------CCCCcccchHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT------GQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~~l~~ 154 (243)
++||||||+||+++.++.+||+|||+++....... .....||+.|+|||.+.+ ..++.++||||+||++|+
T Consensus 131 ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilye 207 (277)
T d1phka_ 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 207 (277)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred CcccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhh
Confidence 99999999999999999999999999976654322 234568999999999863 345789999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|++|..||....+. .....+..... ........++++.+++.+||+.||++|||++|+++
T Consensus 208 ml~g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 208 LLAGSPPFWHRKQM---------------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHSSCSSCCSSHH---------------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hccCCCCCCCCCHH---------------HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 99999999754221 11122222221 22233456778999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=290.39 Aligned_cols=217 Identities=22% Similarity=0.354 Sum_probs=177.0
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCC-CCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 79 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~ 79 (243)
++++++||||++++|++..+...++||||+.+|+|.+++...... ........+++..+.+++.|++.|+.|||+.+
T Consensus 76 il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-- 153 (308)
T d1p4oa_ 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 153 (308)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 468899999999999999999999999999999999998654210 00011112788999999999999999999998
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+|||++.++++||+|||+++...............|++.|+|||.+.+..++.++|+||||+++|||++|.
T Consensus 154 -ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 154 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 9999999999999999999999999998776554443344456899999999999999999999999999999999984
Q ss_pred -CCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHh
Q 026115 160 -KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 236 (243)
Q Consensus 160 -~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 236 (243)
.||... ........+..+.....+..++..+.+++.+||+.||++|||+++|++.|++.+.
T Consensus 233 ~~p~~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 233 EQPYQGL----------------SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCTTTTS----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCC----------------CHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 666533 2233333333344445566677889999999999999999999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=289.31 Aligned_cols=202 Identities=17% Similarity=0.230 Sum_probs=164.9
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||++++++|.+++.+++||||++||+|.+++...... +++..+..++.|++.|++|||+.|
T Consensus 54 il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~--------l~e~~~~~i~~qi~~al~yLH~~~--- 122 (321)
T d1tkia_ 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--------LNEREIVSYVHQVCEALQFLHSHN--- 122 (321)
T ss_dssp HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCC--------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHcC---
Confidence 367899999999999999999999999999999999999765422 899999999999999999999999
Q ss_pred eEeccCCCCceEecCC--CceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLFDD--DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++||||||+||+++.+ ..++++|||+++....... .....+++.|+|||...+..++.++||||+||++|+|++|
T Consensus 123 iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred CCcccccccceeecCCCceEEEEcccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhC
Confidence 9999999999999854 4789999999876543322 2334588999999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCH----HHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQ 232 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~vl~--~l~ 232 (243)
..||..... .+....+..... ..+. ..+.++.+|+.+||+.||++|||++|+++ .++
T Consensus 200 ~~Pf~~~~~---------------~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 200 INPFLAETN---------------QQIIENIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp SCTTCCSSH---------------HHHHHHHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCCCCCCCH---------------HHHHHHHHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 999975422 111222222221 1121 24567999999999999999999999998 354
Q ss_pred H
Q 026115 233 P 233 (243)
Q Consensus 233 ~ 233 (243)
+
T Consensus 263 ~ 263 (321)
T d1tkia_ 263 Q 263 (321)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-45 Score=291.62 Aligned_cols=195 Identities=18% Similarity=0.255 Sum_probs=165.3
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+....++||||+.+|+|..++..... +++..+..++.||+.||.|||+++
T Consensus 94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~--- 161 (350)
T d1rdqe_ 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD--- 161 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 46889999999999999999999999999999999999977653 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 160 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 160 (243)
++||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 162 iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~ 236 (350)
T d1rdqe_ 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236 (350)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCC
Confidence 999999999999999999999999999766432 234569999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 161 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
||.+... ......+..... ..+...+.++.+++.+||+.||.+|+ |++++++
T Consensus 237 Pf~~~~~---------------~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 237 PFFADQP---------------IQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SSCCSSH---------------HHHHHHHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCcCH---------------HHHHHHHhcCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 9974421 111122222221 33445667899999999999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=291.74 Aligned_cols=196 Identities=21% Similarity=0.285 Sum_probs=164.3
Q ss_pred CcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 026115 3 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 82 (243)
Q Consensus 3 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~~ 82 (243)
+.++||||+++++++.++..+++||||+++|+|.+++..... +++..+..++.|++.||+|||+++ ++
T Consensus 58 ~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~---------~~e~~~~~~~~qi~~al~ylH~~~---ii 125 (320)
T d1xjda_ 58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IV 125 (320)
T ss_dssp HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred HhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 368999999999999999999999999999999999987653 889999999999999999999998 99
Q ss_pred eccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhCCCCC
Q 026115 83 HRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 162 (243)
Q Consensus 83 h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 162 (243)
||||||+||+++.++.++++|||+++........ .....||+.|+|||++.+..++.++||||+||++|+|++|..||
T Consensus 126 HrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF 203 (320)
T d1xjda_ 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 203 (320)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eccCcccceeecCCCceeccccchhhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCC
Confidence 9999999999999999999999999765433222 23456999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 026115 163 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG-IVLK 229 (243)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~vl~ 229 (243)
.+..+ ..+...+... ....+...+..+.+|+.+||+.||.+|||+. ++++
T Consensus 204 ~~~~~----------------~~~~~~i~~~-~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 204 HGQDE----------------EELFHSIRMD-NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCSSH----------------HHHHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCH----------------HHHHHHHHcC-CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 75422 1111111111 1234445677899999999999999999995 6764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-45 Score=286.32 Aligned_cols=208 Identities=24% Similarity=0.355 Sum_probs=160.6
Q ss_pred CCcccCCccceeeEEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcC
Q 026115 2 VSRLKNENVVELVGYYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 77 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~ 77 (243)
|++++||||+++++++.... .+++||||++|++|..++..... +++..+..++.|++.|++|||++|
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~ 131 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNG 131 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCC---------CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 57899999999999987643 48999999999999998876653 899999999999999999999998
Q ss_pred CCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc-cccccccccccccCchhhccCCCCcccchHHHHHHHHHHH
Q 026115 78 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 78 ~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 156 (243)
++||||||+||+++.++..+++|||.+......... .......||+.|+|||++.+..++.++||||+||++|+|+
T Consensus 132 ---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyell 208 (277)
T d1o6ya_ 132 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 208 (277)
T ss_dssp ---EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHH
Confidence 999999999999999999999999987654332221 1223456999999999999888999999999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRP-NMGIVLKALQP 233 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~vl~~l~~ 233 (243)
+|..||....+. +.....+..... .......++.+.+++.+||+.||++|| |+++++..|.+
T Consensus 209 tG~~Pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 209 TGEPPFTGDSPV---------------SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HSSCSCCCSSHH---------------HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hCCCCCCCcCHH---------------HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999754221 111111111110 112233456899999999999999999 89999999988
Q ss_pred HHh
Q 026115 234 LLN 236 (243)
Q Consensus 234 ~~~ 236 (243)
+.+
T Consensus 274 ~~n 276 (277)
T d1o6ya_ 274 VHN 276 (277)
T ss_dssp HHC
T ss_pred HhC
Confidence 764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=291.19 Aligned_cols=215 Identities=20% Similarity=0.223 Sum_probs=159.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+++..++||||+.++++..+...... +++..+..++.|++.||+|||++|
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~---------l~~~~~~~~~~qil~aL~~lH~~~--- 120 (299)
T d1ua2a_ 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEYLHQHW--- 120 (299)
T ss_dssp HHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSS---------CCSSHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccC---------CCHHHHHHHHHHHHHHHHHhhccc---
Confidence 35789999999999999999999999999988777766554432 788899999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.+||+|||+++........ .....||+.|+|||++... .++.++||||+||++|+|++|.
T Consensus 121 iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~ 198 (299)
T d1ua2a_ 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198 (299)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred eecccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCc
Confidence 999999999999999999999999999766543222 2345689999999998754 5799999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCchh------hhhhhhccccCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSED------KVKQCVDTKLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
.||.+..+......+.......... ..............+ ...++.+.+|+.+||+.||++||||+|++
T Consensus 199 ~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 9997543321110000000000000 000000000000111 12345799999999999999999999998
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
+
T Consensus 279 ~ 279 (299)
T d1ua2a_ 279 K 279 (299)
T ss_dssp T
T ss_pred C
Confidence 7
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=277.17 Aligned_cols=189 Identities=19% Similarity=0.307 Sum_probs=154.5
Q ss_pred CCccc--CCccceeeEEEEeCCeeEEEEeecCC-CCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 2 VSRLK--NENVVELVGYYVDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 2 l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
|++++ ||||+++++++.+++..++|||++.+ +++.+++..... +++..+..++.|++.||+|||+++
T Consensus 61 l~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~- 130 (273)
T d1xwsa_ 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCG- 130 (273)
T ss_dssp HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 34555 89999999999999999999999976 588888876542 899999999999999999999999
Q ss_pred CCeEeccCCCCceEecCC-CceeecccCCCCCCcccccccccccccccccccCchhhccCCC-CcccchHHHHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELL 156 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~ 156 (243)
++||||||+||+++.+ +.++|+|||+++...... .....||+.|+|||++.+..+ +.++||||+||++|+|+
T Consensus 131 --iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell 204 (273)
T d1xwsa_ 131 --VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204 (273)
T ss_dssp --EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred --CccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHh
Confidence 9999999999999855 799999999987543321 234569999999999987765 56789999999999999
Q ss_pred hCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
+|..||..... +.... ...+...+.++.+++.+||+.||++|||++|+++
T Consensus 205 ~g~~Pf~~~~~---------------------i~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 205 CGDIPFEHDEE---------------------IIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HSSCSCCSHHH---------------------HHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCchH---------------------Hhhcc--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 99999964310 00111 0122234567999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=278.72 Aligned_cols=217 Identities=18% Similarity=0.251 Sum_probs=157.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.++..+++||||+.+ ++..++...... .+++..+..++.|++.||+|||+.|
T Consensus 54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~-------~l~e~~~~~~~~qil~~L~yLH~~~--- 122 (298)
T d1gz8a_ 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQGLAFCHSHR--- 122 (298)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhccc-------CCCHHHHHHHHHHHHHHHHHhhcCC---
Confidence 46899999999999999999999999999976 555555433322 2899999999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC-CCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.++++|||.++....... ......||+.|+|||++.... ++.++|+||+||++|+|++|.
T Consensus 123 IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~ 200 (298)
T d1gz8a_ 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200 (298)
T ss_dssp CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCC
Confidence 99999999999999999999999999865433221 123456899999999987665 478999999999999999999
Q ss_pred CCCCCCCCCCCccceeeccCcCch---hhhhhhhc--cc----cCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWATPKLSE---DKVKQCVD--TK----LGGE---YPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
.||....+......+......... .......+ .. .... .....++.+.+|+.+||+.||++|||+.|+
T Consensus 201 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el 280 (298)
T d1gz8a_ 201 ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280 (298)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999754322110000000000000 00000000 00 0000 011234578999999999999999999999
Q ss_pred HHH
Q 026115 228 LKA 230 (243)
Q Consensus 228 l~~ 230 (243)
++.
T Consensus 281 l~H 283 (298)
T d1gz8a_ 281 LAH 283 (298)
T ss_dssp HTS
T ss_pred hCC
Confidence 984
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=276.09 Aligned_cols=212 Identities=17% Similarity=0.218 Sum_probs=156.7
Q ss_pred cccCCccceeeEEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 4 RLKNENVVELVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 4 ~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
.++||||++++++|.. ...+++++|++.++++......... .+++..+..++.|++.||+|||+++
T Consensus 66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~yLH~~~- 136 (305)
T d1blxa_ 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSHR- 136 (305)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4589999999999863 3478999999988766555443332 2889999999999999999999999
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHHHHhC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 158 (243)
++||||||+||+++.++.++++|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|
T Consensus 137 --ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g 211 (305)
T d1blxa_ 137 --VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211 (305)
T ss_dssp --CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred --EEecCCCccEEEEcCCCCeeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHC
Confidence 99999999999999999999999999876554332 2445699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccceeec----------cCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWA----------TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
..||....+......+... .........................++.+.+|+.+||+.||++|||++|++
T Consensus 212 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 212 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 9999755322111000000 000000000000000000112223456789999999999999999999998
Q ss_pred H
Q 026115 229 K 229 (243)
Q Consensus 229 ~ 229 (243)
+
T Consensus 292 ~ 292 (305)
T d1blxa_ 292 S 292 (305)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.6e-43 Score=272.59 Aligned_cols=215 Identities=18% Similarity=0.242 Sum_probs=156.6
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+++..+++++++.++.+..+...... +++..+..++.|++.||+|||+.+
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~--- 120 (286)
T d1ob3a_ 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIAYCHDRR--- 120 (286)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCC---------cchhhhHHHHHHHHHHHHHhccCc---
Confidence 47899999999999999999999999999988666666554432 899999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.++++|||.+........ ......+++.|+|||.+.+. .++.++|+||+||+++||++|.
T Consensus 121 IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~ 198 (286)
T d1ob3a_ 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (286)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCC
Confidence 99999999999999999999999999865433221 12334588999999998765 4589999999999999999999
Q ss_pred CCCCCCCCCCCccceeec-----cCcCch-hh---h---hhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 026115 160 KPVDHTLPRGQQSLVTWA-----TPKLSE-DK---V---KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 227 (243)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~-----~~~~~~-~~---~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~v 227 (243)
.||.+..+......+... ...+.. .. . ................+..+.+++.+||+.||++|||++|+
T Consensus 199 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el 278 (286)
T d1ob3a_ 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278 (286)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999754322110000000 000000 00 0 00000000011222345679999999999999999999999
Q ss_pred HH
Q 026115 228 LK 229 (243)
Q Consensus 228 l~ 229 (243)
++
T Consensus 279 l~ 280 (286)
T d1ob3a_ 279 LE 280 (286)
T ss_dssp HT
T ss_pred hc
Confidence 85
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=272.89 Aligned_cols=224 Identities=20% Similarity=0.233 Sum_probs=156.2
Q ss_pred CCCcccCCccceeeEEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 1 MVSRLKNENVVELVGYYVD------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+|++++||||++++++|.. ..++++||||+.++.+..+....... ..+++..+..++.|++.||+|||
T Consensus 66 il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~------~~l~~~~~~~i~~qil~aL~yLH 139 (350)
T d1q5ka_ 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK------QTLPVIYVKLYMYQLFRSLAYIH 139 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhcc------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 3678999999999999853 34589999999775433332211100 12899999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCC-ceeecccCCCCCCcccccccccccccccccccCchhhcc-CCCCcccchHHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVL 152 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l 152 (243)
++| ++||||||+||+++.++ .+||+|||+++....... .....|++.|+|||.+.+ ..++.++||||+||++
T Consensus 140 ~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il 213 (350)
T d1q5ka_ 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213 (350)
T ss_dssp TTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred hcC---CcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEE
Confidence 998 99999999999999775 899999999876543321 234568999999998875 4689999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhcc------------ccCCCCCHHHHHHHHHHHHhhcCCCCCC
Q 026115 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT------------KLGGEYPPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|||++|..||...........+.........+........ ..........+..+.+|+.+||+.||++
T Consensus 214 ~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 293 (350)
T d1q5ka_ 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293 (350)
T ss_dssp HHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred EehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhH
Confidence 9999999999754322111000000000000000000000 0000111234557999999999999999
Q ss_pred CCCHHHHHH--HHHHHHh
Q 026115 221 RPNMGIVLK--ALQPLLN 236 (243)
Q Consensus 221 Rps~~~vl~--~l~~~~~ 236 (243)
||||+|+++ .++++..
T Consensus 294 R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 294 RLTPLEACAHSFFDELRD 311 (350)
T ss_dssp SCCHHHHHTSGGGGGGGC
T ss_pred CcCHHHHhcCHhhccccC
Confidence 999999997 4555543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=266.26 Aligned_cols=202 Identities=22% Similarity=0.269 Sum_probs=162.6
Q ss_pred CCcccC-CccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
|++++| |||+++++++.+....++++||+.+|+|.+++..... +....+..++.|++.|++|||+++
T Consensus 82 l~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~~--- 149 (322)
T d1vzoa_ 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG--- 149 (322)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcCC---
Confidence 567867 8999999999999999999999999999999987763 778899999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC--CCCcccchHHHHHHHHHHHhC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTG 158 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g 158 (243)
++||||||+||+++.++.++|+|||+++......... .....|++.|++||.+.+. .++.++|||||||++|+|++|
T Consensus 150 ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG 228 (322)
T d1vzoa_ 150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228 (322)
T ss_dssp CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred EEeccCCccceeecCCCCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhC
Confidence 9999999999999999999999999987665433222 2345689999999999754 457899999999999999999
Q ss_pred CCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 026115 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 229 (243)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~vl~ 229 (243)
..||......... ..+.+.. .......+...+.++.+++.+||+.||++|| |++|+++
T Consensus 229 ~~PF~~~~~~~~~------------~~i~~~~-~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 229 ASPFTVDGEKNSQ------------AEISRRI-LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCTTSCTTSCCCH------------HHHHHHH-HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCCCCCHHHHH------------HHHHHhc-ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 9999765332211 1111111 1112234455677899999999999999999 5889886
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=272.03 Aligned_cols=216 Identities=22% Similarity=0.276 Sum_probs=160.6
Q ss_pred CCCcccCCccceeeEEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 1 MVSRLKNENVVELVGYYVDGP------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+|++++|||||+++++|...+ .+++||||+ +.+|..+..... +++..+..++.|++.||+|||
T Consensus 70 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH 138 (346)
T d1cm8a_ 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIH 138 (346)
T ss_dssp HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHH
Confidence 367899999999999998654 579999999 668888876554 999999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLL 153 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~ 153 (243)
++| ++||||||+||+++.++.++++|||+++..... .....||+.|+|||++.+. .++.++||||+||+++
T Consensus 139 ~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 210 (346)
T d1cm8a_ 139 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210 (346)
T ss_dssp HTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred hCC---CcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHH
Confidence 999 999999999999999999999999999765433 2345689999999998764 4688999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCch--------h---hhhhhhcccc---CCCCCHHHHHHHHHHHHhhcCCCCC
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSE--------D---KVKQCVDTKL---GGEYPPKAIAKMAAVAALCVQYEAD 219 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~ 219 (243)
+|++|..||.+................... . .......... ........+..+.+|+.+||+.||+
T Consensus 211 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 290 (346)
T d1cm8a_ 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290 (346)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChh
Confidence 999999999765322111100000000000 0 0000000000 0011223455789999999999999
Q ss_pred CCCCHHHHHHH--HHHHH
Q 026115 220 FRPNMGIVLKA--LQPLL 235 (243)
Q Consensus 220 ~Rps~~~vl~~--l~~~~ 235 (243)
+|||++|+|+. ++++.
T Consensus 291 ~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 291 QRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TSCCHHHHHHSGGGTTTC
T ss_pred HCcCHHHHhcChhhCcCC
Confidence 99999999983 55443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-41 Score=265.80 Aligned_cols=217 Identities=18% Similarity=0.225 Sum_probs=153.1
Q ss_pred CCCcccCCccceeeEEEEe--------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHH
Q 026115 1 MVSRLKNENVVELVGYYVD--------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 72 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~ 72 (243)
+|++++||||+++++++.. +...+++||++.++.+..+...... ++...+..++.|++.|+.|
T Consensus 62 il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~---------~~~~~~~~i~~qil~~l~~ 132 (318)
T d3blha1 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---------FTLSEIKRVMQMLLNGLYY 132 (318)
T ss_dssp HHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCC---------CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccc---------cccHHHHHHHHHHHHHHHH
Confidence 3678999999999999854 4568999999988666555443332 8889999999999999999
Q ss_pred hhhcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccc--cccccccccccccCchhhccC-CCCcccchHHHH
Q 026115 73 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFG 149 (243)
Q Consensus 73 Lh~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG 149 (243)
||+++ ++||||||+||+++.++.++++|||+++........ .......||+.|+|||++.+. .++.++||||+|
T Consensus 133 lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlG 209 (318)
T d3blha1 133 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 209 (318)
T ss_dssp HHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHH
T ss_pred hccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCC
Confidence 99998 999999999999999999999999999755432221 112234689999999998765 578999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccceeeccC--------cCchhhhhhhhccccCCCCC-------HHHHHHHHHHHHhhc
Q 026115 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATP--------KLSEDKVKQCVDTKLGGEYP-------PKAIAKMAAVAALCV 214 (243)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l 214 (243)
|++++|++|..||.+..+......+..... .................... ......+.+|+.+||
T Consensus 210 vil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL 289 (318)
T d3blha1 210 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289 (318)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHS
T ss_pred ceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHC
Confidence 999999999999975432211111000000 00000011111111111111 111346788999999
Q ss_pred CCCCCCCCCHHHHHH
Q 026115 215 QYEADFRPNMGIVLK 229 (243)
Q Consensus 215 ~~~p~~Rps~~~vl~ 229 (243)
+.||++||||+|+++
T Consensus 290 ~~dP~~R~sa~elL~ 304 (318)
T d3blha1 290 VLDPAQRIDSDDALN 304 (318)
T ss_dssp CSSTTTSCCHHHHHH
T ss_pred cCChhHCcCHHHHHc
Confidence 999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-40 Score=260.48 Aligned_cols=212 Identities=19% Similarity=0.253 Sum_probs=158.0
Q ss_pred CCcccCCccc-eeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 2 VSRLKNENVV-ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 2 l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+++++|+|++ .+.+++.++...++||||+ ++++...+...... +++..+..++.|++.|++|||+++
T Consensus 56 ~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~--- 123 (299)
T d1ckia_ 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRK--------FSLKTVLLLADQMISRIEYIHSKN--- 123 (299)
T ss_dssp HHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCC--------CcHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4677776655 4555667888999999999 55777766554432 899999999999999999999999
Q ss_pred eEeccCCCCceEecC---CCceeecccCCCCCCcccccc-----cccccccccccccCchhhccCCCCcccchHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 152 (243)
Q Consensus 81 ~~h~di~~~nil~~~---~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 152 (243)
++||||||+||+++. +..++++|||+++........ .......||+.|+|||++.+..++.++|||||||++
T Consensus 124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203 (299)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHH
T ss_pred eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHH
Confidence 999999999999864 456999999999876543221 112345699999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG---EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
|||++|..||........... ........... .....++.++.+++..||+.||++||+++++.+
T Consensus 204 ~el~tg~~P~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~ 271 (299)
T d1ckia_ 204 MYFNLGSLPWQGLKAATKRQK------------YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271 (299)
T ss_dssp HHHHHSSCTTCCCC-------------------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHH
T ss_pred HHHHhCCCcccccchHHHHHH------------HHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999999999975433211111 00010100000 011234567999999999999999999999999
Q ss_pred HHHHHHhh
Q 026115 230 ALQPLLNT 237 (243)
Q Consensus 230 ~l~~~~~~ 237 (243)
.|+++..+
T Consensus 272 ~l~~~~~~ 279 (299)
T d1ckia_ 272 LFRNLFHR 279 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99887654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=269.94 Aligned_cols=216 Identities=23% Similarity=0.291 Sum_probs=156.4
Q ss_pred CCCcccCCccceeeEEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 1 MVSRLKNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+|++++||||+++++++.... .++++ +++.+|+|.+++.... +++..+..++.|++.||+|||+
T Consensus 59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~ 127 (345)
T d1pmea_ 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHS 127 (345)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 467899999999999997543 34554 5666899999997654 8999999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCccccccc-ccccccccccccCchhhc-cCCCCcccchHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLL 153 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~ 153 (243)
+| ++||||||+||+++.++.++|+|||+++......... ......|++.|+|||++. ...++.++||||+||+++
T Consensus 128 ~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ 204 (345)
T d1pmea_ 128 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 204 (345)
T ss_dssp TT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHH
T ss_pred CC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceeh
Confidence 98 9999999999999999999999999997654433221 223456899999999985 456688999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccceeeccCcCchh--------hhhh-hhccccCCCCC-----HHHHHHHHHHHHhhcCCCCC
Q 026115 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSED--------KVKQ-CVDTKLGGEYP-----PKAIAKMAAVAALCVQYEAD 219 (243)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~ 219 (243)
+|++|..||...................... .... ..........+ ...+.++.+|+.+||+.||+
T Consensus 205 eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 284 (345)
T d1pmea_ 205 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284 (345)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTT
T ss_pred HHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChh
Confidence 9999999997543221111100000000000 0000 00000000111 12234689999999999999
Q ss_pred CCCCHHHHHHH
Q 026115 220 FRPNMGIVLKA 230 (243)
Q Consensus 220 ~Rps~~~vl~~ 230 (243)
+|||++|+++.
T Consensus 285 ~R~ta~e~L~h 295 (345)
T d1pmea_ 285 KRIEVEQALAH 295 (345)
T ss_dssp TSCCHHHHHTS
T ss_pred HCcCHHHHhcC
Confidence 99999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.8e-40 Score=258.28 Aligned_cols=212 Identities=17% Similarity=0.201 Sum_probs=165.9
Q ss_pred CcccC-CccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 3 SRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 3 ~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
++++| +|++.+++++.++...++||||+ +++|.+++...... ++...+..++.|++.|++|||+.| +
T Consensus 55 ~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~--------~~~~~~~~i~~q~~~~l~~lH~~g---i 122 (293)
T d1csna_ 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRK--------FSVKTVAMAAKQMLARVQSIHEKS---L 122 (293)
T ss_dssp HHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccc--------hhhHHHHHHHHHHHHHHHHHHHCC---c
Confidence 45655 89999999999999999999999 67999998765432 889999999999999999999999 9
Q ss_pred EeccCCCCceEecC-----CCceeecccCCCCCCccccccc-----ccccccccccccCchhhccCCCCcccchHHHHHH
Q 026115 82 IHRNIKSSNVLLFD-----DDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 151 (243)
Q Consensus 82 ~h~di~~~nil~~~-----~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~ 151 (243)
+||||||+||+++. .+.++++|||+++......... ......||+.|+|||++.+..++.++|+||||++
T Consensus 123 iHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~ 202 (293)
T d1csna_ 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 202 (293)
T ss_dssp ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred eeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHH
Confidence 99999999999974 5679999999997664332211 1234569999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCccceeeccCcCchhhhhhhhccccC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 026115 152 LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 228 (243)
Q Consensus 152 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~vl 228 (243)
+|+|++|..||......... .....+...... ......+++++.+++..|++.+|++||+++.+.
T Consensus 203 l~elltg~~Pf~~~~~~~~~------------~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 203 FMYFLRGSLPWQGLKAATNK------------QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHHSSCTTSSCCSCCHH------------HHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HHHHHhCCCcCCCccchhHH------------HHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 99999999999754322111 111111111100 001112346799999999999999999999999
Q ss_pred HHHHHHHhhc
Q 026115 229 KALQPLLNTR 238 (243)
Q Consensus 229 ~~l~~~~~~~ 238 (243)
+.|++++...
T Consensus 271 ~~l~~~~~~~ 280 (293)
T d1csna_ 271 GLFSKVLERL 280 (293)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHc
Confidence 9999887654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-40 Score=257.66 Aligned_cols=215 Identities=17% Similarity=0.193 Sum_probs=160.7
Q ss_pred CCCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 026115 1 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 80 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~ 80 (243)
+|++++||||+++++++.+....+++++++.+++|..++..... ++...+..++.|++.||+|||+++
T Consensus 54 il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~---------~~~~~~~~~~~q~~~aL~~lH~~~--- 121 (292)
T d1unla_ 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD---------LDPEIVKSFLFQLLKGLGFCHSRN--- 121 (292)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccc---------cchhHHHHHHHHHHHHHHHhhcCC---
Confidence 36789999999999999999999999999999999888876543 888999999999999999999998
Q ss_pred eEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC-CCcccchHHHHHHHHHHHhCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGR 159 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~ 159 (243)
++||||||+||+++.++.++++|||.++........ .....++..|.|||.+.... ++.++||||+||++++|++|.
T Consensus 122 IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~ 199 (292)
T d1unla_ 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred EeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCC
Confidence 999999999999999999999999999766543322 23345678899999987655 588999999999999999999
Q ss_pred CCCCCCCCCCCc-cce-eeccC----cCc-hhhhh------hhhccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 026115 160 KPVDHTLPRGQQ-SLV-TWATP----KLS-EDKVK------QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGI 226 (243)
Q Consensus 160 ~pf~~~~~~~~~-~~~-~~~~~----~~~-~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 226 (243)
.||......... ..+ ..... .+. ..... ...............+..+.+|+.+||+.||.+||||+|
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e 279 (292)
T d1unla_ 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp CCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 997533221100 000 00000 000 00000 000001111223344567999999999999999999999
Q ss_pred HHH
Q 026115 227 VLK 229 (243)
Q Consensus 227 vl~ 229 (243)
+++
T Consensus 280 ~L~ 282 (292)
T d1unla_ 280 ALQ 282 (292)
T ss_dssp HTT
T ss_pred Hhc
Confidence 987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.5e-40 Score=260.52 Aligned_cols=210 Identities=15% Similarity=0.216 Sum_probs=154.0
Q ss_pred CCccc-CCccceeeEEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCC
Q 026115 2 VSRLK-NENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 78 (243)
Q Consensus 2 l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~ 78 (243)
|++++ ||||++++++|.. ...+++||||+.+++|..+.. .+++..+..++.|++.||.|||++|
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH~~g- 149 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMG- 149 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhhcc-
Confidence 56675 9999999999984 456999999999999877642 1889999999999999999999999
Q ss_pred CCeEeccCCCCceEecCCC-ceeecccCCCCCCcccccccccccccccccccCchhhccC-CCCcccchHHHHHHHHHHH
Q 026115 79 PRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELL 156 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~ 156 (243)
++||||||+||+++.++ .++++|||+++....... .....+|+.|+|||.+.+. .++.++||||+||++++++
T Consensus 150 --IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~ 224 (328)
T d3bqca1 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224 (328)
T ss_dssp --EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred --cccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhc
Confidence 99999999999998654 689999999876543322 2345689999999998865 4689999999999999999
Q ss_pred hCCCCCCCCCCCCCcc-ceeec------------cCcCchhhhhhh--------hccccCCCCCHHHHHHHHHHHHhhcC
Q 026115 157 TGRKPVDHTLPRGQQS-LVTWA------------TPKLSEDKVKQC--------VDTKLGGEYPPKAIAKMAAVAALCVQ 215 (243)
Q Consensus 157 ~g~~pf~~~~~~~~~~-~~~~~------------~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~ 215 (243)
+|..||.......... .+... ............ .............+.++.+||.+||+
T Consensus 225 ~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~ 304 (328)
T d3bqca1 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304 (328)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSC
T ss_pred cCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHcc
Confidence 9999997543221100 00000 000000000000 00011111223345679999999999
Q ss_pred CCCCCCCCHHHHHH
Q 026115 216 YEADFRPNMGIVLK 229 (243)
Q Consensus 216 ~~p~~Rps~~~vl~ 229 (243)
.||++|||++|+|+
T Consensus 305 ~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 305 YDHQSRLTAREAME 318 (328)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=263.07 Aligned_cols=211 Identities=19% Similarity=0.200 Sum_probs=149.7
Q ss_pred CCCcccCCccceeeEEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhh
Q 026115 1 MVSRLKNENVVELVGYYVD------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 74 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh 74 (243)
+|++++||||++++++|.. ...+++||||+.++ +.+.+... +++..+..++.|++.|+.|||
T Consensus 69 il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~~~-----------~~~~~i~~~~~qil~gl~~LH 136 (355)
T d2b1pa1 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQME-----------LDHERMSYLLYQMLCGIKHLH 136 (355)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhhhcC-----------CCHHHHHHHHHHHHHHHHHhh
Confidence 3578999999999999963 46899999999765 44444321 889999999999999999999
Q ss_pred hcCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHH
Q 026115 75 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 75 ~~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 154 (243)
++| ++||||||+||+++.++.++++|||+++....... .....+|+.|+|||++.+..++.++||||+||++++
T Consensus 137 ~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~e 210 (355)
T d2b1pa1 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_dssp HTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred hcc---cccccCCccccccccccceeeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHH
Confidence 999 99999999999999999999999999876554322 234568999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceee--------ccCc--------------Cchhhhhhhhcccc---CCCCCHHHHHHHHHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTW--------ATPK--------------LSEDKVKQCVDTKL---GGEYPPKAIAKMAAV 209 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~--------~~~~--------------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l 209 (243)
|++|..||.+.........+.. .... .............. ........+..+.+|
T Consensus 211 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 290 (355)
T d2b1pa1 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHH
Confidence 9999999975532211100000 0000 00000000000000 011223457789999
Q ss_pred HHhhcCCCCCCCCCHHHHHH
Q 026115 210 AALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 210 i~~~l~~~p~~Rps~~~vl~ 229 (243)
+.+||+.||++||||+|+|+
T Consensus 291 l~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 291 LSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999996
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=255.40 Aligned_cols=216 Identities=25% Similarity=0.314 Sum_probs=154.4
Q ss_pred CCCcccCCccceeeEEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh
Q 026115 1 MVSRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 75 (243)
Q Consensus 1 ~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~ 75 (243)
+|++++||||+++++++... ...+++++++.+|+|.+++.... +++..+..++.|++.||+|||+
T Consensus 70 il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~----------l~e~~~~~i~~qil~aL~~LH~ 139 (348)
T d2gfsa1 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHS 139 (348)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccccc----------ccHHHHHHHHHHHHHHHHHHHh
Confidence 36789999999999999633 33456667788999999996543 9999999999999999999999
Q ss_pred cCCCCeEeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCchhhccCC-CCcccchHHHHHHHHH
Q 026115 76 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLE 154 (243)
Q Consensus 76 ~~~~~~~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~ 154 (243)
+| ++||||||+||+++.++.++++|||.+...... .....|++.|+|||...+.. ++.++||||+||++|+
T Consensus 140 ~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ 211 (348)
T d2gfsa1 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211 (348)
T ss_dssp TT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHH
T ss_pred CC---CcccccCCccccccccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHH
Confidence 99 999999999999999999999999998765433 23356889999999877654 5889999999999999
Q ss_pred HHhCCCCCCCCCCCCCccceeeccCc--------CchhhhhhhhccccC-CCC-----CHHHHHHHHHHHHhhcCCCCCC
Q 026115 155 LLTGRKPVDHTLPRGQQSLVTWATPK--------LSEDKVKQCVDTKLG-GEY-----PPKAIAKMAAVAALCVQYEADF 220 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~li~~~l~~~p~~ 220 (243)
|++|..||.+.........+...... ............... ... ....+..+.+||.+||+.||.+
T Consensus 212 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 291 (348)
T d2gfsa1 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291 (348)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhh
Confidence 99999999755322111111000000 000000000000000 000 1123457899999999999999
Q ss_pred CCCHHHHHH--HHHHH
Q 026115 221 RPNMGIVLK--ALQPL 234 (243)
Q Consensus 221 Rps~~~vl~--~l~~~ 234 (243)
||||+|+++ .+++.
T Consensus 292 R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 292 RITAAQALAHAYFAQY 307 (348)
T ss_dssp SCCHHHHHTSGGGTTT
T ss_pred CcCHHHHhcCHhhCCC
Confidence 999999998 44443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-32 Score=221.67 Aligned_cols=208 Identities=17% Similarity=0.206 Sum_probs=145.5
Q ss_pred ccCCccceeeEEEEe--CCeeEEEEeecCCC-CHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhh-cCCCC
Q 026115 5 LKNENVVELVGYYVD--GPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPR 80 (243)
Q Consensus 5 l~h~niv~~~~~~~~--~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~-~~~~~ 80 (243)
+.|+||+++++++.. ....++++.+...+ +........... .+++..+..++.|++.|+.|||+ .|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~i~~i~~qil~al~~lh~~~~--- 146 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRCG--- 146 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---
T ss_pred cCcCceEEEEEEeeeccccceeeeeeeccccccccccccccccc-------CCcHHHHHHHHHHHHHHHHHHhhhcC---
Confidence 457999999998864 45666666665444 333333333222 28889999999999999999997 77
Q ss_pred eEeccCCCCceEecCCC------ceeecccCCCCCCcccccccccccccccccccCchhhccCCCCcccchHHHHHHHHH
Q 026115 81 IIHRNIKSSNVLLFDDD------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 154 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 154 (243)
++||||||+||+++.++ .++++|||.+...... .....||+.|+|||++.+..++.++|+||+||++++
T Consensus 147 IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 221 (362)
T d1q8ya_ 147 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 221 (362)
T ss_dssp EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHH
T ss_pred cccccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHH
Confidence 99999999999997654 3899999998654332 234568999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcccee------eccCcCchh---------------------------hhhhhhccccCCCCCHH
Q 026115 155 LLTGRKPVDHTLPRGQQSLVT------WATPKLSED---------------------------KVKQCVDTKLGGEYPPK 201 (243)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~------~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~ 201 (243)
|++|..||............. ......... ....... ........
T Consensus 222 l~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 299 (362)
T d1q8ya_ 222 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKD 299 (362)
T ss_dssp HHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHH
T ss_pred HHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc--cccccCcc
Confidence 999999997543221110000 000000000 0000000 12234567
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 026115 202 AIAKMAAVAALCVQYEADFRPNMGIVLK 229 (243)
Q Consensus 202 ~~~~~~~li~~~l~~~p~~Rps~~~vl~ 229 (243)
.+..+.+|+.+||+.||.+||||+|+|+
T Consensus 300 ~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 300 EAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 7889999999999999999999999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.59 E-value=1.3e-16 Score=116.02 Aligned_cols=117 Identities=14% Similarity=0.119 Sum_probs=80.9
Q ss_pred CCcccCCccceeeEEEEeCCeeEEEEeecCCCCHHHHhccCCCCCCCCCCCccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 026115 2 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 81 (243)
Q Consensus 2 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~Lh~~~~~~~ 81 (243)
+.++.|++++..+++. ..+++||++++..+.. ++...+..++.|++.++++||+.| +
T Consensus 68 l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~g---i 124 (191)
T d1zara2 68 LQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHRG---I 124 (191)
T ss_dssp HHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHccCCCcceEEEec----CCEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhCC---E
Confidence 3567889998877653 2368999998765432 222334578899999999999999 9
Q ss_pred EeccCCCCceEecCCCceeecccCCCCCCcccccccccccccccccccCch-----hhccCCCCcccchHHHHHHH
Q 026115 82 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-----YAMTGQMSSKSDVYSFGVVL 152 (243)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE-----~~~~~~~~~~~DiwslG~~l 152 (243)
+||||||+||+++++ .++++|||.+......... .|.... ......|+..+|+||+.--+
T Consensus 125 iHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 125 VHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEccCChhheeeeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999999999999865 4889999988654322111 111110 01124567788999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.46 E-value=0.00022 Score=52.61 Aligned_cols=28 Identities=21% Similarity=0.394 Sum_probs=24.3
Q ss_pred eEeccCCCCceEecCCCceeecccCCCC
Q 026115 81 IIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 81 ~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
++|+|+.+.||+++.++.+-++||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEeeccCcceeecCCceEEEeechhcc
Confidence 7899999999999877667799998654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.17 E-value=0.0029 Score=45.99 Aligned_cols=29 Identities=10% Similarity=0.143 Sum_probs=24.6
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
.++|+|+.+.||+++.+..+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999887667899998653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.91 E-value=0.022 Score=44.30 Aligned_cols=30 Identities=13% Similarity=0.383 Sum_probs=25.1
Q ss_pred CeEeccCCCCceEecCCCceeecccCCCCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 110 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~~~~ 110 (243)
.++|+|+.+.||+++.++ ++++|+..+...
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 499999999999998765 799999876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.84 E-value=0.025 Score=42.37 Aligned_cols=28 Identities=25% Similarity=0.600 Sum_probs=25.1
Q ss_pred CeEeccCCCCceEecCCCceeecccCCC
Q 026115 80 RIIHRNIKSSNVLLFDDDIAKISDFDLS 107 (243)
Q Consensus 80 ~~~h~di~~~nil~~~~~~~~l~df~~~ 107 (243)
+++|+|+.++|++++.+...-++||+.+
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred ccccCCcchhhhhcccccceeEeccccc
Confidence 3999999999999998877789999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=89.01 E-value=0.29 Score=36.52 Aligned_cols=28 Identities=21% Similarity=0.289 Sum_probs=22.3
Q ss_pred CCeEeccCCCCceEecCCCceeecccCCCC
Q 026115 79 PRIIHRNIKSSNVLLFDDDIAKISDFDLSN 108 (243)
Q Consensus 79 ~~~~h~di~~~nil~~~~~~~~l~df~~~~ 108 (243)
..++|+|+.+.||+++. + ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 34899999999999974 3 4578998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=84.63 E-value=0.19 Score=38.67 Aligned_cols=15 Identities=27% Similarity=0.554 Sum_probs=13.2
Q ss_pred eEeccCCCCceEecC
Q 026115 81 IIHRNIKSSNVLLFD 95 (243)
Q Consensus 81 ~~h~di~~~nil~~~ 95 (243)
++|+|+.+.||++..
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 689999999999854
|